The U.S.A. Container Spy
Select what you are looking for, enter your search-term, and enable the years you want to scan.
Who are the manufacturers of GLENMARK PHARMACEUTICALS INC US?
Let's check GLENMARK PHARMACEUTICALS INC US's supplier list!
glenmark pharmaceuticals inc us is a , and company. This page shows the major manufacturers of GLENMARK PHARMACEUTICALS INC US. Results are limited to 15 suppliers, if you want to see more suppliers visit the manufacturers page of GLENMARK PHARMACEUTICALS INC US.
address of glenmark pharmaceuticals inc us:
301 island rd new jersey mahwah
Select years of GLENMARK PHARMACEUTICALS INC US data:
Supplier list of GLENMARK PHARMACEUTICALS INC US
glenmark pharmaceuticals inc us imports
most of their products from:
- 1. INDIA
- 1
GLENMARK PHA…
- 14 trades
-
PHARMACEUTICALS, PHARMA, PHARMACEUTICAL
2024-09-15 |
45 PKG |
10732.63KG |
45 PALLETS 2141 CARTONS PH ARMACEUTICALS AS UNDER OLME SARTAN MEDOX TAB 20MG 30 NDC CODE:68462043730 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO .: 3004.90.9220 ANDA NO.: 20 3281 THERAPEUTICE USE: - -TR EATMENT OF HYPERTENSION, ALON E OR WITH OTHER ANTIHYPERTEN SIVE AGENTS, TO LOWER BLOOD P RESSURE GABAPENTIN TAB 600M G 500 NDC CODE:68462012605 F DA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE US E:-ANTICONVULSANT CICLOPIRO X OLAMINE CREAM 0.77% 90GM ND C CODE:68462029792 FDA PRODUC T CODE NO.:-61 W C J 03 H. T . S NO.: 3004.40.49.50 ANDA NO.:- 90 - 273 THERAPEUTICE USE:-ANTIFUNGAL USE. MUPIRO CIN OINT 2% 22GM NDC CODE:684 62018022 FDA PRODUCT CODE NO. : 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-48 0 THERAPEUTICE USE: - ANTI-B ACTERIAL COMMERCIAL & CUSTO M INVOICE NO. F22552001860 DT . 18.07.2024 F22552001861 DT. 18.07.2024 F22552001862 DT. 18.07.2024 F22552001859 DT. 1 8.07.2024 S/BILL NO: 2533039 DT 19-JUL-2024 S/BILL NO: 253 3035 DT 19-JUL-2024 S/BILL NO : 2533038 DT 19-JUL-2024 S/BI LL NO: 2533037 DT 19-JUL-2024 NET WT. 8859.238 KGS 02 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 300490 |
2024-09-15 |
43 PKG |
11037.45KG |
43 PALLETS 2397 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 300MG 100 NDC C ODE:68462013801 FDA PRODUCT C ODE NO.:-61 M C A 45 HTS NO. 3004.90.9236 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONV ULSANT AGENT OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:684620 39610 FDA PRODUCT CODE NO.:6 2KCF10 HTS NO.3004.90.9255 A NDA NO.:91672 THERAPEUTICE US E: -TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE GABAPENTIN TAB 800MG 500 NDC CODE:68462012705 FDA PRODUCT CODE:NO : 61 N C A 69 HTS N O.3004.90.9236 ANDA NO.:-77-6 62 THERAPEUTICE USE:-ANTICON VULSANT CICLOPIROX GEL 0.77 % 100GM NDC CODE:68462045594 FDA PRODUCT CODE NO.: 61WCJ4 3 H. T. S NO.: 3004.49.00.50 ANDA NO.: 091595 THERAPEUTI CE USE: - ANTIFUNGAL CLIND AMYCIN PHOS GEL 1% 30GM NDC C ODE:68462086635 FDA PRODUCT C ODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO. :214251 THERAPEUTICE USE: CL INDAMYCIN PHOSPHATE GEL IS IN DICATED IN THE TREATMENT OF A CNE VULGARIS CLINDAMYCIN P HOS GEL 1% 60GM NDC CODE:6846 2086665 FDA PRODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3 004.49.00.50 ANDA NO.:214251 THERAPEUTICE USE: CLINDAMYCI N PHOSPHATE GEL IS INDICATED IN THE TREATMENT OF ACNE VUL GARIS COMMERCIAL & CUSTOM INVOICE NO. F22552001834 DT. 17.07.2024 F22552001835 DT. 17.07.2024 F22552001837 DT. 1 7.07.2024 F22552001838 DT. 17 .07.2024 F22552001839 DT. 17. 07.2024 S/BILL NO: 2510601 DT 18-JUL-2024 S/BILL NO: 25106 08 DT 18-JUL-2024 S/BILL NO: 2510632 DT 18-JUL-2024 S/BILL NO: 2510603 DT 18-JUL-2024 S /BILL NO: 2510628 DT 18-JUL-20 24 NET WT. 9486.640 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2024-09-15 |
32 PKG |
8078.16KG |
32 PALLETS 2440 CARTONS PH ARMACEUTICALS AS UNDER FLUC ONAZOLE TAB 200MG 30 NDC CODE :68462010430 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO .: 3004.90.92.45 ANDA NO.:-7 7 - 253 THERAPEUTICE USE:-AN TIFUNGAL OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO .:91672 THERAPEUTICE USE: -T REATMENT OF TREAT GASTROESOPH AGEAL REFLUX DISEASE CICLO PIROX OLAMINE CREAM 0.77% 30GM NDC CODE:68462029735 FDA PR ODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 A NDA NO.:- 90 - 273 THERAPEUTI CE USE:-ANTIFUNGAL USE. OM EPRAZOLE DR CAP 40MG 90 NDC C ODE:68462039790 FDA PRODUCT C ODE NO.:62KCF10 HTS NO.3004. 90.9255 ANDA NO.:91672 THERA PEUTICE USE: -TREATMENT OF TR EAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22552001798 DT. 15.07.2024 F22552001799 DT. 15.07.2024 F22552001803 DT. 1 5.07.2024 S/BILL NO: 2433485 DT: 15.07.2024 S/BILL NO: 243 3490 DT: 15.07.2024 S/BILL NO : 2439823DT: 15.07.2024 NET W T. 6454.948 KGS 02 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2024-09-15 |
12 PKG |
2950.21KG |
12 PALLETS 1623 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 10MG 90 NDC CODE :68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE N O. F22552001797 DT. 15.07.202 4 S/BILL NO: 2433489 DT.15.07 .2024 NET WT. 2,266.77 KGS 1 2 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE D U PORT 2 NEUCHATEL - 2000 SW ITZERLAND |
HS 684620 |
2024-08-27 |
45 PKG |
10732.63KG |
45 PALLETS 2141 CARTONS PH ARMACEUTICALS AS UNDER OLME SARTAN MEDOX TAB 20MG 30 NDC CODE:68462043730 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO .: 3004.90.9220 ANDA NO.: 20 3281 THERAPEUTICE USE: - -TR EATMENT OF HYPERTENSION, ALON E OR WITH OTHER ANTIHYPERTEN SIVE AGENTS, TO LOWER BLOOD P RESSURE GABAPENTIN TAB 600M G 500 NDC CODE:68462012605 F DA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE US E:-ANTICONVULSANT CICLOPIRO X OLAMINE CREAM 0.77% 90GM ND C CODE:68462029792 FDA PRODUC T CODE NO.:-61 W C J 03 H. T . S NO.: 3004.40.49.50 ANDA NO.:- 90 - 273 THERAPEUTICE USE:-ANTIFUNGAL USE. MUPIRO CIN OINT 2% 22GM NDC CODE:684 62018022 FDA PRODUCT CODE NO. : 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-48 0 THERAPEUTICE USE: - ANTI-B ACTERIAL COMMERCIAL & CUSTO M INVOICE NO. F22552001860 DT . 18.07.2024 F22552001861 DT. 18.07.2024 F22552001862 DT. 18.07.2024 F22552001859 DT. 1 8.07.2024 S/BILL NO: 2533039 DT 19-JUL-2024 S/BILL NO: 253 3035 DT 19-JUL-2024 S/BILL NO : 2533038 DT 19-JUL-2024 S/BI LL NO: 2533037 DT 19-JUL-2024 NET WT. 8859.238 KGS 02 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 300490 |
2024-08-27 |
43 PKG |
11037.45KG |
43 PALLETS 2397 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 300MG 100 NDC C ODE:68462013801 FDA PRODUCT C ODE NO.:-61 M C A 45 HTS NO. 3004.90.9236 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONV ULSANT AGENT OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:684620 39610 FDA PRODUCT CODE NO.:6 2KCF10 HTS NO.3004.90.9255 A NDA NO.:91672 THERAPEUTICE US E: -TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE GABAPENTIN TAB 800MG 500 NDC CODE:68462012705 FDA PRODUCT CODE:NO : 61 N C A 69 HTS N O.3004.90.9236 ANDA NO.:-77-6 62 THERAPEUTICE USE:-ANTICON VULSANT CICLOPIROX GEL 0.77 % 100GM NDC CODE:68462045594 FDA PRODUCT CODE NO.: 61WCJ4 3 H. T. S NO.: 3004.49.00.50 ANDA NO.: 091595 THERAPEUTI CE USE: - ANTIFUNGAL CLIND AMYCIN PHOS GEL 1% 30GM NDC C ODE:68462086635 FDA PRODUCT C ODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO. :214251 THERAPEUTICE USE: CL INDAMYCIN PHOSPHATE GEL IS IN DICATED IN THE TREATMENT OF A CNE VULGARIS CLINDAMYCIN P HOS GEL 1% 60GM NDC CODE:6846 2086665 FDA PRODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3 004.49.00.50 ANDA NO.:214251 THERAPEUTICE USE: CLINDAMYCI N PHOSPHATE GEL IS INDICATED IN THE TREATMENT OF ACNE VUL GARIS COMMERCIAL & CUSTOM INVOICE NO. F22552001834 DT. 17.07.2024 F22552001835 DT. 17.07.2024 F22552001837 DT. 1 7.07.2024 F22552001838 DT. 17 .07.2024 F22552001839 DT. 17. 07.2024 S/BILL NO: 2510601 DT 18-JUL-2024 S/BILL NO: 25106 08 DT 18-JUL-2024 S/BILL NO: 2510632 DT 18-JUL-2024 S/BILL NO: 2510603 DT 18-JUL-2024 S /BILL NO: 2510628 DT 18-JUL-20 24 NET WT. 9486.640 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2024-08-27 |
32 PKG |
8078.16KG |
32 PALLETS 2440 CARTONS PH ARMACEUTICALS AS UNDER FLUC ONAZOLE TAB 200MG 30 NDC CODE :68462010430 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO .: 3004.90.92.45 ANDA NO.:-7 7 - 253 THERAPEUTICE USE:-AN TIFUNGAL OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO .:91672 THERAPEUTICE USE: -T REATMENT OF TREAT GASTROESOPH AGEAL REFLUX DISEASE CICLO PIROX OLAMINE CREAM 0.77% 30GM NDC CODE:68462029735 FDA PR ODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 A NDA NO.:- 90 - 273 THERAPEUTI CE USE:-ANTIFUNGAL USE. OM EPRAZOLE DR CAP 40MG 90 NDC C ODE:68462039790 FDA PRODUCT C ODE NO.:62KCF10 HTS NO.3004. 90.9255 ANDA NO.:91672 THERA PEUTICE USE: -TREATMENT OF TR EAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22552001798 DT. 15.07.2024 F22552001799 DT. 15.07.2024 F22552001803 DT. 1 5.07.2024 S/BILL NO: 2433485 DT: 15.07.2024 S/BILL NO: 243 3490 DT: 15.07.2024 S/BILL NO : 2439823DT: 15.07.2024 NET W T. 6454.948 KGS 02 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2024-08-27 |
12 PKG |
2950.21KG |
12 PALLETS 1623 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 10MG 90 NDC CODE :68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE N O. F22552001797 DT. 15.07.202 4 S/BILL NO: 2433489 DT.15.07 .2024 NET WT. 2,266.77 KGS 1 2 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE D U PORT 2 NEUCHATEL - 2000 SW ITZERLAND |
HS 684620 |
2024-08-06 |
42 PKG |
11241.57KG |
42 PALLETS 2469 CARTONS PH ARMACEUTICALS AS UNDER HAIL EY 1.5/30 TAB 1.5MG/30MCG 63 NDC CODE:68462050481 FDA PROD UCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 AND A NO.: 209297 THERAPEUTICE US E: - CONTRACEPTION TO PREVENT PREGNANCY MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 90-480 THERAP EUTICE USE: - ANTI-BACTERIAL TELMISARTAN TAB 40MG 90 ND C CODE:68462020090 FDA PRODUC T CODE NO :62 O C A 09 HTS N O : 3004.90.92.20 ANDA NO.900 32 THERAPEUTICE USE:-INDICAT ED FOR THE TREATMENT OF HYPE RTENSION, TO LOWER BLOOD PRES SURE ATOMOXETINE CAP 100MG 30 NDC CODE:68462027130 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.: 3004.90.92.90 A NDA NO.: 079019 TREATMENT OF ATTENTION - DEFICIT/HYPERACIV ITY DISORDER (ADHD OLMESAR TAN MEDOX TAB 40MG 30 NDC COD E:68462043830 FDA PRODUCT COD E NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 20328 1 THERAPEUTICE USE: - -TREAT MENT OF HYPERTENSION, ALONE O R WITH OTHER ANTIHYPERTENSIV E AGENTS, TO LOWER BLOOD PRES SURE ONDANSETRON TAB 8MG 30 NDC CODE:68462010630 FDA PR ODUCT CODE NO.:-61 T C A 28 H . T. S NO.: 3004.90.92.40 AN DA NO.:- 77-535 THERAPEUTICE USE:-ANTI -EMETIC COMMERCI AL & CUSTOM INVOICE NO. F2255 2001348 DT. 22.06.2024 F22552 001364 DT. 22.06.2024 F225520 01368 DT. 22.06.2024 S/BILL N O:1895429 DT 24-JUN-2024 S/BI LL NO:1895438 DT 24-JUN-2024 S/BILL NO:1895413 DT 24-JUN-20 24 NET WT. 8998.630 KGS 19 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPECI ALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 300490 |
2024-08-06 |
49 PKG |
12737.09KG |
49 PALLETS 2924 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT COD E:NO : 61 N C A 69 HTS NO.300 4.90.9236 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULSA NT -EMETIC TOPIRAMATE TAB 50MG 60 NDC CODE:68462015360 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.0 0.20 ANDA NO.:- 77-627 THERA PEUTICE USE:-ANTICONVULSANT OLMESARTAN MEDOX TAB 20MG 30 NDC CODE:68462043730 FDA PR ODUCT CODE NO.: 62CCA68 H. T . S NO.: 3004.90.9220 ANDA N O.: 203281 THERAPEUTICE USE: - TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYP ERTENSIVE AGENTS, TO LOWER BL OOD PRESSURE CARVEDILOL TAB 3.125MG 100 NDC CODE:6846201 6201 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR A NTAGONIST NAPROXEN TAB 250M G 100 NDC CODE:68462018801 F DA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-250 THERAPEU TICE USE:-ANTI-INFLAMMATORY, ANALGESIC ROSUVASTATIN TAB 20MG 1000 NDC CODE:684620263 10 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.4 9.00.10 ANDA NO.: 79172 THER APEUTICE USE: TO TREAT HIGH C HOLESTEROL AND RELATED CONDIT IONS, AND TO PREVENT CARDIOVA SCULAR DISEASE CALCIPOTRIE NE CREAM 0.005% 120GM NDC COD E:68462050166 FDA PRODUCT COD E NO.: 62 N C J 04 H. T. S N O.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTICE USE: - T REATMENT OF PLAQUE PSORIASIS IN ADULTS MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 F DA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 90-480 THERAPEU TICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE N O. F22552001470 DT. 27.06.202 4 F22552001471 DT. 27.06.2024 F22552001472 DT. 27.06.2024 F22552001473 DT. 27.06.2024 F22552001475 DT. 27.06.2024 F 22552001481 DT. 28.06.2024 F2 2552001482 DT. 28.06.2024 S/B ILL NO: 2033104 DT. 28-JUN-24 S/BILL NO: 2030303 DT. 28-JUN -24 S/BILL NO: 2019911 DT. 28 -JUN-24 S/BILL NO: 2021913 DT . 28-JUN-24 S/BILL NO: 202602 0 DT. 28-JUN-24 S/BILL NO: 20 19909 DT. 28-JUN-24 S/BILL NO : 2025997 DT. 28-JUN-24 NET W T. 10891.464 KGS 06 DATA LOG GERS NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA NOTIFY PAR TY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWIT ZERLAND |
HS 300490 |
2024-08-01 |
45 PKG |
8808.91KG |
45 PALLETS 2804 CARTONS PH ARMACEUTICALS AS UNDER HAIL EY FE 1.5/30 TAB 1.5MG/30MCG-7 5MG 84 NDC CODE:68462050329 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00 .00 ANDA NO.:206597 THERAPEU TICE USE: HORMONE MEDICATION IS USED TO PREVENT PREGNANCY DROSPIRENONE/EE TAB 3/0.03 MG 84 NDC CODE:68462073329 F DA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00. 00 ANDA NO.: 204848 THERAPEU TICE USE: - CONTRACEPTION TO PREVENT PREGNANCY ATOMOXET INE CAP 18MG 30 NDC CODE:6846 2026630 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.: 300 4.90.92.90 ANDA NO.: 079019 THERAPEUTICE USE : - ATOMOXET INE IS USED TO TREAT ATTENTIO N-DEFICIT HYPERACTIVITY DISOR DER (ADHD) AS PART OF A TOTAL TREATMENT PLAN, INCLUDING P SYCHOLOGICAL, SOCIAL, AND OTH ER TREATMENTS ZONISAMIDE CA P 100MG 100 NDC CODE:68462013 001 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004. 49.00.20 ANDA NO.:-77-651 TH ERAPEUTICE USE:-ANTISEIZURE D RUG ZONISAMIDE CAP 100MG 50 0 NDC CODE:68462013005 FDA P RODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77-651 THERAPEUTICE USE:-ANTISEIZURE DRUG CAR VEDILOL TAB 6.25MG 500 NDC CO DE:68462016305 FDA PRODUCT CO DE NO :62 O C A 22 HTS NO.30 04.90.9221 ANDA NO.78-251 TH ERAPEUTICE USE:-BETA- ADRENO ACEPTOR ANTAGONIST CICLOPI ROX OLAMINE CREAM 0.77% 90GM NDC CODE:68462029792 FDA PROD UCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 AND A NO.:- 90 - 273 THERAPEUTICE USE:-ANTIFUNGAL USE. CLOT RIMAZOLE CREAM 1% 15GM NDC CO DE:68462018117 FDA PRODUCT CO DE NO :61 W C J 04 HTS NO.30 04.90.9240 ANDA NO.90-219 TH ERAPEUTICE USE:-TREATMENT OF CANDIDIASIS ZONISAMIDE CAP 100MG 100 NDC CODE:684620130 01 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.4 9.00.20 ANDA NO.:-77-651 THE RAPEUTICE USE:-ANTISEIZURE DR UG OXCARBAZEPINE TAB 600MG 100 NDC CODE:68462013901 FDA PRODUCT CODE NO.:-61 M C A 4 5 HTS NO.3004.90.9236 ANDA N O.:-77-802 THERAPEUTICE USE:- ANTI CONVULSANT AGENT COMM ERCIAL & CUSTOM INVOICE NO. F 22552001304 DT. 20.06.2024 F2 2552001303 DT. 20.06.2024 F22 552001305 DT. 20.06.2024 F225 52001307 DT. 20.06.2024 F2255 2001306 DT. 20.06.2024 F22552 001313 DT. 20.06.2024 S/BILL NO: 1823108 DT 20-JUN-2024 S/ BILL NO: 1823113 DT 20-JUN-202 4 S/BILL NO: 1823111 DT 20-JU N-2024 S/BILL NO: 1823115 DT 20-JUN-2024 S/BILL NO: 182397 0 DT 20-JUN-2024 S/BILL NO: 1 825578 DT 20-JUN-2024 NET WT. 7002.205 KGS 15 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA NOTIFY PARTY :3 GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE DU PO RT 2 NEUCHATEL - 2000 SWITZE RLAND |
HS 300490 |
2024-08-01 |
41 PKG |
9408.12KG |
41 PALLETS 3129 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 12.5MG 100 NDC COD E:68462016401 FDA PRODUCT COD E NO :62 O C A 22 HTS NO.300 4.90.9221 ANDA NO.78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST TELMISAR TAN-HCTZ TAB 80MG/25MG 30UD N DC CODE:68462084213 62 O D A 09 3004.90.92.20 202544 TEL MISARTAN AND HYDROCHLOROTHIAZ IDE TABLETS ARE INDICATED FOR THE TREATMENT OF HYPERTENS ION, TO LOWER BLOOD PRESSURE. TOPIRAMATE ER CAP (Q) 200M G 30 NDC CODE:68462037130 30 04.49.00.20 61 M C B 40 2102 78 COLESEVELAM HCL TAB 625M G 180 NDC CODE:68462043318 F DA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00. 10 ANDA NO.: 203480 THERAPEU TICE USE: - ANTIHYPERLIPO PR OTEINEMIC. TELMISARTAN-HCTZ TAB 80MG/12.5MG 30UD NDC COD E:68462084113 62 O D A 09 30 04.90.92.20 202544 TELMISART AN AND HYDROCHLOROTHIAZIDE T ABLETS ARE INDICATED FOR THE TREATMENT OF HYPERTENSION, T O LOWER BLOOD PRESSURE. CA RVEDILOL TAB 12.5MG 500 NDC C ODE:68462016405 FDA PRODUCT C ODE NO :62 O C A 22 HTS NO.3 004.90.9221 ANDA NO.78-251 T HERAPEUTICE USE:-BETA- ADREN OACEPTOR ANTAGONIST SEVELA MER HCL TAB 800MG 180 NDC COD E:68462044718 FDA PRODUCT COD E NO.: 63 L D A 04 H. T. S N O.: 3004.90.92.60 ANDA NO.:2 04724 THERAPEUTICE USE:SEVEL AMER HYDROCHLORIDE TABLETS A RE A PHOSPHATE BINDER INDICAT ED FOR THE CONTROL OF SERUM P HOSPHORUS IN PATIENTS WITH CH RONIC KIDNEY DISEASE ON DIAL YSIS DILTIAZEM HCL ER CAP 1 2HR 90MG 100 NDC CODE:6846208 5101 62 O C B 24 3004.49.00. 10 212317 FOR THE TREATMENT OF HYPERTENSION. TACROLIMU S OINT 0.1% 60GM NDC CODE:684 62053465 FDA PRODUCT CODE NO. : 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 21039 3 THERAPEUTICE USE: - TACROL IMUS IS A TOPICAL IMMUNOSUPPR ESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEV ERE ATOPIC DERMATITIS (ECZEM A). PIMECROLIMUS CREAM 1% 6 0GM NDC CODE:68462060965 FDA PRODUCT CODE NO.: 61 S C J 0 4 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTI CE USE: - AS SECOUND-LINE THE RAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTME NT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMUNOCOMP ROMISED ADULT AND CHILDREN 2 YEARS OF AGE SIROLIMUS TAB 1MG 100 NDC CODE:68462068301 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90. 92.15 ANDA NO.: 208691 THERA PEUTICE USE: TO PREVENT REJEC TION OF KIDNEY TRANSPLANTS. PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FDA PROD UCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 AND A NO.: 211769 THERAPEUTICE US E: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-C ONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DER MATITIS IN NONIMMUNOCOMPROMIS ED ADULT AND CHILDREN 2 YEAR S OF AGE COMMERCIAL & CUSTO M INVOICE NO. F22587000467 DT . 19.06.2024 F22587000468 DT. 19.06.2024 F22587000469 DT. 19.06.2024 F22587000470 DT. 1 9.06.2024 F22587000471 DT. 19 .06.2024 S/BILL NO: 4010175 D T:20/06/2024 S/BILL NO: 40101 73 DT:20/06/2024 S/BILL NO: 4 010169 DT:20/06/2024 S/BILL N O: 4010170 DT:20/06/2024 S/BI LL NO: 4010172 DT:20/06/2024 NET WT. 6362.223 KGS 02 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 300490 |
2024-08-01 |
46 PKG |
9736.98KG |
46 PALLETS 4178 CARTONS PH ARMACEUTICALS AS UNDER ONDA NSETRON ODT 4MG 30UD NDC CODE :68462015713 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-152 THERAPEUTICE USE:-ANTI -EMETIC ONDANSETRON TAB 8M G 30 NDC CODE:68462010630 FD A PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUT ICE USE:-ANTI -EMETIC OXCA RBAZEPINE TAB 600MG 100 NDC C ODE:68462013901 FDA PRODUCT C ODE NO.:-61 M C A 45 HTS NO. 3004.90.9236 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONV ULSANT AGENT CLOTRIMAZOLE C REAM 1% 45GM NDC CODE:6846201 8147 FDA PRODUCT CODE NO :61 W C J 04 HTS NO.3004.90.9240 ANDA NO.90-219 THERAPEUTICE USE:-TREATMENT OF CANDIDIAS IS IMIQUIMOD CREAM 5% 0.25G M 24 NDC CODE:68462053670 FD A PRODUCT CODE NO.: 62 V C J 29 H. T. S NO.: 3004.49.00.5 0 ANDA NO.:201994 THERAPEUTI CE USE: - INDICATED FOR ACTIN IC KERATOSES AND EXTERNAL GE NITAL AND PERIANAL WARTS T ELMISARTAN TAB 40MG 30 NDC CO DE:68462020030 FDA PRODUCT CO DE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 090032 THERAPEUTICE USE: IND ICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE ONDANSETRON TAB 8M G 30 NDC CODE:68462010630 FD A PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUT ICE USE:-ANTI -EMETIC COMM ERCIAL & CUSTOM INVOICE NO. F 22552001328 DT. 21.06.2024 F2 2552001331 DT. 21.06.2024 F22 552001336 DT. 21.06.2024 S/BI LL NO:1851894 DT 21-JUN-2024 S/BILL NO:1851900 DT 21-JUN-20 24 S/BILL NO:1853409 DT 21-JU N-2024 NET WT. 7258.043 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREE S TEMPERATURE RANGE : +15 DEG REES TO +25 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A |
HS 300490 |
2024-07-23 |
42 PKG |
6173.5KG |
42 PALLETS 1459 CARTONS PH ARMACEUTICALS AS UNDER FLUC ONAZOLE TAB 150MG 12UD NDC CO DE:68462011944 NDC CODE : 68 462011944 HTS NO : 3004.90.92 .45 FDA CODE : 61 W C A 45 A NDA NO. : 77 - 253 THERAPEUTI CE USE : ANTIFUNGAL OMEPRA ZOLE DR CAP 40MG 90 NDC CODE: 68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9 255 ANDA NO.:91672 THERAPEUT ICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISE ASE OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO.:916 72 THERAPEUTICE USE: -TREATM ENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F225520 01180 DT. 12.06.2024 F2255200 1181 DT. 12.06.2024 S/BILL N O:1641662 DT 13-JUN-2024 S/BI LL NO:1641646 DT 13-JUN-2024 NET WT. 4814.363 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +18 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA |
HS 300490 |
2024-07-12 |
46 PKG |
11284.66KG |
46 PALLETS 3105 CARTONS PH ARMACEUTICALS AS UNDER MUPI ROCIN CREAM 2% 30GM NDC CODE: 68462056435 FDA PRODUCT CODE NO.: 61GCJ82 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 201587 THERAPEUTICE USE: - TOPICAL ANTI-BACTERIAL ATOVAQUONE- PROG TAB 62.5/25MG 100 NDC CO DE:68462040201 FDA PRODUCT CO DE NO.: 62 L D A 44 H. T. S NO.: 3004.90.92.90 ANDA NO.: 91-211 ANTI MALARIAL TOPI RAMATE TAB 25MG 60 NDC CODE:6 8462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77 -627 THERAPEUTICE USE:-ANTIC ONVULSANT NAPROXEN TAB 500M G 100 NDC CODE:68462019001 F DA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-250 THERAPEU TICE USE:-ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TAB 250 MG 100 NDC CODE:68462018801 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92 .40 ANDA NO.:-78-250 THERAPE UTICE USE:-ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TAB 50 0MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAP EUTICE USE:-ANTI-INFLAMMATORY , ANALGESIC NAPROXEN TAB 5 00MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90. 92.40 ANDA NO.:-78-250 THERA PEUTICE USE:-ANTI-INFLAMMATOR Y, ANALGESIC OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68462 039610 FDA PRODUCT CODE NO.: 62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE U SE: -TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 50MG 60 NDC CODE:68462015360 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO .:- 77-627 THERAPEUTICE USE: -ANTICONVULSANT COMMERCIAL & CUSTOM INVOICE NO. F2255200 1030 DT. 31.05.2024 F22552000 961 DT. 31.05.2024 F225520009 93 DT. 31.05.2024 F2255200101 0 DT. 31.05.2024 F22552001048 DT. 31.05.2024 F22552001039 DT. 31.05.2024 F22552001042 D T. 31.05.2024 S/BILL NO: 1426 146 DT 04-JUN-2024 S/BILL NO: 1426563 DT 04-JUN-2024 S/BIL L NO: 1426562 DT 04-JUN-2024 S/BILL NO: 1426456 DT 04-JUN-2 024 S/BILL NO: 1426458 DT 04- JUN-2024 S/BILL NO: 1426341 D T 04-JUN-2024 S/BILL NO: 1426 332 DT 04-JUN-2024 NET WT:950 1.728 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREE S NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2024-07-12 |
45 PKG |
9689.8KG |
45 PALLETS 1978 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAP 40MG 1000 NDC C ODE:68462039710 FDA PRODUCT C ODE NO.:62KCF10 HTS NO.3004. 90.9255 ANDA NO.:91672 THERA PEUTICE USE: -TREATMENT OF TR EAT GASTROESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 25MG 500 NDC CODE:68462010805 FD A PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:077627 THERAPEUTI CE USE: ANTICONVULSANT TOP IRAMATE TAB 25MG 500 NDC CODE :68462010805 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO .: 3004.49.00.20 ANDA NO.:07 7627 THERAPEUTICE USE: ANTIC ONVULSANT TOPIRAMATE TAB 25 MG 1000 NDC CODE:68462010810 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.0 0.20 ANDA NO.:- 77-627 THERA PEUTICE USE:-ANTICONVULSANT TOPIRAMATE TAB 100MG 60 NDC CODE:68462010960 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA N O.:- 77-627 THERAPEUTICE USE :-ANTICONVULSANT OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68 462039610 FDA PRODUCT CODE N O.:62KCF10 HTS NO.3004.90.925 5 ANDA NO.:91672 THERAPEUTIC E USE: -TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS E MUPIROCIN CREAM 2% 15GM NDC CODE:68462056417 FDA PROD UCT CODE NO.: 61GCJ82 H. T. S NO.: 3004.90.92.45 ANDA NO .: 201587 THERAPEUTICE USE: - TOPICAL ANTI-BACTERIAL MU PIROCIN OINT 2% 22GM NDC CODE :68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO .: 3004.90.92.45 ANDA NO.: 9 0-480 THERAPEUTICE USE: - AN TI-BACTERIAL MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 90-480 THERA PEUTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOIC E NO. F22552000892 DT. 29.05. 2024 F22552000938 DT. 30.05.2 024 F22552001038 DT. 31.05.20 24 F22552001016 DT. 31.05.202 4 F22552001017 DT. 31.05.2024 F22552001033 DT. 31.05.2024 S/BILL NO: 1361097 DT 01-JUN- 2024 S/BILL NO: 1361435 DT 01 -JUN-2024 S/BILL NO: 1365596 DT 01-JUN-2024 S/BILL NO: 136 1434 DT 01-JUN-2024 S/BILL NO : 1361106 DT 01-JUN-2024 S/BI LL NO: 1361105 DT 01-JUN-2024 NET WT. 7983.030 KGS 02 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 300490 |
2024-07-12 |
46 PKG |
10435.07KG |
46 PALLETS 3201 CARTONS PH ARMACEUTICALS AS UNDER ROPI NIROLE TAB 0.5MG 100 NDC CODE :68462025401 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TRE ATMENT OF PARKINSONISM TOP IRAMATE TAB 25MG 60 NDC CODE: 68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:- 7 7-627 THERAPEUTICE USE:-ANTI CONVULSANT ROPINIROLE TAB 1 MG 100 NDC CODE:68462025501 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92 .40 ANDA NO.:- 90-135 THERAP EUTICE USE:-TREATMENT OF PAR KINSONISM LEVOCETIRIZINE DI HY TAB 5MG 90 NDC CODE:684620 34690 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 300 4.90.91.80 ANDA NO.:90385 TH ERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPATHIC URTICARIA OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 FDA PR ODUCT CODE NO.:62KCF10 HTS N O.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE LITHIUM CARB CAP 600MG 100 NDC CODE:68462 022201 FDA PRODUCT CODE NO.: -61 N C E 37 H. T. S NO.: 30 04.49.00.20 ANDA NO.:- 79 -13 9 THERAPEUTICE USE:-ANTIMANI C AGENT VERAPAMIL HCL ER TA B 180MG 100 NDC CODE:68462029 301 NDC NO.: 68462029301 FDA PRODUCT CODE NO.: 62 O C B 1 3 HTS NO.3004.90.9221 ANDA N O.: 090700 THERAPEUTICE USE: --ANGINA VERAPAMIL HCL ER TAB 180MG 500 NDC CODE:684620 29305 NDC NO.: 68462029305 F DA PRODUCT CODE NO.: 62 O C B 13 HTS NO.3004.90.9221 ANDA NO.: 090700 THERAPEUTICE USE : --ANGINA MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 90-480 THERAP EUTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE NO. F22552001086 DT. 05.06.2 024 F22552001085 DT. 05.06.20 24 F22552001087 DT. 05.06.202 4 F22552001082 DT. 05.06.2024 S/BILL NO: 1480014 DT 06-JUN -2024 S/BILL NO: 1479656 DT 0 6-JUN-2024 S/BILL NO: 1479659 DT 06-JUN-2024 S/BILL NO: 14 79664 DT 06-JUN-2024 NET WT. 8552.560 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 300490 |
2024-07-12 |
43 PKG |
9763.74KG |
43 PALLETS 4061 CARTONS P HARMACEUTICALS AS UNDER OLM ESARTAN MEDOX TAB 20MG 30 NDC CODE:68462043730 FDA PRODUCT CODE NO.: 62CCA68 H. T. S N O.: 3004.90.9220 ANDA NO.: 2 03281 THERAPEUTICE USE: - -T REATMENT OF HYPERTENSION, ALO NE OR WITH OTHER ANTIHYPERTE NSIVE AGENTS, TO LOWER BLOOD PRESSURE VERAPAMIL HCL ER T AB 180MG 100 NDC CODE:6846202 9301 NDC NO.: 68462029301 FD A PRODUCT CODE NO.: 62 O C B 13 HTS NO.3004.90.9221 ANDA NO.: 090700 THERAPEUTICE USE: --ANGINA TELMISARTAN TAB 80MG 30 NDC CODE:68462020130 HTS NO : 3004.90.92.20 FDA C ODE : 62 O C A 09 ANDA NO.: 9 0032 THERAPEUTICE USE : INDI CATED FOR THE TREATMENT OF H YPERTENSION, TO LOWER BLOOD P RESSURE TOPIRAMATE TAB 100M G 60 NDC CODE:68462010960 FD A PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:- 77-627 THERAPEU TICE USE:-ANTICONVULSANT N APROXEN TAB 500MG 100 NDC COD E:68462019001 FDA PRODUCT COD E NO.:-62 G C A 49 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-ANT I-INFLAMMATORY, ANALGESIC TOPIRAMATE TAB 100MG 500 NDC CODE:68462010905 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO .: 77627 THERAPEUTICE USE: : #ANTICONVULSANT CLINDAMYCIN -BPO GEL JAR 1%/5% 50GM NDC C ODE:68462048627 FDA PRODUCT C ODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO. : 209252 ANTIBIOTIC THAT STOP S THE GROWTH OF ACNE-CAUSING BACTERIA AS WELL AS REDUCE O IL PRODUCTION IN THE SKIN, HE LPING KEEP PORES OPEN ACYC LOVIR OINT 5% 15GM NDC CODE:6 8462074617 FDA PRODUCT CODE N O.: 62 V C J 18 H. T. S NO.: 3004.49.00.50 ANDA NO.: 205 510 THERAPEUTICE USE: - AN A NTIVIRAL MEDICINE USED TO TRE AT OR PREVENT INFECTIONS CAUS ED BY CERTAIN KINDS OF VIRUSE S. EXAMPLES OF THESE INFECTIO NS INCLUDE HERPES AND SHINGLE S COMMERCIAL & CUSTOM INV OICE NO. F22552001109 DT. 06. 06.2024 F22552001110 DT. 06.0 6.2024 F22552001114 DT. 07.06 .2024 F22552001115 DT. 07.06. 2024 F22552001116 DT. 07.06.2 024 F22552001117 DT. 07.06.20 24 NET WT. 7644.895 KGS 06 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA N OTIFY PARTY:3 GLENMARK SPECIA LTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2 000 SWITZERLAND |
HS 300490 |
2024-07-12 |
42 PKG |
7983.36KG |
42 PALLETS 1659 CARTONS PH ARMACEUTICALS AS UNDER SEVE LAMER HCL TAB 400MG 360 NDC C ODE:68462044626 FDA PRODUCT C ODE NO.: 63 L D A 04 H. T. S NO.: 3004.90.92.60 ANDA NO. :204724 THERAPEUTICE USE:SEV ELAMER HYDROCHLORIDE TABLETS ARE A PHOSPHATE BINDER INDIC ATED FOR THE CONTROL OF SERUM PHOSPHORUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON DI ALYSIS CLINDAMYCIN HCL CAP 300MG 100 NDC CODE:6846201440 1 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941.90. 5000 ANDA NO.:216957 THERAPE UTICE USE: :#TREATMENT OF NUM EROUS INFECTIONS, INCLUDING B UT NOT LIMITED TO SEPTICEMI A,INTRAABDOMINAL INFECTIONS, LOWER RESPIRATORY INFECTIONS , GYNECOLOGICAL INFECTIONS, B ONE AND JOINT INFECTIONS, AND SKIN AND SKIN STRUCTURE INF ECTIONS NICARDIPINE HCL CAP 30MG 90 NDC CODE:68462012190 FDA PRODUCT CODE NO.: 62 O C E 48 H. T. S NO.: 3004.90. 9220 ANDA NO.: 216357 THERAP EUTICE USE: :#CARDIOVASCULAR AGENT CALCIUM CHANNEL BLOCKE R GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRO DUCT CODE:NO : 61 N C A 69 H TS NO.3004.90.9236 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT GABAPENTIN TAB 600MG 500 NDC CODE:6846201260 5 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT FLUPH ENAZINE HCL TAB 5MG 100 NDC C ODE:68462033701 FDA PRODUCT C ODE NO.: 66 N C A 99 H. T. S NO.: 3004.90.9235 ANDA NO.: 216350 THERAPEUTICE USE: :# ANTI-PSYCHOTIC TACROLIMUS O INT 0.1% 60GM NDC CODE:684620 53465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 300 4.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMU S IS A TOPICAL IMMUNOSUPPRESS IVE OINTMENT USED FOR THE TR EATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DERM ATITIS (ECZEMA). TACROLIMU S OINTMENT 0.03% 30GM NDC COD E:68462088135 FDA PRODUCT COD E NO.:64 T C J 08 H. T. S NO .: 3004.49.0050 ANDA NO.:210 393 THERAPEUTICE USE: TOPICA L IMMUNOSUPPRESSIVE AGENT CHLORPROMAZINE HCL TAB 50MG 1 00 NDC CODE:68462086301 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDER S SUCH AS SCHIZOPHRENIA OR M ANIC-DEPRESSION IN ADULTS CHLORPROMAZINE HCL TAB 200MG 1 00 NDC CODE:68462086501 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDER S SUCH AS SCHIZOPHRENIA OR M ANIC-DEPRESSION IN ADULTS TACROLIMUS OINTMENT 0.03% 30GM NDC CODE:68462088135 FDA PR ODUCT CODE NO.:64 T C J 08 H . T. S NO.: 3004.49.0050 AND A NO.:210393 THERAPEUTICE USE : TOPICAL IMMUNOSUPPRESSIVE AGENT COMMERCIAL & CUSTOM INVOICE NO. F22587000349 DT. 31.05.2024 F22587000369 DT. 3 1.05.2024 F22587000373 DT. 31 .05.2024 F22587000356 DT. 31. 05.2024 F22587000348 DT. 31.0 5.2024 F22587000332 DT. 31.05 .2024 F22587000350 DT. 31.05. 2024 S/BILL NO: 4009343 DT:05 /06/2024 S/BILL NO: 4009352 D T:05/06/2024 S/BILL NO: 40093 49 DT:05/06/2024 S/BILL NO:40 09351 DT:05/06/2024 S/BILL NO : 4009346 DT:05/06/2024 S/BIL L NO: 4009347 DT:05/06/2024 S /BILL NO: 4009350 DT:05/06/202 4 NET WT. 4480.113 KGS 02 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TE MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 300490 |
2024-07-12 |
4 PKG |
994.29KG |
4 PALLETS 480 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 40MG 30 NDC CODE:6 8462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 0791 72 THERAPEUTICE USE: - TO TR EAT HIGH CHOLESTEROL AND RELA TED CONDITIONS, AND TO PREVEN T CARDIOVASCULAR DISEASE C OMMERCIAL & CUSTOM INVOICE NO. F22587000338 DT. 31.05.2024 S/BILL NO:4009345 DT: 05/06/2 024 NET WT. 729.61 KGS 04 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TE MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERL AND |
HS 611600 |
2024-05-20 |
41 PKG |
5765.26KG |
41 PALLETS 1979 CARTONS PH ARMACEUTICALS AS UNDER LEVO NORGESTREL/EE TAB 0.09/0.02MG 84 NDC CODE:68462063729 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 202791 THERAPEUTICE USE: - : USED FOR PREVENTING PREGNANCY NORETH ACE/EE T AB 1/0.02MG 63 NDC CODE:68462 013281 FDA PRODUCT CODE NO.: 65 J C A 25 H. T. S NO.: 300 6.60.00.00 ANDA NO.:206969 T HERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOMETRIOS IS AN D ABNORMAL UTERINE BLEEDING NORETH ACE/EE TAB 0.5MG/2.5M CG 84 NDC CODE:68462065629 F DA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.: 203038 THERAPEU TICE USE: - TREATMENT OF MODE RATE TO SEVERE VASOMOTOR SYM PTOMS DUE TO MENOPAUSE; OSTE OPOROSIS PREVENTION COMMERC IAL & CUSTOM INVOICE NO. F225 52000047 DT. 06.04.2024 S/BIL L NO: 8975026 DT 08-APR-2024 NET WT.4,184.73 02 DATA LOGG ERS SET TEMPERATURE : +20 D EGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 642900 |
2024-05-14 |
44 PKG |
7728.89KG |
44 PALLETS 2075 CARTONS PH ARMACEUTICALS AS UNDER DROS PIRENONE/EE TAB 3/0.03MG 84 N DC CODE:68462073329 FDA PRODU CT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204848 THERAPEUTICE USE : - CONTRACEPTION TO PREVENT PREGNANCY ESTRADIOL VAG IN SERTS 10MCG 8 NDC CODE:684620 71171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 300 6.60.00.00 ANDA NO.:210264 T HERAPEUTICE USE:THE TREATMENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. TELMISARTAN TAB 80MG 90 NDC CODE:68462020190 NDC NO.: 68462020190 FDA PR ODUCT CODE NO :62 O C A 09 H TS NO : 3004.90.92.20 ANDA NO .90032 THERAPEUTICE USE:-IND ICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE NAPROXEN TAB 500MG 100 NDC CODE:68462019001 FD A PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:-78-250 THERAPEUT ICE USE:-ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TAB 500M G 500 NDC CODE:68462019005 F DA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-250 THERAPEU TICE USE:-ANTI-INFLAMMATORY, ANALGESIC OMEPRAZOLE DR CA P 40MG 1000 NDC CODE:68462039 710 FDA PRODUCT CODE NO.:62K CF10 HTS NO.3004.90.9255 AND A NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROE SOPHAGEAL REFLUX DISEASE O MEPRAZOLE DR CAP 20MG 1000 ND C CODE:68462039610 FDA PRODUC T CODE NO.:62KCF10 HTS NO.30 04.90.9255 ANDA NO.:91672 TH ERAPEUTICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REFLU X DISEASE ONDANSETRON ODT 8MG 30UD NDC CODE:68462015813 FDA PRODUCT CODE.:-61 T C A 26 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-152 THERAPEU TICE USE:-ANTI -EMETIC COM MERCIAL & CUSTOM INVOICE NO. F22452006425 DT. 29.03.2024 F 22452006434 DT. 29.03.2024 F2 2452006394 DT. 27.03.2024 F22 452006441 DT. 29.03.2024 F224 52006442 DT. 29.03.2024 S/BIL L NO: 8770843 DT 30-MAR-2024 S/BILL NO: 8763127 DT 30-MAR-2 024 S/BILL NO: 8763117 DT. 30 -MAR-2024 S/BILL NO: 8763135 DT 30-MAR-2024 S/BILL NO: 876 3126 DT 30-MAR-2024 NET WT. 6 208.81 KGS 02 DATA LOGGERS H UMIDITY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2024-05-14 |
26 PKG |
6467.88KG |
26 PALLETS 1504 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). CLINDAMYCIN HCL C AP 150MG 100 NDC CODE:6846201 4301 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941. 90.5000 ANDA NO.:216957 THER APEUTICE USE: :#TREATMENT OF NUMEROUS INFECTIONS, INCLUDIN G BUT NOT LIMITED TO SEPTIC EMIA,INTRAABDOMINAL INFECTION S, LOWER RESPIRATORY INFECTI ONS, GYNECOLOGICAL INFECTIONS , BONE AND JOINT INFECTIONS, AND SKIN AND SKIN STRUCTURE INFECTIONS POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:684620 35701 FDA PRODUCT CODE NO.:6 5 R C F 14 H. T. S NO.: 3004 .90.92.90 ANDA NO.:202868 TH ERAPEUTICE USE: - TREATMENT O R PREVENTION OF HYPOKALEMIA GABAPENTIN TAB 600MG 500 N DC CODE:68462012605 FDA PRODU CT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT GABAPENTIN TAB 60 0MG 500 NDC CODE:68462012605 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT EZETIMI BE TAB 10MG 500 NDC CODE:6846 2022605 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3 004.49.00.10 ANDA NO.: #07856 0 THERAPEUTICE USE: LIPID LO WERING AGENT GABAPENTIN TAB 600MG 500 NDC CODE:684620126 05 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTIC E USE:-ANTICONVULSANT COMM ERCIAL & CUSTOM INVOICE NO. F 22487002437 DT. 31.03.2024 F2 2487002440 DT. 31.03.2024 F22 487002441 DT. 31.03.2024 F224 87002446 DT. 31.03.2024 F2248 7002447 DT. 31.03.2024 F22487 002449 DT. 31.03.2024 S/BILL NO: 4005655 DT: 02/04/2024 S/ BILL NO: 4005654 DT: 02/04/202 4 S/BILL NO: 4005653 DT: 02/0 4/2024 S/BILL NO: 4005652 DT: 02/04/2024 S/BILL NO: 400565 0 DT: 02/04/2024 S/BILL NO: 4 005649 DT: 02/04/2024 NET WT. 4339.144 KGS DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 300490 |
2024-05-14 |
46 PKG |
11944.65KG |
46 PALLETS 4011 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 3.125MG 500 NDC CO DE:68462016205 FDA PRODUCT CO DE NO :62 O C A 22 HTS NO.30 04.90.9221 ANDA NO.78-251 TH ERAPEUTICE USE:-BETA- ADRENO ACEPTOR ANTAGONIST TELMISA RTAN TAB 80MG 30 NDC CODE:684 62020130 HTS NO : 3004.90.92. 20 FDA CODE : 62 O C A 09 AN DA NO.: 90032 THERAPEUTICE US E : INDICATED FOR THE TREATM ENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE ZOLMITRIPT AN TAB 2.5MG 6UD NDC CODE:684 62049776 FDA PRODUCT CODE NO. : 60 L C A 90 H. T. S NO.: 3004.90.92.28 ANDA NO.: 20177 9 THERAPEUTICE USE: - ANALGE SIC/ HUMAN - RX/SINGLE INGRED IENT / PROMPT RELEASE TABLET S / ZOLMITRIPTAN (ANALGESIC) OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PROD UCT CODE NO.:62KCF10 HTS NO. 3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REF LUX DISEASE ROPINIROLE TAB 1MG 100 NDC CODE:68462025501 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90. 92.40 ANDA NO.:- 90-135 THER APEUTICE USE:-TREATMENT OF P ARKINSONISM GABAPENTIN TAB 800MG 500 NDC CODE:6846201270 5 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT GABAP ENTIN TAB 800MG 500 NDC CODE: 68462012705 FDA PRODUCT CODE :NO : 61 N C A 69 HTS NO.3004 .90.9236 ANDA NO.:-77-662 TH ERAPEUTICE USE:-ANTICONVULSAN T ACYCLOVIR OINT 5% 30GM N DC CODE:68462074635 FDA PRODU CT CODE NO.: 62 V C J 18 H. T. S NO.: 3004.49.00.50 ANDA NO.: 205510 THERAPEUTICE USE : - AN ANTIVIRAL MEDICINE USE D TO TREAT OR PREVENT INFECTI ONS CAUSED BY CERTAIN KINDS OF VIRUSES. EXAMPLES OF THESE INFECTIONS INCLUDE HERPES AN D SHINGLES ROSUVASTATIN TAB 40MG 30 NDC CODE:68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.0 0.10 ANDA NO.: 079172 THERAP EUTICE USE: - TO TREAT HIGH C HOLESTEROL AND RELATED CONDIT IONS, AND TO PREVENT CARDIOV ASCULAR DISEASE ROSUVASTATI N TAB 40MG 500 NDC CODE:68462 026405 61 J C A 16 3004.49.0 0.10 79172 TO TREAT HIGH CHO LESTEROL AND RELATED CONDITIO NS, AND TO PREVENT CARDIOVAS CULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F224520064 95 DT. 31.03.2024 F2255200001 5 DT. 04.04.2024 F22552000016 DT. 04.04.2024 F22552000017 DT. 04.04.2024 F22552000023 D T. 04.04.2024 F22552000018 DT . 04.04.2024 F22552000024 DT. 04.04.2024 F22552000026 DT. 04.04.2024 S/BILL NO: 8904425 DT:04042024 S/BILL NO: 89044 27 DT:04042024 S/BILL NO: 890 4426 DT:04042024 S/BILL NO: 8 904429 DT:04042024 S/BILL NO: 8904438 DT:04042024 S/BILL N O: 8904424 DT:04042024 S/BILL NO: 8904432 DT:04042024 S/BI LL NO: 8904431 DT:04042024 NE T WT. 9970.203 KGS 09 DATA L OGGERS SET TEMPERATURE : +2 0 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA NOTIF Y PARTY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 300490 |
2024-05-07 |
26 PKG |
6175.31KG |
26 PALLETS 3051 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 5MG 90 NDC CODE: 68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079 172 THERAPEUTICE USE: - TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 79172 THERAPEUTICE USE: T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE . ROSUVASTATIN TAB 40MG 500 NDC CODE:68462026405 61 J C A 16 3004.49.00.10 79172 T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PR EVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 40MG 30 N DC CODE:68462026430 FDA PRODU CT CODE NO.:61 J C A 16 H. T . S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DIS EASE ROSUVASTATIN TAB 5MG 1 000 NDC CODE:68462026110 FDA PRODUCT CODE NO.: 61 J C A 1 6 H. T. S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTIC E USE: TO TREAT HIGH CHOLESTE ROL AND RELATED CONDITIONS, A ND TO PREVENT CARDIOVASCULAR DISEASE. COMMERCIAL & CUST OM INVOICE NO. F22452006291 D T. 22.03.2024 F22452006292 DT . 22.03.2024 S/BILL NO: 85873 72 DT 23-MAR-2024 S/BILL NO: 8587363 DT 23-MAR-2024 NET WT .4,880.88 KGS 26 DATA LOGGER S SET TEMPERATURE : +20 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUC HATEL - 2000 SWITZERLAND |
HS 611600 |
2024-05-07 |
2 PKG |
332.49KG |
2 PALLETS 60 CARTONS PHARM ACEUTICALS AS UNDER ROSUVAS TATIN TAB 40MG 500 NDC CODE:6 8462026405 61 J C A 16 3004. 49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED COND ITIONS, AND TO PREVENT CARDI OVASCULAR DISEASE COMMERCIA L & CUSTOM INVOICE NO. F22452 006329 DT. 24.03.2024 S/BILL NO: 8615583 DT 25-MAR-2024 NE T WT.295.49 KGS 02 DATA LOGGE RS SET TEMPERATURE : +20 DE GREES NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE DU PORT 2 NEU CHATEL - 2000 SWITZERLAND |
HS 271019 |
2024-05-07 |
23 PKG |
5019.08KG |
CARGO DESCRIPTION, HS CODE AN D AGENT ADDRESS. 23 PALLETS 1861 CARTONS PHARMACEUTICALS AS UNDER OXCARBAZEPINE TAB 30 0MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 AN DA NO.:-77-802 THERAPEUTICE U SE:-ANTI CONVULSANT AGENT ON DANSETRON ODT 8MG 10UD NDC CO DE:68462015811 FDA PRODUCT CO DE NO.:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-152 THERAPEUTICE USE:-ANT I -EMETIC TROSPIUM CL TAB 20 MG 60 NDC CODE:68462046160 F DA PRODUCT CODE NO.:-61 K C A 69 H. T. S NO.: 3004.49.00. 70 ANDA NO.:-91-575 THERAPEU TICE USE:- TREATMENT OF VENOU S DISEASES URINARY INCONTINE NCE THERAPY OXCARBAZEPINE TA B 300MG 100 NDC CODE:68462013 801 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 ANDA NO.:-77-802 THERAPEUTI CE USE:-ANTI CONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22452006290 DT. 22.03.20 24 F22452006293 DT. 23.03.202 4 S/BILL NO: 8587864 DT 23-MA R-2024 S/BILL NO: 8587491 DT 23-MAR-2024 NET WT.3971.970 K GS 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA CLAUSES - NEW AGENT AT DESTINATION: MAERSK INC. 2 G IRALDA FARMS MADISON AVENUE P.O. BOX 880 07940-0880 MADI SON, NJ USA PHONE: CUSTOMER SERVICE 1 (800) 321-8807 GIR ALDA FARMS (NY/NJ) 1 (973) 514 -5000 BALTIMORE 1 (800) 854-6 553 BOSTON 1 (800) 854-6553 PHILADELPHIA 1 (800) 854-6553 ROCHESTER 1 (800) 854-6553 F AX: GIRALDA FARMS (NY/NJ) 1 ( 973) 514-5410 BALTIMORE 1 (88 8) 249-8016 BOSTON 1 (866) 34 5-8986 PHILADELPHIA 1 (888) 2 49-8016 |
HS 210690 |
2024-05-07 |
39 PKG |
7426.79KG |
39 PALLETS 2365 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAP 20MG 1000 NDC C ODE:68462039610 FDA PRODUCT C ODE NO.:62KCF10 HTS NO.3004. 90.9255 ANDA NO.:91672 THERA PEUTICE USE: -TREATMENT OF TR EAT GASTROESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAP 4 0MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO. :91672 THERAPEUTICE USE: -TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE ONDANS ETRON ODT 8MG 30UD NDC CODE:6 8462015813 FDA PRODUCT CODE.: -61 T C A 26 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-152 THERAPEUTICE USE:-ANTI -EME TIC TROSPIUM CL TAB 20MG 60 NDC CODE:68462046160 FDA PR ODUCT CODE NO.:-61 K C A 69 H. T. S NO.: 3004.49.00.70 A NDA NO.:-91-575 THERAPEUTICE USE:- TREATMENT OF VENOUS DI SEASES URINARY INCONTINENCE THERAPY GABAPENTIN TAB 600M G 500 NDC CODE:68462012605 F DA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE US E:-ANTICONVULSANT MARLISSA TAB 0.15/0.03MG 84 NDC CODE:6 8462038829 FDA PRODUCT CODE N O.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 0914 52 THERAPEUTICE USE: ORAL CO NTRACEPTIVE COMMERCIAL & CU STOM INVOICE NO. F22452006327 DT. 24.03.2024 F22452006328 DT. 24.03.2024 F22452006310 D T. 23.03.2024 S/BILL NO: 8615 589 DT 25-MAR-2024 S/BILL NO: 8615426 DT 25-MAR-2024 S/BIL L NO: 8615425 DT 25-MAR-2024 NET WT.5979.660 KGS 02 DATA LOGGERS SET TEMPERATURE : + 20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 300490 |
2024-05-07 |
40 PKG |
6195.27KG |
40 PALLETS 2400 CARTONS PH ARMACEUTICALS AS UNDER ESTR ADIOL VAG INSERTS 10MCG 8 NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA N O.:210264 THERAPEUTICE USE:TH E TREATMENT OF ATROPIC VAGIN ITIS DUE TO MENOPAUSE. COM MERCIAL & CUSTOM INVOICE NO. F22452006404 DT. 28.03.2024 S /BILL NO: 8715790 DT 28-MAR-20 24 NET WT. 4665.600 KGS 02 D ATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 642800 |
2024-05-07 |
44 PKG |
11115.47KG |
44 PALLETS 3062 CARTONS PH ARMACEUTICALS AS UNDER TELM ISARTAN TAB 80MG 30 NDC CODE: 68462020130 HTS NO : 3004.90. 92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAPEUTICE USE : INDICATED FOR THE TRE ATMENT OF HYPERTENSION, TO LO WER BLOOD PRESSURE ATOMOXE TINE CAP 100MG 30 NDC CODE:68 462027130 FDA PRODUCT CODE NO .: 64 UCA 99 H. T. S NO.: 3 004.90.92.90 ANDA NO.: 079019 TREATMENT OF ATTENTION - DE FICIT/HYPERACIVITY DISORDER ( ADHD NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PR ODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 A NDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMATORY, ANAL GESIC FELODIPINE ER TAB 2.5 MG 100 NDC CODE:68462023301 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-365 THERAPEUTIC E USE: - TREATMENT OF HYPERT ENSION GABAPENTIN TAB 800MG 500 NDC CODE:68462012705 FD A PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE USE :-ANTICONVULSANT OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68 462039710 FDA PRODUCT CODE N O.:62KCF10 HTS NO.3004.90.925 5 ANDA NO.:91672 THERAPEUTIC E USE: -TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS E ROSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PRO DUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 AND A NO.: 079172 THERAPEUTICE US E: - TO TREAT HIGH CHOLESTERO L AND RELATED CONDITIONS, AN D TO PREVENT CARDIOVASCULAR D ISEASE CARVEDILOL TAB 6.25M G 500 NDC CODE:68462016305 F DA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST AC RLF ADAPALENE GEL 0.1 % 45GM (CURIST) NDC CODE:7255 9001513 FDA PRODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 208108 THERAPEUTICE USE: #TOPICAL ANTI-ACNE AGENT COMMERCIAL & CUSTOM INVOICE NO. F2245200 6396 DT. 27.03.2024 F22452006 395 DT. 27.03.2024 F224520063 86 DT. 27.03.2024 F2245200641 3 DT. 28.03.2024 F22452006410 DT. 28.03.2024 F22452006412 DT. 28.03.2024 F22452006401 D T. 28.03.2024 S/BILL NO: 8717 970 DT 28-MAR-2024 S/BILL NO: 8718032 DT 28-MAR-2024 S/BIL L NO: 8717979 DT 28-MAR-2024 S/BILL NO: 8718030 DT 28-MAR-2 024 S/BILL NO: 8718031 DT 28- MAR-2024 S/BILL NO: 8717940 D T 28-MAR-2024 S/BILL NO: 8717 939 DT 28-MAR-2024 NET WT. 94 10.872 KGS 09 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERL AND NOTIFY PARTY:4 CURIST C/ O BAKER INDUSTRIES 184 PENNSY LVANIA AVE PENNSYLVANIA MALV ERN USA- 19355 LABELER CODE : 68462: |
HS 300490 |
2024-05-07 |
43 PKG |
11071.02KG |
43 PALLETS 4062 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 40MG 30 NDC CODE :68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE CARVEDILOL TAB 12.5MG 500 ND C CODE:68462016405 FDA PRODUC T CODE NO :62 O C A 22 HTS N O.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST CAR VEDILOL TAB 12.5MG 500 NDC CO DE:68462016405 FDA PRODUCT CO DE NO :62 O C A 22 HTS NO.30 04.90.9221 ANDA NO.78-251 TH ERAPEUTICE USE:-BETA- ADRENO ACEPTOR ANTAGONIST CARVEDI LOL TAB 25MG 500 NDC CODE:684 62016505 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90. 9221 ANDA NO.78-251 THERAPEU TICE USE:-BETA- ADRENOACEPTO R ANTAGONIST PIMECROLIMUS CREAM 1% 60GM NDC CODE:684620 60965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 300 4.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOUN D-LINE THERAPY FOR THE SHORT- TERM AND NON-CONTINUOS CHRONI C TRERTMENT OF MILD TO MODER ATE ATOPIC DERMATITIS IN NON - IMMUNOCOMPROMISED ADULT AN D CHILDREN 2 YEARS OF AGE SIROLIMUS TAB 0.5MG 100 NDC C ODE:68462068201 FDA PRODUCT C ODE NO.: 64 T C A 12 H. T. S NO.: 3004.90.92.15 ANDA NO. : 208691 THERAPEUTICE USE: TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. SIROLIMUS TAB 2MG 100 NDC CODE:68462068401 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90. 92.15 ANDA NO.: 208691 THERA PEUTICE USE: TO PREVENT REJEC TION OF KIDNEY TRANSPLANTS. COMMERCIAL & CUSTOM INVOICE NO. F22487002384 DT. 27.03.20 24 F22487002385 DT. 27.03.202 4 F22487002386 DT. 27.03.2024 F22487002387 DT. 27.03.2024 F22487002388 DT. 27.03.2024 S/BILL NO: 4005206 DT:28/03/20 24 S/BILL NO: 4005203 DT:28/0 3/2024 S/BILL NO: 4005205 DT: 28/03/2024 S/BILL NO: 4005202 DT:28/03/2024 S/BILL NO: 400 5204 DT:28/03/2024 NET WT. 84 09.173 KGS 18 DATA LOGGERS SET TEMPERATURE : +20 DEGREE S NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA NOTIFY PARTY: 3 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE DU POR T 2 NEUCHATEL - 2000 SWITZER LAND |
HS 300490 |
2024-05-07 |
44 PKG |
9860.36KG |
44 PALLETS 1900 CARTONS PH ARMACEUTICALS AS UNDER VIOR ELE TAB 0.15/0.02-0.01MG 84 N DC CODE:68462031829 FDA PRODU CT CODE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTICE USE : - ORAL CONTRACEPTIVES NO RETH ACE/EE TAB 1MG/5MCG 90 N DC CODE:68462065790 FDA PRODU CT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE : - TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS D UE TO MENOPAUSE; OSTEOPOROSIS PREVENTION NAPROXEN TAB 50 0MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAP EUTICE USE:-ANTI-INFLAMMATORY , ANALGESIC GABAPENTIN TAB 800MG 500 NDC CODE:684620127 05 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTIC E USE:-ANTICONVULSANT GABA PENTIN TAB 800MG 500 NDC CODE :68462012705 FDA PRODUCT COD E:NO : 61 N C A 69 HTS NO.300 4.90.9236 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULSA NT COMMERCIAL & CUSTOM INVO ICE NO. F22452006392 DT. 27.0 3.2024 F22452006371 DT. 27.03 .2024 F22452006373 DT. 27.03. 2024 F22452006384 DT. 27.03.2 024 S/BILL NO: 8700101 DT 28- MAR-2024 S/BILL NO: 8700874 D T 28-MAR-2024 S/BILL NO: 8714 651 DT 28-MAR-2024 S/BILL NO: 8715794 DT 28-MAR-2024 NET W T. 8283.895 KGS 02 DATA LOG GERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2024-04-30 |
42 PKG |
10515.81KG |
42 PALLETS 2227 CARTONS PH ARMACEUTICALS AS UNDER RANO LAZINE ER TAB 500MG 60 NDC CO DE:68462031960 FDA PRODUCT CO DE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.: 211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDICATIO N. IT WORKS BY IMPROVING BLOO D FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CH EST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) A TTACK OF ANGINA EZETIMIBE- SIMVA TAB 10/80MG 30 NDC CODE :68462032430 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO .: 3004.49.00.10 ANDA NO.: 2 08699 THERAPEUTICE USE: - THI S COMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLES TEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOO D CHOLESTEROL (HDL) IN THE BL OOD. EZETIMIBE WORKS BY REDUC ING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS S TATINS. IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL M ADE BY THE LIVER. CARVEDILO L TAB 25MG 500 NDC CODE:68462 016505 FDA PRODUCT CODE NO : 62 O C A 22 HTS NO.3004.90.92 21 ANDA NO.78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST RANOLAZINE ER T AB 500MG 60 NDC CODE:68462031 960 FDA PRODUCT CODE NO.: 61 D C B 02 H. T. S NO.: 3004. 49.00.10 ANDA NO.:211082 THE RAPEUTIC USE: - IT IS AN ANTI -ANGINAL MEDICATION. IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFI CIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN A CUTE (EMERGENCY) ATTACK OF A NGINA CARVEDILOL TAB 25MG 5 00 NDC CODE:68462016505 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA NO. 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 25MG 100 ND C CODE:68462016501 FDA PRODUC T CODE NO :62 O C A 22 HTS N O.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST TER IFLUNOMIDE TAB 7MG 30 NDC COD E:68462042330 FDA PRODUCT COD E NO.: 60 L C A 99 H. T. S NO.:3004.90.9215 ANDA NO.: 20 9663 THERAPEUTICE USE: :#MUL TIPLE SCLEROSIS AGENT TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). SIROLIMUS TAB 1MG 100 NDC CODE:68462068301 FD A PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90.92.1 5 ANDA NO.: 208691 THERAPEUT ICE USE: TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. AP REPITANT CAP 40MG 1UD NDC COD E:68462058340 FDA PRODUCT COD E NO.: 61 T C E 32 H. T. S N O.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE: -AP REPITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NA USEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOT HERAPY). THIS MEDICATION IS A LSO USED TO PREVENT NAUSEA AN D VOMITING AFTER SURGERY. A- EMETIC/NAUSEANT / HUMAN - RX/ SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT COMMERCIAL & CUSTOM INVOICE NO. F22487002342 DT. 20.03.2 024 F22487002345 DT. 21.03.20 24 F22487002346 DT. 21.03.202 4 F22487002347 DT. 21.03.2024 F22487002348 DT. 21.03.2024 S/BILL NO: 4004831 DT: 21/03/ 2024 S/BILL NO: 4004832 DT: 2 1/03/2024 S/BILL NO: 4004833 DT: 21/03/2024 S/BILL NO: 400 4834 DT: 21/03/2024 S/BILL NO : 4004835 DT: 21/03/2024 GROS S WT. 10,515.652 NET WT.7695 .876 13 DATA LOGGERS SE T TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 G LENMARK SPECIALTY S.A. SWITZE RLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 300490 |
2024-03-08 |
48 PKG |
13212.46KG |
48 PALLETS 2583 CARTONS PHAR MACEUTICALS AS UNDER OMEPRAZO LE DR CAP 40MG 1000 NDC CODE: 68462039710 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9 255 ANDA NO.:91672 THERAPEUT ICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISE ASE OXCARBAZEPINE TAB 150MG 1 00 NDC CODE:68462013701 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 ANDA NO .:-77-802 THERAPEUTICE USE:-A NTI CONVULSANT AGENT GABAPEN TIN TAB 600MG 500 NDC CODE:68 462012605 FDA PRODUCT CODE:N O : 61 N C A 69 HTS NO.3004.9 0.9236 ANDA NO.:-77-662 THER APEUTICE USE:-ANTICONVULSANT MUPIROCIN CREAM 2% 30GM NDC CODE:68462056435 FDA PRODUCT CODE NO.: 61GCJ82 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 01587 THERAPEUTICE USE: - TO PICAL ANTI-BACTERIAL GABAPENT IN TAB 600MG 500 NDC CODE:684 62012605 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90 .9236 ANDA NO.:-77-662 THERA PEUTICE USE:-ANTICONVULSANT COMMERCIAL & CUSTOM INVOICE NO . F22452005244 DT. 30.01.2024 F22452005245 DT. 30.01.2024 F22452005240 DT. 30.01.2024 F22452005252 DT. 30.01.2024 S /BILL NO:7132591 DT 30-JAN-202 4 S/BILL NO:7132642 DT 30-JAN -2024 S/BILL NO:7132594 DT 30 -JAN-2024 S/BILL NO:7132859 D T 30-JAN-2024 NET WT. 11,554. 77 KGS 02 DATA LOGGERS SET T EMPERATURE : +20 DEGREES TEMP ERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 300490 |
2024-03-08 |
40 PKG |
8317.66KG |
40 PALLETS 2353 CARTONS PH ARMACEUTICALS AS UNDER PRAM IPEXOLE TAB 0.5MG 90 NDC CODE :68462033290 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO .: 3004.90.92.40 ANDA NO.: 9 0-781 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE OME PRAZOLE DR CAP 40MG 1000 NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004 .90.9255 ANDA NO.:91672 THER APEUTICE USE: -TREATMENT OF T REAT GASTROESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 25M G 500 NDC CODE:68462010805 F DA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00. 20 ANDA NO.:077627 THERAPEUT ICE USE: ANTICONVULSANT TO PIRAMATE TAB 100MG 500 NDC CO DE:68462010905 FDA PRODUCT CO DE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.: 77627 THERAPEUTICE USE: :#A NTICONVULSANT OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68462 039710 FDA PRODUCT CODE NO.: 62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE U SE: -TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE ATOMOXETINE CAP 10MG 30 NDC CODE:68462026530 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.: 3004.90.92.90 ANDA NO. : 079019 THERAPEUTICE USE : - ATOMOXETINE IS USED TO TREA T ATTENTION-DEFICIT HYPERACTI VITY DISORDER (ADHD) AS PART OF A TOTAL TREATMENT PLAN, IN CLUDING PSYCHOLOGICAL, SOCIAL , AND OTHER TREATMENTS THE OPHYLLINE ER TAB 300MG 100 ND C CODE:68462072101 FDA PRODUC T CODE NO :63 B C B 30 HTS N O.3004.90.9289 ANDA NO.90-355 THERAPEUTICE USE:-XANTHINE BRONCHODILATOR COMMERCIAL & CUSTOM INVOICE NO. F2245200 5138 DT. 23.01.2024 F22452005 159 DT. 24.01.2024 F224520052 16 DT. 28.01.2024 F2245200521 5 DT. 28.01.2024 S/BILL NO: 7 099188 DT 29-JAN-2024 S/BILL NO: 7100172 DT 29-JAN-2024 S/ BILL NO: 7100176 DT 29-JAN-202 4 S/BILL NO: 7099182 DT 29-JA N-2024 NET WT. 7,105.73 KGS 02 DATA LOGGERS SET TEMP ERATURE : +20 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2024-03-08 |
43 PKG |
9088.78KG |
43 PALLETS 2308 CARTONS PHAR MACEUTICALS AS UNDER NORETH A CE/EE TAB 1/0.02MG 63 NDC COD E:68462013281 FDA PRODUCT COD E NO.:65 J C A 25 H. T. S NO .: 3006.60.00.00 ANDA NO.:20 6969 THERAPEUTICE USE: - SEC ONDARY AMENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BLE EDING NORGEST/EE TAB 0.25/0.0 35MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.0 0.00 ANDA NO.: 200538 THERAP EUTICE USE: - ORAL CONTRACEPT IVES GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PR ODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT TOPIRAMATE TAB 1 00MG 500 NDC CODE:68462010905 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49. 00.20 ANDA NO.: 77627 THERAP EUTICE USE: :#ANTICONVULSANT RILUZOLE TAB 50MG 60 NDC COD E:68462038160 FDA PRODUCT COD E NO.: 62 J C A 16 H. T. S N O.: 3004.90.92.30 ANDA NO.: 91394 THERAPEUTICE USE: - A- PARKINSONIAN/ HUMAN - RX/SING LE INGREDIENT / PROMPT RELEAS E TABLETS / RILUZOLE (ANTI-P ARKINSONIAN) ACAMPROSATE CALC IUM DR TAB 333MG 180 NDC CODE :68462043518 FDA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO .: 3004.90.92.40 ANDA NO.:20 2229 THERAPEUTICE USE: - FOR TREATING ALCOHOL DEPENDENCE COMMERCIAL & CUSTOM INVOICE N O. F22452005203 DT. 27.01.202 4 F22452005208 DT. 27.01.2024 F22452005137 DT. 23.01.2024 F22452005211 DT. 27.01.2024 F22452005210 DT. 27.01.2024 S /BILL NO:7082761 DT 29-JAN-202 4 S/BILL NO:7082772 DT 29-JAN -2024 S/BILL NO:7088591 DT 29 -JAN-2024 S/BILL NO:7082773 D T 29-JAN-2024 S/BILL NO:70897 12 DT 29-JAN-2024 NET WT. 7,5 39.83 KGS 02 DATA LOGGERS SE T TEMPERATURE : +20 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 |
HS 300490 |
2024-03-08 |
34 PKG |
6281.45KG |
34 PALLETS 1700 CARTONS PH ARMACEUTICALS AS UNDER NORG EST/EE TAB .18,.215,.25/.035MG 84 NDC CODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 2 7 H. T. S NO.: 300660.00.00 ANDA NO.: 200494 THERAPEUTIC E USE: - ORAL CONTRACEPTIVES NORGEST/EE TAB .18,.215,.25 /.035MG 84 NDC CODE:684620565 29 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.6 0.00.00 ANDA NO.: 200494 THE RAPEUTICE USE: - ORAL CONTRAC EPTIVES COMMERCIAL & CUSTOM INVOICE NO. F22452005155 DT. 24.01.2024 F22452005167 DT. 25.01.2024 S/BILL NO: 7027001 DT 25-JAN-2024 S/BILL NO: 70 35045 DT 25-JAN-2024 NET WT: 4920.000 KGS 02 DATA LOGGERS SET TEMPERATURE : +20 DEGR EES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 652700 |
2024-03-08 |
12 PKG |
2068.42KG |
12 PALLETS 600 CARTONS PHA RMACEUTICALS AS UNDER HAILE Y FE 1.5/30 TAB 1.5MG/30MCG-75 MG 84 NDC CODE:68462050329 F DA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.:206597 THERAPEUT ICE USE: HORMONE MEDICATION I S USED TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F22452005133 DT. 23.01.2 024 S/BILL NO: 6985740 DT:24- JAN-24 NET WT. 1,526.40 KGS 12 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S .A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 652500 |
2024-03-08 |
28 PKG |
3835.19KG |
28 PALLETS 1368 CARTONS PH ARMACEUTICALS AS UNDER DROS PIRENONE/EE TAB 3/0.02MG 84 N DC CODE:68462072029 FDA PRODU CT CODE NO.: 65 J D A 39 H. T. S NO.: 300660.00.00 ANDA NO.: 204296 THERAPEUTICE USE: - ORAL CONTRACEPTIVE COMM ERCIAL & CUSTOM INVOICE NO. F 22452005132 DT. 23.01.2024 S/ BILL NO: 6986328 DT:24-JAN-24 NET WT. 2790.720 KGS 01 DAT A LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 653900 |
2024-02-28 |
52 PKG |
11186.68KG |
52 PALLETS 2630 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 10MG 1000 NDC CO DE:68462026210 61 J C A 16 3 004.49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT C ARDIOVASCULAR DISEASE ATOMO XETINE CAP 18MG 30 NDC CODE:6 8462026630 FDA PRODUCT CODE N O.: 64 UCA 99 H. T. S NO.: 3004.90.92.90 ANDA NO.: 07901 9 THERAPEUTICE USE : - ATOMO XETINE IS USED TO TREAT ATTEN TION-DEFICIT HYPERACTIVITY DI SORDER (ADHD) AS PART OF A TO TAL TREATMENT PLAN, INCLUDING PSYCHOLOGICAL, SOCIAL, AND OTHER TREATMENTS OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68 462039710 FDA PRODUCT CODE N O.:62KCF10 HTS NO.3004.90.925 5 ANDA NO.:91672 THERAPEUTIC E USE: -TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS E OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PR ODUCT CODE NO.:62KCF10 HTS N O.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE ROPINIROLE T AB 0.5MG 100 NDC CODE:6846202 5401 FDA PRODUCT CODE NO.:-6 2 J C A 17 H. T. S NO.: 3004 .90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT O F PARKINSONISM CLOTRIMAZOL E CREAM 1% 30GM NDC CODE:6846 2018135 FDA PRODUCT CODE NO :61 W C J 04 HTS NO.3004.90.9 240 ANDA NO.90-219 THERAPEUT ICE USE:-TREATMENT OF CANDID IASIS COMMERCIAL & CUSTOM I NVOICE NO. F22452004926 DT. 1 1.01.2024 F22452004927 DT. 11 .01.2024 F22452004928 DT. 11. 01.2024 S/BILL NO: 6701711 DT 12-JAN-2024 S/BILL NO: 67017 30 DT 12-JAN-2024 S/BILL NO:6 701707 DT 12-JAN-2024 NET WT. 9,409.37 KGS 12 DATA LOGGE RS SET TEMPERATURE : +20 DE GREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PA RTY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWI TZERLAND |
HS 300490 |
2024-02-28 |
40 PKG |
9487.5KG |
40 PALLETS 3137 CARTONS PH ARMACEUTICALS AS UNDER MUPI ROCIN CREAM 2% 15GM NDC CODE: 68462056417 FDA PRODUCT CODE NO.: 61GCJ82 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 201587 THERAPEUTICE USE: - TOPICAL ANTI-BACTERIAL NAPROXEN TA B 500MG 30 NDC CODE:684620190 30 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:-78-250 THE RAPEUTICE USE:-ANTI-INFLAMMAT ORY, ANALGESIC NAPROXEN TA B 500MG 500 NDC CODE:68462019 005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004. 90.92.40 ANDA NO.:-78-250 TH ERAPEUTICE USE:-ANTI-INFLAMMA TORY, ANALGESIC CARVEDILOL TAB 3.125MG 500 NDC CODE:684 62016205 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90. 9221 ANDA NO.78-251 THERAPEU TICE USE:-BETA- ADRENOACEPTO R ANTAGONIST OMEPRAZOLE DR CAP 40MG 100 NDC CODE:684620 39701 FDA PRODUCT CODE NO.:6 2KCF10 HTS NO.3004.90.9255 A NDA NO.:91672 THERAPEUTICE US E: -TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 50MG 60 NDC C ODE:68462015360 FDA PRODUCT C ODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :- 77-627 THERAPEUTICE USE:- ANTICONVULSANT OMEPRAZOLE D R CAP 40MG 90 NDC CODE:684620 39790 FDA PRODUCT CODE NO.:6 2KCF10 HTS NO.3004.90.9255 A NDA NO.:91672 THERAPEUTICE US E: -TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE ZONISAMIDE CAP 25MG 100 NDC CODE:68462012801 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO .:-77-651 THERAPEUTICE USE:- ANTISEIZURE DRUG PRAMIPEXOL E TAB 1.5MG 90 NDC CODE:68462 033490 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 30 04.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN PA RKINSON#S DISEASE OMEPRAZOL E DR CAP 40MG 90 NDC CODE:684 62039790 FDA PRODUCT CODE NO .:62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GA STROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOIC E NO. F22452004892 DT. 09.01. 2024 F22452004887 DT. 09.01.2 024 F22452004889 DT. 09.01.20 24 F22452004888 DT. 09.01.202 4 F22452004893 DT. 09.01.2024 F22452004901 DT. 10.01.2024 S/BILL NO: 6659998 DT 10-JAN- 2024 S/BILL NO: 6656859 DT 10 -JAN-2024 S/BILL NO: 6656861 DT 10-JAN-2024 S/BILL NO: 665 8461 DT 10-JAN-2024 S/BILL NO : 6656860 DT 10-JAN-2024 S/BI LL NO: 6659141 DT 10-JAN-2024 NET WT. 7774.591 KGS 02 DA TA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2024-02-02 |
22 PKG |
3335.32KG |
22 PALLETS 1225 CARTONS PH ARMACEUTICALS AS UNDER ESTR ADIOL VAG INSERTS 10MCG 8 NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA N O.:210264 THERAPEUTICE USE:TH E TREATMENT OF ATROPIC VAGIN ITIS DUE TO MENOPAUSE. DRO SPIRENONE/EE TAB 3/0.03MG 84 NDC CODE:68462073329 FDA PROD UCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 AND A NO.: 204848 THERAPEUTICE US E: - CONTRACEPTION TO PREVENT PREGNANCY COMMERCIAL & CU STOM INVOICE NO. F22452004758 DT. 31.12.2023 F22452004825 DT. 31.12.2023 S/BILL NO:6460 880 DT 01-JAN-2024 S/BILL NO: 6460878 DT 01-JAN-2024 NET WT . 2375.400 KGS 02 DATA LOGG ERS SET TEMPERATURE : +20 DEG REES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA |
HS 642800 |
2024-02-02 |
18 PKG |
3055.45KG |
18 PALLETS 892 CARTONS PHA RMACEUTICALS AS UNDER HAILE Y FE 1.5/30 TAB 1.5MG/30MCG-75 MG 84 NDC CODE:68462050329 F DA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.:206597 THERAPEUT ICE USE: HORMONE MEDICATION I S USED TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F22452004779 DT. 31.12.2 023 S/BILL NO: 6460879 DT. 01 -JAN-2024 NET WT. 2,269.25 K GS 18 DATA LOGGERS SET TEMP ERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 S WITZERLAND |
HS 652500 |
2024-02-02 |
32 PKG |
4012.55KG |
32 PALLETS 1112 CARTONS PH ARMACEUTICALS AS UNDER LEVO NORGESTREL/EE TAB 0.15/0.03MG 273 NDC CODE:68462067295 FDA PRODUCT CODE NO.: 64 G D A 2 9 H. T. S NO.: 3006.60.0000 ANDA NO.: 203164 THERAPEUTIC E USE: - CONTRACEPTION TO PRE VENT PREGNANCY NORETHINDRO NE TAB 0.35MG 84 NDC CODE:684 62030529 FDA PRODUCT CODE NO. : 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTIO N OF PREGNANCY. ESTRADIOL V AG INSERTS 10MCG 8 NDC CODE:6 8462071171 FDA PRODUCT CODE N O.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:2102 64 THERAPEUTICE USE:THE TREA TMENT OF ATROPIC VAGINITIS DU E TO MENOPAUSE. COMMERCIAL & CUSTOM INVOICE NO. F224520 04740 DT. 30.12.2023 F2245200 4747 DT. 30.12.2023 F22452004 749 DT. 30.12.2023 S/BILL NO: 6465166 DT 02-JAN-2024 S/BIL L NO:6465154 DT 02-JAN-2024 S /BILL NO:6466046 DT 02-JAN-202 4 NET WT. 2878.440 KGS 02 DATA LOGGERS SET TEMPERATUR E : +20 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 642900 |
2024-02-02 |
37 PKG |
6926.93KG |
37 PALLETS 2335 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO .:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA RUFINAMIDE TAB 400MG 120 NDC CODE:6846207140 8 61 M C A 99 3004.90.92.30 205075 TO USED WITH OTHER M EDICATIONS TO PREVENT OR CONT ROL SEIZURES (EPILEPSY) ASSO CIATED WITH LENNOX-GASTAUT S YNDROME (LGS SAXAGLIPTIN TA B 5MG 30 NDC CODE:68462072730 FDA PRODUCT CODE NO.:61 P C A 99 H. T. S NO.: 3004.90.9 220 ANDA NO.:205994 THERAPEU TICE USE: :#ANTI-DIABETIC AGE NT INDOMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA PRODUCT CODE: 62 GCE42 H. T . S NO.:3004.90.92.40 ANDA N O.203501 THERAPEUTIC USE: IN DOMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT ST IFFNESS CAUSED BY ARTHRITIS, GOUT, BURSITIS, AND TENDONITI S. IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CON DITIONS. THIS MEDICATION IS K NOWN AS A NONSTEROIDAL ANTI- INFLAMMATORY DRUG (NSAID). .. . THIS EFFECT HELPS TO DECRE ASE SWELLING AND PAIN. FEN OFIBRATE CAP 200MG 100 NDC CO DE:68462058201 FDA PRODUCT CO DE NO.: 61 JCE 09 H. T. S NO .: 3004.90.92.20 ANDA NO.: 2 05566 THERAPEUTICE USE: - IN DICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDE S AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTERO LEMIA OR MIXED DYSLIPIDEMIA FENOFIBRATE CAP 134MG 100 N DC CODE:68462058101 FDA PRODU CT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA N O.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIVE TH ERAPY TO DIET FOR THE REDUCTI ON OF LDL-C, TOTAL-C, TRIGLYC ERIDES AND APO B IN DULT PAT IENTS WITH PRMARY HYPERCHOLE STEROLEMIA OR MIXED DYSLIPIDE MIA NAPROXEN SOD TAB 275MG 100 NDC CODE:68462017801 FDA PRODUCT CODE NO.:-62 G C A 5 0 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-314 THERAPEUTI CE USE:-ANTI -INFLAMMATORY, A NALGESIC TACROLIMUS OINT 0. 1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49. 00.50 ANDA NO.: 210393 THERA PEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATME NT OF MODERATE-TO-SEVERE ATO PIC DERMATITIS (ECZEMA). T ACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS CAP 0.5MG 100 NDC CODE:6846206850 1 FDA PRODUCT CODE NO.: 64 T C E 08 H. T. S NO.:3004.90. 92.15 ANDA NO.: 206662 THERA PEUTICE USE: :#TO PREVENT REJ ECTION OF A KIDNEY,TO PREVENT REJECTION OF A KIDNEY,LIVER TRANSPLANT TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CO DE : 64 T C E 08 ANDA NO.2066 62 THERAPEUTIC USE : TO PREV ENT REJECTION OF A KIDNEY,HEA RT, OR LIVER TRANSPLANT CO MMERCIAL & CUSTOM INVOICE NO. F22487001748 DT. 30.12.2023 F22487001749 DT. 30.12.2023 S /BILL NO: 4020294 DT:30/12/202 3 S/BILL NO: 4020292 DT:30/12 /2023 NET WT. 3110.165 KGS 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2024-02-02 |
42 PKG |
6262.86KG |
42 PALLETS 2450 CARTONS PH ARMACEUTICALS AS UNDER DROS PIRENONE/EE TAB 3/0.03MG 84 N DC CODE:68462073329 FDA PRODU CT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204848 THERAPEUTICE USE : - CONTRACEPTION TO PREVENT PREGNANCY ASHLYNA TAB 0.15 /0.03MG-0.01MG 182 NDC CODE:6 8462064693 FDA PRODUCT CODE N O.: 64 G D A 2 H. T. S NO.: 3006.60.0000 ANDA NO.: 20316 3 THERAPEUTICE USE: - INDICA TED FOR USE BY WOMEN TO PREVE NT PREGNANCY CARVEDILOL TA B 6.25MG 500 NDC CODE:6846201 6305 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST ONDAN SETRON TAB 8MG 30 NDC CODE:68 462010630 FDA PRODUCT CODE N O.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77-5 35 THERAPEUTICE USE:-ANTI -E METIC COMMERCIAL & CUSTOM I NVOICE NO. F22452004826 DT. 3 1.12.2023 F22452004827 DT. 31 .12.2023 F22452004795 DT. 31. 12.2023 F22452004800 DT. 31.1 2.2023 S/BILL NO: 6477035 DT: 02-JAN-24 S/BILL NO: 6477050 DT:02-JAN-24 S/BILL NO:64770 37 DT:02-JAN-24 S/BILL NO: 64 77051 DT:02-JAN-24 NET WT. 47 11.450 03 DATA LOGGERS HU MIDITY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 653900 |
2024-02-02 |
51 PKG |
12037.18KG |
51 PALLETS 4714 CARTONS PH ARMACEUTICALS AS UNDER PRAM IPEXOLE TAB 0.125MG 90 NDC CO DE:68462033090 FDA PRODUCT CO DE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USE D IN PARKINSON#S DISEASE R OPINIROLE TAB 2MG 100 NDC COD E:68462025601 FDA PRODUCT COD E NO.:-62 J C A 17 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TR EATMENT OF PARKINSONISM ON DANSETRON TAB 4MG 30 NDC CODE :68462010530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANTI -EMETIC CARVEDILOL TAB 25 MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92 .20 ANDA NO.:- 78-251 THERAP EUTICE USE:-BETA- ADRENOACEP TOR ANTAGONIST TELMISARTAN TAB 40MG 30 NDC CODE:6846202 0030 FDA PRODUCT CODE NO.: 6 2 O C A 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.:090032 TH ERAPEUTICE USE: INDICATED FOR THE TREATMENT OF HYPERTENSI ON, TO LOWER BLOOD PRESSURE ZONISAMIDE CAP 100MG 100 ND C CODE:68462013001 FDA PRODUC T CODE NO.:-61 M C E 44 H. T . S NO.: 3004.49.00.20 ANDA NO.:-77-651 THERAPEUTICE USE :-ANTISEIZURE DRUG ROPINIRO LE TAB 0.5MG 100 NDC CODE:684 62025401 FDA PRODUCT CODE NO .:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-1 35 THERAPEUTICE USE:-TREATME NT OF PARKINSONISM CARVEDI LOL TAB 6.25MG 500 NDC CODE:6 8462016305 FDA PRODUCT CODE N O : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78 -251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST PRAVASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PRO DUCT CODE NO.: 61 J C A 13 H . T. S NO.: 3004.90.92.20 AN DA NO.: 77-987 THERAPEUTICE U SE: -HYPOLIPDAEMIC PRAVAST ATIN SOD TAB 40MG 90 NDC CODE :68462019790 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO .: 3004.90.92.20 ANDA NO.: 7 7-987 THERAPEUTICE USE: -HYP OLIPDAEMIC GABAPENTIN TAB 6 00MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-662 THERAP EUTICE USE:-ANTICONVULSANT A GENT OXCARBAZEPINE TAB 600M G 100 NDC CODE:68462013901 F DA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92. 30 ANDA NO.:-77-802 THERAPEU TICE USE:-ANTI CONVULSANT AGE NT COMMERCIAL & CUSTOM INVO ICE NO. F22452004648 DT. 28.1 2.2023 F22452004649 DT. 28.12 .2023 F22452004696 DT. 29.12. 2023 F22452004697 DT. 29.12.2 023 F22452004735 DT. 30.12.20 23 F22452004752 DT. 30.12.202 3 S/BILL NO: 6460329 DT 01-JA N-2024 S/BILL NO:6460324 DT 0 1-JAN-2024 S/BILL NO: 6460328 DT 01-JAN-2024 S/BILL NO: 64 60323 DT 01-JAN-2024 S/BILL N O:6460326 DT 01-JAN-2024 S/BI LL NO: 6460325 DT 01-JAN-2024 NET WT. 9997.284 KGS 02 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 684620 |
2024-02-02 |
3 PKG |
687.66KG |
3 PALLETS 86 CARTONS PHARM ACEUTICALS AS UNDER NITROGL YCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA PRO DUCT CODE NO.: 66 S C A 28 H . T. S NO.: 3004.90.9020 AND A NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE,A ND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD F LOW TO THE HEART COMMERCIA L & CUSTOM INVOICE NO. F22487 001750 DT. 30.12.2023 S/BILL NO: 4020297 DT: 30/12/2023 NE T WT. 45.82 KGS 03 DATA LOG GERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE DU PORT 2 N EUCHATEL - 2000 SWITZERLAND |
HS 662800 |
2024-02-02 |
30 PKG |
5152.9KG |
30 PALLETS 1943 CARTONS P HARMACEUTICALS AS UNDER TAC ROLIMUS OINT 0.1% 60GM NDC CO DE:68462053465 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). EZETIMIBE-SIMVA T AB 10/20MG 30 NDC CODE:684620 32230 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 300 4.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: :#LIPID LOW ERING AGENT CLINDAMYCIN HCL CAP 150MG 500 NDC CODE:68462 014305 FDA PRODUCT CODE NO.: 56 J C E 20 H. T. S NO.: 294 1.90.5000 ANDA NO.:216957 TH ERAPEUTICE USE: :#TREATMENT O F NUMEROUS INFECTIONS, INCLUD ING BUT NOT LIMITED TO SEPT ICEMIA,INTRAABDOMINAL INFECTI ONS, LOWER RESPIRATORY INFEC TIONS, GYNECOLOGICAL INFECTIO NS, BONE AND JOINT INFECTIONS , AND SKIN AND SKIN STRUCTURE INFECTIONS RUFINAMIDE TAB 400MG 120 NDC CODE:684620714 08 61 M C A 99 3004.90.92.30 205075 TO USED WITH OTHER MEDICATIONS TO PREVENT OR CON TROL SEIZURES (EPILEPSY) ASS OCIATED WITH LENNOX-GASTAUT SYNDROME (LGS CLINDAMYCIN H CL CAP 150MG 500 NDC CODE:684 62014305 FDA PRODUCT CODE NO .:56 J C E 20 H. T. S NO.: 2 941.90.5000 ANDA NO.:216957 THERAPEUTICE USE: :#TREATMENT OF NUMEROUS INFECTIONS, INCL UDING BUT NOT LIMITED TO SE PTICEMIA,INTRAABDOMINAL INFEC TIONS, LOWER RESPIRATORY INF ECTIONS, GYNECOLOGICAL INFECT IONS, BONE AND JOINT INFECTIO NS, AND SKIN AND SKIN STRUCTU RE INFECTIONS TACROLIMUS C AP 1MG 100 NDC CODE:684620686 01 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.2 06662 THERAPEUTIC USE : TO P REVENT REJECTION OF A KIDNEY, HEART, OR LIVER TRANSPLANT BISOPROLOL-HCTZ TAB 5/6.25MG 100 NDC CODE:68462087901 FDA PRODUCT CODE NO.: 62 O D A 1 8 H. T. S NO.: 3004.40.00.20 ANDA NO.: 215995 THERAPEUTI CE USE: BISOPROLOL FUMARATE A ND HYDROCHLOROTHIAZIDE TABLE TS ARE INDICATED IN THE MANA GEMENT OF HYPERTENSION. BI SOPROLOL-HCTZ TAB 10/6.25MG 50 0 NDC CODE:68462088005 FDA P RODUCT CODE NO.: 62 O D A 18 H. T. S NO.: 3004.40.00.20 ANDA NO.: 215995 THERAPEUTICE USE: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATED IN THE MANAGE MENT OF HYPERTENSION. SOLI FENACIN SUCCINATE TAB 10MG 30 NDC CODE:68462038730 FDA PRO DUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICATED FOR TH E TREATMENT OF OVERACTIVE BL ADDER WITH SYMPTOMS OF URGE U RINARY INCONTINENCE, URGENCY AND URINARY FREQUENCY SOLI FENACIN SUCCINATE TAB 10MG 90 NDC CODE:68462038790 FDA PRO DUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICATED FOR TH E TREATMENT OF OVERACTIVE BL ADDER WITH SYMPTOMS OF URGE U RINARY INCONTINENCE, URGENCY AND URINARY FREQUENCY COMM ERCIAL & CUSTOM INVOICE NO. F 22487001778 DT. 31.12.2023 F2 2487001779 DT. 31.12.2023 F22 487001780 DT. 31.12.2023 F224 87001789 DT. 31.12.2023 F2248 7001797 DT. 31.12.2023 F22487 001823 DT. 04.01.2024 F224870 01824 DT. 04.01.2024 S/BILL N O: 4000147 DT: 04/01/2024 S/B ILL NO: 4000145 DT: 04/01/2024 S/BILL NO: 4000137 DT: 04/01 /2024 S/BILL NO: 4000142 DT: 04/01/2024 S/BILL NO: 4000144 DT: 04/01/2024 S/BILL NO: 40 00149 DT: 04/01/2024 S/BILL N O: 4000148 DT: 04/01/2024 NET WT. 1732.873 KGS HUMIDITY:6 5% SET TEMPERATURE : +20 DEGR EES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (G SSA) PLACE DU PORT 2 NEUCHAT EL - 2000 SWITZERLAND |
HS 300490 |
2024-01-31 |
42 PKG |
6059.19KG |
42 PALLETS 1986 CARTONS PH ARMACEUTICALS AS UNDER ESTR ADIOL VAG INSERTS 10MCG 8 NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA N O.:210264 THERAPEUTICE USE:TH E TREATMENT OF ATROPIC VAGIN ITIS DUE TO MENOPAUSE. NOR ETHINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO. :-91-090 THERAPEUTICE USE:- SECONDARY AMENORRHEA,ENDOMETR IOS IS AND ABNORMAL UTERINE BLEEDING NORETH ACE/EE TAB 0.5MG/2.5MCG 84 NDC CODE:6846 2065629 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3 006.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - TREATME NT OF MODERATE TO SEVERE VASO MOTOR SYMPTOMS DUE TO MENOPA USE; OSTEOPOROSIS PREVENTION NORETH ACE/EE TAB 0.5MG/2.5 MCG 84 NDC CODE:68462065629 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00 .00 ANDA NO.: 203038 THERAPE UTICE USE: - TREATMENT OF MOD ERATE TO SEVERE VASOMOTOR SY MPTOMS DUE TO MENOPAUSE; OST EOPOROSIS PREVENTION DROSPI RENONE/EE TAB 3/0.02MG 84 NDC CODE:68462072029 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA N O.: 204296 THERAPEUTICE USE: - ORAL CONTRACEPTIVE COMME RCIAL & CUSTOM INVOICE NO. F2 2452004568 DT. 23.12.2023 F22 452004569 DT. 23.12.2023 F224 52004570 DT. 23.12.2023 F2245 2004586 DT. 24.12.2023 S/BILL NO: 6262803 DT 23-DEC-2023 S /BILL NO: 6262787 DT 23-DEC-20 23 S/BILL NO: 6263587 DT 23-D EC-2023 S/BILL NO: 6276852 DT 25-DEC-2023 NET WT. 4382.23 0 KGS 02 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 642800 |
2024-01-31 |
30 PKG |
7383.25KG |
30 PALLETS 1690 CARTONS PH ARMACEUTICALS AS UNDER VERA PAMIL HCL ER TAB 180MG 100 ND C CODE:68462029301 FDA PRODUC T CODE NO.: 62 O C B 13 H. T . S NO.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - -ANGINA VERAPAMIL HCL E R TAB 180MG 500 NDC CODE:6846 2029305 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3 004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - -ANGINA NAPROXEN TAB 375MG 500 ND C CODE:68462018905 FDA PRODUC T CODE NO.:-62 G C A 49 H. T . S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE :-ANTI-INFLAMMATORY, ANALGESI C ATOMOXETINE CAP 40MG 30 NDC CODE:68462026830 FDA PROD UCT CODE NO.: 64 UCA 99 H. T . S NO.: 3004.90.92.90 ANDA NO.: 079019 THERAPEUTICE USE: - ATOMOXETINE IS USED TO TR EAT ATTENTION-DEFICIT HYPERAC TIVITY DISORDER (ADHD) AS PAR T OF A TOTAL TREATMENT PLAN, INCLUDING PSYCHOLOGICAL, SOCI AL, AND OTHER TREATMENTS. ATOMOXETINE CAP 100MG 30 NDC CODE:68462027130 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.: 3004.90.92.90 ANDA NO.: 079019 TREATMENT OF ATTENTIO N - DEFICIT/HYPERACIVITY DIS ORDER (ADHD ZOLMITRIPTAN OD T 5MG 3UD NDC CODE:6846205003 3 FDA PRODUCT CODE NO.: 63OC A08 H. T. S NO.: 3004.90.92. 28 ANDA NO.: 202560 THERAPEU TICE USE: :#ANALGESIC/ HUMAN RX/SINGLE INGREDIENT PROMPT RELEASE TABLETS ZOLMITRIPTAN (ANALGESIC) CLOTRIMAZOLE C REAM 1% 30GM NDC CODE:6846201 8135 FDA PRODUCT CODE NO :61 W C J 04 H. T. S NO.: 3004. 90.92.45 ANDA NO.: 90-219 TH ERAPEUTICE USE: TREATMENT OF CANDIDIASIS COMMERCIAL & CU STOM INVOICE NO. F22452004564 DT. 23.12.2023 F22452004562 DT. 23.12.2023 F22452004583 D T. 23.12.2023 F22452004584 DT . 23.12.2023 S/BILL NO: 62871 26 DT 26-DEC-2023 S/BILL NO: 6297034 DT 26-DEC-2023 S/BILL NO: 6279554 DT 25-DEC-2023 S /BILL NO: 6279549 DT 25-DEC-20 23 NET WT. 5410.750 KGS 02 DATA LOGGERS SET TEMPERATU RE : +20 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 621300 |
2024-01-31 |
39 PKG |
6892.91KG |
39 PALLETS 1868 CARTONS PH ARMACEUTICALS AS UNDER NORG EST/EE TAB 0.25/0.035MG 84 ND C CODE:68462030929 FDA PRODUC T CODE NO.: 65 J D A 27 H. T . S NO.: 3006.60.00.00 ANDA NO.: 200538 THERAPEUTICE USE: - ORAL CONTRACEPTIVES DRO SPIRENONE/EE TAB 3/0.02MG 84 NDC CODE:68462072029 FDA PROD UCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 AND A NO.: 204296 THERAPEUTICE US E: - ORAL CONTRACEPTIVE CO MMERCIAL & CUSTOM INVOICE NO. F22452004643 DT. 28.12.2023 S/BILL NO: 6381715 DT 29-DEC-2 023 NET WT. 5216.370 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGREE S TEMPERATURE RANGE : +15 DEG REES TO +25 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A |
HS 652700 |
2024-01-31 |
44 PKG |
9911.61KG |
44 PALLETS 2675 CARTONS PH ARMACEUTICALS AS UNDER VERA PAMIL HCL ER TAB 240MG 500 ND C CODE:68462026005 FDA PRODUC T CODE NO.: 62 O C B 13 H. T . S NO.: 3004.90.92.20 ANDA NO.:-78-906 THERAPEUTICE USE :-ANGINA OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:6846203961 0 FDA PRODUCT CODE NO.: 62KC F10 H. T. S NO.: 3004.90.916 0 ANDA NO.: 91672 THERAPEUTI CE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DIS EASE OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.: 62KCF10 H . T. S NO.: 3004.90.9160 AND A NO.: 91672 THERAPEUTICE USE : - -TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 FDA PRO DUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTROES OPHAGEAL REFLUX DISEASE ON DANSETRON TAB 4MG 30 NDC CODE :68462010530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANTI -EMETIC COMMERCIAL & CUST OM INVOICE NO. F22452004612 D T. 26.12.2023 F22452004621 DT . 27.12.2023 F22452004626 DT. 28.12.2023 S/BILL NO: 636320 9 DT 28-DEC-2023 S/BILL NO: 6 365330 DT 28-DEC-2023 S/BILL NO: 6363216 DT 28-DEC-2023 NE T WT. 8169.584 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +20 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA |
HS 621300 |
2024-01-31 |
40 PKG |
5716.72KG |
40 PALLETS 1982 CARTONS PH ARMACEUTICALS AS UNDER MARL ISSA TAB 0.15/0.03MG 84 NDC C ODE:68462038829 FDA PRODUCT C ODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 091452 THERAPEUTICE USE: ORA L CONTRACEPTIVE DROSPIRENO NE/EE TAB 3/0.02MG 84 NDC COD E:68462072029 FDA PRODUCT COD E NO.: 65 J D A 39 H. T. S N O.: 3006.60.00.00 ANDA NO.: 204296 THERAPEUTICE USE: - OR AL CONTRACEPTIVE COMMERCIA L & CUSTOM INVOICE NO. F22452 004628 DT. 28.12.2023 F224520 04640 DT. 28.12.2023 S/BILL N O: 6373141 DT 28-DEC-2023 S/B ILL NO: 6375512 DT 28-DEC-2023 NET WT. 3969.890 KGS 02 D ATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 847439 |
2024-01-19 |
2 PKG |
210.47KG |
2 PALLETS 128 CARTONS PHAR MACEUTICALS AS UNDER APREPI TANT CAP 80MG 6UD NDC CODE:68 462058476 FDA PRODUCT CODE NO .: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.:20777 7 THERAPEUTICE USE:APREPITAN T IS USED WITH OTHER MEDICATI ONS TO HELP PREVENT NAUSEA AN D VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHERAPY) . THIS MEDICATION IS ALSO USE D TO PREVENT NAUSEA AND VOMI TING AFTER SURGERY. A-EMETIC/ NAUSEANT / HUMAN - RX/SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT NITR OGLYCERIN SUBLING TAB 0.3MG 10 0 NDC CODE:68462063801 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 A NDA NO.:206391 THERAPEUTIC US E: -MEDICATION USED FOR HEAR T FAILURE,HIGH BLOOD PRESSURE ,AND TO TREAT AND PREVENT CHE ST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERC IAL & CUSTOM INVOICE NO. F224 87001626 DT. 13.12.2023 S/BIL L NO: 4019223 DT: 14/12/2024 NET WT. 14.87 KGS 02 DATA LO GGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GL ENMARK SPECIALTY S.A. SWITZER LAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 613200 |
2024-01-19 |
40 PKG |
9642.18KG |
40 PALLETS 4064 CARTONS PH ARMACEUTICALS AS UNDER ACAM PROSATE CALCIUM DR TAB 333MG 1 80 NDC CODE:68462043518 FDA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO.: 3004.90.92.40 ANDA NO.:202229 THERAPEUTICE USE: - FOR TREATING ALCOHOL DEPENDENCE OLMESARTAN MEDO X TAB 20MG 30 NDC CODE:684620 43730 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90 .9220 ANDA NO.: 203281 THERA PEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS , TO LOWER BLOOD PRESSURE ADAPALENE-BPO GEL PUMP 0.1/2.5 % 45GM NDC CODE:68462030147 FDA PRODUCT CODE NO.: 62 S D O 02 H. T. S NO.: 3004.90.92 .45 ANDA NO.: 208108 THERAPE UTICE USE: - USED ON THE SKIN TO TREAT ACNE TOPIRAMATE TAB 25MG 500 NDC CODE:6846201 0805 FDA PRODUCT CODE NO.: 6 1 M C A 40 H. T. S NO.: 3004 .49.00.20 ANDA NO.:077627 TH ERAPEUTICE USE: ANTICONVULSAN T OXCARBAZEPINE TAB 300MG 1 00 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTIC E USE:-ANTI CONVULSANT AGENT TROSPIUM CL TAB 20MG 60 ND C CODE:68462046160 FDA PRODUC T CODE NO.:-61 K C A 69 H. T . S NO.: 3004.49.00.70 ANDA NO.:-91-575 THERAPEUTICE USE: - TREATMENT OF VENOUS DISEAS ES URINARY INCONTINENCE THER APY THEOPHYLLINE ER TAB 600 MG 100 NDC CODE:68462035601 FDA PRODUCT CODE NO.: 63 B C B 30 H. T. S NO.: 3004.90.92 .85 ANDA NO.: 90-355 THERAPE UTICE USE: XANTHINE BRONCHODI LATOR COMMERCIAL & CUSTOM I NVOICE NO. F22452004461 DT. 1 4.12.2023 F22452004465 DT. 15 .12.2023 F22452004468 DT. 15. 12.2023 F22452004469 DT. 15.1 2.2023 S/BILL NO: 6081506 DT 16-DEC-2023 S/BILL NO: 608149 4 DT 16-DEC-2023 S/BILL NO: 6 083781 DT 16-DEC-2023 S/BILL NO: 6081498 DT 16-DEC-2023 NE T WT. 7569.819 KGS 02 DATA L OGGERS SET TEMPERATURE : +2 0 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 609900 |
2024-01-19 |
2 PKG |
363.79KG |
2 PALLETS 121 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 10MG 1000 NDC CODE :68462026210 61 J C A 16 300 4.49.00.10 79172 TO TREAT HI GH CHOLESTEROL AND RELATED CO NDITIONS, AND TO PREVENT CAR DIOVASCULAR DISEASE . COMMERCIAL & CUSTOM INVOICE NO . F22452004414 DT. 12.12.2023 S/BILL NO: 6005163 DT 13-DEC -2023 NET WT. 314.79 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE DU PO RT 2 NEUCHATEL - 2000 SWITZE RLAND |
HS 684620 |
2024-01-19 |
40 PKG |
7825.96KG |
40 PALLETS 2274 CARTONS PH ARMACEUTICALS AS UNDER VIOR ELE TAB 0.15/0.02-0.01MG 84 N DC CODE:68462031829 FDA PRODU CT CODE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTICE USE : - ORAL CONTRACEPTIVES NO RETHINDRONE ACE TAB 5MG 50 ND C CODE:68462030450 FDA PRODUC T CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO .:-91-090 THERAPEUTICE USE:- SECONDARY AMENORRHEA,ENDOMET RIOS IS AND ABNORMAL UTERINE BLEEDING OLMESARTAN MEDOX TAB 20MG 90 NDC CODE:68462043 790 FDA PRODUCT CODE NO.: 62 CCA68 H. T. S NO.: 3004.90.9 220 ANDA NO.: 203281 THERAPE UTICE USE: - -TREATMENT OF H YPERTENSION, ALONE OR WITH OT HER ANTIHYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE CL OTRIMAZOLE CREAM 1% 15GM NDC CODE:68462018117 FDA PRODUCT CODE NO.:61#W#C#J#04 H. T. S NO.: 3004.90.92.45 ANDA NO. : 90-219 THERAPEUTICE USE: T REATMENT OF CANDIDIASIS COM MERCIAL & CUSTOM INVOICE NO. F22452004411 DT. 12.12.2023 F 22452004413 DT. 12.12.2023 F2 2452004412 DT. 12.12.2023 F22 452004416 DT. 12.12.2023 S/BI LL NO: 6005159 DT 13-DEC-2023 S/BILL NO: 6007613 DT 13-DEC- 2023 S/BILL NO: 6005168 DT 13 -DEC-2023 S/BILL NO: 6005694 DT 13-DEC-2023 NET WT. 6098.8 90 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 642700 |
2024-01-19 |
40 PKG |
9705.23KG |
40 PALLETS 2128 CARTONS PH ARMACEUTICALS AS UNDER LAMO TRIGINE TAB CD 25MG 100 NDC C ODE:68462022901 FDA PRODUCT C ODE NO.:- 61 M C A 38 H. T. S NO.: 3004.90.92.30 ANDA NO .:-79 # 099 THERAPEUTICE USE: - ANTICONVULSANT THEOPHYLL INE ER TAB 400MG 100 NDC CODE :68462038001 FDA PRODUCT CODE NO.: 63 B C B 30 H. T. S NO .: 3004.90.92.85 ANDA NO.: 9 0-355 THERAPEUTICE USE: XANT HINE BRONCHODILATOR CLOTRIM AZOLE CREAM 1% 30GM NDC CODE: 68462018135 FDA PRODUCT CODE NO :61 W C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90- 219 THERAPEUTICE USE: TREATM ENT OF CANDIDIASIS CLOTRIMA ZOLE CREAM 1% 45GM NDC CODE:6 8462018147 FDA PRODUCT CODE N O :61 W C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-2 19 THERAPEUTICE USE: TREATME NT OF CANDIDIASIS NORETHIND RONE ACE TAB 5MG 50 NDC CODE: 68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.:-91-0 90 THERAPEUTICE USE:- SECOND ARY AMENORRHEA,ENDOMETRIOS I S AND ABNORMAL UTERINE BLEEDI NG HAILEY 1.5/30 TAB 1.5MG/ 30MCG 63 NDC CODE:68462050481 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60. 00.00 ANDA NO.: 209297 THERA PEUTICE USE: - CONTRACEPTION TO PREVENT PREGNANCY COM MERCIAL & CUSTOM INVOICE NO. F22452004444 DT. 14.12.2023 F 22452004445 DT. 14.12.2023 F2 2452004443 DT. 14.12.2023 F22 452004456 DT. 14.12.2023 F224 52004457 DT. 14.12.2023 S/BIL L NO: 6059648 DT 15-DEC-2023 S/BILL NO: 6059649 DT 15-DEC-2 023 S/BILL NO: 6059674 DT 15- DEC-2023 S/BILL NO: 6059645 D T 15-DEC-2023 S/BILL NO: 6059 654 DT 15-DEC-2023 NET WT. 6 500.780 KGS 20 DATA LOGGERS SET TEMPERATURE : +20 DEGR EES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA NOTIFY PART Y:3 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU P ORT 2 NEUCHATEL - 2000 SWITZ ERLAND |
HS 684620 |
2024-01-19 |
41 PKG |
9601.35KG |
41 PALLETS 2604 CARTONS PH ARMACEUTICALS AS UNDER EZET IMIBE TAB 10MG 30 NDC CODE:68 462022630 FDA PRODUCT CODE NO .: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #078 560 THERAPEUTICE USE: LIPID LOWERING AGENT PRAVASTATIN SOD TAB 80MG 90 NDC CODE:6846 2019890 FDA PRODUCT CODE NO. :-61 J C A 13 H. T. S NO.: 3 004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDA EMIC PRAVASTATIN SOD TAB 20 MG 500 NDC CODE:68462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92 .20 ANDA NO.:-77-987 THERAPE UTICE USE:-HYPOLIPDAEMIC C ARVEDILOL TAB 25MG 500 NDC CO DE:68462016505 FDA PRODUCT CO DE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.: - 78-251 THERAPEUTICE USE:-B ETA- ADRENOACEPTOR ANTAGONIS T PIMECROLIMUS CREAM 1% 100 GM NDC CODE:68462060994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTIC E USE: - AS SECOUND-LINE THER APY FOR THE SHORT-TERM AND N ON-CONTINUOS CHRONIC TRERTMEN T OF MILD TO MODERATE ATOPIC DERMATITIS IN NON- IMMUNOCO MPROMISED ADULT AND CHILDREN 2 YEARS OF AGE PIMECROLIMU S CREAM 1% 60GM NDC CODE:6846 2060965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECO UND-LINE THERAPY FOR THE SHOR T-TERM AND NON-CONTINUOS CHRO NIC TRERTMENT OF MILD TO MOD ERATE ATOPIC DERMATITIS IN N ON- IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PROD UCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 AND A NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERMAT ITIS (ECZEMA). TACROLIMUS OINT 0.1% 30GM NDC CODE:68462 053435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 30 04.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIM US IS A TOPICAL IMMUNOSUPPRES SIVE OINTMENT USED FOR THE T REATMENT OF MODERATE-TO-SEVER E ATOPIC DERMATITIS (ECZEMA) . POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FD A PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.9 0 ANDA NO.: 202868 THERAPEUT ICE USE: - TREATMENT OR PREVE NTION OF HYPOKALEMIA COMME RCIAL & CUSTOM INVOICE NO. F2 2487001625 DT. 13.12.2023 F22 487001627 DT. 13.12.2023 F224 87001628 DT. 13.12.2023 F2248 7001629 DT. 13.12.2023 S/BILL NO: 4019222 DT: 14/12/2024 S /BILL NO: 4019224 DT: 14/12/20 24 S/BILL NO: 4019220 DT: 14/ 12/2024 S/BILL NO: 4019222 DT : 14/12/2024 NET WT. 6496.525 KGS 02 DATA LOGGERS SET T EMPERATURE : +20 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA |
HS 611500 |
2024-01-16 |
42 PKG |
11781.81KG |
42 PALLETS 3441 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 300MG 100 NDC C ODE:68462013801 FDA PRODUCT C ODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-802 THERAPEUTICE USE:-AN TI CONVULSANT AGENT OLMESA RTAN MEDOX TAB 40MG 30 NDC CO DE:68462043830 FDA PRODUCT CO DE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 2032 81 THERAPEUTICE USE: - -TREA TMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSI VE AGENTS, TO LOWER BLOOD PRE SSURE DICLOFENAC SOD GEL 3% 100GM NDC CODE:68462035594 FDA PRODUCT CODE NO.:62 G C J 18 H. T. S NO.: 3004.90.92. 40 ANDA NO.:208301 THERAPEUT ICE USE: - USED FOR THE RELIE F OF JOINT PAIN OF OSTEOARTHR ITIS OLMESARTAN MEDOX TAB 4 0MG 30 NDC CODE:68462043830 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE: - -TREATMENT OF HYPERT ENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS, TO L OWER BLOOD PRESSURE COMMERC IAL & CUSTOM INVOICE NO. F224 52004493 DT. 18.12.2023 F2245 2004496 DT. 18.12.2023 F22452 004506 DT. 18.12.2023 S/BILL NO: 6127407 DT 18-DEC-2023 S/ BILL NO: 6127366 DT 18-DEC-202 3 S/BILL NO: 6134120 DT 18-DE C-2023 NET WT. 9739.126 KGS 02 DATA LOGGERS SET TEMPER ATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 621800 |
2024-01-16 |
2 PKG |
344.74KG |
2 PALLETS 120 CARTONS PHAR MACEUTICALS AS UNDER ACYCLO VIR OINT 5% 30GM NDC CODE:684 62074635 FDA PRODUCT CODE NO. : 62 V C J 18 H. T. S NO.: 3004.49.00.50 ANDA NO.: 20551 0 THERAPEUTICE USE: - AN ANT IVIRAL MEDICINE USED TO TREAT OR PREVENT INFECTIONS CAUSED BY CERTAIN KINDS OF VIRUSES. EXAMPLES OF THESE INFECTIONS INCLUDE HERPES AND SHINGLES COMMERCIAL & CUSTOM INVOICE NO. F22452004495 DT. 18.12.2 023 S/BILL NO: 6127376 DT 18- DEC-2023 02 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK SP ECIALTY S.A. SWITZERLAND (GSS A) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 621800 |
2024-01-16 |
40 PKG |
6368.09KG |
40 PALLETS 2400 CARTONS PH ARMACEUTICALS AS UNDER ESTR ADIOL VAG INSERTS 10MCG 8 NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA N O.:210264 THERAPEUTICE USE:TH E TREATMENT OF ATROPIC VAGIN ITIS DUE TO MENOPAUSE. COM MERCIAL & CUSTOM INVOICE NO. F22452004534 DT. 21.12.2023 S /BILL NO: 6217508 DT 21-DEC-20 23 NET WT. 4550.400 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 642800 |
2024-01-16 |
40 PKG |
8013.3KG |
40 PALLETS 2798 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAP 40MG 1000 NDC C ODE:68462039710 FDA PRODUCT C ODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE USE: - TREATME NT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE TROSPIUM CL TAB 20MG 60 NDC CODE:6846204 6160 FDA PRODUCT CODE NO.:-6 1 K C A 69 H. T. S NO.: 3004 .49.00.70 ANDA NO.:-91-575 T HERAPEUTICE USE:- TREATMENT O F VENOUS DISEASES URINARY IN CONTINENCE THERAPY CARVEDI LOL TAB 3.125MG 500 NDC CODE: 68462016205 FDA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68462039710 FDA PRO DUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO. :91672 THERAPEUTICE USE: - T REATMENT OF TREAT GASTROESOPH AGEAL REFLUX DISEASE OLMES ARTAN MEDOX TAB 40MG 30 NDC C ODE:68462043830 FDA PRODUCT C ODE NO.: 62CCA68 H. T. S NO. : 3004.90.9220 ANDA NO.: 203 281 THERAPEUTICE USE: - -TRE ATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENS IVE AGENTS, TO LOWER BLOOD PR ESSURE TROSPIUM CL TAB 20MG 60 NDC CODE:68462046160 FDA PRODUCT CODE NO.:-61 K C A 6 9 H. T. S NO.: 3004.49.00.70 ANDA NO.:-91-575 THERAPEUTI CE USE:- TREATMENT OF VENOUS DISEASES URINARY INCONTINENC E THERAPY CARVEDILOL TAB 3 .125MG 500 NDC CODE:684620162 05 FDA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO.: 3004.9 0.92.20 ANDA NO.:- 78-251 TH ERAPEUTICE USE:-BETA- ADRENO ACEPTOR ANTAGONIST COMMERC IAL & CUSTOM INVOICE NO. F224 52004524 DT. 21.12.2023 F2245 2004525 DT. 21.12.2023 F22452 004531 DT. 21.12.2023 F224520 04533 DT. 21.12.2023 SBILL NO : 6216284 DT 21-DEC-2023 SBIL L NO: 6216585 DT 21-DEC-2023 SBILL NO: 6217510 DT 21-DEC-20 23 SBILL NO: 6216590 DT 21-DE C-2023 NET WT. 6537.458 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 616900 |
2024-01-16 |
14 PKG |
2983.33KG |
14 PALLETS 985 CARTONS PHA RMACEUTICALS AS UNDER SOLIF ENACIN SUCCINATE TAB 5MG 90 N DC CODE:68462038690 FDA PRODU CT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA N O.: 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLAD DER WITH SYMPTOMS OF URGE URI NARY INCONTINENCE, URGENCY A ND URINARY FREQUENCY ASPIRI N-ER DIPYRIDAMOLE CAP 25/200MG 60 NDC CODE:68462040560 FDA PRODUCT CODE NO.: 60 L D F 0 5 H. T. S NO.: 3004.90.9220 ANDA NO.:210318 NITROGLYCE RIN SUBLING TAB 0.4MG 4X25 ND C CODE:68462063945 FDA PRODUC T CODE NO.: 66 S C A 28 H. T . S NO.: 3004.90.9020 ANDA N O.:206391 THERAPEUTIC USE: - MEDICATION USED FOR HEART FAI LURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART SOLIFENACIN SUCCINATE TAB 5MG 30 NDC CODE :68462038630 FDA PRODUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209 239 INDICATED FOR THE TREATM ENT OF OVERACTIVE BLADDER WIT H SYMPTOMS OF URGE URINARY I NCONTINENCE, URGENCY AND URIN ARY FREQUENCY COMMERCIAL & CUSTOM INVOICE NO. F224870016 72 DT. 19.12.2023 F2248700167 3 DT. 19.12.2023 S/BILL NO: 4 019569 DT: 20/12/2023 S/BILL NO: 4019568 DT: 20/12/2023 NE T WT. 644.97 KGS 14 DATA LOGGERS SET TEMPERATURE : + 20 DEGREES NOTIFY PARTY:2 GL ENMARK SPECIALTY S.A. SWITZER LAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 617200 |
2024-01-16 |
12 PKG |
2137.82KG |
12 PALLETS 1067 CARTONS PH ARMACEUTICALS AS UNDER SOLI FENACIN SUCCINATE TAB 5MG 30 NDC CODE:68462038630 FDA PROD UCT CODE NO.: 61 KCA 72 H. T . S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLA DDER WITH SYMPTOMS OF URGE UR INARY INCONTINENCE, URGENCY AND URINARY FREQUENCY APREP ITANT CAP 125-80MG 3UOU NDC C ODE:68462011233 HTS NO : 3004 .90.92.40 FDA CODE : 61 T C E 32 ANDA NO : 207777 THERAPE UTICE USE : APREPITANT IS USE D WITH OTHER MEDICATIONS TO H ELP PREVENT VOMITING CAUSED BY CANCER DRUG TREATMENT NI TROGLYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FD A PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR H EART FAILURE,HIGH BLOOD PRESS URE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BL OOD FLOW TO THE HEART COMM ERCIAL & CUSTOM INVOICE NO. F 22487001677 DT. 20.12.2023 F2 2487001680 DT. 20.12.2023 F22 487001681 DT. 20.12.2023 S/BI LL NO: 4019639 DT:21/12/2023 S/BILL NO: 4019642 DT:21/12/20 23 S/BILL NO: 4019644 DT:21/1 2/2023 NET WT.340.91 KGS 1 2 DATA LOGGERS SET TEMPERA TURE : +20 DEGREES NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE D U PORT 2 NEUCHATEL - 2000 SW ITZERLAND |
HS 300490 |
2024-01-16 |
28 PKG |
7210.88KG |
28 PALLETS 1662 CARTONS PH ARMACEUTICALS AS UNDER PRAV ASTATIN SOD TAB 20MG 90 NDC C ODE:68462019690 FDA PRODUCT C ODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. :-77-987 THERAPEUTICE USE:-H YPOLIPDAEMIC POTASSIUM CL E R CAP 10MEQ 100 NDC CODE:6846 2035701 FDA PRODUCT CODE NO. :65 R C F 14 H. T. S NO.: 30 04.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMI A CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PROD UCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 AND A NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANT AGONIST POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:684620357 01 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90 .92.90 ANDA NO.:202868 THERA PEUTICE USE: - TREATMENT OR P REVENTION OF HYPOKALEMIA COMMERCIAL & CUSTOM INVOICE NO . F22487001671 DT. 19.12.2023 F22487001676 DT. 20.12.2023 S/BILL NO: 4019570 DT: 20/12/ 2023 S/BILL NO: 4019567 DT: 2 0/12/2023 NET WT. 4808.164 K GS 02 DATA LOGGERS SET T EMPERATURE : +20 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA |
HS 651400 |
2024-01-16 |
26 PKG |
6367.64KG |
26 PALLETS 1305 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0 .1% 30GM NDC CODE:68462053435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49. 00.50 ANDA NO.: 210393 THERA PEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATME NT OF MODERATE-TO-SEVERE ATO PIC DERMATITIS (ECZEMA). T ACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PIMECROLIMUS CR EAM 1% 30GM NDC CODE:68462060 935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004. 90.92.45 ANDA NO.: 211769 TH ERAPEUTICE USE: - AS SECOUND- LINE THERAPY FOR THE SHORT-TE RM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERAT E ATOPIC DERMATITIS IN NONIM MUNOCOMPROMISED ADULT AND CHI LDREN 2 YEARS OF AGE POTAS SIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO. :202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF H YPOKALEMIA GABAPENTIN TAB 6 00MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-662 THERAP EUTICE USE:-ANTICONVULSANT A GENT COMMERCIAL & CUSTOM IN VOICE NO. F22487001678 DT. 20 .12.2023 F22487001679 DT. 20. 12.2023 F22487001682 DT. 20.1 2.2023 S/BILL NO: 4019640 DT: 21/12/2023 S/BILL NO: 4019641 DT:21/12/2023 S/BILL NO: 401 9645 DT:21/12/2023 NET WT. 42 93.181 KGS 02 DATA LOGGERS SET TEMPERATURE : +20 DEGRE ES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA |
HS 640800 |
2023-12-26 |
45 PKG |
11007.06KG |
45 PALLETS 3126 CARTONS P HARMACEUTICALS AS UNDER CAR VEDILOL TAB 3.125MG 500 NDC C ODE:68462016205 FDA PRODUCT C ODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO. :- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST OLMESARTAN MEDOX TAB 5MG 90 NDC CODE:68462043690 FDA PRODUCT CODE NO.:62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE : :#TREATMENT OF HYPERTENSIO N, ALONE OR WITH OTHER ANTIH YPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE OMEPRAZOLE D R CAP 20MG 1000 NDC CODE:6846 2039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004. 90.9160 ANDA NO.: 91672 THER APEUTICE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL REFLU X DISEASE GABAPENTIN TAB 6 00MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-662 THERAP EUTICE USE:-ANTICONVULSANT A GENT OMEPRAZOLE DR CAP 40MG 30 NDC CODE:68462039730 FDA PRODUCT CODE NO.: 62KCF10 H . T. S NO.: 3004.90.9160 AND A NO.: 91672 THERAPEUTICE USE : - -TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE ADAPALENE-BPO GEL PUMP 0.1/2 .5% 45GM NDC CODE:68462030147 FDA PRODUCT CODE NO.: 62 S D O 02 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 208108 THERA PEUTICE USE: - USED ON THE SK IN TO TREAT ACNE ACYCLOVIR OINT 5% 30GM NDC CODE:684620 74635 FDA PRODUCT CODE NO.: 62 V C J 18 H. T. S NO.: 300 4.49.00.50 ANDA NO.: 205510 THERAPEUTICE USE: - AN ANTIVI RAL MEDICINE USED TO TREAT OR PREVENT INFECTIONS CAUSED BY CERTAIN KINDS OF VIRUSES. EX AMPLES OF THESE INFECTIONS IN CLUDE HERPES AND SHINGLES ACYCLOVIR OINT 5% 15GM NDC CO DE:68462074617 FDA PRODUCT CO DE NO.: 62 V C J 18 H. T. S NO.: 3004.49.00.50 ANDA NO.: 205510 THERAPEUTICE USE: - A N ANTIVIRAL MEDICINE USED TO TREAT OR PREVENT INFECTIONS CAUSED BY CERTAIN KINDS OF VI RUSES. EXAMPLES OF THESE INFE CTIONS INCLUDE HERPES AND SHI NGLES ADAPALENE GEL 0.1% 15 GM (PLD) NDC CODE:69842008805 NDC NO.:69842008805 FDA PRO DUCT CODE NO.: 62 S C J 02 H . T. S NO.: 3004.40.00.50 AN DA NO.: 091314 THERAPEUTICE U SE: - TREATMENT OF ACNE AD APALENE GEL 0.1% 15GM (PLD) N DC CODE:69842008805 NDC NO.:6 9842008805 FDA PRODUCT CODE N O.: 62 S C J 02 H. T. S NO.: 3004.40.00.50 ANDA NO.: 091 314 THERAPEUTICE USE: - TREA TMENT OF ACNE ADAPALENE GEL 0.1% 45GM (PLD) NDC CODE:698 42008816 NDC NO.:69842008816 FDA PRODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3004.40.0 0.50 ANDA NO.: 091314 THERAP EUTICE USE: - TREATMENT OF AC NE ADAPALENE GEL 0.1% 45GM (PLD) NDC CODE:69842008816 N DC NO.:69842008816 FDA PRODUC T CODE NO.: 62 S C J 02 H. T . S NO.: 3004.40.00.50 ANDA NO.: 091314 THERAPEUTICE USE: - TREATMENT OF ACNE COMME RCIAL & CUSTOM INVOICE NO. F2 2452004248 DT. 30.11.2023 F22 452004284 DT. 30.11.2023 F224 52004287 DT. 30.11.2023 F2245 2004296 DT. 30.11.2023 F22452 004288 DT. 30.11.2023 F224520 04270 DT. 30.11.2023 F2245200 4285 DT. 30.11.2023 F22452004 254 DT. 30.11.2023 F224520042 36 DT. 30.11.2023 F2245200426 3 DT. 30.11.2023 F22452004237 DT. 30.11.2023 F22452004265 DT. 30.11.2023 S/BILL NO: 574 1924 DT 01-DEC-2023 S/BILL NO : 5741867 DT 01-DEC-2023 S/BI LL NO: 5741862 DT 01-DEC-2023 S/BILL NO: 5741921 DT 01-DEC- 2023 S/BILL NO: 5741866 DT 01 -DEC-2023 S/BILL NO: 5742756 DT 01-DEC-2023 S/BILL NO: 574 1923 DT 01-DEC-2023 S/BILL NO : 5741900 DT 01-DEC-2023 S/BI LL NO: 5741902 DT 01-DEC-2023 S/BILL NO: 5741898 DT 01-DEC- 2023 S/BILL NO: 5741865 DT 01 -DEC-2023 NET WT. 8665.91 KG S 00 DATA LOGGERS HUMIDITY:6 5% SET TEMPERATURE : +18 DEGR EES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (G SSA) PLACE DU PORT 2 NEUCHAT EL - 2000 SWITZERLAND NOTIFY PARTY:4 P&L DEVELOPMENT, LLC 275 GRAND BLVD NEW YORK WE STBURY USA- 11590 LABELER CO DE : 68462: |
HS 626800 |
2023-12-26 |
45 PKG |
9477.97KG |
45 PALLETS 2981 CARTONS PH ARMACEUTICALS AS UNDER OLME SARTAN MEDOX TAB 5MG 90 NDC C ODE:68462043690 FDA PRODUCT C ODE NO.:62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 2032 81 THERAPEUTICE USE: :#TREAT MENT OF HYPERTENSION, ALONE O R WITH OTHER ANTIHYPERTENSIV E AGENTS, TO LOWER BLOOD PRES SURE OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.: 62KCF10 H . T. S NO.: 3004.90.9160 AND A NO.: 91672 THERAPEUTICE USE : - TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE ONDANSETRON ODT 8MG 30UD NDC CODE:68462015813 FDA PRODUCT CODE.:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-152 THERAPEUTICE USE:-ANT I EMETIC PRAMIPEXOLE TAB 1 .5MG 90 NDC CODE:68462033490 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.9 2.40 ANDA NO.: 90-781 THERAP EUTICE USE: USED IN PARKINSON #S DISEASE CARVEDILOL TAB 6 .25MG 500 NDC CODE:6846201630 5 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST PRAMIPEX OLE TAB 0.5MG 90 NDC CODE:684 62033290 FDA PRODUCT CODE NO. : 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-78 1 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE PRAMIPE XOLE TAB 0.25MG 90 NDC CODE:6 8462033190 FDA PRODUCT CODE N O.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90- 781 THERAPEUTICE USE: USED I N PARKINSON#S DISEASE OXCAR BAZEPINE TAB 600MG 100 NDC CO DE:68462013901 FDA PRODUCT CO DE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-802 THERAPEUTICE USE:-ANT I CONVULSANT AGENT NORETHI NDRONE ACE TAB 5MG 50 NDC COD E:68462030450 FDA PRODUCT COD E NO.65 J C A 25 H. T. S NO. : 3004.39.00.50 ANDA NO.:-91 -090 THERAPEUTICE USE:- SECO NDARY AMENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEE DING COMMERCIAL & CUSTOM IN VOICE NO. F22452004148 DT. 26 .11.2023 F22452004147 DT. 26. 11.2023 F22452004167 DT. 28.1 1.2023 F22452004177 DT. 28.11 .2023 F22452004153 DT. 27.11. 2023 S/BILL NO: 5662478 DT 29 -NOV-2023 S/BILL NO: 5656397 DT 29-NOV-2023 S/BILL NO: 565 9670 DT 29-NOV-2023 S/BILL NO : 5658162 DT 29-NOV-2023 S/BI LL NO: 5655052 DT 29-NOV-2023 NET WT. 7889.490 KGS 02 DAT A LOGGERS HUMIDITY:65% SET T EMPERATURE : +18 DEGREES TEMP ERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA GR OSS WEIGHT: 9478.160 KGS |
HS 621000 |
2023-12-26 |
27 PKG |
6408.46KG |
27 PALLETS 2352 CARTONS PH ARMACEUTICALS AS UNDER PRAV ASTATIN SOD TAB 10MG 90 NDC C ODE:68462019590 FDA PRODUCT C ODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. :-77-987 THERAPEUTICE USE:-H YPOLIPDAEMIC NAPROXEN SOD T AB 550MG 500 NDC CODE:6846201 7905 FDA PRODUCT CODE NO.:-6 2 G C A 50 H. T. S NO.: 3004 .90.92.40 ANDA NO.:-78-314 T HERAPEUTICE USE:-ANTI -INFLAM MATORY, ANALGESIC CARVEDILO L TAB 12.5MG 100 NDC CODE:684 62016401 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-2 51 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT EZETIMI BE TAB 10MG 90 NDC CODE:68462 022690 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 30 04.49.00.10 ANDA NO.: #078560 THERAPEUTICE USE: LIPID LOW ERING AGENT SIROLIMUS TAB 0 .5MG 100 NDC CODE:68462068201 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90. 92.15 ANDA NO.: 208691 THERA PEUTICE USE: TO PREVENT REJEC TION OF KIDNEY TRANSPLANTS. COMMERCIAL & CUSTOM INVOICE NO. F22487001526 DT. 30.11.20 23 F22487001529 DT. 30.11.202 3 F22487001530 DT. 30.11.2023 F22487001531 DT. 30.11.2023 F22487001532 DT. 30.11.2023 S/BILL NO: 4018509 DT:30.11.20 23 S/BILL NO: 4018507 DT:30.1 1.2023 S/BILL NO: 4018506 DT: 30.11.2023 S/BILL NO: 4018505 DT:30.11.2023 S/BILL NO: 401 8504 DT:30.11.2023 NET WT. 28 73.407 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 625000 |
2023-12-26 |
25 PKG |
4856.24KG |
25 PALLETS 1084 CARTONS PH ARMACEUTICALS AS UNDER HA ILEY 1.5/30 TAB 1.5MG/30MCG 63 NDC CODE:68462050481 FDA PR ODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 A NDA NO.: 209297 THERAPEUTICE USE: - CONTRACEPTION TO PREVE NT PREGNANCY CICLOPIROX OL AMINE CREAM 0.77% 90GM NDC CO DE:68462029792 FDA PRODUCT CO DE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 ANDA NO.: - 90 - 273 THERAPEUTICE USE: -ANTIFUNGAL USE. VERAPAMIL HCL ER TAB 180MG 500 NDC CODE :68462029305 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO .: 3004.90.92.20 ANDA NO.: 9 0-700 THERAPEUTICE USE: - AN GINA COMMERCIAL & CUSTOM IN VOICE NO. F22452004196 DT. 29 .11.2023 F22452004197 DT. 29. 11.2023 F22452004198 DT. 29.1 1.2023 S/BILL NO: 5699943 DT 30-NOV-2023 S/BILL NO: 569993 9 DT 30-NOV-2023 S/BILL NO:56 99935 DT 30-NOV-2023 NET WT.3 926.290 KGS 21 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA NOTIFY PARTY: 3 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE DU POR T 2 NEUCHATEL - 2000 SWITZER LAND |
HS 652500 |
2023-12-20 |
28 PKG |
5162.88KG |
28 PALLETS 1400 CARTONS PH ARMACEUTICALS AS UNDER HAIL EY FE 1/20 TAB 1MG/20MCG-75MG 84 NDC CODE:68462041929 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.:206597 THERAPEUTICE USE: HORMONE MEDICATION IS USED TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO . F22452004057 DT. 21.11.2023 S/BILL NO: 5500792 DT 22-NOV -2023 NET WT. 3931.200 KGS 01 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 652500 |
2023-12-20 |
6 PKG |
1500.06KG |
6 PALLETS 536 CARTONS PHAR MACEUTICALS AS UNDER NITROG LYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART ROSUVAST ATIN TAB 40MG 30 NDC CODE:684 62026430 FDA PRODUCT CODE NO .:61 J C A 16 H. T. S NO.: 3 004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREA T HIGH CHOLESTEROL AND RELATE D CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE APR EPITANT CAP 125MG 6UD NDC COD E:68462058576 NDC NO.:6846205 8576 FDA PRODUCT CODE NO.: 6 1 T C E 32 H. T. S NO.: 3004 .90.92.40 ANDA NO.:207777 TH ERAPEUTICE USE:APREPITANT IS USED WITH OTHER MEDICATIONS T O HELP PREVENT NAUSEA AND VO MITING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHERAPY). THI S MEDICATION IS ALSO USED TO PREVENT NAUSEA AND VOMITING AFTER SURGERY. A-EMETIC/NAUSE ANT / HUMAN - RX/SINGLE INGR EDIENT / DELAYED RELEASE TABL ETS / APREPITANT COMMERCIA L & CUSTOM INVOICE NO. F22487 001461 DT. 21.11.2023 S/BILL NO: 4017837 DT: 22/11/2023 NE T WT. 732.251 KGS 6 DATA LOG GERS HUMIDITY:65% SET TEMPER ATURE : +18 DEGREES TEMPERATU RE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE DU PORT 2 NEU CHATEL - 2000 SWITZERLAND -GST NO. : 23AAACG2207L2ZZ -- LABELER CODE : 68462: ---ADES [email protected] |
HS 662800 |
2023-12-20 |
6 PKG |
1588.51KG |
6 PALLETS 749 CARTONS PHAR MACEUTICALS AS UNDER CARVED ILOL TAB 12.5MG 500 NDC CODE: 68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST EZETIMIBE TAB 10MG 500 NDC CODE:68462022605 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO .: #078560 THERAPEUTICE USE: LIPID LOWERING AGENT COMME RCIAL & CUSTOM INVOICE NO. F2 2487001485 DT. 23.11.2023 F22 487001486 DT. 23.11.2023 S/BI LL NO: 4017908 DT: 23.11.2023 S/BILL NO: 4017907 DT: 23.11. 2023 NET WT. 1175.340 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 622200 |
2023-12-20 |
34 PKG |
6657.94KG |
34 PALLETS 2008 CARTONS P HARMACEUTICALS AS UNDER EZE TIMIBE TAB 10MG 30 NDC CODE:6 8462022630 FDA PRODUCT CODE N O.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #07 8560 THERAPEUTICE USE: LIPID LOWERING AGENT EZETIMIBE-S IMVA TAB 10/40MG 30 NDC CODE: 68462032330 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO. : 3004.49.00.10 ANDA NO.: 20 8699 THERAPEUTICE USE: - THIS COMBINATION MEDICATION IS U SED TO HELP LOWER BAD CHOLEST EROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLO OD. EZETIMIBE WORKS BY REDUCI NG THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS ST ATINS. IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MA DE BY THE LIVER. METFORMIN HCL ER TAB (Z) 1000MG 90 NDC CODE:68462052190 FDA PRODUCT CODE NO.: 61 P C A 55 H. T. S NO.: 3004.90.92.40 ANDA NO .:212969 THERAPEUTICE USE: TH E MANAGEMENT OF TYPE 2 DIABE TES DILTIAZEM HCL ER CAP 12 HR 60MG 100 NDC CODE:68462085 001 62 O C B 24 3004.49.00.1 0 212317 FOR THE TREATMENT O F HYPERTENSION. CARVEDIL OL TAB 12.5MG 500 NDC CODE:68 462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78- 251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST EZETIMIBE TAB 10MG 90 NDC COD E:68462022690 FDA PRODUCT COD E NO.: 61 J C A 15 H. T. S N O.: 3004.49.00.10 ANDA NO.: #078560 THERAPEUTICE USE: LIP ID LOWERING AGENT TACROLIM US OINT 0.1% 60GM NDC CODE:68 462053465 FDA PRODUCT CODE NO .: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 2103 93 THERAPEUTICE USE: - TACRO LIMUS IS A TOPICAL IMMUNOSUPP RESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SE VERE ATOPIC DERMATITIS (ECZE MA). SIROLIMUS TAB 2MG 100 NDC CODE:68462068401 FDA PRO DUCT CODE NO.: 64 T C A 12 H . T. S NO.: 3004.90.92.15 AN DA NO.: 208691 THERAPEUTICE U SE: TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. POTASSI UM CL ER CAP 10MEQ 100 NDC CO DE:68462035701 FDA PRODUCT CO DE NO.:65 R C F 14 H. T. S N O.: 3004.90.92.90 ANDA NO.:2 02868 THERAPEUTICE USE: - TR EATMENT OR PREVENTION OF HYPO KALEMIA POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:684620357 01 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90 .92.90 ANDA NO.:202868 THERA PEUTICE USE: - TREATMENT OR P REVENTION OF HYPOKALEMIA COMMERCIAL & CUSTOM INVOICE NO . F22487001464 DT. 21.11.2023 F22487001466 DT. 21.11.2023 F22487001467 DT. 21.11.2023 F22487001469 DT. 21.11.2023 F 22487001472 DT. 22.11.2023 S/ BILL NO: 4017836 DT: 22/11/202 3 S/BILL NO: 4017835 DT: 22/1 1/2023 S/BILL NO: 4017834 DT: 22/11/2023 S/BILL NO: 401783 3 DT: 22/11/2023 S/BILL NO: 4 017832 DT: 22/11/2023 NET WT. 2903.005 KGS 02 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA |
HS 611500 |
2023-12-13 |
47 PKG |
12320.68KG |
47 PALLETS 3312 CARTONS PHA RMACEUTICALS AS UNDER OMEPR AZOLE DR CAP 40MG 100 NDC COD E:68462039701 FDA PRODUCT COD E NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATME NT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAP 40MG 30 NDC CODE:68462 039730 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.9 0.9160 ANDA NO.: 91672 THERA PEUTICE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE INDOMETHACIN CAP 25MG 100 NDC CODE:68462040601 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90. 92.40 ANDA NO.:91-276 THERAP EUTICE USE: -ANTI-INFLAMATORY GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PROD UCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE US E:-ANTICONVULSANT AGENT GA BAPENTIN TAB 600MG 500 NDC CO DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT CICLOPIR OX GEL 0.77% 100GM NDC CODE:6 8462045594 FDA PRODUCT CODE N O.: 61WCJ43 H. T. S NO.: 30 04.49.00.50 ANDA NO.: 091595 THERAPEUTICE USE: - ANTIFUNG AL OLMESARTAN MEDOX TAB 40M G 90 NDC CODE:68462043890 FD A PRODUCT CODE NO.: 62 CCA 68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENT S, TO LOWER BLOOD PRESSURE COMMERCIAL & CUSTOM INVOICE N O. F22452003937 DT. 10.11.202 3 F22452003938 DT. 10.11.2023 F22452003940 DT. 10.11.2023 F22452003946 DT. 10.11.2023 F22452003948 DT. 11.11.2023 F 22452003954 DT. 11.11.2023 S/ BILL NO: 5316219 DT 11-NOV-202 3 S/BILL NO: 5317412 DT 11-NO V-2023 S/BILL NO: 5317028 DT 11-NOV-2023 S/BILL NO: 531702 5 DT 11-NOV-2023 S/BILL NO: 5 316220 DT 11-NOV-2023 S/BILL NO: NET WT. 10,329.960 KGS 02 DATA LOGGERS HUMIDITY:65 % SET TEMPERATURE : +18 DEGRE ES TEMPERATURE RANGE : +15 DE GREES TO +25 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA |
HS 621000 |
2023-12-13 |
44 PKG |
10656.88KG |
44 PALLETS 3035 CARTONS PH ARMACEUTICALS AS UNDER TOPI RAMATE TAB 100MG 500 NDC CODE :68462010905 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO .: 3004.49.00.20 ANDA NO.: 7 7627 THERAPEUTICE USE: :#ANT ICONVULSANT TELMISARTAN TAB 20MG 30 NDC CODE:68462019930 FDA PRODUCT CODE NO.: 62 O C A 09 H. T. S NO.: 3004.90. 92.20 ANDA NO.:090032 THERAP EUTICE USE: INDICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE OL MESARTAN MEDOX TAB 40MG 90 ND C CODE:68462043890 FDA PRODUC T CODE NO.: 62 CCA 68 H. T. S NO.: 3004.90.9220 ANDA NO. : 203281 TREATMENT OF HYPERT ENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS, TO L OWER BLOOD PRESSURE TOPIRAM ATE TAB 100MG 1000 NDC CODE:6 8462010910 FDA PRODUCT CODE NO.:61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77- 627 THERAPEUTICE USE:-ANTICO NVULSANT MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FD A PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 90-480 THERAPEUT ICE USE: - ANTI-BACTERIAL OLMESARTAN MEDOX TAB 40MG 30 NDC CODE:68462043830 FDA PROD UCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO. : 203281 THERAPEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPE RTENSIVE AGENTS, TO LOWER BLO OD PRESSURE MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 90-480 THERAP EUTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE NO. F22452003959 DT. 11.11.2 023 F22452003960 DT. 11.11.20 23 F22452003974 DT. 14.11.202 3 F22452003975 DT. 14.11.2023 S/BILL NO: 5360812 DT 15-NOV -2023 S/BILL NO: 5343746 DT 1 4-NOV-2023 S/BILL NO: 5360968 DT 15-NOV-2023 S/BILL NO: 53 60517 DT 15-NOV-2023 NET WT. 8699.468 KGS 02 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA |
HS 684620 |
2023-12-13 |
3 PKG |
591.04KG |
3 PALLETS 55 CARTONS PHARM ACEUTICALS AS UNDER CLINDAM YCIN-BPO GEL JAR 1%/5% 50GM N DC CODE:68462048627 FDA PRODU CT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO.: 209252 ANTIBIOTIC THAT STOPS THE GROWTH OF ACNE-CAUS ING BACTERIA AS WELL AS REDU CE OIL PRODUCTION IN THE SKIN , HELPING KEEP PORES OPEN COMMERCIAL & CUSTOM INVOICE NO . F22452003977 DT. 15.11.2023 S/BILL NO: 5360516 DT 15-NOV -2023 NET WT. 493.18 KGS 3 DATA LOGGERS NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLA ND |
HS 563100 |
2023-12-13 |
12 PKG |
2270.27KG |
12 PALLETS 600 CARTONS PHARM ACEUTICALS AS UNDER HAILEY 1. 5/30 TAB 1.5MG/30MCG 63 NDC C ODE:68462050481 FDA PRODUCT C ODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO. : 209297 THERAPEUTICE USE: - CONTRACEPTION TO PREVENT PRE GNANCY COMMERCIAL & CUSTOM IN VOICE NO. F22452003985 DT. 15 .11.2023 S/BILL NO: 5369133 D T 16-NOV-2023 NET WT. 1,800.0 0 KGS 12 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES NOT IFY PARTY:2 GLENMARK SPECIALT Y S.A. SWITZERLAND (GSSA) PL ACE DU PORT 2 NEUCHATEL - 200 0 SWITZERLAND |
HS 271019 |
2023-12-13 |
46 PKG |
10656.42KG |
46 PALLETS 2751 CARTONS PH ARMACEUTICALS AS UNDER PRAM IPEXOLE TAB 0.5MG 90 NDC CODE :68462033290 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO .: 3004.90.92.40 ANDA NO.: 9 0-781 THERAPEUTICE USE: USED IN PARKINSON S DISEASE OLM ESARTAN MEDOX TAB 40MG 30 NDC CODE:68462043830 FDA PRODUCT CODE NO.: 62CCA68 H. T. S N O.: 3004.90.9220 ANDA NO.: 2 03281 THERAPEUTICE USE: - -T REATMENT OF HYPERTENSION, ALO NE OR WITH OTHER ANTIHYPERTE NSIVE AGENTS, TO LOWER BLOOD PRESSURE OLMESARTAN MEDOX T AB 40MG 90 NDC CODE:684620438 90 FDA PRODUCT CODE NO.: 62 CCA 68 H. T. S NO.: 3004.90. 9220 ANDA NO.: 203281 TREATM ENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS, TO LOWER BLOOD PRESS URE THEOPHYLLINE ER TAB 300 MG 100 NDC CODE:68462072101 63 B C B 30 3004.90.92.85 21 2184 TO RELEASE TABLETS ARE INDICATED FOR THE TREATMENT O F THE SYMPTOMS AND REVERSIBL E AIRFLOW OBSTRUCTION ASSOCIA TED WITH CHRONIC ASTHMA AND OTHER CHRONIC LUNG DISEASES, E.G., EMPHYSEMA AND CHRONIC BRONCHITIS PRAMIPEXOLE TAB 0.5MG 90 NDC CODE:68462033290 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90. 92.40 ANDA NO.: 90-781 THERA PEUTICE USE: USED IN PARKINSO N S DISEASE PRAMIPEXOLE TAB 1MG 90 NDC CODE:68462033390 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.9 2.40 ANDA NO.: 90-781 THERAP EUTICE USE: USED IN PARKINSON S DISEASE OLMESARTAN MEDOX TAB 40MG 30 NDC CODE:6846204 3830 FDA PRODUCT CODE NO.: 6 2CCA68 H. T. S NO.: 3004.90. 9220 ANDA NO.: 203281 THERAP EUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH O THER ANTIHYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE M UPIROCIN OINT 2% 22GM NDC COD E:68462018022 FDA PRODUCT COD E NO.: 61 G J J 81 H. T. S N O.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - A NTI-BACTERIAL MUPIROCIN OIN T 2% 22GM NDC CODE:6846201802 2 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90 .92.45 ANDA NO.: 90-480 THER APEUTICE USE: - ANTI-BACTERIA L COMMERCIAL & CUSTOM INVOI CE NO. F22452003976 DT. 15.11 .2023 F22452003988 DT. 15.11. 2023 F22452003989 DT. 15.11.2 023 F22452003987 DT. 15.11.20 23 F22452003996 DT. 16.11.202 3 S/BILL NO: 5384179 DT 17-NO V-2023 S/BILL NO: 5384173 DT 17-NOV-2023 S/BILL NO: 538417 4 DT 17-NOV-2023 S/BILL NO: 5 386273 DT 17-NOV-2023 S/BILL NO:5386283 DT 17-NOV-2023 NET WT. 8656.120 KGS 02 DATA LO GGERS HUMIDITY:65% SET TEMPE RATURE : +18 DEGREES TEMPERAT URE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 684620 |
2023-12-13 |
28 PKG |
4071.51KG |
28 PALLETS 1382 CARTONS PH ARMACEUTICALS AS UNDER DRO SPIRENONE/EE TAB 3/0.02MG 84 NDC CODE:68462072029 FDA PR ODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204296 THERAPEU TICE USE: - ORAL CONTRACEPTI VE COMMERCIAL & CUSTOM INV OICE NO. F22452003983 DT. 15 .11.2023 S/BILL NO: 5369123 DT 16-NOV-2023 NET WT. 2819.2 80 KGS 01 DATA LOGGERS NOT IFY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 653900 |
2023-12-13 |
40 PKG |
8200.63KG |
40 PALLETS 2025 CARTONS PH ARMACEUTICALS AS UNDER HAIL EY 1.5/30 TAB 1.5MG/30MCG 63 NDC CODE:68462050481 FDA PROD UCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 AND A NO.: 209297 THERAPEUTICE US E: - CONTRACEPTION TO PREVENT PREGNANCY HAILEY FE 1.5/3 0 TAB 1.5MG/30MCG-75MG 84 NDC CODE:68462050329 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA N O.:206597 THERAPEUTICE USE: HORMONE MEDICATION IS USED TO PREVENT PREGNANCY ROSUVAS TATIN TAB 20MG 90 NDC CODE:68 462026390 FDA PRODUCT CODE N O.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 07917 2 THERAPEUTICE USE: - TO TRE AT HIGH CHOLESTEROL AND RELAT ED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE MU PIROCIN OINT 2% 22GM NDC CODE :68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO .: 3004.90.92.45 ANDA NO.: 9 0-480 THERAPEUTICE USE: - AN TI-BACTERIAL COMMERCIAL & C USTOM INVOICE NO. F2245200399 7 DT. 16.11.2023 F22452003998 DT. 16.11.2023 F22452004007 DT. 17.11.2023 F22452004008 D T. 17.11.2023 S/BILL NO: 540 9072 DT 18-NOV-2023 S/BILL NO : 5409077 DT 18-NOV-2023 S/B ILL NO: 5410319 DT 18-NOV-202 3 S/BILL NO: 5410310 DT 18-NO V-2023 NET WT. 6572.772 KGS 32 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREE S TEMPERATURE RANGE : +15 DEG REES TO +25 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A NOTIFY PARTY:3 GLENMARK SP ECIALTY S.A. SWITZERLAND (GSS A) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 652500 |
2023-12-05 |
24 PKG |
6374.44KG |
24 PALLETS 2163 CARTONS PH ARMACEUTICALS AS UNDER EZET IMIBE TAB 10MG 500 NDC CODE:6 8462022605 FDA PRODUCT CODE N O.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #07 8560 THERAPEUTICE USE: LIPID LOWERING AGENT EZETIMIBE T AB 10MG 90 NDC CODE:684620226 90 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.4 9.00.10 ANDA NO.: #078560 TH ERAPEUTICE USE: LIPID LOWERIN G AGENT FENOFIBRATE CAP 134 MG 100 NDC CODE:68462058101 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 205566 THERAPEUT ICE USE: - INDICATED AS ADJUN CTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C , TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY H YPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA CARVEDILOL TAB 25MG 500 NDC CODE:6846201650 5 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST GABAPENT IN TAB 600MG 500 NDC CODE:684 62012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3 004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVU LSANT AGENT TACROLIMUS OIN TMENT 0.03% 60GM NDC CODE:684 62088165 FDA PRODUCT CODE NO .:64 T C J 08 H. T. S NO.: 3 004.49.0050 ANDA NO.:210393 THERAPEUTICE USE: TOPICAL IM MUNOSUPPRESSIVE AGENT TACR OLIMUS OINTMENT 0.03% 100GM N DC CODE:68462088194 FDA PRODU CT CODE NO.:64 T C J 08 H. T . S NO.: 3004.49.0050 ANDA N O.:210393 THERAPEUTICE USE: TOPICAL IMMUNOSUPPRESSIVE AG ENT COMMERCIAL & CUSTOM INV OICE NO. F22487001409 DT. 09. 11.2023 F22487001411 DT. 09.1 1.2023 F22487001414 DT. 09.11 .2023 S/BILL NO: 4017371 DT: 09.11.2023 S/BILL NO: 4017374 DT: 09.11.2023 S/BILL NO: 40 17376 DT: 09.11.2023 NET WT. 3784.776 KGS 02 DATA LOGGE RS HUMIDITY:65% SET TEMPERAT URE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DE GREES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 611500 |
2023-12-05 |
27 PKG |
6176.22KG |
27 PALLETS 2104 CARTONS PH ARMACEUTICALS AS UNDER LITH IUM CARB CAP 600MG 100 NDC CO DE:68462022201 FDA PRODUCT CO DE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO.: - 79 -139 THERAPEUTICE USE:- ANTIMANIC AGENT OXCARBAZEPI NE TAB 150MG 100 NDC CODE:684 62013701 FDA PRODUCT CODE NO .:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-80 2 THERAPEUTICE USE:-ANTI CON VULSANT AGENT ROPINIROLE TA B 0.25MG 100 NDC CODE:6846202 5301 FDA PRODUCT CODE NO.:-6 2 J C A 17 H. T. S NO.: 3004 .90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT O F PARKINSONISM CLOTRIMAZOL E CREAM 1% 15GM NDC CODE:6846 2018117 FDA PRODUCT CODE NO. :61#W#C#J#04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 90-219 THERAPEUTICE USE: TREATMENT OF CANDIDIASIS COMMERCIAL & CUSTOM INVOICE NO. F22452003 919 DT. 09.11.2023 F224520039 22 DT. 09.11.2023 F2245200392 3 DT. 09.11.2023 S/BILL NO: 5 274291 DT 09-NOV-2023 S/BILL NO: 5265689 DT 09-NOV-2023 S/ BILL NO: 5265673 DT 09-NOV-202 3 NET WT.4899.451 KGS 02 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 614500 |
2023-12-05 |
16 PKG |
3898.24KG |
MANUFACTURE D FOR GLENMARK PHARMACEUTICAL S INC., USA 3 01, ISLAND RD MAHWAH 16 PA LLETS 1529 CARTONS PHARMAC EUTICALS AS UNDER NITROGLYC ERIN SUBLING TAB 0.4MG 4X25 N DC CODE:68462063945 FDA PRODU CT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HEART FA ILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST P AIN FROM NOT ENOUGH BLOOD FLO W TO THE HEART ROSUVASTATI N TAB 40MG 30 NDC CODE:684620 26430 FDA PRODUCT CODE NO.:6 1 J C A 16 H. T. S NO.: 3004 .49.00.10 ANDA NO.: 079172 T HERAPEUTICE USE: - TO TREAT H IGH CHOLESTEROL AND RELATED C ONDITIONS, AND TO PREVENT CA RDIOVASCULAR DISEASE COMMER CIAL & CUSTOM INVOICE NO. F22 487001410 DT. 09.11.2023 S/BI LL NO: 4017372 DT: 09.11.2023 NET WT. 2,201.69 KGS 16 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLA ND |
HS 662800 |
2023-12-05 |
40 PKG |
5418.25KG |
40 PALLETS 1953 CARTONS PHARMACEUTICALS AS UNDER H EATHER TAB 0.35MG 84 NDC COD E:68462030329 FDA PRODUCT CO DE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-454 THERAPEUTICE USE: PREVENTION OF PREGNANCY. HEATHER TAB 0.35MG 84 NDC CODE:68462030329 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.00 AN DA NO.:90-454 THERAPEUTICE U SE: PREVENTION OF PREGNANCY. NORETHINDRONE TAB 0.35MG 84 NDC CODE:68462030529 FD A PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.0 0.00 ANDA NO.:91-209 THERA PEUTICE USE: PREVENTION OF P REGNANCY. COMMERCIAL & CUS TOM INVOICE NO. F22452003842 DT. 03.11.2023 F22452003843 DT. 03.11.2023 F22452003847 DT. 04.11.2023 S/BILL NO: 5 132949 DT 04-NOV-2023 S/BILL NO: 5132949 DT 04-NOV-2023 S/ BILL NO: 5129984 DT 04-NOV-202 3 NET WT. 3,755.950 KGS 02 DATA LOGGERS NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 U SA |
HS 652400 |
2023-11-28 |
41 PKG |
9084.7KG |
41 PALLETS 3340 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 600MG 100 NDC C ODE:68462013901 FDA PRODUCT C ODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-802 THERAPEUTICE USE:-AN TI CONVULSANT AGENT ROPINI ROLE TAB 0.25MG 100 NDC CODE: 68462025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 9 0-135 THERAPEUTICE USE:-TREA TMENT OF PARKINSONISM CALC IPOTRIENE OINT 0.005% 60GM ND C CODE:68462031065 FDA PRODUC T CODE NO.: 62 N C J 04 H. T . S NO.: 3004.90.92.45 ANDA NO.: 209297 THIS MEDICATION I S USED TO TREAT PSORIASIS. C ALCIPOTRIENE IS A FORM OF VIT AMIN D. IT WORKS BY SLOWING D OWN THE GROWTH OF SKIN CELLS. TOPIRAMATE TAB 25MG 60 ND C CODE:68462010860 FDA PRODUC T CODE NO.:-61 M C A 40 H. T . S NO.: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTICE US E:-ANTICONVULSANT ROPINIROL E TAB 0.25MG 100 NDC CODE:684 62025301 FDA PRODUCT CODE NO .:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-1 35 THERAPEUTICE USE:-TREATME NT OF PARKINSONISM LITHIUM CARB CAP 150MG 100 NDC CODE: 68462022001 FDA PRODUCT CODE NO.:-61 N C E 37 H. T. S NO. : 3004.49.00.20 ANDA NO.:- 7 9 -139 THERAPEUTICE USE:-ANT IMANIC AGENT ATOVAQUONE-PRO G TAB 250/100MG 24UD NDC CODE :68462040467 FDA PRODUCT CODE NO.: 62 L D A 44 H. T. S NO .: 3004.90.92.90 ANDA NO.: 9 1-211 THERAPEUTICE USE: - ANT I MALARIAL TROSPIUM CL TAB 20MG 60 NDC CODE:68462046160 FDA PRODUCT CODE NO.:-61 K C A 69 H. T. S NO.: 3004.49. 00.70 ANDA NO.:-91-575 THERA PEUTICE USE:- TREATMENT OF VE NOUS DISEASES URINARY INCONT INENCE THERAPY ADAPALENE-B PO GEL PUMP 0.1/2.5% 45GM NDC CODE:68462030147 FDA PRODUCT CODE NO.: 62 S D O 02 H. T. S NO.: 3004.90.92.45 ANDA N O.: 208108 THERAPEUTICE USE: - USED ON THE SKIN TO TREAT ACNE HEATHER TAB 0.35MG 84 NDC CODE:68462030329 FDA PRO DUCT CODE NO.: 65 J C A 24 H . T. S NO.: 3006.60.00.00 AN DA NO.:90-454 THERAPEUTICE US E: PREVENTION OF PREGNANCY. CARVEDILOL TAB 6.25MG 500 N DC CODE:68462016305 FDA PRODU CT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE U SE:-BETA- ADRENOACEPTOR ANTA GONIST COMMERCIAL & CUSTOM INVOICE NO. F22452003698 DT. 30.10.2023 F22452003699 DT. 3 0.10.2023 F22452003711 DT. 30 .10.2023 F22452003725 DT. 31. 10.2023 F22452003739 DT. 31.1 0.2023 F22452003742 DT. 31.10 .2023 F22452003811 DT. 01.11. 2023 F22452003827 DT. 02.11.2 023 S/BILL NO: 5095260 DT 02- NOV-2023 S/BILL NO: 5095269 D T 02-NOV-2023 S/BILL NO: 5095 268 DT 02-NOV-2023 S/BILL NO: 5095258 DT 02-NOV-2023 S/BIL L NO: 5095265 DT 02-NOV-2023 S/BILL NO: 5095417 DT 02-NOV-2 023 S/BILL NO: 5095273 DT 02- NOV-2023 S/BILL NO: 5095259 D T 02-NOV-2023 NET WT. 7,195.2 73 KGS 03 DATA LOGGERS HU MIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 621700 |
2023-11-28 |
14 PKG |
2771.95KG |
14 PALLETS 745 CARTONS PHA RMACEUTICALS AS UNDER NITRO GLYCERIN SUBLING TAB 0.4MG 4X2 5 NDC CODE:68462063945 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 A NDA NO.:206391 THERAPEUTIC US E: -MEDICATION USED FOR HEAR T FAILURE,HIGH BLOOD PRESSURE ,AND TO TREAT AND PREVENT CHE ST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART ROSUVAS TATIN TAB 40MG 30 NDC CODE:68 462026430 FDA PRODUCT CODE N O.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 07917 2 THERAPEUTICE USE: - TO TRE AT HIGH CHOLESTEROL AND RELAT ED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE AP REPITANT CAP 40MG 1UD NDC COD E:68462058340 FDA PRODUCT COD E NO.: 61 T C E 32 H. T. S N O.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE: -AP REPITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NA USEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOT HERAPY). THIS MEDICATION IS A LSO USED TO PREVENT NAUSEA AN D VOMITING AFTER SURGERY. A- EMETIC/NAUSEANT / HUMAN - RX/ SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT COMMERCIAL & CUSTOM INVOICE NO. F22487001354 DT. 31.10.2 023 F22487001356 DT. 31.10.20 23 S/BILL NO: 4017024 DT:02.1 1.2023 S/BILL NO: 4017025 DT: 02.11.2023 NET WT. 832.201 K GS 14 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLA CE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 662800 |
2023-11-28 |
30 PKG |
6909.24KG |
30 PALLETS 2353 CARTONS PH ARMACEUTICALS AS UNDER EZET IMIBE TAB 10MG 90 NDC CODE:68 462022690 FDA PRODUCT CODE NO .: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #078 560 THERAPEUTICE USE: LIPID LOWERING AGENT CARVEDILOL T AB 25MG 500 NDC CODE:68462016 505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004. 90.92.20 ANDA NO.:- 78-251 T HERAPEUTICE USE:-BETA- ADREN OACEPTOR ANTAGONIST TACROL IMUS OINT 0.1% 60GM NDC CODE: 68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO. : 3004.49.00.50 ANDA NO.: 21 0393 THERAPEUTICE USE: - TAC ROLIMUS IS A TOPICAL IMMUNOSU PPRESSIVE OINTMENT USED FOR T HE TREATMENT OF MODERATE-TO- SEVERE ATOPIC DERMATITIS (EC ZEMA). TACROLIMUS CAP 0.5MG 100 NDC CODE:68462068501 FD A PRODUCT CODE NO.: 64 T C E 08 H. T. S NO.:3004.90.92.15 ANDA NO.: 206662 THERAPEUTI CE USE: :#TO PREVENT REJECTIO N OF A KIDNEY,TO PREVENT REJ ECTION OF A KIDNEY,LIVER TRAN SPLANT EZETIMIBE TAB 10MG 9 0 NDC CODE:68462022690 FDA P RODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #078560 THERAPEUTIC E USE: LIPID LOWERING AGENT POTASSIUM CL ER CAP 10MEQ 50 0 NDC CODE:68462035705 FDA P RODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - TREATMENT OR PREVENTI ON OF HYPOKALEMIA TACROLIM US OINT 0.1% 100GM NDC CODE:6 8462053494 FDA PRODUCT CODE N O.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210 393 THERAPEUTICE USE: - TACR OLIMUS IS A TOPICAL IMMUNOSUP PRESSIVE OINTMENT USED FOR TH E TREATMENT OF MODERATE-TO-S EVERE ATOPIC DERMATITIS (ECZ EMA). COMMERCIAL & CUSTOM I NVOICE NO. F22487001353 DT. 3 1.10.2023 F22487001365 DT. 31 .10.2023 F22487001366 DT. 31. 10.2023 F22487001367 DT. 31.1 0.2023 F22487001373 DT. 31.10 .2023 F22487001370 DT. 31.10. 2023 S/BILL NO: 4017023 DT:02 .11.2023 S/BILL NO: 4017016 D T:02.11.2023 S/BILL NO: 40170 17 DT:02.11.2023 S/BILL NO: 4 017018 DT:02.11.2023 S/BILL N O: 4017021 DT:02.11.2023 S/BI LL NO: 4017020 DT:02.11.2023 NET WT. 3914.378 KGS 02 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 611500 |
2023-11-28 |
3 PKG |
778.38KG |
3 PALLETS 340 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 20MG 90 NDC CODE:6 8462026390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 0791 72 THERAPEUTICE USE: - TO TR EAT HIGH CHOLESTEROL AND RELA TED CONDITIONS, AND TO PREVEN T CARDIOVASCULAR DISEASE C OMMERCIAL & CUSTOM INVOICE NO. F22452003828 DT. 02.11.2023 S/BILL NO: 5095261 DT:02-NOV- 23 NET WT. 620.160 KGS 03 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TE MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERL AND |
HS 611600 |
2023-11-28 |
11 PKG |
2034.4KG |
11 PALLETS 729 CARTONS PHA RMACEUTICALS AS UNDER TACRO LIMUS CAP 1MG 100 NDC CODE:68 462068601 HTS NO: 3004.90.92. 15 FDA CODE : 64 T C E 08 AN DA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANSP LANT TACROLIMUS OINT 0.1% 6 0GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 0 8 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTI CE USE: - TACROLIMUS IS A TOP ICAL IMMUNOSUPPRESSIVE OINTM ENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC D ERMATITIS (ECZEMA). TACROL IMUS OINTMENT 0.03% 30GM NDC CODE:68462088135 FDA PRODUCT CODE NO.:64 T C J 08 H. T. S NO.: 3004.49.0050 ANDA NO.: 210393 THERAPEUTICE USE: TOP ICAL IMMUNOSUPPRESSIVE AGENT COMMERCIAL & CUSTOM INVOIC E NO. F22487001361 DT. 31.10. 2023 S/BILL NO: 4016959 DT: 0 1.11.2023 NET WT. 871.384 KGS 04 DATA LOGGERS SET TEMPE RATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2023-11-22 |
43 PKG |
7859.53KG |
43 PALLETS 2784 CARTONS PH ARMACEUTICALS AS UNDER NORG EST/EE TAB 0.25/0.035MG 84 ND C CODE:68462030929 FDA PRODUC T CODE NO.: 65 J D A 27 H. T . S NO.: 3006.60.00.00 ANDA NO.: 200538 THERAPEUTICE USE: - ORAL CONTRACEPTIVES NOR GEST/EE TAB .18,.215,.25/.035M G 84 NDC CODE:68462056529 FD A PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.0 0 ANDA NO.: 200494 THERAPEUT ICE USE: - ORAL CONTRACEPTIVE S NORETH ACE/EE TAB 1MG/5MC G 90 NDC CODE:68462065790 FD A PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.0 0 ANDA NO.: 203038 THERAPEUT ICE USE: - TREATMENT OF MODER ATE TO SEVERE VASOMOTOR SYMP TOMS DUE TO MENOPAUSE; OSTEO POROSIS PREVENTION FLUCONAZ OLE TAB 150MG 12UD NDC CODE:6 8462011944 NDC CODE : 684620 11944 HTS NO : 3004.90.92.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 THERAPEUTICE U SE : ANTIFUNGAL ATOMOXETIN E CAP 40MG 30 NDC CODE:684620 26830 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.: 3004. 90.92.90 ANDA NO.: 079019 TH ERAPEUTICE USE: - ATOMOXETINE IS USED TO TREAT ATTENTION-D EFICIT HYPERACTIVITY DISORDER (ADHD) AS PART OF A TOTAL T REATMENT PLAN, INCLUDING PSYC HOLOGICAL, SOCIAL, AND OTHER TREATMENTS. ATOMOXETINE CAP 80MG 30 NDC CODE:68462027030 FDA PRODUCT CODE NO.: 64 UC A 99 H. T. S NO.:3004.90.92. 90 ANDA NO.: 079019 THERAPEU TICE USE: - ATOMOXETINE IS US ED TO TREAT ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADH D) AS PART OF A TOTAL TREATME NT PLAN, INCLUDING PSYCHOLOGI CAL, SOCIAL, AND OTHER TREATM ENTS ATOVAQUONE-PROG TAB 25 0/100MG 100 NDC CODE:68462040 401 FDA PRODUCT CODE NO.: 62 L D A 44 H. T. S NO.: 3004. 90.92.90 ANDA NO.: 91-211 TH ERAPEUTICE USE: - ANTI MALARI AL ZOLMITRIPTAN TAB 2.5MG 6 UD NDC CODE:68462049776 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90.92.28 ANDA NO.: 201779 THERAPEUTIC E USE: - ANALGESIC/ HUMAN - RX/SINGLE INGREDIENT / PROMPT RELEASE TABLETS / ZOLMITRIP TAN (ANALGESIC) OLMESARTAN MEDOX TAB 20MG 30 NDC CODE:68 462043730 FDA PRODUCT CODE NO .: 62CCA68 H. T. S NO.: 300 4.90.9220 ANDA NO.: 203281 T HERAPEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR W ITH OTHER ANTIHYPERTENSIVE AG ENTS, TO LOWER BLOOD PRESSURE OLMESARTAN MEDOX TAB 20MG 90 NDC CODE:68462043790 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE : - -TREATMENT OF HYPERTENSI ON, ALONE OR WITH OTHER ANTI HYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE INDOMETHACI N CAP 50MG 500 NDC CODE:68462 030205 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 30 04.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: -ANTI-INFLA MATORY COMMERCIAL & CUSTOM INVOICE NO. F22452003568 DT. 25.10.2023 F22452003569 DT. 2 5.10.2023 F22452003574 DT. 25 .10.2023 F22452003575 DT. 25. 10.2023 S/BILL NO: 4904509 DT 26-OCT-2023 S/BILL NO: 49045 08 DT 26-OCT-2023 S/BILL NO: 4904624 DT 26-OCT-2023 S/BILL NO: 4904507 DT 26-OCT-2023 N ET WT. 6,120.971 KGS 02 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH 07430 USA |
HS 300490 |
2023-11-22 |
40 PKG |
7738.87KG |
40 PALLETS 1969 CARTONS PH ARMACEUTICALS AS UNDER NORG EST/EE TAB .18,.215,.25/.035MG 84 NDC CODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 2 7 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200494 THERAPEUTI CE USE: - ORAL CONTRACEPTIVES NORGEST/EE TAB 0.25/0.035M G 84 NDC CODE:68462030929 FD A PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.0 0 ANDA NO.: 200538 THERAPEUT ICE USE: - ORAL CONTRACEPTIVE S COMMERCIAL & CUSTOM INVOI CE NO. F22452003534 DT. 23.10 .2023 F22452003550 DT. 24.10. 2023 S/BILL NO: 4864896 DT 25 -OCT-2023 S/BILL NO:4867553 D T 25-OCT-2023 NET WT. 5,907. 000 KGS 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : + 18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652700 |
2023-11-22 |
47 PKG |
11200.74KG |
47 PALLETS 2422 CARTONS PHARMACEUTICALS AS UNDER GABAPENTIN TAB 800MG 500 ND C CODE:68462012705 FDA PRODU CT CODE NO : 61 N C A 69 H . T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTIC E USE:-ANTICONVULSANT AGEN T GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.3 0 ANDA NO.:-77-662 THERAPE UTICE USE:-ANTICONVULSANT AGENT URSODIOL TAB 250MG 1 00 NDC CODE:68462047301 FD A PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 3004.49.0 0.10 ANDA NO.: 90-801 THER APEUTICE USE: - FOR THE TREA TMENT OF PATIENTS WITH PRIMA RY BILIARY CIRRHOSIS U RSODIOL TAB 250MG 100 NDC CO DE:68462047301 FDA PRODUCT C ODE NO.: 63 N C A 25 H. T. S NO.: 3004.49.00.10 ANDA NO.: 90-801 THERAPEUTICE US E: - FOR THE TREATMENT OF PATIENTS WITH PRIMARY BILIAR Y CIRRHOSIS RIZATRIPTAN BENZ TAB 5MG 18UD NDC CODE:6 8462046599 FDA PRODUCT CODE NO.: 60 L C A 87 H. T. S N O.: 3004.90.92.28 ANDA NO. :201967 THERAPEUTICE USE: - ACUTE TREATMENT OF MIGRAIN E TOPIRAMATE TAB 50MG 6 0 NDC CODE:68462015360 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00 .20 ANDA NO.:- 77-627 THER APEUTICE USE:-ANTICONVULSANT OMEPRAZOLE DR CAP 20MG 1 000 NDC CODE:68462039610 F DA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUT ICE USE: - -TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX DISEASE NORETH ACE/EE TAB 0.5MG/2.5MCG 84 NDC CODE:68 462065629 FDA PRODUCT CODE N O.: 65 J D A 25 H. T. S NO .: 3006.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - TREATMENT OF MODERATE TO S EVERE VASOMOTOR SYMPTOMS D UE TO MENOPAUSE; OSTEOPOROSI S PREVENTION NORETH ACE /EE TAB 0.5MG/2.5MCG 84 NDC CODE:68462065629 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 AN DA NO.: 203038 THERAPEUTICE USE: - TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPT OMS DUE TO MENOPAUSE; OSTE OPOROSIS PREVENTION COM MERCIAL & CUSTOM INVOICE NO. F22452003509 DT. 22.10.2023 F22452003510 DT. 22.10.2023 F22452003511 DT. 22.10.2023 F22452003512 DT. 22.10.2023 F22452003513 DT. 22.10.2023 F22452003515 DT. 22.10.2023 F22452003524 DT. 23.10.2023 S/BILL NO: 4841128 DT 23-OC T-2023 S/BILL NO: 4838257 DT 23-OCT-2023 S/BILL NO: 483826 4 DT 23-OCT-2023 S/BILL NO: 4 838262 DT 23-OCT-2023 S/BILL NO: 4842051 DT 23-OCT-2023 S/ BILL NO: 4838258 DT 23-OCT-202 3 S/BILL NO: 4841129 DT 23-OC T-2023 NET WT. 9,639.59 8 KGS 02 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 616900 |
2023-11-22 |
40 PKG |
6188.46KG |
40 PALLETS 1932 CARTONS P HARMACEUTICALS AS UNDER HAI LEY 24 FE TAB 1MG/20MCG-75MG 8 4 NDC CODE:68462073129 FDA P RODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204847 THERAPEUTICE USE: - CONTRACEPTION TO PREV ENT PREGNANCY HAILEY 24 FE TAB 1MG/20MCG-75MG 84 NDC CO DE:68462073129 FDA PRODUCT CO DE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204847 THERAPEUTICE USE: - CONTRACEPTION TO PREVENT PREG NANCY COMMERCIAL & CUSTOM I NVOICE NO. F22452003505 DT. 2 1.10.2023 F22452003506 DT. 21 .10.2023 S/BILL NO: 4826479 D T 21-OCT-2023 S/BILL NO: 4826 478 DT 21-OCT-2023 NET WT. 4 ,404.960 KGS 02 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA |
HS 652500 |
2023-11-22 |
50 PKG |
12451.32KG |
50 PALLETS 2898 CARTONS PHAR MACEUTICALS AS UNDER GABAPENT IN TAB 600MG 500 NDC CODE:684 62012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3 004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVU LSANT AGENT INDOMETHACIN CAP 50MG 100 NDC CODE:6846203020 1 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90 .92.40 ANDA NO.:91-276 THERA PEUTICE USE: -ANTI-INFLAMATOR Y TOPIRAMATE TAB 25MG 500 ND C CODE:68462010805 FDA PRODUC T CODE NO.: 61 M C A 40 H. T . S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVULSANT THEOPHYLLINE ER TAB 300MG 100 NDC CODE:684 62072101 63 B C B 30 3004.90 .92.85 212184 TO RELEASE TAB LETS ARE INDICATED FOR THE T REATMENT OF THE SYMPTOMS AND REVERSIBLE AIRFLOW OBSTRUCTI ON ASSOCIATED WITH CHRONIC AS THMA AND OTHER CHRONIC LUNG DISEASES, E.G., EMPHYSEMA AND CHRONIC BRONCHITIS INDOMETH ACIN CAP 50MG 500 NDC CODE:68 462030205 FDA PRODUCT CODE NO .: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO.:91-27 6 THERAPEUTICE USE: -ANTI-IN FLAMATORY ZOLMITRIPTAN TAB 5 MG 3UD NDC CODE:68462049833 FDA PRODUCT CODE NO.: 63OCA08 H. T. S NO.: 3004.90.92.28 ANDA NO.: 201779 THERAPEUTIC E USE: :#ANALGESIC/ HUMAN RX /SINGLE INGREDIENT PROMPT REL EASE TABLETS ZOLMITRIPTAN (A NALGESIC) DICLOFENAC SOD GEL 3% 100GM NDC CODE:68462035594 FDA PRODUCT CODE NO.:62 G C J 18 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:208301 THERAPE UTICE USE: - USED FOR THE REL IEF OF JOINT PAIN OF OSTEOART HRITIS COMMERCIAL & CUSTOM IN VOICE NO. F22452003518 DT. 22 .10.2023 F22452003519 DT. 22. 10.2023 F22452003520 DT. 22.1 0.2023 F22452003539 DT. 24.10 .2023 F22452003540 DT. 24.10. 2023 S/BILL NO: 4875188 DT 25 -OCT-2023 S/BILL NO: 4868560 DT 25-OCT-2023 S/BILL NO: 487 1617 DT 25-OCT-2023 S/BILL NO : 4867544 DT 25-OCT-2023 S/BI LL NO: 4864889 DT 25-OCT-2023 S/BILL NO: 4867540 DT 25-OCT- 2023 NET WT. 10,636.449 KGS 02 DATA LOGGERS NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH 07430 USA |
HS 616900 |
2023-11-22 |
40 PKG |
8688.25KG |
40 PALLETS 1882 CARTONS PH ARMACEUTICALS AS UNDER NORG EST/EE TAB 0.25/0.035MG 84 ND C CODE:68462030929 FDA PRODUC T CODE NO.: 65 J D A 27 H. T . S NO.: 3006.60.00.00 ANDA NO.: 200538 THERAPEUTICE USE: - ORAL CONTRACEPTIVES NOR ETHINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO. :-91-090 THERAPEUTICE USE:- SECONDARY AMENORRHEA,ENDOMETR IOS IS AND ABNORMAL UTERINE BLEEDING OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.: 62KCF1 0 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEA SE ROSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PR ODUCT CODE NO.:61 J C A 16 H . T. S NO.: 3004.49.00.10 AN DA NO.: 079172 THERAPEUTICE U SE: - TO TREAT HIGH CHOLESTER OL AND RELATED CONDITIONS, A ND TO PREVENT CARDIOVASCULAR DISEASE MUPIROCIN OINT 2% 2 2GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 8 1 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTI CE USE: - ANTI-BACTERIAL C OMMERCIAL & CUSTOM INVOICE NO. F22452003607 DT. 27.10.2023 F22452003613 DT. 27.10.2023 F22452003609 DT. 27.10.2023 F 22452003612 DT. 27.10.2023 F2 2452003610 DT. 27.10.2023 S/B ILL NO: 4945890 DT 28-OCT-2023 S/BILL NO: 4943045 DT 28-OCT -2023 S/BILL NO: 4943040 DT 2 8-OCT-2023 S/BILL NO: 4943041 DT 28-OCT-2023 S/BILL NO: 49 43042 DT 28-OCT-2023 NET WT. 6,925.654 KGS 05 DATA LOGGE RS HUMIDITY:65% SET TEMPERAT URE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DE GREES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA NOTIFY PART Y:3 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU P ORT 2 NEUCHATEL - 2000 SWITZ ERLAND |
HS 652700 |
2023-11-22 |
41 PKG |
9398.59KG |
41 PALLETS 3015 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT TACROLIMUS CAP 1MG 100 NDC CODE:6846206 8601 HTS NO: 3004.90.92.15 F DA CODE : 64 T C E 08 ANDA NO .206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDNE Y,HEART, OR LIVER TRANSPLANT TACROLIMUS OINT 0.1% 30GM NDC CODE:68462053435 FDA PROD UCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 AND A NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERMAT ITIS (ECZEMA). PRAVASTATIN SOD TAB 20MG 500 NDC CODE:68 462019605 FDA PRODUCT CODE N O.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-9 87 THERAPEUTICE USE:-HYPOLIP DAEMIC EZETIMIBE TAB 10MG 9 0 NDC CODE:68462022690 FDA P RODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #078560 THERAPEUTIC E USE: LIPID LOWERING AGENT PROPAFENONE HCL ER CAP 425MG 60 NDC CODE:68462041060 FDA CODES 63 E C F 28 HTS CODES 3004.49.00.10 ANDA NO. 20526 8 THERAPEUTIC USE AN ANTIARR HYTHMIC AGENT.IT IS USED TO T REAT IRREGULAR HEART RHYTHM A ND CAN SLOW RAPID HEARTBEATS. PRAVASTATIN SOD TAB 20MG 5 00 NDC CODE:68462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTIC E USE:-HYPOLIPDAEMIC PRAVA STATIN SOD TAB 20MG 90 NDC CO DE:68462019690 FDA PRODUCT CO DE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: -77-987 THERAPEUTICE USE:-HY POLIPDAEMIC EZETIMIBE TAB 1 0MG 90 NDC CODE:68462022690 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00 .10 ANDA NO.: #078560 THERAP EUTICE USE: LIPID LOWERING AG ENT NITROGLYCERIN SUBLING T AB 0.4MG 4X25 NDC CODE:684620 63945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 300 4.90.9020 ANDA NO.:206391 TH ERAPEUTIC USE: -MEDICATION US ED FOR HEART FAILURE,HIGH BLO OD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEAR T COMMERCIAL & CUSTOM INVOI CE NO. F22487001322 DT. 26.10 .2023 F22487001323 DT. 26.10. 2023 F22487001324 DT. 26.10.2 023 F22487001328 DT. 27.10.20 23 F22487001330 DT. 27.10.202 3 S/BILL NO: 4016630 DT: 27/1 0/2023 S/BILL NO: 4016626 DT: 27/10/2023 S/BILL NO: 401662 8 DT: 27/10/2023 S/BILL NO: 4 016623 DT: 27/10/2023 S/BILL NO: 4016629 DT: 27/10/2023 NE T WT. 4547.01 KGS 06 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA NOTIF Y PARTY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 300449 |
2023-11-22 |
36 PKG |
10147.49KG |
36 PALLETS 2622 CARTONS PH ARMACEUTICALS AS UNDER INDO METHACIN CAP 50MG 500 NDC COD E:68462030205 FDA PRODUCT COD E NO.: 62 G C E 42 H. T. S N O.: 3004.90.92.40 ANDA NO.:9 1-276 THERAPEUTICE USE: -ANT I-INFLAMATORY LAMOTRIGINE T AB CD 25MG 100 NDC CODE:68462 022901 FDA PRODUCT CODE NO.:- 61 M C A 38 H. T. S NO.: 3 004.90.92.30 ANDA NO.:-79 # 0 99 THERAPEUTICE USE:- ANTICO NVULSANT ROPINIROLE TAB 1MG 100 NDC CODE:68462025501 FD A PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:- 90-135 THERAPEU TICE USE:-TREATMENT OF PARKI NSONISM GABAPENTIN TAB 600M G 500 NDC CODE:68462012605 F DA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.3 0 ANDA NO.:-77-662 THERAPEUT ICE USE:-ANTICONVULSANT AGEN T NORETHINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.:-91-090 THERAPEUTICE USE:- SECONDARY AMENORRHEA, ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIAL & CUSTOM INVOICE NO. F224520 03597 DT. 27.10.2023 F2245200 3598 DT. 27.10.2023 F22452003 599 DT. 27.10.2023 F224520036 00 DT. 27.10.2023 F2245200360 5 DT. 27.10.2023 S/BILL NO: 4 932741 DT 27-OCT-2023 S/BILL NO: 4932742 DT 27-OCT-2023 S/ BILL NO: 4932732 DT 27-OCT-202 3 S/BILL NO: 4932748 DT 27-OC T-2023 S/BILL NO: 4932733 DT 27-OCT-2023 NET WT. 8,770.40 0 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 613800 |
2023-11-15 |
22 PKG |
3475.94KG |
22 PALLETS 1100 CARTONS PH ARMACEUTICALS AS UNDER HAIL EY 24 FE TAB 1MG/20MCG-75MG 84 NDC CODE:68462073129 FDA PR ODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 A NDA NO.: 204847 THERAPEUTICE USE: - CONTRACEPTION TO PREVE NT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F224520034 42 DT. 18.10.2023 S/BILL NO: 4727042 DT 18-OCT-2023 NET WT . 2508.000 KGS 01 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 652500 |
2023-11-15 |
13 PKG |
3416.06KG |
13 PALLETS 1485 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 40MG 30 NDC CODE :68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 40MG 30 NDC CODE:68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE NITROGLYCERIN SUBLING TA B 0.4MG 4X25 NDC CODE:6846206 3945 FDA PRODUCT CODE NO.: 6 6 S C A 28 H. T. S NO.: 3004 .90.9020 ANDA NO.:206391 THE RAPEUTIC USE: -MEDICATION USE D FOR HEART FAILURE,HIGH BLOO D PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT E NOUGH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOIC E NO. F22487001283 DT. 19.10. 2023 F22487001284 DT. 19.10.2 023 F22487001285 DT. 19.10.20 23 S/BILL NO: 4016165 DT: 19. 10.2023 S/BILL NO: 4016166 DT : 19.10.2023 S/BILL NO: 40161 68 DT: 19.10.2023 NET WT. 219 7.986 KGS 13 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 GLENMARK S PECIALTY S.A. SWITZERLAND (GS SA) PLACE DU PORT 2 NEUCHATE L - 2000 SWITZERLAND |
HS 684620 |
2023-11-15 |
29 PKG |
6403.92KG |
29 PALLETS 2278 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA N O.: 202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA FENOFIBRATE CA P 67MG 100 NDC CODE:684620580 01 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90. 92.20 ANDA NO.: 205566 THERA PEUTICE USE: - INDICATED AS A DJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOT AL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMAR Y HYPERCHOLESTEROLEMIA OR MI XED DYSLIPIDEMIA FENOFIBRAT E CAP 134MG 100 NDC CODE:6846 2058101 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 300 4.90.92.20 ANDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIE T FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTEROLEMIA O R MIXED DYSLIPIDEMIA TACRO LIMUS CAP 1MG 100 NDC CODE:68 462068601 HTS NO: 3004.90.92. 15 FDA CODE : 64 T C E 08 AN DA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANSP LANT TACROLIMUS OINT 0.1% 3 0GM NDC CODE:68462053435 FDA PRODUCT CODE NO.: 64 T C J 0 8 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTI CE USE: - TACROLIMUS IS A TOP ICAL IMMUNOSUPPRESSIVE OINTM ENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC D ERMATITIS (ECZEMA). GABAPE NTIN TAB 600MG 500 NDC CODE:6 8462012605 FDA PRODUCT CODE N O: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-6 62 THERAPEUTICE USE:-ANTICON VULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22487001 279 DT. 19.10.2023 F224870012 81 DT. 19.10.2023 F2248700128 6 DT. 19.10.2023 S/BILL NO: 4 016169 DT: 19.10.2023 S/BILL NO: 4016171 DT: 19.10.2023 S/ BILL NO: 4016172 DT: 19.10.202 3 NET WT. 3467.777 KGS 02 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TE MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 300490 |
2023-11-15 |
18 PKG |
3309.01KG |
18 PALLETS 862 CARTONS PHA RMACEUTICALS AS UNDER HAILE Y 1.5/30 TAB 1.5MG/30MCG 63 N DC CODE:68462050481 FDA PRODU CT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 209297 THERAPEUTICE USE : - CONTRACEPTION TO PREVENT PREGNANCY COMMERCIAL & CUS TOM INVOICE NO. F22452003414 DT. 17.10.2023 S/BILL NO: 473 2790 DT 18-OCT-2023 NET WT. 2 ,490.84 KGS 18 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUC HATEL - 2000 SWITZERLAND |
HS 652500 |
2023-11-15 |
35 PKG |
5235KG |
35 PALLETS 1735 CARTONS PH ARMACEUTICALS AS UNDER NORE TH ACE/EE TAB 1/0.02MG 63 NDC CODE:68462013281 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 ANDA NO .:206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOMET RIOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIAL & CUST OM INVOICE NO. F22452003369 D T. 14.10.2023 S/BILL NO: 4638 734 DT 14-OCT-2023 NET WT.362 2.680 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 652500 |
2023-11-15 |
44 PKG |
11519.63KG |
44 PALLETS 3618 CARTONS PH ARMACEUTICALS AS UNDER CALC IPOTRIENE CREAM 0.005% 60GM N DC CODE:68462050165 FDA PRODU CT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTICE USE : - TREATMENT OF PLAQUE PSOR IASIS IN ADULTS MUPIROCIN C REAM 2% 15GM NDC CODE:6846205 6417 FDA PRODUCT CODE NO.: 6 1GCJ82 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 201587 THERA PEUTICE USE: - TOPICAL ANTI-B ACTERIAL VERAPAMIL HCL ER T AB 120MG 100 NDC CODE:6846202 9201 FDA PRODUCT CODE NO.: 6 2 O C B 13 H. T. S NO.: 3004 .90.92.20 ANDA NO.: 90-700 T HERAPEUTICE USE: - -ANGINA OLMESARTAN MEDOX TAB 40MG 30 NDC CODE:68462043830 FDA PRO DUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO .: 203281 THERAPEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYP ERTENSIVE AGENTS, TO LOWER BL OOD PRESSURE ROSUVASTATIN T AB 10MG 1000 NDC CODE:6846202 6210 61 J C A 16 3004.49.00. 10 79172 TO TREAT HIGH CHOLE STEROL AND RELATED CONDITIONS , AND TO PREVENT CARDIOVASCU LAR DISEASE FELODIPINE ER T AB 10MG 100 NDC CODE:68462023 501 FDA PRODUCT CODE NO.: 62 OCB32 H. T. S NO.: 3004.90.9 2.20 ANDA NO.: 90-365 THERAP EUTICE USE: - TREATMENT OF H YPERTENSION OLMESARTAN MEDO X TAB 40MG 30 NDC CODE:684620 43830 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90 .9220 ANDA NO.: 203281 THERA PEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS , TO LOWER BLOOD PRESSURE OLMESARTAN MEDOX TAB 40MG 90 NDC CODE:68462043890 FDA PROD UCT CODE NO.: 62 CCA 68 H. T . S NO.: 3004.90.9220 ANDA N O.: 203281 TREATMENT OF HYPE RTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE COMME RCIAL & CUSTOM INVOICE NO. F2 2452003452 DT. 19.10.2023 F22 452003395 DT. 16.10.2023 F224 52003453 DT. 19.10.2023 F2245 2003454 DT. 19.10.2023 F22452 003455 DT. 19.10.2023 F224520 03471 DT. 19.10.2023 S/BILL N O: 4784861 DT 20-OCT-2023 S/B ILL NO: 4790910 DT 20-OCT-2023 S/BILL NO: 4784858 DT 20-OCT -2023 S/BILL NO: 4784859 DT 2 0-OCT-2023 S/BILL NO: 4788207 DT 20-OCT-2023 S/BILL NO: 47 84863 DT 20-OCT-2023 NET WT. 9,530.361 KGS 12 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA NOTIFY PARTY :3 GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE DU PO RT 2 NEUCHATEL - 2000 SWITZE RLAND |
HS 620400 |
2023-11-15 |
5 PKG |
843.7KG |
5 PALLETS 250 CARTONS PHAR MACEUTICALS AS UNDER HAILEY FE 1.5/30 TAB 1.5MG/30MCG-75M G 84 NDC CODE:68462050329 FD A PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.0 0 ANDA NO.:206597 THERAPEUTI CE USE: HORMONE MEDICATION IS USED TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F22452003378 DT. 14.10.20 23 S/BILL NO: 4644835 DT 14-O CT-2023 NET WT. 630.00 KGS 05 DATA LOGGERS SET TEMPE RATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S .A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 652500 |
2023-11-15 |
47 PKG |
11248.83KG |
47 PALLETS 2967 CARTONS PH ARMACEUTICALS AS UNDER LITH IUM CARB CAP 300MG 100 NDC CO DE:68462022101 FDA PRODUCT CO DE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO.: - 79 -139 THERAPEUTICE USE:- ANTIMANIC AGENT ROSUVASTATI N TAB 10MG 1000 NDC CODE:6846 2026210 61 J C A 16 3004.49. 00.10 79172 TO TREAT HIGH CH OLESTEROL AND RELATED CONDITI ONS, AND TO PREVENT CARDIOVA SCULAR DISEASE LITHIUM CARB CAP 300MG 1000 NDC CODE:6846 2022110 FDA PRODUCT CODE NO. :-61 N C E 37 H. T. S NO.: 3 004.49.00.20 ANDA NO.:- 79 -1 39 THERAPEUTICE USE:-ANTIMAN IC AGENT OMEPRAZOLE DR CAP 40MG 30 NDC CODE:68462039730 FDA PRODUCT CODE NO.: 62KCF1 0 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEA SE OLMESARTAN MEDOX TAB 40M G 90 NDC CODE:68462043890 FD A PRODUCT CODE NO.: 62 CCA 68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENT S, TO LOWER BLOOD PRESSURE ZOLMITRIPTAN TAB 5 MG 3UD ND C CODE:68462049833 FDA PRODUC T CODE NO.: 63OCA08 H. T. S NO.: 3004.90.92.28 ANDA NO.: 201779 THERAPEUTICE USE: :# ANALGESIC/ HUMAN RX/SINGLE IN GREDIENT PROMPT RELEASE TABL ETS ZOLMITRIPTAN (ANALGESIC) GABAPENTIN TAB 800MG 500 N DC CODE:68462012705 FDA PRODU CT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE US E:-ANTICONVULSANT AGENT CO MMERCIAL & CUSTOM INVOICE NO. F22452003479 DT. 20.10.2023 F22452003480 DT. 20.10.2023 F 22452003481 DT. 20.10.2023 F2 2452003482 DT. 20.10.2023 F22 452003485 DT. 20.10.2023 S/BI LL NO: 4799976 DT 20-OCT-2023 S/BILL NO: 4800067 DT 20-OCT- 2023 S/BILL NO: 4799975 DT 20 -OCT-2023 S/BILL NO: 4800152 DT 20-OCT-2023 S/BILL NO: 480 0068 DT 20-OCT-2023 NET WT. 9,258.801 KGS 06 DATA LOGG ERS HUMIDITY:65% SET TEMPERA TURE : +18 DEGREES TEMPERATUR E RANGE : +15 DEGREES TO +25 D EGREES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA NOTIFY PAR TY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWIT ZERLAND |
HS 613700 |
2023-11-07 |
18 PKG |
2946.59KG |
18 PALLETS 865 CARTONS PHA RMACEUTICALS AS UNDER HAILE Y FE 1.5/30 TAB 1.5MG/30MCG-75 MG 84 NDC CODE:68462050329 F DA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.:206597 THERAPEUT ICE USE: HORMONE MEDICATION I S USED TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F22452003323 DT. 11.10.2 023 S/BILL NO: 4574210 DT 12- OCT-2023 NET WT. 2,200.56 KGS 18 DATA LOGGERS HUMIDITY:6 5% SET TEMPERATURE : +18 DEGR EES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 S WITZERLAND |
HS 652500 |
2023-11-07 |
14 PKG |
2166.85KG |
14 PALLETS 396 CARTONS PHA RMACEUTICALS AS UNDER NITRO GLYCERIN SUBLING TAB 0.4MG 4X2 5 NDC CODE:68462063945 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 A NDA NO.:206391 THERAPEUTIC US E: -MEDICATION USED FOR HEAR T FAILURE,HIGH BLOOD PRESSURE ,AND TO TREAT AND PREVENT CHE ST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART APREPIT ANT CAP 40MG 1UD NDC CODE:684 62058340 FDA PRODUCT CODE NO. : 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.: 20777 7 THERAPEUTICE USE: -APREPIT ANT IS USED WITH OTHER MEDICA TIONS TO HELP PREVENT NAUSEA AND VOMITING CAUSED BY CANCE R DRUG TREATMENT (CHEMOTHERAP Y). THIS MEDICATION IS ALSO U SED TO PREVENT NAUSEA AND VO MITING AFTER SURGERY. A-EMETI C/NAUSEANT / HUMAN - RX/SINGL E INGREDIENT / DELAYED RELEA SE TABLETS / APREPITANT CO MMERCIAL & CUSTOM INVOICE NO. F22487001232 DT. 10.10.2023 S/BILL NO: 4015694 DT:11.10.2 023 NET WT. 142.585 KGS 14 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PARTY: 2 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE DU POR T 2 NEUCHATEL - 2000 SWITZER LAND |
HS 662800 |
2023-11-07 |
27 PKG |
4961.48KG |
27 PALLETS 1356 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS CAP 1MG 100 NDC CODE:6 8462068601 HTS NO: 3004.90.92 .15 FDA CODE : 64 T C E 08 A NDA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANS PLANT TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FD A PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 210393 THERAPEUT ICE USE: - TACROLIMUS IS A TO PICAL IMMUNOSUPPRESSIVE OINT MENT USED FOR THE TREATMENT O F MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). CLIND AMYCIN HCL CAP 75MG 100 NDC C ODE:68462014201 PRAVASTATIN SOD TAB 80MG 90 NDC CODE:684 62019890 FDA PRODUCT CODE NO .:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-98 7 THERAPEUTICE USE:-HYPOLIPD AEMIC FENOFIBRATE CAP 67MG 100 NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTI VE THERAPY TO DIET FOR THE R EDUCTION OF LDL-C, TOTAL-C, T RIGLYCERIDES AND APO B IN DUL T PATIENTS WITH PRMARY HYPE RCHOLESTEROLEMIA OR MIXED DYS LIPIDEMIA CLINDAMYCIN HCL C AP 300MG 100 NDC CODE:6846201 4401 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941. 90.5000 ANDA NO.:216957 THER APEUTICE USE: :#TREATMENT OF NUMEROUS INFECTIONS, INCLUDIN G BUT NOT LIMITED TO SEPTIC EMIA,INTRAABDOMINAL INFECTION S, LOWER RESPIRATORY INFECTI ONS, GYNECOLOGICAL INFECTIONS , BONE AND JOINT INFECTIONS, AND SKIN AND SKIN STRUCTURE INFECTIONS COMMERCIAL & CUS TOM INVOICE NO. F22487001233 DT. 10.10.2023 F22487001234 D T. 10.10.2023 F22487001235 DT . 10.10.2023 S/BILL NO: 40156 89 DT: 11.10.2023 S/BILL NO: 4015692 DT: 11.10.2023 S/BILL NO: 4015690 DT: 11.10.2023 N ET WT. 2560.638 KGS 02 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 300490 |
2023-11-07 |
45 PKG |
9354.14KG |
45 PALLETS 3313 CARTONS PH ARMACEUTICALS AS UNDER TELM ISARTAN TAB 40MG 30 NDC CODE: 68462020030 FDA PRODUCT CODE NO.: 62 O C A 09 H. T. S NO. : 3004.90.92.20 ANDA NO.:090 032 THERAPEUTICE USE: INDICA TED FOR THE TREATMENT OF HYP ERTENSION, TO LOWER BLOOD PRE SSURE OMEPRAZOLE DR CAP 20M G 1000 NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS E TELMISARTAN TAB 40MG 30 NDC CODE:68462020030 FDA PROD UCT CODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 AND A NO.:090032 THERAPEUTICE USE : INDICATED FOR THE TREATMEN T OF HYPERTENSION, TO LOWER BLOOD PRESSURE OMEPRAZOLE D R CAP 20MG 1000 NDC CODE:6846 2039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004. 90.9160 ANDA NO.: 91672 THER APEUTICE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL REFLU X DISEASE COMMERCIAL & CUS TOM INVOICE NO. F22452003330 DT. 12.10.2023 F22452003333 D T. 12.10.2023 S/BILL NO: 4591 610 DT 12-OCT-2023 S/BILL NO: 4592182 DT 12-OCT-2023 NET W T. 7,513.673 KGS 02 DATA LOG GERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 620900 |
2023-11-07 |
41 PKG |
10930.4KG |
41 PALLETS 2871 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TAB 600MG 500 NDC COD E:68462012605 FDA PRODUCT COD E NO: 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-662 THERAPEUTICE USE:-ANTI CONVULSANT AGENT CARVEDILO L TAB 25MG 500 NDC CODE:68462 016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 30 04.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST NIC ARDIPINE HCL CAP 30MG 90 NDC CODE:68462012190 FDA PRODUCT CODE NO.: 62 O C E 48 H. T. S NO: 3004.90.9220 ANDA NO.: 216357 THERAPEUTICE USE: #C ARDIOVASCULAR AGENT (CALCIUM CHANNEL BLOCKER) CLINDAMYC IN HCL CAP 75MG 100 NDC CODE: 68462014201 VORICONAZOLE TA B 200MG 30 NDC CODE:684620573 30 FDA PRODUCT CODE NO.:61 W C A 59 H. T. S NO.: 3004.90 .92.10 ANDA NO.:203503 THERA PEUTICE USE: -USED TO TREAT F UNGAL INFECTIONS RUFINAMID E TAB 200MG 120 NDC CODE:6846 2071308 61 M C A 99 3004.90. 92.30 205075 TO USED WITH OT HER MEDICATIONS TO PREVENT OR CONTROL SEIZURES (EPILEPSY) ASSOCIATED WITH LENNOX-GAST AUT SYNDROME (LGS ROSUVAST ATIN TAB 40MG 30 NDC CODE:684 62026430 FDA PRODUCT CODE NO .:61 J C A 16 H. T. S NO.: 3 004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREA T HIGH CHOLESTEROL AND RELATE D CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE NIT ROGLYCERIN SUBLING TAB 0.4MG 4 X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HE ART FAILURE,HIGH BLOOD PRESSU RE,AND TO TREAT AND PREVENT C HEST PAIN FROM NOT ENOUGH BLO OD FLOW TO THE HEART TACRO LIMUS CAP 5MG 100 NDC CODE:68 462068701 HTS NO: 3004.90.92. 15 FDA CODE : 64 T C E 08 AN DA NO.206662 THERAPEUTICE USE : TO PREVENT REJECTION OF A KIDNEY, HEART, OR LIVER TRANS PLANT TACROLIMUS OINT 0.1% 30GM NDC CODE:68462053435 FD A PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 210393 THERAPEUT ICE USE: - TACROLIMUS IS A TO PICAL IMMUNOSUPPRESSIVE OINT MENT USED FOR THE TREATMENT O F MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PROCH LORPERAZINE MAL TAB 10MG 100 NDC CODE:68462089001 FDA PROD UCT CODE NO.:61 T C A 16 H. T. S NO.: 3004.49.0020 ANDA NO.:216595 THERAPEUTICE USE: :#ANTI-PSYCHOTIC COMMERCIA L & CUSTOM INVOICE NO. F22487 001245 DT. 12.10.2023 F224870 01246 DT. 12.10.2023 F2248700 1247 DT. 12.10.2023 F22487001 249 DT. 12.10.2023 F224870012 50 DT. 12.10.2023 F2248700125 1 DT. 12.10.2023 F22487001254 DT. 12.10.2023 S/BILL NO: 40 15875 DT: 13/10/2023 S/BILL N O: 4015878 DT: 13/10/2023 S/B ILL NO: 4015870 DT: 13/10/2023 S/BILL NO: 4015877 DT: 13/10 /2023 S/BILL NO: 4015874 DT: 13/10/2023 S/BILL NO: 4015876 DT: 13/10/2023 S/BILL NO: 40 15879 DT: 13/10/2023 NET WT. 8604.18 KGS 14 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERL AND |
HS 300490 |
2023-11-07 |
46 PKG |
12573.79KG |
46 PALLETS 3401 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 800MG 500 NDC CODE :68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-662 THERAPEUTICE USE:-ANTI CONVULSANT AGENT ROSUVASTA TIN TAB 5MG 90 NDC CODE:68462 026190 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 300 4.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT C ARDIOVASCULAR DISEASE OMEPR AZOLE DR CAP 20MG 1000 NDC CO DE:68462039610 FDA PRODUCT CO DE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 9167 2 THERAPEUTICE USE: - -TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE PRAMIPEXO LE TAB 1MG 90 NDC CODE:684620 33390 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 300 4.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN PAR KINSON#S DISEASE ROSUVASTAT IN TAB 5MG 90 NDC CODE:684620 26190 FDA PRODUCT CODE NO.:6 1 J C A 16 H. T. S NO.: 3004 .49.00.10 ANDA NO.: 079172 T HERAPEUTICE USE: - TO TREAT H IGH CHOLESTEROL AND RELATED C ONDITIONS, AND TO PREVENT CA RDIOVASCULAR DISEASE ZONISA MIDE CAP 100MG 100 NDC CODE:6 8462013001 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77- 651 THERAPEUTICE USE:-ANTISE IZURE DRUG COMMERCIAL & CUS TOM INVOICE NO. F22452003335 DT. 12.10.2023 F22452003337 D T. 12.10.2023 F22452003338 DT . 12.10.2023 F22452003339 DT. 12.10.2023 F22452003343 DT. 12.10.2023 S/BILL NO: 4618505 DT 13-OCT-2023 S/BILL NO: 46 18426 DT 13-OCT-2023 S/BILL N O: 4618437 DT 13-OCT-2023 S/B ILL NO: 4618434 DT 13-OCT-2023 S/BILL NO: 4618379 DT 13-OCT -2023 NET WT. 10,700.122 KGS 10 DATA LOGGERS HUMIDITY:6 5% SET TEMPERATURE : +18 DEGR EES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (G SSA) PLACE DU PORT 2 NEUCHAT EL - 2000 SWITZERLAND |
HS 684620 |
2023-10-31 |
26 PKG |
6502.36KG |
26 PALLETS 1515 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 300MG 100 NDC C ODE:68462013801 FDA PRODUCT C ODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-802 THERAPEUTICE USE:-AN TI CONVULSANT AGENT VERAPA MIL HCL ER TAB 240MG 500 NDC CODE:68462026005 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO .:-78-906 THERAPEUTICE USE:- ANGINA OMEPRAZOLE DR CAP 20 MG 1000 NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF1 0 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEA SE OXCARBAZEPINE TAB 150MG 100 NDC CODE:68462013701 FDA PRODUCT CODE NO.:-61 M C A 4 5 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTI CE USE:-ANTI CONVULSANT AGENT OMEPRAZOLE DR CAP 20MG 100 0 NDC CODE:68462039610 FDA P RODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTRO ESOPHAGEAL REFLUX DISEASE OXCARBAZEPINE TAB 300MG 100 N DC CODE:68462013801 FDA PRODU CT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE :-ANTI CONVULSANT AGENT CO MMERCIAL & CUSTOM INVOICE NO. F22452003109 DT. 29.09.2023 F22452003188 DT. 30.09.2023 F 22452003205 DT. 30.09.2023 F2 2452003214 DT. 30.09.2023 S/B ILL NO: 4338887 DT 02-OCT-2023 S/BILL NO: 4339563 DT 02-OCT -2023 S/BILL NO: 4339539 DT 0 2-OCT-2023 S/BILL NO: 4339523 DT 02-OCT-2023 NET WT. 5545. 512 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 621300 |
2023-10-31 |
41 PKG |
10210.54KG |
41 PALLETS 2748 CARTONS PHARMACEUTICALS AS UNDER TO PIRAMATE TAB 25MG 500 NDC COD E:68462010805 FDA PRODUCT COD E NO.: 61 M C A 40 H. T. S N O.: 3004.49.00.20 ANDA NO.:0 77627 THERAPEUTICE USE: ANTI CONVULSANT OXCARBAZEPINE TA B 300MG 100 NDC CODE:68462013 801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004. 90.92.30 ANDA NO.:-77-802 TH ERAPEUTICE USE:-ANTI CONVULSA NT AGENT VERAPAMIL HCL ER T AB 240MG 100 NDC CODE:6846202 6001 FDA PRODUCT CODE NO.: 6 2 O C B 13 H. T. S NO.: 3004 .90.92.20 ANDA NO.:-78-906 T HERAPEUTICE USE:-ANGINA TO PIRAMATE TAB 25MG 500 NDC COD E:68462010805 FDA PRODUCT COD E NO.: 61 M C A 40 H. T. S N O.: 3004.49.00.20 ANDA NO.:0 77627 THERAPEUTICE USE: ANTI CONVULSANT OXCARBAZEPINE TA B 300MG 100 NDC CODE:68462013 801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004. 90.92.30 ANDA NO.:-77-802 TH ERAPEUTICE USE:-ANTI CONVULSA NT AGENT OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:6846203961 0 FDA PRODUCT CODE NO.: 62KC F10 H. T. S NO.: 3004.90.916 0 ANDA NO.: 91672 THERAPEUTI CE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DIS EASE TROSPIUM CL TAB 20MG 6 0 NDC CODE:68462046160 FDA P RODUCT CODE NO.:-61 K C A 69 H. T. S NO.: 3004.49.00.70 ANDA NO.:-91-575 THERAPEUTICE USE:- TREATMENT OF VENOUS D ISEASES URINARY INCONTINENCE THERAPY COMMERCIAL & CUSTO M INVOICE NO. F22452003147 DT . 30.09.2023 F22452003178 DT. 30.09.2023 F22452003152 DT. 30.09.2023 S/BILL NO: 4334414 DT 01-OCT-2023 S/BILL NO: 43 34459 DT 02-OCT-2023 S/BILL N O: 4334426 DT 02-OCT-2023 NET WT: 8676.018 KGS 02 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 614500 |
2023-10-31 |
43 PKG |
10124.35KG |
43 PALLETS 2319 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT NITROGLYCE RIN SUBLING TAB 0.4MG 4X25 ND C CODE:68462063945 FDA PRODUC T CODE NO.: 66 S C A 28 H. T . S NO.: 3004.90.9020 ANDA N O.:206391 THERAPEUTIC USE: - MEDICATION USED FOR HEART FAI LURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART NAPROXEN SOD TAB 550MG 100 NDC CODE:68462 017901 FDA PRODUCT CODE NO.: -62 G C A 50 H. T. S NO.: 30 04.90.92.40 ANDA NO.:-78-314 THERAPEUTICE USE:-ANTI -INFL AMMATORY, ANALGESIC APREPIT ANT CAP 125MG 6UD NDC CODE:68 462058576 NDC NO.:68462058576 FDA PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 3004.90. 92.40 ANDA NO.:207777 THERAP EUTICE USE:APREPITANT IS USED WITH OTHER MEDICATIONS TO H ELP PREVENT NAUSEA AND VOMITI NG CAUSED BY CANCER DRUG TREA TMENT (CHEMOTHERAPY). THIS M EDICATION IS ALSO USED TO PRE VENT NAUSEA AND VOMITING AFTE R SURGERY. A-EMETIC/NAUSEANT / HUMAN - RX/SINGLE INGREDIE NT / DELAYED RELEASE TABLETS / APREPITANT NITROGLYCERIN SUBLING TAB 0.4MG 4X25 NDC C ODE:68462063945 FDA PRODUCT C ODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEUTIC USE: -MED ICATION USED FOR HEART FAILUR E,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CO DE : 64 T C E 08 ANDA NO.2066 62 THERAPEUTIC USE : TO PREV ENT REJECTION OF A KIDNEY,HEA RT, OR LIVER TRANSPLANT TA CROLIMUS OINT 0.1% 60GM NDC C ODE:68462053465 FDA PRODUCT C ODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO. : 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMU NOSUPPRESSIVE OINTMENT USED F OR THE TREATMENT OF MODERATE -TO-SEVERE ATOPIC DERMATITIS (ECZEMA). GABAPENTIN TAB 6 00MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-662 THERAP EUTICE USE:-ANTICONVULSANT A GENT DILTIAZEM HCL ER CAP 1 2HR 120MG 100 NDC CODE:684620 56201 62 O C B 24 3004.49.00 .10 212317 FOR THE TREATMENT OF HYPERTENSION. PROPAFEN ONE HCL ER CAP 325MG 60 NDC C ODE:68462040960 FDA PRODUCT C ODE NO.: 63 E C F 28 H. T. S NO.: 3004.49.00.10 ANDA NO. : 205268 THERAPEUTICE USE: -A N ANTIARRHYTHMIC AGENT IT IS USED TO TREAT IRREGULAR HEAR TRHYTHM AND CAN SLOW RAPID HE ARTBEATS TOPIRAMATE ER CAP (Q) 50MG 30 NDC CODE:68462037 330 3004.49.00.20 61 M C B 4 0 210278 GABAPENTIN TAB 60 0MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92 .30 ANDA NO.:-77-662 THERAPE UTICE USE:-ANTICONVULSANT AG ENT TOPIRAMATE ER CAP (Q) 2 5MG 30 NDC CODE:68462037230 3004.49.00.20 61 M C B 40 21 0278 GABAPENTIN TAB 600MG 5 00 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT GABAPENTIN TAB 600MG 500 ND C CODE:68462012605 FDA PRODUC T CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-662 THERAPEUTICE USE: -ANTICONVULSANT AGENT COLE SEVELAM HCL TAB 625MG 180 NDC CODE:68462043318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00.10 ANDA N O.: 203480 THERAPEUTICE USE: - ANTIHYPERLIPO PROTEINEMIC. COMMERCIAL & CUSTOM INVO ICE NO. F22487001150 DT. 30.0 9.2023 F22487001163 DT. 30.09 .2023 F22487001167 DT. 30.09. 2023 F22487001173 DT. 30.09.2 023 F22487001174 DT. 30.09.20 23 F22487001175 DT. 30.09.202 3 F22487001183 DT. 30.09.2023 F22487001184 DT. 30.09.2023 F22487001188 DT. 30.09.2023 F22487001191 DT. 30.09.2023 F 22487001192 DT. 30.09.2023 F2 2487001193 DT. 30.09.2023 F22 487001194 DT. 30.09.2023 F224 87001197 DT. 30.09.2023 F2248 7001198 DT. 30.09.2023 S/BILL NO: 4015337 DT: 04.10.2023 S /BILL NO: 4015336 DT: 04.10.20 |
HS 300490 |
2023-10-31 |
23 PKG |
5138.83KG |
23 PALLETS 2472 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 10MG 90 NDC CODE :68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 10MG 90 NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE ROSUVASTATIN TAB 10MG 90 NDC CODE:68462026290 FDA PR ODUCT CODE NO.:61 J C A 16 H . T. S NO.: 3004.49.00.10 AN DA NO.: 079172 THERAPEUTICE U SE: - TO TREAT HIGH CHOLESTER OL AND RELATED CONDITIONS, A ND TO PREVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 10 MG 90 NDC CODE:68462026290 F DA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.1 0 ANDA NO.: 079172 THERAPEUT ICE USE: - TO TREAT HIGH CHOL ESTEROL AND RELATED CONDITION S, AND TO PREVENT CARDIOVASC ULAR DISEASE ROSUVASTATIN T AB 20MG 1000 NDC CODE:6846202 6310 FDA PRODUCT CODE NO.: 6 1 J C A 16 H. T. S NO.: 3004 .49.00.10 ANDA NO.: 79172 TH ERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RELATED COND ITIONS, AND TO PREVENT CARDIO VASCULAR DISEASE ROSUVASTA TIN TAB 10MG 1000 NDC CODE:68 462026210 61 J C A 16 3004.4 9.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED CONDI TIONS, AND TO PREVENT CARDIO VASCULAR DISEASE ROSUVASTAT IN TAB 10MG 1000 NDC CODE:684 62026210 61 J C A 16 3004.49 .00.10 79172 TO TREAT HIGH C HOLESTEROL AND RELATED CONDIT IONS, AND TO PREVENT CARDIOV ASCULAR DISEASE ROSUVASTATI N TAB 10MG 1000 NDC CODE:6846 2026210 61 J C A 16 3004.49. 00.10 79172 TO TREAT HIGH CH OLESTEROL AND RELATED CONDITI ONS, AND TO PREVENT CARDIOVA SCULAR DISEASE ROSUVASTATIN TAB 10MG 1000 NDC CODE:68462 026210 61 J C A 16 3004.49.0 0.10 79172 TO TREAT HIGH CHO LESTEROL AND RELATED CONDITIO NS, AND TO PREVENT CARDIOVAS CULAR DISEASE ROSUVASTATIN TAB 10MG 1000 NDC CODE:684620 26210 61 J C A 16 3004.49.00 .10 79172 TO TREAT HIGH CHOL ESTEROL AND RELATED CONDITION S, AND TO PREVENT CARDIOVASC ULAR DISEASE COMMERCIAL & C USTOM INVOICE NO. F2245200311 0 DT. 29.09.2023 F22452003167 DT. 30.09.2023 F22452003169 DT. 30.09.2023 F22452003146 D T. 30.09.2023 F22452003204 DT . 30.09.2023 F22452003206 DT. 30.09.2023 F22452003208 DT. 30.09.2023 F22452003209 DT. 3 0.09.2023 F22452003211 DT. 30 .09.2023 S/BILL NO: 4338883 D T 02-OCT-2023 S/BILL NO: 4338 889 DT 02-OCT-2023 S/BILL NO: 4338882 DT 02-OCT-2023 S/BIL L NO: 4339583 DT 02-OCT-2023 S/BILL NO: 4339114 DT 02-OCT-2 023 S/BILL NO: 4339111 DT 02- OCT-2023 S/BILL NO: 4339109 D T 02-OCT-2023 S/BILL NO: 4339 108 DT 02-OCT-2023 S/BILL NO: 4339106 DT 02-OCT-2023 NET W T. 4101.161 KGS 23 DATA LO GGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GL ENMARK SPECIALTY S.A. SWITZER LAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 684620 |
2023-10-31 |
7 PKG |
1599.85KG |
7 PALLETS 726 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 20MG 1000 NDC CODE :68462026310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO .: 3004.49.00.10 ANDA NO.: 7 9172 THERAPEUTICE USE: TO TR EAT HIGH CHOLESTEROL AND RELA TED CONDITIONS, AND TO PREVEN T CARDIOVASCULAR DISEASE R OSUVASTATIN TAB 10MG 90 NDC C ODE:68462026290 FDA PRODUCT C ODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 10MG 90 NDC CODE:68462026290 FDA PROD UCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE : - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DI SEASE COMMERCIAL & CUSTOM I NVOICE NO. F22452003111 DT. 2 9.09.2023 F22452003164 DT. 30 .09.2023 F22452003165 DT. 30. 09.2023 S/BILL NO: 4334415 DT 01-OCT-2023 S/BILL NO: 43344 54 DT 02-OCT-2023 S/BILL NO: 4334451 DT 02-OCT-2023 NET WT : 1278.48 KGS 07 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUC HATEL - 2000 SWITZERLAND |
HS 684620 |
2023-10-31 |
42 PKG |
9180.86KG |
42 PALLETS 2985 CARTONS P HARMACEUTICALS AS UNDER POT ASSIUM CL ER CAP 10MEQ 100 N DC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T . S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA PROCHLORPERAZ INE MAL TAB 5MG 100 NDC CODE: 68462088901 POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:68462 035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 30 04.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - TREATMEN T OR PREVENTION OF HYPOKALEMI A TACROLIMUS OINT 0.1% 30GM NDC CODE:68462053435 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DERM ATITIS (ECZEMA). TACROLIMU S CAP 1MG 100 NDC CODE:684620 68601 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA N O.206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDN EY,HEART, OR LIVER TRANSPLANT GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PROD UCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE US E:-ANTICONVULSANT AGENT CL INDAMYCIN HCL CAP 75MG 100 ND C CODE:68462014201 PRAVASTA TIN SOD TAB 80MG 90 NDC CODE: 68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO. : 3004.90.92.20 ANDA NO.:-77 -987 THERAPEUTICE USE:-HYPOL IPDAEMIC COMMERCIAL & CUSTO M INVOICE NO. F22487001158 DT . 30.09.2023 F22487001169 DT. 30.09.2023 F22487001196 DT. 30.09.2023 F22487001211 DT. 0 5.10.2023 F22487001212 DT. 05 .10.2023 S/BILL NO: 4015476 DT: 06.10.2023 S/BILL NO: 401 5475 DT: 06.10.2023 S/BILL N O: 4015474 DT: 06.10.2023 S/ BILL NO: 4015473 DT: 06.10.20 23 S/BILL NO: 4015469 DT: 06 .10.2023 NET WT. 5518.521 KGS 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 300490 |
2023-10-24 |
13 PKG |
3178.38KG |
13 PALLETS 1599 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 10MG 90 NDC CODE :68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 10MG 1000 N DC CODE:68462026210 61 J C A 16 3004.49.00.10 79172 TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO . F22452003004 DT. 25.09.2023 S/BILL NO: 4226608 DT 27-SEP -2023 NET WT. 2,514.78 KGS 13 DATA LOGGERS SET TEMPE RATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S .A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 684620 |
2023-10-24 |
31 PKG |
7792.85KG |
31 PALLETS 2831 CARTONS PH ARMACEUTICALS AS UNDER LITH IUM CARB ER TAB 300MG 100 NDC CODE:68462022301 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00.20 ANDA N O.:91-544 THERAPEUTICE USE: - INDICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER. BIPOLAR DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, IN THE OLDER DSM-II T ERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR DISORDER. MAINTE NANCE THERAPY REDUCES THE FRE QUENCY OF MANIC EPISODES AND DIMINISHES THE INTENSITY OF THOSE EPISODES WHICH MAY OCC UR. LITHIUM CARB ER TAB 30 0MG 100 NDC CODE:68462022301 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.0 0.20 ANDA NO.:91-544 THERAP EUTICE USE: - INDICATED IN TH E TREATMENT OF MANIC EPISODE S OF BIPOLAR DISORDER. BIPO LAR DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO MANIC DEPRES SIVE ILLNESS, MANIC, IN THE O LDER DSM-II TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT FOR INDIVIDUALS WI TH A DIAGNOSIS OF BIPOLAR DIS ORDER. MAINTENANCE THERAPY R EDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISHES THE INTENSITY OF THOSE EPISODES WHICH MAY OCCUR. CARVEDIL OL TAB 6.25MG 500 NDC CODE:68 462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78- 251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST LITHIUM CARB CAP 600MG 100 ND C CODE:68462022201 FDA PRODUC T CODE NO.:-61 N C E 37 H. T . S NO.: 3004.49.00.20 ANDA NO.:- 79 -139 THERAPEUTICE U SE:-ANTIMANIC AGENT CARVEDI LOL TAB 6.25MG 100 NDC CODE:6 8462016301 FDA PRODUCT CODE N O : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78 -251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST OMEPRAZOLE DR CAP 40MG 90 ND C CODE:68462039790 FDA PRODUC T CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -T REATMENT OF TREAT GASTROESOPH AGEAL REFLUX DISEASE ROPIN IROLE TAB 2MG 100 NDC CODE:68 462025601 FDA PRODUCT CODE N O.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90- 135 THERAPEUTICE USE:-TREATM ENT OF PARKINSONISM COMMER CIAL & CUSTOM INVOICE NO. F22 452002972 DT. 23.09.2023 F224 52002950 DT. 22.09.2023 F2245 2002981 DT. 24.09.2023 F22452 002982 DT. 24.09.2023 F224520 03003 DT. 25.09.2023 S/BILL N O: 4226785 DT 27-SEP-2023 S/B ILL NO: 4226772 DT 27-SEP-2023 S/BILL NO: 4227329 DT 27-SEP -2023 S/BILL NO: 4226617 DT 2 7-SEP-2023 S/BILL NO: 4226625 DT 27-SEP-2023 NET WT. 6465. 463 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 613700 |
2023-10-24 |
38 PKG |
8302.69KG |
38 PALLETS 2370 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO .:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA INDOMETHACIN ER CAP 75MG 100 NDC CODE:684620 32501 FDA PRODUCT CODE NO.: 62GCE42 H. T. S NO.: 3004.90 .92.40 ANDA NO.: 203501 THER APEUTICE USE: :#INDOMETHACIN IS USED TO RELIEVE PAIN, SWE LLING,AND JOINT STIFFNESS CAU SED BY ARTHRITIS, GOUT, BURS ITIS,AND TENDONITIS.AND TEND ONITIS.IT IS ALSO USED TO REL IEVE PAIN FROM VARIOUS AS DEC REASE SWELLING ANDTHIS EFFECT HELPS TOANTI-INFLAMMATORY D RUGA NONSTEROIDALTHIS MEDICAT ION IS KNOWNCONDITIONS. IN DOMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA PRODUCT CODE: 62 GCE42 H. T. S NO. :3004.90.92.40 ANDA NO.203501 THERAPEUTIC USE: INDOMETHAC IN IS USED TO RELIEVE PAIN, S WELLING, AND JOINT STIFFNESS CAUSED BY ARTHRITIS, GOUT, BU RSITIS, AND TENDONITIS. IT I S ALSO USED TO RELIEVE PAIN F ROM VARIOUS OTHER CONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMA TORY DRUG (NSAID). ... THIS EFFECT HELPS TO DECREASE SWEL LING AND PAIN. CARVEDILOL TAB 25MG 500 NDC CODE:6846201 6505 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST INDOM ETHACIN ER CAP 75MG 60 NDC CO DE:68462032560 FDA PRODUCT CO DE: 62 GCE42 H. T. S NO.:30 04.90.92.40 ANDA NO.203501 T HERAPEUTIC USE: INDOMETHACIN IS USED TO RELIEVE PAIN, SWEL LING, AND JOINT STIFFNESS CAU SED BY ARTHRITIS, GOUT, BURSI TIS, AND TENDONITIS. IT IS A LSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDITIONS. T HIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMATOR Y DRUG (NSAID). ... THIS EFF ECT HELPS TO DECREASE SWELLIN G AND PAIN. ASPIRIN-ER DIP YRIDAMOLE CAP 25/200MG 60 NDC CODE:68462040560 FDA PRODUCT CODE NO.: 60 L D F 05 H. T. S NO.: 3004.90.9220 ANDA NO .:210318 TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HT S NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANSPLANT TACRO LIMUS OINT 0.1% 100GM NDC COD E:68462053494 FDA PRODUCT COD E NO.: 64 T C J 08 H. T. S N O.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - T ACROLIMUS IS A TOPICAL IMMUNO SUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-T O-SEVERE ATOPIC DERMATITIS ( ECZEMA). SEVELAMER HCL TAB 800MG 180 NDC CODE:6846204471 8 FDA PRODUCT CODE NO.: 63 L D A 04 H. T. S NO.: 3004.90 .92.60 ANDA NO.:204724 THERA PEUTICE USE:SEVELAMER HYDROC HLORIDE TABLETS ARE A PHOSPHA TE BINDER INDICATED FOR THE C ONTROL OF SERUM PHOSPHORUS IN PATIENTS WITH CHRONIC KIDNE Y DISEASE ON DIALYSIS PROP AFENONE HCL ER CAP 225MG 60 N DC CODE:68462040860 FDA PRODU CT CODE NO.: 63 E C F 28 H. T. S NO.: 3004.49.00.10 ANDA NO.:205268 THERAPEUTICE USE: AN ANTIARRHYTHMIC AGENT. IT IS USED TO TREAT IRREGULAR HE ART RHYTHM AND CAN SLOW RAPI D HEARTBEATS COMMERCIAL & CUSTOM INVOICE NO. F224870011 00 DT. 22.09.2023 F2248700110 1 DT. 22.09.2023 F22487001102 DT. 22.09.2023 F22487001103 DT. 22.09.2023 F22487001104 D T. 22.09.2023 F22487001105 DT . 22.09.2023 S/BILL NO: 40145 60 DT: 23/09/2023 S/BILL NO: 4014554 DT: 23/09/2023 S/BILL NO: 4014553 DT: 23/09/2023 S /BILL NO: 4014549 DT: 23/09/20 23 S/BILL NO: 4014551 DT: 23/ 09/2023 S/BILL NO: 4014550 DT : 23/09/2023 NET WT. 4287.102 KGS 03 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA NOTIFY PARTY:3 GLEN MARK SPECIALTY S.A. SWITZERLA ND (GSSA) PLACE DU PORT 2 NE UCHATEL - 2000 SWITZERLAND |
HS 651400 |
2023-10-24 |
31 PKG |
6745.49KG |
31 PALLETS 1607 CARTONS PH ARMACEUTICALS AS UNDER COLE SEVELAM HCL TAB 625MG 180 NDC CODE:68462043318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00.10 ANDA N O.: 203480 THERAPEUTICE USE: - ANTIHYPERLIPO PROTEINEMIC. RUFINAMIDE TAB 400MG 120 NDC CODE:68462071408 61 M C A 99 3004.90.92.30 205075 TO USED WITH OTHER MEDICATIONS TO PREVENT OR CONTROL SEIZURE S (EPILEPSY) ASSOCIATED WITH LENNOX-GASTAUT SYNDROME (LG S PRAVASTATIN SOD TAB 80MG 90 NDC CODE:68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTIC E USE:-HYPOLIPDAEMIC EZETI MIBE-SIMVA TAB 10/40MG 30 NDC CODE:68462032330 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA N O.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDICATION IS USED TO HELP LOWER BAD C HOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN T HE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLES TEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELON GS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY RED UCING THE AMOUNT OF CHOLESTER OL MADE BY THE LIVER. TOPI RAMATE ER CAP (Q) 150MG 30 ND C CODE:68462037030 3004.49.00 .20 61 M C B 40 210278 PO TASSIUM CL ER CAP 10MEQ 500 N DC CODE:68462035705 FDA PRODU CT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE : - TREATMENT OR PREVENTION OF HYPOKALEMIA COMMERCIAL & CUSTOM INVOICE NO. F22487001 133 DT. 27.09.2023 S/BILL NO: 4014895 DT: 28/09/2023 NET WT. 4070.610 KGS 02 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 621300 |
2023-10-24 |
40 PKG |
5972.55KG |
40 PALLETS 1906 CARTONS PH ARMACEUTICALS AS UNDER HAIL EY 24 FE TAB 1MG/20MCG-75MG 84 NDC CODE:68462073129 FDA PR ODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 A NDA NO.: 204847 THERAPEUTICE USE: - CONTRACEPTION TO PREVE NT PREGNANCY NORETH ACE/EE TAB 1MG/5MCG 84 NDC CODE:684 62065729 FDA PRODUCT CODE NO. : 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 20303 8 THERAPEUTICE USE: - TREATM ENT OF MODERATE TO SEVERE VAS OMOTOR SYMPTOMS DUE TO MENOP AUSE; OSTEOPOROSIS PREVENTION HAILEY 24 FE TAB 1MG/20MCG -75MG 84 NDC CODE:68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60. 00.00 ANDA NO.: 204847 THERA PEUTICE USE: - CONTRACEPTION TO PREVENT PREGNANCY NORET H ACE/EE TAB 1/0.02MG 63 NDC CODE:68462013281 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 ANDA NO. :206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOMETR IOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIAL & CUSTO M INVOICE NO. F22452003014 DT . 26.09.2023 F22452003026 DT. 26.09.2023 F22452003061 DT. 28.09.2023 S/BILL NO: 4236270 DT 27-SEP-2023 S/BILL NO: 42 26774 DT 27-SEP-2023 S/BILL N O: 4247734 DT 28-SEP-2023 NET WT. 4,223.970 KGS 02 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 652500 |
2023-10-24 |
10 PKG |
1742.28KG |
10 PALLETS 854 CARTONS PHA RMACEUTICALS AS UNDER NITRO GLYCERIN SUBLING TAB 0.4MG 4X2 5 NDC CODE:68462063945 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 A NDA NO.:206391 THERAPEUTIC US E: -MEDICATION USED FOR HEAR T FAILURE,HIGH BLOOD PRESSURE ,AND TO TREAT AND PREVENT CHE ST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART SOLIFEN ACIN SUCCINATE TAB 5MG 30 NDC CODE:68462038630 FDA PRODUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO. : 209239 INDICATED FOR THE T REATMENT OF OVERACTIVE BLADDE R WITH SYMPTOMS OF URGE URINA RY INCONTINENCE, URGENCY AND URINARY FREQUENCY SOLIFENA CIN SUCCINATE TAB 5MG 90 NDC CODE:68462038690 FDA PRODUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICATED FOR THE TR EATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINAR Y INCONTINENCE, URGENCY AND URINARY FREQUENCY COMMERCIA L & CUSTOM INVOICE NO. F22487 001134 DT. 27.09.2023 F224870 01135 DT. 27.09.2023 S/BILL N O: 4014897 DT: 28/09/2023 S/B ILL NO: 4014899 DT: 28/09/2023 NET WT. 157.902 KGS 10 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY: 2 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE DU POR T 2 NEUCHATEL - 2000 SWITZER LAND |
HS 662800 |
2023-10-24 |
47 PKG |
10640.55KG |
47 PALLETS 4742 CARTONS PH ARMACEUTICALS AS UNDER ONDA NSETRON ODT 8MG 10UD NDC CODE :68462015811 FDA PRODUCT CODE NO.:-61 T C A 26 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-152 THERAPEUTICE USE:-ANTI -EMETIC OXCARBAZEPINE TAB 150MG 100 NDC CODE:6846201370 1 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90 .92.30 ANDA NO.:-77-802 THER APEUTICE USE:-ANTI CONVULSANT AGENT PRAMIPEXOLE TAB 0.12 5MG 90 NDC CODE:68462033090 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92 .40 ANDA NO.: 90-781 THERAPE UTICE USE: USED IN PARKINSON# S DISEASE TOPIRAMATE TAB 50 MG 60 NDC CODE:68462015360 F DA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00. 20 ANDA NO.:- 77-627 THERAPE UTICE USE:-ANTICONVULSANT OXCARBAZEPINE TAB 150MG 100 N DC CODE:68462013701 FDA PRODU CT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE :-ANTI CONVULSANT AGENT PR AMIPEXOLE TAB 0.125MG 90 NDC CODE:68462033090 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO .: 90-781 THERAPEUTICE USE: U SED IN PARKINSON S DISEASE TOPIRAMATE TAB 25MG 500 NDC CODE:68462010805 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO .:077627 THERAPEUTICE USE: A NTICONVULSANT VERAPAMIL HCL ER TAB 240MG 100 NDC CODE:68 462026001 FDA PRODUCT CODE NO .: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-78-9 06 THERAPEUTICE USE:-ANGINA ROSUVASTATIN TAB 10MG 90 N DC CODE:68462026290 FDA PRODU CT CODE NO.:61 J C A 16 H. T . S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DIS EASE ROSUVASTATIN TAB 10MG 90 NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULA R DISEASE COMMERCIAL & CUST OM INVOICE NO. F22452003054 D T. 27.09.2023 F22452003077 DT . 28.09.2023 F22452003090 DT. 28.09.2023 F22452003053 DT. 27.09.2023 F22452003103 DT. 2 9.09.2023 S/BILL NO: 4294215 DT 29-SEP-2023 S/BILL NO: 429 4392 DT 29-SEP-2023 S/BILL NO : 4294391 DT 29-SEP-2023 S/BI LL NO: 4294213 DT 29-SEP-2023 S/BILL NO: 4294216 DT 29-SEP- 2023 NET WT: 8,503.971 KGS 12 DATA LOGGERS HUMIDITY:65 % SET TEMPERATURE : +18 DEGRE ES TEMPERATURE RANGE : +15 DE GREES TO +25 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA NOTIFY PARTY:3 GLENMARK S PECIALTY S.A. SWITZERLAND (GS SA) PLACE DU PORT 2 NEUCHATE L - 2000 SWITZERLAND |
HS 684620 |
2023-10-24 |
35 PKG |
7550.17KG |
35 PALLETS 3464 CARTONS P HARMACEUTICALS AS UNDER OND ANSETRON ODT 8MG 30UD NDC COD E:68462015813 FDA PRODUCT COD E.:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 152 THERAPEUTICE USE:-ANTI E METIC TOPIRAMATE TAB 25MG 5 00 NDC CODE:68462010805 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVULSANT TOPIR AMATE TAB 25MG 60 NDC CODE:68 462010860 FDA PRODUCT CODE N O.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77- 627 THERAPEUTICE USE:-ANTICO NVULSANT ROPINIROLE TAB 2MG 100 NDC CODE:68462025601 FD A PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:- 90-135 THERAPEU TICE USE:-TREATMENT OF PARKI NSONISM ADAPALENE-BPO GEL P UMP 0.1/2.5% 45GM NDC CODE:68 462030147 FDA PRODUCT CODE NO .: 62 S D O 02 H. T. S NO.: 3004.90.92.45 ANDA NO.: 2081 08 THERAPEUTICE USE: - USED ON THE SKIN TO TREAT ACNE COMMERCIAL & CUSTOM INVOICE NO . F22452003027 DT. 26.09.2023 F22452003052 DT. 27.09.2023 F22452003073 DT. 28.09.2023 S/BILL NO: 4264401 DT 29-SEP-2 023 S/BILL NO: 4264159 DT 29- SEP-2023 S/BILL NO: 4264395 D T 29-SEP-2023 NET WT. 5,93 8.056 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 614000 |
2023-10-24 |
2 PKG |
136.08KG |
2 PALLETS 98 CARTONS PHARM ACEUTICALS AS UNDER CLINDAM YCIN-BPO GEL PUMP 1%/5% 50GM NDC CODE:68462085927 FDA PROD UCT CODE NO.: 61 H D J 99 H. T. S NO.: 3004.49.00.50 AND A NO.: #209252 THERAPEUTICE U SE: #CLINDAMYCIN AND BENZOYL PEROXIDE GEL IS INDICATED F OR THE TOPICAL TREATMENT OF A CNE VULGARIS. COMMERCIAL & CUSTOM INVOICE NO. F224520030 72 DT. 28.09.2023 S/BILL NO: 4264402 DT 29-SEP-2023 NET WT . 116.820 KGS 02 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE DU PORT 2 NEU CHATEL - 2000 SWITZERLAND |
HS 619900 |
2023-10-24 |
42 PKG |
9207.17KG |
42 PALLETS 2893 CARTONS PH ARMACEUTICALS AS UNDER OLME SARTAN MEDOX TAB 20MG 90 NDC CODE:68462043790 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO .: 3004.90.9220 ANDA NO.: 20 3281 THERAPEUTICE USE: - TRE ATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENS IVE AGENTS, TO LOWER BLOOD PR ESSURE GABAPENTIN TAB 800MG 500 NDC CODE:68462012705 FD A PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.3 0 ANDA NO.:-77-662 THERAPEUT ICE USE:-ANTICONVULSANT AGEN T ATOVAQUONE-PROG TAB 62.5/ 25MG 100 NDC CODE:68462040201 FDA PRODUCT CODE NO.: 62 L D A 44 H. T. S NO.: 3004.90. 92.90 ANDA NO.: 91-211 ANTI MALARIAL LITHIUM CARB ER TA B 300MG 100 NDC CODE:68462022 301 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004. 49.00.20 ANDA NO.:91-544 TH ERAPEUTICE USE: - INDICATED I N THE TREATMENT OF MANIC EPI SODES OF BIPOLAR DISORDER. B IPOLAR DISORDER, MANIC (DSM-I V) IS EQUIVALENT TO MANIC DEP RESSIVE ILLNESS, INDICATED I N THE TREATMENT OF MANIC EPI SODES OF BIPOLAR DISORDER. B IPOLAR DISORDER, MANIC (DSM-I V) IS EQUIVALENT TO MANIC DEP RESSIVE ILLNESS MANIC, IN THE OLDER DSM-II TERMINOLOGY. AL SO INDICATED AS A MAINTENANC E TREATMENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR D ISORDER. MAINTENANCE THERAPY REDUCES THE FREQUENCY OF MAN IC EPISODES AND DIMINISHES TH E INTENSITY OF THOSE EPISODE S WHICH MAY OCCUR. OLMESA RTAN MEDOX TAB 20MG 30 NDC CO DE:68462043730 FDA PRODUCT CO DE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 2032 81 THERAPEUTICE USE: - TREAT MENT OF HYPERTENSION, ALONE O R WITH OTHER ANTIHYPERTENSIV E AGENTS, TO LOWER BLOOD PRES SURE NORGEST/EE TAB 0.25/0. 035MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60. 00.00 ANDA NO.: 200538 THERA PEUTICE USE: - ORAL CONTRACEP TIVES NORETHINDRONE TAB 0.3 5MG 84 NDC CODE:68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00 .00 ANDA NO.:91-209 THERAPEU TICE USE: PREVENTION OF PREGN ANCY. COMMERCIAL & CUSTOM I NVOICE NO. F22452002928 DT. 2 1.09.2023 F22452002929 DT. 21 .09.2023 F22452002930 DT. 21. 09.2023 F22452002931 DT. 21.0 9.2023 F22452002932 DT. 21.09 .2023 F22452002943 DT. 22.09. 2023 F22452002944 DT. 22.09.2 023 S/BILL NO: 4119839 DT 22- SEP-2023 S/BILL NO: 4121635 D T 22-SEP-2023 S/BILL NO: 4121 638 DT 22-SEP-2023 S/BILL NO: 4119837 DT 22-SEP-2023 S/BIL L NO: 4119840 DT 22-SEP-2023 S/BILL NO: 4121836 DT 22-SEP-2 023 S/BILL NO: 4121839 DT 22- SEP-2023 NET WT: 7308.633 KG S 03 DATA LOGGERS HUMIDITY :65% SET TEMPERATURE : +18 DE GREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 626800 |
2023-10-17 |
43 PKG |
8979.92KG |
43 PALLETS 2002 CARTONS P HARMACEUTICALS AS UNDER DRO SPIRENONE/EE TAB 3/0.02MG 84 NDC CODE:68462072029 FDA PROD UCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 AND A NO.: 204296 THERAPEUTICE US E: - ORAL CONTRACEPTIVE GA BAPENTIN TAB 800MG 500 NDC CO DE:68462012705 FDA PRODUCT CO DE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT GABAPEN TIN TAB 800MG 500 NDC CODE:68 462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-6 62 THERAPEUTICE USE:-ANTICON VULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22452002 859 DT. 16.09.2023 F224520028 67 DT. 16.09.2023 F2245200287 0 DT. 17.09.2023 S/BILL NO:40 19295 DT 18-SEP-2023 S/BILL N O:4015028 DT 18-SEP-2023 S/BI LL NO:4015024 DT 18-SEP-2023 NET WT. 7,290.868 KGS 02 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 653900 |
2023-10-17 |
5 PKG |
1083.65KG |
5 PALLETS 256 CARTONS PHAR MACEUTICALS AS UNDER APREPI TANT CAP 40MG 5UD NDC CODE:68 462058385 FDA PRODUCT CODE NO .: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.:20777 7 THERAPEUTICE USE:APREPITAN T IS USED WITH OTHER MEDICATI ONS TO HELP PREVENT NAUSEA AN D VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHERAPY) . THIS MEDICATION IS ALSO USE D TO PREVENT NAUSEA AND VOMI TING AFTER SURGERY. A-EMETIC/ NAUSEANT / HUMAN - RX/SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT NITR OGLYCERIN SUBLING TAB 0.4MG 4X 25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC U SE: #NAME? HEART FAILURE,HIG H BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOICE NO. F22487001066 DT. 18.09.2023 F22487001067 DT. 1 8.09.2023 S/BILL NO:4014259 D T: 18/09/2023 S/BILL NO: 4014 267 DT: 18/09/2023 NET WT. 6 7.346 KGS 04 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK S PECIALTY S.A. SWITZERLAND (GS SA) PLACE DU PORT 2 NEUCHATE L - 2000 SWITZERLAND |
HS 613200 |
2023-10-17 |
40 PKG |
6203.43KG |
40 PALLETS 1889 CARTONS PH ARMACEUTICALS AS UNDER NORG EST/EE TAB 0.25/0.035MG 84 ND C CODE:68462030929 FDA PRODUC T CODE NO.: 65 J D A 27 H. T . S NO.: 3006.60.00.00 ANDA NO.: 200538 THERAPEUTICE USE: - ORAL CONTRACEPTIVES BRI ELLYN TAB 0.4/0.035MG 84 NDC CODE:68462031629 FDA PRODUCT CODE NO.: 65 J D A 24 H. T. S NO.: 3006.60.00.00 ANDA NO .: 90-538 THERAPEUTICE USE: O RAL CONTRACEPTIVE HAILEY 2 4 FE TAB 1MG/20MCG-75MG 84 ND C CODE:68462073129 FDA PRODUC T CODE NO.: 65 J D A 25 H. T . S NO.: 3006.60.00.00 ANDA NO.: 204847 THERAPEUTICE USE: - CONTRACEPTION TO PREVENT PREGNANCY COMMERCIAL & CUST OM INVOICE NO. F22452002912 D T. 21.09.2023 F22452002914 DT . 21.09.2023 S/BILL NO: 40877 97 DT 21-SEP-2023 S/BILL NO: 4087787 DT 21-SEP-2023 NET WT . 4,482.550 KGS 02 DATA LOGG ERS HUMIDITY:65% SET TEMPERA TURE : +18 DEGREES TEMPERATUR E RANGE : +15 DEGREES TO +25 D EGREES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA |
HS 652700 |
2023-10-17 |
36 PKG |
9368.2KG |
36 PALLETS 2787 CARTONS PH ARMACEUTICALS AS UNDER EZET IMIBE-SIMVA TAB 10/20MG 30 ND C CODE:68462032230 FDA PRODUC T CODE NO.: 61 J D C 15 H. T . S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: :#LIPID LOWERING AGENT EZ ETIMIBE-SIMVA TAB 10/20MG 90 NDC CODE:68462032290 FDA PROD UCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 AND A NO.: 208699 THERAPEUTICE US E: :#LIPID LOWERING AGENT RANOLAZINE ER TAB 500MG 60 ND C CODE:68462031960 FDA PRODUC T CODE NO.: 61 D C B 02 H. T . S NO.: 3004.49.00.10 ANDA NO.:211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDIC ATION. IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENC Y) ATTACK OF ANGINA PRAVAS TATIN SOD TAB 10MG 500 NDC CO DE:68462019505 FDA PRODUCT CO DE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: -77-987 THERAPEUTICE USE:-HY POLIPDAEMIC TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CO DE : 64 T C E 08 ANDA NO.2066 62 THERAPEUTIC USE : TO PREV ENT REJECTION OF A KIDNEY,HEA RT, OR LIVER TRANSPLANT TA CROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90. 92.20 ANDA NO.:- 78-251 THER APEUTICE USE:-BETA- ADRENOAC EPTOR ANTAGONIST CARVEDILO L TAB 25MG 500 NDC CODE:68462 016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 30 04.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST COM MERCIAL & CUSTOM INVOICE NO. F22487001057 DT. 18.09.2023 F 22487001058 DT. 18.09.2023 F2 2487001059 DT. 18.09.2023 F22 487001060 DT. 18.09.2023 F224 87001064 DT. 18.09.2023 F2248 7001065 DT. 18.09.2023 F22487 001068 DT. 18.09.2023 S/BILL NO:4014260 DT: 18/09/2023 S/B ILL NO: 4014262 DT: 18/09/2023 S/BILL NO: 4014264 DT: 18/09 /2023 S/BILL NO: 4014266 DT: 18/09/2023 S/BILL NO: 4014261 DT: 18/09/2023 S/BILL NO: 40 14265 DT: 18/09/2023 S/BILL N O: 4014263 DT: 18/09/2023 NET WT. 6171.094 KGS 00 DATA LO GGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA |
HS 300490 |
2023-10-10 |
6 PKG |
992.93KG |
6 PALLETS 163 CARTONS PHAR MACEUTICALS AS UNDER CLINDA MYCIN-BPO GEL JAR 1%/5% 25GM NDC CODE:68462048619 FDA PROD UCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 AND A NO.: 209252 ANTIBIOTIC THAT STOPS THE GROWTH OF ACNE-CAU SING BACTERIA AS WELL AS RED UCE OIL PRODUCTION IN THE SKI N, HELPING KEEP PORES OPEN ROSUVASTATIN TAB 20MG 1000 N DC CODE:68462026310 FDA PRODU CT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE COMMERCIAL & CUSTOM INVO ICE NO. F22452002802 DT. 13.0 9.2023 F22452002821 DT. 13.09 .2023 S/BILL NO:3936992 DT 14 -SEP-2023 S/BILL NO:3928814 D T 14-SEP-2023 NET WT. 853.17 KGS 06 DATA LOGGERS HUMIDIT Y:65% SET TEMPERATURE : +18 D EGREES TEMPERATURE RANGE : +1 5 DEGREES TO +25 DEGREES NOTI FY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLA CE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 563100 |
2023-10-10 |
36 PKG |
6779.05KG |
36 PALLETS 2113 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT PRAVASTATI N SOD TAB 20MG 500 NDC CODE:6 8462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77- 987 THERAPEUTICE USE:-HYPOLI PDAEMIC CLINDAMYCIN HCL CAP 150MG 500 NDC CODE:684620143 05 HTS NO. 2941.90.5000 FDA PRODUCT CODE. 56 J C E 20 AND A NO. 216957 THERAPEUTICE USE . TREATMENT OF NUMEROUS INFEC TIONS, INCLUDING BUT NOT LIMIT ED TO SEPTICEMIA, INTRA-ABDOMI NAL INFECTIONS, LOWER RESPIRAT ORY INFECTIONS, GYNECOLOGICAL INFECTIONS, BONE AND JOINT INF ECTIONS, AND SKIN AND SKIN STR UCTURE INFECTION TOPIRAMATE ER CAP (Q) 100MG 30 NDC CODE :68462037430 H. T. S NO.: 30 04.49.00.20 FDA PRODUCT CODE 61 M C B 40 ANDA NO.:210278 FROVATRIPTAN SUCCINATE TAB 2.5MG 9 NDC CODE:68462069497 FDA PRODUCT CODE NO.:60 L C A 93 H. T. S NO.: 3004.90.92 .28 ANDA NO.:204730 THERAPEU TICE USE: - USE:THE TREATMENT OF MIGRAINE HEADACHES AND F OR SHORT TERM PREVENTION OF MENSTRUAL MIGRAINE FROVATRI PTAN SUCCINATE TAB 2.5MG 9 ND C CODE:68462069497 FDA PRODUC T CODE NO.:60 L C A 93 H. T. S NO.: 3004.90.92.28 ANDA N O.:204730 THERAPEUTICE USE: - USE:THE TREATMENT OF MIGRAI NE HEADACHES AND FOR SHORT T ERM PREVENTION OF MENSTRUAL M IGRAINE CLINDAMYCIN HCL CAP 150MG 100 NDC CODE:684620143 01 HTS NO. 2941.90.5000 FDA PRODUCT CODE. 56 J C E 20 AND A NO. 216957 THERAPEUTICE USE . TREATMENT OF NUMEROUS INFEC TIONS, INCLUDING BUT NOT LIMIT ED TO SEPTICEMIA, INTRA-ABDOMI NAL INFECTIONS, LOWER RESPIRAT ORY INFECTIONS, GYNECOLOGICAL INFECTIONS, BONE AND JOINT INF ECTIONS, AND SKIN AND SKIN STR UCTURE INFECTION CARVEDILOL TAB 25MG 500 NDC CODE:684620 16505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 300 4.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADR ENOACEPTOR ANTAGONIST TACR OLIMUS CAP 1MG 100 NDC CODE:6 8462068601 HTS NO: 3004.90.92 .15 FDA CODE : 64 T C E 08 A NDA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANS PLANT TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 F DA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 210393 THERAPEU TICE USE: - TACROLIMUS IS A T OPICAL IMMUNOSUPPRESSIVE OIN TMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PIME CROLIMUS CREAM 1% 30GM NDC CO DE:68462060935 FDA PRODUCT CO DE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - A S SECOUND-LINE THERAPY FOR T HE SHORT-TERM AND NON-CONTINU OS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITI S IN NON- IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS O F AGE TACROLIMUS CAP 0.5MG 100 NDC CODE:68462068501 FDA PRODUCT CODE NO.: 64 T C E 0 8 H. T. S NO.:3004.90.92.15 ANDA NO.: 206662 THERAPEUTIC E USE: :#TO PREVENT REJECTION OF A KIDNEY,TO PREVENT REJE CTION OF A KIDNEY,LIVER TRANS PLANT COMMERCIAL & CUSTOM I NVOICE NO. F22487001035 DT. 1 3.09.2023 F22487001036 DT. 13 .09.2023 F22487001037 DT. 13. 09.2023 F22487001038 DT. 13.0 9.2023 F22487001039 DT. 13.09 .2023 F22487001041 DT. 13.09. 2023 S/BILL NO: 4014083 DT: 1 4/09/2023 S/BILL NO: 4014085 DT: 14/09/2023 S/BILL NO: 401 4086 DT: 14/09/2023 S/BILL NO : 4014084 DT: 14/09/2023 S/BI LL NO: 4014089 DT: 14/09/2023 S/BILL NO: 4014088 DT: 14/09/ 2023 NET WT. 4281.056 KGS 02 DATA LOGGERS NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2023-10-10 |
9 PKG |
1756.79KG |
9 PALLETS 516 CARTONS PHAR MACEUTICALS AS UNDER NITROG LYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART SOLIFENA CIN SUCCINATE TAB 10MG 30 NDC CODE:68462038730 FDA PRODUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO. : 209239 INDICATED FOR THE T REATMENT OF OVERACTIVE BLADDE R WITH SYMPTOMS OF URGE URINA RY INCONTINENCE, URGENCY AND URINARY FREQUENCY APREPITA NT CAP 80MG 6UD NDC CODE:6846 2058476 FDA PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 3 004.90.92.40 ANDA NO.:207777 THERAPEUTICE USE:APREPITANT IS USED WITH OTHER MEDICATION S TO HELP PREVENT NAUSEA AND VOMITING CAUSED BY CANCER DR UG TREATMENT (CHEMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSEA AND VOMITI NG AFTER SURGERY. A-EMETIC/NA USEANT / HUMAN - RX/SINGLE I NGREDIENT / DELAYED RELEASE T ABLETS / APREPITANT NITROG LYCERIN SUBLING TAB 0.3MG 100 NDC CODE:68462063801 FDA PRO DUCT CODE NO.: 66 S C A 28 H . T. S NO.: 3004.90.9020 AND A NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE,A ND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD F LOW TO THE HEART COMMERCIA L & CUSTOM INVOICE NO. F22487 001040 DT. 13.09.2023 S/BILL NO: 4014087 DT: 14/09/2023 NE T WT: 138.718 KGS 9 DATA LO GGERS NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE DU PORT 2 NEU CHATEL - 2000 SWITZERLAND |
HS 662800 |
2023-10-10 |
44 PKG |
10763.02KG |
44 PALLETS 3311 CARTONS P HARMACEUTICALS AS UNDER OLM ESARTAN MEDOX TAB 40MG 30 NDC CODE:68462043830 FDA PRODUCT CODE NO.: 62CCA68 H. T. S N O.: 3004.90.9220 ANDA NO.: 2 03281 THERAPEUTICE USE: - -T REATMENT OF HYPERTENSION, ALO NE OR WITH OTHER ANTIHYPERTE NSIVE AGENTS, TO LOWER BLOOD PRESSURE OLMESARTAN MEDOX T AB 40MG 90 NDC CODE:684620438 90 FDA PRODUCT CODE NO.: 62 CCA 68 H. T. S NO.: 3004.90. 9220 ANDA NO.: 203281 TREATM ENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS, TO LOWER BLOOD PRESS URE FELODIPINE ER TAB 5MG 1 00 NDC CODE:68462023401 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3004.90.92.20 AND A NO.: 90-365 THERAPEUTICE US E: - TREATMENT OF HYPERTENSI ON INDOMETHACIN CAP 25MG 10 0 NDC CODE:68462040601 FDA P RODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: -ANTI-INFLAMATORY TRO SPIUM CL TAB 20MG 60 NDC CODE :68462046160 FDA PRODUCT CODE NO.:-61 K C A 69 H. T. S NO .: 3004.49.00.70 ANDA NO.:-9 1-575 THERAPEUTICE USE:- TRE ATMENT OF VENOUS DISEASES URI NARY INCONTINENCE THERAPY OMEPRAZOLE DR CAP 40MG 90 ND C CODE:68462039790 FDA PRODUC T CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -T REATMENT OF TREAT GASTROESOPH AGEAL REFLUX DISEASE TROSP IUM CL TAB 20MG 60 NDC CODE:6 8462046160 FDA PRODUCT CODE NO.:-61 K C A 69 H. T. S NO.: 3004.49.00.70 ANDA NO.:-91- 575 THERAPEUTICE USE:- TREAT MENT OF VENOUS DISEASES URINA RY INCONTINENCE THERAPY C OMMERCIAL & CUSTOM INVOICE NO. F22452002803 DT. 13.09.2023 F22452002804 DT. 13.09.2023 F22452002815 DT. 13.09.2023 S /BILL NO: 3939134 DT 14-SEP-20 23 S/BILL NO: 3926625 DT 14-S EP-2023 S/BILL NO: 3926654 DT 14-SEP-2023 NET WT. 8798.799 KGS 02 DATA LOGGERS HUMIDIT Y:65% SET TEMPERATURE : +18 D EGREES TEMPERATURE RANGE : +1 5 DEGREES TO +25 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 626800 |
2023-10-03 |
46 PKG |
8998.06KG |
46 PALLETS 3658 CARTONS PH ARMACEUTICALS AS UNDER NORE THINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.: -91-090 THERAPEUTICE USE:- S ECONDARY AMENORRHEA,ENDOMETRI OS IS AND ABNORMAL UTERINE B LEEDING LEVONORGESTREL/EE T AB 0.09/0.02MG 84 NDC CODE:68 462063729 FDA PRODUCT CODE NO .: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 20279 1 THERAPEUTICE USE: - : USED FOR PREVENTING PREGNANCY CARVEDILOL TAB 3.125MG 100 ND C CODE:68462016201 FDA PRODUC T CODE NO - 62 O C A 22 H. T . S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE US E:-BETA- ADRENOACEPTOR ANTAG ONIST CARVEDILOL TAB 3.125M G 500 NDC CODE:68462016205 F DA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92. 20 ANDA NO.:- 78-251 THERAPE UTICE USE:-BETA- ADRENOACEPT OR ANTAGONIST ONDANSETRON TAB 4MG 30 NDC CODE:684620105 30 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:- 77-535 TH ERAPEUTICE USE:-ANTI -EMETIC ZONISAMIDE CAP 100MG 100 N DC CODE:68462013001 FDA PRODU CT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77-651 THERAPEUTICE US E:-ANTISEIZURE DRUG OXCARBA ZEPINE TAB 150MG 100 NDC CODE :68462013701 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT OXCARBAZE PINE TAB 600MG 100 NDC CODE:6 8462013901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 802 THERAPEUTICE USE:-ANTI C ONVULSANT AGENT OXCARBAZEPI NE TAB 150MG 100 NDC CODE:684 62013701 FDA PRODUCT CODE NO .:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-80 2 THERAPEUTICE USE:-ANTI CON VULSANT AGENT THEOPHYLLINE ER TAB 300MG 100 NDC CODE:684 62072101 63 B C B 30 3004.90 .92.85 212184 TO RELEASE TAB LETS ARE INDICATED FOR THE T REATMENT OF THE SYMPTOMS AND REVERSIBLE AIRFLOW OBSTRUCTI ON ASSOCIATED WITH CHRONIC AS THMA AND OTHER CHRONIC LUNG DISEASES, E.G., EMPHYSEMA AND CHRONIC BRONCHITIS CARVED ILOL TAB 3.125MG 500 NDC CODE :68462016205 FDA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F22452002702 DT. 05.09.2 023 F22452002696 DT. 05.09.20 23 F22452002697 DT. 05.09.202 3 F22452002705 DT. 05.09.2023 F22452002706 DT. 05.09.2023 F22452002707 DT. 05.09.2023 F22452002708 DT. 05.09.2023 S /BILL NO: 3747588 DT 06-SEP-20 23 S/BILL NO: 3747589 DT 06-S EP-2023 S/BILL NO: 3747294 DT 06-SEP-2023 S/BILL NO: 37436 51 DT 06-SEP-2023 S/BILL NO: 3747292 DT 06-SEP-2023 S/BILL NO: 3747298 DT 06-SEP-2023 S /BILL NO: 3747297 DT 06-SEP-20 23 NET WT. 7,162.785 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652500 |
2023-10-03 |
16 PKG |
4642.6KG |
16 PALLETS 1339 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 600MG 100 NDC C ODE:68462013901 FDA PRODUCT C ODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-802 THERAPEUTICE USE:-AN TI CONVULSANT AGENT OXCARB AZEPINE TAB 600MG 100 NDC COD E:68462013901 FDA PRODUCT COD E NO.:-61 M C A 45 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT URSODIOL TAB 250MG 100 NDC CODE:68462 047301 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 30 04.49.00.10 ANDA NO.: 90-801 THERAPEUTICE USE: - FOR TH E TREATMENT OF PATIENTS WITH PRIMARY BILIARY CIRRHOSIS COMMERCIAL & CUSTOM INVOICE N O. F22452002711 DT. 05.09.202 3 F22452002717 DT. 06.09.2023 F22452002718 DT. 06.09.2023 S/BILL NO: 3795123 DT 08-SEP- 2023 S/BILL NO: 3795122 DT 08 -SEP-2023 S/BILL NO: 3795172 DT 08-SEP-2023 NET WT. 3850.2 31 KGS 04 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 632500 |
2023-10-03 |
40 PKG |
6760.91KG |
40 PALLETS 1968 CARTONS PH ARMACEUTICALS AS UNDER HEAT HER TAB 0.35MG 84 NDC CODE:68 462030329 FDA PRODUCT CODE NO .: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-45 4 THERAPEUTICE USE: PREVENTI ON OF PREGNANCY. HAILEY FE 1/20 TAB 1MG/20MCG-75MG 84 ND C CODE:68462041929 FDA PRODUC T CODE NO.: 65 J D A 25 H. T . S NO.: 3006.60.00.00 ANDA NO.:206597 THERAPEUTICE USE: HORMONE MEDICATION IS USED T O PREVENT PREGNANCY COMMER CIAL & CUSTOM INVOICE NO. F22 452002741 DT. 08.09.2023 F224 52002743 DT. 08.09.2023 S/BIL L NO: 3805182 DT 08-SEP-2023 S/BILL NO: 3805176 DT 08-SEP-2 023 NET WT: 4975.110 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652400 |
2023-10-03 |
47 PKG |
11200.29KG |
47 PALLETS 4103 CARTONS PH ARMACEUTICALS AS UNDER CALC IPOTRIENE CREAM 0.005% 60GM N DC CODE:68462050165 FDA PRODU CT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTICE USE : - TREATMENT OF PLAQUE PSOR IASIS IN ADULTS ONDANSETRON TAB 4MG 30 NDC CODE:68462010 530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004. 90.92.40 ANDA NO.:- 77-535 T HERAPEUTICE USE:-ANTI -EMETIC OMEPRAZOLE DR CAP 40MG 30 NDC CODE:68462039730 FDA PRO DUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTROES OPHAGEAL REFLUX DISEASE UR SODIOL TAB 500MG 100 NDC CODE :68462047401 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO .: 3004.49.00.10 ANDA NO.: 9 0-801 THERAPEUTICE USE: - FOR THE TREATMENT OF PATIENTS W ITH PRIMARY BILIARY CIRRHOSIS OXCARBAZEPINE TAB 600MG 1 00 NDC CODE:68462013901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTIC E USE:-ANTI CONVULSANT AGENT OMEPRAZOLE DR CAP 40MG 30 NDC CODE:68462039730 FDA PROD UCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO. : 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTROESO PHAGEAL REFLUX DISEASE COM MERCIAL & CUSTOM INVOICE NO. F22452002745 DT. 08.09.2023 F 22452002719 DT. 06.09.2023 F2 2452002727 DT. 07.09.2023 F22 452002728 DT. 07.09.2023 F224 52002744 DT. 08.09.2023 S/BIL L NO: 3807185 DT 08-SEP-2023 S/BILL NO: 3807251 DT 08-SEP-2 023 S/BILL NO: 3807193 DT 08- SEP-2023 S/BILL NO: 3807183 D T 08-SEP-2023 S/BILL NO: 3807 208 DT 08-SEP-2023 NET WT: 8, 972.117 KGS 08 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERL AND |
HS 620400 |
2023-10-03 |
10 PKG |
3343.94KG |
10 PALLETS 787 CARTONS PHA RMACEUTICALS AS UNDER PIMEC ROLIMUS CREAM 1% 30GM NDC COD E:68462060935 FDA PRODUCT COD E NO.: 61 S C J 04 H. T. S N O.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR TH E SHORT-TERM AND NON-CONTINUO S CHRONIC TRERTMENT OF MILD T O MODERATE ATOPIC DERMATITIS IN NON- IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE CARVEDILOL TAB 25MG 50 0 NDC CODE:68462016505 FDA P RODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTIC E USE:-BETA- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 2 5MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.9 2.20 ANDA NO.:- 78-251 THERA PEUTICE USE:-BETA- ADRENOACE PTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F224870 00989 DT. 31.08.2023 F2248700 0998 DT. 31.08.2023 F22487001 003 DT. 31.08.2023 S/BILL NO: 4013546 DT: 05/09/2023 S/BIL L NO:4013548 DT: 05/09/2023 S /BILL NO: 4013547 DT: 05/09/20 23 NET WT. 2560.957 KGS 04 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 622200 |
2023-10-03 |
6 PKG |
2161.86KG |
6 PALLETS 511 CARTONS PHAR MACEUTICALS AS UNDER ATOVAQ UONE OS 750MG/5ML 210ML NDC C ODE:68462042121 FDA PRODUCT C ODE NO.: 62 L C L 44 H. T. S NO.: 3004.90.92.90 ANDA NO. : 209685 USED TO PREVENT OR T REAT A SERIOUS LUNG INFECTION CALLED PNEUMOCYSTIS PNEUMON IA (PCP). THIS MEDICATION HEL PS TO STOP INFECTION SYMPTOMS SUCH AS FEVER, COUGH, TIRED NESS, AND SHORTNESS OF BREATH . COMMERCIAL & CUSTOM INVOI CE NO. F22435002400 DT. 31.08 .2023 S/BILL NO: 3757009 DT 0 6-SEP-2023 NET WT. 1876.392 K GS 06 DATA LOGGERS SET T EMPERATURE : +18 DEGREES NO TIFY PARTY:2 GLENMARK SPECIAL TY S.A. SWITZERLAND (GSSA) P LACE DU PORT 2 NEUCHATEL - 20 00 SWITZERLAND |
HS 290719 |
2023-09-26 |
9 PKG |
1795.35KG |
9 PALLETS 356 CARTONS PH ARMACEUTICALS AS UNDER NITR OGLYCERIN SUBLING TAB 0.4MG 4X 25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC U SE: -MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOT ENOUGH BLOO D FLOW TO THE HEART NITROG LYCERIN SUBLING TAB 0.4MG 100 NDC CODE:68462063901 FDA PRO DUCT CODE NO.: 66 S C A 28 H . T. S NO.: 3004.90.9020 AND A NO.: 206391 THERAPEUTICE US E: -MEDICATION USED FOR HEAR T FAILURE, HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOTENOUGH BLOOD FLOW TO THE HEART SOLIFEN ACIN SUCCINATE TAB 5MG 90 NDC CODE:68462038690 FDA PRODUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO. : 209239 INDICATED FOR THE T REATMENT OF OVERACTIVE BLADDE R WITH SYMPTOMS OF URGE URINA RY INCONTINENCE, URGENCY AND URINARY FREQUENCY 09 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NET WT:242.595 KGS COMMERCIAL & CUSTOM INVO ICE NO. F22487000954 DT. 29.0 8.2023 F22487000957 DT. 30.08 .2023 S/BILL NO:4013195 DT:30 .08.2023 S/BILL NO:4013198 DT :30.08.2023 NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLA ND |
HS 662800 |
2023-09-26 |
44 PKG |
11678.84KG |
44 PALLETS 1709 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TAB 800MG 500 NDC COD E:68462012705 FDA PRODUCT COD E NO : 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT OMEPRAZO LE DR CAP 20MG 1000 NDC CODE: 68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3 004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE OLMESARTAN M EDOX TAB 5MG 90 NDC CODE:6846 2043690 FDA PRODUCT CODE NO. :62CCA68 H. T. S NO.: 3004.9 0.9220 ANDA NO.: 203281 THER APEUTICE USE: :#TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS , TO LOWER BLOOD PRESSURE 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NET WT:1 0461.200 KGS COMMERCIAL & CUS TOM INVOICE NO. F22452002577 DT. 30.08.2023 F22452002586 D T. 30.08.2023 F22452002575 DT . 30.08.2023 S/BILL NO:3606 588 DT:31-AUG-2023 S/BILL NO: 3605162 DT 31-AUG-2023 S/BILL NO:3605146 DT 31-AUG-2023 NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 621000 |
2023-09-26 |
1 PKG |
150.14KG |
1 PALLETS 82 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 5MG 1000 NDC CODE: 68462026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 79 172 THERAPEUTICE USE: TO TRE AT HIGH CHOLESTEROL AND RELAT ED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE. 0 1 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NET WT:124 .38 KGS COMMERCIAL & CUSTOM I NVOICE NO. F22452002569 DT. 3 0.08.2023 S/BILL NO:3605157 D T 31-AUG-2023 NOTIFY PARTY: 2 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE DU POR T 2 NEUCHATEL - 2000 SWITZER LAND |
HS 611600 |
2023-09-26 |
31 PKG |
7879.49KG |
31 PALLETS 2634 CARTONS PHARMACEUTICALS AS UNDER PR OPAFENONE HCL ER CAP 225MG 60 NDC CODE:68462040860 FDA PRO DUCT CODE NO.: 63 E C F 28 H . T. S NO.: 3004.49.00.10 AN DA NO.:205268 THERAPEUTICE US E:AN ANTIARRHYTHMIC AGENT. I T IS USED TO TREAT IRREGULAR HEART RHYTHM AND CAN SLOW RA PID HEARTBEATS FENOFIBRATE CAP 200MG 100 NDC CODE:68462 058201 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.: 205566 T HERAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND A PO B IN DULT PATIENTS WITH P RMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA CARVED ILOL TAB 12.5MG 500 NDC CODE: 68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST VORICONAZOLE TAB 200MG 30 N DC CODE:68462057330 FDA PRODU CT CODE NO.:61 W C A 59 H. T . S NO.: 3004.90.92.10 ANDA NO.:203503 THERAPEUTICE USE: -USED TO TREAT FUNGAL INFECT IONS PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FD A PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 211769 THERAPEUT ICE USE: - AS SECOUND-LINE TH ERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTM ENT OF MILD TO MODERATE ATOPI C DERMATITIS IN NON- IMMUNO COMPROMISED ADULT AND CHILDRE N 2 YEARS OF AGE EZETIMIBE TAB 10MG 500 NDC CODE:684620 22605 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 300 4.49.00.10 ANDA NO.: #078560 THERAPEUTICE USE: LIPID LOWE RING AGENT 02 DATA LOGGERS SET TEMPERATURE : +18 DEGRE ES NET WT:5648.991KGS COM MERCIAL & CUSTOM INVOICE NO. F22487000953 DT. 29.08.2023 F 22487000955 DT. 30.08.2023 F2 2487000956 DT. 30.08.2023 F22 487000958 DT. 30.08.2023 S/BI LL NO:4013197 DT:30.08.2023 S /BILL NO:4013196 DT:30.08.2023 S/BILL NO:4013193 DT:30.08.2 023 S/BILL NO:4013199 DT:30.0 8.2023 NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA |
HS 632800 |
2023-09-26 |
3 PKG |
739.37KG |
3 PALLETS 241 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 10MG 1000 NDC CO DE:68462026210 61 J C A 16 3 004.49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT C ARDIOVASCULAR DISEASE 03 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NET WT:640.8 6 KGS COMMERCIAL & CUSTOM IN VOICE NO. F22452002627 DT. 31 .08.2023 S/BILL NO:3636352 DT :01-SEP-23 NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZ ERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAN D |
HS 271019 |
2023-09-26 |
39 PKG |
7762.46KG |
39 PALLETS 1705 CARTONS PHARMACEUTICALS AS UNDER ES TRADIOL VAG INSERTS 10MCG 8 N DC CODE:68462071171 FDA PRODU CT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE: THE TREATMENT OF ATROPIC VAG INITIS DUE TO MENOPAUSE. N ORGEST/EE TAB .18,.215,.25/.03 5MG 84 NDC CODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00 .00 ANDA NO.: 200494 THERAPE UTICE USE: - ORAL CONTRACEPTI VES NORETHINDRONE ACE TAB 5 MG 50 NDC CODE:68462030450 F DA PRODUCT CODE NO.65 J C A 2 5 H. T. S NO.: 3004.39.00.50 ANDA NO.:-91-090 THERAPEUTI CE USE:- SECONDARY AMENORRHE A,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING GABAPENT IN TAB 600MG 500 NDC CODE:684 62012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3 004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVU LSANT AGENT CLOTRIMAZOLE C REAM 1% 15GM NDC CODE:6846201 8117 FDA PRODUCT CODE NO.:61 #W#C#J#04 H. T. S NO.: 3004. 90.92.45 ANDA NO.: 90-219 TH ERAPEUTICE USE: TREATMENT OF CANDIDIASIS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NET WT:6184.066KGS COM MERCIAL & CUSTOM INVOICE NO. F22452002617 DT. 31.08.2023 F 22452002661 DT. 31.08.2023 F2 2452002592 DT. 30.08.2023 F22 452002647 DT. 31.08.2023 S/ BILL NO:3635929 DT:01-SEP-23 S/BILL NO:3639979 DT:01-SEP-23 S/BILL NO:3636367 DT:01-SEP- 23 S/BILL NO:3635927 DT:01-SE P-23 NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA |
HS 642800 |
2023-09-26 |
46 PKG |
10699.52KG |
46 PALLETS 3105 CARTONS PHARMACEUTICALS AS UNDER CL OTRIMAZOLE CREAM 1% 45GM NDC CODE:68462018147 FDA PRODUCT CODE NO :61 W C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO. : 90-219 THERAPEUTICE USE: T REATMENT OF CANDIDIASIS ROS UVASTATIN TAB 10MG 1000 NDC C ODE:68462026210 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE CARV EDILOL TAB 3.125MG 500 NDC CO DE:68462016205 FDA PRODUCT CO DE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.: - 78-251 THERAPEUTICE USE:-B ETA- ADRENOACEPTOR ANTAGONIS T OMEPRAZOLE DR CAP 20MG 10 00 NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO .:-77-662 THERAPEUTICE USE:- ANTICONVULSANT AGENT OMEPR AZOLE DR CAP 20MG 1000 NDC CO DE:68462039610 FDA PRODUCT CO DE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 9167 2 THERAPEUTICE USE: - -TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE ROSUVASTA TIN TAB 20MG 1000 NDC CODE:68 462026310 FDA PRODUCT CODE NO .: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 7917 2 THERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT C ARDIOVASCULAR DISEASE GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT ROSUVASTAT IN TAB 10MG 1000 NDC CODE:684 62026210 61 J C A 16 3004.49 .00.10 79172 TO TREAT HIGH C HOLESTEROL AND RELATED CONDIT IONS, AND TO PREVENT CARDIOV ASCULAR DISEASE CARVEDILOL TAB 3.125MG 500 NDC CODE:6846 2016205 FDA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO.: 3 004.90.92.20 ANDA NO.:- 78-25 1 THERAPEUTICE USE:-BETA- A DRENOACEPTOR ANTAGONIST NE T WT:9151.901 KGS 08 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES COMMERCIAL & C USTOM INVOICE NO. F2245200258 4 DT. 30.08.2023 F22452002638 DT. 31.08.2023 F22452002625 DT. 31.08.2023 F22452002623 D T. 31.08.2023 F22452002663 DT . 31.08.2023 F22452002611 DT. 31.08.2023 F22452002612 DT. 31.08.2023 F22452002610 DT. 3 1.08.2023 F22452002672 DT. 31 .08.2023 F22452002668 DT. 31. 08.2023 S/BILL NO:3648735 D T:01-SEP-23 S/BILL NO:3648629 DT:01-SEP-23 S/BILL NO:36492 39 DT:01-SEP-23 S/BILL NO:364 8633 DT:01-SEP-23 S/BILL NO:3 648626 DT:01-SEP-23 S/BILL NO :3648641 DT:01-SEP-23 S/BILL NO:3648905 DT:01-SEP-23 S/BIL L NO:3648795 DT:01-SEP-23 S/B ILL NO:3648632 DT:01-SEP-23 S /BILL NO:3649256 DT:01-SEP-23 NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY: 3 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE DU POR T 2 NEUCHATEL - 2000 SWITZER LAND |
HS 610400 |
2023-09-22 |
9 PKG |
1569KG |
9 PALLETS 210 CARTONS PHAR MACEUTICALS AS UNDER NITROG LYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART APREPITA NT CAP 80MG 2UOU NDC CODE:684 62058458 FDA PRODUCT CODE NO. : 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.:207777 THERAPEUTICE USE:APREPITANT IS USED WITH OTHER MEDICATIO NS TO HELP PREVENT NAUSEA AND VOMITING CAUSED BY CANCER D RUG TREATMENT (CHEMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSEA AND VOMIT ING AFTER SURGERY. A-EMETIC/N AUSEANT / HUMAN - RX/SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT COMME RCIAL & CUSTOM INVOICE NO. F2 2487000923 DT. 22.08.2023 S/B ILL NO: 4012794 DT: 23/08/203 NET WT: 71.096 KGS 09 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZ ERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAN D |
HS 662800 |
2023-09-22 |
47 PKG |
9803.66KG |
47 PALLETS 3415 CARTONS PH ARMACEUTICALS AS UNDER NORE TH ACE/EE TAB 1/0.02MG 63 NDC CODE:68462013281 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 ANDA NO .:206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOMET RIOS IS AND ABNORMAL UTERINE BLEEDING OMEPRAZOLE DR CAP 20MG 30 NDC CODE:68462039630 FDA PRODUCT CODE NO.: 62KCF 10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTIC E USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEA SE TOPIRAMATE TAB 200MG 60 NDC CODE:68462011060 FDA PRO DUCT CODE NO.:-61 M C A 40 H . T. S NO.: 3004.49.00.20 AN DA NO.:- 77-627 THERAPEUTICE USE:-ANTICONVULSANT OMEPRA ZOLE DR CAP 20MG 1000 NDC COD E:68462039610 FDA PRODUCT COD E NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATM ENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE OXCARBAZEP INE TAB 150MG 100 NDC CODE:68 462013701 FDA PRODUCT CODE N O.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-8 02 THERAPEUTICE USE:-ANTI CO NVULSANT AGENT OXCARBAZEPIN E TAB 600MG 100 NDC CODE:6846 2013901 FDA PRODUCT CODE NO. :-61 M C A 45 H. T. S NO.: 3 004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONV ULSANT AGENT ZONISAMIDE CAP 100MG 100 NDC CODE:684620130 01 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.4 9.00.20 ANDA NO.:-77-651 THE RAPEUTICE USE:-ANTISEIZURE DR UG COMMERCIAL & CUSTOM INVO ICE NO. F22452002422 DT. 22.0 8.2023 F22452002424 DT. 22.08 .2023 F22452002434 DT. 23.08. 2023 S/BILL NO: 3405079 DT 2 3-AUG-2023 S/BILL NO: 342353 8 DT 24-AUG-2023 S/BILL NO: 3 422596 DT 24-AUG-2023 NET WT. 7930.470 KGS 02 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA |
HS 652500 |
2023-09-22 |
41 PKG |
9699.78KG |
41 PALLETS 2797 CARTONS P HARMACEUTICALS AS UNDER NOR ETH ACE/EE TAB 1/0.02MG 63 ND C CODE:68462013281 FDA PRODUC T CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 ANDA N O.:206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOME TRIOS IS AND ABNORMAL UTERINE BLEEDING NORETH ACE/EE TA B 1MG/5MCG 90 NDC CODE:684620 65790 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 300 6.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - TREATMENT OF MODERATE TO SEVERE VASOMO TOR SYMPTOMS DUE TO MENOPAUS E; OSTEOPOROSIS PREVENTION PRAVASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PRO DUCT CODE NO.: 61 J C A 13 H . T. S NO.: 3004.90.92.20 AN DA NO.: 77-987 THERAPEUTICE U SE: -HYPOLIPDAEMIC OXCARBA ZEPINE TAB 300MG 100 NDC CODE :68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT RIZATRIPT AN BENZ ODT 10MG 18UD NDC COD E:68462046806 FDA PRODUCT COD E NO.: 63 O C A 05 H. T. S N O.: 3004.90.92.28 ANDA NO.: 201914 THERAPEUTICE USE : - ANALGESIC/ HUMAN - RX/SINGLE INGREDIENT / PROMPT RELEASE T ABLETS / RIZATRIPTAN BENZOATE (ANALGESIC) OXCARBAZEPINE TAB 600MG 100 NDC CODE:68462 013901 FDA PRODUCT CODE NO.: -61 M C A 45 H. T. S NO.: 30 04.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONVU LSANT AGENT OXCARBAZEPINE T AB 300MG 100 NDC CODE:6846201 3801 FDA PRODUCT CODE NO.:-6 1 M C A 45 H. T. S NO.: 3004 .90.92.30 ANDA NO.:-77-802 T HERAPEUTICE USE:-ANTI CONVULS ANT AGENT COMMERCIAL & CUST OM INVOICE NO. F22452002470 D T. 25.08.2023 F22452002449 DT . 23.08.2023 F22452002463 DT. 25.08.2023 F22452002464 DT. 25.08.2023 F22452002471 DT. 2 5.08.2023 S/BILL NO: 3472035 DT 25-AUG-2023 S/BILL NO: 347 2835 DT 25-AUG-2023 S/BILL NO : 3472233 DT 25-AUG-2023 S/BI LL NO: 3472033 DT 25-AUG-2023 S/BILL NO: 3472032 DT 25-AUG- 2023 NET WT: 7813.898 KGS 0 2 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 652500 |
2023-09-12 |
43 PKG |
5163.78KG |
43 PALLETS 1200 CARTONS P HARMACEUTICALS AS UNDER FLU CONAZOLE TAB 150MG 12UD NDC C ODE:68462011944 NDC CODE : 6 8462011944 HTS NO : 3004.90.9 2.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 THERAPEUT ICE USE : ANTIFUNGAL 02 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES NET WT:3911.1 40KGS COMMERCIAL & CUSTOM IN VOICE NO. F22452002335 DT. 14 .08.2023 S/BILL NO:3211413 DT 16-AUG-2023 NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 300490 |
2023-09-12 |
32 PKG |
7394.59KG |
32 PALLETS 2157 CARTONS PHA RMACEUTICALS AS UNDER GABAP ENTIN TAB 600MG 500 NDC CODE: 68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICO NVULSANT AGENT PRAVASTATIN SOD TAB 80MG 90 NDC CODE:684 62019890 FDA PRODUCT CODE NO .:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-98 7 THERAPEUTICE USE:-HYPOLIPD AEMIC POTASSIUM CL ER CAP 1 0MEQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90. 92.90 ANDA NO.: 202868 THERA PEUTICE USE: - TREATMENT OR P REVENTION OF HYPOKALEMIA P OTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PROD UCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION O F HYPOKALEMIA PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462 060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOU ND-LINE THERAPY FOR THE SHORT -TERM AND NON-CONTINUOS CHRON IC TRERTMENT OF MILD TO MODE RATE ATOPIC DERMATITIS IN NO N- IMMUNOCOMPROMISED ADULT A ND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 60GM N DC CODE:68462060965 FDA PRODU CT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE : - AS SECOUND-LINE THERAPY F OR THE SHORT-TERM AND NON-CO NTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERM ATITIS IN NON- IMMUNOCOMPROM ISED ADULT AND CHILDREN 2 YE ARS OF AGE EZETIMIBE TAB 10 MG 90 NDC CODE:68462022690 F DA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00. 10 ANDA NO.: #078560 THERAPE UTICE USE: LIPID LOWERING AGE NT 02 DATA LOGGERS SET T EMPERATURE : +18 DEGREES NET WT:4386.002KGS COMMERCIAL & C USTOM INVOICE NO. F2248700088 7 DT. 17.08.2023 F22487000888 DT. 17.08.2023 F22487000891 DT. 17.08.2023 F22487000893 D T. 17.08.2023 F22487000894 DT . 17.08.2023 S/BILL NO:401247 7 DT:17.08.2023 S/BILL NO:401 2467 DT:17.08.2023 S/BILL NO: 4012469 DT:17.08.2023 S/BILL NO:4012472 DT:17.08.2023 S/BI LL NO:4012468 DT:17.08.2023 N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA |
HS 616900 |
2023-09-12 |
40 PKG |
6349.95KG |
40 PALLETS 1925 CARTONS P HARMACEUTICALS AS UNDER ALY ACEN 1/35 TAB 1/0.035MG 84 ND C CODE:68462039429 FDA PRODUC T CODE NO.: 65 J D A 24 H. T . S NO.: 3006.60.00.00 ANDA NO.: 091634 THERAPEUTICE USE: ORALCONTRACEPTIVE NORETH ACE/EE TAB 0.5MG/2.5MCG 84 ND C CODE:68462065629 FDA PRODUC T CODE NO.: 65 J D A 25 H. T . S NO.: 3006.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS DU E TO MENOPAUSE; OSTEOPOROSIS PREVENTION NORETHINDRONE TA B 0.35MG 84 NDC CODE:68462030 529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006. 60.00.00 ANDA NO.:91-209 THE RAPEUTICE USE: PREVENTION OF PREGNANCY. NORETH ACE/EE TA B 0.5MG/2.5MCG 84 NDC CODE:68 462065629 FDA PRODUCT CODE NO .: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 2030 38 THERAPEUTICE USE: - TREAT MENT OF MODERATE TO SEVERE VA SOMOTOR SYMPTOMS DUE TO MENO PAUSE; OSTEOPOROSIS PREVENTIO N 02 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NET W T:4652.690KGS COMMERCIAL & CU STOM INVOICE NO. F22452002322 DT. 14.08.2023 F22452002327 DT. 14.08.2023 F22452002353 D T. 16.08.2023 S/BILL NO:32124 17 DT 16-AUG-2023 S/BILL NO:3 229519 DT 16-AUG-2023 S/BILL NO:3242916 DT. 17-AUG-2023 NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652400 |
2023-09-12 |
2 PKG |
485.81KG |
2 PALLETS 61 CARTONS PHAR MACEUTICALS AS UNDER NITROG LYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NET WT:32.501KG S COMMERCIAL & CUSTOM INVOICE NO. F22487000892 DT. 17.08.2 023 S/BILL NO:4012471 DT:17.0 8.2023 NOTIFY PARTY:2 GLEN MARK SPECIALTY S.A. SWITZERLA ND (GSSA) PLACE DU PORT 2 NE UCHATEL - 2000 SWITZERLAND |
HS 662800 |
2023-09-12 |
40 PKG |
10627.85KG |
40 PALLETS 2943 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TAB 600MG 500 NDC COD E:68462012605 FDA PRODUCT COD E NO: 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-662 THERAPEUTICE USE:-ANTI CONVULSANT AGENT TOPIRAMAT E TAB 100MG 500 NDC CODE:6846 2010905 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3 004.49.00.20 ANDA NO.: 77627 THERAPEUTICE USE: :#ANTICONV ULSANT OLMESARTAN MEDOX TAB 40MG 30 NDC CODE:68462043830 FDA PRODUCT CODE NO.: 62CCA 68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 THERAPEUTI CE USE: - -TREATMENT OF HYPE RTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE CICLO PIROX OLAMINE CREAM 0.77% 30GM NDC CODE:68462029735 FDA PR ODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 A NDA NO.:- 90 - 273 THERAPEUTI CE USE:-ANTIFUNGAL USE. CI CLOPIROX OLAMINE CREAM 0.77% 9 0GM NDC CODE:68462029792 FDA PRODUCT CODE NO.:-61 W C J 0 3 H. T. S NO.: 3004.40.49.50 ANDA NO.:- 90 - 273 THERAPE UTICE USE:-ANTIFUNGAL USE. CALCIPOTRIENE OINT 0.005% 60G M NDC CODE:68462031065 FDA P RODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209297 THIS MEDICAT ION IS USED TO TREAT PSORIASI S. CALCIPOTRIENE IS A FORM OF VITAMIN D. IT WORKS BY SLOW ING DOWN THE GROWTH OF SKIN C ELLS. CICLOPIROX OLAMINE CR EAM 0.77% 15GM NDC CODE:68462 029717 FDA PRODUCT CODE NO.: -61 W C J 03 H. T. S NO.: 30 04.40.49.50 ANDA NO.:- 90 - 2 73 THERAPEUTICE USE:-ANTIFUN GAL USE. 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NET WT:8892.170KGS COMME RCIAL & CUSTOM INVOICE NO. F2 2452002316 DT. 12.08.2023 F22 452002317 DT. 12.08.2023 F224 52002334 DT. 14.08.2023 F2245 2002324 DT. 14.08.2023 F22452 002328 DT. 14.08.2023 F224520 02315 DT. 12.08.2023 S/BILL NO:3211224 DT 16-AUG-2023 S/ BILL NO:3217173 DT 16-AUG-2023 S/BILL NO:3211249 DT 16-AUG- 2023 S/BILL NO:3211248 DT 16- AUG-2023 S/BILL NO:3217174 DT 16-AUG-2023 S/BILL NO:321136 3 DT 16-AUG-2023 NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 614000 |
2023-09-12 |
47 PKG |
12051.24KG |
47 PALLETS 4943 CARTONS P HARMACEUTICALS AS UNDER TOP IRAMATE TAB 200MG 60 NDC CODE :68462011060 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO .: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTICE USE:-ANT ICONVULSANT OLMESARTAN MEDO X TAB 40MG 30 NDC CODE:684620 43830 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90 .9220 ANDA NO.: 203281 THERA PEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS , TO LOWER BLOOD PRESSURE FLUCONAZOLE TAB 50MG 30 NDC C ODE:68462010130 FDA PRODUCT C ODE NO : 61 W C A 45 H. T. S NO.: 3004.90.92.45 ANDA NO. :-77 - 253 THERAPEUTICE USE: -ANTIFUNGAL GABAPENTIN TAB 600MG 100 NDC CODE:6846201260 1 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90 .92.30 ANDA NO.:-77-662 THER APEUTICE USE:-ANTICONVULSANT AGENT OLMESARTAN MEDOX TAB 40MG 30 NDC CODE:68462043830 FDA PRODUCT CODE NO.: 62CCA 68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 THERAPEUTI CE USE: - -TREATMENT OF HYPE RTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE PRAMI PEXOLE TAB 1MG 90 NDC CODE:68 462033390 FDA PRODUCT CODE NO .: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-7 81 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE OMEPRA ZOLE DR CAP 40MG 30 NDC CODE: 68462039730 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3 004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE CLINDAMYCIN PHOS GEL 1% 30GM NDC CODE:684 62086635 FDA PRODUCT CODE NO. : 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO.:214251 THERAPEUTICE USE: CLINDAMYC IN PHOSPHATE GEL IS INDICATED IN THE TREATMENT OF ACNE VU LGARIS 02 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NET WT:9658.838 KGS COMMERC IAL & CUSTOM INVOICE NO. F224 52002337 DT. 14.08.2023 F2245 2002339 DT. 14.08.2023 F22452 002356 DT. 17.08.2023 F224520 02357 DT. 17.08.2023 F2245200 2358 DT. 17.08.2023 F22452002 362 DT. 17.08.2023 F224520023 49 DT. 16.08.2023 S/BILL NO:3 274515 DT:18-AUG-23 S/BILL NO :3274506 DT:18-AUG-23 S/BILL NO:3276763 DT:18-AUG-23 S/BIL L NO:3274467 DT:18-AUG-23 S/B ILL NO:3274477 DT:18-AUG-23 S /BILL NO:3274475 DT:18-AUG-23 S/BILL NO:3274474 DT:18-AUG-2 3 NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA |
HS 684620 |
2023-09-07 |
2 PKG |
5000.03KG |
PHARMACEUTICALS AS UNDER |
HS 300680 |
2023-09-06 |
34 PKG |
4613.57KG |
34 PALLETS 2272 CARTONS PHARMACEUTICALS AS UNDER CH ARLOTTE 24 FE CHEW 1MG/20MCG-7 5MG 84 NDC CODE:68462085229 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00 .00 ANDA NO.:210369 THERAPEU TICE USE: CONTRACEPTION TO P REVENTPREGNANCYAFTER BIRTH CO NTROL FAILURE SHEWISE TAB 1 .5MG 1 NDC CODE:72657010812 FDA PRODUCT CODE NO.: 64 G C A 29 H. T. S NO.: 3004.90.92 .40 ANDA NO.: 207044 THERAPE UTICE USE: #AN ESTROGEN/PROGE STIN COC INDICATED FOR USE BY WOMEN TO PREVENT PREGNANCY MARLISSA TAB 0.15/0.03MG 84 NDC CODE:68462038829 FDA PR ODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 AN DA NO.: 091452 THERAPEUTICE U SE: ORAL CONTRACEPTIVE C OMMERCIAL & CUSTOM INVOICE NO. F22452002170 DT. 31.07.2023 F22452002199 DT. 04.08.2023 F22452002208 DT. 05.08.2023 S /BILL NO: 2989303 DT 05-AUG-20 23 S/BILL NO: 2998840 DT 05-A UG-2023 S/BILL NO: 2989852 DT 05-AUG-2023 NET WT. 3047.990 KGS 02 DATA LOGGERS SET T EMPERATURE : +18 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA |
HS 652500 |
2023-09-06 |
6 PKG |
1178.91KG |
6 PALLETS 589 CARTONS PHARMA CEUTICALS AS UNDER FLUCONAZ OLE TAB 200MG 30 NDC CODE:684 62010430 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90.92.45 ANDA NO.:-77 - 253 THERAPEUTICE USE:-ANTIFU NGAL ONDANSETRON TAB 8MG 30 NDC CODE:68462010630 FDA PR ODUCT CODE NO.:-61 T C A 28 H . T. S NO.: 3004.90.92.40 AN DA NO.:- 77-535 THERAPEUTICE USE:-ANTI -EMETIC TOPIRAMA TE TAB 50MG 60 NDC CODE:68462 015360 FDA PRODUCT CODE NO.: -61 M C A 40 H. T. S NO.: 30 04.49.00.20 ANDA NO.:- 77-627 THERAPEUTICE USE:-ANTICONVU LSANT COMMERCIAL & CUSTOM I NVOICE NO. F22452002211 DT. 0 5.08.2023 S/BILL NO: 2999877 DT 05-AUG-2023 NET WT. 905.10 9 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA |
HS 614500 |
2023-09-06 |
22 PKG |
4816.78KG |
22 PALLETS 839 CARTONS PHA RMACEUTICALS AS UNDER CLIND AMYCIN HCL CAP 300MG 100 NDC CODE:68462014401 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941.90.5000 ANDA NO.: 216957 THERAPEUTICE USE: :#A NTI-INFECTIVE AGENT PRAVAST ATIN SOD TAB 20MG 500 NDC COD E:68462019605 FDA PRODUCT COD E NO.:-61 J C A 13 H. T. S N O.: 3004.90.92.20 ANDA NO.:- 77-987 THERAPEUTICE USE:-HYP OLIPDAEMIC INDOMETHACIN ER CAP 75MG 60 NDC CODE:68462032 560 FDA PRODUCT CODE: 62 GCE 42 H. T. S NO.:3004.90.92.40 ANDA NO.203501 THERAPEUTIC USE: INDOMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED BY ART HRITIS, GOUT, BURSITIS, AND T ENDONITIS. IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS OT HER CONDITIONS. THIS MEDICAT ION IS KNOWN AS A NONSTEROIDA L ANTI-INFLAMMATORY DRUG (NS AID). ... THIS EFFECT HELPS T O DECREASE SWELLING AND PAIN . CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PROD UCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 AND A NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANT AGONIST COMMERCIAL & CUSTOM INVOICE NO. F22487000832 DT. 31.07.2023 S/BILL NO: 40118 18 DT: 05.08.2023 NET WT. 3 271.454 KGS 23 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA |
HS 562000 |
2023-09-06 |
21 PKG |
3970.81KG |
21 PALLETS 1143 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS OINT 0.1% 60GM NDC COD E:68462053465 FDA PRODUCT COD E NO.: 64 T C J 08 H. T. S N O.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - T ACROLIMUS IS A TOPICAL IMMUNO SUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-T O-SEVERE ATOPIC DERMATITIS ( ECZEMA). TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HT S NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANSPLANT PRAVA STATIN SOD TAB 20MG 500 NDC C ODE:68462019605 FDA PRODUCT C ODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. :-77-987 THERAPEUTICE USE:-H YPOLIPDAEMIC PROCHLORPERAZI NE MAL TAB 10MG 100 NDC CODE: 68462089001 CLINDAMYCIN HCL CAP 300MG 100 NDC CODE:68462 014401 FDA PRODUCT CODE NO.: 56 J C E 20 H. T. S NO.: 294 1.90.5000 ANDA NO.:216957 TH ERAPEUTICE USE: :#ANTI-INFECT IVE AGENT TACROLIMUS OINT 0 .1% 100GM NDC CODE:6846205349 4 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49 .00.50 ANDA NO.: 210393 THER APEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATM ENT OF MODERATE-TO-SEVERE AT OPIC DERMATITIS (ECZEMA). COMMERCIAL & CUSTOM INVOICE NO . F22487000819 DT. 31.07.2023 F22487000823 DT. 31.07.2023 F22487000855 DT. 04.08.2023 F22487000856 DT. 04.08.2023 F 22487000857 DT. 04.08.2023 F2 2487000858 DT. 04.08.2023 S/B ILL NO: 4011817 DT: 05.08.2023 S/BILL NO: 4011816 DT: 05.08 .2023 S/BILL NO: 4011824 DT: 05.08.2023 S/BILL NO: 4011820 DT: 05.08.2023 S/BILL NO: 40 11825 DT: 05.08.2023 S/BILL N O: 4011826 DT: 05.08.2023 NET WT. 2121.775 KGS 02 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 640800 |
2023-08-29 |
12 PKG |
3077.68KG |
12 PALLETS 1748 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 5MG 90 NDC CODE: 68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079 172 THERAPEUTICE USE: - TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 79172 THERAPEUTICE USE: T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE . 12 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NET WT:2328.711 COMMERCIAL & CU STOM INVOICE NO. F22452002072 DT. 30.07.2023 F22452002084 DT. 30.07.2023 S/BILL NO:2853 358 DT 31-JUL-2023 S/BILL NO: 2843402 DT 31-JUL-2023 NOTIFY PARTY:2 GLENMARK SPECIALTY S .A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 611600 |
2023-08-29 |
10 PKG |
1606.2KG |
10 PALLETS 600 CARTONS P HARMACEUTICALS AS UNDER EST RADIOL VAG INSERTS 10MCG 8 ND C CODE:68462071171 FDA PRODUC T CODE NO.: 64 G C A 28 H. T . S NO.: 3006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE:T HE TREATMENT OF ATROPIC VAGI NITIS DUE TO MENOPAUSE. 01 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES COMMERC IAL & CUSTOM INVOICE NO. F224 52002069 DT. 30.07.2023 S/BIL L NO:2850236 DT 31-JUL-2023 N ET WT:1166.40KGS NOTIFY PARTY :2 SHOROUQ COMMODITIES TRADIN G DMCC UNIT NO. 98, DMCC BUSI NESS CENTRE, LEVEL NO. 8, JEW ELLERY & GEMPLEX 2, DUBAI DU BAI UTD.ARAB EMIR. |
HS 642800 |
2023-08-29 |
29 PKG |
8069.09KG |
29 PALLETS 1954 CARTONS PHA RMACEUTICALS AS UNDER NAPROXE N TAB 500MG 500 NDC CODE:6846 2019005 FDA PRODUCT CODE NO. :-62 G C A 49 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFL AMMATORY, ANALGESIC CARVEDIL OL TAB 6.25MG 500 NDC CODE:68 462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78- 251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST GA BAPENTIN TAB 600MG 500 NDC CO DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT PRAMIPEXOL E TAB 0.25MG 90 NDC CODE:6846 2033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3 004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN P ARKINSONS DISEASE RIZATRIPTAN BENZ ODT TAB 5MG 18UD NDC CO DE:68462046706 FDA PRODUCT CO DE NO.: 60 L C A 87 H. T. S NO.: 3004.90.92.28 ANDA NO.: 201914 THERAPEUTICE USE: - A NALGESIC/ HUMAN - RX/SINGLE I NGREDIENT / PROMPT RELEASE T ABLETS / RIZATRIPTAN BENZOATE (ANALGESIC) 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATUR E : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES COMMERCIAL & CUSTOM I NVOICE NO. F22452002054 DT. 2 9.07.2023 F22452002062 DT. 29 .07.2023 F22452002075 DT. 30. 07.2023 S/BILLNO:2865863 DT 3 1-JUL-2023 S/BILL NO:2863672 DT 31-JUL-2023 S/BILL NO:2865 600 DT 31-JUL-2023 NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 624900 |
2023-08-29 |
30 PKG |
4221.2KG |
30 PALLETS 1109CARTONS P HARMACEUTICALS AS UNDER NORET HINDRONE ACE TAB 5MG 50 NDC C ODE:68462030450 FDA PRODUCT C ODE NO.65 J C A 25 H. T. S N O.: 3004.39.00.50 ANDA NO.:- 91-090 THERAPEUTICE USE:- SE CONDARY AMENORRHEA,ENDOMETRIO S IS AND ABNORMAL UTERINE BL EEDING NORETHINDRONE TAB 0. 35MG 84 NDC CODE:68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.0 0.00 ANDA NO.:91-209 THERAPE UTICE USE: PREVENTION OF PREG NANCY. ASHLYNA TAB 0.15/0.0 3MG-0.01MG 182 NDC CODE:68462 064693 FDA PRODUCT CODE NO.: 64 G D A 2 H. T. S NO.: 300 6.60.0000 ANDA NO.: 203163 T HERAPEUTICE USE: - INDICATED FOR USE BY WOMEN TO PREVENT PREGNANCY 02 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES COMMERCIAL & CUSTOM INVOICE NO. F22452002051 DT. 29.07.2023 F22452002058 DT. 2 9.07.2023 F22452002060 DT. 29 .07.2023 2850242 DT 31-JUL- 2023 2850256 DT 31-JUL-2023 2850240 DT 31-JUL-2023 NET WT :4292.41 KGS NOTIFY PARTY: 2 SHOROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSIN ESS CENTRE, LEVEL NO. 8, JEWE LLERY & GEMPLEX 2, DUBAI DUB AI UTD.ARAB EMIR. |
HS 652600 |
2023-08-29 |
21 PKG |
5475.41KG |
21 PALLET 1295 CARTONS PH ARMACEUTICALS AS UNDER GA BAPENTIN TAB 600MG 500 NDC CO DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT PIMECR OLIMUS CREAM 1% 60GM NDC CODE :68462060965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 11769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NON IMMUNOCOMPROMISED AD ULT AND CHILDREN 2 YEARS OF A GE TACROLIMUS CAP 0.5MG 100 NDC CODE:68462068501 FDA PR ODUCT CODE NO.: 64 T C E 08 H. T. S NO.:3004.90.92.15 AN DA NO.: 206662 THERAPEUTICE U SE: :#TO PREVENT REJECTION OF A KIDNEY,TO PREVENT REJECTI ON OF A KIDNEY,LIVER TRANSPLA NT PRAVASTATIN SOD TAB 20MG 90 NDC CODE:68462019690 FDA PRODUCT CODE NO.:-61 J C A 1 3 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTI CE USE:-HYPOLIPDAEMIC FENO FIBRATE CAP 67MG 100 NDC CODE :68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 205 566 THERAPEUTICE USE: - INDI CATED AS ADJUNCTIVE THERAPY T O DIET FOR THE REDUCTION OF L DL-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTEROLE MIA OR MIXED DYSLIPIDEMIA 01 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES COMMERCI AL & CUSTOM INVOICE NO. F2248 7000801 DT. 30.07.2023 F22487 000825 DT. 31.07.2023 F224870 00833 DT. 31.07.2023 F2248700 0834 DT. 31.07.2023 S/BILL NO :4011614 DT:01.08.2023 S/BILL NO:4011623 DT:01.08.2023 S/B ILL NO:4011617 DT:01.08.2023 S/BILL NO:4011628 DT:01.08.202 3 NET WT:4123.251 KGS NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 684620 |
2023-08-29 |
9 PKG |
2324.25KG |
9 PALLETS 459 CARTONS PHARM ACEUTICALS AS UNDER OXCARBAZE PINE TAB 300MG 100 NDC CODE:6 8462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 802 THERAPEUTICE USE:-ANTI C ONVULSANT AGENT CLOTRIMAZOLE CREAM 1% 15GM NDC CODE:684620 18117 FDA PRODUCT CODE NO.:6 1#W#C#J#04 H. T. S NO.: 3004 .90.92.45 ANDA NO.: 90-219 T HERAPEUTICE USE: TREATMENT OF CANDIDIASIS 00 DATA LOGGERS 00 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES C OMMERCIAL & CUSTOM INVOICE NO. F22452002149 DT. 31.07.2023 F22452002144 DT. 31.07.2023 S/BILL NO:2920693 DT 02-AUG-20 23 S/BILL NO:2917724 DT 02-AU G-2023 NET WT:1907.360 KGS N OTIFY PARTY:2 SHOROUQ COMMODI TIES TRADING DMCC UNIT NO. 98 , DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 614500 |
2023-08-29 |
21 PKG |
4700.66KG |
21 PALLETS 2180 CARTONS PHA RMACEUTICALS AS UNDER ROSUVAS TATIN TAB 5MG 90 NDC CODE:684 62026190 FDA PRODUCT CODE NO .:61 J C A 16 H. T. S NO.: 3 004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREA T HIGH CHOLESTEROL AND RELATE D CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE ROS UVASTATIN TAB 5MG 90 NDC CODE :68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE CALCIPOTRIENE CREAM 0.005% 60 GM NDC CODE:68462050165 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTIC E USE: - TREATMENT OF PLAQUE PSORIASIS IN ADULTS CALCIP OTRIENE CREAM 0.005% 120GM ND C CODE:68462050166 FDA PRODUC T CODE NO.: 62 N C J 04 H. T . S NO.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTICE USE: - TREATMENT OF PLAQUE PSORI ASIS IN ADULTS 21 DATA LOG GERS COMMERCIAL & CUSTOM IN VOICE NO. F22452002161 DT. 31 .07.2023 F22452002182 DT. 03. 08.2023 F22452002183 DT. 03.0 8.2023 S/BILL NO:2944745 DT 0 3-AUG-2023 S/BILL NO:2944743 DT 03-AUG-2023 S/BILL NO:2946 549 DT 03-AUG-2023 NET WT:364 5.532 KGS NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE DU PORT 2 N EUCHATEL - 2000 SWITZERLAND |
HS 611600 |
2023-08-29 |
40 PKG |
9544.2KG |
40 PALLETS 3391 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 12.5MG 100 NDC COD E:68462016401 FDA PRODUCT COD E NO : 62 O C A 22 H. T. S N O.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BE TA- ADRENOACEPTOR ANTAGONIST CLINDAMYCIN HCL CAP 300MG 100 NDC CODE:68462014401 P RAVASTATIN SOD TAB 10MG 500 N DC CODE:68462019505 FDA PRODU CT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE US E:-HYPOLIPDAEMIC DILTIAZEM HCL ER CAP 12HR 120MG 100 NDC CODE:68462056201 62 O C B 24 3004.49.00.10 212317 FOR T HE TREATMENT OF HYPERTENSION. FENOFIBRATE CAP 134MG 100 NDC CODE:68462058101 FDA PRO DUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 205566 THERAPEUTICE USE : - INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUC TION OF LDL-C, TOTAL-C, TRIGL YCERIDES AND APO B IN DULT P ATIENTS WITH PRMARY HYPERCHO LESTEROLEMIA OR MIXED DYSLIPI DEMIA CARVEDILOL TAB 12.5MG 500 NDC CODE:68462016405 FD A PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.2 0 ANDA NO.:- 78-251 THERAPEU TICE USE:-BETA- ADRENOACEPTO R ANTAGONIST 02 DATA LOG GERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & CU STOM INVOICE NO. F22487000799 DT. 30.07.2023 F22487000800 DT. 30.07.2023 S/BILL NO:4011 527 DT:31.07.2023 S/BILL NO:4 011528 DT:31.07.2023 NET WT:6 971.280 KGS NOTIFY PARTY:2 S HOROUQ COMMODITIES TRADING DMC C UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLER Y & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 611300 |
2023-08-29 |
4 PKG |
930.33KG |
4 PALLETS 479 CARTONS PHARM ACEUTICALS AS UNDER TOPIRAMAT E TAB 50MG 500 NDC CODE:68462 015305 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 30 04.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVULS ANT TOPIRAMATE TAB 50MG 60 N DC CODE:68462015360 FDA PRODU CT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTICE U SE:-ANTICONVULSANT 00 DATA LO GGERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & CUSTO M INVOICE NO. F22452002074 DT . 30.07.2023 S/BILL NO:285936 0 DT 31-JUL-2023 NET WT:748.0 0KGS NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEM PLEX 2, DUBAI DUBAI UTD.ARA B EMIR. |
HS 614000 |
2023-08-29 |
12 PKG |
1924.62KG |
12 PALLETS 600 CARTONS PHAR MACEUTICALS AS UNDER CHARLO TTE 24 FE CHEW 1MG/20MCG-75MG 84 NDC CODE:68462085229 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.:210369 THERAPEUTICE USE: CONTRACEPTION TO PREVE NTPREGNANCYAFTER BIRTH CONTRO L FAILURE 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S COMMERCIAL & CUSTOM INVOI CE NO. F22452002169 DT. 31.07 .2023 S/BILL NO:2889306 DT:01 .08.2023 NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652500 |
2023-08-29 |
5 PKG |
981.59KG |
5 PALLETS 229 CARTONS PHARM ACEUTICALS AS UNDER ROSUVASTA TIN TAB 10MG 1000 NDC CODE:68 462026210 61 J C A 16 3004.4 9.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED CONDI TIONS, AND TO PREVENT CARDIO VASCULAR DISEASE ACYCLOVIR OINT 5% 30GM NDC CODE:6846207 4635 FDA PRODUCT CODE NO.: 6 2 V C J 18 H. T. S NO.: 3004 .49.00.50 ANDA NO.: 205510 T HERAPEUTICE USE: - AN ANTIVIR AL MEDICINE USED TO TREAT OR PREVENT INFECTIONS CAUSED BY CERTAIN KINDS OF VIRUSES. EXA MPLES OF THESE INFECTIONS INC LUDE HERPES AND SHINGLES A CYCLOVIR OINT 5% 15GM NDC COD E:68462074617 FDA PRODUCT COD E NO.: 62 V C J 18 H. T. S N O.: 3004.49.00.50 ANDA NO.: 205510 THERAPEUTICE USE: - AN ANTIVIRAL MEDICINE USED TO TREAT OR PREVENT INFECTIONS C AUSED BY CERTAIN KINDS OF VIR USES. EXAMPLES OF THESE INFEC TIONS INCLUDE HERPES AND SHIN GLES 05 DATA LOGGERS COMMERCIAL & CUSTOM INVOICE NO . F22452002121 DT. 31.07.2023 F22452002105 DT. 31.07.2023 F22452002128 DT. 31.07.2023 S/BILL NO:2917730 DT 02-AUG-20 23 S/BILL NO:2917728 DT 02-AU G-2023 S/BILL NO:2916427 DT 0 2-AUG-2023 NET WT:739.54KGS NOTIFY PARTY:2 GLENMARK SPE CIALTY S.A. SWITZERLAND (GSSA ) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 621800 |
2023-08-29 |
2 PKG |
303.46KG |
2 PALLETS 99 CARTONS PHAR MACEUTICALS AS UNDER NORETHIN DRONE TAB 0.35MG 84 NDC CODE: 68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO. : 3006.60.00.00 ANDA NO.:91- 209 THERAPEUTICE USE: PREVEN TION OF PREGNANCY. 01 DATA LO GGERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & CUSTO M INVOICE NO. F22452002166 DT . 31.07.2023 S/BILL NO:288968 5 DT:01.08.2023 NET WT:218.5 90KGS NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADING DMCC UNI T NO. 98, DMCC BUSINESS CENTRE , LEVEL NO. 8, JEWELLERY & GE MPLEX 2, DUBAI DUBAI UTD.AR AB EMIR. |
HS 652600 |
2023-08-29 |
29 PKG |
3944.51KG |
29 PALLET 1093 CARTONS PHA RMACEUTICALS AS UNDER NOR ETHINDRONE TAB 0.35MG 84 NDC CODE:68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO .:91-209 THERAPEUTICE USE: P REVENTION OF PREGNANCY. ASH LYNA TAB 0.15/0.03MG-0.01MG 18 2 NDC CODE:68462064693 FDA P RODUCT CODE NO.: 64 G D A 2 H. T. S NO.: 3006.60.0000 AN DA NO.: 203163 THERAPEUTICE U SE: - INDICATED FOR USE BY W OMEN TO PREVENT PREGNANCY 01 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES COMMER CIAL & CUSTOM INVOICE NO. F22 452002096 DT. 31.07.2023 S/BI LL NO:2865491 DT 31-JUL-2023 NET WT:2887.780KGS NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652600 |
2023-08-29 |
31 PKG |
8970.39KG |
31 PALLETS 1800 CARTONS PHARMACEUTICALS AS UNDER PR AVASTATIN SOD TAB 40MG 500 ND C CODE:68462019705 FDA PRODUC T CODE NO.: 61 J C A 13 H. T . S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: -HYPOLIPDAEMIC URSODIOL T AB 250MG 100 NDC CODE:6846204 7301 FDA PRODUCT CODE NO.: 6 3 N C A 25 H. T. S NO.: 3004 .49.00.10 ANDA NO.: 90-801 T HERAPEUTICE USE: - FOR THE TR EATMENT OF PATIENTS WITH PRIM ARY BILIARY CIRRHOSIS COL ESEVELAM HCL OS 3.75GM 30 NDC CODE:68462062030 FDA PRODUCT CODE NO.: 62 B C L 13 H. T. S NO.: 3004.49.00.10 ANDA N O.: 202190 THERAPEUTICE USE : - COLESEVELAM IS A LIPID (L OW DENSITY LIPOPROTIN CHOLEST EROL) REDUCING DRUG THAT IS U SEFUL FOR REDUCING CHOLESTERO L. GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PR ODUCT CODE NO: 61 N C A 69 H . T. S NO.: 3004.90.92.30 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-662 THERAPEUTICE USE:-A NTICONVULSANT AGENT TOPIRA MATE TAB 50MG 500 NDC CODE:68 462015305 FDA PRODUCT CODE NO .: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:07762 7 THERAPEUTICE USE: ANTICONV ULSANT TOPIRAMATE TAB 50MG 1000 NDC CODE:68462015310 FD A PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:- 77-627 THERAPEU TICE USE:-ANTICONVULSANT G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F224520021 27 DT. 31.07.2023 F2245200210 2 DT. 31.07.2023 F22452002126 DT. 31.07.2023 F22452002107 DT. 31.07.2023 F22452002154 D T. 31.07.2023 S/BILL NO:29206 93 DT 02-AUG-2023 S/BILL NO:2 918719 DT 02-AUG-2023 S/BILL NO:2917733 DT 02-AUG-2023 S/B ILL NO:2917755 DT 02-AUG-2023 S/BILL NO:2917729 DT 02-AUG-2 023 NET WT:8026.085 NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA |
HS 611300 |
2023-08-29 |
12 PKG |
1820.75KG |
12 PALLET 678 CARTONS PHAR MACEUTICALS AS UNDER ESTRADIO L VAG INSERTS 10MCG 8 NDC COD E:68462071171 FDA PRODUCT COD E NO.: 64 G C A 28 H. T. S N O.: 3006.60.00.00 ANDA NO.:2 10264 THERAPEUTICE USE:THE T REATMENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. 01 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES COMMERCIAL & CUST OM INVOICE NO. F22452002071 D T. 30.07.2023 S/BILL NO:28654 93 DT 31-JUL-2023 NET WT:1318 .03 NOTIFY PARTY:2 SHOROUQ C OMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMP LEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 290719 |
2023-08-29 |
25 PKG |
4953.31KG |
25 PALLETS 1681 CARTONS PHA RMACEUTICALS AS UNDER ONDANSE TRON ODT 4MG 30UD NDC CODE:68 462015713 FDA PRODUCT CODE N O,:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-1 52 THERAPEUTICE USE:-ANTI -E METIC PRAVASTATIN SOD TAB 40M G 500 NDC CODE:68462019705 F DA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92. 20 ANDA NO.: 77-987 THERAPEU TICE USE: -HYPOLIPDAEMIC PRA VASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA N O.: 77-987 THERAPEUTICE USE: -HYPOLIPDAEMIC CLOTRIMAZOLE CREAM 1% 45GM NDC CODE:684620 18147 FDA PRODUCT CODE NO :6 1 W C J 04 H. T. S NO.: 3004 .90.92.45 ANDA NO.: 90-219 T HERAPEUTICE USE: TREATMENT OF CANDIDIASIS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES COMMERCIAL & CUSTOM INV OICE NO. F22452002155 DT. 31. 07.2023 F22452002159 DT. 31.0 7.2023 F22452002167 DT. 31.07 .2023 F22452002115 DT. 31.07. 2023 S/BILL NO:2944737 DT 03- AUG-2023 S/BILL NO:2944730 DT 03-AUG-2023 S/BILL NO:294261 3 DT 03-AUG-2023 S/BILL NO:29 42596 DT 03-AUG-2023 NET WT :3685.805 NOTIFY PARTY:2 SHO ROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CE NTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UT D.ARAB EMIR. |
HS 612600 |
2023-08-22 |
7 PKG |
953.92KG |
7 PALLETS 176 CARTONS PHAR MACEUTICALS AS UNDER APREPI TANT CAP 40MG 1UD NDC CODE:68 462058340 FDA PRODUCT CODE NO .: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.: 2077 77 THERAPEUTICE USE: -APREPI TANT IS USED WITH OTHER MEDIC ATIONS TO HELP PREVENT NAUSEA AND VOMITING CAUSED BY CANC ER DRUG TREATMENT (CHEMOTHERA PY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSEA AND V OMITING AFTER SURGERY. A-EMET IC/NAUSEANT / HUMAN - RX/SING LE INGREDIENT / DELAYED RELE ASE TABLETS / APREPITANT N ITROGLYCERIN SUBLING TAB 0.3MG 100 NDC CODE:68462063801 FD A PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR H EART FAILURE,HIGH BLOOD PRESS URE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BL OOD FLOW TO THE HEART NITR OGLYCERIN SUBLING TAB 0.4MG 10 0 NDC CODE:68462063901 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 A NDA NO.: 206391 THERAPEUTICE USE: -MEDICATION USED FOR HE ART FAILURE, HIGH BLOOD PRESS URE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTENOUGH BLO OD FLOW TO THE HEART COMME RCIAL & CUSTOM INVOICE NO. F2 2487000777 DT. 24.07.2023 NET WT. 69.681 KGS S/BILL NO: 4011069 DT:25.07.2023 07 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE DU PO RT 2 NEUCHATEL - 2000 SWITZE RLAND |
HS 613200 |
2023-08-22 |
24 PKG |
4894.34KG |
24 PALLETS 1073 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO .:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA PROPAFENONE HCL ER CAP 225MG 60 NDC CODE:684 62040860 FDA PRODUCT CODE NO. : 63 E C F 28 H. T. S NO.: 3004.49.00.10 ANDA NO.:205268 THERAPEUTICE USE:AN ANTIARR HYTHMIC AGENT. IT IS USED TO TREAT IRREGULAR HEART RHYTHM AND CAN SLOW RAPID HEARTBEA TS CLINDAMYCIN HCL CAP 300M G 100 NDC CODE:68462014401 COMMERCIAL & CUSTOM INVOICE N O. F22487000774 DT. 24.07.202 3 F22487000778 DT. 25.07.2023 NET WT. 2443.298 KGS S/BI LL NO: 4011063 DT: 25.07.2023 S/BILL NO: 4011070 DT: 25.07. 2023 00 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 SHOROUQ COMM ODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LE VEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EM IR. |
HS 651400 |
2023-08-22 |
11 PKG |
3375.69KG |
11 PALLETS 634 CARTONS PHA RMACEUTICALS AS UNDER RANOL AZINE ER TAB 500MG 60 NDC COD E:68462031960 FDA PRODUCT COD E NO.: 61 D C B 02 H. T. S N O.: 3004.49.00.10 ANDA NO.:2 11082 THERAPEUTIC USE: - IT I S AN ANTI-ANGINAL MEDICATION . IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHE ST PAIN). IT IS NOT FOR USE D URING AN ACUTE (EMERGENCY) AT TACK OF ANGINA GABAPENTIN TAB 600MG 500 NDC CODE:684620 12605 FDA PRODUCT CODE NO: 6 1 N C A 69 H. T. S NO.: 3004 .90.92.30 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULSA NT AGENT COMMERCIAL & CUST OM INVOICE NO. F22487000775 D T. 24.07.2023 F22487000776 DT . 24.07.2023 NET WT. 2257.922 KGS S/BILL NO: 4011064 DT: 25.07.2023 S/BILL NO: 4011067 DT:25.07.2023 02 DATA LO GGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA |
HS 616900 |
2023-08-22 |
42 PKG |
7863.16KG |
42 PALLETS 3465 CARTONS PH ARMACEUTICALS AS UNDER HEAT HER TAB 0.35MG 84 NDC CODE:68 462030329 FDA PRODUCT CODE NO .: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-45 4 THERAPEUTICE USE: PREVENTI ON OF PREGNANCY. CARVEDILOL TAB 12.5MG 500 NDC CODE:6846 2016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3 004.90.92.20 ANDA NO.:- 78-25 1 THERAPEUTICE USE:-BETA- A DRENOACEPTOR ANTAGONIST CO LESEVELAM HCL OS 3.75GM 30 ND C CODE:68462062030 FDA PRODUC T CODE NO.: 62 B C L 13 H. T . S NO.: 3004.49.00.10 ANDA NO.: 202190 THERAPEUTICE USE : - COLESEVELAM IS A LIPID ( LOW DENSITY LIPOPROTIN CHOLES TEROL) REDUCING DRUG THAT IS USEFUL FOR REDUCING CHOLESTER OL. CARVEDILOL TAB 3.125MG 500 NDC CODE:68462016205 FDA PRODUCT CODE NO ; 62 O C A 2 2 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUT ICE USE:-BETA- ADRENOACEPTOR ANTAGONIST OLMESARTAN MED OX TAB 5MG 30 NDC CODE:684620 43630 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90 .9220 ANDA NO.: 203281 THERA PEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS , TO LOWER BLOOD PRESSURE S/BILL NO: 2764780 DT 27-JUL- 2023 S/BILL NO: 2764769 DT 27 -JUL-2023 S/BILL NO: 2764785 DT 27-JUL-2023 S/BILL NO: 276 4789 DT 27-JUL-2023 COMME RCIAL & CUSTOM INVOICE NO. F2 2452001992 DT. 26.07.2023 F22 452001994 DT. 26.07.2023 F224 52001995 DT. 26.07.2023 F2245 2001996 DT. 26.07.2023 NET WT . 6032.34 KGS 02 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 SHOROU Q COMMODITIES TRADING DMCC UN IT NO. 98, DMCC BUSINESS CENTR E, LEVEL NO. 8, JEWELLERY & G EMPLEX 2, DUBAI DUBAI UTD.A RAB EMIR. |
HS 652400 |
2023-08-22 |
21 PKG |
5193.72KG |
21 PALLETS 2243 CARTONS PH ARMACEUTICALS AS UNDER OLME SARTAN MEDOX TAB 5MG 30 NDC C ODE:68462043630 FDA PRODUCT C ODE NO.: 62CCA68 H. T. S NO. : 3004.90.9220 ANDA NO.: 203 281 THERAPEUTICE USE: - TREA TMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSI VE AGENTS, TO LOWER BLOOD PRE SSURE CARVEDILOL TAB 3.125M G 500 NDC CODE:68462016205 F DA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92. 20 ANDA NO.:- 78-251 THERAPE UTICE USE:-BETA- ADRENOACEPT OR ANTAGONIST CARVEDILOL T AB 12.5MG 500 NDC CODE:684620 16405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 300 4.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADR ENOACEPTOR ANTAGONIST NAPR OXEN TAB 500MG 500 NDC CODE:6 8462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 250 THERAPEUTICE USE:-ANTI-I NFLAMMATORY, ANALGESIC ROP INIROLE TAB 0.5MG 100 NDC COD E:68462025401 FDA PRODUCT COD E NO.:-62 J C A 17 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TR EATMENT OF PARKINSONISM RO PINIROLE TAB 0.5MG 100 NDC CO DE:68462025401 FDA PRODUCT CO DE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.: - 90-135 THERAPEUTICE USE:-T REATMENT OF PARKINSONISM C OMMERCIAL & CUSTOM INVOICE NO. F22452002010 DT. 27.07.2023 F22452002019 DT. 27.07.2023 F22452002020 DT. 27.07.2023 F 22452002021 DT. 27.07.2023 F2 2452002032 DT. 28.07.2023 S/B ILL NO: 2818984 DT 29-JUL-2023 S/BILL NO: 2818982 DT. 29-JU L-2023 S/BILL NO: 2818981 DT. 29-JUL-2023 S/BILL NO: 28189 83 DT. 29-JUL-2023 S/BILL NO: 2819797 DT. 29-JUL-2023 NET WT. 4238.01 KGS 01 DATA LO GGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 SH OROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS C ENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI U TD.ARAB EMIR. |
HS 622200 |
2023-08-22 |
23 PKG |
6430.23KG |
23 PALLETS 1668 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 6.25MG 500 NDC COD E:68462016305 FDA PRODUCT COD E NO : 62 O C A 22 H. T. S N O.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BE TA- ADRENOACEPTOR ANTAGONIST NAPROXEN TAB 500MG 500 ND C CODE:68462019005 FDA PRODUC T CODE NO.:-62 G C A 49 H. T . S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE :-ANTI-INFLAMMATORY, ANALGESI C CARVEDILOL TAB 6.25MG 500 NDC CODE:68462016305 FDA PR ODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 A NDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR A NTAGONIST NAPROXEN TAB 500M G 500 NDC CODE:68462019005 F DA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-250 THERAPEU TICE USE:-ANTI-INFLAMMATORY, ANALGESIC COMMERCIAL & CUS TOM INVOICE NO. F22452002033 DT. 28.07.2023 F22452002034 D T. 28.07.2023 S/BILL NO: 2820 274 DT. 29-JUL-2023 S/BILL NO : 2820272 DT. 29-JUL-2023 0 2 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A |
HS 624900 |
2023-08-15 |
46 PKG |
10978.48KG |
46 PALLETS 3526 CARTONS PH ARMACEUTICALS AS UNDER ATOM OXETINE CAP 10MG 30 NDC CODE: 68462026530 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.: 3004.90.92.90 ANDA NO.: 0790 19 THERAPEUTICE USE : - ATOM OXETINE IS USED TO TREAT ATTE NTION-DEFICIT HYPERACTIVITY D ISORDER (ADHD) AS PART OF A T OTAL TREATMENT PLAN, INCLUDIN G PSYCHOLOGICAL, SOCIAL, AND OTHER TREATMENTS OMEPRAZOL E DR CAP 40MG 90 NDC CODE:684 62039790 FDA PRODUCT CODE NO. : 62KCF10 H. T. S NO.: 3004 .90.9160 ANDA NO.: 91672 THE RAPEUTICE USE: - -TREATMENT O F TREAT GASTROESOPHAGEAL REFL UX DISEASE ONDANSETRON TAB 4MG 30 NDC CODE:68462010530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:- 77-535 THERA PEUTICE USE:-ANTI -EMETIC OXCARBAZEPINE TAB 600MG 100 N DC CODE:68462013901 FDA PRODU CT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE :-ANTI CONVULSANT AGENT CO MMERCIAL & CUSTOM INVOICE NO. F22452001866 DT. 18.07.2023 S/BILL NO: 2556103 DT 19-JUL-2 023 NET WT. 8854.79 KGS 02 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 SHOROUQ COMMODITIES TRADI NG DMCC UNIT NO. 98, DMCC BUS INESS CENTRE, LEVEL NO. 8, JE WELLERY & GEMPLEX 2, DUBAI D UBAI UTD.ARAB EMIR. |
HS 649900 |
2023-08-13 |
43 PKG |
10775.72KG |
43 PALLET 4261 CARTONS PHARM ACEUTICALS AS UNDER NAPROXE N TAB 500MG 100 NDC CODE:6846 2019001 FDA PRODUCT CODE NO. :-62 G C A 49 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFL AMMATORY, ANALGESIC PRAVAS TATIN SOD TAB 40MG 500 NDC CO DE:68462019705 FDA PRODUCT CO DE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: -H YPOLIPDAEMIC TOPIRAMATE TAB 25MG 60 NDC CODE:68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49. 00.20 ANDA NO.:- 77-627 THER APEUTICE USE:-ANTICONVULSANT VERAPAMIL HCL ER TAB 120MG 10 0 NDC CODE:68462029201 FDA P RODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - -ANGINA CLINDAMYCIN PHOS GEL 1% 30GM NDC CODE:684 62086635 FDA PRODUCT CODE NO. : 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO.:214251 THERAPEUTICE USE: CLINDAMYC IN PHOSPHATE GEL IS INDICATED IN THE TREATMENT OF ACNE VU LGARIS CLINDAMYCIN PHOS GEL 1 % 60GM NDC CODE:68462086665 FDA PRODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00 .50 ANDA NO.:214251 THERAPEU TICE USE: CLINDAMYCIN PHOSPHA TE GEL IS INDICATED IN THE T REATMENT OF ACNE VULGARIS TO PIRAMATE TAB 25MG 500 NDC COD E:68462010805 FDA PRODUCT COD E NO.: 61 M C A 40 H. T. S N O.: 3004.49.00.20 ANDA NO.:0 77627 THERAPEUTICE USE: ANTI CONVULSANT TOPIRAMATE TAB 25M G 60 NDC CODE:68462010860 FD A PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:- 77-627 THERAPEU TICE USE:-ANTICONVULSANT OXC ARBAZEPINE TAB 600MG 100 NDC CODE:68462013901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO .:-77-802 THERAPEUTICE USE:-A NTI CONVULSANT AGENT ATOVAQU ONE-PROG TAB 250/100MG 24UD N DC CODE:68462040467 FDA PRODU CT CODE NO.: 62 L D A 44 H. T. S NO.: 3004.90.92.90 ANDA NO.: 91-211 THERAPEUTICE USE : - ANTI MALARIAL 02 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES COMMERCIAL & CUST OM INVOICE NO. F22452001783 D T. 11.07.2023 F22452001784 DT . 11.07.2023 F22452001780 DT. 11.07.2023 F22452001782 DT. 11.07.2023 F22452001795 DT. 1 2.07.2023 S/BILL NO 2399147 DT 12-JUL-2023 2399150 DT 12- JUL-2023 2400711 DT 12-JUL-20 23 2405339 DT:12-JUL-2023 24 09490 DT 12-JUL-2023 NET WT :8912.22 KGS NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADING DM CC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLE RY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 624900 |
2023-08-13 |
37 PKG |
9381.36KG |
37 PALLETS 1955 CARTONS P HARMACEUTICALS AS UNDER NAP ROXEN TAB 500MG 100 NDC CODE: 68462019001 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC PR AVASTATIN SOD TAB 40MG 500 ND C CODE:68462019705 FDA PRODUC T CODE NO.: 61 J C A 13 H. T . S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: -HYPOLIPDAEMIC PRAVASTATI N SOD TAB 40MG 500 NDC CODE:6 8462019705 FDA PRODUCT CODE N O.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77- 987 THERAPEUTICE USE: -HYPOL IPDAEMIC PRAVASTATIN SOD TA B 40MG 90 NDC CODE:6846201979 0 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90 .92.20 ANDA NO.: 77-987 THER APEUTICE USE: -HYPOLIPDAEMIC CICLOPIROX OLAMINE CREAM 0. 77% 90GM NDC CODE:68462029792 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40. 49.50 ANDA NO.:- 90 - 273 TH ERAPEUTICE USE:-ANTIFUNGAL US E. NORETHINDRONE ACE TAB 5M G 50 NDC CODE:68462030450 FD A PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.:-91-090 THERAPEUTIC E USE:- SECONDARY AMENORRHEA ,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING LEVONORGE STREL/EE TAB 0.09/0.02MG 84 N DC CODE:68462063729 FDA PRODU CT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 202791 THERAPEUTICE USE: - : USED FOR PREVENTING PRE GNANCY OXCARBAZEPINE TAB 30 0MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-802 THERAP EUTICE USE:-ANTI CONVULSANT A GENT 02 DATA LOGGERS COM MERCIAL & CUSTOM INVOICE NO. F22452001733 DT. 08.07.2023 F 22452001734 DT. 08.07.2023 F2 2452001735 DT. 08.07.2023 F22 452001736 DT. 08.07.2023 F224 52001737 DT. 08.07.2023 F2245 2001755 DT. 10.07.2023 S/BILL NO:2346309 DT.10.07.2023 S/B ILL NO:2346285 DT.10.07.2023 S/BILL NO:2346276 DT.10.07.20 23 S/BILL NO:2346877 DT.10.07 .2023 S/BILL NO:2346282 DT.10 .07.2023 S/BILL:NO:2346308 DT .10.07.2023 NET WT:7863.65KGS NOTIFY PARTY:2 SHOROUQ COMM ODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LE VEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EM IR. |
HS 624900 |
2023-08-13 |
40 PKG |
5735.32KG |
40 PALLETS 1874 CARTONS PHA RMACEUTICALS AS UNDER LEVONOR GESTREL/EE TAB 0.09/0.02MG 84 NDC CODE:68462063729 FDA PRO DUCT CODE NO.: 64 G D A 29 H . T. S NO.: 3006.60.0000 AND A NO.: 202791 THERAPEUTICE US E: - : USED FOR PREVENTING P REGNANCY NORETH ACE/EE TAB 1/ 0.02MG 63 NDC CODE:6846201328 1 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60. 00.00 ANDA NO.:206969 THERAP EUTICE USE: - SECONDARY AMEN ORRHEA,ENDOMETRIOS IS AND ABN ORMAL UTERINE BLEEDING NORET H ACE/EE TAB 1MG/5MCG 90 NDC CODE:68462065790 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO .: 203038 THERAPEUTICE USE: - TREATMENT OF MODERATE TO SE VERE VASOMOTOR SYMPTOMS DUE TO MENOPAUSE; OSTEOPOROSIS PR EVENTION 02 DATA LOGGERS SE T TEMPERATURE : +18 DEGREES COMMERCIAL & CUSTOM INVOICE N O. F22452001793 DT. 12.07.202 3 S/BILL NO:2409491 DT 12-JUL -2023 NET WT:4029.25KGS NOT IFY PARTY:2 SHOROUQ COMMODITI ES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL N O. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 642900 |
2023-08-13 |
13 PKG |
2570.55KG |
13 PALLETS 615 CARTONS PHARM ACEUTICALS AS UNDER PRAVASTAT IN SOD TAB 80MG 90 NDC CODE:6 8462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77- 987 THERAPEUTICE USE:-HYPOLI PDAEMIC EZETIMIBE-SIMVA TAB 10/80MG 90 NDC CODE:68462032 490 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004. 49.00.10 ANDA NO.: 208699 TH ERAPEUTICE USE: - THIS COMBIN ATION MEDICATION IS USED TO H ELP LOWER BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCE RIDES) AND RAISE GOOD CHOLEST EROL (HDL) IN THE BLOOD. EZET IMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BO DY ABSORBS FROM YOUR DIET. SI MVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY REDUCING THE AMO UNT OF CHOLESTEROL MADE BY TH E LIVER. INDOMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA PRODUCT CODE: 62 GCE42 H. T. S NO.:3004.90.92.40 AN DA NO.203501 THERAPEUTIC USE: INDOMETHACIN IS USED TO REL IEVE PAIN, SWELLING, AND JOIN T STIFFNESS CAUSED BY ARTHRIT IS, GOUT, BURSITIS, AND TENDO NITIS. IT IS ALSO USED TO REL IEVE PAIN FROM VARIOUS OTHER CONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL A NTI-INFLAMMATORY DRUG (NSAID) . ... THIS EFFECT HELPS TO D ECREASE SWELLING AND PAIN. T ACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA N O.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IM MUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERA TE-TO-SEVERE ATOPIC DERMATITI S (ECZEMA). 02 DATA LOGGERS SET TEMPERATURE : +18 DEGRE ES COMMERCIAL & CUSTOM INVO ICE NO. F22487000718 DT. 12.0 7.2023 F22487000723 DT. 13.07 .2023 F22487000725 DT. 13.07. 2023 4010417 DT:13.07.2023 4 010415 DT:13.07.2023 4010414 DT:13.07.2023 NET WT:1831.799 KGS NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEM PLEX 2, DUBAI DUBA |
HS 611300 |
2023-08-13 |
27 PKG |
6215.68KG |
27 PALLETS 2021 CARTONS P HARMACEUTICALS AS UNDER ESO MEPRAZOLE MAG DR CAP 40MG 30 NDC CODE:68462039130 FDA PROD UCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004.90.92 60 AND A NO.: 209495 THERAPEUTICE US E: ESOMEPRAZOLE MAGNESIUM D ELAYED-RELEASE CAPSULES ARE INDICATED FOR THE LONG-TERM T REATMENT OF PATHOLOGICAL HYP ERSECRETORY CONDITIONS, INCLU DING ZOLLINGER-ELLISON SYNDR OME NITROGLYCERIN SUBLING T AB 0.4MG 4X25 NDC CODE:684620 63945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 300 4.90.9020 ANDA NO.:206391 TH ERAPEUTIC USE: -MEDICATION US ED FOR HEART FAILURE,HIGH BLO OD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEAR T 27 DATA LOGGERS SET TEM PERATURE : +18 DEGREES COMM ERCIAL & CUSTOM INVOICE NO. F 22487000701 DT. 11.07.2023 S/ BILL NO:4010238 DT:11.07.2023 NET WT:720.216 KGS NOTIFY PA RTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWI TZERLAND |
HS 620600 |
2023-08-13 |
38 PKG |
7223.13KG |
38 PALLETS 1820 CARTONS P HARMACEUTICALS AS UNDER HAI LEY FE 1/20 TAB 1MG/20MCG-75MG 84 NDC CODE:68462041929 FDA PRODUCT CODE NO.: 65 J D A 2 5 H. T. S NO.: 3006.60.00.00 ANDA NO.:206597 THERAPEUTIC E USE: HORMONE MEDICATION IS USED TO PREVENT PREGNANCY NORETHINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRO DUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.:-91-090 THERAPEUTICE USE :- SECONDARY AMENORRHEA,ENDO METRIOS IS AND ABNORMAL UTER INE BLEEDING 02 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NET WT:5525.58 KGS COMMERCIAL & CUSTOM INVOICE NO . F22452001804 DT. 13.07.2023 S/BILL NO:2436355 DT:13.07.2 023 NET WT:5525.58 KGS NOTIF Y PARTY:2 SHOROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DM CC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DU BAI DUBAI UTD.ARAB EMIR. |
HS 652500 |
2023-08-13 |
28 PKG |
6556.33KG |
28 PALLETS 2020 CARTONS PHA RMACEUTICALS AS UNDER ESOMEPR AZOLE MAG DR CAP 40MG 30 NDC CODE:68462039130 FDA PRODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004.90.92 60 ANDA NO .: 209495 THERAPEUTICE USE: ESOMEPRAZOLE MAGNESIUM DELAY ED-RELEASE CAPSULES ARE INDI CATED FOR THE LONG-TERM TREAT MENT OF PATHOLOGICAL HYPERSE CRETORY CONDITIONS, INCLUDING ZOLLINGER-ELLISON SYNDROME NITROGLYCERIN SUBLING TAB 0.4 MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9 020 ANDA NO.:206391 THERAPEU TIC USE: -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PR ESSURE,AND TO TREAT AND PREVE NT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART NIT ROGLYCERIN SUBLING TAB 0.4MG 4 X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HE ART FAILURE,HIGH BLOOD PRESSU RE,AND TO TREAT AND PREVENT C HEST PAIN FROM NOT ENOUGH BLO OD FLOW TO THE HEART 28 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & C USTOM INVOICE NO. F2248700071 7 DT. 12.07.2023 F22487000724 DT. 13.07.2023 S/BILL NO:401 0419 DT:13.07.2023 S/BILL NO: 4010418 DT:13.07.2023 NET WT: 4118.766KGS NOTIFY PARTY:2 G LENMARK SPECIALTY S.A. SWITZE RLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 620600 |
2023-08-13 |
13 PKG |
2644.94KG |
13 PALLET 1127 CARTONS PH ARMACEUTICALS AS UNDER NICA RDIPINE HCL CAP 30MG 90 NDC C ODE:68462012190 FDA PRODUCT C ODE NO.: 62 O C E 48 H. T. S NO.: 3004.90.9220 ANDA NO.: 216357 THERAPEUTICE USE: :# CARDIOVASCULAR AGENT CALCIUM CHANNEL BLOCKER EZETIMIBE T AB 10MG 90 NDC CODE:684620226 90 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.4 9.00.10 ANDA NO.: #078560 TH ERAPEUTICE USE: LIPID LOWERIN G AGENT EZETIMIBE-SIMVA TAB 10/40MG 30 NDC CODE:68462032 330 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004. 49.00.10 ANDA NO.: 208699 TH ERAPEUTICE USE: - THIS COMBIN ATION MEDICATION IS USED TO H ELP LOWER BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCE RIDES) AND RAISE GOOD CHOLEST EROL (HDL) IN THE BLOOD. EZET IMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BO DY ABSORBS FROM YOUR DIET. SI MVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY REDUCING THE AMO UNT OF CHOLESTEROL MADE BY TH E LIVER. 02 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22487000 704 DT. 11.07.2023 S/BILL NO: 4010275 DT:11.07.2023 NET WT: 536.893KGS NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 611500 |
2023-08-13 |
11 PKG |
3301.3KG |
11 PALLETS 489 CARTONS PH ARMACEUTICALS AS UNDER NAPR OXEN TAB 500MG 500 NDC CODE:6 8462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 250 THERAPEUTICE USE:-ANTI-I NFLAMMATORY, ANALGESIC PRA VASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA N O.: 77-987 THERAPEUTICE USE: -HYPOLIPDAEMIC 00 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES HUMIDITY:65% SET TEMPE RATURE : +18 DEGREES TEMPERAT URE RANGE : +15 DEGREES TO +25 DEGREES COMMERCIAL & CUSTO M INVOICE NO. F22452001749 DT . 08.07.2023 S/BILL NO:234628 4 DT.10.07.2023 NET WT:2938.2 3KGS NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA |
HS 624900 |
2023-08-02 |
5 PKG |
881.34KG |
5 PALLETS 466 CARTONS PHARMA CEUTICALS AS UNDER APREPITANT CAP 80MG 6UD NDC CODE:684620 58476 FDA PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 300 4.90.92.40 ANDA NO.:207777 T HERAPEUTICE USE:APREPITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVENT NAUSEA AND V OMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHERAPY). TH IS MEDICATION IS ALSO USED T O PREVENT NAUSEA AND VOMITING AFTER SURGERY. A-EMETIC/NAUS EANT / HUMAN - RX/SINGLE ING REDIENT / DELAYED RELEASE TAB LETS / APREPITANT ESOMEPRAZO LE MAG DR CAP 20MG 30 NDC COD E:68462039030 FDA PRODUCT COD E NO.: 62 T C C 06 H. T. S N O.: 3004.90.92 60 ANDA NO.: 209495 THERAPEUTICE USE: ESO MEPRAZOLE MAGNESIUM DELAYED- RELEASE CAPSULES ARE INDICAT ED FOR THE LONG-TERM TREATMEN T OF PATHOLOGICAL HYPERSECRE TORY CONDITIONS, INCLUDING Z OLLINGER-ELLISON SYNDROME S/ BILL NO: 4009604 DT: 28.06.202 3 S/BILL NO: 4009608 DT: 28.0 6.2023 COMMERCIAL & CUSTOM IN VOICE NO. F22487000610 DT. 28 .06.2023 F22487000614 DT. 28. 06.2023 NET WT. 248.806 KGS 05 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE D U PORT 2 NEUCHATEL - 2000 SW ITZERLAND |
HS 613200 |
2023-08-02 |
7 PKG |
1044.19KG |
7 PALLETS 302 CARTONS PHARMA CEUTICALS AS UNDER EZETIMIB E TAB 10MG 90 NDC CODE:684620 22690 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 300 4.49.00.10 ANDA NO.: #078560 THERAPEUTICE USE: LIPID LOWE RING AGENT EZETIMIBE-SIMVA TAB 10/20MG 30 NDC CODE:68462 032230 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 30 04.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: :#LIPID LO WERING AGENT 02 DATA LOGGER S SET TEMPERATURE : +18 DEG REES COMMERCIAL & CUSTOM INVOICE NO. F22487000652 DT. 30.06.2023 S/BILL NO:4009954 DT:07.2023 NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 611500 |
2023-08-02 |
41 PKG |
5446.83KG |
41 PALLETS 1205 CARTONS P HARMACEUTICALS AS UNDER EST RADIOL VAG INSERTS 10MCG 18 N DC CODE:68462071188 NDC NO.:6 8462071188 FDA PRODUCT CODE N O.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:2102 64 THERAPEUTICE USE:THE TREA TMENT OF ATROPIC VAGINITIS DU E TO MENOPAUSE. 02 DATA LO GGERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & CUS TOM INVOICE NO. F22452001690 DT. 05.07.2023 S/BILL NO:2237 921 DT. 05-JUL-2023 NOTIFY PA RTY:2 SHOROUQ COMMODITIES TRA DING DMCC UNIT NO. 98, DMCC B USINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 642800 |
2023-08-02 |
29 PKG |
7134.22KG |
29 PALLETS 1692 CARTONS PHA RMACEUTICALS AS UNDER TELMI SARTAN-HCTZ TAB 80MG/12.5MG 30 UD NDC CODE:68462084113 62 O D A 09 3004.90.92.20 202544 TELMISARTAN AND HYDROCHLORO THIAZIDE TABLETS ARE INDICATE D FOR THE TREATMENT OF HYPE RTENSION, TO LOWER BLOOD PRES SURE. CARVEDILOL TAB 25MG 5 00 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST EZETIMIBE TAB 1 0MG 90 NDC CODE:68462022690 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00 .10 ANDA NO.: #078560 THERAP EUTICE USE: LIPID LOWERING AG ENT TELMISARTAN-HCTZ TAB 80 MG/25MG 30UD NDC CODE:6846208 4213 62 O D A 09 3004.90.92. 20 202544 TELMISARTAN AND H YDROCHLOROTHIAZIDE TABLETS AR E INDICATED FOR THE TREATMEN T OF HYPERTENSION, TO LOWER BLOOD PRESSURE. CARVEDILOL TAB 25MG 500 NDC CODE:6846201 6505 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST 02 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2248700 0624 DT. 30.06.2023 F22487000 630 DT. 30.06.2023 F224870006 41 DT. 30.06.2023 S/BILL:NO:4 009948 DT:04.07.2023 S/BILL: NO:4009946 DT:04.07.2023 S/BI LL NO:4009949 DT:04.07.2023 NOTIFY PARTY:2 SHOROUQ COMMO DITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEV EL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMI R. |
HS 622200 |
2023-08-02 |
10 PKG |
2421.32KG |
10 PALLET 976 CARTONS PHARM ACEUTICALS AS UNDER OMEPRAZ OLE DR CAP 40MG 30 NDC CODE:6 8462039730 FDA PRODUCT CODE N O.: 62KCF10 H. T. S NO.: 30 04.90.9160 ANDA NO.: 91672 T HERAPEUTICE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL RE FLUX DISEASE NET WT:1931.5 4KGS 01 DATA LOGGERS SET T EMPERATURE : +18 DEGREES COMMERCIAL & CUSTOM INVOICE NO . F22452001722 DT. 07.07.2023 S/BILL NO .2304081 DT.07.07. 2023 NOTIFY PARTY:2 SHOROU Q COMMODITIES TRADING DMCC UN IT NO. 98, DMCC BUSINESS CENTR E, LEVEL NO. 8, JEWELLERY & G EMPLEX 2, DUBAI DUBAI UTD.A RAB EMIR. |
HS 621000 |
2023-08-02 |
34 PKG |
8213.34KG |
34 PALLET 3049 CARTONS PHAR MACEUTICALS AS UNDER CICLOP IROX OLAMINE CREAM 0.77% 30GM NDC CODE:68462029735 FDA PRO DUCT CODE NO.:-61 W C J 03 H . T. S NO.: 3004.40.49.50 AN DA NO.:- 90 - 273 THERAPEUTIC E USE:-ANTIFUNGAL USE. PRA MIPEXOLE TAB 0.125MG 90 NDC C ODE:68462033090 FDA PRODUCT C ODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO. : 90-781 THERAPEUTICE USE: US ED IN PARKINSON#S DISEASE OMEPRAZOLE DR CAP 40MG 30 NDC CODE:68462039730 FDA PRODUCT CODE NO.: 62KCF10 H. T. S N O.: 3004.90.9160 ANDA NO.: 9 1672 THERAPEUTICE USE: - -TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE OLMESA RTAN MEDOX TAB 40MG 90 NDC CO DE:68462043890 FDA PRODUCT CO DE NO.: 62 CCA 68 H. T. S NO .: 3004.90.9220 ANDA NO.: 20 3281 TREATMENT OF HYPERTENSI ON, ALONE OR WITH OTHER ANTI HYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE ROPINIROLE TAB 1MG 100 NDC CODE:68462025 501 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004. 90.92.40 ANDA NO.:- 90-135 T HERAPEUTICE USE:-TREATMENT OF PARKINSONISM NET WT:6467. 97 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22452001709 DT. 07.07.20 23 F22452001710 DT. 07.07.202 3 F22452001711 DT. 07.07.2023 F22452001712 DT. 07.07.2023 S/BILL NO 2289142 DT.07.07.2 023 2289136 DT.07.07.2023 23 01044 DT.07.07.2023 2289143 D T.07.07.2023 NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADING DM CC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLE RY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 610300 |
2023-07-25 |
25 PKG |
3832.01KG |
25 PALLETS 1599 CARTONS PH ARMACEUTICALS AS UNDER NORE THINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.: -91-090 THERAPEUTICE USE:- S ECONDARY AMENORRHEA,ENDOMETRI OS IS AND ABNORMAL UTERINE B LEEDING ONDANSETRON ODT 8MG 30UD NDC CODE:68462015813 F DA PRODUCT CODE.:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-152 THERAPEUTIC E USE:-ANTIEMETIC ROPINIROL E TAB 0.5MG 100 NDC CODE:6846 2025401 FDA PRODUCT CODE NO. :-62 J C A 17 H. T. S NO.: 3 004.90.92.40 ANDA NO.:- 90-13 5 THERAPEUTICE USE:-TREATMEN T OF PARKINSONISM ATOVAQUO NE-PROG TAB 250/100MG 24UD ND C CODE:68462040467 FDA PRODUC T CODE NO.: 62 L D A 44 H. T . S NO.: 3004.90.92.90 ANDA NO.: 91-211 THERAPEUTICE USE: - ANTI MALARIAL S/BILL NO : 2092725 DT 29-JUN-2023 S/BI LL NO: 2093458 DT 29-JUN-2023 COMMERCIAL & CUSTOM INVOI CE NO. F22452001545 DT. 28.06 .2023 F22452001555 DT. 28.06. 2023 NET WT. 2980.86 KGS 0 1 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 652500 |
2023-07-25 |
17 PKG |
2998.3KG |
17 PALLETS 815 CARTONS PHA RMACEUTICALS AS UNDER FELOD IPINE ER TAB 10MG 100 NDC COD E:68462023501 FDA PRODUCT COD E NO.: 62OCB32 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-3 65 THERAPEUTICE USE: - TREAT MENT OF HYPERTENSION DROSP IRENONE/EE TAB 3/0.02MG 84 ND C CODE:68462072029 FDA PRODUC T CODE NO.: 65 J D A 39 H. T . S NO.: 3006.60.00.00 ANDA NO.: 204296 THERAPEUTICE USE: - ORAL CONTRACEPTIVE S/BI LL NO: 2092727 DT 29-JUN-2023 S/BILL NO: 2092720 DT 29-JUN- 2023 COMMERCIAL & CUSTOM INVOICE NO. F22452001553 DT. 28.06.2023 F22452001550 DT. 2 8.06.2023 NET WT. 2296.25 KGS 01 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NO TIFY PARTY:2 SHOROUQ COMMODIT IES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 653900 |
2023-07-25 |
45 PKG |
14460.77KG |
45 PALLETS 2289 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT NAPROXEN T AB 500MG 500 NDC CODE:6846201 9005 FDA PRODUCT CODE NO.:-6 2 G C A 49 H. T. S NO.: 3004 .90.92.40 ANDA NO.:-78-250 T HERAPEUTICE USE:-ANTI-INFLAMM ATORY, ANALGESIC LITHIUM C ARB ER TAB 300MG 100 NDC CODE :68462022301 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO .: 3004.49.00.20 ANDA NO.:91 -544 THERAPEUTICE USE: - IND ICATED IN THE TREATMENT OF MA NIC EPISODES OF BIPOLAR DISO RDER. BIPOLAR DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO M ANIC DEPRESSIVE ILLNESS, MANI C, IN THE OLDER DSM-II TERMIN OLOGY. ALSO INDICATED AS A M AINTENANCE TREATMENT FOR INDI VIDUALS WITH A DIAGNOSIS OF BIPOLAR DISORDER. MAINTENANCE THERAPY REDUCES THE FREQUENC Y OF MANIC EPISODES AND DIMI NISHES THE INTENSITY OF THOS E EPISODES WHICH MAY OCCUR. COMMERCIAL & CUSTOM INVOICE NO. F22452001571 DT. 29.06.2 023 F22452001577 DT. 29.06.20 23 S/BILL NO:2107070 DT 29-JU N-2023 S/BILL NO: 2108544 DT 29-JUN-2023 NET WT. 12919.18 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 684620 |
2023-07-25 |
20 PKG |
5913.13KG |
20 PALLETS 1457 CARTONS PH ARMACEUTICALS AS UNDER LITH IUM CARB CAP 300MG 100 NDC CO DE:68462022101 FDA PRODUCT CO DE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO.: - 79 -139 THERAPEUTICE USE:- ANTIMANIC AGENT OXCARBAZEPI NE TAB 300MG 100 NDC CODE:684 62013801 FDA PRODUCT CODE NO .:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-80 2 THERAPEUTICE USE:-ANTI CON VULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F224520014 67 DT. 23.06.2023 F2245200147 3 DT. 23.06.2023 S/BILL NO: 1 990180 DT 24-JUN-2023 S/BILL NO: 1990816 DT 24-JUN-2023 NE T WT. 5007.09 KGS 01 DATA LOG GERS HUMIDITY:65% SET TEMPER ATURE : +18 DEGREES TEMPERATU RE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 SHORO UQ COMMODITIES TRADING DMCC U NIT NO. 98, DMCC BUSINESS CENT RE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD. ARAB EMIR. |
HS 614500 |
2023-07-19 |
23 PKG |
6731.42KG |
23 PALLETS 1120 CARTONS P HARMACEUTICALS AS UNDER NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC OM EPRAZOLE DR CAP 40MG 90 NDC C ODE:68462039790 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - -TREA TMENT OF TREAT GASTROESOPHAGE AL REFLUX DISEASE VERAPAMI L HCL ER TAB 240MG 100 NDC CO DE:68462026001 FDA PRODUCT CO DE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: -78-906 THERAPEUTICE USE:-AN GINA 01 DATA LOGGERS SET T EMPERATURE : +18 DEGREES CO MMERCIAL & CUSTOM INVOICE NO. F22452001350 DT. 17.06.2023 F22452001352 DT. 17.06.2023 F 22452001375 DT. 18.06.2023 S/ BILL NO:1849547 DT 19-JUN-2023 S/BILL NO:1849554 DT. 19-JUN -2023 S/BILL NO:1862758 DT 19 -JUN-2023 NOTIFY PARTY:2 SHO ROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CE NTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UT D.ARAB EMIR. |
HS 624900 |
2023-07-19 |
42 PKG |
8559.89KG |
42 PALLETS 3011 CARTONS PHA RMACEUTICALS AS UNDER OMEPRAZ OLE DR CAP 20MG 100 NDC CODE: 68462039601 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3 004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL RE FLUX DISEASE ONDANSETRON ODT 4MG 30UD NDC CODE:6846201571 3 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO.: 3004.90 .92.40 ANDA NO.:-78-152 THER APEUTICE USE:-ANTI EMETIC OX CARBAZEPINE TAB 300MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-802 THERAPEUTICE USE:- ANTI CONVULSANT AGENT ATOVAQ UONE-PROG TAB 250/100MG 100 N DC CODE:68462040401 FDA PRODU CT CODE NO.: 62 L D A 44 H. T. S NO.: 3004.90.92.90 ANDA NO.: 91-211 THERAPEUTICE USE : - ANTI MALARIAL 03 DATA LO GGERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & CUSTO M INVOICE NO. F22452001451 DT . 22.06.2023 S/BILL NO:195220 3 DT 23-JUN-2023 NOTIFY PARTY :2 SHOROUQ COMMODITIES TRADIN G DMCC UNIT NO. 98, DMCC BUSI NESS CENTRE, LEVEL NO. 8, JEW ELLERY & GEMPLEX 2, DUBAI DU BAI UTD.ARAB EMIR. |
HS 621000 |
2023-07-19 |
28 PKG |
6234.73KG |
28 PALLET 1900 CARTONS PHARM ACEUTICALS AS UNDER ZOLMITRIP TAN TAB 2.5MG 6UD NDC CODE:68 462049776 FDA PRODUCT CODE NO .: 60 L C A 90 H. T. S NO.: 3004.90.92.28 ANDA NO.: 2017 79 THERAPEUTICE USE: - ANALG ESIC/ HUMAN - RX/SINGLE INGRE DIENT / PROMPT RELEASE TABLE TS / ZOLMITRIPTAN (ANALGESIC) ZOLMITRIPTAN ODT 2.5MG 6UD NDC CODE:68462049976 FDA PROD UCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90.92.28 AND A NO.: 202560 THERAPEUTICE US E: - ANALGESIC/ HUMAN - RX/S INGLE INGREDIENT / PROMPT RE LEASE TABLETS / ZOLMITRIPTAN (ANALGESIC) NAPROXEN TAB 375M G 100 NDC CODE:68462018901 F DA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-250 THERAPEU TICE USE:-ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TAB 375MG 500 NDC CODE:68462018905 FD A PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:-78-250 THERAPEUT ICE USE:-ANTI-INFLAMMATORY, ANALGESIC CARVEDILOL TAB 12.5 MG 500 NDC CODE:68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92 .20 ANDA NO.:- 78-251 THERAP EUTICE USE:-BETAADRENOACEPTOR ANTAGONIST NAPROXEN TAB 375 MG 500 NDC CODE:68462018905 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92 .40 ANDA NO.:-78-250 THERAPE UTICE USE:-ANTI-INFLAMMATORY, ANALGESIC ZONISAMIDE CAP 10 0MG 100 NDC CODE:68462013001 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.0 0.20 ANDA NO.:-77-651 THERAP EUTICE USE:-ANTISEIZURE DRUG CALCIPOTRIENE OINT 0.005% 60G M NDC CODE:68462031065 FDA P RODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209297 THIS MEDICAT ION IS USED TO TREAT PSORIASI S. CALCIPOTRIENE IS A FORM OF VITAMIN D. IT WORKS BY SLOW ING DOWN THE GROWTH OF SKIN C ELLS. COMMERCIAL & CUSTOM I NVOICE NO. F22452001378 DT. 1 9.06.2023 F22452001405 DT. 20 .06.2023 F22452001406 DT. 20. 06.2023 F22452001434 DT. 21.0 6.2023 F22452001435 DT. 21.06 .2023 F22452001436 DT. 21.06. 2023 F22452001402 DT. 20.06.2 023 S/BILL NO:1945705 DT 22-J UN-2023 S/BILL NO:1945535 DT 22-JUN-2023 S/BILL NO:1946182 DT 22-JUN-2023 S/BILL NO:194 5645 DT 22-JUN-2023 S/BILL NO :1945537 DT 22-JUN-2023 S/BIL L NO:1945647 DT 22-JUN-2023 S /BILL NO: 1946366 DT 23-JUN-20 23 NOTIFY PARTY:2 SHOROUQ CO MMODITIES TRADING DMCC UNIT N O. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPL EX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 609000 |
2023-07-11 |
31 PKG |
7766.09KG |
31 PALLETS 2380 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 3.125MG 500 NDC CO DE:68462016205 FDA PRODUCT CO DE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.: - 78-251 THERAPEUTICE USE:-B ETA- ADRENOACEPTOR ANTAGONIS T OXCARBAZEPINE TAB 600MG 1 00 NDC CODE:68462013901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTIC E USE:-ANTI CONVULSANT AGENT CARVEDILOL TAB 3.125MG 500 NDC CODE:68462016205 FDA PRO DUCT CODE NO ; 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST LITHIUM CARB CAP 6 00MG 100 NDC CODE:68462022201 FDA PRODUCT CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49. 00.20 ANDA NO.:- 79 -139 THE RAPEUTICE USE:-ANTIMANIC AGEN T MUPIROCIN OINT 2% 22GM N DC CODE:68462018022 FDA PRODU CT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE : - ANTI-BACTERIAL COMMERC IAL & CUSTOM INVOICE NO. F224 52001238 DT. 09.06.2023 F2245 2001239 DT. 09.06.2023 F22452 001244 DT. 10.06.2023 F224520 01233 DT. 09.06.2023 S/BILL N O: 1666674 DT 10-JUN-2023 S/B ILL NO: 1666574 DT 10-JUN-2023 S/BILL NO: 1671611 DT 10-JUN -2023 S/BILL NO: 1666738 DT 1 0-JUN-2023 NET WT. 6,441.13 K GS 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 614500 |
2023-07-11 |
12 PKG |
3113.96KG |
12 PALLETS 749 CARTONS PHA RMACEUTICALS AS UNDER CLOTR IMAZOLE CREAM 1% 45GM NDC COD E:68462018147 FDA PRODUCT COD E NO :61 W C J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 9 0-219 THERAPEUTICE USE: TREA TMENT OF CANDIDIASIS COMMER CIAL & CUSTOM INVOICE NO. F22 452001247 DT. 10.06.2023 S/BI LL NO: 1671610 DT 10-JUN-2023 NET WT. 2,324.17 KGS 00 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 210690 |
2023-07-11 |
21 PKG |
4189.9KG |
21 PALLETS 1437 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 600MG 100 NDC C ODE:68462013901 FDA PRODUCT C ODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-802 THERAPEUTICE USE:-AN TI CONVULSANT AGENT CARVED ILOL TAB 6.25MG 100 NDC CODE: 68462016301 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST HEATHER TAB 0.35MG 84 NDC C ODE:68462030329 FDA PRODUCT C ODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO. :90-454 THERAPEUTICE USE: PR EVENTION OF PREGNANCY. COMM ERCIAL & CUSTOM INVOICE NO. F 22452001220 DT. 08.06.2023 F2 2452001222 DT. 08.06.2023 F22 452001232 DT. 09.06.2023 S/BI LL NO: 1659760 DT 10-JUN-2023 S/BILL NO: 1659763 DT 10-JUN- 2023 S/BILL NO: 1659762 DT 10 -JUN-2023 NET WT. 3,317.91 KG S 02 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 622200 |
2023-07-11 |
28 PKG |
9737.43KG |
28 PALLETS 1954 CARTONS PH ARMACEUTICALS AS UNDER TOPI RAMATE TAB 100MG 500 NDC CODE :68462010905 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO .: 3004.49.00.20 ANDA NO.: 7 7627 THERAPEUTICE USE: :#ANT ICONVULSANT GABAPENTIN TAB 800MG 500 NDC CODE:6846201270 5 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90 .92.30 ANDA NO.:-77-662 THER APEUTICE USE:-ANTICONVULSANT AGENT GABAPENTIN TAB 800MG 500 NDC CODE:68462012705 FD A PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.3 0 ANDA NO.:-77-662 THERAPEUT ICE USE:-ANTICONVULSANT AGEN T ROSUVASTATIN TAB 5MG 90 NDC CODE:68462026190 FDA PROD UCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE : - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DI SEASE S/BILL NO: 1787083 DT 16-JUN-2023 S/BILL NO: 17870 63 DT 16-JUN-2023 S/BILL NO: 1804296 DT 16-JUN-2023 S/BILL NO: 1804509 DT 16-JUN-2023 COMMERCIAL & CUSTOM INVOICE NO. F22452001304 DT. 15.06.2 023 F22452001305 DT. 15.06.20 23 F22452001324 DT. 15.06.202 3 F22452001325 DT. 15.06.2023 NET WT. 8,613.59 KGS 09 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPE CIALTY S.A. SWITZERLAND (GSSA ) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
HS 684620 |
2023-07-11 |
29 PKG |
4168.58KG |
29 PALLETS 1402 CARTONS PH ARMACEUTICALS AS UNDER DROS PIRENONE/EE TAB 3/0.02MG 84 N DC CODE:68462072029 FDA PRODU CT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204296 THERAPEUTICE USE : - ORAL CONTRACEPTIVE S/B ILL NO: 1787051 DT 16-JUN-2023 COMMERCIAL & CUSTOM INVOIC E NO. F22452001316 DT. 15.06. 2023 NET WT. 2,893.730 KGS 01 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 653900 |
2023-07-11 |
4 PKG |
1013.8KG |
4 PALLETS 127 CARTONS PHAR MACEUTICALS AS UNDER NITR OGLYCERIN SUBLING TAB 0.4MG 4X 25 NDC CODE:68462063945 FD A PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9 020 ANDA NO.:206391 THERAP EUTIC USE: -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HE ART S/BILL NO: 4008863 DT: 16.06.2023 COMMERCIAL & CUSTOM INVOICE NO. F22487 000523 DT. 15.06.2023 NET WT : 67.666 KGS 04 DATA LOGGER S SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZER LAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLA ND |
HS 662800 |
2023-07-11 |
37 PKG |
7852.27KG |
37 PALLETS 2393 CARTONS PH ARMACEUTICALS AS UNDER PIME CROLIMUS CREAM 1% 100GM NDC C ODE:68462060994 FDA PRODUCT C ODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO. : 211769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTIN UOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATIT IS IN NON IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS O F AGE TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FD A PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 210393 THERAPEUT ICE USE: - TACROLIMUS IS A TO PICAL IMMUNOSUPPRESSIVE OINT MENT USED FOR THE TREATMENT O F MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PRAVA STATIN SOD TAB 20MG 500 NDC C ODE:68462019605 FDA PRODUCT C ODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. :-77-987 THERAPEUTICE USE:-H YPOLIPDAEMIC POTASSIUM CL E R CAP 10MEQ 100 NDC CODE:6846 2035701 FDA PRODUCT CODE NO. :65 R C F 14 H. T. S NO.: 30 04.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMI A RANOLAZINE ER TAB 1000MG 60 NDC CODE:68462032060 FDA PRODUCT CODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.:211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDICATION. IT WORKS BY IMPR OVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC A NGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EM ERGENCY) ATTACK OF ANGINA TOPIRAMATE ER CAP (Q) 150MG 30 NDC CODE:68462037030 3004.4 9.00.20 61 M C B 40 210278 CARVEDILOL TAB 25MG 100 NDC CODE:68462016501 FDA PRODUCT CODE NO: 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST NAPROXEN SOD TAB 275MG 100 NDC CODE:68462017801 FDA PRODUCT CODE NO.:-62 G C A 5 0 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-314 THERAPEUTI CE USE:-ANTI -INFLAMMATORY, A NALGESIC PROPAFENONE HCL ER CAP 425MG 60 NDC CODE:684620 41060 FDA CODES 63 E C F 28 HTS CODES 3004.49.00.10 ANDA NO. 205268 THERAPEUTIC USE A N ANTIARRHYTHMIC AGENT.IT IS USED TO TREAT IRREGULAR HEAR T RHYTHM AND CAN SLOW RAPID H EARTBEATS. METFORMIN HCL ER TAB (Z) 500MG 100 NDC CODE:6 8462052001 FDA PRODUCT CODE N O.: 61 P C A 55 H. T. S NO.: 3004.90.92.40 ANDA NO.:2129 69 THERAPEUTICE USE: THE MAN AGEMENT OF TYPE 2 DIABETES S/BILL NO: 4008869 DT:16.06.2 023 S/BILL NO: 4008860 DT:16. 06.2023 S/BILL NO: 4008866 DT :16.06.2023 S/BILL NO: 400885 8 DT:16.06.2023 S/BILL NO: 40 08871 DT:16.06.2023 COMME RCIAL & CUSTOM INVOICE NO. F2 2487000513 DT. 15.06.2023 F22 487000519 DT. 15.06.2023 F224 87000520 DT. 15.06.2023 F2248 7000521 DT. 15.06.2023 F22487 000524 DT. 15.06.2023 NET WT. 4056.130 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 300449 |
2023-07-11 |
12 PKG |
2424.95KG |
12 PALLETS 1083 CARTONS PH ARMACEUTICALS AS UNDER METR ONIDAZOLE VAG GEL 0.75% 70GM NDC CODE:68462018449 FDA PROD UCT CODE NO.: 62 L C J 40 H. T. S NO.: 3004.90.92.45 AND A NO.: 215794 THERAPEUTICE US E: METRONIDAZOLE VAGINAL GEL IS INDICATED IN THE TREATMEN T OF BACTERIAL VAGINOSIS (FOR MERLY REFERRED TO AS HAEMOPH ILUS VAGINITIS, GARDNERELLA VAGINITIS, NONSPECIFIC VAGINI TIS, CORYNEBACTERIUM VAGINIT IS, OR ANAEROBIC VAGINOSIS). ONDANSETRON TAB 4MG 30 NDC CODE:68462010530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA N O.:- 77-535 THERAPEUTICE USE: -ANTI EMETIC S/BILL NO: 18 04212 DT 16-JUN-2023 S/BILL N O: 1804510 DT 16-JUN-2023 COMMERCIAL & CUSTOM INVOICE N O. F22452001323 DT. 15.06.202 3 F22452001326 DT. 15.06.2023 NET WT. 1,761.48 KGS 00 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 SHOROUQ COMMODITIES TRADIN G DMCC UNIT NO. 98, DMCC BUSI NESS CENTRE, LEVEL NO. 8, JEW ELLERY & GEMPLEX 2, DUBAI DU BAI UTD.ARAB EMIR. |
HS 624000 |
2023-07-11 |
11 PKG |
1645.21KG |
11 PALLETS 550 CARTONS PHA RMACEUTICALS AS UNDER DROSP IRENONE/EE TAB 3/0.02MG 84 ND C CODE:68462072029 FDA PRODUC T CODE NO.: 65 J D A 39 H. T . S NO.: 3006.60.00.00 ANDA NO.: 204296 THERAPEUTICE USE: - ORAL CONTRACEPTIVE S/BI LL NO: 1804210 DT 16-JUN-2023 COMMERCIAL & CUSTOM INVOICE N O. F22452001330 DT. 16.06.202 3 NET WT. 1135.20 KGS 01 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 SHOROUQ COMMODITIES TRADIN G DMCC UNIT NO. 98, DMCC BUSI NESS CENTRE, LEVEL NO. 8, JEW ELLERY & GEMPLEX 2, DUBAI DU BAI UTD.ARAB EMIR. |
HS 653900 |
2023-06-27 |
40 PKG |
7671.28KG |
40 PALLETS 1951 CARTONS PH ARMACEUTICALS AS UNDER NORG EST/EE TAB .18,.215,.25/.035MG 84 NDC CODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 2 7 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200494 THERAPEUTI CE USE: - ORAL CONTRACEPTIVES NORGEST/EE TAB .18,.215,.2 5/.035MG 84 NDC CODE:68462056 529 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006. 60.00.00 ANDA NO.: 200494 TH ERAPEUTICE USE: - ORAL CONTRA CEPTIVES COMMERCIAL & CUSTO M INVOICE NO. F22452001048 DT . 30.05.2023 F22452001082 DT. 31.05.2023 S/BILL NO: 143924 7 DT 31-MAY-2023 S/BILL NO:14 37212 DT 31-MAY-2023 NET WT.5 862.36 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 SHOROUQ COMMOD ITIES TRADING DMCC UNIT NO. 9 8, DMCC BUSINESS CENTRE, LEVE L NO. 8, JEWELLERY & GEMPLEX 2 , DUBAI DUBAI UTD.ARAB EMIR |
HS 652700 |
2023-06-27 |
5 PKG |
1450.61KG |
5 PALLETS 376 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TAB 600MG 100 NDC COD E:68462012601 FDA PRODUCT COD E NO : 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT CALCIPOT RIENE OINT 0.005% 120GM NDC C ODE:68462031066 FDA PRODUCT C ODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO. : 090633 THERAPEUTICE USE: :# THIS MEDICATION IS USED TO T REAT PSORIASIS.CALCIPOTRIENE IS A FORM OF VITAMIN D. IT W ORKS BY SLOWING DOWN THE GROW TH OF SKIN CELLS S/BILL NO : 1380082 DT 29-MAY-2023 S/BI LL NO: 1396873 DT 30-MAY-2023 COMMERCIAL & CUSTOM INVOI CE NO. F22452000970 DT. 27.05 .2023 F22452001010 DT. 29.05. 2023 NET WT. 1,235.84 00 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 847439 |
2023-06-27 |
29 PKG |
7206.8KG |
29 PALLETS 1495 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO .:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:68462 035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 30 04.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - TREATMEN T OR PREVENTION OF HYPOKALEMI A GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRO DUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 AND A NO.:-77-662 THERAPEUTICE U SE:-ANTICONVULSANT AGENT S /BILL NO: 4007871 DT:30.05.202 3 S/BILL NO: 4007869 DT:30.05 .2023 COMMERCIAL & CUSTOM I NVOICE NO. F22487000391 DT. 2 9.05.2023 F22487000392 DT. 29 .05.2023 NET WT.4851.204 KGS 00 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREE S TEMPERATURE RANGE : +15 DEG REES TO +25 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A |
HS 651400 |
2023-06-27 |
27 PKG |
4389.94KG |
27 PALLETS 1337 CARTONS PH ARMACEUTICALS AS UNDER VIOR ELE TAB 0.15/0.02-0.01MG 84 N DC CODE:68462031829 FDA PRODU CT CODE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTICE USE : - ORAL CONTRACEPTIVES FE LODIPINE ER TAB 10MG 100 NDC CODE:68462023501 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO .: 3004.90.92.20 ANDA NO.: 9 0-365 THERAPEUTICE USE: - TR EATMENT OF HYPERTENSION MO EXIPRIL HCL TAB 15MG 100 NDC CODE:68462020801 FDA PRODUCT CODE NO.:62 O C A 47 H. T. S NO.: 3004.49.00.10 ANDA NO. :-90-416 THERAPEUTICE USE:-A NTIHYPERTENSIVE AGENT-ACE INH IBITOR S/BILL NO: 1396868 D T 30-MAY-2023 S/BILL NO: 1380 075 DT 29-MAY-2023 S/BILL NO: 1380079 DT 29-MAY-2023 C OMMERCIAL & CUSTOM INVOICE NO. F22452001009 DT. 29.05.2023 F22452000959 DT. 26.05.2023 F22452000990 DT. 28.05.2023 N ET WT.3267.93 01 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADING DMCC UNI T NO. 98, DMCC BUSINESS CENTRE , LEVEL NO. 8, JEWELLERY & GE MPLEX 2, DUBAI DUBAI UTD.AR AB EMIR. |
HS 642700 |
2023-06-27 |
12 PKG |
2470.76KG |
12 PALLETS 976 CARTONS PHARMACEUTICALS AS UNDER RO SUVASTATIN TAB 5MG 90 NDC COD E:68462026190 FDA PRODUCT COD E NO.:61 J C A 16 H. T. S NO .: 3004.49.00.10 ANDA NO.: 0 79172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND R ELATED CONDITIONS, AND TO PRE VENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 40MG 500 N DC CODE:68462026405 61 J C A 16 3004.49.00.10 79172 TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE CALCIPOTRIENE CREAM 0.005% 60G M NDC CODE:68462050165 FDA P RODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTICE USE: - TREATMENT OF PLAQUE PSORIASIS IN ADULTS S/BILL NO: 1398406 DT 30-MAY-2023 S/ BILL NO: 1380081 DT 29-MAY-202 3 COMMERCIAL & CUSTOM INV OICE NO. F22452001006 DT. 29. 05.2023 F22452000976 DT. 28.0 5.2023 NET WT.1966.691 12 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY: 2 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE NUMA-D ROZ 2 NEUCHATEL - 2000 SWITZ ERLAND |
HS 620400 |
2023-06-27 |
11 PKG |
2301.57KG |
11 PALLETS 765 CARTONS PHA RMACEUTICALS AS UNDER EZETI MIBE-SIMVA TAB 10/40MG 30 NDC CODE:68462032330 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA N O.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDICATION IS USED TO HELP LOWER BAD C HOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN T HE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLES TEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELON GS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY RED UCING THE AMOUNT OF CHOLESTER OL MADE BY THE LIVER. TOPI RAMATE ER CAP (Q) 200MG 30 ND C CODE:68462037130 3004.49.00 .20 61 M C B 40 210278 TO PIRAMATE ER CAP (Q) 50MG 30 N DC CODE:68462037330 3004.49.0 0.20 61 M C B 40 210278 N APROXEN SOD TAB 550MG 100 NDC CODE:68462017901 FDA PRODUCT CODE NO.:-62 G C A 50 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-314 THERAPEUTICE USE:- ANTI -INFLAMMATORY, ANALGESIC AMLOD-OLMESARTAN TAB 5/40M G 30 NDC CODE:68462056830 FD A PRODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 207807 THERAPEUT ICE USE: -MEDICATION USED TO TREAT HIGH BLOOD PRESSURE AND CORONARY ARTERY DISEASE C ARVEDILOL TAB 12.5MG 500 NDC CODE:68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST S/BILL NO: 4007870 DT: 30.05.2023 COMMERCIAL & CUSTO M INVOICE NO. F22487000390 DT . 29.05.2023 NET WT.1199.553 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREE S TEMPERATURE RANGE : +15 DEG REES TO +25 DEGREES NOTIFY PA RTY:2 SHOROUQ COMMODITIES TRA DING DMCC UNIT NO. 98, DMCC B USINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 611500 |
2023-06-21 |
5 PKG |
788.81KG |
PHARMACEUTICALS AS UNDER HA ILEY FE 1/20 TAB 1MG/20MCG-75M G 84 NDC CODE:68462041929 FD A PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.0 0 ANDA NO.:206597 THERAPEUTI CE USE: HORMONE MEDICATION IS USED TO PREVENT PREGNANCY 00 DATA LOGGERS SET T EMPERATURE : +18 DEGREES INV NO: F22452000820 DT. 20.05 .2023 S/BILL NO: 1172182 DT:2 0.05.2023 NET WT:609.02KGS |
HS 652500 |
2023-06-21 |
35 PKG |
5737.13KG |
HAILEY FE 1/20 TAB 1MG/20MCG -75MG 84 NDC CODE:68462041929 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60. 00.00 ANDA NO.:206597 THERAP EUTICE USE: HORMONE MEDICATIO N IS USED TO PREVENT PREGNAN CY ESTRADIOL VAG INSERTS 10 MCG 8 NDC CODE:68462071171 F DA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00. 00 ANDA NO.:210264 THERAPEUT ICE USE:THE TREATMENT OF ATRO PIC VAGINITIS DUE TO MENOPAU SE. NORETH ACE/EE TAB 1/0.0 2MG 63 NDC CODE:68462013281 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.:206969 THERAPEUT ICE USE: - SECONDARY AMENORR HEA,ENDOMETRIOS IS AND ABNORM AL UTERINE BLEEDING 02 DAT A LOGGERS SET TEMPERA TURE : +18 DEGREES INV NO : F22452000819 DT. 20.05.2023 INV NO: F22452000831 DT. 21.0 5.2023 INV NO: F22452000835 D T. 21.05.2023 S/BILL NO: 1172 175 DT:20.05.2023 S/BILL NO: 1182645 DT:22.05.2023 S/BILL NO: 1182576 DT:22.05.2023 N ET WT:4080.96 KGS |
HS 652500 |
2023-06-21 |
42 PKG |
9828.6KG |
42 PACKAGES 42 PALLETS 2150 CARTONS PHARMACEUTIC ALS AS UNDER OMEPRAZOLE DR CAP 40MG 30 NDC CODE:68462039 730 FDA PRODUCT CODE NO.: 62 KCF10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAPEU TICE USE: - -TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX D ISEASE INDOMETHACIN CAP 25M G 100 NDC CODE:68462040601 F DA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92. 40 ANDA NO.:91-276 THERAPEUT ICE USE: -ANTI-INFLAMATORY OLMESARTAN MEDOX TAB 40MG 90 NDC CODE:68462043890 FDA PRO DUCT CODE NO.: 62 CCA 68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 TREATMENT OF HYP ERTENSION, ALONE OR WITH OTHE R ANTIHYPERTENSIVE AGENTS, T O LOWER BLOOD PRESSURE MUPI ROCIN OINT 2% 22GM NDC CODE:6 8462018022 FDA PRODUCT CODE N O.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90- 480 THERAPEUTICE USE: - ANTI -BACTERIAL LIDOCAINE OINT J AR 5% 50GM NDC CODE:684620418 27 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49 .00.50 ANDA NO.:206498 THERA PEUTICE USE: -USED TO TEMPORA RILY RELIEVE PAIN AND ITCHING ASSOCIATED WITH SKIN MUPI ROCIN OINT 2% 22GM NDC CODE:6 8462018022 FDA PRODUCT CODE N O.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90- 480 THERAPEUTICE USE: - ANTI -BACTERIAL 01 DATA LOGGER S SET TEMPERATURE : +18 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F224520008 11 DT. 19.05.2023 F2245200082 5 DT. 20.05.2023 F22452000843 DT. 21.05.2023 F22452000829 DT. 20.05.2023 F22452000838 D T. 21.05.2023 F22452000850 DT . 22.05.2023 S/BILL NO: 12048 41 DT:22.05.2023 S/BILL NO: 1 204845 DT:22.05.2023 S/BILL N O: 1205085 DT:22.05.2023 S/BI LL NO: 1204880 DT:22.05.2023 S/BILL NO: 1205203 DT:22.05.20 23 S/BILL NO: 1204859 DT:22.0 5.2023 NET WT:7993.17KGS |
HS 621000 |
2023-06-21 |
7 PKG |
1961.82KG |
7 PACKAGES 7 PALLETS 376 CARTONS PHARMACEUTICALS AS UNDER GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FD A PRODUCT CODE NO: 61 N C A 6 9 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTI CE USE:-ANTICONVULSANT AGENT ESTRADIOL VAG INSERTS 10MC G 8 NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 2 8 H. T. S NO.: 3006.60.00.00 ANDA NO.:210264 THERAPEUTIC E USE:THE TREATMENT OF ATROPI C VAGINITIS DUE TO MENOPAUSE . 01 DATA LOGGERS SE T TEMPERATURE : +18 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22452000839 DT. 21.05.2 023 F22452000848 DT. 22.05.20 23 S/BILL NO: 1206463 DT: 22.05.2023 S/BILL NO: 120484 2 DT:22.05.2023 NET WT:1704 .89 KGS |
HS 616900 |
2023-06-21 |
38 PKG |
9139.59KG |
38 PALLETS 4334 CARTONS P HARMACEUTICALS AS UNDER LID OCAINE OINT TUBE 5% 35.44GM N DC CODE:68462041820 FDA PRODU CT CODE NO.:60 Q C J 07 H. T . S NO.: 3004.49.00.50 ANDA NO.:206498 THERAPEUTICE USE: -USED TO TEMPORARILY RELIEVE PAIN AND ITCHING ASSOCIATED WITH SKIN PRAMIPEXOLE TAB 0 .5MG 90 NDC CODE:68462033290 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.9 2.40 ANDA NO.: 90-781 THERAP EUTICE USE: USED IN PARKINSON #S DISEASE FLUCONAZOLE TAB 100MG 30 NDC CODE:68462010230 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90. 92.45 ANDA NO.:-77 - 253 THE RAPEUTICE USE:-ANTIFUNGAL OLMESARTAN MEDOX TAB 20MG 30 NDC CODE:68462043730 FDA PROD UCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO. : 203281 THERAPEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPE RTENSIVE AGENTS, TO LOWER BLO OD PRESSURE FLUCONAZOLE TAB 100MG 30 NDC CODE:6846201023 0 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90 .92.45 ANDA NO.:-77 - 253 TH ERAPEUTICE USE:-ANTIFUNGAL OLMESARTAN MEDOX TAB 20MG 30 NDC CODE:68462043730 FDA PRO DUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO .: 203281 THERAPEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYP ERTENSIVE AGENTS, TO LOWER BL OOD PRESSURE OLMESARTAN MED OX TAB 20MG 90 NDC CODE:68462 043790 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.9 0.9220 ANDA NO.: 203281 THER APEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENT S, TO LOWER BLOOD PRESSURE 02 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES INV N O:F22452000874 DT. 23.05.2023 INV NO:F22452000882 DT. 23.05 .2023 INV NO:F22452000857 DT. 22.05.2023 INV NO:F224520008 98 DT. 24.05.2023 INV NO:F224 52000904 DT. 24.05.2023 S/B ILL NO:1240774 DT:24.05.2023 S/BILL NO:1258613 DT:24.05.202 3 S/BILL NO:1258651 DT:24.05. 2023 S/BILL NO:1262121 DT:24. 05.2023 S/BILL NO:1272791 DT: 25.05.2023 NET WT:7040.41KG S NOTIFY PARTY:2 SHOROUQ C OMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMP LEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 600700 |
2023-06-21 |
23 PKG |
3330.33KG |
23 PALLETS 1656 CARTON PHA RMACEUTICALS AS UNDER ONDANSE TRON ODT 4MG 30UD NDC CODE:68 462015713 FDA PRODUCT CODE N O,:-61 T C A 26 H. T. S NO.: 3004.90.92.4 ANDA NO.:-78-15 2 THERAPEUTICE USE:-ANTI -EM ETIC 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NET WT:2248.12KGS INV NO: F 22452000937 DT. 26.05.2023 S/ BILL NO: 1313968 DT:26 .05.202 3 NOTIFY PARTY:2 SHOROUQ C OMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMP LEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 612600 |
2023-06-21 |
17 PKG |
3329.88KG |
17 PALLETS 837 CARTONS PHA RMACEUTICALS AS UNDER NORGEST/EE TAB 0.25/0.035MG 84 NDC CODE:68462030929 FDA PR ODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 A NDA NO.: 200538 THERAPEUTICE USE: - ORAL CONTRACEPTIVES 01 DATA LOGGERS HUMIDITY: 65% SET TEMPERATURE : +18 DEG REES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES INV NO: F22452000934 DT. 26.0 5.2023 S/BILL NO: 1304718 DT: 26.05 2023 NET WT:2531.09 NOTIFY PARTY:2 SHOROUQ COMM ODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LE VEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EM IR. |
HS 652700 |
2023-06-13 |
11 PKG |
2837.72KG |
11 PALLETS 675 CARTONS PHA RMACEUTICALS AS UNDER NAPRO XEN TAB 500MG 500 NDC CODE:68 462019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI-IN FLAMMATORY, ANALGESIC OMEP RAZOLE DR CAP 10MG 30 NDC COD E:68462039530 FDA PRODUCT COD E NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATM ENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F224520 00803 DT. 19.05.2023 F2245200 0806 DT. 19.05.2023 S/BILL NO : 1156167 DT 20-MAY-2023 S/BI LL NO: 1156161 DT 20-MAY-2023 NET WT.2420.56 01 DATA LOGGE RS HUMIDITY:65% SET TEMPERAT URE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DE GREES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 624900 |
2023-06-13 |
34 PKG |
8901.9KG |
34 PALLETS 2857 CARTONS PH ARMACEUTICALS AS UNDER NAPR OXEN TAB 500MG 100 NDC CODE:6 8462019001 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 250 THERAPEUTICE USE:-ANTI-I NFLAMMATORY, ANALGESIC TEL MISARTAN TAB 80MG 30 NDC CODE :68462020130 HTS NO : 3004.90 .92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAPEUTIC E USE : INDICATED FOR THE TR EATMENT OF HYPERTENSION, TO L OWER BLOOD PRESSURE TOPIRA MATE TAB 100MG 500 NDC CODE:6 8462010905 FDA PRODUCT CODE N O.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.: 776 27 THERAPEUTICE USE: :#ANTIC ONVULSANT TOPIRAMATE TAB 10 0MG 60 NDC CODE:68462010960 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00 .20 ANDA NO.:- 77-627 THERAP EUTICE USE:-ANTICONVULSANT OMEPRAZOLE DR CAP 10MG 100 N DC CODE:68462039501 FDA PRODU CT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - - TREATMENT OF TREAT GASTROESOP HAGEAL REFLUX DISEASE OMEP RAZOLE DR CAP 10MG 30 NDC COD E:68462039530 FDA PRODUCT COD E NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATM ENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F224520 00802 DT. 19.05.2023 F2245200 0800 DT. 19.05.2023 F22452000 807 DT. 19.05.2023 S/BILL NO: 1156166 DT 20-MAY-2023 S/BIL L NO: 1156174 DT 20-MAY-2023 S/BILL NO: 1156162 DT 20-MAY-2 023 NET WT.7325.67 01 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADING DM CC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLE RY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 300490 |
2023-06-13 |
24 PKG |
4660.74KG |
24 PALLETS 1430 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 300MG 100 NDC C ODE:68462013801 FDA PRODUCT C ODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-802 THERAPEUTICE USE:-AN TI CONVULSANT AGENT ZONISA MIDE CAP 100MG 100 NDC CODE:6 8462013001 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77- 651 THERAPEUTICE USE:-ANTISE IZURE DRUG ATOVAQUONE-PROG TAB 250/100MG 100 NDC CODE:68 462040401 FDA PRODUCT CODE NO .: 62 L D A 44 H. T. S NO.: 3004.90.92.90 ANDA NO.: 91-2 11 THERAPEUTICE USE: - ANTI MALARIAL NORETHINDRONE TAB 0.35MG 84 NDC CODE:6846203052 9 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60 .00.00 ANDA NO.:91-209 THERA PEUTICE USE: PREVENTION OF PR EGNANCY. COMMERCIAL & CUSTO M INVOICE NO. F22452000718 DT . 13.05.2023 F22452000728 DT. 13.05.2023 F22452000722 DT. 13.05.2023 NET WT.3610.08 KGS S/BILL NO: 1014601 DT 15 -MAY-2023 S/BILL NO: 1014604 DT 15-MAY-2023 S/BILL NO: 102 0742 DT 15-MAY-2023 02 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 S HOROUQ COMMODITIES TRADING DMC C UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLER Y & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 614400 |
2023-06-13 |
19 PKG |
3154.79KG |
19 PALLETS 920 CARTO NS PHARMACEUTICALS AS UNDER HAILEY FE 1.5/30 TAB 1.5MG/3 0MCG-75MG 84 NDC CODE:6846205 0329 FDA PRODUCT CODE NO.: 6 5 J D A 25 H. T. S NO.: 3006 .60.00.00 ANDA NO.:206597 TH ERAPEUTICE USE: HORMONE MEDIC ATION IS USED TO PREVENT PRE GNANCY HAILEY FE 1.5/30 TAB 1.5MG/30MCG-75MG 84 NDC CODE :68462050329 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO .: 3006.60.00.00 ANDA NO.:20 6597 THERAPEUTICE USE: HORMO NE MEDICATION IS USED TO PREV ENT PREGNANCY S/BILL NO: 1024919 DT 15-MAY-2023 S/BIL L NO: 1020736 DT 15-MAY-2023 COMMERCIAL & CUSTOM INVOIC E NO. F22452000733 DT. 14.05. 2023 F22452000732 DT. 14.05.2 023 NET WT.2362.56 KGS 19 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY: 2 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE NUMA-D ROZ 2 NEUCHATEL - 2000 SWITZ ERLAND |
HS 652500 |
2023-06-05 |
25 PKG |
5496.27KG |
25 PALLETS 2780 CARTONS PHARMACEUTICALS AS UNDER TO PIRAMATE TAB 50MG 60 NDC CODE :68462015360 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO .: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTICE USE:-ANT ICONVULSANT OLMESARTAN MEDO X TAB 5MG 30 NDC CODE:6846204 3630 FDA PRODUCT CODE NO.: 6 2CCA68 H. T. S NO.: 3004.90. 9220 ANDA NO.: 203281 THERAP EUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH O THER ANTIHYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE T ELMISARTAN TAB 40MG 30 NDC CO DE:68462020030 FDA PRODUCT CO DE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 090032 THERAPEUTICE USE: IND ICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE NET WT:4174.307 KG S 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S INV NO:F22452000 596 DT. 06.05.2023 INV NO:F22 452000604 DT. 07.05.2023 INV NO:F22452000605 DT. 07.05.2023 S/BILL NO:9842875 DT:08.0 5.2023 S/BILL NO :9841067 DT: 08.05.2023 S/BILL NO: 9841078 DT: 08-MAY-23 NOTIFY PARTY :2 GLENMARK PHARM ACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA |
HS 684620 |
2023-06-05 |
24 PKG |
5491.74KG |
24 PALLETS 1779 CARTONS P HARMACEUTICALS AS UNDER NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC CA RVEDILOL TAB 6.25MG 500 NDC C ODE:68462016305 FDA PRODUCT C ODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO. :- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST FLUCONAZOLE TAB 200MG 30 NDC CODE:68462010430 FDA PR ODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90.92.45 A NDA NO.:-77 - 253 THERAPEUTIC E USE:-ANTIFUNGAL OMEPRAZO LE DR CAP 20MG 1000 NDC CODE: 68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3 004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE TOPIRAMATE T AB 25MG 60 NDC CODE:684620108 60 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.4 9.00.20 ANDA NO.:- 77-627 TH ERAPEUTICE USE:-ANTICONVULSAN T 01 DATA LOGGERS SET T EMPERATURE : +18 DEGREES NET WT:4561.78 KGS INV NO :F22452000594 DT. 06.05.2023 INV NO:F22452000595 DT. 06.05. 2023 INV NO:F22452000597 DT. 06.05.2023 S/BILL NO:9855046 DT:08.05.2023 S/BILL NO:98550 33 DT:08.05.2023 S/BILL NO:98 55036 DT:08.05.2023 NOTIFY PARTY:2 SHOROUQ COMMODITIE S TRADING DMCC UNIT NO. 98 , DMCC BUSINESS CENTRE, LE VEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UT D.ARAB EMIR. |
HS 624900 |
2023-05-30 |
26 PKG |
5896.35KG |
26 PALLETS 1183 CARTONS PH ARMACEUTICALS AS UNDER TOPI RAMATE TAB 50MG 500 NDC CODE: 68462015305 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:077 627 THERAPEUTICE USE: ANTICO NVULSANT CARVEDILOL TAB 6.2 5MG 500 NDC CODE:68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.9 2.20 ANDA NO.:- 78-251 THERA PEUTICE USE:-BETA- ADRENOACE PTOR ANTAGONIST CARVEDILOL TAB 6.25MG 500 NDC CODE:6846 2016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3 004.90.92.20 ANDA NO.:- 78-25 1 THERAPEUTICE USE:-BETA- A DRENOACEPTOR ANTAGONIST MU PIROCIN OINT 2% 22GM NDC CODE :68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO .: 3004.90.92.45 ANDA NO.: 9 0-480 THERAPEUTICE USE: - AN TI-BACTERIAL MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 90-480 THERA PEUTICE USE: - ANTI-BACTERIAL NAPROXEN TAB 500MG 500 ND C CODE:68462019005 FDA PRODUC T CODE NO.:-62 G C A 49 H. T . S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE :-ANTI-INFLAMMATORY, ANALGESI C COMMERCIAL & CUSTOM INVOI CE NO. F22452000500 DT. 30.04 .2023 F22452000522 DT. 30.04. 2023 F22452000526 DT. 30.04.2 023 F22452000553 DT. 04.05.20 23 F22452000558 DT. 04.05.202 3 F22452000560 DT. 04.05.2023 S/BILL NO: 9774446 DT 05-MAY -2023 S/BILL NO: 9774447 DT 0 5-MAY-2023 S/BILL NO: 9774453 DT 05-MAY-2023 S/BILL NO: 97 74455 DT 05-MAY-2023 S/BILL N O: 9774456 DT 05-MAY-2023 S/B ILL NO: 9774457 DT 05-MAY-2023 NET WT.4880.04 00 DATA LOGG ERS HUMIDITY:65% SET TEMPERA TURE : +18 DEGREES TEMPERATUR E RANGE : +15 DEGREES TO +25 D EGREES NOTIFY PARTY:2 SHOROU Q COMMODITIES TRADING DMCC UN IT NO. 98, DMCC BUSINESS CENTR E, LEVEL NO. 8, JEWELLERY & G EMPLEX 2, DUBAI DUBAI UTD.A RAB EMIR. |
HS 614000 |
2023-05-30 |
9 PKG |
1907.84KG |
9 PALLETS 976 CARTONS PHAR MACEUTICALS AS UNDER TOPIRA MATE TAB 50MG 500 NDC CODE:68 462015305 FDA PRODUCT CODE NO .: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:07762 7 THERAPEUTICE USE: ANTICONV ULSANT TOPIRAMATE TAB 50MG 60 NDC CODE:68462015360 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTI CE USE:-ANTICONVULSANT TOP IRAMATE TAB 50MG 500 NDC CODE :68462015305 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO .: 3004.49.00.20 ANDA NO.:07 7627 THERAPEUTICE USE: ANTIC ONVULSANT COMMERCIAL & CUST OM INVOICE NO. F22452000512 D T. 30.04.2023 F22452000525 DT . 30.04.2023 F22452000492 DT. 30.04.2023 S/BILL NO: 977445 1 DT 05-MAY-2023 S/BILL NO: 9 774452 DT 05-MAY-2023 S/BILL NO: 9774449 DT 05-MAY-2023 NE T WT. 1537.986 02 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA |
HS 614000 |
2023-05-30 |
9 PKG |
1741.82KG |
9 PALLETS 1063 CARTONS PHA RMACEUTICALS AS UNDER ROSUV ASTATIN TAB 5MG 90 NDC CODE:6 8462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 0791 72 THERAPEUTICE USE: - TO TR EAT HIGH CHOLESTEROL AND RELA TED CONDITIONS, AND TO PREVEN T CARDIOVASCULAR DISEASE R OSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 79172 THERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PR EVENT CARDIOVASCULAR DISEASE. ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PRO DUCT CODE NO.: 61 J C A 16 H . T. S NO.: 3004.49.00.10 AN DA NO.: 79172 THERAPEUTICE US E: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DIS EASE. ROSUVASTATIN TAB 5MG 90 NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULA R DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22452000496 DT. 30.04.2023 F22452000527 DT. 30.04.2023 F22452000531 DT. 3 0.04.2023 F22452000508 DT. 30 .04.2023 S/BILL NO: 9774448 D T 05-MAY-2023 S/BILL NO: 9774 458 DT 05-MAY-2023 S/BILL NO: 9774454 DT 05-MAY-2023 S/BIL L NO: 9774445 DT 05-MAY-2023 NET WT.1414.600 09 DATA LOGGE RS HUMIDITY:65% SET TEMPERAT URE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DE GREES NOTIFY PARTY:2 GLENMAR K SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEU CHATEL - 2000 SWITZERLAND |
HS 611600 |
2023-05-30 |
26 PKG |
5896.35KG |
26 PALLETS 1183 CARTONS PH ARMACEUTICALS AS UNDER TOPI RAMATE TAB 50MG 500 NDC CODE: 68462015305 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:077 627 THERAPEUTICE USE: ANTICO NVULSANT CARVEDILOL TAB 6.2 5MG 500 NDC CODE:68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.9 2.20 ANDA NO.:- 78-251 THERA PEUTICE USE:-BETA- ADRENOACE PTOR ANTAGONIST CARVEDILOL TAB 6.25MG 500 NDC CODE:6846 2016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3 004.90.92.20 ANDA NO.:- 78-25 1 THERAPEUTICE USE:-BETA- A DRENOACEPTOR ANTAGONIST MU PIROCIN OINT 2% 22GM NDC CODE :68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO .: 3004.90.92.45 ANDA NO.: 9 0-480 THERAPEUTICE USE: - AN TI-BACTERIAL MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 90-480 THERA PEUTICE USE: - ANTI-BACTERIAL NAPROXEN TAB 500MG 500 ND C CODE:68462019005 FDA PRODUC T CODE NO.:-62 G C A 49 H. T . S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE :-ANTI-INFLAMMATORY, ANALGESI C COMMERCIAL & CUSTOM INVOI CE NO. F22452000500 DT. 30.04 .2023 F22452000522 DT. 30.04. 2023 F22452000526 DT. 30.04.2 023 F22452000553 DT. 04.05.20 23 F22452000558 DT. 04.05.202 3 F22452000560 DT. 04.05.2023 S/BILL NO: 9774446 DT 05-MAY -2023 S/BILL NO: 9774447 DT 0 5-MAY-2023 S/BILL NO: 9774453 DT 05-MAY-2023 S/BILL NO: 97 74455 DT 05-MAY-2023 S/BILL N O: 9774456 DT 05-MAY-2023 S/B ILL NO: 9774457 DT 05-MAY-2023 NET WT.4880.04 00 DATA LOGG ERS HUMIDITY:65% SET TEMPERA TURE : +18 DEGREES TEMPERATUR E RANGE : +15 DEGREES TO +25 D EGREES NOTIFY PARTY:2 SHOROU Q COMMODITIES TRADING DMCC UN IT NO. 98, DMCC BUSINESS CENTR E, LEVEL NO. 8, JEWELLERY & G EMPLEX 2, DUBAI DUBAI UTD.A RAB EMIR. |
HS 614000 |
2023-05-30 |
27 PKG |
5966.65KG |
27 PALLETS 452 CARTONS PHARMACEUTICALS AS UNDER MUPIROCIN OINT 2% 22GM NDC CO DE:68462018022 FDA PRODUCT CO DE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL MUPIROCIN OI NT 2% 22GM NDC CODE:684620180 22 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.9 0.92.45 ANDA NO.: 90-480 THE RAPEUTICE USE: - ANTI-BACTERI AL MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PROD UCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 AND A NO.: 90-480 THERAPEUTICE US E: - ANTI-BACTERIAL COMMER CIAL & CUSTOM INVOICE NO. F22 452000504 DT. 30.04.2023 F224 52000505 DT. 30.04.2023 F2245 2000517 DT. 30.04.2023 S/BILL NO: 9744393 DT 03-MAY-2023 S/BILL NO: 9744396 DT 03 -MAY-2023 S/BILL NO: 9746492 DT 03-MAY-2023 NET WT. 4837.4 8 00 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 SHOROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DM CC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DU BAI DUBAI UTD.ARAB EMIR. |
HS 618100 |
2023-05-30 |
17 PKG |
5342.95KG |
17 PALLETS 1248 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 800MG 500 NDC CO DE:68462012705 FDA PRODUCT CO DE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT GABAPEN TIN TAB 600MG 500 NDC CODE:68 462012605 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-66 2 THERAPEUTICE USE:-ANTICONV ULSANT AGENT TOPIRAMATE TA B 50MG 500 NDC CODE:684620153 05 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.4 9.00.20 ANDA NO.:077627 THER APEUTICE USE: ANTICONVULSANT OXCARBAZEPINE TAB 300MG 100 NDC CODE:68462013801 FDA PR ODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 A NDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE N O. F22452000474 DT. 29.04.202 3 F22452000515 DT. 30.04.2023 F22452000490 DT. 30.04.2023 S/BILL NO: 9743588 DT 03-MAY- 2023 S/BILL NO: 9746473 DT 03 -MAY-2023 S/BILL NO: 9746479 DT 03-MAY-2023 NET WT.4465.27 1 01 DATA LOGGERS HUMIDITY:6 5% SET TEMPERATURE : +18 DEGR EES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 616900 |
2023-05-30 |
3 PKG |
592.4KG |
3 PALLETS 125 CARTONS P HARMACEUTICALS AS UNDER ESO MEPRAZOLE MAG DR CAP 40MG 1000 NDC CODE:68462039110 FDA PR ODUCT CODE NO.: 62TCC06 H. T . S NO.: 3004.90.9260 ANDA N O.: 209495 THERAPEUTICE USE: :#ESOMEPRAZOLE MAGNESIUM DE LAYED-RELEASE CAPSULES ARE I NDICATED FOR THE LONG-TERM TR EATMENT OF PATHOLOGICAL HYPE RSECRETORY CONDITIONS, INCLUD ING ZOLLINGER-ELLISON SYNDRO ME ESOMEPRAZOLE MAG DR CAP 40MG 90 NDC CODE:68462039190 FDA PRODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004.90.92 60 ANDA NO.: 209495 THERAP EUTICE USE: ESOMEPRAZOLE MAG NESIUM DELAYED-RELEASE CAPSU LES ARE INDICATED FOR THE LO NG-TERM TREATMENT OF PATHOLOG ICAL HYPERSECRETORY CONDITIO NS, INCLUDING ZOLLINGER-ELLIS ON SYNDROME S/BILL NO: 400 6455 DT: 04.05.2023 S/BILL NO : 4006454 DT: 04.05.2023 CO MMERCIAL & CUSTOM INVOICE NO. F22487000197 DT. 03.05.2023 F22487000199 DT. 03.05.2023 N ET WT.270.35 3 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEU CHATEL - 2000 SWITZERLAND |
HS 620600 |
2023-05-30 |
38 PKG |
9240.29KG |
38 PALLETS 1951 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT TACROLIMUS CAP 5MG 100 NDC CODE:6846206 8701 HTS NO: 3004.90.92.15 F DA CODE : 64 T C E 08 ANDA NO .206662 THERAPEUTICE USE: TO PREVENT REJECTION OF A KIDNE Y, HEART, OR LIVER TRANSPLANT TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DERM ATITIS (ECZEMA). PROPAFENO NE HCL ER CAP 225MG 60 NDC CO DE:68462040860 FDA PRODUCT CO DE NO.: 63 E C F 28 H. T. S NO.: 3004.49.00.10 ANDA NO.: 205268 THERAPEUTICE USE:AN A NTIARRHYTHMIC AGENT. IT IS US ED TO TREAT IRREGULAR HEART R HYTHM AND CAN SLOW RAPID HE ARTBEATS PROPAFENONE HCL ER CAP 325MG 60 NDC CODE:684620 40960 FDA PRODUCT CODE NO.: 63 E C F 28 H. T. S NO.: 300 4.49.00.10 ANDA NO.: 205268 THERAPEUTICE USE: -AN ANTIARR HYTHMIC AGENT IT IS USED TO T REAT IRREGULAR HEARTRHYTHM AN D CAN SLOW RAPID HEARTBEATS TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PROD UCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 AND A NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERMAT ITIS (ECZEMA). DILTIAZEM H CL ER CAP 12HR 60MG 100 NDC C ODE:68462085001 62 O C B 24 3004.49.00.10 212317 FOR THE TREATMENT OF HYPERTENSION. CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA N O.:- 78-251 THERAPEUTICE USE :-BETA- ADRENOACEPTOR ANTAGO NIST POTASSIUM CL ER CAP 10 MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92 .90 ANDA NO.:202868 THERAPEU TICE USE: - TREATMENT OR PREV ENTION OF HYPOKALEMIA CAR VEDILOL TAB 25MG 500 NDC CODE :68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F22487000167 DT. 30.04.2 023 F22487000172 DT. 30.04.20 23 F22487000178 DT. 30.04.202 3 F22487000179 DT. 30.04.2023 F22487000180 DT. 30.04.2023 F22487000181 DT. 30.04.2023 F22487000186 DT. 30.04.2023 S/BILL NO: 4006447 DT: 04.05. 2023 S/BILL NO: 4006448 DT: 0 4.05.2023 S/BILL NO: 4006449 DT: 04.05.2023 S/BILL NO: 400 6450 DT: 04.05.2023 S/BILL NO : 4006451 DT: 04.05.2023 S/BI LL NO: 4006453 DT: 04.05.2023 S/BILL NO: 4006452 DT: 04.05. 2023 NET WT.6487.98 00 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2023-05-30 |
2 PKG |
352.45KG |
2 PALLETS 192CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 5MG 1000 NDC CODE: 68462026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 79 172 THERAPEUTICE USE: TO TRE AT HIGH CHOLESTEROL AND RELAT ED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE. C OMMERCIAL & CUSTOM INVOICE NO. F22452000509 DT. 30.04.2023 S/BILL NO: 9746493 DT 03-MAY- 2023 NET WT. 290.300 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWITZER LAND |
HS 611600 |
2023-05-24 |
6 PKG |
1366.7KG |
6 PALLETS 219 CARTONS PHARMA CEUTICALS AS UNDER CALCIPO TRIENE OINT 0.005% 60GM N DC CODE:68462031065 FDA P RODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 300 4.90.92.45 ANDA NO.: 2092 97 THIS MEDICATION IS USE D TO TREAT PSORIASIS. CALCIPOTRIENE IS A FORM OF VITAMIN D. IT WORKS BY SLOWING DOWN THE GROWTH OF SKIN CELLS. CAL CIPOTRIENE OINT 0.005% 120GM NDC CODE:68462031066 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 090633 THERAPEUTICE USE: :#THIS MEDICATION IS USE D TO TREAT PSORIASIS .CALCIPOTRIENE IS A FORM OF VITAMIN D. IT WORKS BY SLOWING DOWN THE GROWTH OF SKIN CELLS IMIQUIMOD CREAM 5% 0.25GM 24 NDC CODE:68462053670 FDA PRODUCT CODE NO.: 62 V C J 29 H. T. S NO.: 3004.49.00.50 ANDA NO.: 201994 THERAPEUTICE USE: - INDICATED FOR ACTINIC KERATOSES AND EXTERNAL GENITAL AND PERIANAL WA RTS 00 DATA LOGGERS HUMIDITY:65% COMMERCIAL & CUSTOM INVOICE NO . F22452000291 DT. 22.04. 2023 F22452000292 DT. 22. 04.2023 F22452000303 DT. 23.04.2023 S/BILL NO:94 80663 DT:22.04.2023 S/BILL NO : 9480662 DT:22.04.2023 S/BIL L NO: 9515435 DT:24.04.2023 |
HS 620400 |
2023-05-24 |
44 PKG |
10875.97KG |
44 PALLETS 3925 CARTONS PHARMACEUTICALS AS UNDER TOPIRAMATE TAB 100MG 60 NDC C ODE:68462010960 FDA PRODUCT C ODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :- 77-627 THERAPEUTICE USE:- ANTICONVULSANT NAPROXEN TAB 375MG 100 NDC CODE:684620189 01 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:-78-250 THE RAPEUTICE USE:-ANTI-INFLAMMAT ORY, ANALGESIC LITHIUM CAR B CAP 150MG 100 NDC CODE:6846 2022001 FDA PRODUCT CODE NO. :-61 N C E 37 H. T. S NO.: 3 004.49.00.20 ANDA NO.:- 79 -1 39 THERAPEUTICE USE:-ANTIMAN IC AGENT TOPIRAMATE TAB 100 MG 500 NDC CODE:68462010905 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00 .20 ANDA NO.: 77627 THERAPEU TICE USE: :#ANTICONVULSANT MOEXIPRIL HCL TAB 7.5MG 100 NDC CODE:68462020901 FDA PROD UCT CODE NO.:62 O C A 47 H. T. S NO.: 3004.49.00.10 ANDA NO.:-90-416 THERAPEUTICE US E:-ANTIHYPERTENSIVE AGENT-ACE INHIBITOR OXCARBAZEPINE TA B 150MG 100 NDC CODE:68462013 701 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004. 90.92.30 ANDA NO.:-77-802 TH ERAPEUTICE USE:-ANTI CONVULSA NT AGENT NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FD A PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:-78-250 THERAPEUT ICE USE:-ANTI-INFLAMMATORY, ANALGESIC LITHIUM CARB ER T AB 300MG 100 NDC CODE:6846202 2301 FDA PRODUCT CODE NO.: 6 1 N C B 37 H. T. S NO.: 3004 .49.00.20 ANDA NO.:91-544 TH ERAPEUTICE USE: - INDICATED I N THE TREATMENT OF MANIC EPI SODES OF BIPOLAR DISORDER. B IPOLAR DISORDER, MANIC (DSM-I V) IS EQUIVALENT TO MANIC DEP RESSIVE ILLNESS, MANIC, IN TH E OLDER DSM-II TERMINOLOGY. A LSO INDICATED AS A MAINTENAN CE TREATMENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR DISORDER. MAINTENANCE THERAPY REDUCES THE FREQUENCY OF MA NIC EPISODES AND DIMINISHES T HE INTENSITY OF THOSE EPISOD ES WHICH MAY OCCUR. OXCAR BAZEPINE TAB 150MG 100 NDC CO DE:68462013701 FDA PRODUCT CO DE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-802 THERAPEUTICE USE:-ANT I CONVULSANT AGENT VERAPAM IL HCL ER TAB 240MG 100 NDC C ODE:68462026001 FDA PRODUCT C ODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO. :-78-906 THERAPEUTICE USE:-A NGINA LIDOCAINE OINT JAR 5% 50GM NDC CODE:68462041827 F DA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.5 0 ANDA NO.:206498 THERAPEUTI CE USE: -USED TO TEMPORARILY RELIEVE PAIN AND ITCHING ASS OCIATED WITH SKIN PRAMIPEXO LE TAB 1.5MG 90 NDC CODE:6846 2033490 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3 004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN P ARKINSON#S DISEASE OLMESART AN MEDOX TAB 5MG 30 NDC CODE: 68462043630 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3 004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE: - -TREATME NT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSU RE 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES COMMERCIAL & CUSTOM INVO ICE NO. F22452000254 DT. 19.0 4.2023 F22452000271 DT. 20.04 .2023 F22452000272 DT. 20.04. 2023 F22452000286 DT. 21.04.2 023 F22452000304 DT. 22.04.20 23 F22452000305 DT. 22.04.202 3 F22452000324 DT. 23.04.2023 F22452000314 DT. 23.04.2023 S/BILLNO: 9515391 DT:24.04. 203 S/BILL NO: 9522730 DT. 25 .04.2023 S/BILL NO: 9515385 D T:24.04.2023 S/BILL NO: 95153 92 DT:24.04.2023 S/BILL NO: 9 522729 DT.25.04.2023 S/BILL N O :9518250 DT:24.04.2023 S/ BILL NO: 9518251 DT:24.04.2023 S/BILL NO : 9518254 DT:24.04 .2023 |
HS 624900 |
2023-05-24 |
4 PKG |
472.65KG |
4 PALLETS 155 CARTONS PHA RMACEUTICALS AS UNDER DROSP IRENONE/EE TAB 3/0.02MG 84 ND C CODE:68462072029 FDA PRODUC T CODE NO.: 65 J D A 39 H. T . S NO.: 3006.60.00.00 ANDA NO.: 204296 THERAPEUTICE USE: - ORAL CONTRACEPTIVE NET WT:319.92 KGS 01 DATA LOG GERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & CU STOM INVOICE NO. F22452000407 DT. 27.04.2023 S/BILL NO:963 4805 DT:28.04.2023 NOTIFY P ARTY:2 SHOROUQ COMMODITIES TR ADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 653900 |
2023-05-24 |
27 PKG |
5993.42KG |
27 PALLETS 1796 CARTONS P HARMACEUTICALS AS UNDER RAN OLAZINE ER TAB 500MG 60 NDC C ODE:68462031960 FDA PRODUCT C ODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO. :211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDICATI ON. IT WORKS BY IMPROVING BLO OD FLOW TO HELP THE HEART WOR K MORE EFFICIENTLY. IT IS USE D TO TREAT CHRONIC ANGINA (C HEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA RANOLAZIN E ER TAB 1000MG 60 NDC CODE:6 8462032060 FDA PRODUCT CODE N O.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.:2110 82 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDICATION. I T WORKS BY IMPROVING BLOOD FL OW TO HELP THE HEART WORK MOR E EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURI NG AN ACUTE (EMERGENCY) ATTAC K OF ANGINA EZETIMIBE-SIMV A TAB 10/40MG 30 NDC CODE:684 62032330 FDA PRODUCT CODE NO. : 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 20869 9 THERAPEUTICE USE: - THIS C OMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTERO L AND FATS (SUCH AS LDL, TRI GLYCERIDES) AND RAISE GOOD CH OLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YO UR BODY ABSORBS FROM YOUR DIE T. SIMVASTATIN BELONGS TO A G ROUP OF DRUGS KNOWN AS STATI NS. IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE BY THE LIVER. TOPIRAMATE ER CAP (Q) 25MG 30 NDC CODE:684 62037230 3004.49.00.20 61 M C B 40 210278 RUFINAMIDE T AB 400MG 120 NDC CODE:6846207 1408 61 M C A 99 3004.90.92. 30 205075 TO USED WITH OTHER MEDICATIONS TO PREVENT OR C ONTROL SEIZURES (EPILEPSY) A SSOCIATED WITH LENNOX-GASTAUT SYNDROME (LGS FENOFIBRATE CAP 200MG 100 NDC CODE:68462 058201 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.: 205566 T HERAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND A PO B IN DULT PATIENTS WITH P RMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA CARVED ILOL TAB 12.5MG 500 NDC CODE: 68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST EZETIMIBE-SIMVA TAB 10/40MG 90 NDC CODE:68462032390 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTIC E USE: :#LIPID LOWERING AGENT TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DERM ATITIS (ECZEMA). 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREE S TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES COM MERCIAL & CUSTOM INVOICE NO. F22487000139 DT. 26.04.2023 F 22487000141 DT. 26.04.2023 F2 2487000142 DT. 26.04.2023 S /BILL NO:4005995 DT:27.04.2023 S/BILL NO:4005998 DT:27.04.2 023 S/BILL NO:4006001 DT:27.0 4.2023 NET WT.:2452.388 NO TIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 610200 |
2023-05-24 |
50 PKG |
13750.88KG |
50 PALLETS 2943 CARTONS PHAR MACEUTICALS AS UNDER MUPIRO CIN OINT 2% 22GM NDC CODE:684 62018022 FDA PRODUCT CODE NO. : 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-48 0 THERAPEUTICE USE: - ANTI-B ACTERIAL NAPROXEN TAB 500MG 5 00 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTIC E USE:-ANTI-INFLAMMATORY, AN ALGESIC OXCARBAZEPINE TAB 300 MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92 .30 ANDA NO.:-77-802 THERAPE UTICE USE:-ANTI CONVULSANT AG ENT LAMOTRIGINE TAB CD 25MG 1 00 NDC CODE:68462022901 FDA PRODUCT CODE NO.:- 61 M C A 3 8 H. T. S NO.: 3004.90.92.30 ANDA NO.:-79 # 099 THERAPEU TICE USE:- ANTICONVULSANT NA PROXEN TAB 500MG 500 NDC CODE :68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC CAR VEDILOL TAB 3.125MG 500 NDC C ODE:68462016205 FDA PRODUCT C ODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO. :- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST OXCARBAZEPINE TAB 300MG 10 0 NDC CODE:68462013801 FDA P RODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.9092.30 A NDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT N ET WT::11771.69 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2245200 0409 DT. 27.04.2023 F22452000 405 DT. 27.04.2023 F224520004 06 DT. 27.04.2023 F2245200039 7 DT. 26.04.2023 F22452000384 DT. 26.04.2023 F22452000385 DT. 26.04.2023 F22452000386 D T. 26.04.2023 S/BILL NO:963 4815 DT:28.04.2023 S/BILL NO: 9634808 DT:28.04.2023 S/BILL NO:9634814 DT:28.04.2023 S/BI LL NO:9636651 DT:28.04.2023 S /BILL NO:9634817 DT:28.04.2023 S/BILL NO:9634804 DT:28.04.2 023 S/BILL NO:9634813 DT:28.0 4.2023 NOTIFY PARTY:2 SHOR OUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CEN TRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD .ARAB EMIR. |
HS 618100 |
2023-05-24 |
2 PKG |
373.31KG |
02 PALLETS 127 CARTONS PHAR MACEUTICALS AS UNDER ROSUVAST ATIN TAB 10MG 1000 NDC CODE:6 8462026210 61 J C A 16 3004. 49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED COND ITIONS, AND TO PREVENT CARDI OVASCULAR DISEASE NET WT 3 25.122 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGRE ES CONTAINER NO. MNBU02576 72 COMMERCIAL & CUSTOM INVOI CE NO. F22452000391 DT. 26.04 .2023 S/BILL NO:9634818 DT:28 .04.2023 NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZ ERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERL AND |
HS 271019 |
2023-05-24 |
36 PKG |
5627.36KG |
36 PALLETS 2160 CARTONS PH ARMACEUTICALS AS UNDER ESTR ADIOL VAG INSERTS 10MCG 8 NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA N O.:210264 THERAPEUTICE USE:TH E TREATMENT OF ATROPIC VAGIN ITIS DUE TO MENOPAUSE. NET W T:4199.04 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES COMMERCIAL & CUSTOM I NVOICE NO. F22452000408 DT. 2 7.04.2023 S/BILL NO:9638615 DT:29.04.2023 NOTIFY PARTY :2 SHOROUQ COMMODITIES TRADIN G DMCC UNIT NO. 98, DMCC BUSI NESS CENTRE, LEVEL NO. 8, JEW ELLERY & GEMPLEX 2, DUBAI DU BAI UTD.ARAB EMIR. |
HS 642800 |
2023-05-24 |
40 PKG |
6581.74KG |
40 PALLETS 1961 CARTONS PHARMACEUTICALS AS UNDER NORG EST/EE TAB .18,.215,.25/.035MG 84 NDC CODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 2 7 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200494 THERAPEUTI CE USE: - ORAL CONTRACEPTIVES DROSPIRENONE/EE TAB 3/0.02 MG 84 NDC CODE:68462072029 F DA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00. 00 ANDA NO.: 204296 THERAPEU TICE USE: - ORAL CONTRACEPTIV E 02 DATA LOGGERS SET TE MPERATURE : +18 DEGREES C OMMERCIAL & CUSTOM INVOICE NO. F22452000387 DT. 26.04.2023 F22452000402 DT. 27.04.2023 S/BILL NO:9600727 DT:27.04. 2023 S/BILL NO:9602152 DT:27. 04.2023 NET WT:4723.27KGS NOTIFY PARTY:2 SHOROUQ COMMO DITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEV EL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMI R. |
HS 652700 |
2023-05-24 |
17 PKG |
4013KG |
17 PALLETS 1251 CARTONS PHARMACEUTICALS AS UNDER SO LIFENACIN SUCCINATE TAB 10MG 3 0 NDC CODE:68462038730 FDA PRODUCT CODE NO.: 61 KCA 72 H. T. S NO.: 30 04 49 00 70 ANDA NO. : 209239 INDICATED FOR TH E TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONT INENCE, URGENCY AND URINA RY FREQUENCY SOLIFE NACIN SUCCINATE TAB 10MG 90 NDC CODE:68462038790 F DA PRODUCT CODE NO.: 61 K CA 72 H. T. S NO.: 3004 4 9 00 70 ANDA NO.: 20 9239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS O F URGE URINARY INCONTINEN CE, URGENCY AND URINARY F REQUENCY NITROGLYCE RIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FD A PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206 391 THERAPEUTIC USE: -MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRE SSURE,AND TO TREAT AND PR EVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART ESOMEPRAZOLE MAG DR CAP 40MG 30 NDC C ODE:68462039130 FDA PRODU CT CODE NO.: 62 T C C 06 H. T. S NO.: 3004.90.92 60 ANDA NO.: 209495 THERAPEUTICE USE: ESO MEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR THE LONG-TERM TREATMENT OF PATHOLOGICAL HYPERSECRETO RY CONDITIONS, INCLUDING ZOLLINGER-ELLISON SY NDROME 17 DAT A LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGRE ES TEMPERATURE RANGE : +1 5 DEGREES TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22487000140 DT. 26.04.20 23 F22487000143 DT. 26.04.202 3 S/BILL NO:4005991 DT:27.0 4.2023 S/BILL NO:400600 DT:27 .04.2023 NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 617200 |
2023-05-24 |
12 PKG |
3356.64KG |
12 PALLETS 759 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TAB 600MG 500 NDC COD E:68462012605 FDA PRODUCT COD E NO: 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-662 THERAPEUTICE USE:-ANTI CONVULSANT AGENT PRAVASTAT IN SOD TAB 40MG 500 NDC CODE: 68462019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO. : 3004.90.92.20 ANDA NO.: 77 -987 THERAPEUTICE USE: -HYPO LIPDAEMIC ROSUVASTATIN TAB 10MG 1000 NDC CODE:6846202621 0 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLESTE ROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE INV NO:F2245200042 0 DT. 27.04.2023 INV NO:F2245 2000432 DT. 28.04.2023 INV NO :F22452000430 DT. 28.04.2023 S/BILL NO:9653726 DT:29.04.2 023 S/BILL NO:9659605 DT:29.0 4.2023 S/BILL NO:9659625 DT:2 9.04.2023 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NET WT:2982. 885 NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 S WITZERLAND |
HS 611300 |
2023-05-24 |
33 PKG |
7262.14KG |
33 PALLETS 1826 CARTONS PH ARMACEUTICALS AS UNDER NAPR OXEN TAB 500MG 500 NDC CODE:6 8462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 250 THERAPEUTICE USE:-ANTI-I NFLAMMATORY, ANALGESIC LIT HIUM CARB CAP 150MG 100 NDC C ODE:68462022001 FDA PRODUCT C ODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO. :- 79 -139 THERAPEUTICE USE: -ANTIMANIC AGENT ONDANSETRO N ODT 8MG 10UD NDC CODE:68462 015811 FDA PRODUCT CODE NO.: -61 T C A 26 H. T. S NO.: 30 04.90.92.40 ANDA NO.:-78-152 THERAPEUTICE USE:-ANTI -EMET IC OXCARBAZEPINE TAB 150MG 100 NDC CODE:68462013701 FDA PRODUCT CODE NO.:-61 M C A 4 5 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTI CE USE:-ANTI CONVULSANT AGENT ONDANSETRON ODT 8MG 30UD NDC CODE:68462015813 FDA PROD UCT CODE.:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-152 THERAPEUTICE USE:- ANTI -EMETIC PRAVASTATIN S OD TAB 40MG 500 NDC CODE:6846 2019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3 004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: -HYPOLIPD AEMIC OXCARBAZEPINE TAB 150 MG 100 NDC CODE:68462013701 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92 .30 ANDA NO.:-77-802 THERAPE UTICE USE:-ANTI CONVULSANT AG ENT IMIQUIMOD CREAM 5% 0.25 GM 24 NDC CODE:68462053670 F DA PRODUCT CODE NO.: 62 V C J 29 H. T. S NO.: 3004.49.00. 50 ANDA NO.:201994 THERAPEUT ICE USE: - INDICATED FOR ACTI NIC KERATOSES AND EXTERNAL G ENITAL AND PERIANAL WARTS MUPIROCIN OINT 2% 22GM NDC CO DE:68462018022 FDA PRODUCT CO DE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL 02 DATA LOGG ERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES COMM ERCIAL & CUSTOM INVOICE NO. F 22452000417 DT. 27.04.2023 F2 2452000418 DT. 27.04.2023 F22 452000419 DT. 27.04.2023 F224 52000429 DT. 28.04.2023 F2245 2000434 DT. 28.04.2023 F22452 000416 DT. 27.04.2023 F224520 00438 DT. 28.04.2023 S/BI LL NO:9668234 DT:29.04.2023 S /BILL NO:9655968 DT 29-04-2023 S/BILL NO:9653733 DT:29..04. 2023 S/BILL NO:9667811 DT:29. 04.2023 S/BILL NO:9653743 DT: 29.04.2023 S/BILL NO:9653709 DT:29.04.2023 S/BILL NO:96537 47 DT:29.04.2023 NOTIFY PAR TY:2 SHOROUQ COMM ODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO . 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EM IR. |
HS 624900 |
2023-05-16 |
13 PKG |
2952.94KG |
13 PALLETS 1741 CARTONS PHARMACEUTICALS AS UNDER R OSUVASTATIN TAB 5MG 90 NDC C ODE:68462026190 FDA PRODUCT C ODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOIC E NO. F22452000215 DT. 18.04. 2023 NET WT.2231.30 13 DATA LOGGERS S/BILL NO: 9413978 DT: 19-APR-23 NOTIFY PARTY: 2 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE NUMA-D ROZ 2 NEUCHATEL - 2000 SWITZ ERLAND |
HS 290719 |
2023-05-16 |
37 PKG |
9878.95KG |
37 PALLETS 3082 CARTONS PHARMACEUTICALS AS UNDER NAPROXEN TAB 500MG 500 NDC C ODE:68462019005 FDA PRODUCT C ODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO. :-78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY, ANALGESIC OMEPRAZOLE DR CAP 40MG 100 NDC CODE:68462039701 FDA PROD UCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO. : 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOP HAGEAL REFLUX DISEASE TOPI RAMATE TAB 50MG 60 NDC CODE:6 8462015360 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77 -627 THERAPEUTICE USE:-ANTIC ONVULSANT VERAPAMIL HCL ER TAB 180MG 500 NDC CODE:684620 29305 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 300 4.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - -ANGINA TELMISARTAN TAB 80MG 30 NDC CODE:68462020130 HTS NO : 30 04.90.92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAP EUTICE USE : INDICATED FOR TH E TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE L ITHIUM CARB ER TAB 300MG 100 NDC CODE:68462022301 FDA PROD UCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00.20 AND A NO.:91-544 THERAPEUTICE USE : - INDICATED IN THE TREATME NT OF MANIC EPISODES OF BIPO LAR DISORDER. BIPOLAR DISORDE R, MANIC (DSM-IV) IS EQUIVALE NT TO MANIC DEPRESSIVE ILLNES S, MANIC, IN THE OLDER DSM-I I TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT FOR INDIVIDUALS WITH A DIAGNO SIS OF BIPOLAR DISORDER. MAI NTENANCE THERAPY REDUCES THE FREQUENCY OF MANIC EPISODES A ND DIMINISHES THE INTENSITY OF THOSE EPISODES WHICH MAY OCCUR. TOPIRAMATE TAB 50MG 500 NDC CODE:68462015305 FD A PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:077627 THERAPEUTI CE USE: ANTICONVULSANT TEL MISARTAN TAB 80MG 30 NDC CODE :68462020130 HTS NO : 3004.90 .92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAPEUTIC E USE : INDICATED FOR THE TR EATMENT OF HYPERTENSION, TO L OWER BLOOD PRESSURE COMMER CIAL & CUSTOM INVOICE NO. F22 452000161 DT. 14.04.2023 F224 52000160 DT. 14.04.2023 F2245 2000184 DT. 16.04.2023 F22452 000185 DT. 16.04.2023 F224520 00170 DT. 15.04.2023 S/BILL N O: 9355869 DT 17-APR-2023 S /BILL NO: 9355909 DT 17-APR-2 023 S/BILL NO: 9355875 DT 17 -APR-2023 S/BILL NO: 9355868 DT 17-APR-2023 S/BILL NO: 9 355912 DT 17-APR-2023 NET WT. 8363.00 KGS 01 DATA LOGGERS NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADING DMCC UNI T NO. 98, DMCC BUSINESS CENTRE , LEVEL NO. 8, JEWELLERY & GE MPLEX 2, DUBAI DUBAI UTD.AR AB EMIR. |
HS 300490 |
2023-05-16 |
39 PKG |
6144.01KG |
39 PALLETS 2159 CARTONS PHARMACEUTICALS AS UNDER ES TRADIOL VAG INSERTS 10MCG 8 N DC CODE:68462071171 FDA PRODU CT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE: THE TREATMENT OF ATROPIC VAG INITIS DUE TO MENOPAUSE. N ORETHINDRONE TAB 0.35MG 84 ND C CODE:68462030529 FDA PRODUC T CODE NO.: 65 J C A 26 H. T . S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTION OF PREGNANCY. C OMMERCIAL & CUSTOM INVOICE NO. F22452000203 DT. 17.04.2023 F22452000191 DT. 17.04.2023 S/BILL NO: 9365391 DT 18-APR-2 023 S/BILL NO: 9365423 DT 18 -APR-2023 NET WT.4337.04 02 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 SHOROUQ COMMODITIES TRADI NG DMCC UNIT NO. 98, DMCC BUS INESS CENTRE, LEVEL NO. 8, JE WELLERY & GEMPLEX 2, DUBAI D UBAI UTD.ARAB EMIR. |
HS 642800 |
2023-05-16 |
32 PKG |
4650.31KG |
32 PALLETS 1052 CARTONS PHARMACEUTICALS AS UNDER NO RGEST/EE TAB 0.25/0.035MG 84 NDC CODE:68462030929 FDA PRO DUCT CODE NO.: 65 J D A 27 H . T. S NO.: 3006.60.00.00 AN DA NO.: 200538 THERAPEUTICE U SE: - ORAL CONTRACEPTIVES LEVONORGESTREL/EE TAB 0.15/0.0 3MG 273 NDC CODE:68462067295 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0 000 ANDA NO.: 203164 THERAPE UTICE USE: - CONTRACEPTION TO PREVENT PREGNANCY COMMERC IAL & CUSTOM INVOICE NO. F224 52000246 DT. 19.04.2023 F2245 2000244 DT. 19.04.2023 NET WT .3482.88 KGS 01 DATA LOGGER S S/BILL NO: 9430367 DT 20- APR-2023 S/BILL NO: 9430384 D T 20-APR-202 NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINE SS CENTRE, LEVEL NO. 8, JEWEL LERY & GEMPLEX 2, DUBAI DUBA I UTD.ARAB EMIR. |
HS 652700 |
2023-05-16 |
30 PKG |
7424.52KG |
30 PALLETS 2361 CARTONS PHARMACEUTICALS AS UNDER LI THIUM CARB ER TAB 300MG 100 NDC CODE:68462022301 FDA PROD UCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00.20 AND A NO.:91-544 THERAPEUTICE USE : - INDICATED IN THE TREATME NT OF MANIC EPISODES OF BIPO LAR DISORDER. BIPOLAR DISORDE R, MANIC (DSM-IV) IS EQUIVALE NT TO MANIC DEPRESSIVE ILLNES S, MANIC, IN THE OLDER DSM-I I TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT FOR INDIVIDUALS WITH A DIAGNO SIS OF BIPOLAR DISORDER. MAI NTENANCE THERAPY REDUCES THE FREQUENCY OF MANIC EPISODES A ND DIMINISHES THE INTENSITY OF THOSE EPISODES WHICH MAY OCCUR. TOPIRAMATE TAB 50MG 60 NDC CODE:68462015360 FDA PRODUCT CODE NO.:-61 M C A 4 0 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUT ICE USE:-ANTICONVULSANT RO PINIROLE TAB 0.25MG 100 NDC C ODE:68462025301 FDA PRODUCT C ODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO. :- 90-135 THERAPEUTICE USE:- TREATMENT OF PARKINSONISM NAPROXEN TAB 375MG 500 NDC CO DE:68462018905 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC LITHIUM CARB ER TAB 300MG 100 NDC CODE:68462022301 FDA PR ODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00.20 A NDA NO.:91-544 THERAPEUTICE U SE: - INDICATED IN THE TREAT MENT OF MANIC EPISODES OF BI POLAR DISORDER. BIPOLAR DISOR DER, MANIC (DSM-IV) IS EQUIVA LENT TO MANIC DEPRESSIVE ILLN ESS, MANIC, IN THE OLDER DSM -II TERMINOLOGY. ALSO INDICAT ED AS A MAINTENANCE TREATMEN T FOR INDIVIDUALS WITH A DIAG NOSIS OF BIPOLAR DISORDER. M AINTENANCE THERAPY REDUCES TH E FREQUENCY OF MANIC EPISODES AND DIMINISHES THE INTENSITY OF THOSE EPISODES WHICH MA Y OCCUR. ROPINIROLE TAB 0. 25MG 100 NDC CODE:68462025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90. 92.40 ANDA NO.:- 90-135 THER APEUTICE USE:-TREATMENT OF P ARKINSONISM VERAPAMIL HCL E R TAB 240MG 500 NDC CODE:6846 2026005 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3 004.90.92.20 ANDA NO.:-78-906 THERAPEUTICE USE:-ANGINA IMIQUIMOD CREAM 5% 0.25GM 24 NDC CODE:68462053670 FDA PRO DUCT CODE NO.: 62 V C J 29 H . T. S NO.: 3004.49.00.50 AN DA NO.:201994 THERAPEUTICE US E: - INDICATED FOR ACTINIC K ERATOSES AND EXTERNAL GENITAL AND PERIANAL WARTS COMMER CIAL & CUSTOM INVOICE NO. F22 452000201 DT. 17.04.2023 F224 52000202 DT. 17.04.2023 F2245 2000217 DT. 18.04.2023 F22452 000218 DT. 18.04.2023 F224520 00219 DT. 18.04.2023 NET WT.6 201.57 02 DATA LOGGERS NOTIFY PARTY:2 SHOROUQ COMMOD ITIES TRADING DMCC UNIT NO. 9 8, DMCC BUSINESS CENTRE, LEVE L NO. 8, JEWELLERY & GEMPLEX 2 , DUBAI DUBAI UTD.ARAB EMIR . S/BILL NO: 9413980 DT:19- APR-23 S/BILL NO: 9413983 DT: 19-APR-23 S/BILL NO: 9413985 DT:19-APR-23 S/BILL NO: 94139 77 DT:19-APR-23 S/BILL NO: 94 13973 DT:19-APR-23 |
HS 613700 |
2023-05-16 |
6 PKG |
1237.87KG |
6 PALLETS 602 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 5MG 90 NDC CODE:6 8462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 0791 72 THERAPEUTICE USE: - TO TR EAT HIGH CHOLESTEROL AND RELA TED CONDITIONS, AND TO PREVEN T CARDIOVASCULAR DISEASE R OSUVASTATIN TAB 20MG 1000 NDC CODE:68462026310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 79172 THERAPEUTICE USE: T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOIC E NO. F22452000252 DT. 19.04. 2023 S/BILL NO: 9460342 DT 2 1-APR-2023 NET WT.977.54 KGS 06 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 611600 |
2023-05-16 |
36 PKG |
7389.14KG |
36 PALLETS 1189 CARTONS PH ARMACEUTICALS AS UNDER MUPI ROCIN OINT 2% 22GM NDC CODE:6 8462018022 FDA PRODUCT CODE N O.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90- 480 THERAPEUTICE USE: - ANTI -BACTERIAL NORGEST/EE TAB 0 .25/0.035MG 84 NDC CODE:68462 030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 30 06.60.00.00 ANDA NO.: 200538 THERAPEUTICE USE: - ORAL CON TRACEPTIVES LEVONORGESTREL/ EE TAB 0.09/0.02MG 84 NDC COD E:68462063729 FDA PRODUCT COD E NO.: 64 G D A 29 H. T. S N O.: 3006.60.0000 ANDA NO.: 2 02791 THERAPEUTICE USE: - : USED FOR PREVENTING PREGNANCY COMMERCIAL & CUSTOM INVOIC E NO. F22452000253 DT. 19.04. 2023 F22452000276 DT. 21.04.2 023 F22452000277 DT. 21.04.20 23 S/BILL NO: 9459689 DT 21-A PR-2023 S/BILL NO: 9463530 DT 21-APR-2023 S/BILL NO: 94635 19 DT 21-APR-2023 NET WT.5873 .43 KGS 02 DATA LOGGERS NOTIFY PARTY:2 SHOROUQ COMM ODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LE VEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EM IR. |
HS 618100 |
2023-05-09 |
42 PKG |
8275.93KG |
42 PALLETS 2158 CARTONS PH ARMACEUTICALS AS UNDER CLIN DAMYCIN HCL CAP 75MG 100 NDC CODE:68462014201 CLINDAMYCI N HCL CAP 300MG 100 NDC CODE: 68462014401 TOPIRAMATE ER C AP (Q) 100MG 30 NDC CODE:6846 2037430 3004.49.00.20 61 M C B 40 210278 FENOFIBRATE C AP 67MG 100 NDC CODE:68462058 001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90 .92.20 ANDA NO.: 205566 THER APEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET FO R THE REDUCTION OF LDL-C, TO TAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMA RY HYPERCHOLESTEROLEMIA OR M IXED DYSLIPIDEMIA CARVEDILO L TAB 25MG 500 NDC CODE:68462 016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 30 04.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST CHL ORPROMAZINE HCL TAB 10MG 100 NDC CODE:68462086101 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SU CH AS SCHIZOPHRENIA OR MANIC -DEPRESSION IN ADULTS POTA SSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA N O.: 202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA TACROLIMUS CAP 0.5MG 100 NDC CODE:684620685 01 FDA PRODUCT CODE NO.: 64 T C E 08 H. T. S NO.:3004.90 .92.15 ANDA NO.: 206662 THER APEUTICE USE: :#TO PREVENT RE JECTION OF A KIDNEY,TO PREVEN T REJECTION OF A KIDNEY,LIVER TRANSPLANT CLINDAMYCIN HC L CAP 150MG 100 NDC CODE:6846 2014301 TACROLIMUS OINT 0.1 % 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00 .50 ANDA NO.: 210393 THERAPE UTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OI NTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPI C DERMATITIS (ECZEMA). COM MERCIAL & CUSTOM INVOICE NO. F22487000039 DT. 10.04.2023 F 22487000040 DT. 10.04.2023 F2 2487000041 DT. 10.04.2023 F22 487000042 DT. 10.04.2023 F224 87000043 DT. 10.04.2023 F2248 7000044 DT. 10.04.2023 S/BILL NO: 4005171 DT: 11.04.2023 S/BILL NO: 4005175 DT: 11.04. 2023 S/BILL NO: 4005172 DT: 11.04.2023 S/BILL NO: 4005176 DT: 11.04.2023 S/BILL NO: 4 005175 DT: 11.04.2023 S/BILL NO: 4005174 DT: 11.04.2023 NET WT.4254.095 02 DATA LOG GERS HUMIDITY:65% SET TEMPER ATURE : +20 DEGREES TEMPERATU RE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 150100 |
2023-05-09 |
20 PKG |
5371.08KG |
20 PALLETS 906 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT SEVELAM ER HCL TAB 400MG 360 NDC CODE :68462044626 FDA PRODUCT CODE NO.: 63 L D A 04 H. T. S NO .: 3004.90.92.60 ANDA NO.:20 4724 THERAPEUTICE USE:SEVELA MER HYDROCHLORIDE TABLETS AR E A PHOSPHATE BINDER INDICATE D FOR THE CONTROL OF SERUM PH OSPHORUS IN PATIENTS WITH CHR ONIC KIDNEY DISEASE ON DIALY SIS TACROLIMUS OINT 0.1% 30 GM NDC CODE:68462053435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTIC E USE: - TACROLIMUS IS A TOPI CAL IMMUNOSUPPRESSIVE OINTME NT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DE RMATITIS (ECZEMA). NITROGL YCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA PRO DUCT CODE NO.: 66 S C A 28 H . T. S NO.: 3004.90.9020 AND A NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE,A ND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD F LOW TO THE HEART S/BILL NO : 4005246 DT:12/04/2023 S/BIL L NO: 4005248 DT:12/04/2023 S /BILL NO: 4005250 DT:12/04/202 3 S/BILL NO: 4005291 DT:13/04 /2023 COMMERCIAL & CUSTOM INVOICE NO. F22487000052 DT. 12.04.2023 F22487000053 DT. 12.04.2023 F22487000054 DT. 1 2.04.2023 F22487000056 DT. 13 .04.2023 NET WT.3535.65 10 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TE MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY :3 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHA TEL - 2000 SWITZERLAND |
HS 684620 |
2023-05-09 |
23 PKG |
3216.48KG |
23 PALLETS 1059 CARTONS PHARMACEUTICALS AS UNDER N ORETH ACE/EE TAB 1/0.02MG 63 NDC CODE:68462013281 FDA PROD UCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.:206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDO METRIOS IS AND ABNORMAL UTERI NE BLEEDING NORETHINDRONE TAB 0.35MG 84 NDC CODE:684620 30529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 300 6.60.00.00 ANDA NO.:91-209 T HERAPEUTICE USE: PREVENTION O F PREGNANCY. NORETH ACE/EE TAB 0.5MG/2.5MCG 84 NDC CODE: 68462065629 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO. : 3006.60.00.00 ANDA NO.: 20 3038 THERAPEUTICE USE: - TRE ATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS DUE TO ME NOPAUSE; OSTEOPOROSIS PREVENT ION COMMERCIAL & CUSTOM INV OICE NO. F22452000075 DT. 10. 04.2023 F22452000090 DT. 11.0 4.2023 F22452000092 DT. 11.04 .2023 S/BILL NO: 9217643 DT 1 1-APR-2023 S/BILL NO: 9219030 DT 11-APR-2023 S/BILL NO:922 0676 DT 11-APR-2023 NET WT.22 62.67 01 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES NOT IFY PARTY:2 SHOROUQ COMMODIT IES TRADING DMCC UNIT NO. 98 , DMCC BUSINESS CENTRE, LEVE L NO. 8, JEWELLERY & GEMPLEX 2 , DUBAI DUBAI UTD.ARAB E MIR. |
HS 652500 |
2023-05-09 |
19 PKG |
2876.28KG |
19 PALLETS 901 CARTONS PHA RMACEUTICALS AS UNDER HAILE Y 24 FE TAB 1MG/20MCG-75MG 84 NDC CODE:68462073129 FDA PRO DUCT CODE NO.: 65 J D A 25 H . T. S NO.: 3006.60.00.00 AN DA NO.: 204847 THERAPEUTICE U SE: - CONTRACEPTION TO PREVEN T PREGNANCY COMMERCIAL & C USTOM INVOICE NO. F2245200007 3 DT. 10.04.2023 S/BILL NO: 9 198714 DT 11-APR-2023 NET WT. 2054.28 01 DATA LOGGERS HUMI DITY:65% SET TEMPERATURE : +2 0 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA |
HS 652500 |
2023-05-03 |
3 PKG |
611.91KG |
3 PALLETS 87 CARTONS PH ARMACEUTICALS AS UNDER NORETHINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRODUCT CODE NO.65 J C A 2 5 H. T. S NO.: 3004.39.0 0.50 ANDA NO.:-91-090 TH ERAPEUTICE USE:- SECONDARY AMENORRHEA,ENDOMETRIOS I S AND ABNORMAL UTERINE BLEE DING COMMERCIAL & CUST OM INVOICE NO. F22452000048 DT. 06.04.2023 S/BILL NO: 9125851 DT 06-APR-2023 NET WT.525.28 KGS 01 DATA LOGGE RS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652500 |
2023-05-03 |
36 PKG |
5342.95KG |
36 PALLETS 1773 CARTONS PH ARMACEUTICALS AS UNDER NORE TH ACE/EE TAB 1/0.02MG 63 ND C CODE:68462013281 FDA PRODUC T CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 ANDA N O.:206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOME TRIOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIAL & CUS TOM INVOICE NO. F22452000049 DT. 06.04.2023 S/BILL NO: 912 5848 DT 06-APR-2023 NET WT.36 84.24 KGS 01 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADI NG DMCC UNIT NO. 98 , DMCC BUSINESS CENTRE, LEV EL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD. ARAB EMIR. |
HS 652500 |
2023-04-25 |
41 PKG |
6292.34KG |
41 PALLETS 2201 CARTONS PHA RMACEUTICALS AS UNDER HA ILEY 24 FE TAB 1MG/20MCG-75MG 84 NDC CODE:68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204847 THERAPEUTIC E USE: - CONTRACEPTION TO PRE VENT PREGNANCY ESTRADIOL VAG INSERTS 10MCG 8 NDC CODE :68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO .: 3006.60.00.00 ANDA NO.:21 0264 THERAPEUTICE USE:THE TR EATMENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. COMMER CIAL & CUSTOM INVOICE NO. F22 352006155 DT. 28.03.2023 F223 52006156 DT. 28.03.2023 S/BIL L NO: 8913308 DT 29-MAR-2023 S/BILL NO: 8900144 DT 29-MAR- 2023 NET WT.4538.23 KGS 02 D ATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652500 |
2023-04-25 |
40 PKG |
6960.95KG |
40 PALLETS 2210 CARTONS PHARMACEUTICALS AS UNDER NOR GEST/EE TAB .18,.215,.25/.035M G 84 NDC CODE:68462056529 FD A PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.0 0 ANDA NO.: 200494 THERAPEUT ICE USE: - ORAL CONTRACEPTIVE S ESTRADIOL VAG INSERTS 10M CG 8 NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 30 06.60.00.00 ANDA NO.:210264 THERAPEUTICE USE:THE TR EATMENT OF ATROPIC VAGINITI S DUE TO MENOPAUSE. COMM ERCIAL & CUSTOM INVOICE NO. F22352006144 DT. 28.03.2023 F22352006145 DT. 28.03.2023 S/BILL NO: 8889631 DT 28-MA R-2023 S/BILL NO: 8882191 D T 28-MAR-2023 NET WT.5223.6 0 KGS 02 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA |
HS 652700 |
2023-04-25 |
32 PKG |
8435.15KG |
32 PALLETS 1766 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 600MG 500 NDC CO DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT INDOMETH ACIN CAP 25MG 100 NDC CODE:68 462040601 FDA PRODUCT CODE NO .: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO.:91-27 6 THERAPEUTICE USE: -ANTI-IN FLAMATORY INDOMETHACIN CAP 25MG 1000 NDC CODE:6846204061 0 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90 .92.40 ANDA NO.:91-276 THERA PEUTICE USE: -ANTI-INFLAMATOR Y LITHIUM CARB ER TAB 450MG 100 NDC CODE:68462022401 FD A PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:91-616 THERAPEUTI CE USE: - INDICATED IN THE T REATMENT OF MANIC EPISODES O F BIPOLAR DISORDER. BIPOLAR D ISORDER, MANIC (DSM-IV) IS EQ UIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, IN THE OLDER DSM-II TERMINOLOGY. ALSO IND ICATED AS A MAINTENANCE TREA TMENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR DISORDER . MAINTENANCE THERAPY REDUCE S THE FREQUENCY OF MANIC EPIS ODES AND DIMINISHES THE INTEN SITY OF THOSE EPISODES WHICH MAY OCCUR CALCIPOTRIENE O INT 0.005% 60GM NDC CODE:6846 2031065 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 209297 THIS MEDICATION IS USED TO TREAT PSORIASIS. CALCIPOTRIEN E IS A FORM OF VITAMIN D. IT WORKS BY SLOWING DOWN THE GRO WTH OF SKIN CELLS. CICLOPI ROX GEL 0.77% 30GM NDC CODE:6 8462045535 FDA PRODUCT CODE N O.: 61WCJ43 H. T. S NO.: 30 04.49.00.50 ANDA NO.: 091595 THERAPEUTICE USE: - ANTIFUNG AL MUPIROCIN CREAM 2% 15GM NDC CODE:68462056417 FDA PRO DUCT CODE NO.: 61GCJ82 H. T. S NO.: 3004.90.92.45 ANDA N O.: 201587 THERAPEUTICE USE: - TOPICAL ANTI-BACTERIAL C OMMERCIAL & CUSTOM INVOICE NO. F22352006177 DT. 29.03.2023 F22352006173 DT. 29.03.2023 F22352006178 DT. 29.03.2023 F 22352006161 DT. 29.03.2023 F2 2352006162 DT. 29.03.2023 F22 352006151 DT. 28.03.2023 S/BI LL NO: 8954449 DT 30-MAR-2023 S/BILL NO: 8954438 DT 30-MAR- 2023 S/BILL NO: 8954440 DT 30 -MAR-2023 S/BILL NO: 8954443 DT 30-MAR-2023 S/BILL NO: 895 4439 DT 30-MAR-2023 S/BILL NO : 8954431 DT 30-MAR-2023 NET WT.7338.99 KGS 02 DATA LOGGER S SET TEMPERATURE : +20 DEG REES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA |
HS 624200 |
2023-04-25 |
40 PKG |
9860.36KG |
40 PALLETS 2247 CARTONS PHA RMACEUTICALS AS UNDER PRAV ASTATIN SOD TAB 20MG 90 NDC C ODE:68462019690 FDA PRODUCT C ODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. :-77-987 THERAPEUTICE USE:-H YPOLIPDAEMIC RANOLAZINE ER TAB 1000MG 60 NDC CODE:68462 032060 FDA PRODUCT CODE NO.: 61 D C B 02 H. T. S NO.: 30 04.49.00.10 ANDA NO.:211082 THERAPEUTIC USE: - IT IS AN A NTI-ANGINAL MEDICATION. IT WO RKS BY IMPROVING BLOOD FLOW T O HELP THE HEART WORK MORE E FFICIENTLY. IT IS USED TO TRE AT CHRONIC ANGINA (CHEST PAIN ). IT IS NOT FOR USE DURING A N ACUTE (EMERGENCY) ATTACK OF ANGINA EZETIMIBE-SIMVA T AB 10/10MG 90 NDC CODE:684620 32190 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 300 4.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: - THIS COMB INATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL A ND FATS (SUCH AS LDL, TRIGLY CERIDES) AND RAISE GOOD CHOLE STEROL (HDL) IN THE BLOOD. EZ ETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROU P OF DRUGS KNOWN AS STATINS. IT WORKS BY REDUCING THE A MOUNT OF CHOLESTEROL MADE BY THE LIVER. EZETIMIBE-SIMVA TAB 10/40MG 30 NDC CODE:6846 2032330 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3 004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: - THIS CO MBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIG LYCERIDES) AND RAISE GOOD CHO LESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING T HE AMOUNT OF CHOLESTEROL YOU R BODY ABSORBS FROM YOUR DIET . SIMVASTATIN BELONGS TO A GR OUP OF DRUGS KNOWN AS STATIN S. IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE B Y THE LIVER. EZETIMIBE-SIM VA TAB 10/40MG 90 NDC CODE:68 462032390 FDA PRODUCT CODE NO .: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 2086 99 THERAPEUTICE USE: :#LIPID LOWERING AGENT POTASSIUM CL ER CAP 10MEQ 500 NDC CODE: 68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO. : 3004.90.92.90 ANDA NO.: 20 2868 THERAPEUTICE USE: - TRE ATMENT OR PREVENTION OF HYPOK ALEMIA GABAPENTIN TAB 600M G 500 NDC CODE:68462012605 F DA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.3 0 ANDA NO.:-77-662 THERAPEUT ICE USE:-ANTICONVULSANT AGEN T COMMERCIAL & CUSTOM INVO ICE NO. F22387002396 DT. 28.0 3.2023 F22387002397 DT. 28.03 .2023 F22387002398 DT. 28.03. 2023 F22387002399 DT. 28.03.2 023 S/BILL NO: 4004458 DT: 29 .03.2023 S/BILL NO: 4004452 D T: 29.03.2023 S/BILL NO: 4004 457 DT: 29.03.2023 S/BILL NO: 4004455 DT: 29.03.2023 NET W T.6857.916 KGS 02 DATA LOGGER S NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA |
HS 610200 |
2023-04-25 |
32 PKG |
6969.56KG |
32 PALLETS 1951 CARTONS PHARMACEUTICALS AS UNDER OMEPRAZOLE DR CAP 40MG 100 NDC CODE:68462039701 FD A PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.91 60 ANDA NO.: 91672 THERA PEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REF LUX DISEASE ROPINIR OLE TAB 2MG 100 NDC CODE:68 462025601 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT OF PARKIN SONISM NORGEST/EE TAB .18,.215,.25/.035MG 84 NDC CODE:68462056529 FDA PRODUC T CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200494 THERAPE UTICE USE: - ORAL CONTRACEP TIVES NORGEST/EE TAB . 18,.215,.25/.035MG 84 NDC C ODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 27 H . T. S NO.: 3006.60.00.00 ANDA NO.: 200494 THERAPEU TICE USE: - ORAL CONTRACEPT IVES COMMERCIAL & CUST OM INVOICE NO. F22352006117 DT. 26.03.2023 F2235200613 7 DT. 27.03.2023 F223520061 43 DT. 28.03.2023 S/BILL NO : 8792234 DT 27-MAR-2023 S/ BILL NO: 8877796 DT 28-MAR-202 3 S/BILL NO: 8877817 DT 28- MAR-2023 NET WT.5465.24 KGS 02 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 621000 |
2023-04-25 |
12 PKG |
2498.88KG |
12 PALLETS 1005 CARTONS PHA RMACEUTICALS AS UNDER ROSUV ASTATIN TAB 20MG 90 NDC CODE: 68462026390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079 172 THERAPEUTICE USE: - TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE C OMMERCIAL & CUSTOM INVOICE NO. F22352006119 DT. 26.03.2023 S/BILL NO: 8792224 DT 27-MA R-2023 NET WT.2016.72 KGS 12 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S .A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 611600 |
2023-04-25 |
13 PKG |
2816.4KG |
13 PALLETS 1703 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 5MG 90 NDC CODE: 68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079 172 THERAPEUTICE USE: - TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 79172 THERAPEUTICE USE: T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE . ROSUVASTATIN TAB 5MG 90 NDC CODE:68462026190 FDA PROD UCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE : - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DI SEASE ROSUVASTATIN TAB 5MG 90 NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULA R DISEASE COMMERCIAL & CUST OM INVOICE NO. F22352006163 D T. 29.03.2023 F22352006174 DT . 29.03.2023 F22352006176 DT. 29.03.2023 S/BILL NO: 895444 4 DT 30-MAR-2023 S/BILL NO: 8 954451 DT 30-MAR-2023 S/BILL NO: 8954455 DT 30-MAR-2023 NE T WT.2139.55 KGS 13 DATA LOGG ERS SET TEMPERATURE : +20 D EGREES NOTIFY PARTY:2 GLEN MARK SPECIALTY S.A. SWITZERLA ND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 611600 |
2023-04-25 |
40 PKG |
8550.36KG |
40 PALLETS 1990 CARTONS PHARMACEUTICALS AS UNDER PIMECROLIMUS CREAM 1% 30GM N DC CODE:68462060935 FDA PRODU CT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE : - AS SECOUND-LINE THERAPY F OR THE SHORT-TERM AND NON-CO NTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERM ATITIS IN NONIMMUNOCOMPROMISE D ADULT AND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 60GM NDC CODE:68462060965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 211769 THERA PEUTICE USE: - AS SECOUND-LIN E THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TR ERTMENT OF MILD TO MODERATE A TOPIC DERMATITIS IN NONIMMUN OCOMPROMISED ADULT AND CHILDR EN 2 YEARS OF AGE PIMECRO LIMUS CREAM 1% 100GM NDC CODE :68462060994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 11769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMUNOCOMPROMISED ADUL T AND CHILDREN 2 YEARS OF AGE SIROLIMUS TAB 2MG 100 ND C CODE:68462068401 FDA PRODUC T CODE NO.: 64 T C A 12 H. T . S NO.: 3004.90.92.15 ANDA NO.: 208691 THERAPEUTICE USE: TO PREVENT REJECTION OF KID NEY TRANSPLANTS. POTASSIUM CL ER CAP 10MEQ 100 NDC CODE :68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO. : 3004.90.92.90 ANDA NO.:202 868 THERAPEUTICE USE: - TREA TMENT OR PREVENTION OF HYPOK ALEMIA SEVELAMER HCL TAB 8 00MG 180 NDC CODE:68462044718 FDA PRODUCT CODE NO.: 63 L D A 04 H. T. S NO.: 3004.90. 92.60 ANDA NO.:204724 THERAP EUTICE USE:SEVELAMER HYDROCH LORIDE TABLETS ARE A PHOSPHAT E BINDER INDICATED FOR THE CO NTROL OF SERUM PHOSPHORUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON DIALYSIS DILT IAZEM HCL ER CAP 12HR 120MG 10 0 NDC CODE:68462056201 62 O C B 24 3004.49.00.10 212317 FOR THE TREATMENT OF HYPERTE NSION. DILTIAZEM HCL ER CA P 12HR 90MG 100 NDC CODE:6846 2085101 62 O C B 24 3004.49. 00.10 212317 FOR THE TREATME NT OF HYPERTENSION. ESOME PRAZOLE MAG DR CAP 40MG 30 ND C CODE:68462039130 FDA PRODUC T CODE NO.: 62 T C C 06 H. T . S NO.: 3004.90.92 60 ANDA NO.: 209495 THERAPEUTICE USE: ESOMEPRAZOLE MAGNESIUM DEL AYED-RELEASE CAPSULES ARE IN DICATED FOR THE LONG-TERM TRE ATMENT OF PATHOLOGICAL HYPER SECRETORY CONDITIONS, INCLUDI NG ZOLLINGER-ELLISON SYNDROM E CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRO DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST NITROGLYCERIN SUB LING TAB 0.4MG 4X25 NDC CODE: 68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO. : 3004.90.9020 ANDA NO.:2063 91 THERAPEUTIC USE: MEDICATI ON USED FOR HEART FAILURE,HIG H BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART ESOMEPRAZOLE MAG DR CAP 40MG 90 NDC CODE:6846203 9190 FDA PRODUCT CODE NO.: 6 2 T C C 06 H. T. S NO.: 3004. 90.92 60 ANDA NO.: 209495 T HERAPEUTICE USE: ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR TH E LONG-TERM TREATMENT OF PAT HOLOGICAL HYPERSECRETORY CON DITIONS, INCLUDING ZOLLINGER- ELLISON SYNDROME COMMERCI AL & CUSTOM INVOICE NO. F2238 7002438 DT. 30.03.2023 F22387 002437 DT. 30.03.2023 F223870 02436 DT. 30.03.2023 F2238700 2434 DT. 30.03.2023 F22387002 446 DT. 31.03.2023 F223870024 35 DT. 30.03.2023 NET WT. 439 8.13 KGS 10 DATA LOGGERS N OTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY :3 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PL ACE NUMA-DROZ 2 NEUCHATEL - 2 000 SWITZERLAND S/BILL NO: 4004756 DT: 31.03.2023 S/BIL L NO: 4004753 DT: 31.03.2023 S/BILL NO: 4004752 DT: 31.03.2 023 S/BILL NO: 4004749 DT: 31 .03.2023 S/BILL NO: 4004757 D T: 31.03.2023 S/BILL NO: 4004 750 DT: 31.03.2023 |
HS 610400 |
2023-04-25 |
40 PKG |
6925.56KG |
40 PALLETS 1956 CARTONS PHARMACEUTICALS AS UNDER H AILEY FE 1/20 TAB 1MG/20MCG-75 MG 84 NDC CODE:68462041929 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00 .00 ANDA NO.:206597 THERAPEU TICE USE: HORMONE MEDICATION IS USED TO PREVENT PREGNANCY NORETH ACE/EE TAB 1MG/5MC G 84 NDC CODE:68462065729 FD A PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.0 0 ANDA NO.: 203038 THERAPEUT ICE USE: - TREATMENT OF MODER ATE TO SEVERE VASOMOTOR SYMP TOMS DUE TO MENOPAUSE; OSTEO POROSIS PREVENTION HAILEY 24 FE TAB 1MG/20MCG-75MG 84 N DC CODE:68462073129 FDA PRODU CT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204847 THERAPEUTICE USE : - CONTRACEPTION TO PREVENT PREGNANCY COMMERCIAL & CU STOM INVOICE NO. F22352006216 DT. 30.03.2023 F22352006241 DT. 31.03.2023 NET WT.5103.62 KGS 02 DATA LOGGERS S/B ILL NO: 8982843 DT 31-MAR-2023 S/BILL NO: 8997894 DT 01-APR -2023 NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652500 |
2023-04-25 |
40 PKG |
6697.86KG |
40 PALLETS 1752 CARTONS PHARMACEUTICALS AS UNDER NORETHINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PROD UCT CODE NO.65 J C A 25 H. T . S NO.: 3004.39.00.50 ANDA NO.:-91-090 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOM ETRIOS IS AND ABNORMAL UTERI NE BLEEDING HAILEY 24 FE TA B 1MG/20MCG-75MG 84 NDC CODE: 68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO. : 3006.60.00.00 ANDA NO.: 20 4847 THERAPEUTICE USE: - CON TRACEPTION TO PREVENT PREGNAN CY NORETH ACE/EE TAB 1MG/5M CG 84 NDC CODE:68462065729 F DA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.: 203038 THERAPEU TICE USE: - TREATMENT OF MODE RATE TO SEVERE VASOMOTOR SYM PTOMS DUE TO MENOPAUSE; OSTE OPOROSIS PREVENTION HAILEY 24 FE TAB 1MG/20MCG-75MG 84 N DC CODE:68462073129 FDA PRODU CT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204847 THERAPEUTICE USE : - CONTRACEPTION TO PREVENT PREGNANCY NORETHINDRONE AC E TAB 5MG 50 NDC CODE:6846203 0450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.3 9.00.50 ANDA NO.:-91-090 THE RAPEUTICE USE:- SECONDARY AM ENORRHEA,ENDOMETRIOS IS AND A BNORMAL UTERINE BLEEDING N ORGEST/EE TAB 0.25/0.035MG 84 NDC CODE:68462030929 FDA PRO DUCT CODE NO.: 65 J D A 27 H . T. S NO.: 3006.60.00.00 AN DA NO.: 200538 THERAPEUTICE U SE: - ORAL CONTRACEPTIVES COMMERCIAL & CUSTOM INVOICE NO . F22352006254 DT. 31.03.2023 F22352006275 DT. 31.03.2023 F22352006280 DT. 31.03.2023 F22352006281 DT. 31.03.2023 S /BILL NO: 9016588 DT 01-APR-20 23 S/BILL NO: 9016576 DT 01-A PR-2023 S/BILL NO: 9016583 DT 01-APR-2023 S/BILL NO: 90150 64 DT 01-APR-2023 NET WT.5031 .19 KGS 02 DATA LOGGERS HUMI DITY:65% SET TEMPERATURE : +2 0 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA |
HS 652500 |
2023-04-25 |
44 PKG |
11366.76KG |
44 PALLETS 3135 CARTONS PHARMACEUTICALS AS UNDER L ITHIUM CARB ER TAB 450MG 100 NDC CODE:68462022401 FDA PROD UCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00.20 AND A NO.:91-616 THERAPEUTICE USE : - INDICATED IN THE TREATME NT OF MANIC EPISODES OF BIPO LAR DISORDER. BIPOLAR DISORDE R, MANIC (DSM-IV) IS EQUIVALE NT TO MANIC DEPRESSIVE ILLNES S, MANIC, IN THE OLDER DSM-I I TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT FOR INDIVIDUALS WITH A DIAGNO SIS OF BIPOLAR DISORDER. MAI NTENANCE THERAPY REDUCES THE FREQUENCY OF MANIC EPISODES A ND DIMINISHES THE INTENSITY OF THOSE EPISODES WHICH MAY OCCUR. INDOMETHACIN CAP 25M G 1000 NDC CODE:68462040610 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92 .40 ANDA NO.:91-276 THERAPEU TICE USE: ANTI-INFLAMATORY GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO .:-77-662 THERAPEUTICE USE:- ANTICONVULSANT AGENT TELMI SARTAN TAB 40MG 30 NDC CODE:6 8462020030 FDA PRODUCT CODE N O.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.:0900 32 THERAPEUTICE USE: INDICAT ED FOR THE TREATMENT OF HYPE RTENSION, TO LOWER BLOOD PRES SURE TOPIRAMATE TAB 25MG 60 NDC CODE:68462010860 FDA PR ODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 A NDA NO.:- 77-627 THERAPEUTICE USE:-ANTICONVULSANT TOPIR AMATE TAB 100MG 500 NDC CODE: 68462010905 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.: 77 627 THERAPEUTICE USE: :#ANTI CONVULSANT PRAVASTATIN SOD TAB 40MG 90 NDC CODE:68462019 790 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004. 90.92.20 ANDA NO.: 77-987 TH ERAPEUTICE USE: HYPOLIPDAEMIC GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PROD UCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE US E:-ANTICONVULSANT AGENT S/BILL NO: 8997224 DT 31-MAR-2 023 S/BILL NO: 8997225 DT 31- MAR-2023 S/BILL NO: 8997220 D T 31-MAR-2023 S/BILL NO: 8997 221 DT 31-MAR-2023 S/BILL NO: 8997222 DT 31-MAR-2023 S/BIL L NO: 8997223 DT 31-MAR-2023 COMMERCIAL & CUSTOM INVO ICE NO. F22352006193 DT. 29.0 3.2023 F22352006192 DT. 29.03 .2023 F22352006189 DT. 29.03. 2023 F22352006190 DT. 29.03.2 023 F22352006204 DT. 30.03.20 23 F22352006205 DT. 30.03.202 3 NET WT.9802.38 KGS 02 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 613700 |
2023-04-25 |
45 PKG |
11657.07KG |
45 PALLETS 3618 CARTONS PHARMACEUTICALS AS UNDER PRAMIPEXOLE TAB 0.125MG 90 NDC CODE:68462033090 FD A PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.9 0.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE TO PIRAMATE TAB 25MG 500 NDC C ODE:68462010805 FDA PRODUCT CODE NO.: 61 M C A 40 H . T. S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUT ICE USE: ANTICONVULSANT TOPIRAMATE TAB 25MG 60 NDC CODE:68462010860 FDA P RODUCT CODE NO.:-61 M C A 4 0 H. T. S NO.: 3004.49.0 0.20 ANDA NO.:- 77-627 T HERAPEUTICE USE:-ANTICONVUL SANT LITHIUM CARB ER T AB 450MG 100 NDC CODE:68462 022401 FDA PRODUCT CODE NO. : 61 N C B 37 H. T. S NO .: 3004.49.00.20 ANDA NO .:91-616 THERAPEUTICE USE: - INDICATED IN THE TREAT MENT OF MANIC EPISODES O F BIPOLAR DISORDER. BIPOLAR DISORDER, MANIC (DSM-IV) I S EQUIVALENT TO MANIC DEPRE SSIVE ILLNESS, MANIC, IN TH E OLDER DSM-II TERMINOLOGY. ALSO INDICATED AS A MAI NTENANCE TREATMENT FOR INDI VIDUALS WITH A DIAGNOSIS OF BIPOLAR DISORDER. MAINT ENANCE THERAPY REDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISHES THE INTENSI TY OF THOSE EPISODES WHI CH MAY OCCUR. TOPIR AMATE TAB 25MG 500 NDC CODE :68462010805 FDA PRODUCT CO DE NO.: 61 M C A 40 H. T . S NO.: 3004.49.00.20 A NDA NO.:077627 THERAPEUTICE USE: ANTICONVULSANT TOPIRAMATE TAB 100MG 60 N DC CODE:68462010960 FDA PRO DUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00. 20 ANDA NO.:- 77-627 THE RAPEUTICE USE:-ANTICONVULSA NT PRAMIPEXOLE TAB 0.1 25MG 90 NDC CODE:6846203309 0 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90 -781 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE LITHIUM CARB ER TAB 450MG 100 NDC CODE:68462022401 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 30 04.49.00.20 ANDA NO.:91-616 THERAPEUTICE USE: - IND ICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOLA R DISORDER. BIPOLAR DISORDE R, MANIC (DSM-IV) IS EQUIVA LENT TO MANIC DEPRESSIVE IL LNESS, MANIC, IN THE OLDER DSM-II TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPO LAR DISORDER. MAINTENANCE T HERAPY REDUCES THE FREQUENC Y OF MANIC EPISODES AND DIMINISHES THE INTENSITY OF THOSE EPISODES WHICH MA Y OCCUR. NAPROXEN TAB 500MG 500 NDC CODE:68462019 005 FDA PRODUCT CODE NO. :-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE: -ANTI-INFLAMMATORY, ANALGES IC PRAVASTATIN SOD TAB 40MG 500 NDC CODE:68462019 705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: HYPOLIPDAEMIC ACYCLOV IR OINT 5% 30GM NDC CODE:68 462074635 FDA PRODUCT CODE NO.: 62 V C J 18 H. T. S NO.: 3004.49.00.50 ANDA NO.: 205510 THERAPEUTICE U SE: - AN ANTIVIRAL MEDICINE USED TO TREAT OR PREVENT I NFECTIONS CAUSED BY CERTAIN KINDS OF VIRUSES. EXAMPLES OF THESE INFECTIONS INCLUD E HERPES AND SHINGLES COMMERCIAL & CUSTOM INVOICE NO. F22352006234 DT. 31.03 .2023 F22352006202 DT. 30.0 3.2023 F22352006233 DT. 31. 03.2023 F22352006232 DT. 31 .03.2023 F22352006211 DT. 3 0.03.2023 F22352006210 DT. 30.03.2023 F22352006209 DT. 30.03.2023 F22352006203 DT . 30.03.2023 F22352006201 D T. 30.03.2023 S/BILL NO: 89 97833 DT 01-APR-2023 S/BILL NO: 8995840 DT 31-MAR-2023 S/BILL NO: 8995805 DT 31-MAR- 2023 S/BILL NO: 8995829 DT 31-MAR-2023 S/BILL NO: 8995 814 DT 31-MAR-2023 S/BILL N O: 8995826 DT 31-MAR-2023 S /BILL NO: 8995836 DT 31-MAR-20 23 S/BILL NO: 8995815 DT 31 -MAR-2023 S/BILL NO: 899582 5 DT 31-MAR-2023 NET WT.963 9.42 KGS 03 DATA LOGGERS SET TEMPERATURE : +20 DEG |
HS 621500 |
2023-04-25 |
40 PKG |
6169.41KG |
40 PALLETS 1966 CARTONS PHARMACEUTICALS AS UNDER DROSPIRENONE/EE TAB 3/0.02MG 8 4 NDC CODE:68462072029 FDA P RODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204296 THERAPEUTICE USE: - ORAL CONTRACEPTIVE VIORELE TAB 0.15/0.02-0.01MG 84 NDC CODE:68462031829 FDA PRODUCT CODE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTIC E USE: - ORAL CONTRACEPTIVES NORGEST/EE TAB .18,.215,. 25/.035MG 84 NDC CODE:6846205 6529 FDA PRODUCT CODE NO.: 6 5 J D A 27 H. T. S NO.: 3006 .60.00.00 ANDA NO.: 200494 T HERAPEUTICE USE: - ORAL CON TRACEPTIVES COMMERCIAL & CUSTOM INVOICE NO. F2235 2006111 DT. 26.03.2023 F223 52006124 DT. 27.03.2023 F22 352006133 DT. 27.03.2023 S/ BILL NO: 8792226 DT 27-MAR-20 23 S/BILL NO: 8792233 DT 27 -MAR-2023 S/BILL NO: 887780 7 DT 28-MAR-2023 NET WT.446 7.22 KGS 02 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 653900 |
2023-04-25 |
40 PKG |
6510.97KG |
40 PALLETS 1962 CARTONS PHARMACEUTICALS AS UNDER ES TRADIOL VAG INSERTS 10MCG 8 NDC CODE:68462071171 FDA PROD UCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 AND A NO.:210264 THERAPEUTICE USE :THE TREATMENT OF ATROPIC VA GINITIS DUE TO MENOPAUSE. NORETH ACE/EE TAB 1MG/5MCG 90 NDC CODE:68462065790 FDA PRO DUCT CODE NO.: 65 J D A 25 H . T. S NO.: 3006.60.00.00 AN DA NO.: 203038 THERAPEUTICE U SE: - TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS DUE TO MENOPAUSE; OSTEOPOROS IS PREVENTION HAILEY 24 FE TAB 1MG/20MCG-75MG 84 NDC COD E:68462073129 FDA PRODUCT COD E NO.: 65 J D A 25 H. T. S N O.: 3006.60.00.00 ANDA NO.: 204847 THERAPEUTICE USE: - C ONTRACEPTION TO PREVENT PREGN ANCY HAILEY FE 1/20 TAB 1MG /20MCG-75MG 84 NDC CODE:68462 041929 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 30 06.60.00.00 ANDA NO.:206597 THERAPEUTICE USE: HORMONE MED ICATION IS USED TO PREVENT P REGNANCY COMMERCIAL & CUSTO M INVOICE NO. F22352006167 DT . 29.03.2023 F22352006191 DT. 29.03.2023 F22352006214 DT. 30.03.2023 S/BILL NO: 8941574 DT 30-MAR-2023 S/BILL NO: 89 41554 DT 30-MAR-2023 S/BILL N O: 8976861 DT 31-MAR-2023 NET WT.4768.66 KGS 02 DATA LOGGE RS SET TEMPERATURE : +20 DE GREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 642800 |
2023-04-25 |
12 PKG |
2532KG |
12 PALLETS 1122 CARTONS PH ARMACEUTICALS AS UNDER NITR OGLYCERIN SUBLING TAB 0.4MG 4X 25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR H EART FAILURE,HIGH BLOOD PRESS URE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BL OOD FLOW TO THE HEART SOLI FENACIN SUCCINATE TAB 5MG 30 NDC CODE:68462038630 FDA PROD UCT CODE NO.: 61 KCA 72 H. T . S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLA DDER WITH SYMPTOMS OF URGE UR INARY INCONTINENCE, URGENCY AND URINARY FREQUENCY COMME RCIAL & CUSTOM INVOICE NO. F2 2387002307 DT. 13.03.2023 S/B ILL NO: 4003600 DT: 14.03.20 23 NET WT.151.87 KGS 12 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWITZER LAND |
HS 662800 |
2023-04-18 |
42 PKG |
9850.38KG |
42 PALLETS 2281 CARTONS PHARMACEUTICALS AS UNDER NAPROXEN TAB 500MG 5 00 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 300 4.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC FELODIPINE ER TAB 2.5MG 1 00 NDC CODE:68462023301 FDA PRODUCT CODE NO.: 62OCB 32 H. T. S NO.: 3004.90. 92.20 ANDA NO.: 90-365 T HERAPEUTICE USE: - TREATMEN T OF HYPERTENSION G ABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODU CT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPE UTICE USE:-ANTICONVULSANT AGENT TELMISARTAN TA B 80MG 30 NDC CODE:68462020 130 HTS NO : 3004.90.92.20 FDA CODE : 62 O C A 09 A NDA NO.: 90032 THERAPEUTICE USE : INDICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE NORETHINDRONE TAB 0.35MG 84 NDC CODE:68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 300 6.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVEN TION OF PREGNANCY. TEL MISARTAN TAB 80MG 30 NDC CO DE:68462020130 HTS NO : 300 4.90.92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 T HERAPEUTICE USE : INDICATED FOR THE TREATMENT OF HY PERTENSION, TO LOWER BLOOD PRESSURE COMMERCIAL & CUSTOM INVOICE NO. F2235200 5968 DT. 18.03.2023 F223520 05969 DT. 18.03.2023 F22352 005970 DT. 18.03.2023 F2235 2005972 DT. 18.03.2023 F223 52005977 DT. 18.03.2023 S/B ILL NO: 8583088 DT 18-MAR-2023 S/BILL NO: 8583079 DT 18-M AR-2023 S/BILL NO: 8583082 DT 18-MAR-2023 S/BILL NO: 8 583087 DT 18-MAR-2023 S/BIL L NO: 8586589 DT 18-MAR-2023 NET WT. 8321.52 KGS 02 DA TA LOGGERS SET TEMPERAT URE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2023-04-18 |
1 PKG |
193.69KG |
1 PALLETS 64 CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 10MG 1000 NDC CODE:68462026210 61 J C A 16 3004.49.00.1 0 79172 TO TREAT HIGH CH OLESTEROL AND RELATED CONDI TIONS, AND TO PREVENT CA RDIOVASCULAR DISEASE C OMMERCIAL & CUSTOM INVOICE NO. F22352005971 DT. 18.03.202 3 S/BILL NO: 8583080 DT 18- MAR-2023 NET WT. 167.73 KGS 01 DATA LOGGERS SET TEM PERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATE L - 2000 SWITZERLAND |
HS 210690 |
2023-04-18 |
28 PKG |
4062.44KG |
28 PALLETS 1367 CARTONS PHARMACEUTICALS AS UNDER DR OSPIRENONE/EE TAB 3/0.02MG 84 NDC CODE:68462072029 FDA PRO DUCT CODE NO.: 65 J D A 39 H . T. S NO.: 3006.60.00.00 AN DA NO.: 204296 THERAPEUTICE U SE: - ORAL CONTRACEPTIVE C OMMERCIAL & CUSTOM INVOICE NO. F22352006077 DT. 23.03.2023 S/BILL NO: 8704831 DT 23-MAR -2023 NET WT.2821.49 01 DA TA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 653900 |
2023-04-18 |
44 PKG |
12833.7KG |
44 PALLETS 3213 CARTONS PHARMACEUTICALS AS UNDER TELMISARTAN TAB 20MG 30 NDC CODE:68462019930 FDA P RODUCT CODE NO.: 62 O C A 0 9 H. T. S NO.: 3004.90.9 2.20 ANDA NO.:090032 THE RAPEUTICE USE: INDICATED FO R THE TREATMENT OF HYPER TENSION, TO LOWER BLOOD PRE SSURE ZONISAMIDE CAP 5 0MG 100 NDC CODE:6846201290 1 FDA PRODUCT CODE NO.:- 61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77 -651 THERAPEUTICE USE:-A NTISEIZURE DRUG TELMIS ARTAN TAB 20MG 30 NDC CODE: 68462019930 FDA PRODUCT COD E NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 AN DA NO.:090032 THERAPEUTICE USE: INDICATED FOR THE T REATMENT OF HYPERTENSION, T O LOWER BLOOD PRESSURE VERAPAMIL HCL ER TAB 120MG 100 NDC CODE:68462029201 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 30 04.90.92.20 ANDA NO.: 90-70 0 THERAPEUTICE USE: - -A NGINA GABAPENTIN TAB 6 00MG 500 NDC CODE:684620126 05 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-A NTICONVULSANT AGENT ROPINIROLE TAB 2MG 100 NDC CODE:68462025601 FDA PRODU CT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 THERA PEUTICE USE:-TREATMENT OF PARKINSONISM GABAPEN TIN TAB 600MG 500 NDC CODE: 68462012605 FDA PRODUCT COD E NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 AND A NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGEN T COMMERCIAL & CUSTOM INVOICE NO. F22352006052 DT . 22.03.2023 F22352006053 D T. 22.03.2023 F22352006078 DT. 23.03.2023 F22352006079 DT. 23.03.2023 F2235200608 7 DT. 24.03.2023 F223520060 88 DT. 24.03.2023 S/BILL NO : 8736674 DT 24-MAR-2023 S/ BILL NO: 8736712 DT 24-MAR-202 3 S/BILL NO: 8736653 DT 24- MAR-2023 S/BILL NO: 8736629 DT 24-MAR-2023 S/BILL NO: 8736616 DT 24-MAR-2023 S/BI LL NO: 8736608 DT 24-MAR-2023 NET WT. 11,053.45 KGS 02 DATA LOGGERS SET TEMPERA TURE : +20 DEGREES NOTI FY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 620900 |
2023-04-18 |
12 PKG |
2334.68KG |
12 PALLETS 583 CARTONS PH ARMACEUTICALS AS UNDER NORG EST/EE TAB 0.25/0.035MG 84 ND C CODE:68462030929 FDA PRODUC T CODE NO.: 65 J D A 27 H. T . S NO.: 3006.60.00.00 ANDA NO.: 200538 THERAPEUTICE USE: - ORAL CONTRACEPTIVES COM MERCIAL & CUSTOM INVOICE NO. F22352006058 DT. 23.03.2023 S /BILL NO: 8704754 DT 23-MAR-20 23 NET WT.1776.98 01 DATA LO GGERS SET TEMPERATURE: +20 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652700 |
2023-04-11 |
28 PKG |
6025.17KG |
28 PALLETS 1741 CARTONS PHARMACEUTICALS AS UNDER TA CROLIMUS CAP 0.5MG 100 NDC CO DE:68462068501 FDA PRODUCT CO DE NO.: 64 T C E 08 H. T. S NO.:3004.90.92.15 ANDA NO.: 206662 THERAPEUTICE USE: :#T O PREVENT REJECTION OF A KID NEY,TO PREVENT REJECTION OF A KIDNEY,LIVER TRANSPLANT P OTASSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PROD UCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 AND A NO.: 202868 THERAPEUTICE US E: - TREATMENT OR PREVENTION OF HYPOKALEMIA PIMECROLIMU S CREAM 1% 60GM NDC CODE:6846 2060965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECO UND-LINE THERAPY FOR THE SHOR T-TERM AND NON-CONTINUOS CHRO NIC TRERTMENT OF MILD TO MOD ERATE ATOPIC DERMATITIS IN N ON-IMMUNOCOMPROMISED ADULT AN D CHILDREN 2 YEARS OF AGE PROPAFENONE HCL ER CAP 325MG 6 0 NDC CODE:68462040960 FDA P RODUCT CODE NO.: 63 E C F 28 H. T. S NO.: 3004.49.00.10 ANDA NO.: 205268 THERAPEUTICE USE: -AN ANTIARRHYTHMIC AGEN T IT IS USED TO TREAT IRREGUL AR HEARTRHYTHM AND CAN SLOW RAPID HEARTBEATS TACROLIMUS OINT 0.1% 60GM NDC CODE:6846 2053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLI MUS IS A TOPICAL IMMUNOSUPPRE SSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVE RE ATOPIC DERMATITIS (ECZEMA ). COMMERCIAL & CUSTOM INVO ICE NO. F22387002274 DT. 09.0 3.2023 F22387002306 DT. 13.03 .2023 F22387002308 DT. 13.03. 2023 F22387002309 DT. 14.03.2 023 F22387002314 DT. 14.03.20 23 S/BILL NO: 4003605 DT: 14. 03.2023 S/BILL NO: 4003601 DT : 14.03.2023 S/BILL NO: 40035 97 DT: 14.03.2023 S/BILL NO: 4003599 DT: 14.03.2023 S/BILL NO: 4003622 DT: 14.03.2023 N ET WT.3839.205 02 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA |
HS 651400 |
2023-04-11 |
12 PKG |
2532KG |
12 PALLETS 1122 CARTONS PH ARMACEUTICALS AS UNDER NITR OGLYCERIN SUBLING TAB 0.4MG 4X 25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HE ART FAILURE,HIGH BLOOD PRESSU RE,AND TO TREAT AND PREVENT C HEST PAIN FROM NOT ENOUGH BLO OD FLOW TO THE HEART SOLIF ENACIN SUCCINATE TAB 5MG 30 N DC CODE:68462038630 FDA PRODU CT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA N O.: 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLAD DER WITH SYMPTOMS OF URGE URI NARY INCONTINENCE, URGENCY A ND URINARY FREQUENCY COMMER CIAL & CUSTOM INVOICE NO. F22 387002307 DT. 13.03.2023 S/BI LL NO: 4003600 DT: 14.03.202 3 NET WT.151.87 KGS 12 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +20 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GL ENMARK SPECIALTY S.A. SWITZER LAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAN D |
HS 662800 |
2023-04-11 |
40 PKG |
5670.45KG |
40 PALLETS 1511 CARTONS PHARMACEUTICALS AS UNDER NO RETHINDRONE TAB 0.35MG 84 NDC CODE:68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA N O.:91-209 THERAPEUTICE USE: PREVENTION OF PREGNANCY. ES TRADIOL VAG INSERTS 10MCG 18 NDC CODE:68462071188 NDC NO.: 68462071188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO. : 3006.60.00.00 ANDA NO.:210 264 THERAPEUTICE USE:THE TRE ATMENT OF ATROPIC VAGINITIS D UE TO MENOPAUSE. COMMERCIA L & CUSTOM INVOICE NO. F22352 005866 DT. 13.03.2023 F223520 05868 DT. 13.03.2023 S/BILL N O: 8435323 DT 13-MAR-2023 S/B ILL NO: 8442448 DT 13-MAR-2023 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA |
HS 652600 |
2023-04-11 |
49 PKG |
10127.98KG |
49 PALLETS 2830 CARTONS PHARMACEUTICALS AS UNDER CA RVEDILOL TAB 6.25MG 500 NDC C ODE:68462016305 FDA PRODUCT C ODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO. :- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST CICLOPIROX OLAMINE CREAM 0.77% 90GM NDC CODE:68462029 792 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004. 40.49.50 ANDA NO.:- 90 - 273 THERAPEUTICE USE:-ANTIFUNGAL USE. GABAPENTIN TAB 800MG 500 NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 6 9 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTI CE USE:-ANTICONVULSANT AGENT CARVEDILOL TAB 6.25MG 500 NDC CODE:68462016305 FDA PRO DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST PRAMIPEXOLE TAB 0. 125MG 90 NDC CODE:68462033090 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90. 92.40 ANDA NO.: 90-781 THERA PEUTICE USE: USED IN PARKINSO N#S DISEASE OMEPRAZOLE DR C AP 10MG 100 NDC CODE:68462039 501 FDA PRODUCT CODE NO.: 62 KCF10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAPEU TICE USE: - -TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX D ISEASE ATOVAQUONE-PROG TAB 250/100MG 100 NDC CODE:684620 40401 FDA PRODUCT CODE NO.: 62 L D A 44 H. T. S NO.: 300 4.90.92.90 ANDA NO.: 91-211 THERAPEUTICE USE: - ANTI MALA RIAL LIDOCAINE OINT TUBE 5% 35.44GM NDC CODE:68462041820 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.0 0.50 ANDA NO.:206498 THERAPE UTICE USE: -USED TO TEMPORARI LY RELIEVE PAIN AND ITCHING ASSOCIATED WITH SKIN ESTRAD IOL VAG INSERTS 10MCG 18 NDC CODE:68462071188 NDC NO.:6846 2071188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3 006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE:THE TREATME NT OF ATROPIC VAGINITIS DUE T O MENOPAUSE. NORETH ACE/EE TAB 1/0.02MG 63 NDC CODE:684 62013281 FDA PRODUCT CODE NO .:65 J C A 25 H. T. S NO.: 3 006.60.00.00 ANDA NO.:206969 THERAPEUTICE USE: - SECONDAR Y AMENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIAL & CUSTOM INVOIC E NO. F22352005861 DT. 12.03. 2023 F22352005871 DT. 13.03.2 023 F22352005879 DT. 13.03.20 23 F22352005880 DT. 13.03.202 3 F22352005881 DT. 13.03.2023 F22352005882 DT. 13.03.2023 F22352005883 DT. 13.03.2023 F22352005878 DT. 13.03.2023 F 22352005889 DT. 14.03.2023 S/ BILL NO: 8417191 DT 13-MAR-202 3 S/BILL NO: 8442468 DT 13-MA R-2023 S/BILL NO: 8457168 DT 14-MAR-2023 S/BILL NO: 845716 6 DT 14-MAR-2023 S/BILL NO: 8 457547 DT 14-MAR-2023 S/BILL NO: 8457169 DT 14-MAR-2023 S/ BILL NO: 8457162 DT 14-MAR-202 3 S/BILL NO: 8457167 DT 14-MA R-2023 S/BILL NO: 8457158 DT 14-MAR-2023 NET WT.8165.935 KGS 02 DATA LOGGERS SET TE MPERATURE : +20 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA |
HS 610300 |
2023-04-04 |
33 PKG |
7625.92KG |
33 PALLETS 1895 CARTONS PHARMACEUTICALS AS UNDER EZETIMIBE-SIMVA TAB 10/40M G 90 NDC CODE:68462032390 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 30 04.49.00.10 ANDA NO.: 20869 9 THERAPEUTICE USE: :#LI PID LOWERING AGENT POT ASSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PR ODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92. 90 ANDA NO.:202868 THERA PEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEM IA COLESEVELAM HCL TAB 625MG 180 NDC CODE:6846204 3318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00.10 ANDA NO.: 203480 THERAPEUTICE USE: - ANTIHYPERLIPO PROTEINEM IC. POTASSIUM CL ER CA P 10MEQ 500 NDC CODE:684620 35705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO. : 3004.90.92.90 ANDA NO. : 202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA COMME RCIAL & CUSTOM INVOICE NO. F22387002275 DT. 09.03.2023 S/BILL NO: 4003441 DT: 10.03 .2023 NET WT.4589.562 KGS 02 DATA LOGGERS SET T EMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 611500 |
2023-04-04 |
14 PKG |
3977.62KG |
14 PALLETS 626 CARTONS PHARMACEUTICALS AS UNDER CARVEDILOL TAB 6.25MG 100 NDC CODE:68462016301 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 300 4.90.92.20 ANDA NO.:- 78-25 1 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONI ST NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 300 4.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC COMMERCIAL & CUSTOM INVOI CE NO. F22352005843 DT. 10. 03.2023 S/BILL NO: 8404630 DT 11-MAR-2023 NET WT.3509. 11 01 DATA LOGGERS HUMID ITY:65% SET TEMPERATURE : + 20 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 622200 |
2023-04-04 |
19 PKG |
3497.26KG |
19 PALLETS 917 CARTONS PHARMACEUTICALS AS UNDER HAILEY 1.5/30 TAB 1.5M G/30MCG 63 NDC CODE:6846205 0481 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 209297 THERAPEUTICE USE: - CONTRACEPTION TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F2235 2005830 DT. 10.03.2023 S/BI LL NO: 8378008 DT 10-MAR-2023 NET WT.2662.97 KGS 19 DA TA LOGGERS SET TEMPERAT URE : +20 DEGREES NOTIF Y PARTY:2 GLENMARK SPECIALT Y S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHAT EL - 2000 SWITZERLAND |
HS 652500 |
2023-04-04 |
30 PKG |
8906.44KG |
30 PALLETS 2214 CARTONS PHARMACEUTICALS AS UNDER CICLOPIROX OLAMINE CR EAM 0.77% 30GM NDC CODE:6 8462029735 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 AND A NO.:- 90 - 273 THERAPEUTI CE USE:-ANTIFUNGAL USE. CICLOPIROX OLAMINE CREAM 0.77% 90GM NDC CODE:6846202 9792 FDA PRODUCT CODE NO .:-61 W C J 03 H. T. S NO.: 3004.40.49.50 ANDA NO.: - 90 - 273 THERAPEUTICE USE:-ANTIFUNGAL USE. P RAMIPEXOLE TAB 1.5MG 90 NDC CODE:68462033490 FDA PRODU CT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAP EUTICE USE: USED IN PARKINS ONS DISEASE CARVEDILOL TAB 6.25MG 500 NDC CODE:68 462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST GABAPEN TIN TAB 800MG 500 NDC CODE: 68462012705 FDA PRODUCT COD E NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGE NT COMMERCIAL & CUSTOM INVOICE NO. F22352005838 D T. 10.03.2023 F22352005840 DT. 10.03.2023 F22352005842 DT. 10.03.2023 F2235200584 4 DT. 10.03.2023 F223520058 45 DT. 10.03.2023 S/BILL NO : 8405161 DT 11-MAR-2023 S/ BILL NO: 8404617 DT 11-MAR-202 3 S/BILL NO: 8405167 DT 11- MAR-2023 S/BILL NO: 8404631 DT 11-MAR-2023 S/BILL NO: 8404622 DT 11-MAR-2023 NET WT.7604.59 KGS 01 DATA LOGG ERS SET TEMPERATURE : + 20 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 610300 |
2023-04-04 |
21 PKG |
4514.23KG |
21 PALLETS 910 CARTONS PHARMACEUTICALS AS UNDER NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FD A PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INF LAMMATORY, ANALGESIC INDOMETHACIN CAP 50MG 500 NDC CODE:68462030205 FDA P RODUCT CODE NO.: 62 G C E 4 2 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:91-276 THE RAPEUTICE USE: -ANTI-INFLAM ATORY INDOMETHACIN CAP 50MG 100 NDC CODE:68462030 201 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO.:9 1-276 THERAPEUTICE USE: -ANTI-INFLAMATORY DROS PIRENONE/EE TAB 3/0.02MG 84 NDC CODE:68462072029 FDA P RODUCT CODE NO.: 65 J D A 3 9 H. T. S NO.: 3006.60.0 0.00 ANDA NO.: 204296 TH ERAPEUTICE USE: - ORAL CONT RACEPTIVE COMMERCIAL & CUSTOM INVOICE NO. F223520 05827 DT. 10.03.2023 F22352 005829 DT. 10.03.2023 S/BIL L NO: 8378015 DT: 10-MAR-23 S/BILL NO: 8378006 DT:10-MAR- 23 NET WT.3749.85 KGS 01 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGRE ES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTI FY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 624900 |
2023-04-04 |
8 PKG |
1634.77KG |
8 PALLETS 506 CARTONS PHARMACEUTICALS AS UNDER ESOMEPRAZOLE MAG DR CAP 40M G 30 NDC CODE:68462039130 FDA PRODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004. 90.92 60 ANDA NO.: 20949 5 THERAPEUTICE USE: ESOM EPRAZOLE MAGNESIUM DELAY ED-RELEASE CAPSULES ARE INDICATED FOR THE LONG-TERM TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITION S, INCLUDING ZOLLINGER-ELLI SON SYNDROME NITROG LYCERIN SUBLING TAB 0.4MG 100 NDC CODE:68462063901 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90 .9020 ANDA NO.: 206391 T HERAPEUTICE USE: -MEDICATIO N USED FOR HEART FAILURE, H IGH BLOOD PRESSURE,AND TO T REAT AND PREVENT CHEST PAIN FROM NOTENOUGH BLOOD FLOW TO THE HEART COMMER CIAL & CUSTOM INVOICE NO. F 22387002277 DT. 09.03.2023 S/BILL NO: 4003442 DT: 10.03. 2023 NET WT.188.551 KGS 08 DATA LOGGERS SET TEM PERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK SPE CIALTY S.A. SWITZERLAND (GS SA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND |
HS 620600 |
2023-03-31 |
1 PKG |
5000.03KG |
PHARMACEUTICALS AS UNDER |
HS 300680 |
2023-03-31 |
40 PKG |
7755.65KG |
40 PALLETS 1986 CARTONS PH ARMACEUTICALS AS UNDER NORG EST/EE TAB .18,.215,.25/.035MG 84 NDC CODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 2 7 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200494 THERAPEUTI CE USE: - ORAL CONTRACEPTIVES COMMERCIAL & CUSTOM INVOIC E NO. F22352005604 DT. 26.02. 2023 S/BILL NO: 8100365 DT 27 -FEB-2023 NET WT.6000.00 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGREE S TEMPERATURE RANGE : +15 DEG REES TO +25 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A |
HS 652700 |
2023-03-31 |
15 PKG |
3229.63KG |
15 PALLETS 1537 CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 10MG 1000 NDC CODE:68462026210 61 J C A 16 3004.49.00.1 0 79172 TO TREAT HIGH CH OLESTEROL AND RELATED CONDI TIONS, AND TO PREVENT CA RDIOVASCULAR DISEASE R OSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PRODU CT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPE UTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CON DITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 10MG 90 N DC CODE:68462026290 FDA PRO DUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.1 0 ANDA NO.: 079172 THERA PEUTICE USE: - TO TREAT HIG H CHOLESTEROL AND RELATED C ONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352005587 DT. 25.02 .2023 S/BILL NO: 8080640 DT 26-FEB-2023 NET WT. 2601.9 0 KGS 15 DATA LOGGERS HU MIDITY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE R ANGE : +15 DEGREES TO +25 DEGR EES NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZ ERLAND |
HS 611600 |
2023-03-31 |
26 PKG |
6565.86KG |
26 PALLETS 1204 CARTONS PHARMACEUTICALS AS UNDER VIORELE TAB 0.15/0.02 -0.01MG 84 NDC CODE:6846203 1829 FDA PRODUCT CODE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTICE USE: - ORAL CONTRACEPTIVES NAPROXEN TAB 500MG 500 ND C CODE:68462019005 FDA PROD UCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:-78-250 THERA PEUTICE USE:-ANTI-INFLAMMAT ORY, ANALGESIC LITH IUM CARB ER TAB 300MG 100 N DC CODE:68462022301 FDA PRO DUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00. 20 ANDA NO.:91-544 THERA PEUTICE USE: - INDICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDE R. BIPOLAR DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, IN THE OLDER DSM-II TERMINOLOGY. ALSO INDICATE D AS A MAINTENANCE TREAT MENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR DISOR DER. MAINTENANCE THERAPY REDUCES THE FREQUENCY OF M ANIC EPISODES AND DIMINISHE S THE INTENSITY OF THOSE EPISODES WHICH MAY OCCUR. IMIQUIMOD CREAM 5% 0. 25GM 24 NDC CODE:6846205367 0 FDA PRODUCT CODE NO.: 62 V C J 29 H. T. S NO.: 3004.49.00.50 ANDA NO.:201 994 THERAPEUTICE USE: - INDICATED FOR ACTINIC KERAT OSES AND EXTERNAL GENITAL AND PERIANAL WARTS C OMMERCIAL & CUSTOM INVOICE NO. F22352005566 DT. 24.02.202 3 F22352005585 DT. 25.02.20 23 F22352005586 DT. 25.02.2 023 S/BILL NO: 8080704 DT 2 6-FEB-2023 S/BILL NO: 80806 37 DT 26-FEB-2023 S/BILL NO : 8080635 DT 26-FEB-2023 NE T WT. 5630.76 KGS 02 DATA L OGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 074 30 USA |
HS 642700 |
2023-03-31 |
5 PKG |
886.33KG |
5 PALLETS 89 CARTONS P HARMACEUTICALS AS UNDER CA LCIPOTRIENE CREAM 0.005% 60GM NDC CODE:68462050165 FDA PR ODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 A NDA NO.: 205772 THERAPEUTICE USE: - TREATMENT OF PLAQUE P SORIASIS IN ADULTS CALCIPOT RIENE CREAM 0.005% 120GM NDC CODE:68462050166 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO .: 205772 THERAPEUTICE USE: - TREATMENT OF PLAQUE PSORIAS IS IN ADULTS CALCIPOTRIENE CREAM 0.005% 120GM (GS) NDC C ODE:51407060512 FDA PRODUCT C ODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO. : 205772 THERAPEUTICE USE: T OPICAL ANTI-PSORIATIC COMME RCIAL & CUSTOM INVOICE NO. F2 2352005612 DT. 26.02.2023 F22 352005613 DT. 26.02.2023 NET WT.724.92 KGS 05 DATA LOGGERS SET TEMPERATURE : +20 DEGR EES NOTIFY PARTY:2 GLENMAR K SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEU CHATEL - 2000 SWITZERLAND S/BILL NO: 8143231 DT 28-FEB-2 023 S/BILL NO: 8143244 DT 28- FEB-2023 |
HS 620400 |
2023-03-31 |
43 PKG |
13398.44KG |
43 PALLETS 2964 CARTONS PHARMACEUTICALS AS UNDER C ARVEDILOL TAB 6.25MG 500 NDC CODE:68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST LITHIUM CARB ER TAB 300 MG 100 NDC CODE:68462022301 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00 .20 ANDA NO.:91-544 THERAPEU TICE USE: - INDICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER. BIPOLAR DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO MANIC DEPRESSIV E ILLNESS, MANIC, IN THE OLDE R DSM-II TERMINOLOGY. ALSO I NDICATED AS A MAINTENANCE TR EATMENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR DISORD ER. MAINTENANCE THERAPY REDU CES THE FREQUENCY OF MANIC EP ISODES AND DIMINISHES THE INT ENSITY OF THOSE EPISODES WHI CH MAY OCCUR. LITHIUM CARB ER TAB 450MG 100 NDC CODE:68 462022401 FDA PRODUCT CODE NO .: 61 N C B 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:91-61 6 THERAPEUTICE USE: - INDICA TED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDE R. BIPOLAR DISORDER, MANIC ( DSM-IV) IS EQUIVALENT TO MANI C DEPRESSIVE ILLNESS, MANIC, IN THE OLDER DSM-II TERMINOLO GY. ALSO INDICATED AS A MAIN TENANCE TREATMENT FOR INDIVID UALS WITH A DIAGNOSIS OF BIP OLAR DISORDER. MAINTENANCE TH ERAPY REDUCES THE FREQUENCY O F MANIC EPISODES AND DIMINIS HES THE INTENSITY OF THOSE E PISODES WHICH MAY OCCUR. G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT OXCARBA ZEPINE TAB 300MG 100 NDC CODE :68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT GABAPENTI N TAB 600MG 500 NDC CODE:6846 2012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 30 04.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVUL SANT AGENT MUPIROCIN CREAM 2% 30GM NDC CODE:68462056435 FDA PRODUCT CODE NO.: 61GCJ 82 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 201587 THERAPEUT ICE USE: - TOPICAL ANTI-BACTE RIAL COMMERCIAL & CUSTOM IN VOICE NO. F22352005609 DT. 26 .02.2023 F22352005610 DT. 26. 02.2023 F22352005611 DT. 26.0 2.2023 F22352005623 DT. 27.02 .2023 F22352005614 DT. 26.02. 2023 NET WT.11781.16 KGS 02 DATA LOGGERS SET TEMPERATUR E : +20 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA S/BILL NO: 8143270 DT 28- FEB-2023 S/BILL NO: 8143268 D T 28-FEB-2023 S/BILL NO: 8143 228 DT 28-FEB-2023 S/BILL NO: 8143272 DT 28-FEB-2023 S/BIL L NO: 8143230 DT 28-FEB-2023 |
HS 622200 |
2023-03-21 |
40 PKG |
6318.19KG |
40 PALLETS 1903 CARTONS PHARMACEUTICALS AS UNDER NO RETH ACE/EE TAB 1/0.02MG 63 N DC CODE:68462013281 FDA PRODU CT CODE NO.:65 J C A 25 H. T . S NO.: 3006.60.00.00 ANDA NO.:206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOM ETRIOS IS AND ABNORMAL UTERIN E BLEEDING NORETHINDRONE A CE TAB 5MG 50 NDC CODE:684620 30450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004. 39.00.50 ANDA NO.:-91-090 TH ERAPEUTICE USE:- SECONDARY A MENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIAL & CUSTOM INVOICE NO . F22352005452 DT. 18.02.2023 F22352005458 DT. 18.02.2023 NET WT.4541.05 KGS 02 DATA L OGGERS HUMIDITY:65% SET TEMP ERATURE : +20 DEGREES TEMPERA TURE RANGE : +15 DEGREES TO +2 5 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BIL L NO: 7898219 DT:18-FEB-23 S/ BILL NO: 7898223 DT:18-FEB-23 |
HS 652500 |
2023-03-21 |
43 PKG |
6149KG |
43 PALLETS 1724 CARTONS PHARMACEUTICALS AS UNDER FL UCONAZOLE TAB 150MG 12UD NDC CODE:68462011944 NDC CODE : 68462011944 HTS NO : 3004.90. 92.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 THERAPEU TICE USE : ANTIFUNGAL TRAN DO-VERAPAMIL TAB 2/240MG 100 NDC CODE:68462029601 FDA PROD UCT CODE NO.:-62 O D A 11 H. T. S NO.: 3004.90.92.20 AND A NO.:-79-135 THERAPEUTICE U SE:-TREATMENT OF HYPERTENSION CARVEDILOL TAB 12.5MG 500 NDC CODE:68462016405 FDA PRO DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST COMMERCIAL & CUSTO M INVOICE NO. F22352005482 DT . 20.02.2023 F22352005483 DT. 20.02.2023 S/BILL NO: 7931 637 DT: 20-FEB-23 S/BILL NO: 7931636 DT: 20-FEB-23 NET W T.4676.58 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATUR E : +20 DEGREES TEMPERATURE R ANGE : +15 DEGREES TO +25 DEGR EES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA |
HS 300490 |
2023-03-21 |
40 PKG |
7906.7KG |
40 PALLETS 2006 CARTONS PH ARMACEUTICALS AS UNDER CALC IPOTRIENE OINT 0.005% 60GM ND C CODE:68462031065 FDA PRODUC T CODE NO.: 62 N C J 04 H. T . S NO.: 3004.90.92.45 ANDA NO.: 209297 THIS MEDICATION I S USED TO TREAT PSORIASIS. C ALCIPOTRIENE IS A FORM OF VIT AMIN D. IT WORKS BY SLOWING D OWN THE GROWTH OF SKIN CELLS. HAILEY FE 1/20 TAB 1MG/20M CG-75MG 84 NDC CODE:684620419 29 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.6 0.00.00 ANDA NO.:206597 THER APEUTICE USE: HORMONE MEDICAT ION IS USED TO PREVENT PREGN ANCY COMMERCIAL & CUSTOM IN VOICE NO. F22352005486 DT. 20 .02.2023 F22352005491 DT. 20. 02.2023 S/BILL NO: 7942695 DT 21-FEB-2023 S/BILL NO:794269 4 DT 21-FEB-2023 NET WT.6032. 47 KGS 02 DATA LOGGERS HUMID ITY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA |
HS 620400 |
2023-03-21 |
4 PKG |
569.27KG |
4 PALLETS 101 CARTONS P HARMACEUTICALS AS UNDER NIT ROGLYCERIN SUBLING TAB 0.3MG 1 00 NDC CODE:68462063801 FDA PRODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOT ENOUGH BLOO D FLOW TO THE HEART ESOMEP RAZOLE MAG DR CAP 40MG 1000 N DC CODE:68462039110 FDA PRODU CT CODE NO.: 62TCC06 H. T. S NO.: 3004.90.9260 ANDA NO.: 209495 THERAPEUTICE USE: :# ESOMEPRAZOLE MAGNESIUM DELAY ED-RELEASE CAPSULES ARE INDI CATED FOR THE LONG-TERM TREAT MENT OF PATHOLOGICAL HYPERSE CRETORY CONDITIONS, INCLUDING ZOLLINGER-ELLISON SYNDROME COMMERCIAL & CUSTOM INVOICE NO. F22387002163 DT. 22.02.2 023 NET WT. 197.696 KGS 04 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGREES TE MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE NUMA-DR OZ 2 NEUCHATEL - 2000 SWITZE RLAND S/BILL NO: 4002606 DT : 23.02.2023 |
HS 662800 |
2023-03-21 |
35 PKG |
7386.88KG |
35 PALLETS 2250 CARTONS PHARMACEUTICALS AS UNDER G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-662 THERAPEUTICE USE:-A NTICONVULSANT AGENT RANOLA ZINE ER TAB 1000MG 60 NDC COD E:68462032060 FDA PRODUCT COD E NO.: 61 D C B 02 H. T. S N O.: 3004.49.00.10 ANDA NO.:2 11082 THERAPEUTIC USE: - IT I S AN ANTI-ANGINAL MEDICATION . IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHE ST PAIN). IT IS NOT FOR USE D URING AN ACUTE (EMERGENCY) AT TACK OF ANGINA TOPIRAMATE ER CAP (Q) 25MG 30 NDC CODE:6 8462037230 3004.49.00.20 61 M C B 40 210278 INDOMETHAC IN ER CAP 75MG 60 NDC CODE:68 462032560 FDA PRODUCT CODE: 6 2 GCE42 H. T. S NO.:3004.90 .92.40 ANDA NO.203501 THERAP EUTIC USE: INDOMETHACIN IS US ED TO RELIEVE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED BY ARTHRITIS, GOUT, BURSITIS, AND TENDONITIS. IT IS ALSO U SED TO RELIEVE PAIN FROM VARI OUS OTHER CONDITIONS. THIS M EDICATION IS KNOWN AS A NONST EROIDAL ANTI-INFLAMMATORY DRU G (NSAID). ... THIS EFFECT H ELPS TO DECREASE SWELLING AND PAIN. FENOFIBRATE CAP 134 MG 100 NDC CODE:68462058101 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 205566 THERAPEUT ICE USE: - INDICATED AS ADJUN CTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C , TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY H YPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA TACROLIMUS OIN T 0.1% 30GM NDC CODE:68462053 435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 210393 TH ERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIV E OINTMENT USED FOR THE TREA TMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 60GM N DC CODE:68462053465 FDA PRODU CT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE : - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT US ED FOR THE TREATMENT OF MODE RATE-TO-SEVERE ATOPIC DERMATI TIS (ECZEMA). TACROLIMUS C AP 1MG 100 NDC CODE:684620686 01 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.2 06662 THERAPEUTIC USE : TO P REVENT REJECTION OF A KIDNEY, HEART, OR LIVER TRANSPLANT INDOMETHACIN ER CAP 75MG 90 NDC CODE:68462032590 FDA PROD UCT CODE NO.: 62 GCE42 H. T. S NO.: 3004.90.92.40 ANDA N O.: 203501 THERAPEUTICE USE: #INDOMETHACIN IS USED TO REL IEVE PAIN, SWELLING AND JOINT STIFFNESS CAUSED BY ARTHRITI S, GOUT, BURSITIS AND TENDONI TIS IT IS ALSO USED TO RELIEV E PAIN FROM VARIOUS OTHER CO NDITIONS.THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI -INFLAMMATORY DRUG THIS EFFEC T HELPS TO DECREASE SWELLING AND PAIN. COMMERCIAL & CUS TOM INVOICE NO. F22387002162 DT. 22.02.2023 F22387002164 D T. 22.02.2023 F22387002169 DT . 23.02.2023 F22387002166 DT. 22.02.2023 F22387002165 DT. 22.02.2023 NET WT. 3678.343 KGS 02 DATA LOGGERS HUMIDIT Y:65% SET TEMPERATURE : +20 D EGREES TEMPERATURE RANGE : +1 5 DEGREES TO +25 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA S/BILL NO: 4002607 D T: 23.02.2023 S/BILL NO: 4002 604 DT: 23.02.2023 S/BILL NO: 4002608 DT: 23.02.2023 S/BIL L NO: 4002603 DT: 23.02.2023 S/BILL NO: 4002605 DT: 23.02.2 023 |
HS 300490 |
2023-03-21 |
15 PKG |
2424.04KG |
15 PALLETS 750 CARTONS P HARMACEUTICALS AS UNDER VI ORELE TAB 0.15/0.02-0.01MG 84 NDC CODE:68462031829 FDA PRO DUCT CODE NO.: 64 G D A 27 H . T. S NO.: 3004.39.00.50 AN DA NO.: 091346 THERAPEUTICE U SE: - ORAL CONTRACEPTIVES COMMERCIAL & CUSTOM INVOICE N O. F22352005565 DT. 24.02.202 3 S/BILL NO: 8061204 DT 25-FE B-2023 NET WT. 1800.00 KGS 0 1 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 642700 |
2023-03-21 |
28 PKG |
6092.76KG |
28 PALLETS 2168 CARTONS PHA RMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT ONDANSETR ON ODT 8MG 30UD NDC CODE:6846 2015813 FDA PRODUCT CODE.:-61 T C A 26 H. T. S NO.: 3004 .90.92.40 ANDA NO.:-78-152 T HERAPEUTICE USE:-ANTI -EMETIC OLMESARTAN MEDOX TAB 20MG 90 NDC CODE:68462043790 FDA PRODUCT CODE NO.: 62CCA68 H . T. S NO.: 3004.90.9220 AND A NO.: 203281 THERAPEUTICE US E: - #NAME? HYPERTENSION, AL ONE OR WITH OTHER ANTIHYPERT ENSIVE AGENTS, TO LOWER BLOOD PRESSURE CARVEDILOL TAB 6 .25MG 500 NDC CODE:6846201630 5 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST COMMERC IAL & CUSTOM INVOICE NO. F223 52005546 DT. 23.02.2023 F2235 2005552 DT. 24.02.2023 F22352 005553 DT. 24.02.2023 F223520 05562 DT. 24.02.2023 S/BILL N O: 8049488 DT 24-FEB-2023 S/B ILL NO: 8049487 DT 24-FEB-2023 S/BILL NO: 8049483 DT 24-FEB -2023 S/BILL NO: 8049489 DT 2 4-FEB-2023 NET WT.4943.32 KGS 01 DATA LOGGERS HUMIDITY:65 % SET TEMPERATURE : +20 DEGRE ES TEMPERATURE RANGE : +15 DE GREES TO +25 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA |
HS 684620 |
2023-03-15 |
39 PKG |
7419.08KG |
39 PALLETS 2989 CARTONS PHARMACEUTICALS AS UNDER HE ATHER TAB 0.35MG 84 NDC CODE: 68462030329 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO. : 3006.60.00.00 ANDA NO.:90- 454 THERAPEUTICE USE: PREVEN TION OF PREGNANCY. ATOVAQUO NE-PROG TAB 250/100MG 24UD ND C CODE:68462040467 FDA PRODUC T CODE NO.: 62 L D A 44 H. T . S NO.: 3004.90.92.90 ANDA NO.: 91-211 THERAPEUTICE USE: - ANTI MALARIAL TOPIRAMAT E TAB 25MG 500 NDC CODE:68462 010805 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 30 04.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVULS ANT ROPINIROLE TAB 2MG 100 NDC CODE:68462025601 FDA PRO DUCT CODE NO.:-62 J C A 17 H . T. S NO.: 3004.90.92.40 AN DA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT OF PARKINSONI SM TOPIRAMATE TAB 25MG 500 NDC CODE:68462010805 FDA PRO DUCT CODE NO.: 61 M C A 40 H . T. S NO.: 3004.49.00.20 AN DA NO.:077627 THERAPEUTICE US E: ANTICONVULSANT CICLOPIR OX OLAMINE CREAM 0.77% 30GM N DC CODE:68462029735 FDA PRODU CT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 ANDA NO.:- 90 - 273 THERAPEUTICE USE:-ANTIFUNGAL USE. MUPIR OCIN OINT 2% 22GM NDC CODE:68 462018022 FDA PRODUCT CODE NO .: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-4 80 THERAPEUTICE USE: - ANTI- BACTERIAL COMMERCIAL & CUST OM INVOICE NO. F22352005414 D T. 16.02.2023 F22352005405 DT . 15.02.2023 F22352005406 DT. 15.02.2023 F22352005383 DT. 14.02.2023 F22352005386 DT. 1 4.02.2023 F22352005403 DT. 15 .02.2023 NET WT.5650.46 KGS 02 DATA LOGGERS S/BILL NO: 7844456 DT 16-FEB-2023 S/BILL NO: 7833288 DT 16-FEB-2023 S /BILL NO: 7844446 DT 16-FEB-20 23 S/BILL NO: 7804349 DT 15-F EB-2023 S/BILL NO: 7804360 DT 15-FEB-2023 S/BILL NO: 78324 19 DT 16-FEB-2023 NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652400 |
2023-03-15 |
32 CTN |
5973.46KG |
32 PALLETS 1876 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA N O.: 202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA TACROLIMUS OIN T 0.1% 30GM NDC CODE:68462053 435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 210393 TH ERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIV E OINTMENT USED FOR THE TREA TMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 60GM N DC CODE:68462053465 FDA PRODU CT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE : - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT US ED FOR THE TREATMENT OF MODE RATE-TO-SEVERE ATOPIC DERMATI TIS (ECZEMA). TELMISARTAN- HCTZ TAB 80MG/25MG 30UD NDC C ODE:68462084213 62 O D A 09 3004.90.92.20 202544 TELMISA RTAN AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATED FOR TH E TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE. COLESEVELAM HCL TAB 625MG 180 NDC CODE:68462043318 FDA PRO DUCT CODE NO.: 62 B D A 13 H . T. S NO.: 3004.49.00.10 AN DA NO.: 203480 THERAPEUTICE U SE: - ANTIHYPERLIPO PROTEINE MIC. DILTIAZEM HCL ER CAP 1 2HR 120MG 100 NDC CODE:684620 56201 62 O C B 24 3004.49.00 .10 212317 FOR THE TREATMENT OF HYPERTENSION. TOPIRAMA TE TAB 25MG 60 NDC CODE:68462 010860 FDA PRODUCT CODE NO.: -61 M C A 40 H. T. S NO.: 30 04.49.00.20 ANDA NO.:- 77-627 THERAPEUTICE USE:-ANTICONVU LSANT NITROGLYCERIN SUBLING TAB 0.3MG 100 NDC CODE:68462 063801 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 30 04.90.9020 ANDA NO.:206391 T HERAPEUTIC USE: MEDICATION US ED FOR HEART FAILURE,HIGH BLO OD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEAR T NITROGLYCERIN SUBLING TAB 0.4MG 100 NDC CODE:684620639 01 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.9 0.9020 ANDA NO.: 206391 THER APEUTICE USE: MEDICATION USED FOR HEART FAILURE, HIGH BLOO D PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTEN OUGH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOICE NO. F22387002116 DT. 14.02.2 023 F22387002117 DT. 14.02.20 23 F22387002119 DT. 14.02.202 3 F22387002121 DT. 14.02.2023 F22387002124 DT. 15.02.2023 F22352005385 DT. 14.02.2023 F22387002118 DT. 14.02.2023 S /BILL NO: 4002213 DT: 16.02.20 23 S/BILL NO: 4002211 DT: 16. 02.2023 S/BILL NO: 4002209 DT : 16.02.2023 S/BILL NO: 40022 07 DT: 16.02.2023 S/BILL NO: 4002214 DT: 16.02.2023 S/BILL NO: 7804342 DT 15-FEB-2023 S /BILL NO: 4002210 DT: 16.02.20 23 NET WT.2827.21 KGS 13 DAT A LOGGERS HUMIDITY:65% SET T EMPERATURE : +18 DEGREES TEMP ERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 U SA NOT IFY PARTY:3 GLENMARK PHARMACEUTICALS LTD. PLOT NO S-7, COLVALE INDUSTRIAL ESTATE COLVALE, BARDEZ - 403513 GOA INDIA GST NO. : 30AAACG2 207L1Z5 NOTIFY PARTY:4 GLENMARK SP ECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NU MA-DROZ 2 NEUCHATEL - 2 000 SWITZERLAND |
HS 651400 |
2023-03-15 |
2 PKG |
641.39KG |
2 PALLETS 141 CARTONS P HARMACEUTICALS AS UNDER ATO VAQUONE-PROG TAB 250/100MG 100 NDC CODE:68462040401 FDA PR ODUCT CODE NO.: 62 L D A 44 H. T. S NO.: 3004.90.92.90 A NDA NO.: 91-211 THERAPEUTICE USE: - ANTI MALARIAL COMME RCIAL & CUSTOM INVOICE NO. F2 2352005377 DT. 14.02.2023 NET WT.538.74 KGS 00 DATA LOGGER S S/BILL NO: 7804334 DT 15- FEB-2023 NOTIFY PARTY:2 SH OROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS C ENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI U TD.ARAB EMIR. |
HS 624400 |
2023-03-15 |
7 CTN |
1881.53KG |
7 PALLETS 437 CARTONS PHAR MACEUTICALS AS UNDER OMEPRA ZOLE DR CAP 40MG 100 NDC CODE :68462039701 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352005 378 DT. 14.02.2023 NET WT.153 7.56 KGS 02 DATA LOGGERS HUM IDITY:65% S/BILL NO: 780434 4 DT 15-FEB-2023 NOTIFY PAR TY:2 SHOROUQ COMMODITIES TRAD ING DMCC UNIT NO. 98, DMCC BU SINESS CENTRE, LEVEL NO. 8, J EWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 684620 |
2023-03-08 |
24 PKG |
6459.26KG |
24 PALLETS 1792 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 600MG 500 NDC CO DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT TACROLIM US CAP 1MG 100 NDC CODE:68462 068601 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE : T O PREVENT REJECTION OF A KID NEY,HEART, OR LIVER TRANSPLAN T TACROLIMUS CAP 0.5MG 100 NDC CODE. 68462068501 HTS NO : 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THE RAPEUTICE USE: TO PREVENT REJ ECTION OF A KIDNEY, HEART, O R LIVER TRANSPLANT BISOPROL OL-HCTZ TAB 10/6.25MG 100 NDC CODE:68462088001 FDA PRODUCT CODE NO.: 62 O D A 18 H. T. S NO.: 3004.40.00.20 ANDA N O.: 215995 THERAPEUTICE USE: BISOPROLOL FUMARATE AND HYDR OCHLOROTHIAZIDE TABLETS ARE INDICATED IN THE MANAGEMENT O F HYPERTENSION. COMMERCIAL & CUSTOM INVOICE NO. F223870 02074 DT. 08.02.2023 F2238700 2076 DT. 08.02.2023 F22387002 080 DT. 09.02.2023 S/BILL NO: 4001816 DT: 09.02.2023 S/BIL L NO: 4001818 DT: 09.02.2023 S/BILL NO: 4001822 DT: 09.02.2 023 NET WT. 4451.877 KGS 02 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +20 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2023-03-08 |
40 PKG |
12108.4KG |
40 PALLETS 2233 CARTONS PHARMACEUTICALS AS UNDER VE RAPAMIL HCL ER TAB 240MG 100 NDC CODE:68462026001 FDA PROD UCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 AND A NO.:-78-906 THERAPEUTICE USE:-ANGINA ZONISAMIDE CAP 25MG 100 NDC CODE:68462012801 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49. 00.20 ANDA NO.:-77-651 THERA PEUTICE USE:-ANTISEIZURE DRUG OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PRO DUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTROES OPHAGEAL REFLUX DISEASE GA BAPENTIN TAB 800MG 500 NDC CO DE:68462012705 FDA PRODUCT CO DE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT ROPINIR OLE TAB 3MG 100 NDC CODE:6846 2025701 FDA PRODUCT CODE NO. :-62 J C A 17 H. T. S NO.: 3 004.90.92.40 ANDA NO.:- 90-13 5 THERAPEUTICE USE:-TREATMEN T OF PARKINSONISM COMMERCI AL & CUSTOM INVOICE NO. F2235 2005310 DT. 09.02.2023 F22352 005322 DT. 10.02.2023 F223520 05323 DT. 10.02.2023 S/BILL N O: 7716638 DT 11-FEB-2023 S/B ILL NO: 7722760 DT 11-FEB-2023 S/BILL NO: 7716637 DT 11-FEB -2023 NET WT. 10650.71 KGS 0 2 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES NOTIFY PART Y:2 SHOROUQ COMMODITIES TRADI NG DMCC UNIT NO. 98, DMCC BUS INESS CENTRE, LEVEL NO. 8, JE WELLERY & GEMPLEX 2, DUBAI D UBAI UTD.ARAB EMIR. |
HS 621300 |
2023-03-08 |
6 PKG |
1544.51KG |
6 PALLETS 215 CARTONS PH ARMACEUTICALS AS UNDER CICL OPIROX OLAMINE CREAM 0.77% 90G M NDC CODE:68462029792 FDA P RODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 ANDA NO.:- 90 - 273 THERAPEUT ICE USE:-ANTIFUNGAL USE. C OMMERCIAL & CUSTOM INVOICE NO. F22352005326 DT. 10.02.2023 S/BILL NO: 7716634 DT 11-FEB- 2023 NET WT. 1218.21 KGS 00 DATA LOGGERS SET TEMPERATUR E : +20 DEGREES NOTIFY PART Y:2 SHOROUQ COMMODITIES TRADI NG DMCC UNIT NO. 98, DMCC BUS INESS CENTRE, LEVEL NO. 8, JE WELLERY & GEMPLEX 2, DUBAI D UBAI UTD.ARAB EMIR. |
HS 610300 |
2023-03-03 |
8 PKG |
1643.39KG |
8 PALLETS 661 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TABLETS 20MG 90 S NDC CODE:68462026390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO. : 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEAS E COMMERCIAL & CUSTOM INVOI CE NO. F22352005065 DT. 28.01 .2023 S/BILL NO: 7386944 DT 3 0-JAN-2023 NET WT. 1326.421 K GS 08 DATA LOGGERS SET TEM PERATURE : +20 DEGREES NOTI FY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLA CE NUMA-DROZ 2 NEUCHATEL - 20 00 SWITZERLAND |
HS 611600 |
2023-03-03 |
41 PKG |
11790.42KG |
41 PALLETS 2958 CARTONS PHARMACEUTICALS AS UNDER TE LMISARTAN TAB 20MG 30 NDC COD E:68462019930 FDA PRODUCT COD E NO.: 62 O C A 09 H. T. S N O.: 3004.90.92.20 ANDA NO.:0 90032 THERAPEUTICE USE: INDI CATED FOR THE TREATMENT OF H YPERTENSION, TO LOWER BLOOD P RESSURE OXCARBAZEPINE TAB 3 00MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90. 92.30 ANDA NO.:-77-802 THERA PEUTICE USE:-ANTI CONVULSANT AGENT GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTIC E USE:-ANTICONVULSANT AGENT VERAPAMIL HCL ER TAB 120MG 100 NDC CODE:68462029201 FDA PRODUCT CODE NO.: 62 O C B 1 3 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTI CE USE: - -ANGINA TRANDO-V ERAPAMIL TAB 4/240MG 100 NDC CODE:68462032901 FDA PRODUCT CODE NO.:-62 O D A 11 H. T. S NO.: 3004.90.92.20 ANDA NO .:-79-135 THERAPEUTICE USE:- TREATMENT OF HYPERTENSION CICLOPIROX GEL 0.77% 30GM NDC CODE:68462045535 FDA PRODUCT CODE NO.: 61WCJ43 H. T. S N O.: 3004.49.00.50 ANDA NO.: 091595 THERAPEUTICE USE: - A NTIFUNGAL CICLOPIROX GEL 0. 77% 45GM NDC CODE:68462045547 FDA PRODUCT CODE NO.: 61WCJ 43 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 091595 THERAPEUT ICE USE: - ANTIFUNGAL COMM ERCIAL & CUSTOM INVOICE NO. F 22352005067 DT. 28.01.2023 F2 2352005080 DT. 28.01.2023 F22 352005082 DT. 28.01.2023 F223 52005076 DT. 28.01.2023 F2235 2005077 DT. 28.01.2023 S/BILL NO: 7385586 DT 30-JAN-2023 S /BILL NO: 7366186 DT 30-JAN-20 23 S/BILL NO: 7366179 DT 30-J AN-2023 S/BILL NO: 7385595 DT 30-JAN-2023 S/BILL NO: 73855 83 DT 30-JAN-2023 NET WT. 985 5.255 KGS 02 DATA LOGGERS HU MIDITY:65% NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA |
HS 614500 |
2023-03-03 |
40 PKG |
6368.09KG |
40 PALLETS 2400 CARTONS PHARMACEUTICALS AS UNDER ES TRADIOL VAG INSERTS 10MCG 8 N DC CODE:68462071171 FDA PRODU CT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE: THE TREATMENT OF ATROPIC VAG INITIS DUE TO MENOPAUSE. C OMMERCIAL & CUSTOM INVOICE NO. F22352005198 DT. 31.01.2023 S/BILL NO: 7443048 DT 01-FEB -2023 NET WT. 4608.00 KGS 01 DATA LOGGERS SET TEMPERATU RE : +20 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 642800 |
2023-03-03 |
40 PKG |
6607.14KG |
40 PALLETS 2397 CARTONS PHARMACEUTICALS AS UNDER E STRADIOL VAG INSERTS 10MCG 8 NDC CODE:68462071171 FDA PROD UCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 AND A NO.:210264 THERAPEUTICE USE :THE TREATMENT OF ATROPIC VA GINITIS DUE TO MENOPAUSE. NORETH ACE/EE TAB 1MG/5MCG 90 NDC CODE:68462065790 FDA PRO DUCT CODE NO.: 65 J D A 25 H . T. S NO.: 3006.60.00.00 AN DA NO.: 203038 THERAPEUTICE U SE: - TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS DUE TO MENOPAUSE; OSTEOPOROS IS PREVENTION NORETH ACE/EE TAB 1MG/5MCG 84 NDC CODE:684 62065729 FDA PRODUCT CODE NO. : 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 20303 8 THERAPEUTICE USE: - TREATM ENT OF MODERATE TO SEVERE VAS OMOTOR SYMPTOMS DUE TO MENOP AUSE; OSTEOPOROSIS PREVENTION ESTRADIOL VAG INSERTS 10MC G 18 NDC CODE:68462071188 ND C NO.:68462071188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA N O.:210264 THERAPEUTICE USE:TH E TREATMENT OF ATROPIC VAGIN ITIS DUE TO MENOPAUSE. DRO SPIRENONE/EE TAB 3/0.02MG 84 NDC CODE:68462072029 FDA PROD UCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 AND A NO.: 204296 THERAPEUTICE US E: - ORAL CONTRACEPTIVE NO RETH ACE/EE TAB 0.5MG/2.5MCG 8 4 NDC CODE:68462065629 FDA P RODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOM S DUE TO MENOPAUSE; OSTEOPOR OSIS PREVENTION CARVEDILOL TAB 12.5MG 500 NDC CODE:68462 016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 30 04.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST CAR VEDILOL TAB 3.125MG 500 NDC C ODE:68462016205 FDA PRODUCT C ODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO. :- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST S/BILL NO: 7486801 DT 02-FEB-2023 S/BILL NO: 748554 6 DT 02-FEB-2023 S/BILL NO: 7 485920 DT 02-FEB-2023 S/BILL NO: 7486804 DT 02-FEB-2023 S/ BILL NO: 7487561 DT 02-FEB-202 3 S/BILL NO: 7486797 DT 02-FE B-2023 S/BILL NO: 7486802 DT 02-FEB-2023 S/BILL NO: 748592 3 DT 02-FEB-2023 COMMERCI AL & CUSTOM INVOICE NO. F2235 2005199 DT. 31.01.2023 F22352 005183 DT. 31.01.2023 F223520 05184 DT. 31.01.2023 F2235200 5194 DT. 31.01.2023 F22352005 210 DT. 02.02.2023 F223520052 13 DT. 02.02.2023 F2235200519 1 DT. 31.01.2023 F22352005179 DT. 31.01.2023 NET WT. 4941. 984 KGS 03 DATA LOGGERS SE T TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 642800 |
2023-03-03 |
22 PKG |
3880.55KG |
22 PALLETS 1526 CARTONS PHARMACEUTICALS AS UNDER PRAMIPEXOLE TAB 0.25MG 90 NDC CODE:68462033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA N O.: 90-781 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE PRAMIPEXOLE TAB 0.25MG 90 N DC CODE:68462033190 FDA PRODU CT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE : USED IN PARKINSON#S DISEASE ONDANSETRON ODT 8MG 30UD NDC CODE:68462015813 FDA PROD UCT CODE.:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-152 THERAPEUTICE USE:- ANTI -EMETIC RIZATRIPTAN B ENZ ODT 10MG 18UD NDC CODE:68 462046806 FDA PRODUCT CODE NO .: 63 O C A 05 H. T. S NO.: 3004.90.92.28 ANDA NO.: 2019 14 THERAPEUTICE USE : - ANAL GESIC/ HUMAN - RX/SINGLE INGR EDIENT / PROMPT RELEASE TABLE TS / RIZATRIPTAN BENZOATE (A NALGESIC) COMMERCIAL & CUST OM INVOICE NO. F22352005168 D T. 31.01.2023 F22352005148 DT . 31.01.2023 S/BILL NO: 74574 50 DT 02-FEB-2023 S/BILL NO: 7457452 DT 02-FEB-2023 NET W T. 3018.77 KGS 01 DATA LOGGER S SET TEMPERATURE : +20 DEG REES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA |
HS 621500 |
2023-03-03 |
13 PKG |
3760.34KG |
13 PALLETS 883 CARTONS PHARMACEUTICALS AS UNDER TOPIRAMATE TAB 50MG 500 NDC CODE:68462015305 FDA PR ODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00 .20 ANDA NO.:077627 THER APEUTICE USE: ANTICONVULSAN T CARVEDILOL TAB 12.5M G 500 NDC CODE:68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3 004.90.92.20 ANDA NO.:- 78- 251 THERAPEUTICE USE:-BE TA- ADRENOACEPTOR ANTAGO NIST NAPROXEN TAB 500M G 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANT I-INFLAMMATORY, ANALGESIC GABAPENTIN TAB 600MG 50 0 NDC CODE:68462012605 F DA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONV ULSANT AGENT COMMER CIAL & CUSTOM INVOICE NO. F 22352005174 DT. 31.01.2023 F22352005195 DT. 31.01.2023 F22352005185 DT. 31.01.2023 F22352005178 DT. 31.01.2023 NET WT. 3337.74 KGS 04 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DE GREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 7503778 DT: 03/02/2023 S/ BILL NO: 7503712 DT:03/02/2023 S/BILL NO: 7503753 DT:03/02/ 2023 S/BILL NO: 7502657 DT: 0 3/02/2023 |
HS 614000 |
2023-03-03 |
17 PKG |
2776.03KG |
17 PALLETS 803 CARTONS PHARMACEUTICALS AS UNDER H AILEY FE 1.5/30 TAB 1.5MG/30MC G-75MG 84 NDC CODE:6846205032 9 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.6 0.00.00 ANDA NO.:206597 THER APEUTICE USE: HORMONE MEDICAT ION IS USED TO PREVENT PREGN ANCY COMMERCIAL & CUSTOM IN VOICE NO. F22352005139 DT. 31 .01.2023 S/BILL NO: 7443041 DT 01-FEB-2023 NET WT. 2,062 .10 KGS 17 DATA LOGGERS S ET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK SPE CIALTY S.A. SWITZERLAND (GSSA ) PLACE NUMA-DROZ 2 NEUCHATE L - 2000 SWITZERLAND |
HS 652500 |
2023-03-03 |
28 PKG |
5334.34KG |
28 PALLETS 1571 CARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 300 4.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - TRE ATMENT OR PREVENTION OF HYP OKALEMIA FENOFIBRATE C AP 200MG 100 NDC CODE:68462 058201 FDA PRODUCT CODE NO. : 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE RE DUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMAR Y HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA T ACROLIMUS OINT 0.1% 100GM N DC CODE:68462053494 FDA PRO DUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 210393 THER APEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESS IVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO- SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 30GM NDC CODE:684 62053435 FDA PRODUCT CODE N O.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICA L IMMUNOSUPPRESSIVE OINT MENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE A TOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 1 00GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 30 04.49.00.50 ANDA NO.: 21039 3 THERAPEUTICE USE: - TA CROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERM ATITIS (ECZEMA). TA CROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRODU CT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAP EUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIV E OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SE VERE ATOPIC DERMATITIS ( ECZEMA). TACROLIMUS CA P 1MG 100 NDC CODE:68462068 601 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 AN DA NO.206662 THERAPEUTIC US E : TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANSPLANT NITROGLYC ERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA P RODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9 020 ANDA NO.:206391 THER APEUTIC USE: -MEDICATION US ED FOR HEART FAILURE,HIGH B LOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART TACROLIMUS OINT 0.1% 60GM NDC CODE:68 462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE U SE: - TACROLIMUS IS A TOPIC AL IMMUNOSUPPRESSIVE OIN TMENT USED FOR THE TREATMEN T OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). POTASSIUM CL ER CAP 1 0MEQ 100 NDC CODE:684620357 01 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.:202 868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA COMMERC IAL & CUSTOM INVOICE NO. F2 2387002027 DT. 31.01.2023 F 22387002028 DT. 31.01.2023 F22387002035 DT. 31.01.2023 F22387002040 DT. 31.01.2023 F22387002047 DT. 03.02.2023 F22387002048 DT. 03.02.2023 F22387002049 DT. 03.02.202 3 F22387002050 DT. 03.02.20 23 NET WT. 2609.99 KGS 1 1 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGR EES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES S/B ILL NO: 4001523 DT: 03/02/2023 S/BILL NO: 4001514 DT: 03/02 /2023 S/BILL NO: 4001524 DT: 03/02/2023 S/BILL NO: 4001519 DT: 03/02/2023 S/BILL NO: 40 01516 DT: 03/02/2023 S/BILL N O: 4001521 DT: 03/02/2023 S/B ILL NO: 4001518 DT: 03/02/2023 S/BILL NO: 4001522 DT: 03/02 /2023 NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLE NMARK SPECIALTY S.A. SWITZE RLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWI |
HS 300490 |
2023-03-03 |
23 PKG |
3164.77KG |
23 PALLETS 690 CARTONS P HARMACEUTICALS AS UNDER ES TRADIOL VAG INSERTS 10MCG 18 NDC CODE:68462071188 NDC NO.: 68462071188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO. : 3006.60.00.00 ANDA NO.:210 264 THERAPEUTICE USE:THE TRE ATMENT OF ATROPIC VAGINITIS D UE TO MENOPAUSE. COMMERCIA L & CUSTOM INVOICE NO. F22352 005192 DT. 31.01.2023 S/BILL NO: 7443708 DT 01-FEB-2023 N ET WT. 2,384.64 KGS 01 DATA L OGGERS SET TEMPERATURE : +2 0 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 642800 |
2023-03-03 |
45 PKG |
10385.17KG |
45 PALLETS 4053 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 3.125MG 100 NDC CO DE:68462016201 FDA PRODUCT CO DE NO - 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.: - 78-251 THERAPEUTICE USE:-B ETA- ADRENOACEPTOR ANTAGONIS T CARVEDILOL TAB 3.125MG 50 0 NDC CODE:68462016205 FDA P RODUCT CODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTIC E USE:-BETA- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 1 2.5MG 500 NDC CODE:6846201640 5 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST CARVEDIL OL TAB 3.125MG 500 NDC CODE:6 8462016205 FDA PRODUCT CODE N O ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78 -251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 12.5MG 500 ND C CODE:68462016405 FDA PRODUC T CODE NO : 62 O C A 22 H. T . S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE US E:-BETA- ADRENOACEPTOR ANTAG ONIST PRAMIPEXOLE TAB 0.125 MG 90 NDC CODE:68462033090 F DA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92. 40 ANDA NO.: 90-781 THERAPEU TICE USE: USED IN PARKINSONS DISEASE GABAPENTIN TAB 600M G 500 NDC CODE:68462012605 F DA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.3 0 ANDA NO.:-77-662 THERAPEUT ICE USE:-ANTICONVULSANT AGEN T PRAVASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PRODUCT CODE NO.: 61 J C A 1 3 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTI CE USE: -HYPOLIPDAEMIC OND ANSETRON TAB 4MG 30 NDC CODE: 68462010530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 7 7-535 THERAPEUTICE USE:-ANTI -EMETIC CLOTRIMAZOLE CREAM 1% 45GM NDC CODE:68462018147 FDA PRODUCT CODE NO :61 W C J 04 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 90-219 THERAP EUTICE USE: TREATMENT OF CAND IDIASIS COMMERCIAL & CUSTOM INVOICE NO. F22352005216 DT. 02.02.2023 F22352005217 DT. 02.02.2023 F22352005218 DT. 0 2.02.2023 F22352005220 DT. 02 .02.2023 F22352005221 DT. 02. 02.2023 F22352005226 DT. 03.0 2.2023 F22352005219 DT. 02.02 .2023 NET WT. 8180.597 KGS 0 2 DATA LOGGERS S/BILL NO: 7 515762 DT 03-FEB-2023 S/BILL NO: 7514936 DT 03-FEB-2023 S/ BILL NO: 7514937 DT 03-FEB-202 3 S/BILL NO: 7515671 DT 03-FE B-2023 S/BILL NO: 7515706 DT 03-FEB-2023 S/BILL NO: 751568 6 DT 03-FEB-2023 S/BILL NO: 7 516844 DT 03-FEB-2023 SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 622200 |
2023-03-03 |
14 PKG |
2594.14KG |
14 PALLETS 847 CARTONS P HARMACEUTICALS AS UNDER RO SUVASTATIN TAB 10MG 90 NDC C ODE:68462026290 FDA PRODUCT C ODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 20MG 1000 NDC CODE:68462026310 FDA PR ODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 A NDA NO.: 79172 THERAPEUTICE U SE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DI SEASE ROSUVASTATIN TAB 10MG 1000 NDC CODE:68462026210 6 1 J C A 16 3004.49.00.10 791 72 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DIS EASE ROSUVASTATIN TAB 10MG 1000 NDC CODE:68462026210 61 J C A 16 3004.49.00.10 7917 2 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND T O PREVENT CARDIOVASCULAR DISE ASE ROSUVASTATIN TAB 10MG 1 000 NDC CODE:68462026210 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLESTEROL A ND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE COMMERCIAL & CUSTOM INVO ICE NO. F22352005149 DT. 31.0 1.2023 F22352005170 DT. 31.01 .2023 F22352005187 DT. 31.01. 2023 F22352005188 DT. 31.01.2 023 S/BILL NO: 7457454 DT 02- FEB-2023 S/BILL NO: 7457448 D T 02-FEB-2023 S/BILL NO: 7457 449 DT 02-FEB-2023 S/BILL NO: 7457469 DT 02-FEB-2023 NET WT . 2193.012 KGS 14 DATA LOGGER S SET TEMPERATURE : +20 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND |
HS 611600 |
2023-03-03 |
2 PKG |
337.48KG |
2 PALLETS 59 CARTONS PHA RMACEUTICALS AS UNDER ROSUV ASTATIN TAB 20MG 1000 NDC COD E:68462026310 FDA PRODUCT COD E NO.: 61 J C A 16 H. T. S N O.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO . F22352005222 DT. 02.02.2023 NET WT.301.53 KGS 02 DATA L OGGERS SET TEMPERATURE : +2 0 DEGREES NOTIFY PARTY:2 G LENMARK SPECIALTY S.A. SWITZE RLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLA ND S/BILL NO: 7514934 DT 03 -FEB-2023 |
HS 290719 |
2023-02-22 |
38 PKG |
5684.06KG |
38 PALLETS 1889 CARTONS P HARMACEUTICALS AS UNDER NOR ETHINDRONE TAB 0.35MG 84 NDC CODE:68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO .:91-209 THERAPEUTICE USE: P REVENTION OF PREGNANCY. NOR ETH ACE/EE TAB 1/0.02MG 63 ND C CODE:68462013281 FDA PRODUC T CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 ANDA N O.:206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOME TRIOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIAL & CUS TOM INVOICE NO. F22352004921 DT. 20.01.2023 F22352004926 D T. 20.01.2023 S/BILL NO: 7148 632 DT 21-JAN-2023 S/BILL NO: 7149897 DT 21-JAN-2023 NET W T. 3974.640 KGS 02 DATA LOGGE RS NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEM PLEX 2, DUBAI DUBAI UTD.ARA B EMIR. |
HS 652600 |
2023-02-22 |
11 PKG |
4120.5KG |
11 PALLETS 514 CARTONS PHARMACEUTICALS AS UNDER NAPROXEN TAB 500MG 500 NDC CO DE:68462019005 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC GABAPENTIN TAB 800MG 500 NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-662 THERAPEUTICE USE: -ANTICONVULSANT AGENT COMM ERCIAL & CUSTOM INVOICE NO. F 22352005012 DT. 24.01.2023 NE T WT. 3760.897 KGS 00 DATA LO GGERS S/BILL NO: 7268134 DT 25-JAN-2023 NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINE SS CENTRE, LEVEL NO. 8, JEWEL LERY & GEMPLEX 2, DUBAI DUBA I UTD.ARAB EMIR. |
HS 616900 |
2023-02-22 |
4 PKG |
1023.78KG |
4 PALLETS 126 CARTONS PHARMACEUTICALS AS UNDER N ITROGLYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 F DA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.902 0 ANDA NO.:206391 THERAPEUTI C USE: -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRES SURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH B LOOD FLOW TO THE HEART COM MERCIAL & CUSTOM INVOICE NO. F22387001957 DT. 23.01.2023 N ET WT. 67.134 KGS 04 DATA LOG GERS S/BILL NO: 4000923 DT: 24.01.2023 NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWITZER LAND |
HS 662800 |
2023-02-22 |
37 PKG |
8494.11KG |
37 PALLETS 1886 CARTONS PHARMACEUTICALS AS UNDER TA CROLIMUS OINT 0.1% 30GM NDC C ODE:68462053435 FDA PRODUCT C ODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO. : 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMU NOSUPPRESSIVE OINTMENT USED F OR THE TREATMENT OF MODERATE -TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 60GM NDC CODE:6846205346 5 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49 .00.50 ANDA NO.: 210393 THER APEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATM ENT OF MODERATE-TO-SEVERE AT OPIC DERMATITIS (ECZEMA). PRAVASTATIN SOD TAB 20MG 500 NDC CODE:68462019605 FDA PROD UCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 AND A NO.:-77-987 THERAPEUTICE U SE:-HYPOLIPDAEMIC PRAVASTAT IN SOD TAB 80MG 90 NDC CODE:6 8462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77- 987 THERAPEUTICE USE:-HYPOLI PDAEMIC INDOMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA PRODUCT CODE: 62 GCE42 H. T. S NO.:3004.90.92.40 A NDA NO.203501 THERAPEUTIC USE : INDOMETHACIN IS USED TO RE LIEVE PAIN, SWELLING, AND JOI NT STIFFNESS CAUSED BY ARTHRI TIS, GOUT, BURSITIS, AND TEND ONITIS. IT IS ALSO USED TO RE LIEVE PAIN FROM VARIOUS OTHER CONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID ). ... THIS EFFECT HELPS TO DECREASE SWELLING AND PAIN. CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA N O.:- 78-251 THERAPEUTICE USE :-BETA- ADRENOACEPTOR ANTAGO NIST PRAVASTATIN SOD TAB 20 MG 500 NDC CODE:68462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92 .20 ANDA NO.:-77-987 THERAPE UTICE USE:-HYPOLIPDAEMIC T ACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). COMMERCIAL & CU STOM INVOICE NO. F22387001958 DT. 23.01.2023 F22387001961 DT. 23.01.2023 F22387001962 D T. 23.01.2023 F22387001965 DT . 23.01.2023 S/BILL NO: 400 0922 DT: 24.01.2023 S/BILL N O: 4000921 DT: 24.01.2023 S/ BILL NO: 4000926 DT: 24.01.20 23 S/BILL NO: 4000924 DT: 24 .01.2023 NET WT. 5931.653 KGS 02 DATA LOGGERS HUMIDIT Y:65% SET TEMPERATURE : +20 D EGREES TEMPERATURE RANGE : +1 5 DEGREES TO +25 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 640800 |
2023-02-22 |
8 PKG |
1674.24KG |
8 PALLETS 570 CARTONS PH ARMACEUTICALS AS UNDER NAPR OXEN TAB 250MG 100 NDC CODE:6 8462018801 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 250 THERAPEUTICE USE:-ANTI-I NFLAMMATORY, ANALGESIC NAP ROXEN TAB 250MG 500 NDC CODE: 68462018805 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC OL MESARTAN MEDOX TAB 5MG 90 NDC CODE:68462043690 FDA PRODUCT CODE NO.:62CCA68 H. T. S NO .: 3004.90.9220 ANDA NO.: 20 3281 THERAPEUTICE USE: :#TRE ATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENS IVE AGENTS, TO LOWER BLOOD PR ESSURE COMMERCIAL & CUSTOM INVOICE NO. F22352004943 DT. 21.01.2023 F22352004942 DT. 2 1.01.2023 S/BILL NO: 7189624 DT 23-JAN-2023 S/BILL NO:7202 306 DT 23-JAN-2023 NET WT. 13 69.24 KGS 01 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 624900 |
2023-02-22 |
33 PKG |
5766.62KG |
33 PALLETS 2855 CARTONS PHARMACEUTICALS AS UNDER NO RETH ACE/EE TAB 1/0.02MG 63 N DC CODE:68462013281 FDA PRODU CT CODE NO.:65 J C A 25 H. T . S NO.: 3006.60.00.00 ANDA NO.:206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOM ETRIOS IS AND ABNORMAL UTERIN E BLEEDING FLUCONAZOLE TAB 100MG 30 NDC CODE:6846201023 0 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90 .92.45 ANDA NO.:-77 - 253 TH ERAPEUTICE USE:-ANTIFUNGAL OLMESARTAN MEDOX TAB 5MG 30 NDC CODE:68462043630 FDA PROD UCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO. : 203281 THERAPEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPE RTENSIVE AGENTS, TO LOWER BLO OD PRESSURE COMMERCIAL & CU STOM INVOICE NO. F22352004927 DT. 20.01.2023 F22352004956 DT. 21.01.2023 F22352004957 D T. 21.01.2023 S/BILL NO: 7163 994 DT 21-JAN-2023 S/BILL NO: 7199212 DT 23-JAN-2023 S/BIL L NO:7199212 DT 23-JAN-2023 N ET WT. 4106.39 KGS 02 DATA LO GGERS NOTIFY PARTY:2 SHORO UQ COMMODITIES TRADING DMCC U NIT NO. 98, DMCC BUSINESS CENT RE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD. ARAB EMIR. |
HS 652500 |
2023-02-22 |
8 PKG |
1891.06KG |
8 PALLETS 992 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 40MG 30 NDC CODE :68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE N O. F22352004958 DT. 22.01.202 3 S/BILL NO:7197153 DT 23-JAN -2023 NET WT.1507.854 KGS 08 DATA LOGGERS NOTIFY PARTY: 2 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE NUMA-D ROZ 2 NEUCHATEL - 2000 SWITZ ERLAND |
HS 684620 |
2023-02-22 |
11 PKG |
2447.63KG |
11 PALLETS 1586 CARTONS PH ARMACEUTICALS AS UNDER THEO PHYLLINE ER TAB 300MG 100 NDC CODE:68462072101 63 B C B 30 3004.90.92.85 212184 TO RE LEASE TABLETS ARE INDICATED F OR THE TREATMENT OF THE SYMP TOMS AND REVERSIBLE AIRFLOW OBSTRUCTION ASSOCIATED WITH C HRONIC ASTHMA AND OTHER CHRO NIC LUNG DISEASES, E.G., EMPH YSEMA AND CHRONIC BRONCHITIS TOPIRAMATE TAB 25MG 500 ND C CODE:68462010805 FDA PRODUC T CODE NO.: 61 M C A 40 H. T . S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVULSANT TOPIRAMATE TAB 25MG 500 NDC CODE:6846201 0805 FDA PRODUCT CODE NO.: 6 1 M C A 40 H. T. S NO.: 3004 .49.00.20 ANDA NO.:077627 TH ERAPEUTICE USE: ANTICONVULSAN T TOPIRAMATE TAB 25MG 60 N DC CODE:68462010860 FDA PRODU CT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTICE U SE:-ANTICONVULSANT COMMERCI AL & CUSTOM INVOICE NO. F2235 2005033 DT. 25.01.2023 F22352 005034 DT. 25.01.2023 F223520 05032 DT. 25.01.2023 S/BILL NO: 7289432 DT 27-JAN-2023 S /BILL NO: 7296854 DT 27-JAN-20 23 S/BILL NO: 7285420 DT 27-J AN-2023 NET WT. 1844.447 KGS 01 DATA LOGGERS HUMIDITY :65% SET TEMPERATURE : +20 DE GREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 614000 |
2023-02-22 |
2 PKG |
331.13KG |
2 PALLETS 90 CARTONS PHA RMACEUTICALS AS UNDER ALYAC EN 777 TAB 0.5,0.75,1/0.035MG 84 NDC CODE:68462055629 FDA PRODUCT CODE NO.: 65 J D A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.: 091636 THERAPEUTIC E USE: ORAL CONTRACEPTIVE COMMERCIAL & CUSTOM INVOICE NO. F22352004918 DT. 20.01.20 23 S/BILL NO:7143008 DT 20-JA N-2023 NET WT.248.400 KGS 00 DATA LOGGERS NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652400 |
2023-02-22 |
22 PKG |
3791.64KG |
22 PALLETS 1260 CARTONS PHARMACEUTICALS AS UNDER RO SUVASTATIN TAB 10MG 90 NDC CO DE:68462026290 FDA PRODUCT CO DE NO.:61 J C A 16 H. T. S N O.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PR EVENT CARDIOVASCULAR DISEASE HAILEY FE 1.5/30 TAB 1.5MG/ 30MCG-75MG 84 NDC CODE:684620 50329 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 300 6.60.00.00 ANDA NO.:206597 T HERAPEUTICE USE: HORMONE MEDI CATION IS USED TO PREVENT PR EGNANCY COMMERCIAL & CUSTOM INVOICE NO. F22352005008 DT. 24.01.2023 F22352005017 DT. 25.01.2023 NET WT. 2817.506 K GS 22 DATA LOGGERS S/BILL NO: 7273521 DT. 25-JAN-2023 S /BILL NO: 7265658 DT 25-JAN-20 23 NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND |
HS 652500 |
2023-02-22 |
9 PKG |
2089.74KG |
9 PALLETS 726 CARTONS PHARMACEUTICALS AS UNDER T HEOPHYLLINE ER TAB 300MG 100 NDC CODE:68462072101 63 B C B 30 3004.90.92.85 212184 TO RELEASE TABLETS ARE INDICATE D FOR THE TREATMENT OF THE S YMPTOMS AND REVERSIBLE AIRFLO W OBSTRUCTION ASSOCIATED WIT H CHRONIC ASTHMA AND OTHER C HRONIC LUNG DISEASES, E.G., E MPHYSEMA AND CHRONIC BRONCHIT IS NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PROD UCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 AND A NO.:-78-250 THERAPEUTICE U SE:-ANTI-INFLAMMATORY, ANALGE SIC TOPIRAMATE TAB 25MG 60 NDC CODE:68462010860 FDA PRO DUCT CODE NO.:-61 M C A 40 H . T. S NO.: 3004.49.00.20 AN DA NO.:- 77-627 THERAPEUTICE USE:-ANTICONVULSANT COMMER CIAL & CUSTOM INVOICE NO. F22 352005007 DT. 24.01.2023 F223 52005009 DT. 24.01.2023 NET W T.1620.153 KGS 01 DATA LOGGER S S/BILL NO: 7271100 DT 25- JAN-2023 S/BILL NO: 7268108 D T 25-JAN-2023 NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 624900 |
2023-02-22 |
34 PKG |
5809.71KG |
34 PALLETS 1674 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 600MG 500 NDC CO DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT CICLOPIR OX GEL 0.77% 100GM NDC CODE:6 8462045594 FDA PRODUCT CODE N O.: 61WCJ43 H. T. S NO.: 30 04.49.00.50 ANDA NO.: 091595 THERAPEUTICE USE: - ANTIFUNG AL NORETH ACE/EE TAB 1/0.02 MG 63 NDC CODE:68462013281 F DA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.0 0 ANDA NO.:206969 THERAPEUTI CE USE: - SECONDARY AMENORRH EA,ENDOMETRIOS IS AND ABNORMA L UTERINE BLEEDING COMMERC IAL & CUSTOM INVOICE NO. F223 52004946 DT. 21.01.2023 F2235 2004959 DT. 22.01.2023 F22352 004969 DT. 23.01.2023 S/BILL NO: 7189612 DT 23-JAN-2023 S /BILL NO: 7189418 DT 23-JAN-20 23 S/BILL NO: 7200133 DT 23-J AN-2023 NET WT.4402.29 KGS 0 2 DATA LOGGERS NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 614300 |
2023-02-22 |
29 PKG |
5647.32KG |
29 PALLETS 2288 CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 5MG 1000 N DC CODE:68462026110 FDA PRODU CT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE. ROSUVASTATIN TAB 10MG 9 0 NDC CODE:68462026290 FDA P RODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 A NDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTE ROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 5 MG 90 NDC CODE:68462026190 F DA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.1 0 ANDA NO.: 079172 THERAPEUT ICE USE: - TO TREAT HIGH CHOL ESTEROL AND RELATED CONDITION S, AND TO PREVENT CARDIOVASC ULAR DISEASE ACYCLOVIR OINT 5% 30GM NDC CODE:68462074635 FDA PRODUCT CODE NO.: 62 V C J 18 H. T. S NO.: 3004.49. 00.50 ANDA NO.: 205510 THERA PEUTICE USE: - AN ANTIVIRAL M EDICINE USED TO TREAT OR PREV ENT INFECTIONS CAUSED BY CERT AIN KINDS OF VIRUSES. EXAMPLE S OF THESE INFECTIONS INCLUDE HERPES AND SHINGLES HAILE Y FE 1.5/30 TAB 1.5MG/30MCG-75 MG 84 NDC CODE:68462050329 F DA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.:206597 THERAPEUT ICE USE: HORMONE MEDICATION I S USED TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F22352005027 DT. 25.01.2 023 F22352005028 DT. 25.01.20 23 F22352005026 DT. 25.01.202 3 F22352005040 DT. 27.01.2023 S/BILL NO: 7296844 DT 27-J AN-2023 S/BILL NO: 7289435 DT 27-JAN-2023 S/BILL NO: 72968 47 DT 27-JAN-2023 S/BILL NO: 7293384 DT 27-JAN-2023 NE T WT: 4247.905 KGS 29 DATA L OGGERS HUMIDITY:65% SET TEMP ERATURE : +20 DEGREES TEMPERA TURE RANGE : +15 DEGREES TO +2 5 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2 000 SWITZERLAND |
HS 611600 |
2023-02-14 |
7 PKG |
1520.92KG |
7 PALLETS 370 CARTONS PHAR MACEUTICALS AS UNDER NITROG LYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART SOLIFENA CIN SUCCINATE TAB 5MG 90 NDC CODE:68462038690 FDA PRODUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICATED FOR THE TR EATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINAR Y INCONTINENCE, URGENCY AND URINARY FREQUENCY COMMERCIA L & CUSTOM INVOICE NO. F22387 001933 DT. 17.01.2023 F223870 01934 DT. 17.01.2023 S/BILL N O: 4000653 DT:18.01.2023 S/BI LL NO: 4000654 DT:18.01.2023 NET WT: 148.109 KGS 07 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLEN MARK SPECIALTY S.A. SWITZERLA ND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 662800 |
2023-02-14 |
16 PKG |
2430.84KG |
16 PALLETS 793 CARTONS P HARMACEUTICALS AS UNDER NOR ETHINDRONE TAB 0.35MG 84 NDC CODE:68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO .:91-209 THERAPEUTICE USE: P REVENTION OF PREGNANCY. COM MERCIAL & CUSTOM INVOICE NO. F22352004899 DT. 19.01.2023 S /BILL NO: 7116139 DT 20-JAN-20 23 NET WT.1731.910 KGS 01 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 652600 |
2023-02-14 |
30 PKG |
5498.09KG |
30 PALLETS 639 CARTONS P HARMACEUTICALS AS UNDER MUP IROCIN OINT 2% 22GM NDC CODE: 68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO. : 3004.90.92.45 ANDA NO.: 90 -480 THERAPEUTICE USE: - AN TI-BACTERIAL MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 90-480 THERA PEUTICE USE: - ANTI-BACTERIAL FLUCONAZOLE TAB 150MG 12UD NDC CODE:68462011944 NDC CO DE : 68462011944 HTS NO : 30 04.90.92.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 TH ERAPEUTICE USE : ANTIFUNGAL COMMERCIAL & CUSTOM INVOICE NO. F22352004869 DT. 17.01.20 23 F22352004881 DT. 18.01.202 3 F22352004893 DT. 19.01.2023 S/BILL NO: 7077844 DT 19-JAN -2023 S/BILL NO: 7077822 DT 1 9-JAN-2023 S/BILL NO: 7077847 DT 19-JAN-2023 NET WT. 4408. 63 KGS 02 DATA LOGGERS TEM P. +20 NOTIFY PARTY:2 SHOROU Q COMMODITIES TRADING DMCC UN IT NO. 98, DMCC BUSINESS CENTR E, LEVEL NO. 8, JEWELLERY & G EMPLEX 2, DUBAI DUBAI UTD.A RAB EMIR. |
HS 300490 |
2023-02-14 |
24 PKG |
4449.36KG |
24 PALLETS 1154 CARTONS PHAR MACEUTICALS AS UNDER NORGES T/EE TAB 0.25/0.035MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO .: 200538 THERAPEUTICE USE: - ORAL CONTRACEPTIVES COMME RCIAL & CUSTOM INVOICE NO. F2 2352004901 DT. 19.01.2023 S/B ILL NO: 7116127 DT 20-JAN-2023 NET WT.3386.760KGS 01 DATA LOGGERS TEMP. +20 NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA |
HS 652700 |
2023-02-14 |
12 PKG |
2415.42KG |
12 PALLETS 966 CARTONS P HARMACEUTICALS AS UNDER ROS UVASTATIN TAB 20MG 90 NDC CO DE:68462026390 FDA PRODUCT CO DE NO.:61 J C A 16 H. T. S N O.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PR EVENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352004891 DT. 19.01.2 023 S/BILL NO: 7077846 DT 19- JAN-2023 NET WT: 1924.260 KGS 12 DATA LOGGERS TEMP. 20 C NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 293379 |
2023-02-14 |
34 PKG |
8189.29KG |
34 PALLETS 1855 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TAB 600MG 500 NDC COD E:68462012605 FDA PRODUCT COD E NO: 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-662 THERAPEUTICE USE:-ANTI CONVULSANT AGENT TACROLIMU S OINT 0.1% 30GM NDC CODE:684 62053435 FDA PRODUCT CODE NO. : 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 21039 3 THERAPEUTICE USE: - TACROL IMUS IS A TOPICAL IMMUNOSUPPR ESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEV ERE ATOPIC DERMATITIS (ECZEM A). POTASSIUM CL ER CAP 10M EQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92. 90 ANDA NO.:202868 THERAPEUT ICE USE: - TREATMENT OR PREVE NTION OF HYPOKALEMIA CARV EDILOL TAB 25MG 500 NDC CODE: 68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F22387001914 DT. 14.01.20 23 F22387001931 DT. 17.01.202 3 F22387001932 DT. 17.01.2023 S/BILL NO:4000647 DT: 18.01. 2023 S/BILL NO: 4000650 DT: 1 8.01.2023 S/BILL NO: 4000651 DT: 18.01.2023 NET WT: 5195.3 41 KGS 02 DATA LOGGERS SE T TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 640800 |
2023-02-14 |
11 PKG |
2536.53KG |
11 PALLETS 834 CARTONS P HARMACEUTICALS AS UNDER NIT ROGLYCERIN SUBLING TAB 0.4MG 4 X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HE ART FAILURE,HIGH BLOOD PRESSU RE,AND TO TREAT AND PREVENT C HEST PAIN FROM NOT ENOUGH BLO OD FLOW TO THE HEART SOLIF ENACIN SUCCINATE TAB 5MG 30 N DC CODE:68462038630 FDA PRODU CT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA N O.: 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLAD DER WITH SYMPTOMS OF URGE URI NARY INCONTINENCE, URGENCY A ND URINARY FREQUENCY ASPIRI N-ER DIPYRIDAMOLE CAP 25/200MG 60 NDC CODE:68462040560 FDA PRODUCT CODE NO.: 60 L D F 0 5 H. T. S NO.: 3004.90.9220 ANDA NO.:210318 COMMERCIAL & CUSTOM INVOICE NO. F223870 01910 DT. 14.01.2023 S/BILL N O: 4000514 DT: 14.01.2023 N ET WT.1995.86 KGS 11 DATA LOG GERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 662800 |
2023-02-14 |
30 PKG |
7417.27KG |
30 PALLETS 1535 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 600MG 500 NDC CO DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT DILTIAZE M HCL ER CAP 12HR 120MG 100 N DC CODE:68462056201 62 O C B 24 3004.49.00.10 212317 FOR THE TREATMENT OF HYPERTENSIO N. PRAVASTATIN SOD TAB 20MG 90 NDC CODE:68462019690 FDA PRODUCT CODE NO.:-61 J C A 1 3 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTI CE USE:-HYPOLIPDAEMIC POTA SSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO .:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68462 035701 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 300 4.90.92.90 ANDA NO.:202868 T HERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA COMMERCIAL & CUSTOM INVOIC E NO. F22387001908 DT. 14.01. 2023 F22387001909 DT. 14.01.2 023 F22387001912 DT. 14.01.20 23 F22387001915 DT. 14.01.202 3 S/BILL NO: 400510 DT: 14.01 .2022 S/BILL NO: 400509 DT: 14.01.2022 S/BILL NO: 400507 DT: 14.01.2022 S/BILL NO: 400 511 DT: 14.01.2022 NET WT.481 6.118 KGS 02 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 611300 |
2023-02-14 |
16 PKG |
3426.04KG |
16 PALLETS 2005 CARTONS PHARMACEUTICALS AS UNDER ON DANSETRON TAB 8MG 30 NDC CODE :68462010630 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 7 7-535 THERAPEUTICE USE:-ANTI -EMETIC ONDANSETRON TAB 8M G 30 NDC CODE:68462010630 FD A PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUT ICE USE:-ANTI -EMETIC COMM ERCIAL & CUSTOM INVOICE NO. F 22352004831 DT. 14.01.2023 F2 2352004829 DT. 15.01.2023 S/B ILL NO: 7010282 DT 16-JAN-2023 S/BILL NO: 7010325 DT 16-JAN -2023 NET WT.2454.12 KGS 00 DATA LOGGERS NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINE SS CENTRE, LEVEL NO. 8, JEWEL LERY & GEMPLEX 2, DUBAI DUBA I UTD.ARAB EMIR. |
HS 684620 |
2023-02-14 |
27 PKG |
4256.58KG |
27 PALLETS 1638 CARTONS PHARMACEUTICALS AS UNDER ON DANSETRON ODT 8MG 10UD NDC CO DE:68462015811 FDA PRODUCT CO DE NO.:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-152 THERAPEUTICE USE:-ANT I -EMETIC NORGEST/EE TAB 0 .25/0.035MG 84 NDC CODE:68462 030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 30 06.60.00.00 ANDA NO.: 200538 THERAPEUTICE USE: - ORAL CON TRACEPTIVES COMMERCIAL & CU STOM INVOICE NO. F22352004823 DT. 14.01.2023 F22352004837 DT. 16.01.2023 S/BILL NO: 701 0324 DT 16-JAN-2023 S/BILL NO :7011186 DT 16-JAN-2023 NET W T.3073.200 KGS 02 DATA LOGGE RS SET TEMPERATURE : +20 DE GREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652700 |
2023-02-07 |
30 PKG |
6609.86KG |
30 PALLETS 2246 CARTONS PHA RMACEUTICALS AS UNDER OLMES ARTAN MEDOX TAB 5MG 30 NDC CO DE:68462043630 FDA PRODUCT CO DE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 2032 81 THERAPEUTICE USE: - -TREA TMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSI VE AGENTS, TO LOWER BLOOD PRE SSURE OXCARBAZEPINE TAB 600 MG 100 NDC CODE:68462013901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92 .30 ANDA NO.:-77-802 THERAPE UTICE USE:-ANTI CONVULSANT AG ENT NORETHINDRONE ACE TAB 5 MG 50 NDC CODE:68462030450 F DA PRODUCT CODE NO.65 J C A 2 5 H. T. S NO.: 3004.39.00.50 ANDA NO.:-91-090 THERAPEUTI CE USE:- SECONDARY AMENORRHE A,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING OMEPRAZO LE DR CAP 40MG 90 NDC CODE:68 462039790 FDA PRODUCT CODE NO .: 62KCF10 H. T. S NO.: 300 4.90.9160 ANDA NO.: 91672 TH ERAPEUTICE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL REF LUX DISEASE COMMERCIAL & C USTOM INVOICE NO. F2235200470 6 DT. 06.01.2023 F22352004701 DT. 06.01.2023 F22352004715 DT. 07.01.2023 S/BILL NO: 682 9796 DT 09-JAN-2023 S/BILL NO : 6761301 DT 06-JAN-2023 S/BI LL NO: 6828792 DT 09-JAN-2023 NET WT.5335.740 KGS 01 DATA LOGGERS NOTIFY PARTY:2 S HOROUQ COMMODITIES TRADING DMC C UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLER Y & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 614500 |
2023-02-07 |
12 PKG |
2072.04KG |
12 PALLETS 1109 CARTONS PHARMACEUTICALS AS UNDER HA ILEY 24 FE TAB 1MG/20MCG-75MG 84 NDC CODE:68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204847 THERAPEUTIC E USE: - CONTRACEPTION TO PRE VENT PREGNANCY ONDANSETRON TAB 4MG 30 NDC CODE:68462010 530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004. 90.92.40 ANDA NO.:- 77-535 T HERAPEUTICE USE:-ANTI -EMETIC COMMERCIAL & CUSTOM INVOIC E NO. F22352004699 DT. 06.01. 2023 F22352004711 DT. 07.01.2 023 S/BILL NO: 6761255 DT 06- JAN-2023 S/BILL NO: 6829986 D T 09-JAN-2023 NET WT.1480.87 KGS 00 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA |
HS 652500 |
2023-02-07 |
40 PKG |
6289.62KG |
40 PALLETS 2369 CARTONS PHARMACEUTICALS AS UNDER E STRADIOL VAG INSERTS 10MCG 8 NDC CODE:68462071171 FDA PROD UCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 AND A NO.:210264 THERAPEUTICE USE :THE TREATMENT OF ATROPIC VA GINITIS DUE TO MENOPAUSE. COMMERCIAL & CUSTOM INVOICE NO . F22352004758 DT. 11.01.2023 S/BILL NO: 6882287 DT 11-JAN -2023 NET WT.4491.620 KGS 02 DATA LOGGERS SET TEMPERATU RE : +18 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 642800 |
2023-02-07 |
5 PKG |
1222KG |
5 PALLETS 86 CARTONS PHA RMACEUTICALS AS UNDER CALCI POTRIENE CREAM 0.005% 60GM ND C CODE:68462050165 FDA PRODUC T CODE NO.: 62 N C J 04 H. T . S NO.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTICE USE: - TREATMENT OF PLAQUE PSORI ASIS IN ADULTS CALCIPOTRIEN E CREAM 0.005% 60GM NDC CODE: 68462050165 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO. : 3004.90.92.45 ANDA NO.: 20 5772 THERAPEUTICE USE: - TRE ATMENT OF PLAQUE PSORIASIS IN ADULTS COMMERCIAL & CUSTOM INVOICE NO. F22352004736 DT. 09.01.2023 F22352004733 DT. 09.01.2023 S/BILL NO: 6861560 DT 10-JAN-2023 S/BILL NO: 68 61569 DT 10-JAN-2023 NET WT.1 023.100 KGS 05 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (G SSA) PLACE NUMA-DROZ 2 NEUCH ATEL - 2000 SWITZERLAND |
HS 620400 |
2023-02-07 |
37 PKG |
9185.85KG |
37 PALLETS 2426 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 600MG 500 NDC CO DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT TACROLIM US OINT 0.1% 30GM NDC CODE:68 462053435 FDA PRODUCT CODE NO .: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 2103 93 THERAPEUTICE USE: - TACRO LIMUS IS A TOPICAL IMMUNOSUPP RESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SE VERE ATOPIC DERMATITIS (ECZE MA). PRAVASTATIN SOD TAB 10 MG 500 NDC CODE:68462019505 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92 .20 ANDA NO.:-77-987 THERAPE UTICE USE:-HYPOLIPDAEMIC P RAVASTATIN SOD TAB 20MG 500 N DC CODE:68462019605 FDA PRODU CT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE US E:-HYPOLIPDAEMIC PROPAFENON E HCL ER CAP 425MG 60 NDC COD E:68462041060 FDA CODES 63 E C F 28 HTS CODES 3004.49.00. 10 ANDA NO. 205268 THERAPEUT IC USE AN ANTIARRHYTHMIC AGEN T.IT IS USED TO TREAT IRREGUL AR HEART RHYTHM AND CAN SLOW RAPID HEARTBEATS. POTASSIU M CL ER CAP 10MEQ 500 NDC COD E:68462035705 FDA PRODUCT COD E NO.: 65 R C F 14 H. T. S N O.: 3004.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - T REATMENT OR PREVENTION OF HYP OKALEMIA FENOFIBRATE CAP 67 MG 100 NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 205566 THERAPEUT ICE USE: - INDICATED AS ADJUN CTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C , TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY H YPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA GABAPENTIN TAB 600MG 500 NDC CODE:684620126 05 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90 .92.30 ANDA NO.:-77-662 THER APEUTICE USE:-ANTICONVULSANT AGENT BISOPROLOL-HCTZ TAB 10/6.25MG 100 NDC CODE:684620 88001 FDA PRODUCT CODE NO.: 62 O D A 18 H. T. S NO.: 300 4.40.00.20 ANDA NO.: 215995 THERAPEUTICE USE: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZ IDE TABLETS ARE INDICATED IN THE MANAGEMENT OF HYPERTENS ION. FENOFIBRATE CAP 67MG 1 00 NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 A NDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIV E THERAPY TO DIET FOR THE RE DUCTION OF LDL-C, TOTAL-C, TR IGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPER CHOLESTEROLEMIA OR MIXED DYSL IPIDEMIA GABAPENTIN TAB 600 MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92. 30 ANDA NO.:-77-662 THERAPEU TICE USE:-ANTICONVULSANT AGE NT COMMERCIAL & CUSTOM INVO ICE NO. F22387001880 DT. 10.0 1.2023 F22387001879 DT. 10.01 .2023 F22387001877 DT. 10.01. 2023 F22387001875 DT. 10.01.2 023 F22387001882 DT. 11.01.20 23 F22387001885 DT. 11.01.202 3 NET WT.6729.197 KGS 02 DAT A LOGGERS NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA S/B ILL NO: 4000334 DT: 11.01.2023 S/BILL NO: 4000338 DT: 11.01 .2023 S/BILL NO: 4000335 DT: 11.01.2023 S/BILL NO: 4000336 DT: 11.01.2023 S/BILL NO: 40 00345 DT: 11.01.2023 S/BILL N O: 4000360 DT: 11.01.2023 |
HS 300449 |
2023-02-07 |
42 PKG |
9454.84KG |
42 PALLETS 3262 CARTONS PH ARMACEUTICALS AS UNDER ALYA CEN 1/35 TAB 1/0.035MG 84 NDC CODE:68462039429 FDA PRODUCT CODE NO.: 65 J D A 24 H. T. S NO.: 3006.60.00.00 ANDA N O.: 091634 THERAPEUTICE USE: ORALCONTRACEPTIVE OMEPRAZO LE DR CAP 40MG 30 NDC CODE:68 462039730 FDA PRODUCT CODE NO .: 62KCF10 H. T. S NO.: 300 4.90.9160 ANDA NO.: 91672 TH ERAPEUTICE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL REF LUX DISEASE PRAVASTATIN SO D TAB 40MG 500 NDC CODE:68462 019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 30 04.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: -HYPOLIPDA EMIC ROPINIROLE TAB 1MG 100 NDC CODE:68462025501 FDA PR ODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 A NDA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT OF PARKINSON ISM PRAMIPEXOLE TAB 0.25MG 90 NDC CODE:68462033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTIC E USE: USED IN PARKINSON#S DI SEASE COMMERCIAL & CUSTOM I NVOICE NO. F22352004719 DT. 0 7.01.2023 F22352004716 DT. 07 .01.2023 F22352004717 DT. 07. 01.2023 F22352004718 DT. 07.0 1.2023 S/BILL NO: 6832386 DT 09-JAN-2023 S/BILL NO: 682880 2 DT 09-JAN-2023 S/BILL NO: 6 830901 DT 09-JAN-2023 S/BILL NO: 6829427 DT 09-JAN-2023 NE T WT.7447.980 KGS 02 DATA LOG GERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 SHO ROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CE NTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UT D.ARAB EMIR |
HS 652400 |
2023-02-07 |
3 PKG |
739.82KG |
3 PALLETS 92 CARTONS PHA RMACEUTICALS AS UNDER NITRO GLYCERIN SUBLING TAB 0.4MG 4X2 5 NDC CODE:68462063945 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 A NDA NO.:206391 THERAPEUTIC US E: -MEDICATION USED FOR HEAR T FAILURE,HIGH BLOOD PRESSURE ,AND TO TREAT AND PREVENT CHE ST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERC IAL & CUSTOM INVOICE NO. F223 87001878 DT. 10.01.2023 NET W T.49.017 KGS 03 DATA LOGGERS NOTIFY PARTY:2 GLENMARK SP ECIALTY S.A. SWITZERLAND (GSS A) PLACE NUMA-DROZ 2 NEUCHAT EL - 2000 SWITZERLAND S/BI LL NO: 4000339 DT: 11.01.2023 |
HS 662800 |
2023-02-07 |
8 PKG |
1768.59KG |
8 PALLETS 474 CARTONS P HARMACEUTICALS AS UNDER FEL ODIPINE ER TAB 10MG 100 NDC C ODE:68462023501 FDA PRODUCT C ODE NO.: 62OCB32 H. T. S NO. : 3004.90.92.20 ANDA NO.: 90 -365 THERAPEUTICE USE: - TRE ATMENT OF HYPERTENSION PRA MIPEXOLE TAB 0.25MG 90 NDC CO DE:68462033190 FDA PRODUCT CO DE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USE D IN PARKINSON#S DISEASE C OMMERCIAL & CUSTOM INVOICE NO. F22352004735 DT. 09.01.2023 F22352004737 DT. 09.01.2023 S/BILL NO:6862618 DT 10-JAN-20 23 S/BILL NO:6861324 DT 10-JA N-2023 NET WT.1457.258 KGS 0 1 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIFY PA RTY:2 SHOROUQ COMMODITIES TRA DING DMCC UNIT NO. 98, DMCC B USINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR. |
HS 210690 |
2023-01-31 |
14 PKG |
3769.42KG |
14 PALLETS 1082 CARTONS PHAR MACEUTICALS AS UNDER PRAMIP EXOLE TAB 0.125MG 90 NDC CODE :68462033090 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO .: 3004.90.92.40 ANDA NO.: 9 0-781 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE VER APAMIL HCL ER TAB 240MG 100 N DC CODE:68462026001 FDA PRODU CT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-78-906 THERAPEUTICE US E:-ANGINA VERAPAMIL HCL ER TAB 180MG 100 NDC CODE:684620 29301 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 300 4.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - -ANGINA COMMERCIAL & CUSTOM INVOICE NO. F22352004588 DT. 30.12.20 22 S/BILL NO: 6703524 DT 04-J AN-2023 NET WT. 3044.24 KGS 00 DATA LOGGERS NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 684620 |
2023-01-31 |
8 PKG |
788.81KG |
8 PALLETS 128 CARTONS PHARMACEUTICALS AS UNDER LE VONORGESTREL/EE TAB 0.15/0.03M G 273 NDC CODE:68462067295 F DA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.000 0 ANDA NO.: 203164 THERAPEUT ICE USE: - CONTRACEPTION TO P REVENT PREGNANCY COMMERCIA L & CUSTOM INVOICE NO. F22352 004650 DT. 31.12.2022 NET WT. 559.12 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA S/BILL NO: 6 614871 DT 31-DEC-2022 |
HS 642900 |
2023-01-31 |
26 PKG |
5843.73KG |
26 PALLETS 1380 CARTONS P HARMACEUTICALS AS UNDER PRA VASTATIN SOD TAB 20MG 500 NDC CODE:68462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA N O.:-77-987 THERAPEUTICE USE: -HYPOLIPDAEMIC POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68 462035701 FDA PRODUCT CODE N O.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATME NT OR PREVENTION OF HYPOKALE MIA POTASSIUM CL ER CAP 10M EQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92 .90 ANDA NO.: 202868 THERAPE UTICE USE: - TREATMENT OR PRE VENTION OF HYPOKALEMIA COMME RCIAL & CUSTOM INVOICE NO. F2 2387001799 DT. 31.12.2022 F22 387001825 DT. 31.12.2022 NET WT.3274.916 KGS 02 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO:4000042 DT: 03.01.2023 S/B ILL NO: 4000047 DT: 03.01.2023 |
HS 611300 |
2023-01-31 |
32 PKG |
5222.3KG |
32 PALLETS 1436 CARTONS PHARMACEUTICALS AS UNDER NORETHINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PROD UCT CODE NO.65 J C A 25 H. T . S NO.: 3004.39.00.50 ANDA NO.:-91-090 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOM ETRIOS IS AND ABNORMAL UTERI NE BLEEDING NORETHINDRONE T AB 0.35MG 84 NDC CODE:6846203 0529 FDA PRODUCT CODE NO.: 6 5 J C A 26 H. T. S NO.: 3006 .60.00.00 ANDA NO.:91-209 TH ERAPEUTICE USE: PREVENTION OF PREGNANCY. HAILEY 24 FE TA B 1MG/20MCG-75MG 84 NDC CODE: 68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO. : 3006.60.00.00 ANDA NO.: 20 4847 THERAPEUTICE USE: - CON TRACEPTION TO PREVENT PREGNAN CY NORETHINDRONE ACE TAB 5M G 50 NDC CODE:68462030450 FD A PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.:-91-090 THERAPEUTIC E USE:- SECONDARY AMENORRHEA ,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIA L & CUSTOM INVOICE NO. F22352 004583 DT. 30.12.2022 F223520 04613 DT. 31.12.2022 F2235200 4614 DT. 31.12.2022 01 DATA L OGGERS S/BILL NO: 6595354 D T 31-DEC-2022 S/BILL NO: 6605 260 DT 31-DEC-2022 S/BILL NO: 6609754 DT 31-DEC-2022 NET WT: 3867.78 KGS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 652500 |
2023-01-31 |
44 PKG |
11691.09KG |
44 PALLETS 3568 CARTONS PHARMACEUTICALS AS UNDER V ERAPAMIL HCL ER TAB 240MG 100 NDC CODE:68462026001 FDA PRO DUCT CODE NO.: 62 O C B 13 H . T. S NO.: 3004.90.92.20 AN DA NO.:-78-906 THERAPEUTICE USE:-ANGINA CARVEDILOL TAB 3.125MG 500 NDC CODE:68462016 205 FDA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO.: 3004. 90.92.20 ANDA NO.:- 78-251 T HERAPEUTICE USE:-BETA- ADREN OACEPTOR ANTAGONIST OMEPRA ZOLE DR CAP 20MG 30 NDC CODE: 68462039630 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3 004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL RE FLUX DISEASE VERAPAMIL HCL ER TAB 180MG 100 NDC CODE:68 462029301 FDA PRODUCT CODE NO .: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-7 00 THERAPEUTICE USE: - ,-ANG INA VERAPAMIL HCL ER TAB 24 0MG 500 NDC CODE:68462026005 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.9 2.20 ANDA NO.:-78-906 THERAP EUTICE USE:-ANGINA CARVEDI LOL TAB 6.25MG 500 NDC CODE:6 8462016305 FDA PRODUCT CODE N O : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78 -251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 6.25MG 100 ND C CODE:68462016301 FDA PRODUC T CODE NO : 62 O C A 22 H. T . S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE US E:-BETA- ADRENOACEPTOR ANTAG ONIST VERAPAMIL HCL ER TAB 240MG 500 NDC CODE:6846202600 5 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90 .92.20 ANDA NO.:-78-906 THER APEUTICE USE:-ANGINA ROPIN IROLE TAB 1MG 100 NDC CODE:68 462025501 FDA PRODUCT CODE N O.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90- 135 THERAPEUTICE USE:-TREATM ENT OF PARKINSONISM LIDOCA INE OINT TUBE 5% 35.44GM NDC CODE:68462041820 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO. :206498 THERAPEUTICE USE: -US ED TO TEMPORARILY RELIEVE PA IN AND ITCHING ASSOCIATED WIT H SKIN COMMERCIAL & CUSTOM INVOICE NO. F22352004608 DT. 31.12.2022 F22352004592 DT. 3 1.12.2022 F22352004638 DT. 31 .12.2022 F22352004547 DT. 29. 12.2022 F22352004635 DT. 31.1 2.2022 F22352004611 DT. 31.12 .2022 F22352004621 DT. 31.12. 2022 F22352004636 DT. 31.12.2 022 F22352004671 DT. 03.01.20 23 NET WT.9548.24 KGS 02 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA S/BILL NO: 6735782 DT 05-JAN- 2023 S/BILL NO: 6735837 DT 0 5-JAN-2023 S/BILL NO: 673583 8 DT 05-JAN-2023 S/BILL NO: 6570999 DT 30-DEC-2022 S/BILL NO: 6735828 DT 05-JAN-2023 S/BILL NO: 6735769 DT 05-JAN- 2023 S/BILL NO: 6735770 DT 0 5-JAN-2023 S/BILL NO: 673582 7 DT 05-JAN-2023 S/BILL NO: 6735802 DT 05-JAN-2023 |
HS 621300 |
2023-01-31 |
14 PKG |
2695.29KG |
14 PALLETS 1150 CARTONS P HARMACEUTICALS AS UNDER NIT ROGLYCERIN SUBLING TAB 0.3MG 1 00 NDC CODE:68462063801 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC U SE: -MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOT ENOUGH BLOO D FLOW TO THE HEART SOLIFE NACIN SUCCINATE TAB 10MG 30 N DC CODE:68462038730 FDA PRODU CT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA N O.: 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLAD DER WITH SYMPTOMS OF URGE URI NARY INCONTINENCE, URGENCY A ND URINARY FREQUENCY SOLIFE NACIN SUCCINATE TAB 10MG 30 N DC CODE:68462038730 FDA PRODU CT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA N O.: 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLAD DER WITH SYMPTOMS OF URGE URI NARY INCONTINENCE, URGENCY A ND URINARY FREQUENCY NITROG LYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOICE NO. F223870 01803 DT. 31.12.2022 F2238700 1811 DT. 31.12.2022 F22387001 837 DT. 31.12.2022 F223870018 39 DT. 31.12.2022 NET WT.274. 018 KGS 14 DATA LOGGERS SE T TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPEC IALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND S/BILL NO: 4000043 DT: 03.01.2023 S /BILL NO: 4000045 DT: 03.01.20 23 S/BILL NO: 4000048 DT: 03. 01.2023 S/BILL NO: 4000049 DT : 03.01.2023 |
HS 662800 |
2023-01-31 |
17 PKG |
3694.57KG |
17 PALLETS 1654 CARTONS PHARMACEUTICALS AS UNDER R OSUVASTATIN TAB 40MG 30 NDC C ODE:68462026430 FDA PRODUCT C ODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PROD UCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE : - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DI SEASE ROSUVASTATIN TAB 10MG 90 NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTIC E USE: - TO TREAT HIGH CHOLES TEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCUL AR DISEASE ROSUVASTATIN TAB 10MG 1000 NDC CODE:684620262 10 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULA R DISEASE ROSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00 .10 ANDA NO.: 079172 THERAPE UTICE USE: - TO TREAT HIGH CH OLESTEROL AND RELATED CONDITI ONS, AND TO PREVENT CARDIOVA SCULAR DISEASE ROSUVASTATIN TAB 20MG 90 NDC CODE:6846202 6390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004. 49.00.10 ANDA NO.: 079172 TH ERAPEUTICE USE: - TO TREAT HI GH CHOLESTEROL AND RELATED CO NDITIONS, AND TO PREVENT CAR DIOVASCULAR DISEASE COMMERC IAL & CUSTOM INVOICE NO. F223 52004536 DT. 29.12.2022 F2235 2004537 DT. 29.12.2022 F22352 004538 DT. 29.12.2022 S/BILL NO:6568243 DT 30-DEC-2022 S/B ILL NO: 6568255 DT 30-DEC-2022 S/BILL NO: 6568244 DT 30-DEC -2022 17 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES NOT IFY PARTY:2 GLENMARK SPECIALT Y S.A. SWITZERLAND (GSSA) PL ACE NUMA-DROZ 2 NEUCHATEL - 2 000 SWITZERLAND |
HS 611600 |
2023-01-31 |
36 PKG |
10400.14KG |
36 PALLETS 3152 CARTONS PHARMACEUTICALS AS UNDER NAPROXEN TAB 500MG 100 NDC CO DE:68462019001 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC TELMISARTAN TAB 80MG 30 NDC CODE:68462020130 HTS NO : 300 4.90.92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAPE UTICE USE : INDICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE OX CARBAZEPINE TAB 600MG 100 NDC CODE:68462013901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-802 THERAPEUTICE USE:- ANTI CONVULSANT AGENT ROPI NIROLE TAB 1MG 100 NDC CODE:6 8462025501 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90 -135 THERAPEUTICE USE:-TREAT MENT OF PARKINSONISM COMME RCIAL & CUSTOM INVOICE NO. F2 2352004694 DT. 05.01.2023 F22 352004695 DT. 05.01.2023 S/BI LL NO: 6745056 DT 06-JAN-2023 S/BILL NO: 6755011 DT 06-JAN- 2023 NET WT.8730.411 KGS 01 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 SHOROUQ COMMODITIES TRADI NG DMCC UNIT NO. 98, DMCC BUS INESS CENTRE, LEVEL NO. 8, JE WELLERY & GEMPLEX 2, DUBAI D UBAI UTD.ARAB EMIR. |
HS 300490 |
2023-01-31 |
12 PKG |
3524.93KG |
12 PALLETS 418 CARTONS PHA RMACEUTICALS AS UNDER NAPR OXEN TAB 500MG 500 NDC CODE:6 8462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 250 THERAPEUTICE USE:-ANTI-I NFLAMMATORY, ANALGESIC COM MERCIAL & CUSTOM INVOICE NO. F22352004700 DT. 06.01.2023 S /BILL NO: 6760995 DT 06-JAN-2 023 NET WT: 3155.050 KGS 01 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 SHOROUQ COMMODITIES TRADI NG DMCC UNIT NO. 98, DMCC BUS INESS CENTRE, LEVEL NO. 8, JE WELLERY & GEMPLEX 2, DUBAI D UBAI UTD.ARAB EMIR. |
HS 624900 |
2023-01-31 |
15 PKG |
2860.4KG |
15 PALLETS 964 CARTONS PHARMACEUTICALS AS UNDER EZETIMIBE-SIMVA TAB 10/10MG 30 NDC CODE:68462032130 FDA PR ODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 A NDA NO.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDIC ATION IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUC H AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORK S BY REDUCING THE AMOUNT OF C HOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS K NOWN AS STATINS. IT WORKS B Y REDUCING THE AMOUNT OF CHOL ESTEROL MADE BY THE LIVER. PROPAFENONE HCL ER CAP 325MG 60 NDC CODE:68462040960 FDA PRODUCT CODE NO.: 63 E C F 28 H. T. S NO.: 3004.49.00.10 ANDA NO.: 205268 THERAPEUTIC E USE: -AN ANTIARRHYTHMIC AGE NT IT IS USED TO TREAT IRREGU LAR HEARTRHYTHM AND CAN SLOW RAPID HEARTBEATS SODIUM PH ENYLBUTYRATE TAB 500MG 250 ND C CODE:68462085320 FDA PRODUC T CODE NO.: 65 C D A 09 H. T . S NO.: 3004.90.1000 ANDA N O.: 216462 THERAPEUTICE USE: :#UREA CYCLE DISORDER AGENT TACROLIMUS OINT 0.1% 30GM NDC CODE:68462053435 FDA PROD UCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 AND A NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERMAT ITIS (ECZEMA). POTASSIUM C L ER CAP 10MEQ 500 NDC CODE:6 8462035705 FDA PRODUCT CODE N O.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.: 202 868 THERAPEUTICE USE: - TREA TMENT OR PREVENTION OF HYPOKA LEMIA S/BILL NO: 4000061 D T: 04.01.2023 S/BILL NO: 4000 068 DT: 04.01.2023 S/BILL NO: 4000062 DT: 04.01.2023 C OMMERCIAL & CUSTOM INVOICE NO. F22387001813 DT. 31.12.2022 F22387001820 DT. 31.12.2022 F22387001829 DT. 31.12.2022 N ET WT.1454.79 KGS 06 DATA LOG GERS HUMIDITY:65% SET TEMPER ATURE : +18 DEGREES TEMPERATU RE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 611500 |
2023-01-31 |
28 PKG |
5970.74KG |
28 PALLETS 2038 CARTONS PH ARMACEUTICALS AS UNDER URSO DIOL TAB 250MG 100 NDC CODE:6 8462047301 FDA PRODUCT CODE N O.: 63 N C A 25 H. T. S NO.: 3004.49.00.10 ANDA NO.: 90- 801 THERAPEUTICE USE: - FO R THE TREATMENT OF PATIEN TS WITH PRIMARY BILIARY CIRRH OSIS CARVEDILOL TAB 6.25MG 500 NDC CODE:68462016305 FD A PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.2 0 ANDA NO.:- 78-251 THERAPEU TICE USE:-BETA- ADRENOACEPTO R ANTAGONIST LAMOTRIGINE T AB CD 25MG 100 NDC CODE:68462 022901 FDA PRODUCT CODE NO.:- 61 M C A 38 H. T. S NO.: 3 004.90.92.30 ANDA NO.:-79 # 0 99 THERAPEUTICE USE:- ANTICO NVULSANT OMEPRAZOLE DR CAP 20MG 90 NDC CODE:68462039690 FDA PRODUCT CODE NO.: 62KCF1 0 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEA SE OMEPRAZOLE DR CAP 20MG 1 00 NDC CODE:68462039601 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE NORETH ACE/EE TAB 1/0.02MG 63 NDC CODE:68462013281 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.:206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA, ENDOMETRIOS IS AND ABNORMAL U TERINE BLEEDING COMMERCIAL & CUSTOM INVOICE NO. F223520 04598 DT. 31.12.2022 F2235200 4618 DT. 31.12.2022 F22352004 672 DT. 03.01.2023 F223520046 73 DT. 03.01.2023 F2235200468 3 DT. 04.01.2023 F22352004692 DT. 05.01.2023 NET WT.4480.8 2 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 67 56454 DT 06-JAN-2023 S/BILL N O: 6740320 DT 06-JAN-2023 S/ BILL NO: 6751694 DT 06-JAN-20 23 S/BILL NO: 6753696 DT 06- JAN-2023 S/BILL NO: 6749930 DT 06-JAN-2023 S/BILL NO: 67 41840 DT 06-JAN-2023 |
HS 632500 |
2023-01-31 |
13 PKG |
3789.37KG |
13 PALLETS 1025 CARTONS PHARMACEUTICALS AS UNDER NA PROXEN TAB 500MG 100 NDC CODE :68462019001 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC T ELMISARTAN TAB 80MG 30 NDC CO DE:68462020130 HTS NO : 3004. 90.92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAPEUT ICE USE : INDICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE COMM ERCIAL & CUSTOM INVOICE NO. F 22352004677 DT. 04.01.2023 F2 2352004682 DT. 04.01.2023 NET WT.3181.137 KGS 01 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES NOTIFY PARTY:2 SHOR OUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CEN TRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD .ARAB EMIR. S/BILL NO: 6745189 DT 06-JAN-2023 S/BI LL NO: 6751617 DT 06-JAN-2023 |
HS 300490 |
2023-01-31 |
29 PKG |
7571.94KG |
29 PALLETS 1966 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAP 20MG 100 NDC CO DE:68462039601 FDA PRODUCT CO DE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 9167 2 THERAPEUTICE USE: - -TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE OXCARBAZ EPINE TAB 600MG 100 NDC CODE: 68462013901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT CLINDAMY CIN PHOS GEL 1% 30GM NDC CODE :68462086635 FDA PRODUCT CODE NO.: 56 J D J 31 H. T. S NO .: 3004.49.00.50 ANDA NO.:21 4251 THERAPEUTICE USE: CLIND AMYCIN PHOSPHATE GEL IS INDIC ATED IN THE TREATMENT OF ACNE VULGARIS CALCIPOTRIENE OI NT 0.005% 60GM NDC CODE:68462 031065 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 209297 THIS MEDICATION IS USED TO T REAT PSORIASIS. CALCIPOTRIENE IS A FORM OF VITAMIN D. IT W ORKS BY SLOWING DOWN THE GROW TH OF SKIN CELLS. CALCI POTRIENE OINT 0.005% 60GM NDC CODE:68462031065 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA N O.: 209297 THIS MEDICATION IS USED TO TREAT PSORIASIS. CA LCIPOTRIENE IS A FORM OF VITA MIN D. IT WORKS BY SLOWING DO WN THE GROWTH OF SKIN CELLS. LEVONORGESTREL/EE TAB 0.15/ 0.03MG 273 NDC CODE:684620672 95 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.6 0.0000 ANDA NO.: 203164 THER APEUTICE USE: - CONTRACEPTION TO PREVENT PREGNANCY NOR ETHINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO. :-91-090 THERAPEUTICE USE:- SECONDARY AMENORRHEA,ENDOMETR IOS IS AND ABNORMAL UTERINE BLEEDING NORETHINDRONE ACE TAB 5MG 50 NDC CODE:68462030 450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39 .00.50 ANDA NO.:-91-090 THER APEUTICE USE:- SECONDARY AME NORRHEA,ENDOMETRIOS IS AND AB NORMAL UTERINE BLEEDING COMMERCIAL & CUSTOM INVOICE N O. F22352004563 DT. 30.12.202 2 F22352004622 DT. 31.12.2022 F22352004515 DT. 28.12.2022 F22352004560 DT. 30.12.2022 F22352004570 DT. 30.12.2022 F 22352004651 DT. 31.12.2022 F2 2352004652 DT. 31.12.2022 F22 352004653 DT. 31.12.2022 S/BI LL NO: 6703551 DT 04-JAN-2023 S/BILL NO: 6703547 DT 04-JAN- 2023 S/BILL NO: 6568191 DT 30 -DEC-2022 S/BILL NO: 6703587 DT 04-JAN-2023 S/BILL NO: 658 2930 DT 30-DEC-2022 S/BILL NO : 6703594 DT 04-JAN-2023 S/BI LL NO: 6703528 DT 04-JAN-2023 S/BILL NO: 6705845 DT 04-JAN- 2023 NET WT.6268.31 KGS 02 D ATA LOGGERS NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 614500 |
2023-01-24 |
23 PKG |
5119.33KG |
23 PALLETS 2398 CARTONS PHARMACEUTICALS AS UNDER ON DANSETRON TAB 4MG 30 NDC CODE :68462010530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANTI -EMETIC OXCARBAZEPINE TAB 300MG 100 NDC CODE:684620138 01 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-802 THE RAPEUTICE USE:-ANTI CONVULSAN T AGENT COMMERCIAL & CUSTOM INVOICE NO. F22352004402 DT. 23.12.2022 S/BILL NO: 64200 45 DT 24-DEC-2022 NET WT.3842 .01 KGS 01 DATA LOGGERS SE T TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 684620 |
2023-01-24 |
22 PKG |
5665.92KG |
22 PALLETS 2046 CARTONS PHARMACEUTICALS AS UNDER ON DANSETRON TAB 4MG 30 NDC CODE :68462010530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANTI -EMETIC OXCARBAZEPINE TAB 300MG 100 NDC CODE:684620138 01 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-802 THE RAPEUTICE USE:-ANTI CONVULSAN T AGENT VERAPAMIL HCL ER TA B 120MG 100 NDC CODE:68462029 201 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004. 90.92.20 ANDA NO.: 90-700 TH ERAPEUTICE USE: - -ANGINA COMMERCIAL & CUSTOM INVOICE NO . F22352004420 DT. 24.12.2022 S/BILL NO: 6448509 DT 26-DEC -2022 NET WT.4589.09 KGS 01 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 684620 |
2023-01-24 |
10 PKG |
2449.89KG |
10 PALLETS 778 CARTONS PHA RMACEUTICALS AS UNDER NAPRO XEN TAB 500MG 500 NDC CODE:68 462019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI-IN FLAMMATORY, ANALGESIC URSO DIOL TAB 250MG 100 NDC CODE:6 8462047301 FDA PRODUCT CODE N O.: 63 N C A 25 H. T. S NO.: 3004.49.00.10 ANDA NO.: 90- 801 THERAPEUTICE USE: - FOR THE TREATMENT OF PATIENTS WI TH PRIMARY BILIARY CIRRHOSIS THE TREATMENT OF PATIENTS W ITH PRIMARY BILIARY CIRRHOSIS TOPIRAMATE TAB 50MG 500 NDC CODE:68462015305 FDA PROD UCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 AND A NO.:077627 THERAPEUTICE USE : ANTICONVULSANT COMMERCIA L & CUSTOM INVOICE NO. F22352 004391 DT. 23.12.2022 F223520 04392 DT. 23.12.2022 F2235200 4393 DT. 23.12.2022 S/BILL NO : 6420036 DT 24-DEC-2022 S/BI LL NO: 6420037 DT 24-DEC-2022 S/BILL NO: 6420015 DT 24-DEC- 2022 NET WT.2097.080 KGS 01 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 SHOROUQ COMMODITIES TRADI NG DMCC UNIT NO. 98, DMCC BUS INESS CENTRE, LEVEL NO. 8, JE WELLERY & GEMPLEX 2, DUBAI D UBAI UTD.ARAB EMIR. |
HS 624900 |
2023-01-24 |
35 PKG |
8745.86KG |
35 PALLETS 1579 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT GABAPENTIN TAB 800MG 500 NDC CODE:68462 012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 30 04.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVUL SANT AGENT NAPROXEN TAB 50 0MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAP EUTICE USE:-ANTI-INFLAMMATORY , ANALGESIC POTASSIUM CL E R TAB 20MEQ 100 NDC CODE:6846 2047201 FDA PRODUCT CODE NO.: 65 R C A 14 H. T. S NO.: 3 004.90.9190 ANDA NO.: 203562 THERAPEUTICE USE: - TO TREAT OR PREVENT LOW AMOUNTS OF PO TASSIUM IN THE BLOOD CLOTR IMAZOLE CREAM 1% 45GM NDC COD E:68462018147 FDA PRODUCT COD E NO :61 W C J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 9 0-219 THERAPEUTICE USE: TREA TMENT OF CANDIDIASIS NORETH INDRONE TAB 0.35MG 84 NDC COD E:68462030529 FDA PRODUCT COD E NO.: 65 J C A 26 H. T. S N O.: 3006.60.00.00 ANDA NO.:9 1-209 THERAPEUTICE USE: PREV ENTION OF PREGNANCY. ROSUVA STATIN TAB 40MG 500 NDC CODE: 68462026405 61 J C A 16 3004 .49.00.10 79172 TO TREAT HIG H CHOLESTEROL AND RELATED CON DITIONS, AND TO PREVENT CARD IOVASCULAR DISEASE COMMERCI AL & CUSTOM INVOICE NO. F2235 2004349 DT. 22.12.2022 F22352 004390 DT. 23.12.2022 F223520 04383 DT. 23.12.2022 F2235200 4377 DT. 23.12.2022 F22352004 403 DT. 23.12.2022 S/BILL NO: 6401858 DT 23-DEC-2022 S/BIL L NO: 6420049 DT 24-DEC-2022 S/BILL NO: 6401791 DT 23-DEC-2 022 S/BILL NO: 6401819 DT 23- DEC-2022 S/BILL NO: 6420034 D T 24-DEC-2022 NET WT.7448.76 KGS 03 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA NOTIFY PARTY:3 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE NUMA-DROZ 2 N EUCHATEL - 2000 SWITZERLAND |
HS 684620 |
2023-01-24 |
30 PKG |
6021.09KG |
30 PALLETS 1764 CARTONS PHARMACEUTICALS AS UNDER PR AVASTATIN SOD TAB 20MG 500 ND C CODE:68462019605 FDA PRODUC T CODE NO.:-61 J C A 13 H. T . S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE :-HYPOLIPDAEMIC PRAVASTATIN SOD TAB 20MG 90 NDC CODE:684 62019690 FDA PRODUCT CODE NO .:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-98 7 THERAPEUTICE USE:-HYPOLIPD AEMIC PRAVASTATIN SOD TAB 8 0MG 90 NDC CODE:68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92 .20 ANDA NO.:-77-987 THERAPE UTICE USE:-HYPOLIPDAEMIC C OLESEVELAM HCL TAB 625MG 180 NDC CODE:68462043318 FDA PROD UCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00.10 AND A NO.: 203480 THERAPEUTICE US E: - ANTIHYPERLIPO PROTEINEM IC. BISOPROLOL-HCTZ TAB 5/6 .25MG 100 NDC CODE:6846208790 1 FDA PRODUCT CODE NO.: 62 O D A 18 H. T. S NO.: 3004.40 .00.20 ANDA NO.: 215995 THER APEUTICE USE: BISOPROLOL FUMA RATE AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATED IN THE MANAGEMENT OF HYPERTENSION. FROVATRIPTAN SUCCINATE TAB 2.5MG 9 NDC CODE:68462069497 FDA PRODUCT CODE NO.:60 L C A 93 H. T. S NO.: 3004.90.9 2.28 ANDA NO.:204730 THERAPE UTICE USE: - USE:THE TREATMEN T OF MIGRAINE HEADACHES AND FOR SHORT TERM PREVENTION OF MENSTRUAL MIGRAINE POTASSI UM CL ER CAP 10MEQ 500 NDC CO DE:68462035705 FDA PRODUCT CO DE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HY POKALEMIA COMMERCIAL & CUST OM INVOICE NO. F22387001763 D T. 26.12.2022 S/BILL NO: 401 8412 DT: 27.12.2022 NET WT. 3,663.82 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 611300 |
2023-01-24 |
42 PKG |
8795.76KG |
42 PALLETS 2623 CARTONS PHARMACEUTICALS AS UNDER O NDANSETRON TAB 4MG 30 NDC COD E:68462010530 FDA PRODUCT COD E NO.:-61 T C A 28 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANT I -EMETIC ACAMPROSATE CALC IUM DR TAB 333MG 180 NDC CODE :68462043518 FDA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO .: 3004.90.92.40 ANDA NO.:20 2229 THERAPEUTICE USE: - FOR TREATING ALCOHOL DEPENDENCE NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-250 THERAPEUTICE USE: -ANTI-INFLAMMATORY, ANALGESIC GABAPENTIN TAB 800MG 500 NDC CODE:68462012705 FDA PROD UCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 AND A NO.:-77-662 THERAPEUTICE U SE:-ANTICONVULSANT AGENT G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT HAILEY 24 FE TAB 1MG/20MCG-75MG 84 N DC CODE:68462073129 FDA PRODU CT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204847 THERAPEUTICE USE : - CONTRACEPTION TO PREVENT PREGNANCY COMMERCIAL & CUS TOM INVOICE NO. F22352004520 DT. 29.12.2022 F22352004521 D T. 29.12.2022 F22352004523 DT . 29.12.2022 F22352004524 DT. 29.12.2022 F22352004528 DT. 29.12.2022 S/BILL NO:6545682 DT 29-DEC-2022 S/BILL NO:6545 758 DT 29-DEC-2022 S/BILL NO: 6545759 DT 29-DEC-2022 S/BILL NO:6545319 DT 29-DEC-2022 S/ BILL NO:6545326 DT 29-DEC-2022 NET WT.6963.44 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +18 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA |
HS 684620 |
2023-01-24 |
19 PKG |
3215.57KG |
19 PALLETS 925 CARTONS P HARMACEUTICALS AS UNDER HAI LEY FE 1.5/30 TAB 1.5MG/30MCG- 75MG 84 NDC CODE:68462050329 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.0 0.00 ANDA NO.:206597 THERAPE UTICE USE: HORMONE MEDICATION IS USED TO PREVENT PREGNANC Y COMMERCIAL & CUSTOM INVOI CE NO. F22352004442 DT. 26.12 .2022 S/BILL NO: 6450556 DT 2 6-DEC-2022 NET WT.2397.60 KGS 19 DATA LOGGERS SET TEMPE RATURE: +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 652500 |
2023-01-24 |
12 PKG |
2511.13KG |
12 PALLETS 846 CARTONS PHARMACEUTICALS AS UNDER ES OMEPRAZOLE MAG DR CAP 40MG 30 NDC CODE:68462039130 FDA PRO DUCT CODE NO.: 62 T C C 06 H . T. S NO.: 3004.90.92 60 AN DA NO.: 209495 THERAPEUTICE U SE: ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR THE LONG-TERM TREATMENT OF PATHOLOGICAL HY PERSECRETORY CONDITIONS, INCL UDING ZOLLINGER-ELLISON SYND ROME APREPITANT CAP 125MG 6 UD NDC CODE:68462058576 NDC NO.:68462058576 FDA PRODUCT C ODE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO. :207777 THERAPEUTICE USE:APR EPITANT IS USED WITH OTHER ME DICATIONS TO HELP PREVENT NAU SEA AND VOMITING CAUSED BY C ANCER DRUG TREATMENT (CHEMOTH ERAPY). THIS MEDICATION IS AL SO USED TO PREVENT NAUSEA AND VOMITING AFTER SURGERY. A-E METIC/NAUSEANT / HUMAN - RX/S INGLE INGREDIENT / DELAYED R ELEASE TABLETS / APREPITANT COMMERCIAL & CUSTOM INVOICE NO. F22387001765 DT. 26.12.20 22 F22387001766 DT. 26.12.202 2 S/BILL NO: 4018409 DT: 27.1 2.2022 S/BILL NO:4018408 DT: 27.12.2022 NET WT.293.561 KGS 12 DATA LOGGERS SET TEMPE RATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S .A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 620600 |
2023-01-24 |
21 PKG |
4847.62KG |
21 PALLETS 1830 CARTONS PHARMACEUTICALS AS UNDER INDOMETHACIN CAP 25MG 100 NDC CODE:68462040601 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA N O.:91-276 THERAPEUTICE USE: -ANTI-INFLAMATORY NAPROXEN TAB 500MG 500 NDC CODE:684620 19005 FDA PRODUCT CODE NO.:- 62 G C A 49 H. T. S NO.: 300 4.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAM MATORY, ANALGESIC ONDANSET RON TAB 4MG 30 NDC CODE:68462 010530 FDA PRODUCT CODE NO.: -61 T C A 28 H. T. S NO.: 30 04.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANTI -EME TIC VERAPAMIL HCL ER TAB 12 0MG 100 NDC CODE:68462029201 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.9 2.20 ANDA NO.: 90-700 THERAP EUTICE USE: - -ANGINA COMM ERCIAL & CUSTOM INVOICE NO. F 22352004422 DT. 25.12.2022 F2 2352004434 DT. 25.12.2022 F22 352004435 DT. 25.12.2022 S/BI LL NO: 6451729 DT 26-DEC-2022 S/BILL NO: 6449485 DT 26-DEC- 2022 S/BILL NO: 6447068 DT 26 -DEC-2022 NET WT.3867.96 KGS 01 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 624200 |
2023-01-24 |
19 PKG |
3537.63KG |
19 PALLETS 922 CARTONS PHARMACEUTICALS AS UNDER HA ILEY 1.5/30 TAB 1.5MG/30MCG 63 NDC CODE:68462050481 FDA PR ODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 A NDA NO.: 209297 THERAPEUTICE USE: - CONTRACEPTION TO PREVE NT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F223520044 57 DT. 26.12.2022 S/BILL NO: 6473531 DT 27-DEC-2022 NET WT .2699.62 KGS 19 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEU CHATEL - 2000 SWITZERLAND |
HS 652500 |
2023-01-24 |
4 PKG |
818.75KG |
4 PALLETS 120 CARTONS PH ARMACEUTICALS AS UNDER NITR OGLYCERIN SUBLING TAB 0.4MG 4X 25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC U SE: -MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOT ENOUGH BLOO D FLOW TO THE HEART ESOMEP RAZOLE MAG DR CAP 40MG 1000 N DC CODE:68462039110 FDA PRODU CT CODE NO.: 62 T C C 06 H. T . S NO.: 3004.90.92 60 ANDA N O.: 209495 THERAPEUTICE USE: ESOMEPRAZOLE MAGNESIUM DELA YED-RELEASE CAPSULES ARE IND ICATED FOR THE LONG-TERM TREA TMENT OF PATHOLOGICAL HYPERS ECRETORY CONDITIONS, INCLUDIN G ZOLLINGER-ELLISON SYNDROME COMMERCIAL & CUSTOM INVOIC E NO. F22387001779 DT. 29.12. 2022 S/BILL NO: 4018617 DT: 29.12.2022 NET WT.205.111 KGS 04 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK SPECIALT Y S.A. SWITZERLAND (GSSA) PL ACE NUMA-DROZ 2 NEUCHATEL - 2 000 SWITZERLAND |
HS 662800 |
2023-01-24 |
22 PKG |
5622.37KG |
22 PALLETS 1453 CARTONS PHARMACEUTICALS AS UNDER C LINDAMYCIN PHOS GEL 1% 30GM N DC CODE:68462086635 FDA PRODU CT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO.:214251 THERAPEUTICE USE: CLINDAMYCIN PHOSPHATE GEL I S INDICATED IN THE TREATMENT OF ACNE VULGARIS CLINDAMYC IN PHOS GEL 1% 60GM NDC CODE: 68462086665 FDA PRODUCT CODE NO.: 56 J D J 31 H. T. S NO. : 3004.49.00.50 ANDA NO.:214 251 THERAPEUTICE USE: CLINDA MYCIN PHOSPHATE GEL IS INDICA TED IN THE TREATMENT OF ACNE VULGARIS NAPROXEN TAB 500M G 500 NDC CODE:68462019005 F DA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-250 THERAPEU TICE USE:-ANTI-INFLAMMATORY, ANALGESIC TELMISARTAN TAB 40MG 30 NDC CODE:68462020030 FDA PRODUCT CODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.9 2.20 ANDA NO.:090032 THERAPE UTICE USE: INDICATED FOR THE TREATMENT OF HYPERTENSION, T O LOWER BLOOD PRESSURE COM MERCIAL & CUSTOM INVOICE NO. F22352004517 DT. 28.12.2022 F 22352004516 DT. 28.12.2022 F2 2352004505 DT. 28.12.2022 NET WT.4763.03 KGS 02 DATA LOGGE RS HUMIDITY:65% NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA S/BILL NO: 6545533 DT 29 -DEC-2022 S/BILL NO: 6549243 DT 29-DEC-2022 S/BILL NO: 654 5770 DT 29-DEC-2022 |
HS 563100 |
2023-01-24 |
36 PKG |
7833.67KG |
36 PALLETS 2369 CARTONS PHARMACEUTICALS AS UNDER PO TASSIUM CL ER CAP 10MEQ 100 N DC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T . S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA DILTIAZEM HCL ER CAP 12HR 60MG 100 NDC COD E:68462085001 62 O C B 24 30 04.49.00.10 212317 FOR THE T REATMENT OF HYPERTENSION. BISOPROLOL-HCTZ TAB 10/6.25MG 30 NDC CODE:68462088030 FDA PRODUCT CODE NO.: 62 O D A 18 H. T. S NO.: 3004.40.00.20 ANDA NO.: 215995 THERAPEUTIC E USE: BISOPROLOL FUMARATE AN D HYDROCHLOROTHIAZIDE TABLET S ARE INDICATED IN THE MANAG EMENT OF HYPERTENSION. BIS OPROLOL-HCTZ TAB 5/6.25MG 100 NDC CODE:68462087901 FDA PRO DUCT CODE NO.: 62 O D A 18 H . T. S NO.: 3004.40.00.20 AN DA NO.: 215995 THERAPEUTICE U SE: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATED IN THE MANAGEME NT OF HYPERTENSION. CARVED ILOL TAB 25MG 500 NDC CODE:68 462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78- 251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST TACROLIMUS CAP 1MG 100 NDC CO DE:68462068601 HTS NO: 3004.9 0.92.15 FDA CODE : 64 T C E 0 8 ANDA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION O F A KIDNEY,HEART, OR LIVER T RANSPLANT TACROLIMUS OINT 0 .1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49. 00.50 ANDA NO.: 210393 THERA PEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATME NT OF MODERATE-TO-SEVERE ATO PIC DERMATITIS (ECZEMA). T ACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA N O.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IM MUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERA TE-TO-SEVERE ATOPIC DERMATITI S (ECZEMA). SIROLIMUS TAB 1MG 100 NDC CODE:68462068301 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90.9 2.15 ANDA NO.: 208691 THERAP EUTICE USE: TO PREVENT REJECT ION OF KIDNEY TRANSPLANTS. PRAVASTATIN SOD TAB 20MG 500 NDC CODE:68462019605 FDA PRO DUCT CODE NO.:-61 J C A 13 H . T. S NO.: 3004.90.92.20 AN DA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEMIC TACROLIM US CAP 1MG 100 NDC CODE:68462 068601 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE : T O PREVENT REJECTION OF A KID NEY,HEART, OR LIVER TRANSPLAN T TACROLIMUS OINT 0.1% 30GM NDC CODE:68462053435 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DERM ATITIS (ECZEMA). S/BILL NO : 4018618 DT: 30.12.2022 S/B ILL NO: 4018616 DT: 30.12.202 2 S/BILL NO: 4018613 DT: 30. 12.2022 S/BILL NO: 4018619 DT : 30.12.2022 COMMERCIAL & CUSTOM INVOICE NO. F2238700 1778 DT. 29.12.2022 F22387001 780 DT. 29.12.2022 F223870017 83 DT. 29.12.2022 F2238700176 4 DT. 26.12.2022 NET WT.4414. 787 KGS 02 DATA LOGGERS SE T TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2023-01-24 |
21 PKG |
3861.04KG |
21 PALLETS 1034 CARTONS PHARMACEUTICALS AS UNDER A CYCLOVIR OINT 5% 30GM NDC COD E:68462074635 FDA PRODUCT COD E NO.: 62 V C J 18 H. T. S N O.: 3004.49.00.50 ANDA NO.: 205510 THERAPEUTICE USE: - AN ANTIVIRAL MEDICINE USED TO TREAT OR PREVENT INFECTIONS C AUSED BY CERTAIN KINDS OF VIR USES. EXAMPLES OF THESE INFEC TIONS INCLUDE HERPES AND SHIN GLES HAILEY 1.5/30 TAB 1.5M G/30MCG 63 NDC CODE:684620504 81 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.6 0.00.00 ANDA NO.: 209297 THE RAPEUTICE USE: - CONTRACEPTIO N TO PREVENT PREGNANCY COM MERCIAL & CUSTOM INVOICE NO. F22352004501 DT. 28.12.2022 F 22352004495 DT. 28.12.2022 NE T WT.2929.36 KGS 21 DATA LOGG ERS NOTIFY PARTY:2 GLENMAR K SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEU CHATEL - 2000 SWITZERLAND S/BILL NO: 6547192 DT 29- DEC-2022 S/BILL NO: 6524716 D T 29-DEC-2022 |
HS 652500 |
2023-01-24 |
2 PKG |
398.71KG |
2 PALLETS 109 CARTONS PHAR MACEUTICALS AS UNDER ACAMPR OSATE CALCIUM DR TAB 333MG 180 NDC CODE:68462043518 FDA PR ODUCT CODE NO.: 60 T C C 99 H. T. S NO.: 3004.90.92.40 A NDA NO.:202229 THERAPEUTICE U SE: - FOR TREATING ALCOHOL D EPENDENCE COMMERCIAL & CUST OM INVOICE NO. F22352004550 D T. 29.12.2022 S/BILL NO: 657 3529 DT 30-DEC-2022 NET WT.34 7.53 KGS 00 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 609900 |
2023-01-24 |
22 PKG |
4821.77KG |
22 PALLETS 1491 CARTONS PHARMACEUTICALS AS UNDER N ORETH ACE/EE TAB 1MG/5MCG 90 NDC CODE:68462065790 FDA PROD UCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 AND A NO.: 203038 THERAPEUTICE US E: - TREATMENT OF MODERATE T O SEVERE VASOMOTOR SYMPTOMS DUE TO MENOPAUSE; OSTEOPOROSI S PREVENTION NORETH ACE/EE TAB 1MG/5MCG 84 NDC CODE:6846 2065729 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3 006.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - TREATME NT OF MODERATE TO SEVERE VASO MOTOR SYMPTOMS DUE TO MENOPA USE; OSTEOPOROSIS PREVENTION HAILEY 24 FE TAB 1MG/20MCG- 75MG 84 NDC CODE:68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.0 0.00 ANDA NO.: 204847 THERAP EUTICE USE: - CONTRACEPTION T O PREVENT PREGNANCY TOPIRA MATE TAB 100MG 500 NDC CODE:6 8462010905 FDA PRODUCT CODE N O.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.: 776 27 THERAPEUTICE USE: :#ANTIC ONVULSANT TOPIRAMATE TAB 10 0MG 60 NDC CODE:68462010960 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00 .20 ANDA NO.:- 77-627 THERAP EUTICE USE:-ANTICONVULSANT PRAMIPEXOLE TAB 1MG 90 NDC C ODE:68462033390 FDA PRODUCT C ODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO. : 90-781 THERAPEUTICE USE: US ED IN PARKINSON#S DISEASE URSODIOL TAB 250MG 100 NDC CO DE:68462047301 FDA PRODUCT CO DE NO.: 63 N C A 25 H. T. S NO.: 3004.49.00.10 ANDA NO.: 90-801 THERAPEUTICE USE: - FOR THE TREATMENT OF PATIENT S WITH PRIMARY BILIARY CIRRHO SIS THE TREATMENT OF PATIEN TS WITH PRIMARY BILIARY CIRRH OSIS COMMERCIAL & CUSTOM I NVOICE NO. F22352004463 DT. 2 6.12.2022 F22352004467 DT. 27 .12.2022 F22352004472 DT. 27. 12.2022 F22352004476 DT. 27.1 2.2022 S/BILL NO:6473469 DT 2 7-DEC-2022 S/BILL NO:6485351 DT 27-DEC-2022 S/BILL NO:6495 740 DT 28-DEC-2022 S/BILL NO: 6494267 DT 28-DEC-2022 NET WT .3885.00 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGRE ES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA |
HS 652500 |
2023-01-24 |
38 PKG |
6304.59KG |
38 PALLETS 1839 CARTONS PHARMACEUTICALS AS UNDER HA ILEY 24 FE TAB 1MG/20MCG-75MG 84 NDC CODE:68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204847 THERAPEUTIC E USE: - CONTRACEPTION TO PRE VENT PREGNANCY ALYACEN 1/3 5 TAB 1/0.035MG 84 NDC CODE:6 8462039429 FDA PRODUCT CODE N O.: 65 J D A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.: 091 634 THERAPEUTICE USE: ORALCO NTRACEPTIVE COMMERCIAL & CU STOM INVOICE NO. F22352004565 DT. 30.12.2022 F22352004546 DT. 29.12.2022 S/BILL NO: 657 7875 DT 30-DEC-2022 S/BILL NO : 6568248 DT 30-DEC-2022 NET WT.4572.31 KGS SET TEMPERAT URE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A |
HS 652500 |
2023-01-18 |
40 PKG |
5939.44KG |
40 PALLETS 1970 CARTONS PHARMACEUTICALS AS UNDER NORETH ACE/EE TAB 1/0.02MG 63 NDC CODE:68462013281 FDA PRO DUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 AND A NO.:206969 THERAPEUTICE USE : - SECONDARY AMENORRHEA,END OMETRIOS IS AND ABNORMAL UTER INE BLEEDING NORETH ACE/EE TAB 1/0.02MG 63 NDC CODE:684 62013281 FDA PRODUCT CODE NO .:65 J C A 25 H. T. S NO.: 3 006.60.00.00 ANDA NO.:206969 THERAPEUTICE USE: - SECONDAR Y AMENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING S/BILL NO: 6355692 DT 22-D EC-2022 S/BILL NO: 6355585 DT 22-DEC-2022 COMMERCIAL & CUSTOM INVOICE NO. F22352004 312 DT. 20.12.2022 F223520043 50 DT. 22.12.2022 NET WT.4111 .250 KGS 02 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 SHOROUQ COMM ODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LE VEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EM IR. |
HS 652500 |
2023-01-18 |
26 PKG |
5769.79KG |
26 PALLETS 1010 CARTONS PH ARMACEUTICALS AS UNDER IMIQ UIMOD CREAM 5% 0.25GM 24 NDC CODE:68462053670 FDA PRODUCT CODE NO.: 62 V C J 29 H. T. S NO.: 3004.49.00.50 ANDA NO .:201994 THERAPEUTICE USE: - INDICATED FOR ACTINIC KERATO SES AND EXTERNAL GENITAL AND PERIANAL WARTS URSODIOL TAB 250MG 100 NDC CODE:684620473 01 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 3004.4 9.00.10 ANDA NO.: 90-801 TH ERAPEUTICE USE: - FOR THE TRE ATMENT OF PATIENTS WITH PRIMA RY BILIARY CIRRHOSIS NAPR OXEN TAB 500MG 500 NDC CODE:6 8462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 250 THERAPEUTICE USE:-ANTI-I NFLAMMATORY, ANALGESIC NOR ETHINDRONE TAB 0.35MG 84 NDC CODE:68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO .:91-209 THERAPEUTICE USE: P REVENTION OF PREGNANCY. NOR ETH ACE/EE TAB 1/0.02MG 63 ND C CODE:68462013281 FDA PRODUC T CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 ANDA N O.:206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOME TRIOS IS AND ABNORMAL UTERINE BLEEDING POTASSIUM CL ER TAB 20MEQ 500 NDC CODE:684620 47205 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 300 4.90.9020 ANDA NO.: 203562 T HERAPEUTICE USE: :#MEDICATION USED FOR HEART FAILURE, HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOICE NO. F22352004331 DT. 21.12.2022 F22352004339 DT. 2 1.12.2022 F22352004358 DT. 22 .12.2022 F22352004359 DT. 22. 12.2022 S/BILL NO: 6336971 DT 21-DEC-2022 S/BILL NO: 63967 47 DT 23-DEC-2022 S/BILL NO: 6383830 DT 23-DEC-2022 S/BILL NO: 6383818 DT 23-DEC-2022 N ET WT.4834.56 KGS 02 DATA LOG GERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 622900 |
2023-01-18 |
4 PKG |
935.78KG |
4 PALLETS 491 CARTONS P HARMACEUTICALS AS UNDER ROS UVASTATIN TAB 40MG 30 NDC COD E:68462026430 FDA PRODUCT COD E NO.:61 J C A 16 H. T. S NO .: 3004.49.00.10 ANDA NO.: 0 79172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND R ELATED CONDITIONS, AND TO PRE VENT CARDIOVASCULAR DISEASE S/BILL NO: 6356401 DT 22-DEC -2022 COMMERCIAL & CUSTOM I NVOICE NO. F22352004335 DT. 2 1.12.2022 NET WT.746.33 KGS 04 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 290719 |
2023-01-18 |
17 PKG |
5172.85KG |
17 PALLETS 804 CARTONS P HARMACEUTICALS AS UNDER NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC NA PROXEN TAB 500MG 500 NDC CODE :68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC O XCARBAZEPINE TAB 300MG 100 ND C CODE:68462013801 FDA PRODUC T CODE NO.:-61 M C A 45 H. T . S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE: -ANTI CONVULSANT AGENT COM MERCIAL & CUSTOM INVOICE NO. F22352004354 DT. 22.12.2022 F 22352004366 DT. 22.12.2022 F2 2352004367 DT. 23.12.2022 S/B ILL NO: 6383961 DT 23-DEC-2022 S/BILL NO: 6398030 DT 23-DEC -2022 S/BILL NO: 6398017 DT 2 3-DEC-2022 NET WT.4555.443 KG S 00 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 SHOROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DM CC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DU BAI DUBAI UTD.ARAB EMIR. |
HS 624900 |
2023-01-10 |
40 PKG |
7289.35KG |
40 PALLETS 2150 CARTONS PHARMACEUTICALS AS UNDER NO RGEST/EE TAB .18,.215,.25/.035 MG 84 NDC CODE:68462056529 F DA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00. 00 ANDA NO.: 200494 THERAPEU TICE USE: - ORAL CONTRACEPTIV ES ESTRADIOL VAG INSERTS 10 MCG 8 NDC CODE:68462071171 F DA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00. 00 ANDA NO.:210264 THERAPEUT ICE USE:THE TREATMENT OF ATRO PIC VAGINITIS DUE TO MENOPAU SE. COMMERCIAL & CUSTOM INV OICE NO. F22352004201 DT. 13. 12.2022 F22352004210 DT. 14.1 2.2022 S/BILL NO:6147934 DT: 14-DEC-22 S/BILL NO: 6149956 DT:14-DEC-22 NET WT.5478.00 K GS 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 652700 |
2023-01-10 |
40 PKG |
6574.93KG |
40 PALLETS 2270 CARTONS PHARMACEUTICALS AS UNDER ES TRADIOL VAG INSERTS 10MCG 8 N DC CODE:68462071171 FDA PRODU CT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE: THE TREATMENT OF ATROPIC VAG INITIS DUE TO MENOPAUSE. N ORGEST/EE TAB .18,.215,.25/.03 5MG 84 NDC CODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00 .00 ANDA NO.: 200494 THERAPE UTICE USE: - ORAL CONTRACEPTI VES COMMERCIAL & CUSTOM INV OICE NO. F22352004215 DT. 14. 12.2022 S/BILL NO: 6156519 DT :14.12.2022 NET WT. 4790.40 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA |
HS 642800 |
2023-01-10 |
45 PKG |
8100.84KG |
45 PALLETS 2537 CARTONS PHARMACEUTICALS AS UNDER NO RETHINDRONE ACE TAB 5MG 50 ND C CODE:68462030450 FDA PRODUC T CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO .:-91-090 THERAPEUTICE USE:- SECONDARY AMENORRHEA,ENDOMET RIOS IS AND ABNORMAL UTERINE BLEEDING DROSPIRENONE/EE T AB 3/0.02MG 84 NDC CODE:68462 072029 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 30 06.60.00.00 ANDA NO.: 204296 THERAPEUTICE USE: - ORAL CON TRACEPTIVE ACAMPROSATE CALC IUM DR TAB 333MG 180 NDC CODE :68462043518 FDA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO .: 3004.90.92.40 ANDA NO.:20 2229 THERAPEUTICE USE: - FOR TREATING ALCOHOL DEPENDENCE PRAMIPEXOLE TAB 0.125MG 90 NDC CODE:68462033090 FDA PRO DUCT CODE NO.: 62 J C A 15 H . T. S NO.: 3004.90.92.40 AN DA NO.: 90-781 THERAPEUTICE U SE: USED IN PARKINSON#S DISEA SE INDOMETHACIN CAP 25MG 10 0 NDC CODE:68462040601 FDA P RODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: -ANTI-INFLAMATORY LIT HIUM CARB ER TAB 300MG 100 ND C CODE:68462022301 FDA PRODUC T CODE NO.: 61 N C B 37 H. T . S NO.: 3004.49.00.20 ANDA NO.:91-544 THERAPEUTICE USE: - INDICATED IN THE TREATMEN T OF MANIC EPISODES INDICAT ED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER . BIPOLAR DISORDER, MANIC (D SM-IV) IS EQUIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, I N THE OLDER DSM-II TERMINOLOG Y. ALSO INDICATED AS A MAINT ENANCE TREATMENT FOR INDIVIDU ALS WITH A DIAGNOSIS OF BIPO LAR DISORDER. MAINTENANCE THE RAPY REDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISH ES THE INTENSITY OF THOSE EP ISODES WHICH MAY OCCUR. A CAMPROSATE CALCIUM DR TAB 333M G 180 NDC CODE:68462043518 F DA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO.: 3004.90.92. 40 ANDA NO.:202229 THERAPEUT ICE USE: - FOR TREATING ALCOH OL DEPENDENCE OMEPRAZOLE D R CAP 10MG 30 NDC CODE:684620 39530 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90 .9160 ANDA NO.: 91672 THERAP EUTICE USE: - -TREATMENT OF T REAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTO M INVOICE NO. F22352004173 DT . 11.12.2022 F22352004194 DT. 12.12.2022 F22352004200 DT. 13.12.2022 NET WT.6284.641 KG S 02 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 6107201 DT 13-DEC-2022 S/BILL NO: 612 6324 DT 13-DEC-2022 S/BILL NO : 6147959 DT 14-DEC-2022 |
HS 652500 |
2023-01-10 |
4 PKG |
647.74KG |
4 PALLETS 94 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 40MG 500 NDC COD E:68462026405 61 J C A 16 30 04.49.00.10 79172 TO TREAT H IGH CHOLESTEROL AND RELATED C ONDITIONS, AND TO PREVENT CA RDIOVASCULAR DISEASE CALCIP OTRIENE CREAM 0.005% 120GM ND C CODE:68462050166 FDA PRODUC T CODE NO.: 62 N C J 04 H. T . S NO.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTICE USE: - TREATMENT OF PLAQUE PSORI ASIS IN ADULTS COMMERCIAL & CUSTOM INVOICE NO. F22352004 192 DT. 12.12.2022 F223520041 93 DT. 12.12.2022 NET WT. 561 .03 KGS 04 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPE CIALTY S.A. SWITZERLAND (GSSA ) PLACE NUMA-DROZ 2 NEUCHATE L - 2000 SWITZERLAND S/BIL L NO: 6127077 DT 13-DEC-2022 S/BILL NO: 6125264 DT 13-DEC-2 022 |
HS 620400 |
2023-01-04 |
16 PKG |
4028.42KG |
16 PALLETS 932 CARTONS PHARMACEUTICALS AS UNDER OMEPRAZOLE DR CAP 40MG 100 ND C CODE:68462039701 FDA PRODUC T CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE OMEPRA ZOLE DR CAP 40MG 90 NDC CODE: 68462039790 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3 004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352004 144 DT. 08.12.2022 F223520041 45 DT. 08.12.2022 NET WT.3282 .54 KGS 02 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 60 37398 DT:09/12/2022 S/BILL N O: 6035461 DT:09/12/2022 |
HS 621000 |
2023-01-04 |
17 PKG |
3260.48KG |
17 PALLETS 956 CARTO NS PHARMACEUTICALS AS UNDER EZETIMIBE TAB 10MG 90 NDC CODE:68462022690 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA N O.: #078560 THERAPEUTICE USE: LIPID LOWERING AGENT EZET IMIBE TAB 10MG 500 NDC CODE:6 8462022605 FDA PRODUCT CODE N O.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #07 8560 THERAPEUTICE USE: LIPID LOWERING AGENT NAPROXEN SO D TAB 550MG 100 NDC CODE:6846 2017901 FDA PRODUCT CODE NO. :-62 G C A 50 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-314 THERAPEUTICE USE:-ANTI -INF LAMMATORY, ANALGESIC EZETIM IBE TAB 10MG 500 NDC CODE:684 62022605 FDA PRODUCT CODE NO. : 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #0785 60 THERAPEUTICE USE: LIPID L OWERING AGENT RUFINAMIDE TA B 400MG 120 NDC CODE:68462071 408 61 M C A 99 3004.90.92.3 0 205075 TO USED WITH OTHER MEDICATIONS TO PREVENT OR CO NTROL SEIZURES (EPILEPSY) AS SOCIATED WITH LENNOX-GASTAUT SYNDROME (LGS PIMECROLIMUS CREAM 1% 60GM NDC CODE:68462 060965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOU ND-LINE THERAPY FOR THE SHORT -TERM AND NON-CONTINUOS CHRON IC TRERTMENT OF MILD TO MODE RATE ATOPIC DERMATITIS IN NO N- IMMUNOCOMPROMISED ADULT A ND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 100GM NDC CODE:68462060994 FDA PROD UCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 AND A NO.: 211769 THERAPEUTICE US E: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-C ONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DER MATITIS IN NON- IMMUNOCOMPRO MISED ADULT AND CHILDREN 2 Y EARS OF AGE TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053 494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 210393 TH ERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIV E OINTMENT USED FOR THE TREA TMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). COMMERCIAL & CUSTOM INVOICE NO. F22387001628 DT. 07.12.20 22 F22387001629 DT. 07.12.202 2 F22387001631 DT. 07.12.2022 F22387001632 DT. 07.12.2022 F22387001633 DT. 07.12.2022 NET WT. 1,931.60 KGS 11 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA S /BILL NO: 4017519 DT:08/12/20 22 S/BILL NO: 4017518 DT:08/ 12/2022 S/BILL NO: 4017508 D T:08/12/2022 S/BILL NO: 4017 517 DT:08/12/2022 S/BILL NO: 4017514 DT:08/12/2022 |
HS 611500 |
2023-01-04 |
6 PKG |
1435.64KG |
6 PALLETS 180 CARTONS PHARMACEUTICALS AS UNDER N ITROGLYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 F DA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.902 0 ANDA NO.:206391 THERAPEUTI C USE: -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRES SURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH B LOOD FLOW TO THE HEART COM MERCIAL & CUSTOM INVOICE NO. F22387001630 DT. 07.12.2022 N ET WT. 95.90 KGS 06 DATA LOG GERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND S/BILL NO: 4017509 DT: 08 /12/2022 |
HS 662800 |
2023-01-04 |
5 PKG |
1157.59KG |
5 PALLETS 289 CARTONS PHAR MACEUTICALS AS UNDER POTASS IUM CL ER CAP 10MEQ 500 NDC C ODE:68462035705 FDA PRODUCT C ODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO. : 202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF H YPOKALEMIA COMMERCIAL & CUS TOM INVOICE NO. F22387001588 DT. 30.11.2022 S/BILL NO: 401 7306 DT:03/12/2022 NET WT: 79 5.993 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 271019 |
2023-01-04 |
34 PKG |
8695.51KG |
34 PALLETS 2822 CARTONS PH ARMACEUTICALS AS UNDER NAPR OXEN TAB 500MG 500 NDC CODE:6 8462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 250 THERAPEUTICE USE:-ANTI-I NFLAMMATORY, ANALGESIC NAP ROXEN TAB 375MG 100 NDC CODE: 68462018901 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC NA PROXEN TAB 375MG 500 NDC CODE :68462018905 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC T OPIRAMATE TAB 50MG 500 NDC CO DE:68462015305 FDA PRODUCT CO DE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.: 077627 THERAPEUTICE USE: ANT ICONVULSANT CARVEDILOL TAB 6.25MG 500 NDC CODE:684620163 05 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.9 0.92.20 ANDA NO.:- 78-251 TH ERAPEUTICE USE:-BETA- ADRENO ACEPTOR ANTAGONIST CARVEDI LOL TAB 6.25MG 500 NDC CODE:6 8462016305 FDA PRODUCT CODE N O : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78 -251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST ROSUVASTATIN TAB 5MG 90 NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO. : 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEAS E ROSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PRO DUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 AND A NO.: 079172 THERAPEUTICE US E: - TO TREAT HIGH CHOLESTERO L AND RELATED CONDITIONS, AN D TO PREVENT CARDIOVASCULAR D ISEASE ROSUVASTATIN TAB 20M G 1000 NDC CODE:68462026310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00 .10 ANDA NO.: 79172 THERAPEU TICE USE: TO TREAT HIGH CHOLE STEROL AND RELATED CONDITIONS , AND TO PREVENT CARDIOVASCUL AR DISEASE ROSUVASTATIN TA B 20MG 1000 NDC CODE:68462026 310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004. 49.00.10 ANDA NO.: 79172 THE RAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDI TIONS, AND TO PREVENT CARDIOV ASCULAR DISEASE ROSUVASTAT IN TAB 5MG 1000 NDC CODE:6846 2026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3 004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT H IGH CHOLESTEROL AND RELATED C ONDITIONS, AND TO PREVENT CAR DIOVASCULAR DISEASE. CALCI POTRIENE CREAM 0.005% 60GM (GS ) NDC CODE:51407060560 FDA P RODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTICE USE: TOPICAL ANTI-PSORIATIC COMMERCIAL & CUSTOM INVOICE NO. F22352004079 DT. 02.12.2 022 F22352004080 DT. 02.12.20 22 F22352004050 DT. 30.11.202 2 F22352004082 DT. 02.12.2022 F22352004092 DT. 03.12.2022 F22352004052 DT. 30.11.2022 F22352004029 DT. 30.11.2022 S /BILL NO: 5937375 DT:05/12/202 2 S/BILL NO: 5933578 DT:05/12 /2022 S/BILL NO: 5932230 DT:0 5/12/2022 S/BILL NO: 5932167 DT:05/12/2022 S/BILL NO: 5936 093 DT:05/12/2022 S/BILL NO: 5933587 DT:05/12/2022 S/BILL NO: 5859138 DT:01/12/2022 NET WT. 7087.103 KGS 24 DATA LOG GERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 624900 |
2022-12-19 |
29 PKG |
4032.05KG |
29 PALLETS 870 CARTONS P HARMACEUTICALS AS UNDER EST RADIOL VAG INSERTS 10MCG 18 N DC CODE:68462071188 NDC NO.:6 8462071188 FDA PRODUCT CODE N O.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:2102 64 THERAPEUTICE USE:THE TREA TMENT OF ATROPIC VAGINITIS DU E TO MENOPAUSE. COMMERCIAL & CUSTOM INVOICE NO. F223520 03829 DT. 21.11.2022 S/BILL N O: 5617275 DT 21-NOV-2022 NET WT. 3,069.36 KGS 01 DATA LO GGERS HUMIDITY:65% SET TEMPE RATURE : +18 DEGREES TEMPERAT URE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 642800 |
2022-12-19 |
11 PKG |
1348.55KG |
11 PALLETS 255 CARTONS PHA RMACEUTICALS AS UNDER ASHLY NA TAB 0.15/0.03MG-0.01MG 182 NDC CODE:68462064693 FDA PRO DUCT CODE NO.: 64 G D A 2 H. T. S NO.: 3006.60.0000 ANDA NO.: 203163 THERAPEUTICE USE : - INDICATED FOR USE BY WOM EN TO PREVENT PREGNANCY CO MMERCIAL & CUSTOM INVOICE NO. F22352003811 DT. 19.11.2022 S/BILL NO: 5603267 DT 21-NOV-2 022 NET WT. 973.04 KGS 01 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 271019 |
2022-12-19 |
12 PKG |
2644.94KG |
12 PALLETS 634 CARTONS PHARMACEUTICALS AS UNDER OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.: 62KC F10 H. T. S NO.: 3004.90 .9160 ANDA NO.: 91672 TH ERAPEUTICE USE: - -TREATMEN T OF TREAT GASTROESOPHAGEAL REFLUX DISEASE FEL ODIPINE ER TAB 2.5MG 100 ND C CODE:68462023301 FDA PROD UCT CODE NO.: 62OCB32 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-365 THERAPEUT ICE USE: - TREATMENT OF HYPERTENSION ACAMPROSA TE CALCIUM DR TAB 333MG 180 NDC CODE:68462043518 FDA P RODUCT CODE NO.: 60 T C C 9 9 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:202229 THE RAPEUTICE USE: - FOR TREATI NG ALCOHOL DEPENDENCE COMMERCIAL & CUSTOM INVOICE NO. F22352003801 DT. 18.11 .2022 S/BILL NO: 5591796 DT 20-NOV-2022 NET WT. 2,173. 34 KGS 01 DATA LOGGERS H UMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 621000 |
2022-12-19 |
44 PKG |
9260.24KG |
44 PALLETS 3440 CARTONS PHARMACEUTICALS AS UNDER CA RVEDILOL TAB 3.125MG 100 NDC CODE:68462016201 FDA PRODUCT CODE NO - 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST CARVEDILOL TAB 3.125MG 500 NDC CODE:68462016205 FDA PRODUCT CODE NO ; 62 O C A 2 2 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUT ICE USE:-BETA- ADRENOACEPTOR ANTAGONIST OXCARBAZEPINE TAB 600MG 100 NDC CODE:684620 13901 FDA PRODUCT CODE NO.:- 61 M C A 45 H. T. S NO.: 300 4.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONVUL SANT AGENT FELODIPINE ER TA B 2.5MG 100 NDC CODE:68462023 301 FDA PRODUCT CODE NO.: 62 OCB32 H. T. S NO.: 3004.90.9 2.20 ANDA NO.: 90-365 THERAP EUTICE USE: - TREATMENT OF H YPERTENSION HEATHER TAB 0.3 5MG 84 NDC CODE:68462030329 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00 .00 ANDA NO.:90-454 THERAPEU TICE USE: PREVENTION OF PREGN ANCY. HEATHER TAB 0.35MG 84 NDC CODE:68462030329 FDA PR ODUCT CODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.00 A NDA NO.:90-454 THERAPEUTICE U SE: PREVENTION OF PREGNANCY. CARVEDILOL TAB 3.125MG 500 NDC CODE:68462016205 FDA PRO DUCT CODE NO ; 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST LITHIUM CARB CAP 6 00MG 100 NDC CODE:68462022201 FDA PRODUCT CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49. 00.20 ANDA NO.:- 79 -139 THE RAPEUTICE USE:-ANTIMANIC AGEN T OXCARBAZEPINE TAB 600MG 1 00 NDC CODE:68462013901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTIC E USE:-ANTI CONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22352003774 DT. 18.11.2 022 F22352003775 DT. 18.11.20 22 F22352003784 DT. 18.11.202 2 F22352003786 DT. 18.11.2022 F22352003778 DT. 18.11.2022 F22352003776 DT. 18.11.2022 F22352003777 DT. 18.11.2022 S /BILL NO: 5563883 DT 18-NOV-20 22 S/BILL NO: 5563872 DT 18-N OV-2022 S/BILL NO: 5564118 DT 18-NOV-2022 S/BILL NO: 55631 62 DT 18-NOV-2022 S/BILL NO: 5563891 DT 18-NOV-2022 S/BILL NO: 5564166 DT 18-NOV-2022 S /BILL NO: 5563185 DT 18-NOV-20 22 NET WT. 7,451.73 02 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 622200 |
2022-12-19 |
1 PKG |
192.33KG |
1 PALLETS 63 CARTONS PHA RMACEUTICALS AS UNDER ROSUV ASTATIN TAB 10MG 1000 NDC COD E:68462026210 61 J C A 16 30 04.49.00.10 79172 TO TREAT H IGH CHOLESTEROL AND RELATED C ONDITIONS, AND TO PREVENT CA RDIOVASCULAR DISEASE COMMER CIAL & CUSTOM INVOICE NO. F22 352003779 DT. 18.11.2022 S/BI LL NO: 5563904 DT 18-NOV-2022 NET WT. 162.69 KGS 01 DATA L OGGERS HUMIDITY:65% SET TEMP ERATURE : +18 DEGREES TEMPERA TURE RANGE : +15 DEGREES TO +2 5 DEGREES NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 271019 |
2022-12-19 |
7 PKG |
799.7KG |
7 PALLETS 363 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO .:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA COMMERCIAL & CU STOM INVOICE NO. F22387001461 DT. 17.11.2022 S/BILL NO: 4 016467 DT: 18.11.2022 NET WT. 799.94 KGS 00 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA |
HS 651400 |
2022-12-19 |
33 PKG |
6980.9KG |
33 PALLETS 1883 CARTONS PHARMACEUTICALS AS UNDER PO TASSIUM CL ER CAP 10MEQ 100 N DC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T . S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA BISOPROLOL-HC TZ TAB 2.5/6.25MG 100 NDC COD E:68462087801 FDA PRODUCT COD E NO.: 62 O D A 18 H. T. S N O.: 3004.40.00.20 ANDA NO.: 215995 THERAPEUTICE USE: BIS OPROLOL FUMARATE AND HYDROCHL OROTHIAZIDE TABLETS ARE INDI CATED IN THE MANAGEMENT OF H YPERTENSION. BISOPROLOL-HCT Z TAB 5/6.25MG 30 NDC CODE:68 462087930 FDA PRODUCT CODE NO .: 62 O D A 18 H. T. S NO.: 3004.40.00.20 ANDA NO.: 2159 95 THERAPEUTICE USE: BISOPRO LOL FUMARATE AND HYDROCHLOROT HIAZIDE TABLETS ARE INDICATE D IN THE MANAGEMENT OF HYPER TENSION. BISOPROLOL-HCTZ TA B 5/6.25MG 500 NDC CODE:68462 087905 FDA PRODUCT CODE NO.: 62 O D A 18 H. T. S NO.: 30 04.40.00.20 ANDA NO.: 215995 THERAPEUTICE USE: BISOPROLOL FUMARATE AND HYDROCHLOROTHIA ZIDE TABLETS ARE INDICATED I N THE MANAGEMENT OF HYPERTEN SION. TACROLIMUS OINT 0.1% 30GM NDC CODE:68462053435 FD A PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 210393 THERAPEUT ICE USE: - TACROLIMUS IS A TO PICAL IMMUNOSUPPRESSIVE OINT MENT USED FOR THE TREATMENT O F MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). COMME RCIAL & CUSTOM INVOICE NO. F2 2387001459 DT. 17.11.2022 F22 387001460 DT. 17.11.2022 S/BI LL NO: 4016465 DT: 18.11.2022 S/BILL NO: 4016466 DT: 18.1 1.2022 NET WT. 3,437.68 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA |
HS 256251 |
2022-12-19 |
17 PKG |
5347.04KG |
17 PALLETS 945 CARTONS PHARMACEUTICALS AS UNDER OXCARBAZEPINE TAB 300MG 100 N DC CODE:68462013801 FDA PRODU CT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE :-ANTI CONVULSANT AGENT RO PINIROLE TAB 4MG 100 NDC CODE :68462025801 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TRE ATMENT OF PARKINSONISM NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC GA BAPENTIN TAB 800MG 500 NDC CO DE:68462012705 FDA PRODUCT CO DE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT COMMERC IAL & CUSTOM INVOICE NO. F223 52003841 DT. 21.11.2022 F2235 2003896 DT. 24.11.2022 F22352 003897 DT. 24.11.2022 NET WT. 4,705.40 KGS 02 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 5642798 DT 22-NOV- 2022 S/BILL NO: 5718502 DT 25-NOV-2022 S/BILL NO: 5718 496 DT 25-NOV-2022 |
HS 614500 |
2022-12-19 |
21 PKG |
4614.93KG |
21 PALLETS 1856 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 20MG 90 NDC CODE :68462026390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE COMMERCIAL & CUSTOM INVO ICE NO. F22352003894 DT. 24.1 1.2022 F22352003895 DT. 24.11 .2022 NET WT. 3,724.41 KGS 21 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND S/BILL NO: 572 2389 DT 25-NOV-2022 S/BILL NO : 5718494 DT 25-NOV-2022 |
HS 684620 |
2022-12-19 |
6 PKG |
1488.72KG |
6 PALLETS 187 CARTONS P HARMACEUTICALS AS UNDER NIT ROGLYCERIN SUBLING TAB 0.4MG 4 X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HE ART FAILURE,HIGH BLOOD PRESSU RE,AND TO TREAT AND PREVENT C HEST PAIN FROM NOT ENOUGH BLO OD FLOW TO THE HEART COMME RCIAL & CUSTOM INVOICE NO. F2 2387001490 DT. 22.11.2022 S/B ILL NO: 4016728 DT: 23.11.202 2 NET WT. 99.63 KGS 06 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWITZER LAND |
HS 662800 |
2022-12-19 |
40 PKG |
10319.4KG |
40 PALLETS 2208 CARTONS PHARMACEUTICALS AS UNDER TA CROLIMUS OINT 0.1% 60GM NDC C ODE:68462053465 FDA PRODUCT C ODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO. : 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMU NOSUPPRESSIVE OINTMENT USED F OR THE TREATMENT OF MODERATE -TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PRAVASTATIN SOD TAB 80MG 90 NDC CODE:68462019 890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004. 90.92.20 ANDA NO.:-77-987 TH ERAPEUTICE USE:-HYPOLIPDAEMIC PRAVASTATIN SOD TAB 20MG 5 00 NDC CODE:68462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTIC E USE:-HYPOLIPDAEMIC PRAVA STATIN SOD TAB 80MG 500 NDC C ODE:68462019805 FDA PRODUCT C ODE NO.:61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: -77-987 THERAPEUTICE USE:-HY POLIPDAEMIC CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90. 92.20 ANDA NO.:- 78-251 THER APEUTICE USE:-BETA- ADRENOAC EPTOR ANTAGONIST GABAPENTI N TAB 600MG 500 NDC CODE:6846 2012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 30 04.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVUL SANT AGENT PRAVASTATIN SOD TAB 20MG 500 NDC CODE:684620 19605 FDA PRODUCT CODE NO.:- 61 J C A 13 H. T. S NO.: 300 4.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEM IC PROPAFENONE HCL ER CAP 2 25MG 60 NDC CODE:68462040860 FDA PRODUCT CODE NO.: 63 E C F 28 H. T. S NO.: 3004.49.0 0.10 ANDA NO.:205268 THERAPE UTICE USE:AN ANTIARRHYTHMIC A GENT. IT IS USED TO TREAT IR REGULAR HEART RHYTHM AND CAN SLOW RAPID HEARTBEATS S/B ILL NO: 4016883 DT: 25.11.202 2 S/BILL NO: 4016889 DT: 25. 11.2022 S/BILL NO: 4016885 DT : 25.11.2022 S/BILL NO: 4016 888 DT: 25.11.2022 S/BILL NO : 4016887 DT: 25.11.2022 COMMERCIAL & CUSTOM INVOICE N O. F22387001500 DT. 23.11.202 2 F22387001501 DT. 23.11.2022 F22387001502 DT. 23.11.2022 F22387001503 DT. 23.11.2022 F22387001515 DT. 24.11.2022 N ET WT. 8,180.00 02 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 611300 |
2022-12-14 |
6 PKG |
1279.61KG |
6 PALLETS 761 CARTONS PH ARMACEUTICALS AS UNDER OLME SARTAN MEDOX TAB 5MG 30 NDC C ODE:68462043630 FDA PRODUCT C ODE NO.: 62CCA68 H. T. S NO. : 3004.90.9220 ANDA NO.: 203 281 THERAPEUTICE USE: - TREA TMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSI VE AGENTS, TO LOWER BLOOD PRE SSURE COMMERCIAL & CUSTOM I NVOICE NO. F22352003942 DT. 2 7.11.2022 S/BILL NO: 5760361 DT 28-NOV-2022 NET WT. 931.4 6 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 271019 |
2022-12-14 |
26 PKG |
7730.7KG |
26 PALLETS 1006 CARTONS PHARMACEUTICALS AS UNDER NA PROXEN TAB 500MG 500 NDC CODE :68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC P RAMIPEXOLE TAB 1MG 90 NDC COD E:68462033390 FDA PRODUCT COD E NO.: 62 J C A 15 H. T. S N O.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN PARKINSONS DISEASE COM MERCIAL & CUSTOM INVOICE NO. F22352003915 DT. 25.11.2022 S /BILL NO:5747646 DT:26.11.2022 NET WT;6875.47 KGS 02 D ATA LOGGERS SET TEMPER ATURE : +18 DEGREES CONTAIN ER NO. MNBU0252768 NO TIFY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 684620 |
2022-12-14 |
34 PKG |
4993.23KG |
34 PALLETS 1606 CARTONS PH ARMACEUTICALS AS UNDER NORE THINDRONE TAB 0.35MG 84 NDC C ODE:68462030529 FDA PRODUCT C ODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO. :91-209 THERAPEUTICE USE: PR EVENTION OF PREGNANCY. COMM ERCIAL & CUSTOM INVOICE NO. F 22352003933 DT. 26.11.2022 S/ BILL NO: 5756303 DT 27-NOV-202 2 NET WT. 3,526.70 01 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 271019 |
2022-12-14 |
40 PKG |
5166.96KG |
40 PALLETS 1570 CARTONS PHARMACEUTICALS AS UNDER LE VONORGESTREL/EE TAB 0.15/0.03M G 273 NDC CODE:68462067295 F DA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.000 0 ANDA NO.: 203164 THERAPEUT ICE USE: - CONTRACEPTION TO P REVENT PREGNANCY DROSPIREN ONE/EE TAB 3/0.02MG 84 NDC CO DE:68462072029 FDA PRODUCT CO DE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204296 THERAPEUTICE USE: - O RAL CONTRACEPTIVE COMMERCI AL & CUSTOM INVOICE NO. F2235 2003953 DT. 28.11.2022 F22352 003954 DT. 28.11.2022 S/BILL NO: 5776768 DT 28-NOV-2022 S/ BILL NO: 5781673 DT 28-NOV-202 2 NET WT. 3,622.25 KGS 02 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 642900 |
2022-12-14 |
45 PKG |
11204.37KG |
45 PALLETS 2997 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 800MG 500 NDC CODE :68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-662 THERAPEUTICE USE:-ANTI CONVULSANT AGENT URSODIOL TAB 500MG 100 NDC CODE:684620 47401 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 300 4.49.00.10 ANDA NO.: 90-801 THERAPEUTICE USE: - FOR THE TREATMENT OF PATIENTS WITH PR IMARY BILIARY CIRRHOSIS FLUCONAZOLE TAB 50MG 30 NDC C ODE:68462010130 FDA PRODUCT C ODE NO : 61 W C A 45 H. T. S NO.: 3004.90.92.45 ANDA NO. :-77 - 253 THERAPEUTICE USE: -ANTIFUNGAL ROPINIROLE TAB 2MG 100 NDC CODE:68462025601 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:- 90-135 THERA PEUTICE USE:-TREATMENT OF PA RKINSONISM RIZATRIPTAN BENZ TAB 10MG 18UD NDC CODE:68462 046699 FDA PRODUCT CODE NO.: 60 L C A 87 H. T. S NO.: 30 04.90.92.28 ANDA NO.:201967 THERAPEUTICE USE: - ACUTE TRE ATMENT OF MIGRAINE MUPIROC IN CREAM 2% 30GM NDC CODE:684 62056435 FDA PRODUCT CODE NO. : 61GCJ82 H. T. S NO.: 3004 .90.92.45 ANDA NO.: 201587 T HERAPEUTICE USE: - TOPICAL AN TI-BACTERIAL COMMERCIAL & C USTOM INVOICE NO. F2235200394 4 DT. 27.11.2022 F22352003945 DT. 27.11.2022 F22352003947 DT. 27.11.2022 S/BILL NO: 577 6530 DT:28-NOV-22 S/BILL NO: 5777599 DT:28-NOV-22 S/BILL N O: 5776461 DT:28-NOV-22 NET W T:9464.34 KGS 02 DATA LOGGER S SET TEMPERATURE : +18 D EGREES CONTAINER NO. MNBU0 142760 NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 684620 |
2022-12-14 |
39 PKG |
10579.31KG |
39 PALLETS 2075 CARTONS PHARMACEUTICALS AS UNDER CA RVEDILOL TAB 25MG 500 NDC COD E:68462016505 FDA PRODUCT COD E NO : 62 O C A 22 H. T. S N O.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BE TA- ADRENOACEPTOR ANTAGONIST TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRO DUCT CODE NO.: 64 T C J 08 H . T. S NO.: 3004.49.00.50 AN DA NO.: 210393 THERAPEUTICE U SE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MO DERATE-TO-SEVERE ATOPIC DERMA TITIS (ECZEMA). CARVEDILOL TAB 25MG 500 NDC CODE:684620 16505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 300 4.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADR ENOACEPTOR ANTAGONIST COLE SEVELAM HCL TAB 625MG 180 NDC CODE:68462043318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00.10 ANDA N O.: 203480 THERAPEUTICE USE: - ANTIHYPERLIPO PROTEINEMIC. POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 1 4 H. T. S NO.: 3004.90.92.90 ANDA NO.: 202868 THERAPEUTI CE USE: - TREATMENT OR PREVEN TION OF HYPOKALEMIA CARVED ILOL TAB 25MG 500 NDC CODE:68 462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78- 251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO . F22387001530 DT. 26.11.2022 F22387001543 DT. 29.11.2022 F22387001554 DT. 29.11.2022 F22387001558 DT. 29.11.2022 F 22387001560 DT. 30.11.2022 S/ BILL NO: 4017127 DT: 30.11.202 2 S/BILL NO: 4017128 DT: 30.1 1.2022 S/BILL NO: 4017129 DT: 30.11.2022 S/BILL NO:4017131 DT: 30.11.2022 S/BILL NO:401 7130 DT: 30.11.2022 NET WT. 8 ,422.91 02 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 640800 |
2022-12-14 |
2 PKG |
493.52KG |
2 PALLETS 62 CARTONS PH ARMACEUTICALS AS UNDER NITR OGLYCERIN SUBLING TAB 0.4MG 4X 25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC U SE: -MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOT ENOUGH BLOO D FLOW TO THE HEART COMMER CIAL & CUSTOM INVOICE NO. F22 387001553 DT. 29.11.2022 S/BI LL NO: 4017125 DT: 30.11.2022 NET WT. 33.03 02 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE NUMA-DROZ 2 N EUCHATEL - 2000 SWITZERLAND |
HS 662800 |
2022-12-14 |
37 PKG |
8123.52KG |
37 PALLETS 2603 CARTONS PHARMACEUTICALS AS UNDER CA RVEDILOL TAB 6.25MG 500 NDC C ODE:68462016305 FDA PRODUCT C ODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO. :- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST CARVEDILOL TAB 6.25MG 50 0 NDC CODE:68462016305 FDA P RODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTIC E USE:-BETA- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 2 5MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.9 2.20 ANDA NO.:- 78-251 THERA PEUTICE USE:-BETA- ADRENOACE PTOR ANTAGONIST NAPROXEN T AB 375MG 500 NDC CODE:6846201 8905 FDA PRODUCT CODE NO.:-6 2 G C A 49 H. T. S NO.: 3004 .90.92.40 ANDA NO.:-78-250 T HERAPEUTICE USE:-ANTI-INFLAMM ATORY, ANALGESIC THEOPHYLL INE ER TAB 600MG 100 NDC CODE :68462035601 FDA PRODUCT CODE NO.: 63 B C B 30 H. T. S NO .: 3004.90.92.85 ANDA NO.: 9 0-355 THERAPEUTICE USE: XANT HINE BRONCHODILATOR NAPROXE N TAB 500MG 500 NDC CODE:6846 2019005 FDA PRODUCT CODE NO. :-62 G C A 49 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFL AMMATORY, ANALGESIC NAPROX EN TAB 375MG 500 NDC CODE:684 62018905 FDA PRODUCT CODE NO .:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-25 0 THERAPEUTICE USE:-ANTI-INF LAMMATORY, ANALGESIC NORET HINDRONE ACE TAB 5MG 50 NDC C ODE:68462030450 FDA PRODUCT C ODE NO.65 J C A 25 H. T. S N O.: 3004.39.00.50 ANDA NO.:- 91-090 THERAPEUTICE USE:- SE CONDARY AMENORRHEA,ENDOMETRIO S IS AND ABNORMAL UTERINE BL EEDING DROSPIRENONE/EE TAB 3/0.02MG 84 NDC CODE:68462072 029 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006. 60.00.00 ANDA NO.: 204296 TH ERAPEUTICE USE: - ORAL CONTRA CEPTIVE S/BILL NO: 5867551 DT 01-DEC-2022 S/BILL NO: 5 870373 DT 01-DEC-2022 S/BILL NO: 5870968 DT 01-DEC-2022 S /BILL NO: 5866261 DT 01-DEC-2 022 S/BILL NO: 5866188 DT 01 -DEC-2022 S/BILL NO: 5866585 DT 01-DEC-2022 COMMERCIA L & CUSTOM INVOICE NO. F22352 004023 DT. 30.11.2022 F223520 04032 DT. 30.11.2022 F2235200 4042 DT. 30.11.2022 F22352004 055 DT. 30.11.2022 F223520040 56 DT. 30.11.2022 F2235200405 4 DT. 30.11.2022 NET WT. 6,70 1.88 02 DATA LOGGERS HUMID ITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA |
HS 622200 |
2022-12-14 |
3 PKG |
491.25KG |
3 PALLETS 60 CARTONS PH ARMACEUTICALS AS UNDER NITR OGLYCERIN SUBLING TAB 0.4MG 4X 25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC U SE: -MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOT ENOUGH BLOO D FLOW TO THE HEART NITROG LYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART S/BILL N O: 4017248 DT: 02/12/2022 S /BILL NO: 4017251 DT: 02/12/ 2022 COMMERCIAL & CUSTOM INVOICE NO. F22387001594 DT. 30.11.2022 F22387001595 DT. 3 0.11.2022 NET WT.31.968 KGS 03 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE N UMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 662800 |
2022-12-14 |
37 PKG |
8891.92KG |
37 PALLETS 1933 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS CAP 0.5MG 100 NDC CODE :68462068501 HTS NO: 3004.90. 92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC U SE : TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRA NSPLANT POTASSIUM CL ER C AP 10MEQ 100 NDC CODE:6846203 5701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004. 90.92.90 ANDA NO.:202868 THE RAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA PRAVASTATIN SOD TAB 80MG 90 NDC CODE:68462019890 FDA PRO DUCT CODE NO.:-61 J C A 13 H . T. S NO.: 3004.90.92.20 AN DA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEMIC TACROLIM US OINT 0.1% 100GM NDC CODE:6 8462053494 FDA PRODUCT CODE N O.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210 393 THERAPEUTICE USE: - TACR OLIMUS IS A TOPICAL IMMUNOSUP PRESSIVE OINTMENT USED FOR TH E TREATMENT OF MODERATE-TO-S EVERE ATOPIC DERMATITIS (ECZ EMA). TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FD A PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 210393 THERAPEUT ICE USE: - TACROLIMUS IS A TO PICAL IMMUNOSUPPRESSIVE OINT MENT USED FOR THE TREATMENT O F MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). VORIC ONAZOLE TAB 50MG 30 NDC CODE: 68462057230 FDA PRODUCT CODE NO.:61 W C A 59 H. T. S NO.: 3004.90.92.10 ANDA NO.:2035 03 THERAPEUTICE USE: -USED T O TREAT FUNGAL INFECTIONS GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-662 THERAPEUTICE USE:-A NTICONVULSANT AGENT NAPROX EN SOD TAB 550MG 100 NDC CODE :68462017901 FDA PRODUCT CODE NO.:-62 G C A 50 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-314 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT GABAPEN TIN TAB 600MG 500 NDC CODE:68 462012605 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-66 2 THERAPEUTICE USE:-ANTICONV ULSANT AGENT POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:684 62035705 FDA PRODUCT CODE NO. : 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.: 20286 8 THERAPEUTICE USE: - TREATM ENT OR PREVENTION OF HYPOKALE MIA COMMERCIAL & CUSTOM INV OICE NO. F22387001575 DT. 30. 11.2022 F22387001574 DT. 30.1 1.2022 F22387001573 DT. 30.11 .2022 F22387001572 DT. 30.11. 2022 F22387001578 DT. 30.11.2 022 F22387001579 DT. 30.11.20 22 F22387001580 DT. 30.11.202 2 F22387001587 DT. 30.11.2022 F22387001600 DT. 30.11.2022 F22387001597 DT. 30.11.2022 S/BILL NO: 4017247 DT: 02/12/2 022 S/BILL NO: 4017243 DT: 02 /12/2022 S/BILL NO: 4017244 D T: 02/12/2022 S/BILL NO: 4017 242 DT: 02/12/2022 S/BILL NO: 4017245 DT: 02/12/2022 S/BIL L NO: 4017250 DT: 02/12/2022 S/BILL NO: 4017246 DT: 02/12/2 022 S/BILL NO: 4017252 DT: 02 /12/2022 S/BILL NO: 4017253 D T: 02/12/2022 S/BILL NO: 4017 249 DT: 02/12/2022 NET WT. 6, 595.47 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2022-12-14 |
2 PKG |
549.31KG |
02 PALLETS 96 CARTONS PHARM ACEUTICALS AS UNDER ROSUVAS TATIN TAB 20MG 1000 NDC CODE: 68462026310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 79 172 THERAPEUTICE USE: TO TRE AT HIGH CHOLESTEROL AND RELAT ED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE CO MMERCIAL & CUSTOM INVOICE NO. F22352003946 DT. 27.11.2022 S/BILL NO:5776525 DT:28.11.202 2 NET WT:490.62 KGS 02 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES CONTAIN ER NO. MNBU0142760 NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 611600 |
2022-12-14 |
6 PKG |
1218.37KG |
6 PALLETS 708 CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 79172 THERAPEUTICE USE: T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE . ROSUVASTATIN TAB 5MG 90 NDC CODE:68462026190 FDA PROD UCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE : - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DI SEASE S/BILL NO: 5866260 D T 01-DEC-2022 S/BILL NO: 586 6321 DT 01-DEC-2022 COMME RCIAL & CUSTOM INVOICE NO. F2 2352004033 DT. 30.11.2022 F22 352004049 DT. 30.11.2022 NET WT. 944.02 06 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 GLENMARK S PECIALTY S.A. SWITZERLAND (GS SA) PLACE NUMA-DROZ 2 NEUCHA TEL - 2000 SWITZERLAND |
HS 611600 |
2022-12-13 |
40 PKG |
9912.07KG |
40 PALLETS 2861 CARTONS PHARMACEUTICALS AS UNDER CHLORPROMAZINE HCL TAB 50MG 10 0 NDC CODE:68462086301 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA OR MA NIC-DEPRESSION IN ADULTS R ANOLAZINE ER TAB 1000MG 60 ND C CODE:68462032060 FDA PRODUC T CODE NO.: 61 D C B 02 H. T . S NO.: 3004.49.00.10 ANDA NO.:211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDIC ATION. IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENC Y) ATTACK OF ANGINA CHLORP ROMAZINE HCL TAB 100MG 100 ND C CODE:68462086401 61 T C A 0 4 3004.90.92.40 212144 TO T REAT PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA OR MANIC-D EPRESSION IN ADULTS INDOME THACIN ER CAP 75MG 60 NDC COD E:68462032560 FDA PRODUCT COD E: 62 GCE42 H. T. S NO.:300 4.90.92.40 ANDA NO.203501 TH ERAPEUTIC USE: INDOMETHACIN I S USED TO RELIEVE PAIN, SWELL ING, AND JOINT STIFFNESS CAUS ED BY ARTHRITIS, GOUT, BURSIT IS, AND TENDONITIS. IT IS AL SO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDITIONS. TH IS MEDICATION IS KNOWN AS A N ONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID). ... THIS EFFE CT HELPS TO DECREASE SWELLING AND PAIN. GABAPENTIN TAB 600MG 500 NDC CODE:6846201260 5 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90. 92.30 ANDA NO.:-77-662 THERA PEUTICE USE:-ANTICONVULSANT AGENT COLESEVELAM HCL TAB 6 25MG 180 NDC CODE:68462043318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49. 00.10 ANDA NO.: 203480 THERA PEUTICE USE: - ANTIHYPERLIPO PROTEINEMIC. BISOPROLOL-HC TZ TAB 2.5/6.25MG 30 NDC CODE :68462087830 FDA PRODUCT CODE NO.: 62 O D A 18 H. T. S NO .: 3004.40.00.20 ANDA NO.: 2 15995 THERAPEUTICE USE: BISO PROLOL FUMARATE AND HYDROCHLO ROTHIAZIDE TABLETS ARE INDIC ATED IN THE MANAGEMENT OF HY PERTENSION. POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68462 035701 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 300 4.90.92.90 ANDA NO.:202868 T HERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA S/BILL NO: 4016362 DT: 16 .11.2022 S/BILL NO: 4016364 DT: 16.11.2022 S/BILL NO: 40 16359 DT: 16.11.2022 S/BILL N O: 4016357 DT: 16.11.2022 S/ BILL NO: 4016363 DT: 16.11.20 22 COMMERCIAL & CUSTOM IN VOICE NO. F22387001435 DT. 15 .11.2022 F22387001436 DT. 15. 11.2022 F22387001437 DT. 15.1 1.2022 F22387001444 DT. 16.11 .2022 F22387001445 DT. 16.11. 2022 NET WT. 5,217.15 02 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 256253 |
2022-12-13 |
2 PKG |
470.84KG |
2 PALLETS 59 CARTONS PHA RMACEUTICALS AS UNDER NITRO GLYCERIN SUBLING TAB 0.4MG 4X2 5 NDC CODE:68462063945 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 A NDA NO.:206391 THERAPEUTIC US E: -MEDICATION USED FOR HEAR T FAILURE,HIGH BLOOD PRESSURE ,AND TO TREAT AND PREVENT CHE ST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART S/BILL NO: 4016358 DT: 16.11.2022 COMMERCIAL & CUSTOM INVOICE NO. F22387001438 DT. 15.11.20 22 NET WT. 31.44 02 DATA LO GGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GL ENMARK SPECIALTY S.A. SWITZER LAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAN D |
HS 662800 |
2022-12-13 |
1 PKG |
185.07KG |
1 PALLETS 63 CARTONS PHARM ACEUTICALS AS UNDER ROSUVAS TATIN TAB 10MG 1000 NDC CODE: 68462026210 61 J C A 16 3004 .49.00.10 79172 TO TREAT HIG H CHOLESTEROL AND RELATED CON DITIONS, AND TO PREVENT CARD IOVASCULAR DISEASE COMMERCI AL & CUSTOM INVOICE NO. F2235 2003661 DT. 11.11.2022 S/BILL NO: 5420430 DT: 12.11.2022 NET WT.161.281 KGS 1 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK SPECIALTY S.A. SWITZE RLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLA ND |
HS 210690 |
2022-12-13 |
10 PKG |
2178.19KG |
10 PALLETS 219 CARTONS P HARMACEUTICALS AS UNDER CLO TRIMAZOLE CREAM 1% 15GM NDC C ODE:68462018117 FDA PRODUCT C ODE NO.:61#W#C#J#04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-219 THERAPEUTICE USE: TR EATMENT OF CANDIDIASIS COMM ERCIAL & CUSTOM INVOICE NO. F 22352003676 DT. 12.11.2022 S/ BILL NO: 5427112 DT 13-NOV-20 22 NET WT.1684.02 KGS 00 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 271019 |
2022-12-13 |
35 PKG |
7100.2KG |
35 PALLETS 3002 CARTONS PHARMACEUTICALS AS UNDER FL UCONAZOLE TAB 150MG 12UD NDC CODE:68462011944 NDC CODE : 68462011944 HTS NO : 3004.90. 92.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 THERAPEU TICE USE : ANTIFUNGAL ONDA NSETRON TAB 8MG 30 NDC CODE:6 8462010630 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77- 535 THERAPEUTICE USE:-ANTI - EMETIC ONDANSETRON TAB 8MG 30 NDC CODE:68462010630 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUTIC E USE:-ANTI -EMETIC GABAPE NTIN TAB 600MG 500 NDC CODE:6 8462012605 FDA PRODUCT CODE N O: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-6 62 THERAPEUTICE USE:-ANTICON VULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22352003 689 DT. 13.11.2022 F223520036 90 DT. 13.11.2022 F2235200368 7 DT. 13.11.2022 S/BILL NO: 5 451560 DT 14-NOV-2022 S/BILL NO: 5451530 DT 14-NOV-2022 S/ BILL NO: 5451548 DT 14-NOV-202 2 NET WT.5379.15 KGS 02 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 300490 |
2022-12-13 |
45 PKG |
11517.36KG |
45 PALLETS 3814 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT ATOMOXETIN E CAP 40MG 30 NDC CODE:684620 26830 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.: 3004. 90.92.90 ANDA NO.: 079019 TH ERAPEUTICE USE: - ATOMOXETINE IS USED TO TREAT ATTENTION-D EFICIT HYPERACTIVITY DISORDER (ADHD) AS PART OF A TOTAL T REATMENT PLAN, INCLUDING PSYC HOLOGICAL, SOCIAL, AND OTHER TREATMENTS. ONDANSETRON TAB 8MG 30 NDC CODE:68462010630 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92 .40 ANDA NO.:- 77-535 THERAP EUTICE USE:-ANTI -EMETIC T OPIRAMATE TAB 50MG 500 NDC CO DE:68462015305 FDA PRODUCT CO DE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.: 077627 THERAPEUTICE USE: ANT ICONVULSANT ONDANSETRON TAB 4MG 30 NDC CODE:68462010530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:- 77-535 THERA PEUTICE USE:-ANTI -EMETIC ROPINIROLE TAB 1MG 100 NDC CO DE:68462025501 FDA PRODUCT CO DE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.: - 90-135 THERAPEUTICE USE:-T REATMENT OF PARKINSONISM C ALCIPOTRIENE OINT 0.005% 60GM NDC CODE:68462031065 FDA PRO DUCT CODE NO.: 62 N C J 04 H . T. S NO.: 3004.90.92.45 AN DA NO.: 209297 THIS MEDICATIO N IS USED TO TREAT PSORIASIS. CALCIPOTRIENE IS A FORM OF VITAMIN D. IT WORKS BY SLOWIN G DOWN THE GROWTH OF SKIN CEL LS. CALCIPOTRIENE OINT 0.00 5% 120GM NDC CODE:68462031066 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 209297 THIS MEDICATION IS USED TO TREAT P SORIASIS. CALCIPOTRIENE IS A FORM OF VITAMIN D. IT WORKS B Y SLOWING DOWN THE GROWTH OF SKIN CELLS. COMMERCIAL & CUSTOM INVOICE NO. F22352003 678 DT. 12.11.2022 F223520036 79 DT. 12.11.2022 F2235200368 0 DT. 12.11.2022 F22352003662 DT. 11.11.2022 F22352003663 DT. 11.11.2022 F22352003664 D T. 11.11.2022 S/BILL NO: 5427 120 DT 13-NOV-22 S/BILL NO: 5427077 DT 13-NOV-22 S/BILL N O: 5427079 DT 13-NOV-22 S/BIL L NO: 5419946 DT 12-NOV-22 S/ BILL NO: 5420431 DT 12-NOV-22 S/BILL NO: 5420419 DT 12-NOV- 22 NET WT. 9,408.80 KGS 02 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 684620 |
2022-12-06 |
40 PKG |
7424.52KG |
40 PALLETS 1968 CARTONS PHARMACEUTICALS AS UNDER NO RGEST/EE TAB .18,.215,.25/.035 MG 84 NDC CODE:68462056529 F DA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00. 00 ANDA NO.: 200494 THERAPEU TICE USE: - ORAL CONTRACEPTIV ES NORGEST/EE TAB 0.25/0.03 5MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00 .00 ANDA NO.: 200538 THERAPE UTICE USE: - ORAL CONTRACEPTI VES NORGEST/EE TAB .18,.215 ,.25/.035MG 84 NDC CODE:68462 056529 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 30 06.60.00.00 ANDA NO.: 200494 THERAPEUTICE USE: - ORAL CON TRACEPTIVES COMMERCIAL & CU STOM INVOICE NO. F22352003596 DT. 07.11.2022 F22352003597 DT. 07.11.2022 F22352003606 D T. 07.11.2022 S/BILL NO: 5315 979 DT: 08-NOV-22 S/BILL NO: 5316024 DT: 08-NOV-22 S/BI LL NO: 5316526 DT: 08-NOV-22 NET WT. 5,692.37 02 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 652700 |
2022-12-06 |
46 PKG |
11769.56KG |
46 PALLETS 2998 CARTONS PHARMACEUTICALS AS UNDER M UPIROCIN OINT 2% 22GM NDC COD E:68462018022 FDA PRODUCT COD E NO.: 61 G J J 81 H. T. S N O.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - A NTI-BACTERIAL MUPIROCIN OIN T 2% 22GM NDC CODE:6846201802 2 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90 .92.45 ANDA NO.: 90-480 THER APEUTICE USE: - ANTI-BACTERIA L ROPINIROLE TAB 0.25MG 100 NDC CODE:68462025301 FDA PR ODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 A NDA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT OF PARKINSON ISM NAPROXEN TAB 500MG 100 NDC CODE:68462019001 FDA PRO DUCT CODE NO.:-62 G C A 49 H . T. S NO.: 3004.90.92.40 AN DA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMATORY, ANALG ESIC GABAPENTIN TAB 600MG 5 00 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT ROSUVASTATIN TAB 10MG 90 ND C CODE:68462026290 FDA PRODUC T CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL A ND RELATED CONDITIONS, AND T O PREVENT CARDIOVASCULAR DISE ASE COMMERCIAL & CUSTOM INV OICE NO. F22352003582 DT. 05. 11.2022 F22352003583 DT. 05.1 1.2022 F22352003598 DT. 07.11 .2022 F22352003599 DT. 07.11. 2022 F22352003600 DT. 07.11.2 022 S/BILL NO: 5310856 DT: 0 7-NOV-22 S/BILL NO: 5310857 D T:07-NOV-22 S/BILL NO: 531085 4 DT:07-NOV-22 S/BILL NO: 531 0841 DT:07-NOV-22 S/BILL NO: 5310493 DT:07-NOV-22 NET WT. 9,654.93 14 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWITZER LAND |
HS 618100 |
2022-12-06 |
5 PKG |
1075.49KG |
5 PALLETS 311 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 20MG 90 NDC CODE :68462026390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE CALCIPOTRIENE CREAM 0.005% 12 0GM NDC CODE:68462050166 FDA PRODUCT CODE NO.: 62 N C J 0 4 H. T. S NO.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTI CE USE: - TREATMENT OF PLAQUE PSORIASIS IN ADULTS S/BIL L NO: 5199222 DT: 02/11/2022 S/BILL NO: 5238984 DT:04/11/20 22 COMMERCIAL & CUSTOM IN VOICE NO. F22352003497 DT. 31 .10.2022 F22352003510 DT. 31. 10.2022 NET WT.838.45 KGS 05 DATA LOGGERS SET TEMPERATU RE : +18 DEGREES NOTIFY PAR TY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUM A-DROZ 2 NEUCHATEL - 2000 SW ITZERLAND |
HS 684620 |
2022-12-06 |
13 PKG |
2365.52KG |
13 PALLETS 651 CARTONS P HARMACEUTICALS AS UNDER CAR VEDILOL TAB 12.5MG 100 NDC CO DE:68462016401 FDA PRODUCT CO DE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.: - 78-251 THERAPEUTICE USE:-B ETA- ADRENOACEPTOR ANTAGONIS T NITROGLYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063 945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004. 90.9020 ANDA NO.:206391 THER APEUTIC USE: -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND P REVENT CHEST PAIN FROM NOT EN OUGH BLOOD FLOW TO THE HEART TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PROD UCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 AND A NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERMAT ITIS (ECZEMA). INDOMETHACI N ER CAP 75MG 60 NDC CODE:684 62032560 FDA PRODUCT CODE: 62 GCE42 H. T. S NO.:3004.90. 92.40 ANDA NO.203501 THERAPE UTIC USE: INDOMETHACIN IS USE D TO RELIEVE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED B Y ARTHRITIS, GOUT, BURSITIS, AND TENDONITIS. IT IS ALSO US ED TO RELIEVE PAIN FROM VARIO US OTHER CONDITIONS. THIS ME DICATION IS KNOWN AS A NONSTE ROIDAL ANTI-INFLAMMATORY DRUG (NSAID). ... THIS EFFECT HE LPS TO DECREASE SWELLING AND PAIN. NITROGLYCERIN SUBLIN G TAB 0.4MG 100 NDC CODE:6846 2063901 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3 004.90.9020 ANDA NO.: 206391 THERAPEUTICE USE: -MEDICATIO N USED FOR HEART FAILURE, HIG H BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTENOUGH BLOOD FLOW TO THE HEART NITROGLYCERIN SUBLING TAB 0.4MG 100 NDC CODE:68462 063901 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 30 04.90.9020 ANDA NO.: 206391 THERAPEUTICE USE: -MEDICATION USED FOR HEART FAILURE, HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTENOUGH BLOOD FLOW TO THE H EART CHLORPROMAZINE HCL TAB 25MG 100 NDC CODE:6846208620 1 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC D ISORDERS SUCH AS SCHIZOPHRENI A OR MANIC-DEPRESSION IN ADU LTS S/BILL NO: 4015822 DT:0 4/11/2022 S/BILL NO: 4015823 DT:04/11/2022 S/BILL NO: 4015 824 DT:04/11/2022 S/BILL NO: 4015830 DT:04/11/2022 S/BILL NO: 4015828 DT:04/11/2022 S/B ILL NO: 4015829 DT:04/11/2022 S/BILL NO: 4015831 DT:04/11/2 022 COMMERCIAL & CUSTOM I NVOICE NO. F22387001346 DT. 3 1.10.2022 F22387001349 DT. 31 .10.2022 F22387001353 DT. 31. 10.2022 F22387001357 DT. 31.1 0.2022 F22387001361 DT. 31.10 .2022 F22387001362 DT. 31.10. 2022 F22387001373 DT. 04.11.2 022 NET WT. 1,159.16 07 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA NO TIFY PARTY:3 GLENMARK SPECIAL TY S.A. SWITZERLAND (GSSA) P LACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 662800 |
2022-12-06 |
19 PKG |
5068.07KG |
19 PALLETS 859 CARTONS PHA RMACEUTICALS AS UNDER NAPRO XEN TAB 500MG 500 NDC CODE:68 462019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI-IN FLAMMATORY, ANALGESIC PRAM IPEXOLE TAB 0.5MG 90 NDC CODE :68462033290 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO .: 3004.90.92.40 ANDA NO.: 9 0-781 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE S/B ILL NO: 5244983 DT: 04/11/202 2 COMMERCIAL & CUSTOM INVOI CE NO. F22352003556 DT. 03.11 .2022 NET WT. 4,287.24 KGS 0 6 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A |
HS 624900 |
2022-12-06 |
4 PKG |
972.06KG |
4 PALLETS 122 CARTONS P HARMACEUTICALS AS UNDER NIT ROGLYCERIN SUBLING TAB 0.4MG 4 X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HE ART FAILURE,HIGH BLOOD PRESSU RE,AND TO TREAT AND PREVENT C HEST PAIN FROM NOT ENOUGH BLO OD FLOW TO THE HEART NITRO GLYCERIN SUBLING TAB 0.4MG 4X2 5 NDC CODE:68462063945 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 A NDA NO.:206391 THERAPEUTIC US E: -MEDICATION USED FOR HEAR T FAILURE,HIGH BLOOD PRESSURE ,AND TO TREAT AND PREVENT CHE ST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERC IAL & CUSTOM INVOICE NO. F223 87001404 DT. 09.11.2022 F2238 7001411 DT. 09.11.2022 S/BILL NO: 4016043 DT:09.11.2022 S/ BILL NO: 4016059 DT:09.11.2022 NET WT. 65.00 KGS 04 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZ ERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERL AND |
HS 662800 |
2022-12-06 |
4 PKG |
830.09KG |
4 PALLETS 58 CARTONS PH ARMACEUTICALS AS UNDER CALC IPOTRIENE CREAM 0.005% 60GM N DC CODE:68462050165 FDA PRODU CT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTICE USE : - TREATMENT OF PLAQUE PSOR IASIS IN ADULTS COMMERCIAL & CUSTOM INVOICE NO. F2235200 3629 DT. 09.11.2022 S/BILL NO : 5369831 DT 10-NOV-2022 NET WT. 690.68 KGS 4 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEU CHATEL - 2000 SWITZERLAND |
HS 620400 |
2022-12-06 |
37 PKG |
8157.09KG |
37 PALLETS 2275 CARTONS PHARMACEUTICALS AS UNDER LEVONORGESTREL/EE TAB 0.09 /0.02MG 84 NDC CODE:6846206 3729 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 202791 THERAPEUTICE USE: - : USED FOR PREVENTING PR EGNANCY NORETHINDRONE ACE TAB 5MG 50 NDC CODE:684 62030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO .: 3004.39.00.50 ANDA NO .:-91-090 THERAPEUTICE USE: - SECONDARY AMENORRHEA,E NDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING TO PIRAMATE TAB 50MG 500 NDC C ODE:68462015305 FDA PRODUCT CODE NO.: 61 M C A 40 H . T. S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUT ICE USE: ANTICONVULSANT TOPIRAMATE TAB 100MG 500 NDC CODE:68462010905 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49 .00.20 ANDA NO.: 77627 T HERAPEUTICE USE: :#ANTICONV ULSANT TOPIRAMATE TAB 50MG 60 NDC CODE:6846201536 0 FDA PRODUCT CODE NO.:- 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 7 7-627 THERAPEUTICE USE:- ANTICONVULSANT ROPINIR OLE TAB 1MG 100 NDC CODE:68 462025501 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT OF PARKIN SONISM MUPIROCIN OINT 2% 22GM NDC CODE:6846201802 2 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90 -480 THERAPEUTICE USE: - ANTI-BACTERIAL CALCIP OTRIENE OINT 0.005% 60GM ND C CODE:68462031065 FDA PROD UCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 209297 THIS MEDICATION IS USED TO TREAT PSORIASIS. CALCIPOTRIENE I S A FORM OF VITAMIN D. IT W ORKS BY SLOWING DOWN THE GR OWTH OF SKIN CELLS. COMMERCIAL & CUSTOM INVOICE N O. F22352003641 DT. 10.11.2 022 F22352003647 DT. 10.11. 2022 F22352003648 DT. 10.11 .2022 F22352003644 DT. 10.1 1.2022 F22352003646 DT. 10. 11.2022 S/BILL NO: 5383301 DT 10-NOV-2022 S/BILL NO: 5 403529 DT 11-NOV-2022 S/BIL L NO: 5399889 DT 11-NOV-2022 S/BILL NO: 5403515 DT 11-NOV -2022 S/BILL NO: 5399810 DT 11-NOV-2022 NET WT. 6,533. 56 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGRE ES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 642900 |
2022-12-06 |
12 PKG |
2594.14KG |
12 PALLETS 1427 CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 10MG 90 NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO. : 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEAS E ROSUVASTATIN TAB 10MG 90 NDC CODE:68462026290 FDA PRO DUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 AND A NO.: 079172 THERAPEUTICE US E: - TO TREAT HIGH CHOLESTERO L AND RELATED CONDITIONS, AN D TO PREVENT CARDIOVASCULAR D ISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352003616 DT. 08.11.2022 F22352003617 DT. 0 8.11.2022 S/BILL NO: 5329484 DT 08-NOV-2022 S/BILL NO: 532 9485 DT 08-NOV-2022 NET WT.19 93.027 KGS 12 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEU CHATEL - 2000 SWITZERLAND |
HS 611600 |
2022-12-06 |
37 PKG |
7436.32KG |
37 PALLETS 1615 CARTONS PHARMACEUTICALS AS UNDER PR AVASTATIN SOD TAB 80MG 90 NDC CODE:68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA N O.:-77-987 THERAPEUTICE USE: -HYPOLIPDAEMIC PRAVASTATIN SOD TAB 20MG 500 NDC CODE:684 62019605 FDA PRODUCT CODE NO .:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-98 7 THERAPEUTICE USE:-HYPOLIPD AEMIC TOPIRAMATE ER CAP (Q) 150MG 30 NDC CODE:6846203703 0 3004.49.00.20 61 M C B 40 210278 TOPIRAMATE ER CAP ( Q) 25MG 30 NDC CODE:684620372 30 3004.49.00.20 61 M C B 40 210278 EZETIMIBE-SIMVA TA B 10/40MG 30 NDC CODE:6846203 2330 FDA PRODUCT CODE NO.: 6 1 J D C 15 H. T. S NO.: 3004 .49.00.10 ANDA NO.: 208699 T HERAPEUTICE USE: - THIS COMBI NATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL AN D FATS (SUCH AS LDL, TRIGLYC ERIDES) AND RAISE GOOD CHOLES TEROL (HDL) IN THE BLOOD. EZE TIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR B ODY ABSORBS FROM YOUR DIET. S IMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY REDUCING THE AM OUNT OF CHOLESTEROL MADE BY T HE LIVER. FROVATRIPTAN SUCC INATE TAB 2.5MG 9 NDC CODE:68 462069497 FDA PRODUCT CODE N O.:60 L C A 93 H. T. S NO.: 3004.90.92.28 ANDA NO.:204730 THERAPEUTICE USE: - USE:THE TREATMENT OF MIGRAINE HEADA CHES AND FOR SHORT TERM PREVE NTION OF MENSTRUAL MIGRAINE RANOLAZINE ER TAB 500MG 60 NDC CODE:68462031960 FDA PROD UCT CODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 AND A NO.:211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MED ICATION. IT WORKS BY IMPROVIN G BLOOD FLOW TO HELP THE HEAR T WORK MORE EFFICIENTLY. IT I S USED TO TREAT CHRONIC ANGIN A (CHEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGE NCY) ATTACK OF ANGINA TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PRAVASTATIN SOD T AB 20MG 500 NDC CODE:68462019 605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004. 90.92.20 ANDA NO.:-77-987 TH ERAPEUTICE USE:-HYPOLIPDAEMIC INDOMETHACIN ER CAP 75MG 6 0 NDC CODE:68462032560 FDA P RODUCT CODE: 62 GCE42 H. T. S NO.:3004.90.92.40 ANDA NO. 203501 THERAPEUTIC USE: INDO METHACIN IS USED TO RELIEVE P AIN, SWELLING, AND JOINT STIF FNESS CAUSED BY ARTHRITIS, GO UT, BURSITIS, AND TENDONITIS. IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDI TIONS. THIS MEDICATION IS KNO WN AS A NONSTEROIDAL ANTI-IN FLAMMATORY DRUG (NSAID). ... THIS EFFECT HELPS TO DECREAS E SWELLING AND PAIN. INDOM ETHACIN ER CAP 75MG 90 NDC CO DE:68462032590 FDA PRODUCT CO DE NO.: 62 GCE42 H. T. S NO. : 3004.90.92.40 ANDA NO.: 20 3501 THERAPEUTICE USE: #INDO METHACIN IS USED TO RELIEVE P AIN, SWELLING AND JOINT STIFF NESS CAUSED BY ARTHRITIS, GOU T, BURSITIS AND TENDONITIS IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDITIO NS.THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLA MMATORY DRUG THIS EFFECT HELP S TO DECREASE SWELLING AND P AIN. INDOMETHACIN ER CAP 75 MG 60 NDC CODE:68462032560 F DA PRODUCT CODE: 62 GCE42 H. T. S NO.:3004.90.92.40 ANDA NO.203501 THERAPEUTIC USE: INDOMETHACIN IS USED TO RELIE VE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED BY ARTHRITIS , GOUT, BURSITIS, AND TENDONI TIS. IT IS ALSO USED TO RELIE VE PAIN FROM VARIOUS OTHER C ONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANT I-INFLAMMATORY DRUG (NSAID). ... THIS EFFECT HELPS TO DEC REASE SWELLING AND PAIN. C OMMERCIAL & CUSTOM INVOICE NO. F22387001394 DT. 07.11.2022 F22387001395 DT. 07.11.2022 F22387001398 DT. 07.11.2022 F 22387001399 DT. 08.11.2022 F2 2387001400 DT. 08.11.2022 F22 387001403 DT. 09.11.2022 F223 87001405 DT. 09.11.2022 S/BIL L NO:4016038 DT:09.11.2022 S/ BILL NO:4016040 DT:09.11.2022 S/BILL NO: 4016041 DT:09.11.2 |
HS 611300 |
2022-12-06 |
9 PKG |
2027.14KG |
9 PALLETS 1072 CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 10MG 90 NDC CODE:68462026290 FDA P RODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00 .10 ANDA NO.: 079172 THE RAPEUTICE USE: - TO TREAT H IGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOI CE NO. F22352003645 DT. 10. 11.2022 S/BILL NO: 5400752 DT 11-NOV-2022 NET WT.1497 .215 9 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZ ERLAND |
HS 611600 |
2022-12-06 |
32 PKG |
7504.81KG |
32 PALLETS 1468 CARTONS PHARMACEUTICALS AS UNDER N ORGEST/EE TAB .18,.215,.25/.03 5MG 84 NDC CODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00 .00 ANDA NO.: 200494 THERAPE UTICE USE: - ORAL CONTRACEPTI VES NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRO DUCT CODE NO.:-62 G C A 49 H . T. S NO.: 3004.90.92.40 AN DA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMATORY, ANALG ESIC CARVEDILOL TAB 25MG 50 0 NDC CODE:68462016505 FDA P RODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTIC E USE:-BETA- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUS TOM INVOICE NO. F22352003613 DT. 08.11.2022 F22352003620 D T. 08.11.2022 S/BILL NO: 532 9480 DT 08-NOV-2022 S/BILL NO :5329493 DT 08-NOV-2022 NET W T. 6,394.42 02 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 652700 |
2022-12-06 |
41 PKG |
10751.23KG |
41 PALLETS 4180 CARTONS PHARMACEUTICALS AS UNDER NAPROXEN TAB 500MG 100 NDC CO DE:68462019001 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC TOPIRAMATE TAB 50MG 60 NDC C ODE:68462015360 FDA PRODUCT C ODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :- 77-627 THERAPEUTICE USE:- ANTICONVULSANT OLMESARTAN M EDOX TAB 5MG 30 NDC CODE:6846 2043630 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3004. 90.9220 ANDA NO.: 203281 THE RAPEUTICE USE: - -TREATMENT O F HYPERTENSION, ALONE OR WIT H OTHER ANTIHYPERTENSIVE AGEN TS, TO LOWER BLOOD PRESSURE TOPIRAMATE TAB 50MG 500 NDC CODE:68462015305 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA N O.:077627 THERAPEUTICE USE: ANTICONVULSANT ONDANSETRON TAB 4MG 30 NDC CODE:684620105 30 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:- 77-535 TH ERAPEUTICE USE:-ANTI -EMETIC TOPIRAMATE TAB 100MG 60 ND C CODE:68462010960 FDA PRODUC T CODE NO.:-61 M C A 40 H. T . S NO.: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTICE US E:-ANTICONVULSANT COMMERCIA L & CUSTOM INVOICE NO. F22352 003628 DT. 09.11.2022 F223520 03636 DT. 09.11.2022 S/BILL N O: 5371168 DT 10-NOV-2022 S/B ILL NO:5369838 DT 10-NOV-2022 NET WT. 8,435.96 02 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 626800 |
2022-11-29 |
40 PKG |
5865.5KG |
40 PALLETS 1992 CARTONS PHARMACEUTICALS AS UNDER NORETH ACE/EE TAB 1/0.02MG 6 3 NDC CODE:68462013281 FDA PRODUCT CODE NO.:65 J C A 2 5 H. T. S NO.: 3006.60.00. 00 ANDA NO.:206969 THERAPE UTICE USE: - SECONDARY AME NORRHEA,ENDOMETRIOS IS AND A BNORMAL UTERINE BLEEDING DROSPIRENONE/EE TAB 3/0.02MG 84 NDC CODE:68462072029 F DA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60. 00.00 ANDA NO.: 204296 THE RAPEUTICE USE: - ORAL CONTRA CEPTIVE COMMERCIAL & C USTOM INVOICE NO. F223520035 05 DT. 31.10.2022 F223520035 23 DT. 31.10.2022 S/BILL NO: 5173328 DT 01-NOV-2022 S/BIL L NO: 5185054 DT 01-NOV-2022 NET WT. 4,142.50 KGS 02 DA TA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DE GREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 074 30 USA |
HS 652500 |
2022-11-29 |
38 PKG |
7295.7KG |
38 PALLETS 3230 CARTONS PHARMACEUTICALS AS UNDER EZETIMIBE TAB 10MG 90 N DC CODE:68462022690 FDA PRO DUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00. 10 ANDA NO.: #078560 THE RAPEUTICE USE: LIPID LOWERI NG AGENT CARVEDILOL TA B 12.5MG 500 NDC CODE:68462 016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO .: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST PRAVASTATI N SOD TAB 80MG 90 NDC CODE: 68462019890 FDA PRODUCT COD E NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 AN DA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEMIC EZETIMIBE TAB 10MG 90 NDC CODE:68462022690 FDA PRODUC T CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #078560 THERAP EUTICE USE: LIPID LOWERING AGENT EZETIMIBE-SIMVA TAB 10/40MG 90 NDC CODE:684 62032390 FDA PRODUCT CODE N O.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTICE US E: LIPID LOWERING AGENT FENOFIBRATE CAP 134MG 100 NDC CODE:68462058101 FD A PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90. 92.20 ANDA NO.: 205566 T HERAPEUTICE USE: - INDICATE D AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF L DL-C, TOTAL-C, TRIGLYCERIDE S AND APO B IN DULT PATI ENTS WITH PRMARY HYPERCH OLESTEROLEMIA OR MIXED DYSL IPIDEMIA POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:6 8462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE US E: - TREATMENT OR PREVENTIO N OF HYPOKALEMIA CO MMERCIAL & CUSTOM INVOICE NO. F22387001332 DT. 31.10.2022 F22387001339 DT. 31.10.202 2 F22387001341 DT. 31.10.20 22 S/BILL NO: 4015773 DT: 0 3.11.2022 S/BILL NO: 401577 4 DT: 03.11.2022 S/BILL NO: 4015772 DT: 03.11.2022 NET WT. 4,478.81 KGS 02 DATA L OGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 0 7430 USA |
HS 611500 |
2022-11-29 |
5 PKG |
787KG |
5 PALLETS 240 CARTON S PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TAB 0 .4MG 100 NDC CODE:68462063901 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90. 9020 ANDA NO.: 206391 THERAP EUTICE USE: MEDICATION USED F OR HEART FAILURE, HIGH BLOOD PRESSURE,AND TO TREAT AND PR EVENT CHEST PAIN FROM NOTENOU GH BLOOD FLOW TO THE HEART NITROGLYCERIN SUBLING TAB 0.4 MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9 020 ANDA NO.:206391 THERAPEU TIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRE SSURE,AND TO TREAT AND PREVEN T CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART AP REPITANT CAP 40MG 5UD NDC COD E:68462058385 FDA PRODUCT COD E NO.: 61 T C E 32 H. T. S N O.: 3004.90.92.40 ANDA NO.:2 07777 THERAPEUTICE USE:APREP ITANT IS USED WITH OTHER MEDI CATIONS TO HELP PREVENT NAUSE A AND VOMITING CAUSED BY CAN CER DRUG TREATMENT (CHEMOTHER APY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSEA AND VOMITING AFTER SURGERY. A-EME TIC/NAUSEANT / HUMAN - RX/SIN GLE INGREDIENT / DELAYED REL EASE TABLETS / APREPITANT S/BILL NO: 4015771 DT:03.11.20 22 S/BILL NO: 4015776 DT:03.1 1.2022 COMMERCIAL & CUSTO M INVOICE NO. F22387001344 DT . 31.10.2022 F22387001345 DT. 31.10.2022 NET WT. 54.27 KG S 05 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND |
HS 662800 |
2022-11-29 |
34 PKG |
7087.95KG |
34 PALLETS 1695 CARTONS PHARMACEUTICALS AS UNDER PO TASSIUM CL ER CAP 10MEQ 100 N DC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T . S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA CARVEDILOL TA B 12.5MG 500 NDC CODE:6846201 6405 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST TACRO LIMUS OINT 0.1% 100GM NDC COD E:68462053494 FDA PRODUCT COD E NO.: 64 T C J 08 H. T. S N O.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - T ACROLIMUS IS A TOPICAL IMMUNO SUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-T O-SEVERE ATOPIC DERMATITIS ( ECZEMA). TACROLIMUS OINT 0. 1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.0 0.50 ANDA NO.: 210393 THERAP EUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE O INTMENT USED FOR THE TREATMEN T OF MODERATE-TO-SEVERE ATOP IC DERMATITIS (ECZEMA). PI MECROLIMUS CREAM 1% 100GM NDC CODE:68462060994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA N O.: 211769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONT INUOS CHRONIC TRERTMENT OF MI LD TO MODERATE ATOPIC DERMAT ITIS IN NONIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS O F AGE S/BILL NO: 4015597 D T: 31.10.2022 S/BILL NO: 401 5596 DT: 31.10.2022 S/BILL NO : 4015595 DT: 31.10.2022 COMMERCIAL & CUSTOM INVOICE NO. F22387001313 DT. 29.10.2 022 F22387001320 DT. 29.10.20 22 F22387001323 DT. 29.10.202 2 NET WT. 4,083.58 KGS 02 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 651400 |
2022-11-29 |
10 PKG |
2259.84KG |
10 PALLETS 761 CARTONS P HARMACEUTICALS AS UNDER ESO MEPRAZOLE MAG DR CAP 40MG 30 NDC CODE:68462039130 FDA PROD UCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004.90.92 60 AND A NO.: 209495 THERAPEUTICE US E: ESOMEPRAZOLE MAGNESIUM D ELAYED-RELEASE CAPSULES ARE INDICATED FOR THE LONG-TERM T REATMENT OF PATHOLOGICAL HYP ERSECRETORY CONDITIONS, INCLU DING ZOLLINGER-ELLISON SYNDR OME S/BILL NO: 4015598 DT: 31.10.2022 COMMERCIAL & CU STOM INVOICE NO. F22387001319 DT. 29.10.2022 NET WT. 267.0 2 KGS 10 DATA LOGGERS SET TEMPERATURE : +18 DEGREES N OTIFY PARTY:2 GLENMARK SPECIA LTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 620600 |
2022-11-29 |
43 PKG |
9448.49KG |
43 PALLETS 1951 CARTONS PH ARMACEUTICALS AS UNDER DROS PIRENONE/EE TAB 3/0.03MG 84 N DC CODE:68462073329 FDA PRODU CT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204848 THERAPEUTICE USE : - CONTRACEPTION TO PREVENT PREGNANCY OMEPRAZOLE DR CA P 20MG 1000 NDC CODE:68462039 610 FDA PRODUCT CODE NO.: 62 KCF10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAPEU TICE USE: - -TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX D ISEASE CARVEDILOL TAB 12.5M G 500 NDC CODE:68462016405 F DA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92. 20 ANDA NO.:- 78-251 THERAPE UTICE USE:-BETA- ADRENOACEPT OR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F223520 03440 DT. 29.10.2022 F2235200 3441 DT. 29.10.2022 F22352003 442 DT. 29.10.2022 S/BILL NO: 5132087 DT 30-OCT-2022 S/BIL L NO: 5131378 DT 30-OCT-2022 S/BILL NO: 5131380 DT 30-OCT-2 022 NET WT. 7,412.37 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 653900 |
2022-11-25 |
44 PKG |
8806.19KG |
44 PALLETS 2888 CARTONS PHARMACEUTICALS AS UNDER LI THIUM CARB CAP 300MG 100 NDC CODE:68462022101 FDA PRODUCT CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO .:- 79 -139 THERAPEUTICE USE :-ANTIMANIC AGENT OLMESARTA N MEDOX TAB 5MG 30 NDC CODE:6 8462043630 FDA PRODUCT CODE N O.: 62CCA68 H. T. S NO.: 30 04.90.9220 ANDA NO.: 203281 THERAPEUTICE USE: - TREATMENT OF HYPERTENSION, ALONE OR W ITH OTHER ANTIHYPERTENSIVE AG ENTS, TO LOWER BLOOD PRESSURE LIDOCAINE OINT TUBE 5% 35. 44GM NDC CODE:68462041820 FD A PRODUCT CODE NO.:60 Q C J 0 7 H. T. S NO.: 3004.49.00.50 ANDA NO.:206498 THERAPEUTIC E USE: -USED TO TEMPORARILY R ELIEVE PAIN AND ITCHING ASSO CIATED WITH SKIN MUPIROCIN OINT 2% 22GM NDC CODE:6846201 8022 FDA PRODUCT CODE NO.: 6 1 G J J 81 H. T. S NO.: 3004 .90.92.45 ANDA NO.: 90-480 T HERAPEUTICE USE: - ANTI-BACTE RIAL ONDANSETRON ODT 8MG 10 UD NDC CODE:68462015811 FDA PRODUCT CODE NO.:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-152 THERAPEUTIC E USE:-ANTI EMETIC NAPROXEN TAB 500MG 100 NDC CODE:68462 019001 FDA PRODUCT CODE NO.: -62 G C A 49 H. T. S NO.: 30 04.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLA MMATORY, ANALGESIC ROPINIR OLE TAB 1MG 100 NDC CODE:6846 2025501 FDA PRODUCT CODE NO. :-62 J C A 17 H. T. S NO.: 3 004.90.92.40 ANDA NO.:- 90-13 5 THERAPEUTICE USE:-TREATMEN T OF PARKINSONISM COMMERCI AL & CUSTOM INVOICE NO. F2235 2003321 DT. 22.10.2022 F22352 003336 DT. 23.10.2022 F223520 03337 DT. 23.10.2022 S/BILL N O:5050385 DT:25-OCT-22 S/BIL L NO: 5050051 DT:25-OCT-22 S /BILL NO:5050095 DT: 25-OCT-2 2 NET WT. 6,923.35 KGS 02 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 613700 |
2022-11-25 |
40 PKG |
7971.57KG |
40 PALLETS 2481 CARTONS PHARMACEUTICALS AS UNDER TO PIRAMATE TAB 100MG 500 NDC CO DE:68462010905 FDA PRODUCT CO DE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.: 77627 THERAPEUTICE USE: :#A NTICONVULSANT PRAMIPEXOLE T AB 0.25MG 90 NDC CODE:6846203 3190 FDA PRODUCT CODE NO.: 6 2 J C A 15 H. T. S NO.: 3004 .90.92.40 ANDA NO.: 90-781 T HERAPEUTICE USE: USED IN PARK INSON#S DISEASE CHARLOTTE 2 4 FE CHEW 1MG/20MCG-75MG 84 N DC CODE:68462085229 FDA PRODU CT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.:210369 THERAPEUTICE USE: CONTRACEPTION TO PREVENTPRE GNANCYAFTER BIRTH CONTROL FAI LURE HAILEY FE 1.5/30 TAB 1 .5MG/30MCG-75MG 84 NDC CODE:6 8462050329 FDA PRODUCT CODE N O.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.:2065 97 THERAPEUTICE USE: HORMONE MEDICATION IS USED TO PREVEN T PREGNANCY COMMERCIAL & C USTOM INVOICE NO. F2235200339 0 DT. 27.10.2022 F22352003408 DT. 28.10.2022 F22352003407 DT. 28.10.2022 S/BILL NO: 510 2856 DT 28-OCT-2022 S/BILL NO : 5103609 DT 28-OCT-2022 S/BI LL NO: 5103143 DT 28-OCT-2022 NET WT. 6,144.56 KGS SET TEMPERATURE : +18 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA NOTIFY PARTY:3 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 621500 |
2022-11-25 |
49 PKG |
12568.8KG |
49 PALLETS 3259 CARTONS PHARMACEUTICALS AS UNDER G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT ATOMOXE TINE CAP 80MG 30 NDC CODE:684 62027030 FDA PRODUCT CODE NO. : 64 UCA 99 H. T. S NO.:300 4.90.92.90 ANDA NO.: 079019 THERAPEUTICE USE: - ATOMOXETI NE IS USED TO TREAT ATTENTION -DEFICIT HYPERACTIVITY DISORD ER (ADHD) AS PART OF A TOTAL TREATMENT PLAN, INCLUDING PS YCHOLOGICAL, SOCIAL, AND OTHE R TREATMENTS ONDANSETRON OD T 8MG 30UD NDC CODE:684620158 13 FDA PRODUCT CODE.:-61 T C A 26 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-152 THERAP EUTICE USE:-ANTI -EMETIC G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT TOPIRAM ATE TAB 100MG 60 NDC CODE:684 62010960 FDA PRODUCT CODE NO .:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77-6 27 THERAPEUTICE USE:-ANTICON VULSANT THEOPHYLLINE ER TAB 400MG 100 NDC CODE:684620380 01 FDA PRODUCT CODE NO.: 63 B C B 30 H. T. S NO.: 3004.9 0.92.85 ANDA NO.: 90-355 THE RAPEUTICE USE: XANTHINE BRONC HODILATOR PRAMIPEXOLE TAB 0 .25MG 90 NDC CODE:68462033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90. 92.40 ANDA NO.: 90-781 THERA PEUTICE USE: USED IN PARKINSO N#S DISEASE COMMERCIAL & CU STOM INVOICE NO. F22352003374 DT. 27.10.2022 F22352003377 DT. 27.10.2022 F22352003378 D T. 27.10.2022 F22352003383 DT . 27.10.2022 F22352003387 DT. 27.10.2022 S/BILL NO: 50801 91 DT 27-OCT-2022 S/BILL NO: 5081551 DT 27-OCT-2022 S/BILL NO: 5080185 DT 27-OCT-2022 S /BILL NO: 5081569 DT 27-OCT-20 22 S/BILL NO: 5081524 DT 27-O CT-2022 NET WT. 10,545.96 KG S 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 649900 |
2022-11-25 |
46 PKG |
9841.76KG |
46 PALLETS 2192 CARTONS PHARMACEUTICALS AS UNDER MUPIROCIN OINT 2% 22GM NDC CO DE:68462018022 FDA PRODUCT CO DE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL MUPIROCIN OI NT 2% 22GM NDC CODE:684620180 22 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.9 0.92.45 ANDA NO.: 90-480 THE RAPEUTICE USE: - ANTI-BACTERI AL LITHIUM CARB CAP 300MG 1 000 NDC CODE:68462022110 FDA PRODUCT CODE NO.:-61 N C E 3 7 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 79 -139 THERAPEU TICE USE:-ANTIMANIC AGENT ATOVAQUONE-PROG TAB 62.5/25MG 100 NDC CODE:68462040201 FDA PRODUCT CODE NO.: 62 L D A 4 4 H. T. S NO.: 3004.90.92.90 ANDA NO.: 91-211 ANTI MALAR IAL PRAVASTATIN SOD TAB 40M G 500 NDC CODE:68462019705 F DA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92. 20 ANDA NO.: 77-987 THERAPEU TICE USE: HYPOLIPDAEMIC NA PROXEN TAB 500MG 500 NDC CODE :68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC O NDANSETRON ODT 4MG 30UD NDC C ODE:68462015713 FDA PRODUCT C ODE NO,:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO. :-78-152 THERAPEUTICE USE:-AN TI EMETIC ROPINIROLE TAB 0 .5MG 100 NDC CODE:68462025401 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90. 92.40 ANDA NO.:- 90-135 THER APEUTICE USE:-TREATMENT OF P ARKINSONISM PRAMIPEXOLE TAB 0.125MG 90 NDC CODE:68462033 090 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004. 90.92.40 ANDA NO.: 90-781 TH ERAPEUTICE USE: USED IN PARKI NSON#S DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352003 300 DT. 21.10.2022 F223520033 20 DT. 22.10.2022 F2235200330 2 DT. 21.10.2022 F22352003319 DT. 22.10.2022 S/BILL NO: 5 036399 DT: 23-OCT-22 S/BILL NO: 5036389 DT: 23-OCT-22 S /BILL NO: 5036696 DT: 23-OCT- 22 S/BILL NO: 5036388 DT: 23-OCT-22 NET WT. 7,980.30 KG S 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 618100 |
2022-11-25 |
37 PKG |
8706.85KG |
37 PALLETS 1767 CARTONS PHARMACEUTICALS AS UNDER G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT TACROLI MUS OINT 0.1% 100GM NDC CODE: 68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO. : 3004.49.00.50 ANDA NO.: 21 0393 THERAPEUTICE USE: - TAC ROLIMUS IS A TOPICAL IMMUNOSU PPRESSIVE OINTMENT USED FOR T HE TREATMENT OF MODERATE-TO- SEVERE ATOPIC DERMATITIS (EC ZEMA). PIMECROLIMUS CREAM 1 % 100GM NDC CODE:68462060994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 211769 THERAP EUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM A ND NON-CONTINUOS CHRONIC TRE RTMENT OF MILD TO MODERATE AT OPIC DERMATITIS IN NON-IMMUN OCOMPROMISED ADULT AND CHILDR EN 2 YEARS OF AGE PRAVASTA TIN SOD TAB 20MG 90 NDC CODE: 68462019690 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO. : 3004.90.92.20 ANDA NO.:-77 -987 THERAPEUTICE USE:-HYPOL IPDAEMIC PRAVASTATIN SOD TA B 20MG 500 NDC CODE:684620196 05 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.9 0.92.20 ANDA NO.:-77-987 THE RAPEUTICE USE:-HYPOLIPDAEMIC AMLOD-OLMESARTAN TAB 10/20M G 30 NDC CODE:68462056730 FD A PRODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 207807 THERAPEUT ICE USE: -MEDICATION USED TO TREAT HIGH BLOOD PRESSURE AND CORONARY ARTERY DISEASE P RAVASTATIN SOD TAB 10MG 90 ND C CODE:68462019590 FDA PRODUC T CODE NO.:-61 J C A 13 H. T . S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE :-HYPOLIPDAEMIC COMMERCIAL & CUSTOM INVOICE NO. F2238700 1292 DT. 26.10.2022 F22387001 295 DT. 26.10.2022 F223870012 96 DT. 26.10.2022 F2238700129 7 DT. 26.10.2022 F22387001298 DT. 26.10.2022 S/BILL NO: 40 15284 DT: 26.10.2022 S/BILL N O:4015282 DT: 26.10.2022 S/BI LL NO:4015296 DT: 26.10.2022 S/BILL NO: 4015297 DT: 26.10.2 022 S/BILL NO: 4015298 DT: 26 .10.2022 NET WT. 6,439.20 KG S 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES |
HS 640800 |
2022-11-25 |
6 PKG |
1466.04KG |
6 PALLETS 184 CARTONS P HARMACEUTICALS AS UNDER NIT ROGLYCERIN SUBLING TAB 0.4MG 4 X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HE ART FAILURE,HIGH BLOOD PRESSU RE,AND TO TREAT AND PREVENT C HEST PAIN FROM NOT ENOUGH BLO OD FLOW TO THE HEART COM MERCIAL & CUSTOM INVOICE NO. F22387001293 DT. 26.10.2022 S /BILL NO: 4015283 DT: 26.10.2 022 NET WT. 98.04 KGS 06 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE NUMA- DROZ 2 NEUCHATEL - 2000 SWIT ZERLAND |
HS 662800 |
2022-11-25 |
31 PKG |
4993.68KG |
31 PALLETS 2134 CARTONS PH ARMACEUTICALS AS UNDER HAILEY 24 FE TAB 1MG/20MCG-75MG 84 NDC CODE:68462073129 FDA PROD UCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 AND A NO.: 204847 THERAPEUTICE US E: - CONTRACEPTION TO PREVENT PREGNANCY NORETH ACE/EE T AB 1MG/5MCG 90 NDC CODE:68462 065790 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 30 06.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - TREATMEN T OF MODERATE TO SEVERE VASOM OTOR SYMPTOMS DUE TO MENOPAU SE; OSTEOPOROSIS PREVENTION CARVEDILOL TAB 3.125MG 500 NDC CODE:68462016205 FDA PROD UCT CODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 AND A NO.:- 78-251 THERAPEUTICE USE:-BETAADRENOACEPTOR ANTAGO NIST ROPINIROLE TAB 5MG 100 NDC CODE:68462025901 FDA PR ODUCT CODE NO.:62 J C A 17 H . T. S NO.: 3004.90.92.40 AN DA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT OF PARKINSONI SM RILUZOLE TAB 50MG 60 NDC CODE:68462038160 FDA PRODUCT CODE NO.: 62 J C A 16 H. T. S NO.: 3004.90.92.30 ANDA NO .: 91394 THERAPEUTICE USE: - A-PARKINSONIAN/ HUMAN - RX/S INGLE INGREDIENT / PROMPT REL EASE TABLETS / RILUZOLE (ANT I-PARKINSONIAN) COMMERCIAL & CUSTOM INVOICE NO. F2235200 3353 DT. 26.10.2022 F22352003 361 DT. 26.10.2022 S/BILL NO: 5057121 DT 26-OCT-2022 S/BIL L NO: 5062864 DT 26-OCT-2022 NET WT. 3,678.56 KGS 01 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 652500 |
2022-11-25 |
3 PKG |
900.4KG |
3 PALLETS 105 CARTONS P HARMACEUTICALS AS UNDER NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC CO MMERCIAL & CUSTOM INVOICE NO. F22352003301 DT. 21.10.2022 S/BILL NO: 5026925 DT:22-OCT-2 2 NET WT: 806.19 KGS 01 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 624900 |
2022-11-25 |
37 PKG |
5907.69KG |
37 PALLETS 2021 CARTONS PHARMACEUTICALS AS UNDER ES TRADIOL VAG INSERTS 10MCG 8 N DC CODE:68462071171 FDA PRODU CT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE: THE TREATMENT OF ATROPIC VAG INITIS DUE TO MENOPAUSE. V IORELE TAB 0.15/0.02-0.01MG 84 NDC CODE:68462031829 FDA PR ODUCT CODE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 A NDA NO.: 091346 THERAPEUTICE USE: - ORAL CONTRACEPTIVES COMMERCIAL & CUSTOM INVOICE N O. F22352003299 DT. 21.10.202 2 S/BILL NO: 5027577 DT:22-OC T-22 NET WT: 4199.52 KGS 01 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 642800 |
2022-11-15 |
42 PKG |
9505.64KG |
42 PALLETS 2415 CARTONS PHARMACEUTICALS AS UNDER OM EPRAZOLE DR CAP 20MG 30 NDC C ODE:68462039630 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE MOEXIPRIL HCL TAB 7.5MG 100 NDC CODE:6 8462020901 FDA PRODUCT CODE NO.:62 O C A 47 H. T. S NO.: 3004.49.00.10 ANDA NO.:-90-4 16 THERAPEUTICE USE:-ANTIHYP ERTENSIVE AGENT-ACE INHIBITOR NAPROXEN TAB 250MG 100 ND C CODE:68462018801 FDA PRODUC T CODE NO.:-62 G C A 49 H. T . S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE :-ANTI-INFLAMMATORY, ANALGESI C LITHIUM CARB CAP 150MG 10 0 NDC CODE:68462022001 FDA P RODUCT CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 79 -139 THERAPEUTI CE USE:-ANTIMANIC AGENT OM EPRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S N O.: 3004.90.9160 ANDA NO.: 9 1672 THERAPEUTICE USE: - -TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE TROSPI UM CL TAB 20MG 60 NDC CODE:68 462046160 FDA PRODUCT CODE N O.:-61 K C A 69 H. T. S NO.: 3004.49.00.70 ANDA NO.:-91-5 75 THERAPEUTICE USE:- TREATM ENT OF VENOUS DISEASES URINAR Y INCONTINENCE THERAPY CL OTRIMAZOLE CREAM 1% 30GM NDC CODE:68462018135 FDA PRODUCT CODE NO :61 W C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO. : 90-219 THERAPEUTICE USE: T REATMENT OF CANDIDIASIS NOR GEST/EE TAB 0.25/0.035MG 84 N DC CODE:68462030929 FDA PRODU CT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200538 THERAPEUTICE USE : - ORAL CONTRACEPTIVES CO MMERCIAL & CUSTOM INVOICE NO. F22352003194 DT. 16.10.2022 F22352003198 DT. 17.10.2022 F 22352003199 DT. 17.10.2022 S/ BILL NO: 4880049 DT:17-OCT-2 2 S/BILL NO:4870781 DT:17-OC T-22 S/BILL NO: 4869050 DT: 17-OCT-22 NET WT. 6,799.45 KGS 02 DATA LOGGERS SET T EMPERATURE : +18 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA |
HS 624700 |
2022-11-15 |
6 PKG |
1322.7KG |
6 PALLETS 805 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 5MG 90 NDC CODE:68 462026190 FDA PRODUCT CODE N O.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 07917 2 THERAPEUTICE USE: - TO TRE AT HIGH CHOLESTEROL AND RELAT ED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE CO MMERCIAL & CUSTOM INVOICE NO. F22352003186 DT. 15.10.2022 S/BILL NO: 4876065 DT:17-OCT -22 NET WT. 990.69 6 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK SPECIALTY S.A. SWITZE RLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLA ND |
HS 611600 |
2022-11-15 |
45 PKG |
10819.72KG |
45 PALLETS 2885 CARTONS PHARMACEUTICALS AS UNDER M UPIROCIN OINT 2% 22GM NDC COD E:68462018022 FDA PRODUCT COD E NO.: 61 G J J 81 H. T. S N O.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - A NTI-BACTERIAL OXCARBAZEPINE TAB 300MG 100 NDC CODE:68462 013801 FDA PRODUCT CODE NO.: -61 M C A 45 H. T. S NO.: 30 04.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONVU LSANT AGENT NAPROXEN TAB 50 0MG 100 NDC CODE:68462019001 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAP EUTICE USE:-ANTI-INFLAMMATORY , ANALGESIC PRAMIPEXOLE TA B 0.125MG 90 NDC CODE:6846203 3090 FDA PRODUCT CODE NO.: 6 2 J C A 15 H. T. S NO.: 3004 .90.92.40 ANDA NO.: 90-781 T HERAPEUTICE USE: USED IN PARK INSON#S DISEASE OLMESARTAN MEDOX TAB 5MG 30 NDC CODE:684 62043630 FDA PRODUCT CODE NO. : 62CCA68 H. T. S NO.: 3004 .90.9220 ANDA NO.: 203281 TH ERAPEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WI TH OTHER ANTIHYPERTENSIVE AGE NTS, TO LOWER BLOOD PRESSURE COMMERCIAL & CUSTOM INVOICE NO. F22352003274 DT. 20.10.2 022 F22352003276 DT. 20.10.20 22 S/BILL NO: 4997181 DT:21 -OCT-22 S/BILL NO: 4994153 DT: 21-OCT-22 NET WT. 8,596.4 6 02 DATA LOGGERS HUMIDITY :65% SET TEMPERATURE : +18 DE GREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 614500 |
2022-11-15 |
43 PKG |
11009.33KG |
43 PALLETS 3133 CARTONS PHARMACEUTICALS AS UNDER ON DANSETRON ODT 4MG 30UD NDC CO DE:68462015713 FDA PRODUCT CO DE NO,:-61 T C A 26 H. T. S NO.: 300490.92.40 ANDA NO.:- 78-152 THERAPEUTICE USE:-ANTI -EMETIC NAPROXEN TAB 250M G 100 NDC CODE:68462018801 F DA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-250 THERAPEU TICE USE:-ANTI-INFLAMMATORY, ANALGESIC LITHIUM CARB ER TAB 450MG 100 NDC CODE:684620 22401 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 300 4.49.00.20 ANDA NO.:91-616 T HERAPEUTICE USE: - INDICATED IN THE TREATMENT OF MANIC EP ISODES OF BIPOLAR DISORDER. BIPOLAR DISORDER, MANIC (DSM- IV) IS EQUIVALENT TO MANIC DE PRESSIVE ILLNESS, MANIC, IN T HE OLDER DSM-II TERMINOLOGY. ALSO INDICATED AS A MAINTENA NCE TREATMENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR DISORDER. MAINTENANCE THERAP Y REDUCES THE FREQUENCY OF M ANIC EPISODES AND DIMINISHES THE INTENSITY OF THOSE EPISO DES WHICH MAY OCCUR. PRAMI PEXOLE TAB 0.125MG 90 NDC COD E:68462033090 FDA PRODUCT COD E NO.: 62 J C A 15 H. T. S N O.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE OX CARBAZEPINE TAB 300MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-802 THERAPEUTICE USE:- ANTI CONVULSANT AGENT LAMO TRIGINE TAB CD 25MG 100 NDC C ODE:68462022901 FDA PRODUCT C ODE NO.:- 61 M C A 38 H. T. S NO.: 3004.90.92.30 ANDA NO .:-79 # 099 THERAPEUTICE USE: - ANTICONVULSANT COMMERCIA L & CUSTOM INVOICE NO. F22352 003223 DT. 18.10.2022 F223520 03227 DT. 19.10.2022 F2235200 3230 DT. 19.10.2022 S/BILL NO : 4929694 DT: 19-OCT-22 S/ BILL NO: 4941715 DT: 19-OCT- 22 S/BILL NO: 4941648 19-OCT -22 NET WT: 8,128.11 KGS 02 DATA LOGGERS SET TEMPERATU RE : +18 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 624900 |
2022-11-15 |
41 PKG |
6941.89KG |
41 PALLETS 2266 CARTONS PHARMACEUTICALS AS UNDER NO RGEST/EE TAB 0.25/0.035MG 84 NDC CODE:68462030929 FDA PROD UCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 AND A NO.: 200538 THERAPEUTICE US E: - ORAL CONTRACEPTIVES F LUCONAZOLE TAB 150MG 12UD NDC CODE:68462011944 NDC CODE : 68462011944 HTS NO : 3004.90 .92.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 THERAPE UTICE USE : ANTIFUNGAL OND ANSETRON TAB 4MG 30 NDC CODE: 68462010530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 7 7-535 THERAPEUTICE USE:-ANTI -EMETIC COMMERCIAL & CUSTO M INVOICE NO. F22352003183 DT . 15.10.2022 F22352003185 DT. 15.10.2022 S/BILL NO: 487076 1 DT:17-OCT-22 S/BILL NO: 48 68692 DT:17-OCT-22 NET WT. 5,156.91 KGS 02 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA |
HS 300490 |
2022-11-15 |
40 PKG |
8690.52KG |
40 PALLETS 2982 CARTONS P HARMACEUTICALS AS UNDER ACA MPROSATE CALCIUM DR TAB 333MG 180 NDC CODE:68462043518 FDA PRODUCT CODE NO.: 60 T C C 9 9 H. T. S NO.: 3004.90.92.40 ANDA NO.:202229 THERAPEUTIC E USE: - FOR TREATING ALCOHOL DEPENDENCE FLUCONAZOLE TA B 200MG 30 NDC CODE:684620104 30 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.9 0.92.45 ANDA NO.:-77 - 253 T HERAPEUTICE USE:-ANTIFUNGAL LITHIUM CARB CAP 150MG 100 NDC CODE:68462022001 FDA PROD UCT CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 AND A NO.:- 79 -139 THERAPEUTICE USE:-ANTIMANIC AGENT OMEPR AZOLE DR CAP 20MG 100 NDC COD E:68462039601 FDA PRODUCT COD E NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATM ENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE ONDANSETRO N TAB 4MG 30 NDC CODE:6846201 0530 FDA PRODUCT CODE NO.:-6 1 T C A 28 H. T. S NO.: 3004 .90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANTI -EMETI C ROPINIROLE TAB 0.5MG 100 NDC CODE:68462025401 FDA PRO DUCT CODE NO.:-62 J C A 17 H . T. S NO.: 3004.90.92.40 AN DA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT OF PARKINSONI SM OMEPRAZOLE DR CAP 20MG 1 000 NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H . T. S NO.: 3004.90.9160 AND A NO.: 91672 THERAPEUTICE USE : - -TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352003187 DT. 15.10.20 22 F22352003192 DT. 16.10.202 2 S/BILL NO: 4879860 DT: 17-O CT-22 S/BILL NO: 4876067 DT: 17-OCT-22 NET WT. 6,960.87 0 2 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 609900 |
2022-11-15 |
35 PKG |
9832.23KG |
35 PALLETS 1472 CARTONS PHARMACEUTICALS AS UNDER NA PROXEN TAB 250MG 100 NDC CODE :68462018801 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC O MEPRAZOLE DR CAP 20MG 1000 ND C CODE:68462039610 FDA PRODUC T CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE CLOTRI MAZOLE CREAM 1% 30GM NDC CODE :68462018135 FDA PRODUCT CODE NO :61 W C J 04 H. T. S NO. : 3004.90.92.45 ANDA NO.: 90 -219 THERAPEUTICE USE: TREAT MENT OF CANDIDIASIS OXCARBA ZEPINE TAB 300MG 100 NDC CODE :68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT COMMERCIA L & CUSTOM INVOICE NO. F22352 003210 DT. 17.10.2022 F223520 03211 DT. 17.10.2022 F2235200 3218 DT. 18.10.2022 S/BILL NO : 4896038 DT: 18-OCT-22 S/BI LL NO: 4893049 DT: 18-OCT-22 S/BILL NO: 4907455 DT: 18-OC T-22 NET WT. 8,163.04 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA |
HS 684620 |
2022-11-15 |
4 PKG |
994.74KG |
4 PALLETS 125 CARTON S PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TAB 0 .4MG 4X25 NDC CODE:6846206394 5 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90 .9020 ANDA NO.:206391 THERAP EUTIC USE: -MEDICATION USED F OR HEART FAILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PRE VENT CHEST PAIN FROM NOT ENOU GH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOICE N O. F22387001239 DT. 17.10.202 2 NET WT.66.60 04 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES NOTIFY PARTY:2 GLEN MARK SPECIALTY S.A. SWITZERLA ND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND S/BILL NO: 4014879 DT: 17.1 0.2022 |
HS 662800 |
2022-11-15 |
38 PKG |
9966.05KG |
38 PALLETS 2086 CART ONS PHARMACEUTICALS AS UNDE R GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRO DUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 AND A NO.:-77-662 THERAPEUTICE U SE:-ANTICONVULSANT AGENT A MLOD-OLMESARTAN TAB 10/20MG 30 NDC CODE:68462056730 FDA PR ODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90.92.20 A NDA NO.: 207807 THERAPEUTICE USE: -MEDICATION USED TO TREA T HIGH BLOOD PRESSURE AND CO RONARY ARTERY DISEASE POTAS SIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO. :202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF H YPOKALEMIA POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:684620 35705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 300 4.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA COMMERCIAL & CUSTOM INVOIC E NO. F22387001253 DT. 18.10. 2022 F22387001254 DT. 18.10.2 022 F22387001255 DT. 18.10.20 22 NET WT. 7,146.02 02 DAT A LOGGERS SET TEMPERATURE : +18 DEGREE S/BILL NO: 40 15033 DT: 19.10.2022 S/BILL N O: 4015036 DT: 19.10.2022 S/B ILL NO: 4015034 DT: 19.10.2022 NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 616900 |
2022-11-15 |
18 PKG |
6149.91KG |
18 PALLETS 1092 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 800MG 500 NDC CO DE:68462012705 FDA PRODUCT CO DE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT OXCARBA ZEPINE TAB 150MG 100 NDC CODE :68462013701 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT COMMERC IAL & CUSTOM INVOICE NO. F223 52003287 DT. 21.10.2022 F2235 2003288 DT. 21.10.2022 S/BILL NO: 5002518 DT:21-OCT-22 S/ BILL NO: 5002621 DT:21-OCT-22 NET WT.5450.55 KGS 01 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 684620 |
2022-11-15 |
38 PKG |
9641.72KG |
38 PALLETS 2679 CART ONS PHARMACEUTICALS AS UNDE R SIROLIMUS TAB 2MG 100 ND C CODE:68462068401 FDA PRODUC T CODE NO.: 64 T C A 12 H. T . S NO.: 3004.90.92.15 ANDA NO.: 208691 THERAPEUTICE USE: TO PREVENT REJECTION OF KID NEY TRANSPLANTS. GABAPENTIN TAB 600MG 500 NDC CODE:68462 012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 300 4.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULS ANT AGENT PRAVASTATIN SOD TAB 40MG 90 NDC CODE:68462019 790 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004. 90.92.20 ANDA NO.: 77-987 TH ERAPEUTICE USE: -HYPOLIPDAEMI C POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FD A PRODUCT CODE NO.:65 R C F 1 4 H. T. S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTIC E USE: - TREATMENT OR PREVENT ION OF HYPOKALEMIA FENOFI BRATE CAP 134MG 100 NDC CODE: 68462058101 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 2055 66 THERAPEUTICE USE: - INDIC ATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LD L-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS W ITH PRMARY HYPERCHOLESTEROLEM IA OR MIXED DYSLIPIDEMIA A MLOD-OLMESARTAN TAB 5/20MG 30 NDC CODE:68462056630 FDA PRO DUCT CODE NO.: 62 C D A 68 H . T. S NO.: 3004.90.92.20 AN DA NO.: 207807 THERAPEUTICE U SE: -MEDICATION USED TO TREAT HIGH BLOOD PRESSURE AND COR ONARY ARTERY DISEASE PRAVAS TATIN SOD TAB 40MG 500 NDC CO DE:68462019705 FDA PRODUCT CO DE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: -H YPOLIPDAEMIC OMEPRAZOLE DR CAP 40MG 30 NDC CODE:68462039 730 FDA PRODUCT CODE NO.: 62 KCF10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAPEU TICE USE: - -TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX D ISEASE COMMERCIAL & CUSTOM INVOICE NO. F22387001130 DT. 30.09.2022 F22387001233 DT. 1 5.10.2022 F22387001237 DT. 15 .10.2022 F22387001238 DT. 15. 10.2022 NET WT. 7,294.54 0 2 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A S/BILL NO: 4014874 DT: 17 .10.2022 S/BILL NO: 4014875 D T: 17.10.2022 S/BILL NO: 4014 876 DT: 17.10.2022 S/BILL NO: 4014878 DT: 17.10.2022 |
HS 641200 |
2022-11-15 |
26 PKG |
8564.88KG |
26 PALLETS 1718 CARTONS PHARMACEUTICALS AS UNDER O XCARBAZEPINE TAB 150MG 100 ND C CODE:68462013701 FDA PRODUC T CODE NO.:-61 M C A 45 H. T . S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE: -ANTI CONVULSANT AGENT LAM OTRIGINE TAB CD 25MG 100 NDC CODE:68462022901 FDA PRODUCT CODE NO.:- 61 M C A 38 H. T. S NO.: 3004.90.92.30 ANDA N O.:-79 # 099 THERAPEUTICE USE :- ANTICONVULSANT GABAPENT IN TAB 800MG 500 NDC CODE:684 62012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-66 2 THERAPEUTICE USE:-ANTICONV ULSANT AGENT FLUCONAZOLE T AB 200MG 30 NDC CODE:68462010 430 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004. 90.92.45 ANDA NO.:-77 - 253 THERAPEUTICE USE:-ANTIFUNGAL VERAPAMIL HCL ER TAB 240MG 100 NDC CODE:68462026001 FDA PRODUCT CODE NO.: 62 O C B 1 3 H. T. S NO.: 3004.90.92.20 ANDA NO.:-78-906 THERAPEUTI CE USE:-ANGINA VERAPAMIL H CL ER TAB 180MG 100 NDC CODE: 68462029301 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO. : 3004.90.92.20 ANDA NO.: 90 -700 THERAPEUTICE USE: - -AN GINA COMMERCIAL & CUSTOM IN VOICE NO. F22352003278 DT. 20 .10.2022 F22352003279 DT. 20. 10.2022 F22352003284 DT. 21.1 0.2022 S/BILL NO: 4995281 DT :21-OCT-2022 S/BILL NO: 50051 74 DT :21-OCT-22 S/BILL NO: 5 002541 DT :21-OCT-22 NET WT. 7,585.29 01 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : + 18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 614500 |
2022-11-15 |
4 PKG |
994.74KG |
4 PALLETS 125 CARTON S PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TAB 0 .4MG 4X25 NDC CODE:6846206394 5 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90 .9020 ANDA NO.:206391 THERAP EUTIC USE: -MEDICATION USED F OR HEART FAILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PRE VENT CHEST PAIN FROM NOT ENOU GH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOICE N O. S/BILL NO: 4015035 DT: 19 .10.2022 F22352003158 DT. 19. 10.2022 NET WT. 66.60 04 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE NUMA- DROZ 2 NEUCHATEL - 2000 SWIT ZERLAND |
HS 662800 |
2022-11-15 |
13 PKG |
3087.66KG |
13 PALLETS 464 CARTONS P HARMACEUTICALS AS UNDER AZE LAIC ACID GEL 15% 50GM NDC CO DE:68462062652 FDA PRODUCT CO DE NO.: 62 S C J 03 H. T. S NO.: 3004.49.00.50 ANDA NO.: 204637 INDICATED FOR TOPICAL TREATMENT OF THE INFLAMMATO RY PAPULES AND PUSTULES OF MI LD TO MODERATE ROSACEA ROS UVASTATIN TAB 20MG 90 NDC COD E:68462026390 FDA PRODUCT COD E NO.:61 J C A 16 H. T. S NO .: 3004.49.00.10 ANDA NO.: 0 79172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND R ELATED CONDITIONS, AND TO PRE VENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352003209 DT. 17.10.20 22 F22352003216 DT. 18.10.202 2 S/BILL NO: 4892987 DT:18-OC T-22 S/BILL NO: 4894355 DT:1 8-OCT-22 NET WT. 2,506.30 KGS 13 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND |
HS 210690 |
2022-11-08 |
36 PKG |
10165.18KG |
36 PALLETS 2177 CARTONS PH ARMACEUTICALS AS UNDER CLOT RIMAZOLE CREAM 1% 15GM NDC CO DE:68462018117 FDA PRODUCT CO DE NO.:61#W#C#J#04 H. T. S N O.: 3004.90.92.45 ANDA NO.: 90-219 THERAPEUTICE USE: TRE ATMENT OF CANDIDIASIS ROPIN IROLE TAB 0.25MG 100 NDC CODE :68462025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TRE ATMENT OF PARKINSONISM VER APAMIL HCL ER TAB 120MG 100 N DC CODE:68462029201 FDA PRODU CT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE : - ;-ANGINA NAPROXEN TAB 500MG 500 NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90 .92.40 ANDA NO.:-78-250 THER APEUTICE USE:-ANTI-INFLAMMATO RY, ANALGESIC PRAVASTATIN SOD TAB 40MG 500 NDC CODE:684 62019705 FDA PRODUCT CODE NO. : 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-98 7 THERAPEUTICE USE: -HYPOLIP DAEMIC COMMERCIAL & CUSTOM INVOICE NO. F22352003105 DT. 11.10.2022 F22352003112 DT. 1 2.10.2022 S/BILL NO: 4767569 DT 12-OCT-2022 S/BILL NO: 477 4193 DT 12-OCT-2022 NET WT. 8 ,739.24 2 DATA LOGGERS HUMID ITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA |
HS 684620 |
2022-11-08 |
16 PKG |
2864.03KG |
16 PALLETS 800 CARTONS PHA RMACEUTICALS AS UNDER NORET HINDRONE TAB 0.35MG 84 NDC CO DE:68462030529 FDA PRODUCT CO DE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO.: 91-209 THERAPEUTICE USE: PRE VENTION OF PREGNANCY. COMME RCIAL & CUSTOM INVOICE NO. F2 2352003098 DT. 11.10.2022 S/B ILL NO: 4746735 DT 11-OCT-2022 NET WT. 2,019.84 01 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 210120 |
2022-11-08 |
21 PKG |
4490.19KG |
21 PALLETS 2154 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 10MG 1000 NDC CO DE:68462026210 61 J C A 16 3 004.49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT C ARDIOVASCULAR DISEASE ROSUV ASTATIN TAB 10MG 90 NDC CODE: 68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079 172 THERAPEUTICE USE: - TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO. : 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEAS E COMMERCIAL & CUSTOM INVOI CE NO. F22352003054 DT. 08.10 .2022 S/BILL NO: 4695034 DT:0 8-OCT-22 NET WT. 3,559.29 21 DATA LOGGERS SET TEMPERATU RE : +18 DEGREES NOTIFY PAR TY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUM A-DROZ 2 NEUCHATEL - 2000 SW ITZERLAND |
HS 611600 |
2022-11-08 |
9 PKG |
1999.02KG |
9 PALLETS 804 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 20MG 90 NDC CODE :68462026390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352003111 DT. 11.10.2 022 S/BILL NO: 4767565 DT 12- OCT-2022 NET WT: 1,613.38 KGS 9 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 684620 |
2022-11-08 |
7 PKG |
1778.11KG |
7 PALLETS 996 CARTONS PHA RMACEUTICALS AS UNDER ONDANSE TRON TAB 8MG 30 NDC CODE:6846 2010630 FDA PRODUCT CODE NO. :-61 T C A 28 H. T. S NO.: 30 04.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANTI -EME TIC COMMERCIAL & CUSTOM IN VOICE NO. F22352003158 DT. 14 .10.2022 S/BILL NO: 4828893 DT:14-OCT-22 NET WT. 1,243.00 NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 612800 |
2022-11-08 |
28 PKG |
6393.95KG |
28 PALLETS 1001 CARTONS PH ARMACEUTICALS AS UNDER VERA PAMIL HCL ER TAB 180MG 500 ND C CODE:68462029305 FDA PRODUC T CODE NO.: 62 O C B 13 H. T . S NO.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - ANGINA OMEPRAZOLE DR CA P 20MG 1000 NDC CODE:68462039 610 FDA PRODUCT CODE NO.: 62 KCF10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAPEU TICE USE: - TREATMENT OF TREA T GASTROESOPHAGEAL REFLUX DI SEASE CALCIPOTRIENE OINT 0. 005% 60GM NDC CODE:6846203106 5 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90 .92.45 ANDA NO.: 209297 THIS MEDICATION IS USED TO TREAT PSORIASIS. CALCIPOTRIENE IS A FORM OF VITAMIN D. IT WORKS BY SLOWING DOWN THE GROWTH O F SKIN CELLS. NORETHINDRONE ACE TAB 5MG 50 NDC CODE:6846 2030450 FDA PRODUCT CODE NO. 65 J C A 25 H. T. S NO.: 300 4.39.00.50 ANDA NO.:-91-090 THERAPEUTICE USE:- SECONDARY AMENORRHEA,ENDOMETRIOS IS AN D ABNORMAL UTERINE BLEEDING HAILEY 24 FE TAB 1MG/20MCG-7 5MG 84 NDC CODE:68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00 .00 ANDA NO.: 204847 THERAPE UTICE USE: - CONTRACEPTION TO PREVENT PREGNANCY COMMERC IAL & CUSTOM INVOICE NO. F223 52003046 DT. 07.10.2022 F2235 2003052 DT. 08.10.2022 F22352 003056 DT. 08.10.2022 F223520 03057 DT. 08.10.2022 S/BILL N O: 4694698 DT. 08-OCT-22 S/BI LL NO: 4694677 DT. 08-OCT-22 S/BILL NO: 4694685 DT. 08-OCT- 22 S/BILL NO: 4694684 DT. 08- OCT-22 NET WT. 5,378.62 KGS 03 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA |
HS 621300 |
2022-11-08 |
3 PKG |
656.36KG |
3 PALLETS 260 CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 20MG 9 0 NDC CODE:68462026390 F DA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.4 9.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TRE AT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PRE VENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM I NVOICE NO. F22352003083 DT. 10.10.2022 S/BILL NO: 4745 553 DT 11-OCT-2022 03 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK SPECIALTY S .A. SWITZERLAND (GSSA) P LACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 611600 |
2022-11-08 |
19 PKG |
7557.88KG |
19 PALLETS 952 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TAB 800MG 500 NDC COD E:68462012705 FDA PRODUCT COD E NO : 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT COMMERCI AL & CUSTOM INVOICE NO. F2235 2003075 DT. 09.10.2022 S/BILL NO: 4713819 DT:10-OCT-22 NE T WT. 6,901.30 KGS 01 DATA LO GGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA |
HS 847439 |
2022-11-08 |
37 PKG |
9346.88KG |
37 PALLETS 3230 CARTONS PH ARMACEUTICALS AS UNDER CLOT RIMAZOLE CREAM 1% 15GM NDC CO DE:68462018117 FDA PRODUCT CO DE NO.:61#W#C#J#04 H. T. S N O.: 3004.90.92.45 ANDA NO.: 90-219 THERAPEUTICE USE: TRE ATMENT OF CANDIDIASIS ROPIN IROLE TAB 0.25MG 100 NDC CODE :68462025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TRE ATMENT OF PARKINSONISM THE OPHYLLINE ER TAB 300MG 100 ND C CODE:68462072101 63 B C B 3 0 3004.90.92.85 212184 TO R ELEASE TABLETS ARE INDICATED FOR THE TREATMENT OF THE SYM PTOMS AND REVERSIBLE AIRFLOW OBSTRUCTION ASSOCIATED WITH CHRONIC ASTHMA AND OTHER CHR ONIC LUNG DISEASES, E.G., EMP HYSEMA AND CHRONIC BRONCHITIS PRAVASTATIN SOD TAB 40MG 5 00 NDC CODE:68462019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTIC E USE: -HYPOLIPDAEMIC GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT THEOPHYLLI NE ER TAB 300MG 100 NDC CODE: 68462072101 63 B C B 30 3004 .90.92.85 212184 TO RELEASE TABLETS ARE INDICATED FOR THE TREATMENT OF THE SYMPTOMS A ND REVERSIBLE AIRFLOW OBSTRU CTION ASSOCIATED WITH CHRONIC ASTHMA AND OTHER CHRONIC LU NG DISEASES, E.G., EMPHYSEMA AND CHRONIC BRONCHITIS ACA MPROSATE CALCIUM DR TAB 333MG 180 NDC CODE:68462043518 FDA PRODUCT CODE NO.: 60 T C C 9 9 H. T. S NO.: 3004.90.92.40 ANDA NO.:202229 THERAPEUTIC E USE: - FOR TREATING ALCOHOL DEPENDENCE ONDANSETRON TA B 8MG 30 NDC CODE:68462010630 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:- 77-535 THERA PEUTICE USE:-ANTI -EMETIC OLMESARTAN MEDOX TAB 5MG 30 N DC CODE:68462043630 FDA PRODU CT CODE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE: - -TREATMENT OF HYPERTENSION, A LONE OR WITH OTHER ANTIHYPER TENSIVE AGENTS, TO LOWER BLOO D PRESSURE DICLOFENAC SOD G EL 3% 100GM NDC CODE:68462035 594 FDA PRODUCT CODE NO.:62 G C J 18 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:208301 THER APEUTICE USE: - USED FOR THE RELIEF OF JOINT PAIN OF OSTEO ARTHRITIS COMMERCIAL & CU STOM INVOICE NO. F22352003146 DT. 13.10.2022 F22352003115 DT. 12.10.2022 F22352003125 D T. 12.10.2022 F22352003126 DT . 12.10.2022 F22352003151 DT. 13.10.2022 F22352003124 DT. 12.10.2022 S/BILL NO: 482300 0 DT 14-OCT-2022 S/BILL NO: 4767372 DT 12-OCT-2022 S/BILL NO: 4800093 DT 13-OCT-2022 S/BILL NO: 4798778 DT 13-OCT- 2022 S/BILL NO: 4825095 DT 1 4-OCT-2022 S/BILL NO: 479877 2 DT 13-OCT-2022 NET WT. 7,40 5.92 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 684620 |
2022-11-08 |
28 PKG |
6546.36KG |
28 PALLETS 2678 CARTONS PHARMACEUTICALS AS UNDER PR OPAFENONE HCL ER CAP 325MG 60 NDC CODE:68462040960 FDA PRO DUCT CODE NO.: 63 E C F 28 H . T. S NO.: 3004.49.00.10 AN DA NO.: 205268 THERAPEUTICE U SE: -AN ANTIARRHYTHMIC AGENT IT IS USED TO TREAT IRREGULAR HEARTRHYTHM AND CAN SLOW RA PID HEARTBEATS AMLOD-OLMESA RTAN TAB 5/40MG 30 NDC CODE:6 8462056830 FDA PRODUCT CODE N O.: 62 C D A 68 H. T. S NO.: 3004.90.92.20 ANDA NO.: 207 807 THERAPEUTICE USE: -MEDIC ATION USED TO TREAT HIGH BLOO D PRESSURE AND CORONARY ARTER Y DISEASE AMLOD-OLMESARTAN TAB 5/40MG 90 NDC CODE:684620 56890 FDA PRODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 300 4.90.92.20 ANDA NO.: 207807 THERAPEUTICE USE: -MEDICATION USED TO TREAT HIGH BLOOD PRE SSURE AND CORONARY ARTERY DIS EASE AMLOD-OLMESARTAN TAB 5 /20MG 30 NDC CODE:68462056630 FDA PRODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90. 92.20 ANDA NO.: 207807 THERA PEUTICE USE: -MEDICATION USED TO TREAT HIGH BLOOD PRESSURE AND CORONARY ARTERY DISEASE OMEPRAZOLE DR CAP 40MG 30 NDC CODE:68462039730 FDA PROD UCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO. : 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTROESO PHAGEAL REFLUX DISEASE PRA VASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA N O.: 77-987 THERAPEUTICE USE: -HYPOLIPDAEMIC COMMERCIAL & CUSTOM INVOICE NO. F2238700 1194 DT. 11.10.2022 F22387001 195 DT. 11.10.2022 F223870011 96 DT. 11.10.2022 NET WT. 3,8 23.25 01 DATA LOGGERS SE T TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 632800 |
2022-11-08 |
8 PKG |
2053.45KG |
8 PALLETS 544 CARTONS PH ARMACEUTICALS AS UNDER PIME CROLIMUS CREAM 1% 30GM NDC CO DE:68462060935 FDA PRODUCT CO DE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - A S SECOUND-LINE THERAPY FOR T HE SHORT-TERM AND NON-CONTINU OS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITI S IN NON-IMMUNOCOMPROMISED A DULT AND CHILDREN 2 PIMECRO LIMUS CREAM 1% 30GM NDC CODE: 68462060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO. : 3004.90.92.45 ANDA NO.: 21 1769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS I N NON-IMMUNOCOMPROMISED ADUL T AND CHILDREN 2 GABAPENTIN TAB 600MG 500 NDC CODE:68462 012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 300 4.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULS ANT AGENT AMLOD-OLMESARTAN TAB 5/20MG 90 NDC CODE:68462 056690 FDA PRODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 30 04.90.92.20 ANDA NO.: 207807 THERAPEUTICE USE: -MEDICATIO N USED TO TREAT HIGH BLOOD PR ESSURE AND CORONARY ARTERY DI SEASE COMMERCIAL & CUSTOM I NVOICE NO. F22387001128 DT. 3 0.09.2022 F22387001134 DT. 30 .09.2022 F22387001093 DT. 29. 09.2022 F22387001147 DT. 30.0 9.2022 S/BILL NO:4014370 DT: 06.10.2022 S/BILL NO: 4014371 DT: 06.10.2022 S/BILL NO: 40 14363 DT: 06.10.2022 S/BILL N O: 4014460 DT: 07.10.2022 NET WT. 1,492.73 04 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA |
HS 610400 |
2022-11-08 |
32 PKG |
8553.54KG |
32 PALLETS 1685 CARTONS PHARMACEUTICALS AS UNDER NO RGEST/EE TAB 0.25/0.035MG 84 NDC CODE:68462030929 FDA PROD UCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 AND A NO.: 200538 THERAPEUTICE US E: - ORAL CONTRACEPTIVES G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT THEOPHY LLINE ER TAB 300MG 100 NDC CO DE:68462072101 63 B C B 30 3 004.90.92.85 212184 TO RELEA SE TABLETS ARE INDICATED FOR THE TREATMENT OF THE SYMPTOM S AND REVERSIBLE AIRFLOW OBS TRUCTION ASSOCIATED WITH CHRO NIC ASTHMA AND OTHER CHRONIC LUNG DISEASES, E.G., EMPHYSE MA AND CHRONIC BRONCHITIS COMMERCIAL & CUSTOM INVOICE NO. F22352003143 DT. 13.10.20 22 F22352003141 DT. 13.10.202 2 F22352003142 DT. 13.10.2022 S/BILL NO: 4822932 DT 14-OCT -2022 S/BILL NO: 4825093 DT 1 4-OCT-2022 S/BILL NO: 4822962 DT 14-OCT-2022 NET WT. 7,110 .69 05 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA |
HS 652700 |
2022-11-08 |
12 PKG |
3673.25KG |
12 PALLETS 570 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 600MG 500 NDC CO DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT GABAPENT IN TAB 600MG 500 NDC CODE:684 62012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3 004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVU LSANT AGENT COMMERCIAL & C USTOM INVOICE NO. F2238700116 4 DT. 07.10.2022 F22387001191 DT. 11.10.2022 NET WT. 3,149 .06 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA |
HS 616900 |
2022-11-08 |
24 PKG |
6515.51KG |
24 PALLETS 1649 CARTONS PH ARMACEUTICALS AS UNDER VERA PAMIL HCL ER TAB 120MG 100 ND C CODE:68462029201 FDA PRODUC T CODE NO.: 62 O C B 13 H. T . S NO.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - -ANGINA NAPROXEN TAB 50 0MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAP EUTICE USE:-ANTI-INFLAMMATORY , ANALGESIC OXCARBAZEPINE TAB 600MG 100 NDC CODE:684620 13901 FDA PRODUCT CODE NO.:- 61 M C A 45 H. T. S NO.: 300 4.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONVUL SANT AGENT OXCARBAZEPINE TA B 600MG 100 NDC CODE:68462013 901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004. 90.92.30 ANDA NO.:-77-802 TH ERAPEUTICE USE:-ANTI CONVULSA NT AGENT COMMERCIAL & CUSTO M INVOICE NO. F22352003093 DT . 11.10.2022 F22352003099 DT. 11.10.2022 S/BILL NO: 47476 52 DT:11-OCT-22 S/BILL NO:47 42227 DT 11-OCT-2022 NET WT. 5,606.96 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 621300 |
2022-11-01 |
6 PKG |
1439.27KG |
6 PALLETS 367 CARTON S PHARMACEUTICALS AS UNDER GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO .:-77-662 THERAPEUTICE USE:- ANTICONVULSANT AGENT FENOF IBRATE CAP 67MG 100 NDC CODE: 68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 2055 66 THERAPEUTICE USE: - INDIC ATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LD L-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS W ITH PRMARY HYPERCHOLESTEROLEM IA OR MIXED DYSLIPIDEMIA A MLOD-OLMESARTAN TAB 10/40MG 30 NDC CODE:68462056930 FDA PR ODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90.92.20 A NDA NO.: 207807 THERAPEUTICE USE: MEDICATION USED TO TREAT HIGH BLOOD PRESSURE AND COR ONARY ARTERY DISEASE COMMER CIAL & CUSTOM INVOICE NO. F22 387001101 DT. 30.09.2022 F223 87001122 DT. 30.09.2022 F2238 7001140 DT. 30.09.2022 S/BILL NO: 4014364 DT:06/10/2022 S/BILL NO: 4014367 DT:06/10/2 022 S/BILL NO: 4014372 DT:06 /10/2022 NET WT. 882.37 3 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 616900 |
2022-11-01 |
42 PKG |
9759.2KG |
42 PALLETS 2872 CARTONS PH ARMACEUTICALS AS UNDER NAPR OXEN TAB 500MG 500 NDC CODE:6 8462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 250 THERAPEUTICE USE:-ANTI-I NFLAMMATORY, ANALGESIC FEL ODIPINE ER TAB 2.5MG 100 NDC CODE:68462023301 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO .: 3004.90.92.20 ANDA NO.: 9 0-365 THERAPEUTICE USE: - TR EATMENT OF HYPERTENSION RO PINIROLE TAB 2MG 100 NDC CODE :68462025601 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TRE ATMENT OF PARKINSONISM OLM ESARTAN MEDOX TAB 20MG 90 NDC CODE:68462043790 FDA PRODUCT CODE NO.: 62CCA68 H. T. S N O.: 3004.90.9220 ANDA NO.: 2 03281 THERAPEUTICE USE: - -T REATMENT OF HYPERTENSION, ALO NE OR WITH OTHER ANTIHYPERTE NSIVE AGENTS, TO LOWER BLOOD PRESSURE CLOTRIMAZOLE CREAM 1% 30GM NDC CODE:68462018135 FDA PRODUCT CODE NO :61 W C J 04 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 90-219 THERAP EUTICE USE: TREATMENT OF CAND IDIASIS TOPIRAMATE TAB 50MG 500 NDC CODE:68462015305 FD A PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:077627 THERAPEUTI CE USE: ANTICONVULSANT VER APAMIL HCL ER TAB 120MG 100 N DC CODE:68462029201 FDA PRODU CT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE : - -ANGINA NORETH ACE/EE TAB 1/0.02MG 63 NDC CODE:6846 2013281 FDA PRODUCT CODE NO. :65 J C A 25 H. T. S NO.: 30 06.60.00.00 ANDA NO.:206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOMETRIOS IS A ND ABNORMAL UTERINE BLEEDING LITHIUM CARB CAP 300MG 1000 NDC CODE:68462022110 FDA PR ODUCT CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 A NDA NO.:- 79 -139 THERAPEUTIC E USE:-ANTIMANIC AGENT COM MERCIAL & CUSTOM INVOICE NO. F22352002902 DT. 29.09.2022 F 22352002842 DT. 28.09.2022 F2 2352002923 DT. 30.09.2022 F22 352002899 DT. 29.09.2022 F223 52002930 DT. 30.09.2022 NET W T. 8,127.25 3 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA S/BILL NO : 4587917 DT:01-OCT-22 S/BILL NO: 4587911 DT:01-OCT-22 S/B ILL NO: 4587931 DT: 01-OCT-22 S/BILL NO: 4556370 DT:30-SEP- 22 S/BILL NO: 4587907 DT:01-O CT-22 |
HS 624900 |
2022-11-01 |
2 PKG |
459.95KG |
2 PALLETS 111 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 20MG 1000 NDC CODE :68462026310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO .: 3004.49.00.10 ANDA NO.: 7 9172 THERAPEUTICE USE: TO TR EAT HIGH CHOLESTEROL AND RELA TED CONDITIONS, AND TO PREVEN T CARDIOVASCULAR DISEASE R OSUVASTATIN TAB 10MG 1000 NDC CODE:68462026210 61 J C A 16 3004.49.00.10 79172 TO TRE AT HIGH CHOLESTEROL AND RELAT ED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE CO MMERCIAL & CUSTOM INVOICE NO. F22352002984 DT. 01.10.2022 F22352003001 DT. 04.10.2022 S /BILL NO: 4610011 DT. 03.10.20 22 S/BILL NO: 4628194 DT. 04. 10.2022 NET WT.406.592 2 DAT A LOGGERS HUMIDITY:65% SET T EMPERATURE : +18 DEGREES TEMP ERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZ ERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERL AND |
HS 684620 |
2022-11-01 |
21 PKG |
3270.46KG |
21 PALLETS 1010 CARTONS PHARMACEUTICALS AS UNDER HA ILEY 24 FE TAB 1MG/20MCG-75MG 84 NDC CODE:68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204847 THERAPEUTIC E USE: - CONTRACEPTION TO PRE VENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F2235200 2938 DT. 30.09.2022 NET WT. 2 ,278.56 DATA LOGGERS HUMIDIT Y:65% SET TEMPERATURE : +18 D EGREES TEMPERATURE RANGE : +1 5 DEGREES TO +25 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 652500 |
2022-11-01 |
43 PKG |
9398.14KG |
43 PALLETS 3778 CARTONS P HARMACEUTICALS AS UNDER OME PRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO .: 3004.90.9160 ANDA NO.: 91 672 THERAPEUTICE USE: - -TRE ATMENT OF TREAT GASTROESOPHAG EAL REFLUX DISEASE TOPIRAM ATE TAB 25MG 500 NDC CODE:684 62010805 FDA PRODUCT CODE NO. : 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVU LSANT TOPIRAMATE TAB 25MG 6 0 NDC CODE:68462010860 FDA P RODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTIC E USE:-ANTICONVULSANT TOPI RAMATE TAB 50MG 500 NDC CODE: 68462015305 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:077 627 THERAPEUTICE USE: ANTICO NVULSANT TELMISARTAN TAB 80 MG 30 NDC CODE:68462020130 H TS NO : 3004.90.92.20 FDA COD E : 62 O C A 09 ANDA NO.: 900 32 THERAPEUTICE USE : INDICA TED FOR THE TREATMENT OF HYP ERTENSION, TO LOWER BLOOD PRE SSURE TOPIRAMATE TAB 25MG 5 00 NDC CODE:68462010805 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVULSANT TOPIR AMATE TAB 50MG 60 NDC CODE:68 462015360 FDA PRODUCT CODE N O.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77- 627 THERAPEUTICE USE:-ANTICO NVULSANT TOPIRAMATE TAB 25M G 500 NDC CODE:68462010805 F DA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00. 20 ANDA NO.:077627 THERAPEUT ICE USE: ANTICONVULSANT OM EPRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S N O.: 3004.90.9160 ANDA NO.: 9 1672 THERAPEUTICE USE: - -TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE OMEPRA ZOLE DR CAP 20MG 1000 NDC COD E:68462039610 FDA PRODUCT COD E NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATM ENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F223520 02954 DT. 30.09.2022 F2235200 2978 DT. 01.10.2022 F22352002 976 DT. 01.10.2022 F223520030 00 DT. 04.10.2022 F2235200297 5 DT. 30.09.2022 F22352002962 DT. 30.09.2022 F22352002967 DT. 30.09.2022 S/BILL NO: 460 9209 DT: 03-OCT-22 S/BILL NO: 4609714 DT: 03-OCT-22 S/BILL NO: 4609740 DT: 03-OCT-22 S/ BILL NO: 4628340 DT: 04-OCT-22 S/BILL NO: 4609214 DT: 03-OC T-22 S/BILL NO: 4610522 DT: 0 3-OCT-22 S/BILL NO: 4609219 D T: 03-OCT-22 NET WT. 7,588.09 SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 300490 |
2022-11-01 |
19 PKG |
3181.1KG |
19 PALLETS 908 CARTONS PHA RMACEUTICALS AS UNDER HAILE Y FE 1.5/30 TAB 1.5MG/30MCG-75 MG 84 NDC CODE:68462050329 F DA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.:206597 THERAPEUT ICE USE: HORMONE MEDICATION I S USED TO PREVENT PREGNANCY S/BILL NO: 4575385 DT: 01.1 0.2022 COMMERCIAL & CUSTOM INVOICE NO. F22352002925 DT. 30.09.2022 NET WT. 2,353.54 19 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE N UMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND S/BILL NO: 4575 385 DT: 01.10.2022 |
HS 652500 |
2022-11-01 |
4 PKG |
972.06KG |
4 PALLETS 200 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 20MG 1000 NDC CO DE:68462026310 FDA PRODUCT CO DE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 10MG 1000 N DC CODE:68462026210 61 J C A 16 3004.49.00.10 79172 TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO . F22352002903 DT. 29.09.2022 F22352002968 DT. 30.09.2022 NET WT.863.99 4 DATA LOGGERS HUMIDITY:65% SET TEMPERATUR E : +18 DEGREES TEMPERATURE R ANGE : +15 DEGREES TO +25 DEGR EES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (G SSA) PLACE NUMA-DROZ 2 NEUCH ATEL - 2000 SWITZERLAND |
HS 271019 |
2022-11-01 |
23 PKG |
4470.68KG |
23 PALLETS 461 CARTONS PHARMACEUTICALS AS UNDER CLOBETASOL PROP SOLN 0.05% 50M L NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92 .45 ANDA NO.: 210190 THERA PEUTICE USE: - GLUCOCORTICOI D / HUMAN - RX/SINGLE INGRED IENT / NONSTERILE LIQUID / CLOBETASOL PROPIONATE (GLUC OCORTICOID) MOMETASONE FU RO OINT 0.1% 15GM NDC CODE:6 8462022517 FDA PRODUCT CODE NO.: 62 F C J 53 H. T. S N O.: 3004.40.49.50 ANDA NO. :78-571 THERAPEUTICE USE: ANTI-INFLAMMATORY- DERMATOLO GIC MOMETASONE FURO OINT 0.1% 45GM NDC CODE:684620225 55 FDA PRODUCT CODE NO.: 6 2 F C J 53 H. T. S NO.: 30 04.40.49.50 ANDA NO.:78-571 THERAPEUTICE USE: ANTI-INF LAMMATORY- DERMATOLOGIC COMMERCIAL & CUSTOM INVOICE N O. F22335002988 DT. 30.09.20 22 F22335002931 DT. 30.09.20 22 S/BILL NO: 4643422 DT:06/ 10/2022 S/BILL NO: 4642120 D T:06/10/2022 NET WT.2078.112 23 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NO TIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 646700 |
2022-11-01 |
7 PKG |
1101.34KG |
7 PALLETS 156 CARTONS PHARMACEUTICALS AS UNDER NIT ROGLYCERIN SUBLING TAB 0.4MG 4 X25 NDC CODE:68462063945 F DA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90. 9020 ANDA NO.:206391 THERA PEUTIC USE: #NAME? HEART F AILURE,HIGH BLOOD PRESSURE,A ND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART DEFE RASIROX TAB OS 500MG 30 NDC CODE:68462049630 FDA PRODUCT CODE NO.: 63 J C A 09 H. T. S NO.: 3004.90.92.70 AN DA NO.:209433 THERAPEUTICE USE:TREATMENT OF CHRONIC IR ON OVERLOAD DUE TO BLOOD TRA NSFUSIONS IN PATIENTS 2 YEAR OF AGE AND OLDER. DEFE RASIROX TAB OS 500MG 30 NDC CODE:68462049630 FDA PRODUCT CODE NO.: 63 J C A 09 H. T. S NO.: 3004.90.92.70 AN DA NO.:209433 THERAPEUTICE USE:TREATMENT OF CHRONIC IR ON OVERLOAD DUE TO BLOOD TRA NSFUSIONS IN PATIENTS 2 YEAR OF AGE AND OLDER. NITR OGLYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90 .9020 ANDA NO.:206391 THER APEUTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOO D PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NO T ENOUGH BLOOD FLOW TO THE H EART NITROGLYCERIN SUBLIN G TAB 0.4MG 4X25 NDC CODE: 68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO. :206391 THERAPEUTIC USE: M EDICATION USED FOR HEART FAI LURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD F LOW TO THE HEART COMMER CIAL & CUSTOM INVOICE NO. F2 2387001109 DT. 30.09.2022 F2 2387001124 DT. 30.09.2022 F2 2387001126 DT. 30.09.2022 F2 2387001144 DT. 30.09.2022 F2 2387001146 DT. 30.09.2022 S/ BILL NO: 4014365 DT: 06/10/202 2 S/BILL NO: 4014368 DT: 06/ 10/2022 S/BILL NO: 4014369 D T: 06/10/2022 S/BILL NO: 401 4374 DT: 06/10/2022 S/BILL N O: 4014376 DT: 06/10/2022 NE T WT. 88.84 07 DATA LOGGERS SET TEMPERATURE : +18 DEGRE ES -- |
HS 662800 |
2022-10-25 |
40 PKG |
6201.17KG |
40 PALLETS 1906 CARTONS PHARMACEUTICALS AS UNDER NO RETH ACE/EE TAB 1/0.02MG 63 N DC CODE:68462013281 FDA PRODU CT CODE NO.:65 J C A 25 H. T . S NO.: 3006.60.00.00 ANDA NO.:206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOM ETRIOS IS AND ABNORMAL UTERIN E BLEEDING NORGEST/EE TAB .18,.215,.25/.035MG 84 NDC CO DE:68462056529 FDA PRODUCT CO DE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200494 THERAPEUTICE USE: - O RAL CONTRACEPTIVES LEVONOR GESTREL/EE TAB 0.09/0.02MG 84 NDC CODE:68462063729 FDA PRO DUCT CODE NO.: 64 G D A 29 H . T. S NO.: 3006.60.0000 AND A NO.: 202791 THERAPEUTICE US E: - : USED FOR PREVENTING P REGNANCY COMMERCIAL & CUSTO M INVOICE NO. F22352002883 DT . 29.09.2022 F22352002843 DT. 28.09.2022 S/BILL NO: 45442 11 DT: 30-SEP-22 S/BILL NO: 4560288 DT: 30-SEP-22 NET WT . 4,416.73 KGS 02 DATA LOGGER S SET TEMPERATURE : +18 DEGRE ES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 652500 |
2022-10-25 |
41 PKG |
8327.64KG |
41 PALLETS 2040 CARTONS P HARMACEUTICALS AS UNDER D ROSPIRENONE/EE TAB 3/0.02MG 84 NDC CODE:68462072029 FDA PRODUCT CODE NO.: 65 J D A 3 9 H. T. S NO.: 3006.60.00. 00 ANDA NO.: 204296 THERAP EUTICE USE: - ORAL CONTRACEP TIVE GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90. 92.30 ANDA NO.:-77-662 THE RAPEUTICE USE:-ANTICONVULSAN T AGENT GABAPENTIN TAB 800MG 500 NDC CODE:684620127 05 FDA PRODUCT CODE NO : 6 1 N C A 69 H. T. S NO.: 30 04.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICON VULSANT AGENT COMMERCIA L & CUSTOM INVOICE NO. F2235 2002811 DT. 26.09.2022 F2235 2002812 DT. 26.09.2022 S/BIL L NO: 4463263 DT:27-SEP-22 S/BILL NO: 4462841 DT: 27-SEP- 22 NET WT. 6,577.92 02 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 653900 |
2022-10-25 |
40 PKG |
6339.06KG |
40 PALLETS 2343 CARTONS PHA RMACEUTICALS AS UNDER ESTRADI OL VAG INSERTS 10MCG 8 NDC CO DE:68462071171 FDA PRODUCT CO DE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.: 210264 THERAPEUTICE USE:THE TREATMENT OF ATROPIC VAGINITI S DUE TO MENOPAUSE. DROSPIRE NONE/EE TAB 3/0.02MG 84 NDC C ODE:68462072029 FDA PRODUCT C ODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO. : 204296 THERAPEUTICE USE: - ORAL CONTRACEPTIVE COMMERCIA L & CUSTOM INVOICE NO. F22352 002798 DT. 25.09.2022 NET WT. 4,527.36 02 DATA LOGGERS S/BILL NO: 4433494 DT 26-SEP -2022 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA |
HS 551342 |
2022-10-25 |
16 PKG |
3345.3KG |
16 PALLETS 360 CARTONS PHARMACEUTICALS AS UNDER T RIAMCINOLONE ACE OINT 0.5% 15G M NDC CODE:68462079817 FDA P RODUCT CODE NO.:64 L C J 61 H. T. S NO.: 3004.49.00.50 A NDA NO.:206379 THERAPEUTICE U SE: - REDUCES THE SWELLING, ITCHING, AND REDNESS OF SKIN BETAMETHASONE DIP AUG CREAM 0.05% 15GM NDC CODE:68462029 017 FDA PRODUCT CODE NO.: 64 L C J 06 H. T. S NO.: 3004. 90.92.45 ANDA NO.:78-930 THE RAPEUTICE USE: DERMALOGIC USE BETAMETHASONE DIP AUG CREA M 0.05% 50GM NDC CODE:6846202 9052 FDA PRODUCT CODE NO.: 6 4 L C J 06 H. T. S NO.: 3004 .90.92.45 ANDA NO.:78-930 TH ERAPEUTICE USE: DERMALOGIC US E MOMETASONE FURO SOLN 0.1% 60ML NDC CODE:68462038502 F DA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.90.92. 45 ANDA NO.:090506 THERAPEUT ICE USE: MOMETASONE FUROATE TOPICAL SOLUTION (LOTION) IS A CORTICOSTEROID INDICATED F OR THE RELIEF OF THE INFLAMMA TORY AND PRURITIC MANIFESTATI ONS OF CORTICOSTEROID-RESPONS IVE DERMATOSES IN PATIENTS # 12 YEARS OF AGE. S/BILL NO : 4423236 DT: 26/09/2022 C OMMERCIAL & CUSTOM INVOICE NO. F22335002775 DT. 22.09.2022 NET WT. 1,507.78 16 DATA LO GGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA |
HS 646100 |
2022-10-25 |
19 PKG |
5265.84KG |
19 PALLETS 1005 CARTONS PH ARMACEUTICALS AS UNDER PIME CROLIMUS CREAM 1% 60GM NDC CO DE:68462060965 FDA PRODUCT CO DE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - A S SECOUND-LINE THERAPY FOR T HE SHORT-TERM AND NON-CONTINU OS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITI S IN NONIMMUNOCOMPROMISED AD ULT AND CHILDREN 2 YEARS OF A GE GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PR ODUCT CODE NO: 61 N C A 69 H . T. S NO.: 3004.90.92.30 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRO DUCT CODE NO.: 65 R C F 14 H . T. S NO.: 3004.90.92.90 AN DA NO.: 202868 THERAPEUTICE U SE: - TREATMENT OR PREVENTION OF HYPOKALEMIA GABAPENTIN TAB 600MG 500 NDC CODE:68462 012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 300 4.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULS ANT AGENT TACROLIMUS CAP 5 MG 100 NDC CODE:68462068701 HTS NO: 3004.90.92.15 FDA COD E : 64 T C E 08 ANDA NO.20666 2 THERAPEUTICE USE: TO PREVE NT REJECTION OF A KIDNEY, HE ART, OR LIVER TRANSPLANT CO MMERCIAL & CUSTOM INVOICE NO. F22387001092 DT. 29.09.2022 F22387001087 DT. 29.09.2022 F 22387001086 DT. 29.09.2022 F2 2387001084 DT. 29.09.2022 F22 387001090 DT. 29.09.2022 S/BI LL NO: 4014161 DT:30.09.2022 S/BILL NO:4014165 DT:30.09.202 2 S/BILL NO: 4014166 DT:30.09 .2022 S/BILL NO: 4014169 DT:3 0.09.2022 S/BILL NO:4014163 D T:30.09.2022 NET WT. 4,220.3 1 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 300490 |
2022-10-25 |
22 PKG |
4796.82KG |
22 PALLETS 1552 CARTONS P HARMACEUTICALS AS UNDER ROS UVASTATIN TAB 20MG 90 NDC COD E:68462026390 FDA PRODUCT COD E NO.:61 J C A 16 H. T. S NO .: 3004.49.00.10 ANDA NO.: 0 79172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND R ELATED CONDITIONS, AND TO PRE VENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 20MG 90 ND C CODE:68462026390 FDA PRODUC T CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL A ND RELATED CONDITIONS, AND T O PREVENT CARDIOVASCULAR DISE ASE NITROGLYCERIN SUBLING T AB 0.4MG 100 NDC CODE:6846206 3901 FDA PRODUCT CODE NO.: 6 6 S C A 28 H. T. S NO.: 3004 .90.9020 ANDA NO.: 206391 TH ERAPEUTICE USE: MEDICATION US ED FOR HEART FAILURE, HIGH BL OOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEAR T DEFERASIROX TAB OS 500MG 30 NDC CODE:68462049630 FDA PRODUCT CODE NO.: 63 J C A 09 H. T. S NO.: 3004.90.92.70 ANDA NO.:209433 THERAPEUTICE USE:TREATMENT OF CHRONIC IR ON OVERLOAD DUE TO BLOOD TRAN SFUSIONS IN PATIENTS 2 YEAR O F AGE AND OLDER. NITROGLYC ERIN SUBLING TAB 0.4MG 4X25 N DC CODE:68462063945 FDA PRODU CT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEART FAI LURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART NITROGLYCERI N SUBLING TAB 0.4MG 100 NDC C ODE:68462063901 FDA PRODUCT C ODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEUTICE USE: ME DICATION USED FOR HEART FAILU RE, HIGH BLOOD PRESSURE,AND T O TREAT AND PREVENT CHEST PAI N FROM NOTENOUGH BLOOD FLOW T O THE HEART COMMERCIAL & C USTOM INVOICE NO. F2238700107 8 DT. 29.09.2022 F22387001088 DT. 29.09.2022 F22387001083 DT. 29.09.2022 F22387001085 D T. 29.09.2022 F22387001082 DT . 29.09.2022 S/BILL NO: 40141 67 DT:30.09.2022 S/BILL NO:40 14159 DT:30.09.2022 S/BILL NO : 4014171 DT:30.09.2022 S/BIL L NO:4014174 DT:30.09.2022 S/ BILL NO: 4014170 DT:30.09.2022 NET WT. 2,805.08 22 DATA LO GGERS HUMIDITY:65% SET TEMPE RATURE : +18 DEGREES TEMPERAT URE RANGE : +15 DEGREES TO +25 DEGREES CONTAINER NO. MNBU04 74723 NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE NUMA-DROZ 2 N EUCHATEL - 2000 SWITZERLAND |
HS 611600 |
2022-10-25 |
6 PKG |
1213.38KG |
6 PALLETS 477 CARTONS P HARMACEUTICALS AS UNDER ROS UVASTATIN TAB 20MG 90 NDC COD E:68462026390 FDA PRODUCT COD E NO.:61 J C A 16 H. T. S NO .: 3004.49.00.10 ANDA NO.: 0 79172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND R ELATED CONDITIONS, AND TO PRE VENT CARDIOVASCULAR DISEASE S/BILL NO: 4547014 DT 30-SE P-2022 COMMERCIAL & CUSTOM INVOICE NO. F22352002888 DT. 29.09.2022 NET WT. 954.75 0 6 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NU MA-DROZ 2 NEUCHATEL - 2000 S WITZERLAND |
HS 290719 |
2022-10-25 |
20 PKG |
3927.72KG |
20 PALLETS 1000 CARTONS PH ARMACEUTICALS AS UNDER NORG EST/EE TAB .18,.215,.25/.035MG 84 NDC CODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 2 7 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200494 THERAPEUTI CE USE: - ORAL CONTRACEPTIVES COMMERCIAL & CUSTOM INVOIC E NO. F22352002838 DT. 28.09. 2022 S/BILL NO: 4505498 DT :29/09/2022 NET WT. 3,000.00 02 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 652700 |
2022-10-25 |
17 PKG |
3290.87KG |
17 PALLETS 342 CARTONS PHA RMACEUTICALS AS UNDER CLOBE TASOL PROP SOLN 0.05% 50ML ND C CODE:68462053253 FDA PRODUC T CODE NO.: 64 L C L 67 H. T . S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTE RILE LIQUID / CLOBETASOL PROP IONATE (GLUCOCORTICOID) NY STATIN-TRIAM 100K UNIT/0.1% CR EAM 15GM NDC CODE:68462031417 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40. 0050 ANDA NO.: 208136 THERAP EUTICE USE: - TREATMENT OF FU NGAL INFECTIONS OF THE SKIN, ESPECIALLY YEAST INFECTIONS. TRIAMCINOLONE ACE OINT 0.5 % 15GM NDC CODE:68462079817 FDA PRODUCT CODE NO.:64 L C J 61 H. T. S NO.: 3004.49.00. 50 ANDA NO.:206379 THERAPEUT ICE USE: - REDUCES THE SWELLI NG, ITCHING, AND REDNESS OF SKIN HYDROCORTISONE VAL OIN T 0.2% 15GM NDC CODE:68462083 617 FDA PRODUCT CODE NO.: 64 L C L 71 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 211750 TH ERAPEUTICE USE: - INDICATED F OR THE RELIEF OF THE INFLAMMA TORY AND PRURITIC MANIFESTATI ONS OF CORTICOSTEROID RESPONS IVE DERMATOSES IN ADULT PATI ENTS. DESOXIMETASONE OINT 0 .25% 60GM NDC CODE:6846205316 5 FDA PRODUCT CODE NO.: 62 G C J 17 H. T. S NO.: 3004.39 .0050 ANDA NO.:202838 THERAP EUTICE USE: FOR THE RELIEF OF VARIOUS INFLAMMATORY SKIN C ONDITIONS, INCLUDING RASHES S/BILL NO: 4383831 DT:23/09 /2022 COMMERCIAL & CUSTOM I NVOICE NO. F22335002753 DT. 2 0.09.2022 NET WT. 1,407.36 1 7 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A |
HS 646700 |
2022-10-25 |
17 PKG |
3262.29KG |
17 PALLETS 835 CARTONS PHA RMACEUTICALS AS UNDER NORGE ST/EE TAB 0.25/0.035MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA N O.: 200538 THERAPEUTICE USE: - ORAL CONTRACEPTIVES S/BI LL NO: 4414680 DT 24-SEP-2022 COMMERCIAL & CUSTOM INVOIC E NO. F22352002768 DT. 24.09. 2022 NET WT. 2,464.92 01 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652700 |
2022-10-18 |
13 PKG |
1966.36KG |
13 PALLETS 631 CARTO NS PHARMACEUTICALS AS UNDER MARLISSA TAB 0.15/0.03MG 8 4 NDC CODE:68462038829 FDA P RODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 A NDA NO.: 091452 THERAPEUTICE USE: ORAL CONTRACEPTIVE CO MMERCIAL & CUSTOM INVOICE NO. F22352002642 DT. 17.09.2022 S/BILL NO: 4263421 DT:19-SEP- 22 NET WT. 1,378.10 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 642900 |
2022-10-18 |
8 PKG |
2015.34KG |
8 PALLETS 472 CARTON S PHARMACEUTICALS AS UNDER NAPROXEN SOD TAB 550MG 100 NDC CODE:68462017901 FDA PRO DUCT CODE NO.:-62 G C A 50 H . T. S NO.: 3004.90.92.40 AN DA NO.:-78-314 THERAPEUTICE U SE:-ANTI -INFLAMMATORY, ANALG ESIC GABAPENTIN TAB 600MG 5 00 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22387001006 DT. 16.09.20 22 F22387001007 DT. 16.09.202 2 S/BILL NO: 4013415 DT:17.09 .2022 S/BILL NO: 4013416 DT:1 7.09.2022 NET WT. 1,726.19 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA |
HS 625000 |
2022-10-18 |
32 PKG |
7589.64KG |
32 PALLETS 2847 CARTONS PH ARMACEUTICALS AS UNDER ATOM OXETINE CAP 60MG 30 NDC CODE: 68462026930 FDA PRODUCT CODE NO.: 79019 H. T. S NO.: 300 4.90.92.90 ANDA NO.: 079019 THERAPEUTICE USE: - TREATMENT OF ATTENTION - DEFICIT/HYPER ACIVITY DISORDER (ADHD NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC RO PINIROLE TAB 0.5MG 100 NDC CO DE:68462025401 FDA PRODUCT CO DE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.: - 90-135 THERAPEUTICE USE:-T REATMENT OF PARKINSONISM R OPINIROLE TAB 2MG 100 NDC COD E:68462025601 FDA PRODUCT COD E NO.:-62 J C A 17 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TR EATMENT OF PARKINSONISM AT OMOXETINE CAP 60MG 30 NDC COD E:68462026930 FDA PRODUCT COD E NO.: 79019 H. T. S NO.: 3 004.90.92.90 ANDA NO.: 079019 THERAPEUTICE USE: - TREATME NT OF ATTENTION - DEFICIT/HYP ERACIVITY DISORDER (ADHD R OPINIROLE TAB 4MG 100 NDC COD E:68462025801 FDA PRODUCT COD E NO.:-62 J C A 17 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TR EATMENT OF PARKINSONISM COMMERCIAL & CUSTOM INVOICE NO. F22352002653 DT. 18.09.20 22 F22352002660 DT. 19.09.202 2 S/BILL NO: 4270125 DT: 19 -SEP-22 S/BILL NO: 4284597 D T: 19-SEP-22 NET WT. 6,178.36 01 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 790190 |
2022-10-18 |
2 PKG |
559.74KG |
2 PALLETS 308 CARTON S PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 10MG 90 NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE S/BILL NO: 4338910 DT: 2 1-SEP-22 COMMERCIAL & CUSTO M INVOICE NO. F22352002701 DT . 21.09.2022 NET WT. 430.17 K GS 02 DATA LOGGERS NOTIF Y PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND |
HS 611600 |
2022-10-18 |
30 PKG |
5889.09KG |
30 PALLETS 565 CARTONS P HARMACEUTICALS AS UNDER CLO BETASOL PROP SOLN 0.05% 50ML NDC CODE:68462053253 FDA PROD UCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.45 AND A NO.: 210190 THERAPEUTICE US E: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONS TERILE LIQUID / CLOBETASOL PR OPIONATE (GLUCOCORTICOID) MOMETASONE FURO CREAM 0.1% 15G M NDC CODE:68462019217 FDA P RODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49.50 ANDA NO.:78-541 THERAPEUTICE USE: ANTI-INFLAMMATORY- DERM ATOLOGIC MOMETASONE FURO CR EAM 0.1% 45GM NDC CODE:684620 19255 FDA PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 300 4.40.49.50 ANDA NO.:78-541 T HERAPEUTICE USE: ANTI-INFLAMM ATORY- DERMATOLOGIC CLOBET ASOL PROP SOLN 0.05% 50ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.45 ANDA N O.: 210190 THERAPEUTICE USE: - GLUCOCORTICOID / HUMAN - R X/SINGLE INGREDIENT / NONSTER ILE LIQUID / CLOBETASOL PROPI ONATE (GLUCOCORTICOID) NYS TATIN-TRIAM 100K UNIT/0.1% CRE AM NDC CODE:68462031435 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.0050 ANDA NO.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPEC IALLY YEAST INFECTIONS COM MERCIAL & CUSTOM INVOICE NO. F22335002596 DT. 12.09.2022 F 22335002643 DT. 14.09.2022 S/ BILL NO: 4154808 DT:13/09/20 22 S/BILL NO: 4188109 DT:15 /09/2022 NET WT.2887.392 30 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 646700 |
2022-10-18 |
3 PKG |
362.43KG |
3 PALLETS 60 CARTONS PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TAB 0.3M G 100 NDC CODE:68462063801 F DA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.902 0 ANDA NO.:206391 THERAPEUTI C USE: -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRES SURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH B LOOD FLOW TO THE HEART NIT ROGLYCERIN SUBLING TAB 0.3MG 1 00 NDC CODE:68462063801 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC U SE: -MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOT ENOUGH BLOO D FLOW TO THE HEART S/BILL NO: 4013655 DT:22.09.2022 S/ BILL NO: 4013656 DT:22.09.202 2 COMMERCIAL & CUSTOM INV OICE NO. F22387001032 DT. 21. 09.2022 F22387001033 DT. 21.0 9.2022 NET WT. 31.71 3 DATA LOGGERS NOTIFY PARTY:2 GL ENMARK SPECIALTY S.A. SWITZER LAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAN D |
HS 662800 |
2022-10-12 |
8 PKG |
1564.47KG |
8 PALLETS 164 CARTONS PHAR MACEUTICALS AS UNDER CLOBET ASOL PROP SOLN 0.05% 50ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.45 ANDA N O.: 210190 THERAPEUTICE USE: - GLUCOCORTICOID / HUMAN - R X/SINGLE INGREDIENT / NONSTER ILE LIQUID / CLOBETASOL PROPI ONATE (GLUCOCORTICOID) COM MERCIAL & CUSTOM INVOICE NO. F22335002540 DT. 08.09.2022 S /BILL NO: 4061125 DT:08/09/202 2 NET WT: 787.20 KGS 08 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 646700 |
2022-10-12 |
12 PKG |
2346.93KG |
12 PALLETS 246 CARTONS P HARMACEUTICALS AS UNDER CLO BETASOL PROP SOLN 0.05% 50ML NDC CODE:68462053253 FDA PROD UCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.45 AND A NO.: 210190 THERAPEUTICE US E: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONS TERILE LIQUID / CLOBETASOL PR OPIONATE (GLUCOCORTICOID) COMMERCIAL & CUSTOM INVOICE NO . F22335002504 DT. 06.09.2022 S/BILL NO: 4060117 DT:08/09/ 2022 NET WT: 1180.80 KGS 12 DATA LOGGERS SET TEMPERATU RE : +18 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 646700 |
2022-10-12 |
15 PKG |
2555.13KG |
15 PALLETS 342 CARTONS PHA RMACEUTICALS AS UNDER CLOBE TASOL PROP CREAM 0.05% 60GM N DC CODE:68462052965 FDA PRODU CT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209095 THERAPEUTICE USE : - CLOBETASOL PROPIONATE CR EAM IS A SUPER-HIGH POTENCY C ORTICOSTEROID FORMULATIONS IN DICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC M ANIFESTATIONS OF CORTICOSTERO ID-RESPONSIVE DERMATOSES C LOTRI-BETAMETHASONE CREAM 1.0/ .05% NDC CODE:68462029855 FD A PRODUCT CODE NO.: 61 W D J 04 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 202894 THERAPEUT ICE USE: - TREATMENT A VARIET Y OF INFLAMED FUNGAL SKIN IN FECTIONS COMMERCIAL & CUSTO M INVOICE NO. F22335002505 DT . 06.09.2022 F22335002539 DT. 08.09.2022 S/BILL NO: 406013 3 DT:08/09/2022 S/BILL NO: 40 61128 DT:08/09/2022 NET WT: 1,300.32 KGS 15 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEU CHATEL - 2000 SWITZERLAND. |
HS 646700 |
2022-10-12 |
49 PKG |
10255.44KG |
49 PALLETS 3387 CARTONS P HARMACEUTICALS AS UNDER ATO MOXETINE CAP 100MG 30 NDC COD E:68462027130 FDA PRODUCT COD E NO.: 64 UCA 99 H. T. S NO. : 3004.90.92.90 ANDA NO.: 07 9019 TREATMENT OF ATTENTION - DEFICIT/HYPERACIVITY DISORD ER (ADHD ATOMOXETINE CAP 25 MG 30 NDC CODE:68462026730 F DA PRODUCT CODE NO.: 64 UCA 9 9 H. T. S NO.: 3004.90.92.90 ANDA NO.: 079019 THERAPEUTI CE USE : - ATOMOXETINE IS USE D TO TREAT ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD ) AS PART OF A TOTAL TREATMEN T PLAN, INCLUDING PSYCHOLOGIC AL, SOCIAL, AND OTHER TREATME NTS LEVOCETIRIZINE DIHY TAB 5MG 90 NDC CODE:68462034690 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.90.9 1.80 ANDA NO.:90385 THERAPEU TICE USE: TREATMENT OF CHRONI C IDIOPATHIC URTICARIA NAP ROXEN TAB 250MG 500 NDC CODE: 68462018805 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC NA PROXEN TAB 500MG 100 NDC CODE :68462019001 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC O XCARBAZEPINE TAB 150MG 100 ND C CODE:68462013701 FDA PRODUC T CODE NO.:-61 M C A 45 H. T . S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE: -ANTI CONVULSANT AGENT NAP ROXEN TAB 375MG 500 NDC CODE: 68462018905 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC TR ANDO-VERAPAMIL TAB 1/240MG 100 NDC CODE:68462029401 FDA PR ODUCT CODE NO.:-62 O D A 11 H. T. S NO.: 3004.90.92.20 A NDA NO.:-79-135 THERAPEUTICE USE:-TREATMENT OF HYPERTENSI ON TRANDO-VERAPAMIL TAB 4/2 40MG 100 NDC CODE:68462032901 FDA PRODUCT CODE NO.:-62 O D A 11 H. T. S NO.: 3004.90. 92.20 ANDA NO.:-79-135 THERA PEUTICE USE:-TREATMENT OF HY PERTENSION PRAMIPEXOLE TAB 1MG 90 NDC CODE:68462033390 FDA PRODUCT CODE NO: 62 J C A 15 H. T. S NO.: 3004.90.92. 40 ANDA NO.: 90-781 THERAPEU TICE USE: USED IN PARKINSON S DISEASE ZOLMITRIPTAN TAB 5 MG 3UD NDC CODE:68462049833 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90.9 2.28 ANDA NO.: 201779 THERAP EUTICE USE: - ANALGESIC/ HUMA N - RX/SINGLE INGREDIENT / P ROMPT RELEASE TABLETS / ZOLM ITRIPTAN (ANALGESIC) CLINDA MYCIN PHOS GEL 1% 30GM NDC CO DE:68462086635 FDA PRODUCT CO DE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO.: 214251 THERAPEUTICE USE: CLI NDAMYCIN PHOSPHATE GEL IS IND ICATED IN THE TREATMENT OF AC NE VULGARIS COMMERCIAL & C USTOM INVOICE NO. F2235200256 2 DT. 11.09.2022 F22352002561 DT. 11.09.2022 S/BILL NO: 41 27099 DT:12.09.2022 S/BILL NO :4126955 DT:12.09.2022 NET WT . 8,250.37 KGS 02 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA |
HS 649900 |
2022-10-12 |
5 PKG |
988.85KG |
5 PALLETS 471 CARTON S PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 10MG 90 NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE ACYCLOVIR OINT 5% 30GM NDC CODE:68462074635 FDA PROD UCT CODE NO.: 62 V C J 18 H. T. S NO.: 3004.49.00.50 AND A NO.: 205510 THERAPEUTICE US E: - AN ANTIVIRAL MEDICINE US ED TO TREAT OR PREVENT INFECT IONS CAUSED BY CERTAIN KINDS OF VIRUSES. EXAMPLES OF THES E INFECTIONS INCLUDE HERPES A ND SHINGLES COMMERCIAL & CU STOM INVOICE NO. F22352002556 DT. 10.09.2022 F22352002553 DT. 10.09.2022 NET WT. 741.92 KGS 05 DATA LOGGERS S/BI LL NO: 4118462 DT:12.09.2022 S/BILL NO: 4109165 DT 12-SEP- 2022 NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND |
HS 611600 |
2022-10-12 |
40 PKG |
5779.32KG |
40 PALLETS 1401 CART ONS PHARMACEUTICALS AS UNDER FLUCONAZOLE TAB 150MG 12UD NDC CODE:68462011944 NDC COD E : 68462011944 HTS NO : 300 4.90.92.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 THE RAPEUTICE USE : ANTIFUNGAL ONDANSETRON TAB 4MG 30 NDC C ODE:68462010530 FDA PRODUCT C ODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO. :- 77-535 THERAPEUTICE USE:-A NTI -EMETIC COMMERCIAL & C USTOM INVOICE NO. F2235200255 5 DT. 10.09.2022 NET WT. 3,98 8.09 02 DATA LOGGERS S/B ILL NO: 4112506 DT:12.09.2022 NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2022-10-12 |
6 PKG |
1208.39KG |
6 PALLETS 547 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 10MG 1000 NDC CODE :68462026210 61 J C A 16 300 4.49.00.10 79172 TO TREAT HI GH CHOLESTEROL AND RELATED CO NDITIONS, AND TO PREVENT CAR DIOVASCULAR DISEASE ROSUVAS TATIN TAB 10MG 90 NDC CODE:68 462026290 FDA PRODUCT CODE N O.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 07917 2 THERAPEUTICE USE: - TO TRE AT HIGH CHOLESTEROL AND RELAT ED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE CO MMERCIAL & CUSTOM INVOICE NO. F22352002594 DT. 14.09.2022 NET WT. 986.17 06 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND S/BILL NO: 4173324 DT 14-SEP- 2022 |
HS 684620 |
2022-10-12 |
39 PKG |
5186.46KG |
39 PALLETS 1258 CARTONS PH ARMACEUTICALS AS UNDER ESTR ADIOL VAG INSERTS 10MCG 18 ND C CODE:68462071188 NDC NO.:68 462071188 FDA PRODUCT CODE NO .: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:21026 4 THERAPEUTICE USE:THE TREAT MENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. NORETHINDRO NE TAB 0.35MG 84 NDC CODE:684 62030529 FDA PRODUCT CODE NO. : 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTIO N OF PREGNANCY. NORETHINDRO NE ACE TAB 5MG 50 NDC CODE:68 462030450 FDA PRODUCT CODE N O.65 J C A 25 H. T. S NO.: 3 004.39.00.50 ANDA NO.:-91-090 THERAPEUTICE USE:- SECONDAR Y AMENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING FLUCONAZOLE TAB 150MG 12UD NDC CODE:68462011944 NDC CO DE : 68462011944 HTS NO : 30 04.90.92.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 TH ERAPEUTICE USE : ANTIFUNGAL LAMOTRIGINE TAB CD 5MG 100 NDC CODE:68462022801 FDA PROD UCT CODE NO.:- 61 M C A 38 H . T. S NO.: 3004.90.92.30 AN DA NO.:-79 # 099 THERAPEUTICE USE:- ANTICONVULSANT ROPINI ROLE TAB 5MG 100 NDC CODE:684 62025901 FDA PRODUCT CODE NO .:62 J C A 17 H. T. S NO.: 3 004.90.92.40 ANDA NO.:- 90-13 5 THERAPEUTICE USE:-TREATMEN T OF PARKINSONISM COMMERCI AL & CUSTOM INVOICE NO. F2235 2002586 DT. 13.09.2022 F22352 002593 DT. 13.09.2022 NET WT . 3,960.37 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA S/BILL NO: 4178201 DT:14.09.2022 S/BILL NO: 4178271 DT:14.09.2022 |
HS 300490 |
2022-10-12 |
37 PKG |
9542.38KG |
37 PALLETS 2057 CARTONS PHARMACEUTICALS AS UNDER MUPIROCIN OINT 2% 22GM NDC CO DE:68462018022 FDA PRODUCT CO DE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL TOPIRAMATE T AB 25MG 500 NDC CODE:68462010 805 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004. 49.00.20 ANDA NO.:077627 THE RAPEUTICE USE: ANTICONVULSANT PRAMIPEXOLE TAB 1MG 90 ND C CODE:68462033390 FDA PRODUC T CODE NO.: 62 J C A 15 H. T . S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE RILUZOLE TAB 50MG 60 NDC C ODE:68462038160 FDA PRODUCT C ODE NO.: 62 J C A 16 H. T. S NO.: 3004.90.92.30 ANDA NO. : 91394 THERAPEUTICE USE: - A-PARKINSONIAN/ HUMAN - RX/SI NGLE INGREDIENT / PROMPT RELE ASE TABLETS / RILUZOLE (ANTI -PARKINSONIAN) GABAPENTIN T AB 800MG 500 NDC CODE:6846201 2705 FDA PRODUCT CODE NO : 6 1 N C A 69 H. T. S NO.: 3004 .90.92.30 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULSA NT AGENT ZOLMITRIPTAN TAB 5 MG 3UD NDC CODE:68462049833 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90. 92.28 ANDA NO.: 201779 THERA PEUTICE USE: - ANALGESIC/ HUM AN - RX/SINGLE INGREDIENT / PROMPT RELEASE TABLETS / ZOL MITRIPTAN (ANALGESIC) CLIND AMYCIN PHOS GEL 1% 60GM NDC C ODE:68462086665 FDA PRODUCT C ODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO. :214251 THERAPEUTICE USE: CL INDAMYCIN PHOSPHATE GEL IS IN DICATED IN THE TREATMENT OF A CNE VULGARIS COMMERCIAL & CUSTOM INVOICE NO. F223520025 76 DT. 13.09.2022 F2235200257 7 DT. 13.09.2022 F22352002578 DT. 13.09.2022 F22352002575 DT. 13.09.2022 F22352002584 D T. 13.09.2022 NET WT. 8,144.6 6 02 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA S/BILL NO: 4147118 DT 13-SEP-2022 S/BILL NO: 4 147185 DT 13-SEP-2022 S/BILL NO: 4145633 DT 13-SEP-2022 S /BILL NO: 4148246 DT 13-SEP-2 022 S/BILL NO: 4147244 DT 13 -SEP-2022 |
HS 614000 |
2022-10-12 |
40 PKG |
5781.59KG |
40 PALLETS 1946 CARTONS PH ARMACEUTICALS AS UNDER HEAT HER TAB 0.35MG 84 NDC CODE:68 462030329 FDA PRODUCT CODE NO .: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-45 4 THERAPEUTICE USE: PREVENTI ON OF PREGNANCY. NORETHINDR ONE TAB 0.35MG 84 NDC CODE:68 462030529 FDA PRODUCT CODE NO .: 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO.:91-20 9 THERAPEUTICE USE: PREVENTI ON OF PREGNANCY. COMMERCIAL & CUSTOM INVOICE NO. F223520 02567 DT. 12.09.2022 F2235200 2574 DT. 12.09.2022 NET WT. 4 ,032.10 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA |
HS 652400 |
2022-10-12 |
45 PKG |
16904.76KG |
45 PALLETS 3019 CARTONS PHA RMACEUTICALS AS UNDER TELMISA RTAN TAB 40MG 30 NDC CODE:684 62020030 FDA PRODUCT CODE NO. : 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.:090032 THERAPEUTICE USE: INDICATED FOR THE TREATMENT OF HYPERT ENSION, TO LOWER BLOOD PRESSU RE OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PRO DUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTROES OPHAGEAL REFLUX DISEASE LEVO CETIRIZINE DIHY TAB 5MG 90 ND C CODE:68462034690 FDA PRODUC T CODE NO.: 61 X C A 51 H. T . S NO.: 3004.90.91.80 ANDA NO.:90385 THERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPATH IC URTICARIA MUPIROCIN OINT 2 % 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92 .45 ANDA NO.: 90-480 THERAPE UTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE NO . F22352002557 DT. 10.09.2022 F22352002554 DT. 10.09.2022 NET WT. 13,428.53 02 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 620900 |
2022-10-12 |
9 PKG |
1970.44KG |
9 PALLETS 1084 CARTONS PHARMACEUTICALS AS UNDER RO SUVASTATIN TAB 10MG 90 NDC CO DE:68462026290 FDA PRODUCT CO DE NO.:61 J C A 16 H. T. S N O.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PR EVENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352002579 DT. 13.09.2 022 NET WT. 1,513.97 09 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE NUMA-DR OZ 2 NEUCHATEL - 2000 SWITZE RLAND S/BILL NO: 4146834 D T 13-SEP-2022 |
HS 293299 |
2022-10-12 |
42 PKG |
11183.51KG |
42 PALLETS 3378 CART ONS PHARMACEUTICALS AS UNDER TELMISARTAN TAB 80MG 30 ND C CODE:68462020130 HTS NO : 3 004.90.92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERA PEUTICE USE : INDICATED FOR T HE TREATMENT OF HYPERTENSION , TO LOWER BLOOD PRESSURE TELMISARTAN TAB 80MG 30 NDC C ODE:68462020130 HTS NO : 3004 .90.92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAPEU TICE USE : INDICATED FOR THE TREATMENT OF HYPERTENSION, T O LOWER BLOOD PRESSURE NAP ROXEN TAB 250MG 100 NDC CODE: 68462018801 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC OX CARBAZEPINE TAB 300MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-802 THERAPEUTICE USE:- ANTI CONVULSANT AGENT ACAM PROSATE CALCIUM DR TAB 333MG 1 80 NDC CODE:68462043518 FDA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO.: 3004.90.92.40 ANDA NO.:202229 THERAPEUTICE USE: - FOR TREATING ALCOHOL DEPENDENCE COMMERCIAL & CU STOM INVOICE NO. F22352002625 DT. 16.09.2022 F22352002621 DT. 15.09.2022 S/BILL NO:4229 649 DT 16-SEP-2022 S/BILL NO: 4229703 DT 16-SEP-2022 NET W T. 9,446.33 KGS 02 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2022-10-12 |
3 PKG |
650.46KG |
3 PALLETS 358 CARTON S PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 10MG 90 NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE COMMERCIAL & CUSTOM INVO ICE NO. F22352002606 DT. 14.0 9.2022 NET WT. 500.00 03 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY: 2 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE NUMA-D ROZ 2 NEUCHATEL - 2000 SWITZ ERLAND S/BILL NO: 4186537 DT 15-SEP-2022 |
HS 611600 |
2022-10-12 |
6 PKG |
1488.72KG |
6 PALLETS 187 CARTON S PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TAB 0.4 MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9 020 ANDA NO.:206391 THERAPEU TIC USE: -MEDICATION USED FOR . HEART FAILURE,HIGH BLOOD P RESSURE,AND TO TREAT AND PREV ENT CHEST PAIN FROM NOT ENOUG H BLOOD FLOW TO THE HEART NITROGLYCERIN SUBLING TAB 0.4M G 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.90 20 ANDA NO.:206391 THERAPEUT IC USE: -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRE SSURE,AND TO TREAT AND PREVEN T CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART CO MMERCIAL & CUSTOM INVOICE NO. F22387000978 DT. 13.09.2022 F22387000983 DT. 14.09.2022 N ET WT. 99.63 06 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEU CHATEL - 2000 SWITZERLAND S/BILL NO: 4013271 DT:14.09.2 022 S/BILL NO: 4013274 DT:14 .09.2022 |
HS 662800 |
2022-10-12 |
36 PKG |
9197.19KG |
36 PALLETS 1704 CART ONS PHARMACEUTICALS AS UNDER GABAPENTIN TAB 600MG 500 N DC CODE:68462012605 FDA PRODU CT CODE NO: 61 N C A 69 H. T . S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE :-ANTICONVULSANT AGENT RAN OLAZINE ER TAB 500MG 60 NDC C ODE:68462031960 FDA PRODUCT C ODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO. :211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDICATI ON. IT WORKS BY IMPROVING BLO OD FLOW TO HELP THE HEART WOR K MORE EFFICIENTLY. IT IS USE D TO TREAT CHRONIC ANGINA (C HEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA TOPIRAMAT E ER CAP (Q) 200MG 30 NDC COD E:68462037130 3004.49.00.20 61 M C B 40 210278 SEVELAM ER HCL TAB 400MG 360 NDC CODE :68462044626 FDA PRODUCT CODE NO.: 63 L D A 04 H. T. S NO .: 3004.90.92.60 ANDA NO.:20 4724 THERAPEUTICE USE:SEVELA MER HYDROCHLORIDE TABLETS AR E A PHOSPHATE BINDER INDICATE D FOR THE CONTROL OF SERUM PH OSPHORUS IN PATIENTS WITH CHR ONIC KIDNEY DISEASE ON DIALY SIS POTASSIUM CL ER CAP 10M EQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92 .90 ANDA NO.: 202868 THERAPE UTICE USE: - TREATMENT OR PRE VENTION OF HYPOKALEMIA TAC ROLIMUS OINT 0.1% 100GM NDC C ODE:68462053494 FDA PRODUCT C ODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO. : 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMU NOSUPPRESSIVE OINTMENT USED F OR THE TREATMENT OF MODERATE -TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 30GM NDC CODE:6846205343 5 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49 .00.50 ANDA NO.: 210393 THER APEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATM ENT OF MODERATE-TO-SEVERE AT OPIC DERMATITIS (ECZEMA). CHLORPROMAZINE HCL TAB 25MG 10 0 NDC CODE:68462086201 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA OR MA NIC-DEPRESSION IN ADULTS C OMMERCIAL & CUSTOM INVOICE NO. F22387000975 DT. 13.09.2022 F22387000976 DT. 13.09.2022 F22387000977 DT. 13.09.2022 F 22387000981 DT. 14.09.2022 F2 2387000982 DT. 14.09.2022 NET WT. 6,833.79 02 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA . S/BIL L NO: 4013267 DT:14.09.2022 S/BILL NO: 4013268 DT: 14.09. 2022 S/BILL NO: 4013269 DT: 14.09.2022 S/BILL NO: 401327 3 DT: 14.09.2022 S/BILL NO: 4013272 DT:14.09.2022 |
HS 616900 |
2022-10-12 |
43 PKG |
8732.25KG |
43 PALLETS 2780 CART ONS PHARMACEUTICALS AS UNDER NORETHINDRONE TAB 0.35MG 84 NDC CODE:68462030529 FDA PR ODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00.00 A NDA NO.:91-209 THERAPEUTICE U SE: PREVENTION OF PREGNANCY. NORETHINDRONE ACE TAB 5MG 5 0 NDC CODE:68462030450 FDA P RODUCT CODE NO.65 J C A 25 H . T. S NO.: 3004.39.00.50 AN DA NO.:-91-090 THERAPEUTICE U SE:- SECONDARY AMENORRHEA,EN DOMETRIOS IS AND ABNORMAL UT ERINE BLEEDING ATOMOXETINE CAP 40MG 30 NDC CODE:68462026 830 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.: 3004.90 .92.90 ANDA NO.: 079019 THER APEUTICE USE: - ATOMOXETINE I S USED TO TREAT ATTENTION-DEF ICIT HYPERACTIVITY DISORDER (ADHD) AS PART OF A TOTAL TRE ATMENT PLAN, INCLUDING PSYCHO LOGICAL, SOCIAL, AND OTHER TR EATMENTS. FLUCONAZOLE TAB 1 00MG 30 NDC CODE:68462010230 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90.9 2.45 ANDA NO.:-77 - 253 THER APEUTICE USE:-ANTIFUNGAL O XCARBAZEPINE TAB 300MG 100 ND C CODE:68462013801 FDA PRODUC T CODE NO.:-61 M C A 45 H. T . S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE: -ANTI CONVULSANT AGENT ZOL MITRIPTAN TAB 2.5MG 6UD NDC C ODE:68462049776 FDA PRODUCT C ODE NO.: 60 L C A 90 H. T. S NO.: 3004.90.92.28 ANDA NO. : 201779 THERAPEUTICE USE: - ANALGESIC/ HUMAN - RX/SINGLE INGREDIENT / PROMPT RELEASE TABLETS / ZOLMITRIPTAN (ANAL GESIC) COMMERCIAL & CUSTOM INVOICE NO. F22352002601 DT. 14.09.2022 F22352002604 DT. 1 4.09.2022 NET WT. 6,785.77 02 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 4181482 DT 14-SEP-2022 S/BILL NO: 41877 52 DT 15-SEP-2022 |
HS 652600 |
2022-10-05 |
36 PKG |
11745.97KG |
36 PALLETS 2093 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT NAPROXEN T AB 500MG 500 NDC CODE:6846201 9005 FDA PRODUCT CODE NO.:-6 2 G C A 49 H. T. S NO.: 3004 .90.92.40 ANDA NO.:-78-250 T HERAPEUTICE USE:-ANTI-INFLAMM ATORY, ANALGESIC ROPINIROL E TAB 1MG 100 NDC CODE:684620 25501 FDA PRODUCT CODE NO.:- 62 J C A 17 H. T. S NO.: 300 4.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT OF PARKINSONISM GABAPENTIN TAB 600MG 500 NDC CODE:68462 012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 300 4.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULS ANT AGENT NAPROXEN TAB 500 MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92 .40 ANDA NO.:-78-250 THERAPE UTICE USE:-ANTI-INFLAMMATORY, ANALGESIC COMMERCIAL & CU STOM INVOICE NO. F22352002452 DT. 31.08.2022 F22352002445 DT. 31.08.2022 F22352002479 D T. 03.09.2022 F22352002480 DT . 03.09.2022 S/BILL NO: 39789 99 DT 05-SEP-2022 S/BILL NO: 3973299 DT 05-SEP-2022 S/BILL NO: 3974750 DT 05-SEP-2022 S /BILL NO: 3979444 DT 05-SEP-20 22 NET WT. 10,446.58 KGS 02 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 684620 |
2022-10-05 |
6 PKG |
1188.89KG |
6 PALLETS 399 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 5MG 90 NDC CODE:68 462026190 FDA PRODUCT CODE N O.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 07917 2 THERAPEUTICE USE: - TO TRE AT HIGH CHOLESTEROL AND RELAT ED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE RO SUVASTATIN TAB 40MG 500 NDC C ODE:68462026405 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE ROSU VASTATIN TAB 5MG 1000 NDC COD E:68462026110 FDA PRODUCT COD E NO.: 61 J C A 16 H. T. S N O.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE. COMMERCIAL & CUSTOM INVOICE N O. F22352002439 DT. 31.08.202 2 F22352002443 DT. 31.08.2022 S/BILL NO: 3978394 DT 05-SEP -2022 S/BILL NO: 3978239 DT 0 5-SEP-2022 NET WT: 1,009.55 KGS 06 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK SPECIALT Y S.A. SWITZERLAND (GSSA) PL ACE NUMA-DROZ 2 NEUCHATEL - 2 000 SWITZERLAND |
HS 611600 |
2022-10-05 |
19 PKG |
3654.2KG |
19 PALLETS 435 CARTONS PHA RMACEUTICALS AS UNDER CLOTR I-BETAMETHASONE CREAM 1.0/.05% 45GM NDC CODE:68462029855 FDA PRODUCT CODE NO.: 61 W D J 04 H. T. S NO.: 3004.90.92 .45 ANDA NO.: 202894 THERAPE UTICE USE: - TREATMENT A VARI ETY OF INFLAMED FUNGAL SKIN INFECTIONS CLOTRI-BETAMETHA SONE CREAM 1.0/.05% 45GM NDC CODE:68462029855 FDA PRODUCT CODE NO.: 61 W D J 04 H. T. S NO.: 3004.90.92.45 ANDA NO .: 202894 THERAPEUTICE USE: - TREATMENT A VARIETY OF INFL AMED FUNGAL SKIN INFECTIONS COMMERCIAL & CUSTOM INVOICE NO. F22335002400 DT. 30.08.20 22 F22335002403 DT. 31.08.202 2 S/BILL NO: 3907862 DT:01/09 /2022 S/BILL NO: 3978575 DTL: 05/09/2022 NET WT: 1879.20 K GS 19 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLA CE NUMA-DROZ 2 NEUCHATEL - 20 00 SWITZERLAND |
HS 610400 |
2022-10-05 |
48 PKG |
18739.12KG |
48 PALLETS 3579 CART ONS PHARMACEUTICALS AS UNDER MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA N O.: 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL CLOTRIMAZ OLE CREAM 1% 15GM NDC CODE:68 462018117 FDA PRODUCT CODE N O.:61#W#C#J#04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-21 9 THERAPEUTICE USE: TREATMEN T OF CANDIDIASIS NAPROXEN T AB 500MG 500 NDC CODE:6846201 9005 FDA PRODUCT CODE NO.:-6 2 G C A 49 H. T. S NO.: 3004 .90.92.40 ANDA NO.:-78-250 T HERAPEUTICE USE:-ANTI-INFLAMM ATORY, ANALGESIC TOPIRAMAT E TAB 100MG 500 NDC CODE:6846 2010905 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3 004.49.00.20 ANDA NO.: 77627 THERAPEUTICE USE: :#ANTICONV ULSANT ONDANSETRON TAB 4MG 30 NDC CODE:68462010530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUTI CE USE:-ANTI EMETIC ZONISA MIDE CAP 100MG 500 NDC CODE:6 8462013005 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77- 651 THERAPEUTICE USE:-ANTISE IZURE DRUG COMMERCIAL & CUS TOM INVOICE NO. F22352002503 DT. 06.09.2022 F22352002423 D T. 31.08.2022 F22352002500 DT . 06.09.2022 F22352002501 DT. 06.09.2022 F22352002502 DT. 06.09.2022 F22352002436 DT. 3 1.08.2022 S/BILL NO:4027427 D T. 07.09.2022 S/BILL NO:40274 42 DT. 07.09.2022 S/BILL NO:4 027486 DT. 07.09.2022 S/BILL NO:4027432 DT. 07.09.2022 S/B ILL NO:4027434 DT. 07.09.2022 S/BILL NO:4027526 DT. 07.09. 2022 NET WT. 13,574.40 02 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TE MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 618100 |
2022-10-05 |
22 PKG |
4756.9KG |
22 PALLETS 797 CARTONS PHA RMACEUTICALS AS UNDER NYSTA TIN-TRIAM 100K UNIT/0.1% CREAM 60GM NDC CODE:68462031465 F DA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.005 0 ANDA NO.: 208136 THERAPEUT ICE USE: - TREATMENT OF FUNGA L INFECTIONS OF THE SKIN, ES PECIALLY YEAST INFECTIONS. BETAMETHASONE DIP AUG CREAM 0 .05% 15GM NDC CODE:6846202901 7 FDA PRODUCT CODE NO.: 64 L C J 06 H. T. S NO.: 3004.90 .92.45 ANDA NO.:78-930 THERA PEUTICE USE: DERMALOGIC USE CLOBETASOL PROP SOLN 0.05% 5 0ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 6 7 H. T. S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTI CE USE: - GLUCOCORTICOID / HU MAN - RX/SINGLE INGREDIENT / NONSTERILE LIQUID / CLOBETAS OL PROPIONATE (GLUCOCORTICOID ) NYSTATIN-TRIAM 100K UNIT/ 0.1% OINT 30GM NDC CODE:68462 079935 FDA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 30 04.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - TREATMEN T OF FUNGAL INFECTIONS OF THE SKIN, ESPECIALLY YEAST INFE CTIONS. MOMETASONE FURO SOL N 0.1% 60ML NDC CODE:68462038 502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004. 90.92.45 ANDA NO.:090506 THE RAPEUTICE USE: MOMETASONE FUR OATE TOPICAL SOLUTION (LOTION ) IS A CORTICOSTEROID INDICA TED FOR THE RELIEF OF THE IN FLAMMATORY AND PRURITIC MANIF ESTATIONS OF CORTICOSTEROID-R ESPONSIVE DERMATOSES IN PATIE NTS #12 YEARS OF AGE. COM MERCIAL & CUSTOM INVOICE NO. F22335002372 DT. 30.08.2022 F 22335002395 DT. 30.08.2022 F2 2335002408 DT. 31.08.2022 S/B ILL NO: 3934470 DT 03-SEP-2022 S/BILL NO: 3984537 DT 05/09/ 2022 S/BILL NO: 3998498 DT 06 /09/2022 NET WT. 2,459.33 24 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 646100 |
2022-10-05 |
41 PKG |
7737.51KG |
41 PALLETS 1464 CARTONS P HARMACEUTICALS AS UNDER HAI LEY FE 1/20 TAB 1MG/20MCG-75MG 84 NDC CODE:68462041929 FDA PRODUCT CODE NO.: 65 J D A 2 5 H. T. S NO.: 3006.60.00.00 ANDA NO.:206597 THERAPEUTIC E USE: HORMONE MEDICATION IS USED TO PREVENT PREGNANCY HEATHER TAB 0.35MG 84 NDC CO DE:68462030329 FDA PRODUCT CO DE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.: 90-454 THERAPEUTICE USE: PRE VENTION OF PREGNANCY MUPIRO CIN OINT 2% 22GM NDC CODE:684 62018022 FDA PRODUCT CODE NO. : 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-48 0 THERAPEUTICE USE: - ANTI-B ACTERIAL NAPROXEN TAB 375MG 100 NDC CODE:68462018901 FD A PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:-78-250 THERAPEUT ICE USE:-ANTI-INFLAMMATORY, ANALGESIC COMMERCIAL & CUST OM INVOICE NO. F22352002527 D T. 08.09.2022 F22352002531 DT . 08.09.2022 F22352002532 DT. 08.09.2022 S/BILL NO: 407016 4 DT 09-SEP-2022 S/BILL NO: 4 082065 DT 09-SEP-2022 S/BILL NO: 4082095 DT 09-SEP-2022 NE T WT: 5,942.02 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +18 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA |
HS 652500 |
2022-10-05 |
40 PKG |
6978.18KG |
40 PALLETS 1967 CARTONS PHARMACEUTICALS AS UNDER V IORELE TAB 0.15/0.02-0.01MG 84 NDC CODE:68462031829 FDA PR ODUCT CODE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 A NDA NO.: 091346 THERAPEUTICE USE: - ORAL CONTRACEPTIVES HAILEY FE 1/20 TAB 1MG/20MCG- 75MG 84 NDC CODE:68462041929 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.0 0.00 ANDA NO.:206597 THERAPE UTICE USE: HORMONE MEDICATION IS USED TO PREVENT PREGNANC Y COMMERCIAL & CUSTOM INVOI CE NO. F22352002508 DT. 07.09 .2022 F22352002513 DT. 07.09. 2022 S/BILL NO: 4050673 DT: 08-SEP-22 S/BILL NO: 4050760 DT: 08-SEP-22 NET WT. 5,214. 72 02 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA |
HS 642700 |
2022-10-05 |
8 PKG |
1686.48KG |
8 PALLETS 187 CARTON S PHARMACEUTICALS AS UNDER TRIAMCINOLONE ACE OINT 0.5% 1 5GM NDC CODE:68462079817 FDA PRODUCT CODE NO.:64 L C J 61 H. T. S NO.: 3004.49.00.50 ANDA NO.:206379 THERAPEUTICE USE: - REDUCES THE SWELLING, ITCHING, AND REDNESS OF SKI N MOMETASONE FURO SOLN 0.1% 60ML NDC CODE:68462038502 F DA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.90.92. 45 ANDA NO.:090506 THERAPEUT ICE USE: MOMETASONE FUROATE TOPICAL SOLUTION (LOTION) IS A CORTICOSTEROID INDICATED F OR THE RELIEF OF THE INFLAMMA TORY AND PRURITIC MANIFESTATI ONS OF CORTICOSTEROID-RESPONS IVE DERMATOSES IN PATIENTS # 12 YEARS OF AGE. S/BILL NO : 3958917 DT: 04/09/2022 CO MMERCIAL & CUSTOM INVOICE NO. F22335002448 DT. 31.08.2022 NET WT. 685.44 8 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA |
HS 646100 |
2022-10-05 |
17 PKG |
3441.92KG |
17 PALLETS 835 CARTONS PH ARMACEUTICALS AS UNDER PRAV ASTATIN SOD TAB 80MG 500 NDC CODE:68462019805 FDA PRODUCT CODE NO.:61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. :-77-987 THERAPEUTICE USE:-H YPOLIPDAEMIC PRAVASTATIN SO D TAB 80MG 90 NDC CODE:684620 19890 FDA PRODUCT CODE NO.:- 61 J C A 13 H. T. S NO.: 300 4.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEM IC EZETIMIBE-SIMVA TAB 10/1 0MG 90 NDC CODE:68462032190 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00 .10 ANDA NO.: 208699 THERAPE UTICE USE: - THIS COMBINATION MEDICATION IS USED TO HELP L OWER BAD CHOLESTEROL AND FAT S (SUCH AS LDL, TRIGLYCERIDES ) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUN T OF CHOLESTEROL YOUR BODY AB SORBS FROM YOUR DIET. SIMVAST ATIN BELONGS TO A GROUP OF D RUGS KNOWN AS STATINS. IT W ORKS BY REDUCING THE AMOUNT O F CHOLESTEROL MADE BY THE LIV ER. PIMECROLIMUS CREAM 1% 3 0GM NDC CODE:68462060935 FDA PRODUCT CODE NO.: 61 S C J 0 4 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTI CE USE: - AS SECOUND-LINE THE RAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTME NT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMUNOCOMP ROMISED ADULT AND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 100GM NDC CODE:68462 060994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOU ND-LINE THERAPY FOR THE SHORT -TERM AND NON-CONTINUOS CHRON IC TRERTMENT OF MILD TO MODE RATE ATOPIC DERMATITIS IN NO NIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE TA CROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053 494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 210393 TH ERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIV E OINTMENT USED FOR THE TREA TMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). COMMERCIAL & CUSTOM INVOICE NO. F22387000878 DT. 30.08.20 22 F22387000898 DT. 31.08.202 2 F22387000901 DT. 31.08.2022 F22387000904 DT. 31.08.2022 S/BILL NO: 4012571 DT:30/08/2 022 S/BILL NO: 4012785 DT:03 /09/2022 S/BILL NO: 4012791 DT:03/09/2022 S/BILL NO: 4012 790 DT:03/09/2022 NET WT. 2,6 67.06 KGS 04 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 611300 |
2022-10-05 |
8 PKG |
1703.72KG |
8 PALLETS 497 CARTON S PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP 10MEQ 5 00 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.: 202868 THERAPEUTIC E USE: - TREATMENT OR PREVENT ION OF HYPOKALEMIA TACROLI MUS OINT 0.1% 100GM NDC CODE: 68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO. : 3004.49.00.50 ANDA NO.: 21 0393 THERAPEUTICE USE: - TAC ROLIMUS IS A TOPICAL IMMUNOSU PPRESSIVE OINTMENT USED FOR T HE TREATMENT OF MODERATE-TO- SEVERE ATOPIC DERMATITIS (EC ZEMA). COLESEVELAM HCL TAB 625MG 180 NDC CODE:6846204331 8 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49 .00.10 ANDA NO.: 203480 THER APEUTICE USE: - ANTIHYPERLIPO PROTEINEMIC. VORICONAZOLE TAB 200MG 30 NDC CODE:684620 57330 FDA PRODUCT CODE NO.:6 1 W C A 59 H. T. S NO.: 3004 .90.92.10 ANDA NO.:203503 TH ERAPEUTICE USE: -USED TO TREA T FUNGAL INFECTIONS S/BILL NO: 4012953 DT: 07/09/2022 S/BILL NO: 4012951 DT: 07/09/ 2022 S/BILL NO: 4013021 DT: 08/09/2022 S/BILL NO: 4013023 DT: 08/09/2022 COMMERCI AL & CUSTOM INVOICE NO. F2238 7000943 DT. 08.09.2022 F22387 000945 DT. 08.09.2022 F223870 00937 DT. 07.09.2022 F2238700 0938 DT. 07.09.2022 NET WT. 980.57 KGS 04 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA |
HS 651400 |
2022-10-05 |
3 PKG |
609.18KG |
3 PALLETS 83 CARTONS PHAR MACEUTICALS AS UNDER NITROG LYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART NITROGLY CERIN SUBLING TAB 0.3MG 100 N DC CODE:68462063801 FDA PRODU CT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HEART FA ILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST P AIN FROM NOT ENOUGH BLOOD FLO W TO THE HEART COMMERCIAL & CUSTOM INVOICE NO. F2238700 0893 DT. 31.08.2022 F22387000 895 DT. 31.08.2022 S/BILL NO: 4012787 DT:03/09/2022 S/BILL NO:4012800 DT:03/09/2022 NET WT.44.137 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S NOTIFY PARTY:2 GLENMARK SP ECIALTY S.A. SWITZERLAND (GSS A) PLACE NUMA-DROZ 2 NEUCHAT EL - 2000 SWITZERLAND |
HS 662800 |
2022-10-05 |
10 PKG |
1854.32KG |
10 PALLETS 220 CARTO NS PHARMACEUTICALS AS UNDER CLOTRI-BETAMETHASONE CREAM 1 .0/.05% 45GM NDC CODE:6846202 9855 FDA PRODUCT CODE NO.: 6 1 W D J 04 H. T. S NO.: 3004 .90.92.45 ANDA NO.: 202894 T HERAPEUTICE USE: - TREATMENT A VARIETY OF INFLAMED FUNGAL SKIN INFECTIONS S/BILL N O: 3999319 DT: 06/09/2022 C OMMERCIAL & CUSTOM INVOICE NO. F22335002409 DT. 31.08.2022 NET WT. 950.40 KGS 10 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK SPECIALTY S.A. SWITZE RLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLA ND |
HS 610400 |
2022-10-05 |
14 PKG |
3099.45KG |
14 PALLETS 1265 CART ONS PHARMACEUTICALS AS UNDER SOLIFENACIN SUCCINATE TAB 1 0MG 30 NDC CODE:68462038730 FDA PRODUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 7 0 ANDA NO.: 209239 INDICATED FOR THE TREATMENT OF OVERACT IVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, U RGENCY AND URINARY FREQUENCY SOLIFENACIN SUCCINATE TAB 1 0MG 90 NDC CODE:68462038790 FDA PRODUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 7 0 ANDA NO.: 209239 INDICATED FOR THE TREATMENT OF OVERACT IVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, U RGENCY AND URINARY FREQUENCY NITROGLYCERIN SUBLING TAB 0 .4MG 4X25 NDC CODE:6846206394 5 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90 .9020 ANDA NO.:206391 THERAP EUTIC USE: MEDICATION USED FO R HEART FAILURE,HIGH BLOOD P RESSURE,AND TO TREAT AND PREV ENT CHEST PAIN FROM NOT ENOUG H BLOOD FLOW TO THE HEART S/BILL NO: 4012949 DT: 07/09/ 2022 S/BILL NO: 4013022 DT: 08/09/2022 COMMERCIAL & C USTOM INVOICE NO. F2238700094 4 DT. 08.09.2022 F22387000936 DT. 07.09.2022 NET WT. 432.4 9 14 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLA CE NUMA-DROZ 2 NEUCHATEL - 20 00 SWITZERLAND |
HS 617200 |
2022-10-05 |
2 PKG |
356.08KG |
2 PALLETS 33 CARTONS PHAR MACEUTICALS AS UNDER NYSTAT IN-TRIAM 100K UNIT/0.1% OINT 1 5GM NDC CODE:68462079917 FDA PRODUCT CODE NO.: 64 L D J 6 0 H. T. S NO.: 3004.49.00.50 ANDA NO.: 208300 THERAPEUTI CE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESP ECIALLY YEAST INFECTIONS. COMMERCIAL & CUSTOM INVOICE NO . F22335002454 DT. 31.08.2022 S/BILL NO:3949804 DT:03/09/ 2022 NET WT: 142.56 KGS 0 2 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 646000 |
2022-10-05 |
38 PKG |
9674.83KG |
38 PALLETS 3282 CART ONS PHARMACEUTICALS AS UNDER ESTRADIOL VAG INSERTS 10MCG 8 NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:210264 THERAPEUTIC E USE:THE TREATMENT OF ATROPI C VAGINITIS DUE TO MENOPAUSE . ONDANSETRON TAB 4MG 30 N DC CODE:68462010530 FDA PRODU CT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE US E:-ANTI -EMETIC OXCARBAZEP INE TAB 150MG 100 NDC CODE:68 462013701 FDA PRODUCT CODE N O.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-8 02 THERAPEUTICE USE:-ANTI CO NVULSANT AGENT NAPROXEN TAB 375MG 500 NDC CODE:684620189 05 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:-78-250 THE RAPEUTICE USE:-ANTI-INFLAMMAT ORY, ANALGESIC TELMISARTAN TAB 40MG 30 NDC CODE:6846202 0030 FDA PRODUCT CODE NO.: 6 2 O C A 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.:090032 TH ERAPEUTICE USE: INDICATED FOR THE TREATMENT OF HYPERTENSI ON, TO LOWER BLOOD PRESSURE COMMERCIAL & CUSTOM INVOICE NO. F22352002544 DT. 09.09.20 22 F22352002534 DT. 08.09.202 2 F22352002533 DT. 08.09.2022 S/BILL NOL:4082235 DT 09-SEP -2022 S/BILL NO:4082254 DT 09 -SEP-2022 S/BILL NO: 4081977 DT 09-SEP-2022 NET WT: 7200.6 5 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA |
HS 642800 |
2022-10-05 |
22 PKG |
3548.06KG |
22 PALLETS 547 CARTONS PH ARMACEUTICALS AS UNDER CLOB ETASOL PROP CREAM 0.05% 30GM NDC CODE:68462052935 FDA PROD UCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 AND A NO.: 209095 THERAPEUTICE US E: - CLOBETASOL PROPIONATE C REAM IS A SUPER-HIGH POTENCY CORTICOSTEROID FORMULATIONS I NDICATED FOR THE RELIEF OF TH E INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTER OID-RESPONSIVE DERMATOSES CLOTRI-BETAMETHASONE CREAM 1.0 /.05% NDC CODE:68462029855 F DA PRODUCT CODE NO.: 61 W D J 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 202894 THERAPEU TICE USE: - TREATMENT A VARIE TY OF INFLAMED FUNGAL SKIN I NFECTIONS CLOBETASOL PROP C REAM 0.05% 15GM NDC CODE:6846 2052917 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 209095 CLOBETASOL PROPIONATE CREAM IS A SUPER-HIGH POTENCY CORT ICOSTEROID FORMULATIONS INDIC ATED FOR THE RELIEF OF THE I NFLAMMATORY AND PRURITIC MANI FESTATIONS OF CORTICOSTEROID- RESPONSIVE DERMATOSES CLOT RI-BETAMETHASONE CREAM 1.0/.05 % 15GM NDC CODE:68462029817 FDA PRODUCT CODE NO.:61 W D J 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.:202894 THERAPEUT ICE USE: - TREATMENT A VARIET Y OF INFLAMED FUNGAL SKIN IN FECTIONS CLOBETASOL PROP CR EAM 0.05% 15GM NDC CODE:68462 052917 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 209095 CLOBETASOL PROPIONATE CREAM IS A SUPER-HIGH POTENCY CORTI COSTEROID FORMULATIONS INDICA TED FOR THE RELIEF OF THE IN FLAMMATORY AND PRURITIC MANIF ESTATIONS OF CORTICOSTEROID-R ESPONSIVE DERMATOSES CLOBE TASOL PROP CREAM 0.05% 45GM N DC CODE:68462052947 FDA PRODU CT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209095 THERAPEUTICE USE : - CLOBETASOL PROPIONATE CR EAM IS A SUPER-HIGH POTENCY C ORTICOSTEROID FORMULATIONS IN DICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC M ANIFESTATIONS OF CORTICOSTERO ID-RESPONSIVE DERMATOSES C OMMERCIAL & CUSTOM INVOICE NO. F22335002444 DT. 31.08.2022 F22335002449 DT. 31.08.2022 F22335002453 DT. 31.08.2022 S /BILL NO:3949781 DT:03/09/2022 S/BILL NO: 3958918 DT:04/09 /2022 S/BILL NO: 3958921 DT: 04/09/2022 NET WT. 1,784.16 24 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIFY PART Y:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA -DROZ 2 NEUCHATEL - 2000 SWI TZERLAND |
HS 646700 |
2022-09-27 |
40 PKG |
6271.02KG |
40 PALLETS 1968 CARTONS PHARMACEUTICALS AS UNDER D ROSPIRENONE/EE TAB 3/0.03MG 84 NDC CODE:68462073329 FDA PR ODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 A NDA NO.: 204848 THERAPEUTICE USE: - CONTRACEPTION TO PREVE NT PREGNANCY DROSPIRENONE/ EE TAB 3/0.03MG 84 NDC CODE:6 8462073329 FDA PRODUCT CODE N O.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204 848 THERAPEUTICE USE: - CONT RACEPTION TO PREVENT PREGNANC Y COMMERCIAL & CUSTOM INVOI CE NO. F22352002305 DT. 27.08 .2022 F22352002314 DT. 27.08. 2022 S/BILL NO:3806498 DT 28- AUG-2022 S/BILL NO:3806431 DT 28-AUG-2022 NET WT: 4,321. 51 KGS 02 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 653900 |
2022-09-27 |
41 PKG |
13342.19KG |
41 PALLETS 3197 CARTONS PHARMACEUTICALS AS UNDER CA LCIPOTRIENE OINT 0.005% 120GM NDC CODE:68462031066 FDA PRO DUCT CODE NO.: 62 N C J 04 H . T. S NO.: 3004.90.92.45 AN DA NO.: 209297 THIS MEDICATIO N IS USED TO TREAT PSORIASIS. CALCIPOTRIENE IS A FORM OF VITAMIN D. IT WORKS BY SLOWIN G DOWN THE GROWTH OF SKIN CEL LS. CALCIPOTRIENE OINT 0.00 5% 60GM NDC CODE:68462031065 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 209297 THIS M EDICATION IS USED TO TREAT PS ORIASIS. CALCIPOTRIENE IS A F ORM OF VITAMIN D. IT WORKS BY SLOWING DOWN THE GROWTH OF SKIN CELLS. PRAVASTATIN SOD TAB 40MG 500 NDC CODE:684620 19705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 300 4.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: HYPOLIPDAEM IC ROPINIROLE TAB 1MG 100 NDC CODE:68462025501 FDA PROD UCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 AND A NO.:- 90-135 THERAPEUTICE USE:-TREATMENT OF PARKINSONIS M PRAVASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PRODUCT CODE NO.: 61 J C A 1 3 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTI CE USE: HYPOLIPDAEMIC PRAV ASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO .: 77-987 THERAPEUTICE USE: HYPOLIPDAEMIC GABAPENTIN TA B 600MG 500 NDC CODE:68462012 605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-662 THE RAPEUTICE USE:-ANTICONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22352002372 DT. 30.08.2022 F22352002373 DT. 30.08.2022 F22352002391 DT. 3 0.08.2022 F22352002353 DT. 30 .08.2022 F22352002407 DT. 31. 08.2022 F22352002412 DT. 31.0 8.2022 S/BILL NO: 3899375 DT 01-SEP-2022 S/BILL NO: 389929 7 DT 01-SEP-2022 S/BILL NO: 3 903556 DT 01-SEP-2022 S/BILL NO: 3903141 DT 01-SEP-2022 S/ BILL NO: 3903130 DT 01-SEP-202 2 S/BILL NO: 3904353 DT 01-SE P-2022 NET WT. 11,466.71 02 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 620400 |
2022-09-27 |
4 PKG |
860.48KG |
4 PALLETS 523 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 5MG 90 NDC CODE: 68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079 172 THERAPEUTICE USE: - TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO . F22352002451 DT. 31.08.2022 S/BILL NO: 3907429 DT 01-SE P-2022 NET WT. 651.65 04 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE NUMA-DR OZ 2 NEUCHATEL - 2000 SWITZE RLAND |
HS 611600 |
2022-09-27 |
40 PKG |
11438.88KG |
40 PALLETS 2076 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TAB 600MG 500 NDC COD E:68462012605 FDA PRODUCT COD E NO: 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-662 THERAPEUTICE USE:-ANTI CONVULSANT AGENT OMEPRAZOL E DR CAP 20MG 1000 NDC CODE:6 8462039610 FDA PRODUCT CODE N O.: 62KCF10 H. T. S NO.: 30 04.90.9160 ANDA NO.: 91672 T HERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REF LUX DISEASE NAPROXEN TAB 5 00MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90. 92.40 ANDA NO.:-78-250 THERA PEUTICE USE:-ANTI-INFLAMMATOR Y, ANALGESIC PRAMIPEXOLE T AB 1MG 90 NDC CODE:6846203339 0 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90 .92.40 ANDA NO.: 90-781 THER APEUTICE USE: USED IN PARKINS ON#S DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352002 434 DT. 31.08.2022 F223520024 22 DT. 31.08.2022 S/BILL NO: 3933986 DT 02-SEP-2022 S/BILL NO: 3933989 DT 02-SEP-2022 N ET WT. 10,009.53 02 DATA LO GGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA |
HS 621000 |
2022-09-27 |
2 PKG |
227.71KG |
2 PALLETS 79 CARTONS PHARM ACEUTICALS AS UNDER ACYCLOV IR OINT 5% 30GM NDC CODE:6846 2074635 FDA PRODUCT CODE NO.: 62 V C J 18 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 205510 THERAPEUTICE USE: - AN ANTI VIRAL MEDICINE USED TO TREAT OR PREVENT INFECTIONS CAUSED BY CERTAIN KINDS OF VIRUSES. EXAMPLES OF THESE INFECTIONS INCLUDE HERPES AND SHINGLES COMMERCIAL & CUSTOM INVOICE NO. F22352002344 DT. 29.08.20 22 S/BILL NO: 3866299 DT 31-A UG-2022 NET WT. 165.90 02 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY: 2 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE NUMA-D ROZ 2 NEUCHATEL - 2000 SWITZ ERLAND |
HS 621800 |
2022-09-27 |
25 PKG |
6526.4KG |
25 PALLETS 2152 CARTONS PH ARMACEUTICALS AS UNDER VERA PAMIL HCL ER TAB 120MG 100 ND C CODE:68462029201 FDA PRODUC T CODE NO.: 62 O C B 13 H. T . S NO.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - ANGINA ACAMPROSATE CALC IUM DR TAB 333MG 180 NDC CODE :68462043518 FDA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO .: 3004.90.92.40 ANDA NO.:20 2229 THERAPEUTICE USE: - FOR TREATING ALCOHOL DEPENDENCE CARVEDILOL TAB 12.5MG 500 NDC CODE:68462016405 FDA PROD UCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 AND A NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANT AGONIST POTASSIUM CL ER TAB 20MEQ 100 NDC CODE:684620472 01 FDA PRODUCT CODE NO.: 65 R C A 14 H. T. S NO.: 3004.9 0.9190 ANDA NO.: 203562 THER APEUTICE USE: - TO TREAT OR P REVENT LOW AMOUNTS OF POTASSI UM IN THE BLOOD TROSPIUM C L TAB 20MG 60 NDC CODE:684620 46160 FDA PRODUCT CODE NO.:- 61 K C A 69 H. T. S NO.: 300 4.49.00.70 ANDA NO.:-91-575 THERAPEUTICE USE:- TREATMENT OF VENOUS DISEASES URINARY I NCONTINENCE THERAPY VERAPA MIL HCL ER TAB 120MG 100 NDC CODE:68462029201 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO .: 90-700 THERAPEUTICE USE: - ANGINA ROSUVASTATIN TAB 2 0MG 90 NDC CODE:68462026390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00. 10 ANDA NO.: 079172 THERAPEU TICE USE: - TO TREAT HIGH CHO LESTEROL AND RELATED CONDITIO NS, AND TO PREVENT CARDIOVAS CULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F223520022 84 DT. 26.08.2022 F2235200228 5 DT. 26.08.2022 F22352002286 DT. 26.08.2022 S/BILL NO: 37 70670 DT:26/08/2022 S/BILL NO : 3766429 DT: 26/08/2022 S/BI LL NO: 3770891 DT:26/08/2022 NET WT. 4,973.93 KGS 11 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +18 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S .A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 621300 |
2022-09-27 |
15 PKG |
3273.63KG |
15 PALLETS 790 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA N O.: 202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA PRAVASTATIN SO D TAB 20MG 500 NDC CODE:68462 019605 FDA PRODUCT CODE NO.: -61 J C A 13 H. T. S NO.: 30 04.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAE MIC PRAVASTATIN SOD TAB 20M G 90 NDC CODE:68462019690 FD A PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.2 0 ANDA NO.:-77-987 THERAPEUT ICE USE:-HYPOLIPDAEMIC T ACROLIMUS OINT 0.1% 30GM NDC CODE:68462053435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). NITROGLYCERIN S UBLING TAB 0.4MG 4X25 NDC COD E:68462063945 FDA PRODUCT COD E NO.: 66 S C A 28 H. T. S N O.: 3004.90.9020 ANDA NO.:20 6391 THERAPEUTIC USE: MEDICA TION USED FOR HEART FAILURE,H IGH BLOOD PRESSURE,AND TO TRE AT AND PREVENT CHEST PAIN FRO M NOT ENOUGH BLOOD FLOW TO T HE HEART COMMERCIAL & CUSTO M INVOICE NO. F22387000840 DT . 25.08.2022 F22387000841 DT. 25.08.2022 F22387000842 DT. 25.08.2022 F22387000846 DT. 2 5.08.2022 F22387000845 DT. 25 .08.2022 S/BILL NO: 4012282 DT. 25.08.2022 S/BILL NO: 40 12279 DT. 25.08.2022 S/BILL N O: 4012281 DT. 25.08.2022 S/ BILL NO: 4012286 DT. 25.08.20 22 S/BILL NO: 4012285 DT. 25 .08.2022 NET WT: 1909.36 K GS 07 DATA LOGGERS NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A NOTIFY PARTY:3 GLENMARK SP ECIALTY S.A. SWITZERLAND (GSS A) PLACE NUMA-DROZ 2 NEUCHAT EL - 2000 SWITZERLAND |
HS 651400 |
2022-09-27 |
3 PKG |
631.41KG |
3 PALLETS 341 CARTONS PHA RMACEUTICALS AS UNDER ROSUV ASTATIN TAB 10MG 90 NDC CODE: 68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079 172 THERAPEUTICE USE: - TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO . F22352002328 DT. 28.08.2022 S/BILL NO: 3807390 DT 29-AUG -2022 NET WT: 474.68 KGS 03 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE N UMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 611600 |
2022-09-27 |
1 PKG |
267.62KG |
1 PALLETS 49 CARTONS PHARMACEUTICALS AS UNDER METFORMIN HCL ER TAB (Z) 1000M G 90 NDC CODE:68462052190 FD A PRODUCT CODE NO.: 61 P C A 55 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:212969 THERAPEUTI CE USE: THE MANAGEMENT OF TYP E 2 DIABETES S/BILL NO: 4012566 DT:30/08/2022 COMMERC IAL & CUSTOM INVOICE NO. F223 87000876 DT. 30.08.2022 NET W T. 144.07 01 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 615500 |
2022-09-27 |
35 PKG |
6432.05KG |
35 PALLETS 1732 CARTONS P HARMACEUTICALS AS UNDER HAI LEY FE 1/20 TAB 1MG/20MCG-75MG 84 NDC CODE:68462041929 FDA PRODUCT CODE NO.: 65 J D A 2 5 H. T. S NO.: 3006.60.00.00 ANDA NO.:206597 THERAPEUTIC E USE: HORMONE MEDICATION IS USED TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE N O. F22352002349 DT. 29.08.202 2 S/BILL NO: 3835576 DT 29-AU G-2022 NET WT: 4780.320 KGS 02 DATA LOGGERS SET TEMPE RATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA |
HS 652500 |
2022-09-27 |
26 PKG |
6750.48KG |
26 PALLETS 1337 CART ONS PHARMACEUTICALS AS UNDER OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 FDA PR ODUCT CODE NO.: 62KCF10 H. T . S NO.: 3004.90.9160 ANDA N O.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROES OPHAGEAL REFLUX DISEASE NA PROXEN TAB 500MG 500 NDC CODE :68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC R OPINIROLE TAB 1MG 100 NDC COD E:68462025501 FDA PRODUCT COD E NO.:-62 J C A 17 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TR EATMENT OF PARKINSONISM S/ BILL NO: 3907519 DT:01-SEP-22 COMMERCIAL & CUSTOM INVOIC E NO. F22352002428 DT. 31.08. 2022 NET WT. 5,850.23 01 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 621000 |
2022-09-27 |
5 PKG |
1051.9KG |
5 PALLETS 621 CARTONS PHA RMACEUTICALS AS UNDER ROSUV ASTATIN TAB 5MG 90 NDC CODE:6 8462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 0791 72 THERAPEUTICE USE: - TO TR EAT HIGH CHOLESTEROL AND RELA TED CONDITIONS, AND TO PREVEN T CARDIOVASCULAR DISEASE R OSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 79172 THERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PR EVENT CARDIOVASCULAR DISEASE. COMMERCIAL & CUSTOM INVOIC E NO. F22352002334 DT. 29.08. 2022 S/BILL NO: 3828052 DT 29 -AUG-2022 NET WT: 809.284 KG S 05 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLA CE NUMA-DROZ 2 NEUCHATEL - 20 00 SWITZERLAND |
HS 611600 |
2022-09-27 |
38 PKG |
10171.07KG |
38 PALLETS 2389 CARTONS P HARMACEUTICALS AS UNDER LIT HIUM CARB CAP 300MG 1000 NDC CODE:68462022110 FDA PRODUCT CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO .:- 79 -139 THERAPEUTICE USE :-ANTIMANIC AGENT CARVEDILO L TAB 12.5MG 500 NDC CODE:684 62016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-2 51 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST N APROXEN TAB 500MG 500 NDC COD E:68462019005 FDA PRODUCT COD E NO.:-62 G C A 49 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-ANT I-INFLAMMATORY, ANALGESIC PRAVASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PROD UCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 AND A NO.: 77-987 THERAPEUTICE US E: HYPOLIPDAEMIC ROPINIROL E TAB 1MG 100 NDC CODE:684620 25501 FDA PRODUCT CODE NO.:- 62 J C A 17 H. T. S NO.: 300 4.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT OF PARKINSONISM OMEPRAZOLE DR CAP 40MG 90 NDC CODE:6846 2039790 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004. 90.9160 ANDA NO.: 91672 THER APEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE ZOLMITRIPTAN ODT 5MG 3UD NDC CODE:68462050033 FDA PRODUCT CODE NO.: 63OCA0 8 H. T. S NO.: 3004.90.92.28 ANDA NO.: 202560 THERAPEUTI CE USE: :#ANALGESIC/ HUMAN R X/SINGLE INGREDIENT PROMPT RE LEASE TABLETS ZOLMITRIPTAN ( ANALGESIC) COMMERCIAL & CUS TOM INVOICE NO. F22352002327 DT. 28.08.2022 S/BILL NO:3820 365 DT 29-AUG-2022 NET WT: 8 ,474.01 KGS 03 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 613700 |
2022-09-27 |
1 PKG |
153.32KG |
1 PALLETS 14 CARTONS PHARMACEUTICALS AS UNDER CLOBETASOL PROP OINT 0.05% 15G M NDC CODE:68462053017 FDA P RODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTICE USE: - INDICATED FOR THE REL IEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CO RTICOSTEROID-RESPONSIVE DERMA TOESE S/BILL NO: 3866268 D T: 31/08/2022 COMMERCIAL & CU STOM INVOICE NO. F22335002347 DT. 29.08.2022 NET WT. 60.48 01 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLA CE NUMA-DROZ 2 NEUCHATEL - 20 00 SWITZERLAND |
HS 646700 |
2022-09-27 |
16 PKG |
2732.03KG |
16 PALLETS 775 CARTO NS PHARMACEUTICALS AS UNDER HAILEY FE 1.5/30 TAB 1.5MG/3 0MCG-75MG 84 NDC CODE:6846205 0329 FDA PRODUCT CODE NO.: 6 5 J D A 25 H. T. S NO.: 3006 .60.00.00 ANDA NO.:206597 TH ERAPEUTICE USE: HORMONE MEDIC ATION IS USED TO PREVENT PRE GNANCY S/BILL NO: 3917303 DT:02-SEP-22 COMMERCIAL & CUS TOM INVOICE NO. F22352002449 DT. 31.08.2022 NET WT. 1,990. 20 KGS 16 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECI ALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 652500 |
2022-09-27 |
28 PKG |
5849.17KG |
28 PALLETS 721 CARTO NS PHARMACEUTICALS AS UNDER NYSTATIN-TRIAM 100K UNIT/0.1 % OINT 60GM NDC CODE:68462079 965 FDA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 208300 TH ERAPEUTICE USE: - TREATMENT O F FUNGAL INFECTIONS OF THE SK IN, ESPECIALLY YEAST INFECTI ONS. NYSTATIN-TRIAM 100K UN IT/0.1% CREAM 15 GM NDC CODE: 68462031417 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO. : 3004.40.0050 ANDA NO.: 208 136 THERAPEUTICE USE: - TREA TMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPECIALLY YEAST INFECTIONS. BETAMETHASONE D IP AUG CREAM 0.05% 50GM NDC C ODE:68462029052 FDA PRODUCT C ODE NO.: 64 L C J 06 H. T. S NO.: 3004.90.92.45 ANDA NO. :78-930 THERAPEUTICE USE: DE RMALOGIC USE MOMETASONE FUR O SOLN 0.1% 60ML NDC CODE:684 62038502 FDA PRODUCT CODE NO. : 62 F C L 53 H. T. S NO.: 3004.90.92.45 ANDA NO.:090506 THERAPEUTICE USE: MOMETASON E FUROATE TOPICAL SOLUTION (L OTION) IS A CORTICOSTEROID I NDICATED FOR THE RELIEF OF TH E INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTER OID-RESPONSIVE DERMATOSES IN PATIENTS #12 YEARS OF AGE. MOMETASONE FURO SOLN 0.1% 30 ML NDC CODE:68462038537 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.90.92.45 ANDA NO.:090506 THERAPEUTICE USE: MOMETASONE FUROATE TOP ICAL SOLUTION (LOTION) IS A CORTICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATOR Y AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DERMATOSES IN PATIENTS #12 YEARS OF AGE. CLOBETASOL P ROP SOLN 0.05% 50ML NDC CODE: 68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO. : 3004.90.92.45 ANDA NO.: 21 0190 THERAPEUTICE USE: - GLU COCORTICOID / HUMAN - RX/SING LE INGREDIENT / NONSTERILE LI QUID / CLOBETASOL PROPIONATE (GLUCOCORTICOID) NYSTATIN- TRIAM 100K UNIT/0.1% CREAM ND C CODE:68462031435 FDA PRODUC T CODE NO.: 64 L D J 61 H. T . S NO.: 3004.40.0050 ANDA N O.: 208136 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECT IONS OF THE SKIN, ESPECIALLY YEAST INFECTIONS S/BILL NO : 3860776 DT:30/08/2022 S/BI LL NO: 3778572 DT:27/08/2022 S/BILL NO: 3862973 DT:30/08/ 2022 COMMERCIAL & CUSTOM IN VOICE NO. F22335002345 DT. 29 .08.2022 F22335002302 DT. 26. 08.2022 F22335002346 DT. 29.0 8.2022 NET WT. 3,013.82 29 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 646000 |
2022-09-27 |
9 PKG |
1609.83KG |
9 PALLETS 202 CARTON S PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TAB 0.4 MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9 020 ANDA NO.:206391 THERAPEU TIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRE SSURE,AND TO TREAT AND PREVEN T CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART AP REPITANT CAP 80MG 2UOU NDC CO DE:68462058458 FDA PRODUCT CO DE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE:APRE PITANT IS USED WITH OTHER MED ICATIONS TO HELP PREVENT NAUS EA AND VOMITING CAUSED BY CA NCER DRUG TREATMENT (CHEMOTHE RAPY). THIS MEDICATION IS ALS O USED TO PREVENT NAUSEA AND VOMITING AFTER SURGERY. A-EM ETIC/NAUSEANT / HUMAN - RX/SI NGLE INGREDIENT / DELAYED RE LEASE TABLETS / APREPITANT S/BILL NO: 4012568 DT:30/08/ 2022 S/BILL NO: 4012565 DT:3 0/08/2022 COMMERCIAL & CUST OM INVOICE NO. F22387000877 D T. 30.08.2022 F22387000875 DT . 30.08.2022 NET WT. 68.75 09 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PAR TY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUM A-DROZ 2 NEUCHATEL - 2000 SW ITZERLAND |
HS 662800 |
2022-09-20 |
45 PKG |
11095.96KG |
45 PALLETS 3027 CARTONS PHARMACEUTICALS AS UNDER VE RAPAMIL HCL ER TAB 120MG 100 NDC CODE:68462029201 FDA PROD UCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 AND A NO.: 90-700 THERAPEUTICE US E: - ANGINA ACAMPROSATE CA LCIUM DR TAB 333MG 180 NDC CO DE:68462043518 FDA PRODUCT CO DE NO.: 60 T C C 99 H. T. S NO.: 3004.90.92.40 ANDA NO.: 202229 THERAPEUTICE USE: - FO R TREATING ALCOHOL DEPENDENC E CARVEDILOL TAB 12.5MG 500 NDC CODE:68462016405 FDA PR ODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 A NDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR A NTAGONIST GABAPENTIN TAB 60 0MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92 .30 ANDA NO.:-77-662 THERAPE UTICE USE:-ANTICONVULSANT AG ENT TELMISARTAN TAB 40MG 30 NDC CODE:68462020030 FDA PR ODUCT CODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 A NDA NO.:090032 THERAPEUTICE U SE: INDICATED FOR THE TREATM ENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE NORGEST/EE TAB 0.25/0.035MG 84 NDC CODE :68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO .: 3006.60.00.00 ANDA NO.: 2 00538 THERAPEUTICE USE: - ORA L CONTRACEPTIVES COMMERCIA L & CUSTOM INVOICE NO. F22352 002262 DT. 24.08.2022 F223520 02263 DT. 24.08.2022 F2235200 2264 DT. 24.08.2022 F22352002 271 DT. 25.08.2022 S/BILL NO: 3733753 DT 25-AUG-2022 S/BILL NO: 3733703 DT 25-AUG-2022 S /BILL NO: 3732653 DT 25-AUG-20 22 S/BILL NO:3733698 DT 25-AU G-2022 NET WT. 9,064.04 KGS 02 DATA LOGGERS SET TEMPE RATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA |
HS 621300 |
2022-09-20 |
41 PKG |
8802.11KG |
41 PALLETS 2123 CARTONS P HARMACEUTICALS AS UNDER PRA VASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA N O.: 77-987 THERAPEUTICE USE: HYPOLIPDAEMIC GABAPENTIN T AB 600MG 500 NDC CODE:6846201 2605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004. 90.92.30 ANDA NO.:-77-662 TH ERAPEUTICE USE:-ANTICONVULSAN T AGENT NORGEST/EE TAB 0.2 5/0.035MG 84 NDC CODE:6846203 0929 FDA PRODUCT CODE NO.: 6 5 J D A 27 H. T. S NO.: 3006 .60.00.00 ANDA NO.: 200538 T HERAPEUTICE USE: - ORAL CONTR ACEPTIVES NORGEST/EE TAB 0. 25/0.035MG 84 NDC CODE:684620 30929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 300 6.60.00.00 ANDA NO.: 200538 THERAPEUTICE USE: - ORAL CONT RACEPTIVES COMMERCIAL & CUS TOM INVOICE NO. F22352002225 DT. 23.08.2022 F22352002226 D T. 23.08.2022 F22352002230 DT . 23.08.2022 F22352002254 DT. 24.08.2022 S/BILL NO: 371819 8 DT 24-AUG-2022 S/BILL NO: 3 714040 DT 24-AUG-2022 S/BILL NO:3718195 DT 24-AUG-2022 S/B ILL NO:3718015 DT 24-AUG-2022 NET WT. 7,001.46 KGS 03 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 611300 |
2022-09-20 |
42 PKG |
11836.24KG |
42 PALLETS 2696 CART ONS PHARMACEUTICALS AS UNDER OMEPRAZOLE DR CAP 20MG 100 NDC CODE:68462039601 FDA PRO DUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESO PHAGEAL REFLUX DISEASE VER APAMIL HCL ER TAB 240MG 100 N DC CODE:68462026001 FDA PRODU CT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-78-906 THERAPEUTICE US E:-ANGINA LEVOCETIRIZINE DI HY TAB 5MG 90 NDC CODE:684620 34690 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 300 4.90.91.80 ANDA NO.:90385 TH ERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPATHIC URTICARIA OXCARBAZEPINE TAB 300MG 100 NDC CODE:68462013801 FDA PR ODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 A NDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT VERAPAMIL HCL ER TAB 240MG 50 0 NDC CODE:68462026005 FDA P RODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-78-906 THERAPEUTICE USE:-ANGINA VERAPAMIL HCL ER TAB 180MG 100 NDC CODE:68 462029301 FDA PRODUCT CODE NO .: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-7 00 THERAPEUTICE USE: - ANGIN A OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PR ODUCT CODE NO.: 62KCF10 H. T . S NO.: 3004.90.9160 ANDA N O.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROES OPHAGEAL REFLUX DISEASE CO MMERCIAL & CUSTOM INVOICE NO. F22352002193 DT. 20.08.2022 F22352002204 DT. 22.08.2022 S /BILL NO: 3655438 DT 22-AUG-20 22 S/BILL NO: 3655481 DT 22-A UG-2022 NET WT. 10,205.50 KG S 02 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 621000 |
2022-09-20 |
43 PKG |
5395.57KG |
43 PALLETS 1218 CARTONS P HARMACEUTICALS AS UNDER FLU CONAZOLE TAB 150MG 12UD NDC C ODE:68462011944 NDC CODE : 6 8462011944 HTS NO : 3004.90.9 2.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 THERAPEUT ICE USE : ANTIFUNGAL OMEPR AZOLE DR CAP 20MG 1000 NDC CO DE:68462039610 FDA PRODUCT CO DE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 9167 2 THERAPEUTICE USE: - TREATM ENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE ZOLMITRIPT AN TAB 5 MG 3UD NDC CODE:6846 2049833 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3 004.90.92.28 ANDA NO.: 201779 THERAPEUTICE USE: - ANALGES IC/ HUMAN - RX/SINGLE INGREDI ENT / PROMPT RELEASE TABLETS / ZOLMITRIPTAN (ANALGESIC) COMMERCIAL & CUSTOM INVOICE NO. F22352002185 DT. 20.08.20 22 F22352002186 DT. 20.08.202 2 S/BILL NO: 3623134 DT:20- AUG-22 S/BILL NO: 3623025 DT :20-AUG-22 NET WT. 4,183.20 02 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 300490 |
2022-09-20 |
7 PKG |
1448.34KG |
7 PALLETS 624 CARTON S PHARMACEUTICALS AS UNDER PRAVASTATIN SOD TAB 20MG 500 NDC CODE:68462019605 FDA PRO DUCT CODE NO.:-61 J C A 13 H . T. S NO.: 3004.90.92.20 AN DA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEMIC TACROLIM US CAP 1MG 100 NDC CODE:68462 068601 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE : T O PREVENT REJECTION OF A KID NEY,HEART, OR LIVER TRANSPLAN T CHLORPROMAZINE HCL TAB 10 0MG 100 NDC CODE:68462086401 61 T C A 04 3004.90.92.40 2 12144 TO TREAT PSYCHOTIC DIS ORDERS SUCH AS SCHIZOPHRENIA OR MANIC-DEPRESSION IN ADULT S S/BILL NO: 4012187 DT:24 /08/2022 S/BILL NO: 4012188 DT:24/08/2022 S/BILL NO: 401 2181 DT:24/08/2022 COMMER CIAL & CUSTOM INVOICE NO. F22 387000825 DT. 23.08.2022 F223 87000822 DT. 23.08.2022 F2238 7000824 DT. 23.08.2022 NET WT . 701.23 03 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2022-09-20 |
8 PKG |
3174.75KG |
8 PALLETS 406 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TAB 800MG 500 NDC COD E:68462012705 FDA PRODUCT COD E NO : 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT COMMERCI AL & CUSTOM INVOICE NO. F2235 2002291 DT. 26.08.2022 NET WT . 2,896.81 DATA LOGGERS S/BI LL NO: 3775416 DT:26-AUG-22 SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 847439 |
2022-09-20 |
3 PKG |
601.93KG |
3 PALLETS 200 CARTON S PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TAB 0.4 MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9 020 ANDA NO.:206391 THERAPEU TICE USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PR ESSURE,AND TO TREAT AND PREVE NT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART A PREPITANT CAP 40MG 5UD NDC CO DE:68462058385 FDA PRODUCT CO DE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE:APRE PITANT IS USED WITH OTHER MED ICATIONS TO HELP PREVENT NAUS EA AND VOMITING CAUSED BY CA NCER DRUG TREATMENT (CHEMOTHE RAPY). THIS MEDICATION IS ALS O USED TO PREVENT NAUSEA AND VOMITING AFTER SURGERY. A-EM ETIC/NAUSEANT / HUMAN - RX/SI NGLE INGREDIENT / DELAYED RE LEASE TABLETS / APREPITANT S/BILL NO: 4012183 DT:24/08/ 2022 S/BILL NO: 4012184 DT: 24/08/2022 COMMERCIAL & C USTOM INVOICE NO. F2238700082 3 DT. 23.08.2022 F22387000821 DT. 23.08.2022 NET WT. 34.42 03 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND |
HS 662800 |
2022-09-20 |
12 PKG |
2879KG |
12 PALLETS 1565 CARTONS P HARMACEUTICALS AS UNDER ROS UVASTATIN TAB 5MG 90 NDC CODE :68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 40MG 30 NDC CODE:68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE ACYCLOVIR OINT 5% 30GM NDC CODE:68462074635 FDA PROD UCT CODE NO.: 62 V C J 18 H. T. S NO.: 3004.49.00.50 AND A NO.: 205510 THERAPEUTICE US E: - AN ANTIVIRAL MEDICINE US ED TO TREAT OR PREVENT INFECT IONS CAUSED BY CERTAIN KINDS OF VIRUSES. EXAMPLES OF THES E INFECTIONS INCLUDE HERPES A ND SHINGLES COMMERCIAL & CU STOM INVOICE NO. F22352002250 DT. 24.08.2022 F22352002252 DT. 24.08.2022 S/BILL NO: 371 5186 DT. 24-AUG-22 S/BILL NO : 3716607 DT. 24-AUG-22 NET WT. 2,244.63 12 DATA LOGGERS HUMIDITY:65% SET TEMPERATUR E : +18 DEGREES TEMPERATURE R ANGE : +15 DEGREES TO +25 DEGR EES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (G SSA) PLACE NUMA-DROZ 2 NEUCH ATEL - 2000 SWITZERLAND |
HS 684620 |
2022-09-20 |
28 PKG |
7611.41KG |
28 PALLETS 1684 CARTONS PHARMACEUTICALS AS UNDER FLUCONAZOLE TAB 200MG 30 NDC CODE:68462010430 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90.92.45 ANDA NO .:-77 - 253 THERAPEUTICE USE :-ANTIFUNGAL NAPROXEN TAB 5 00MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90. 92.40 ANDA NO.:-78-250 THERA PEUTICE USE:-ANTI-INFLAMMATOR Y, ANALGESIC CARVEDILOL TA B 25MG 500 NDC CODE:684620165 05 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.9 0.92.20 ANDA NO.:- 78-251 TH ERAPEUTICE USE:-BETA- ADRENO ACEPTOR ANTAGONIST COMMERC IAL & CUSTOM INVOICE NO. F223 52002292 DT. 26.08.2022 NET W T. 6,658.38 02 D ATA LOGGERS S/BILL NO: 378 8981 DT: 27-AUG-22 SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 614500 |
2022-09-20 |
34 PKG |
8190.2KG |
34 PALLETS 864 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 600MG 100 NDC C ODE:68462013901 FDA PRODUCT C ODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-802 THERAPEUTICE USE:-AN TI CONVULSANT AGENT GABAPE NTIN TAB 600MG 500 NDC CODE:6 8462012605 FDA PRODUCT CODE N O: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-6 62 THERAPEUTICE USE:-ANTICON VULSANT AGENT MUPIROCIN OI NT 2% 22GM NDC CODE:684620180 22 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.9 0.92.45 ANDA NO.: 90-480 THE RAPEUTICE USE: - ANTI-BACTERI AL COMMERCIAL & CUSTOM INVO ICE NO. F22352002247 DT. 24.0 8.2022 F22352002249 DT. 24.08 .2022 F22352002251 DT. 24.08. 2022 S/BILL NO: 3713626 DT. 2 4-AUG-22 S/BILL NO: 3716606 D T. 24-AUG-22 S/BILL NO: 37162 90 DT. 24-AUG-22 NET WT. 6,75 3.47 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 616900 |
2022-09-20 |
33 PKG |
6176.67KG |
33 PALLETS 747 CARTO NS PHARMACEUTICALS AS UNDER CLOBETASOL PROP SOLN 0.05% 5 0ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 6 7 H. T. S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTI CE USE: - GLUCOCORTICOID / HU MAN - RX/SINGLE INGREDIENT / NONSTERILE LIQUID / CLOBETAS OL PROPIONATE (GLUCOCORTICOID ) CLOBETASOL PROP SOLN 0.05 % 50ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92 .45 ANDA NO.: 210190 THERAPE UTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTERILE LIQUID / CLOBE TASOL PROPIONATE (GLUCOCORTIC OID) FLUOCINONIDE CREAM 0.1 % 30GM NDC CODE:68462050535 FDA PRODUCT CODE NO.: 64 L C L 28 H. T. S NO.: 3004.32.00 .00 ANDA NO.: 91-282 THERAPE UTICE USE: - INDICATED FOR TH E RELIEF OF VARIOUS INFLAMMAT ORY AND PRURITIC MANIFESTATIO NS OF CORTICOSTEROID RESPONSI VE DERMATOSES IN PATIENTS. FLUOCINONIDE CREAM 0.1% 120G M NDC CODE:68462050566 FDA P RODUCT CODE NO.: 64 L C L 28 H. T. S NO.: 3004.32.00.00 ANDA NO.: 91-282 THERAPEUTICE USE: - INDICATED FOR THE REL IEF OF VARIOUS INFLAMMATORY A ND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE D ERMATOSES IN PATIENTS. FLU OCINONIDE CREAM 0.1% 60GM NDC CODE:68462050565 FDA PRODUCT CODE NO.: 64 L C L 28 H. T. S NO.: 3004.32.00.00 ANDA N O.: 91-282 THERAPEUTICE USE: - INDICATED FOR THE RELIEF OF VARIOUS INFLAMMATORY AND PR URITIC MANIFESTATIONS OF CORT ICOSTEROID RESPONSIVE DERMATO SES IN PATIENTS. S/BILL NO : 3607149 DT: 20/08/2022 S/B ILL NO: 3724324 DT: 25/08/2 022 S/BILL NO: 3724338 DT: 25/08/2022 COMMERCIAL & C USTOM INVOICE NO. F2233500214 6 DT. 18.08.2022 F22335002223 DT. 22.08.2022 F22335002224 DT. 22.08.2022 NET WT. 3,194. 88 17 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA |
HS 646700 |
2022-09-17 |
45 PKG |
9815.45KG |
45 PALLETS 2636 CARTONS P HARMACEUTICALS AS UNDER MUP IROCIN OINT 2% 22GM NDC CODE: 68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO. : 3004.90.92.45 ANDA NO.: 90 -480 THERAPEUTICE USE: - ANT I-BACTERIAL OMEPRAZOLE DR C AP 40MG 100 NDC CODE:68462039 701 FDA PRODUCT CODE NO.: 62 KCF10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAPEU TICE USE: - TREATMENT OF TREA T GASTROESOPHAGEAL REFLUX DI SEASE LEVOCETIRIZINE DIHY T AB 5MG 90 NDC CODE:6846203469 0 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.90 .91.80 ANDA NO.:90385 THERAP EUTICE USE: TREATMENT OF CHRO NIC IDIOPATHIC URTICARIA C ARVEDILOL TAB 6.25MG 500 NDC CODE:68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PR ODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 A NDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR A NTAGONIST FELODIPINE ER TAB 5MG 100 NDC CODE:68462023401 FDA PRODUCT CODE NO.: 62OCB 32 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 90-365 THERAPEUT ICE USE: - TREATMENT OF HYPE RTENSION ZOLMITRIPTAN TAB 5 MG 3UD NDC CODE:68462049833 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90.9 2.28 ANDA NO.: 201779 THERAP EUTICE USE: - ANALGESIC/ HUMA N - RX/SINGLE INGREDIENT / P ROMPT RELEASE TABLETS / ZOLM ITRIPTAN (ANALGESIC) COMMER CIAL & CUSTOM INVOICE NO. F22 352002160 DT. 18.08.2022 F223 52002168 DT. 18.08.2022 S/BIL L NO: 3596923 DT 19-AUG-2022 S/BILL NO: 3596355 DT 19-AUG- 2022 NET WT. 7,788.76 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 618100 |
2022-09-17 |
43 PKG |
9715.66KG |
43 PALLETS 3350 CART ONS PHARMACEUTICALS AS UNDER MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA N O.: 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL ONDANSETR ON ODT 4MG 30UD NDC CODE:6846 2015713 FDA PRODUCT CODE NO, :-61 T C A 26 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-152 THERAPEUTICE USE:-ANTI EMET IC LEVOCETIRIZINE DIHY TAB 5MG 90 NDC CODE:68462034690 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.90.91 .80 ANDA NO.:90385 THERAPEUT ICE USE: TREATMENT OF CHRONIC IDIOPATHIC URTICARIA POTA SSIUM CL ER TAB 10MEQ 100 NDC CODE:68462047101 FDA PRODUCT CODE NO.: 65 R C A 14 H. T. S NO.: 3004.90.9190 ANDA NO .: 203562 THIS MEDICATION IS A MINERAL SUPPLEMENT USED TO TREAT OR PREVENT LOW AMOUNTS OF POTASSIUM IN THE BLOOD.SO ME CONDITIONS THAT CAN LOWER YOUR BODY S POTASSIUM LEVEL INCLUDE SEVERE PROLONGED DIAR RHEA AND VOMITING, HORMONE P ROBLEMS SUCH AS HYPERALDOSTER ONISM, OR TREATMENT WITH WAT ER PILLS /DIURETICS. ONDAN SETRON TAB 4MG 30 NDC CODE:68 462010530 FDA PRODUCT CODE N O.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77- 535 THERAPEUTICE USE:-ANTI E METIC OLMESARTAN MEDOX TAB 40MG 30 NDC CODE:68462043830 FDA PRODUCT CODE NO.: 62CCA6 8 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 THERAPEUTIC E USE: - TREATMENT OF HYPERT ENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS, TO L OWER BLOOD PRESSURE OLMESAR TAN MEDOX TAB 40MG 90 NDC COD E:68462043890 FDA PRODUCT COD E NO.: 62 CCA 68 H. T. S NO. : 3004.90.9220 ANDA NO.: 203 281 TREATMENT OF HYPERTENSIO N, ALONE OR WITH OTHER ANTIH YPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE COMMERCIAL & CUSTOM INVOICE NO. F22352002 120 DT. 16.08.2022 F223520021 21 DT. 16.08.2022 S/BILL NO: 3547747 DT 17-AUG-2022 S/ BILL NO: 3551621 DT 17-AUG-202 2 NET WT. 7,770.65 02 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 618100 |
2022-09-17 |
42 PKG |
7462.17KG |
42 PALLETS 2771 CART ONS PHARMACEUTICALS AS UNDER ALYACEN 1/35 TAB 1/0.035MG 84 NDC CODE:68462039429 FDA PRODUCT CODE NO.: 65 J D A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.: 091634 THERAPEUTIC E USE: ORALCONTRACEPTIVE O NDANSETRON ODT 4MG 30UD NDC C ODE:68462015713 FDA PRODUCT C ODE NO,:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO. :-78-152 THERAPEUTICE USE:-AN TI EMETIC ROPINIROLE TAB 0 .25MG 100 NDC CODE:6846202530 1 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90 .92.40 ANDA NO.:- 90-135 THE RAPEUTICE USE:-TREATMENT OF PARKINSONISM S/BILL NO: 354 7023 DT 17-AUG-2022 S/BILL NO : 3547057 DT 17-AUG-2022 S/BI LL NO: 3547054 DT 17-AUG-2022 COMMERCIAL & CUSTOM INVOI CE NO. F22352002113 DT. 16.08 .2022 F22352002115 DT. 16.08. 2022 F22352002134 DT. 17.08.2 022 NET WT. 5,564.19 02 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 652400 |
2022-09-17 |
24 PKG |
5786.12KG |
24 PALLETS 963 CARTONS PH ARMACEUTICALS AS UNDER CLIN DAMYCIN PHOS GEL 1% 30GM NDC CODE:68462086635 FDA PRODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO .:214251 THERAPEUTICE USE: C LINDAMYCIN PHOSPHATE GEL IS I NDICATED IN THE TREATMENT OF ACNE VULGARIS MUPIROCIN OI NT 2% 22GM NDC CODE:684620180 22 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.9 0.92.45 ANDA NO.: 90-480 THE RAPEUTICE USE: - ANTI-BACTERI AL COMMERCIAL & CUSTOM INVO ICE NO. F22352002075 DT. 12.0 8.2022 S/BILL NO: 3479406 DT: 12.08.2022 NET WT. 4,724.05 KGS DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 563100 |
2022-09-17 |
29 PKG |
7797.38KG |
29 PALLETS 1446 CARTONS PH ARMACEUTICALS AS UNDER ALYA CEN 1/35 TAB 1/0.035MG 84 NDC CODE:68462039429 FDA PRODUCT CODE NO.: 65 J D A 24 H. T. S NO.: 3006.60.00.00 ANDA N O.: 091634 THERAPEUTICE USE: ORALCONTRACEPTIVE NORETH A CE/EE TAB 0.5MG/2.5MCG 84 NDC CODE:68462065629 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA N O.: 203038 THERAPEUTICE USE: - TREATMENT OF MODERATE TO S EVERE VASOMOTOR SYMPTOMS DUE TO MENOPAUSE; OSTEOPOROSIS P REVENTION GABAPENTIN TAB 80 0MG 500 NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-662 THERAP EUTICE USE:-ANTICONVULSANT A GENT COMMERCIAL & CUSTOM IN VOICE NO. F22352002089 DT. 13 .08.2022 F22352002092 DT. 13. 08.2022 S/BILL NO: 3502709 DT 15-AUG-2022 S/BILL NO: 35025 20 DT 15-AUG-2022 NET WT: 6, 635.23 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 652400 |
2022-09-17 |
37 PKG |
10988.91KG |
37 PALLETS 2296 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TAB 800MG 500 NDC COD E:68462012705 FDA PRODUCT COD E NO : 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT ROPINIRO LE TAB 0.5MG 100 NDC CODE:684 62025401 FDA PRODUCT CODE NO .:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-1 35 THERAPEUTICE USE:-TREATME NT OF PARKINSONISM ONDANSE TRON TAB 4MG 30 NDC CODE:6846 2010530 FDA PRODUCT CODE NO. :-61 T C A 28 H. T. S NO.: 3 004.90.92.40 ANDA NO.:- 77-53 5 THERAPEUTICE USE:-ANTI EME TIC MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRO DUCT CODE NO.: 61 G J J 81 H . T. S NO.: 3004.90.92.45 AN DA NO.: 90-480 THERAPEUTICE U SE: - ANTI-BACTERIAL COMME RCIAL & CUSTOM INVOICE NO. F2 2352002094 DT. 13.08.2022 F22 352002095 DT. 13.08.2022 F223 52002096 DT. 13.08.2022 S/BIL L NO:3502517 DT 15-AUG-2022 S /BILL NO:3502322 DT 15-AUG-202 2 S/BILL NO:3502325 DT 15-AUG -2022 NET WT. 9,424.87 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA |
HS 621700 |
2022-09-17 |
1 PKG |
192.33KG |
1 PALLETS 18 CARTONS PHARMACEUTICALS AS UNDER CLOBETASOL PROP OINT 0.05% 15G M NDC CODE:68462053017 FDA P RODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTICE USE: - INDICATED FOR THE REL IEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CO RTICOSTEROID-RESPONSIVE DERMA TOESE S/BILL NO: 3433930 D T:10-AUG-22 COMMERCIAL & CU STOM INVOICE NO. F22335002032 DT. 10.08.2022 NET WT. 77.76 02 DATA LOGGERS S/BILL NO: 3433930 DT:10-AUG-22 NOTI FY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLA CE NUMA-DROZ 2 NEUCHATEL - 20 00 SWITZERLAND |
HS 646700 |
2022-09-17 |
6 PKG |
1266KG |
6 PALLETS 528 CARTON S PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 10MG 1000 N DC CODE:68462026210 61 J C A 16 3004.49.00.10 79172 TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 10MG 90 NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO. : 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEAS E ROSUVASTATIN TAB 20MG 100 0 NDC CODE:68462026310 FDA P RODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT HIGH CHOLESTERO L AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR D ISEASE S/BILL NO: 3585308 D T 18-AUG-2022 COMMERCIAL & CUSTOM INVOICE NO. F223520021 48 DT. 17.08.2022 NET WT. 1,0 33.52 KGS 06 DATA LOGGERS H UMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPE CIALTY S.A. SWITZERLAND (GSSA ) PLACE NUMA-DROZ 2 NEUCHATE L - 2000 SWITZERLAND |
HS 611600 |
2022-09-17 |
29 PKG |
7323.83KG |
29 PALLETS 1735 CARTONS PHARMACEUTICALS AS UNDER P RAVASTATIN SOD TAB 20MG 500 N DC CODE:68462019605 FDA PRODU CT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE US E:-HYPOLIPDAEMIC TELMISARTA N-HCTZ TAB 80MG/25MG 30UD NDC CODE:68462084213 62 O D A 09 3004.90.92.20 202544 TELMI SARTAN AND HYDROCHLOROTHIAZID E TABLETS ARE INDICATED FOR THE TREATMENT OF HYPERTENSIO N, TO LOWER BLOOD PRESSURE. GABAPENTIN TAB 600MG 500 ND C CODE:68462012605 FDA PRODUC T CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-662 THERAPEUTICE USE: -ANTICONVULSANT AGENT TACR OLIMUS CAP 5MG 100 NDC CODE:6 8462068701 HTS NO: 3004.90.92 .15 FDA CODE : 64 T C E 08 A NDA NO.206662 THERAPEUTICE US E: TO PREVENT REJECTION OF A KIDNEY, HEART, OR LIVER TRAN SPLANT TACROLIMUS CAP 0.5MG 100 NDC CODE:68462068501 TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA N O.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IM MUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERA TE-TO-SEVERE ATOPIC DERMATITI S (ECZEMA). GABAPENTIN TAB 600MG 500 NDC CODE:684620126 05 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90 .92.30 ANDA NO.:-77-662 THER APEUTICE USE:-ANTICONVULSANT AGENT S/BILL NO: 4011872 D T: 18.08.2022 S/BILL NO: 4011 873 DT: 18.08.2022 S/BILL NO: 4011875 DT: 18.08.2022 S/BIL L NO: 4011876 DT: 18.08.2022 S/BILL NO: 4011874 DT: 18.08.2 022 COMMERCIAL & CUSTOM INV OICE NO. F22387000791 DT. 17. 08.2022 F22387000792 DT. 17.0 8.2022 F22387000800 DT. 18.08 .2022 F22387000801 DT. 18.08. 2022 F22387000802 DT. 18.08.2 022 NET WT. 5,390.43 KGS 0 2 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 300490 |
2022-09-06 |
45 PKG |
10915.88KG |
45 PALLETS 3589 CART ONS PHARMACEUTICALS AS UNDER TOPIRAMATE TAB 50MG 500 ND C CODE:68462015305 FDA PRODUC T CODE NO.: 61 M C A 40 H. T . S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVULSANT TELMISARTAN TAB 20MG 30 NDC CODE:6846201 9930 FDA PRODUCT CODE NO.: 6 2 O C A 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.:090032 TH ERAPEUTICE USE: INDICATED FOR THE TREATMENT OF HYPERTENSI ON, TO LOWER BLOOD PRESSURE TELMISARTAN TAB 80MG 30 NDC CODE:68462020130 HTS NO : 30 04.90.92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAP EUTICE USE : INDICATED FOR TH E TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE T ROSPIUM CL TAB 20MG 60 NDC CO DE:68462046160 FDA PRODUCT CO DE NO.:-61 K C A 69 H. T. S NO.: 3004.49.00.70 ANDA NO.: -91-575 THERAPEUTICE USE:- T REATMENT OF VENOUS DISEASES U RINARY INCONTINENCE THERAPY TOPIRAMATE TAB 50MG 60 NDC CODE:68462015360 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA N O.:- 77-627 THERAPEUTICE USE :-ANTICONVULSANT NAPROXEN T AB 500MG 100 NDC CODE:6846201 9001 FDA PRODUCT CODE NO.:-6 2 G C A 49 H. T. S NO.: 3004 .90.92.40 ANDA NO.:-78-250 T HERAPEUTICE USE:-ANTI-INFLAMM ATORY, ANALGESIC NAPROXEN TAB 500MG 500 NDC CODE:684620 19005 FDA PRODUCT CODE NO.:- 62 G C A 49 H. T. S NO.: 300 4.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAM MATORY, ANALGESIC COMMERCI AL & CUSTOM INVOICE NO. F2235 2002009 DT. 06.08.2022 S/BILL NO: 3379283 DT 08-AUG-2022 N ET WT. 8,544.06 KGS 02 DATA LOGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2022-09-06 |
24 PKG |
5486.29KG |
24 PALLETS 1568 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 600MG 500 NDC CO DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT FLUCONAZ OLE TAB 100MG 30 NDC CODE:684 62010230 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90.92.45 ANDA NO.:-77 - 253 THERAPEUTICE USE:-ANTIFU NGAL OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 F DA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 A NDA NO.: 91672 THERAPEUTICE U SE: - TREATMENT OF TREAT GAS TROESOPHAGEAL REFLUX DISEASE FLUCONAZOLE TAB 150MG 12UD NDC CODE:68462011944 NDC COD E : 68462011944 HTS NO : 300 4.90.92.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 THE RAPEUTICE USE : ANTIFUNGAL VERAPAMIL HCL ER TAB 180MG 10 0 NDC CODE:68462029301 FDA P RODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - ANGINA TOPIRAMATE TAB 50MG 500 NDC CODE:6846201 5305 FDA PRODUCT CODE NO.: 6 1 M C A 40 H. T. S NO.: 3004 .49.00.20 ANDA NO.:077627 TH ERAPEUTICE USE: ANTICONVULSAN T CARVEDILOL TAB 6.25MG 100 NDC CODE:68462016301 FDA PR ODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 A NDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR A NTAGONIST S/BILL NO: 3333 252 DT 05-AUG-2022 S/BILL NO: 3333495 DT 05-AUG-2022 S/BIL L NO: 3281023 DT 03-AUG-2022 S/BILL NO: 3333411 DT 05-AUG-2 022 S/BILL NO: 3333412 DT 05- AUG-2022 COMMERCIAL & CUS TOM INVOICE NO. F22352001989 DT. 05.08.2022 F22352001990 D T. 05.08.2022 F22352001914 DT . 31.07.2022 F22352001941 DT. 31.07.2022 F22352001945 DT. 31.07.2022 NET WT. 4,589.97 KGS 02 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2022-09-06 |
22 PKG |
4896.61KG |
22 PALLETS 1457 CARTONS PH ARMACEUTICALS AS UNDER ADAP ALENE-BPO GEL PUMP 0.1/2.5% 45 GM NDC CODE:68462030147 FDA PRODUCT CODE NO.: 62 S D O 02 H. T. S NO.: 3004.90.92.45 ANDA NO.: 208108 THERAPEUTIC E USE: - USED ON THE SKIN TO TREAT ACNE CICLOPIROX GEL 0.77% 30GM NDC CODE:684620455 35 FDA PRODUCT CODE NO.: 61W CJ43 H. T. S NO.: 3004.49.00 .50 ANDA NO.: 091595 THERAPE UTICE USE: - ANTIFUNGAL VE RAPAMIL HCL ER TAB 120MG 100 NDC CODE:68462029201 FDA PROD UCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 AND A NO.: 90-700 THERAPEUTICE US E: - ANGINA ACAMPROSATE CA LCIUM DR TAB 333MG 180 NDC CO DE:68462043518 FDA PRODUCT CO DE NO.: 60 T C C 99 H. T. S NO.: 3004.90.92.40 ANDA NO.: 202229 THERAPEUTICE USE: - FO R TREATING ALCOHOL DEPENDENC E ONDANSETRON ODT 8MG 30UD NDC CODE:68462015813 FDA PRO DUCT CODE.:-61 T C A 26 H. T . S NO.: 3004.90.92.40 ANDA NO.:-78-152 THERAPEUTICE USE: -ANTI EMETIC S/BILL NO: 33 33253 DT 05-AUG-2022 S/BILL N O: 3333481 DT 05-AUG-2022 S/B ILL NO: 3333256 DT 05-AUG-2022 COMMERCIAL & CUSTOM INVO ICE NO. F22352001976 DT. 04.0 8.2022 F22352001978 DT. 04.08 .2022 F22352001980 DT. 04.08. 2022 NET WT. 3,967.74 KGS D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 620200 |
2022-09-06 |
31 PKG |
6516.87KG |
31 PALLETS 1774 CART ONS PHARMACEUTICALS AS UNDER HEATHER TAB 0.35MG 84 NDC CODE:68462030329 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO .:90-454 THERAPEUTICE USE: P REVENTION OF PREGNANCY. ROP INIROLE TAB 0.5MG 100 NDC COD E:68462025401 FDA PRODUCT COD E NO.:-62 J C A 17 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TR EATMENT OF PARKINSONISM VE RAPAMIL HCL ER TAB 180MG 100 NDC CODE:68462029301 FDA PROD UCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 AND A NO.: 90-700 THERAPEUTICE US E: - ANGINA VERAPAMIL HCL ER TAB 180MG 500 NDC CODE:684 62029305 FDA PRODUCT CODE NO. : 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-70 0 THERAPEUTICE USE: - ANGINA TOPIRAMATE TAB 200MG 1000 NDC CODE:68462011010 FDA PRO DUCT CODE NO.:-61 M C A 40 H . T. S NO.: 3004.49.00.20 AN DA NO.:- 77-627 THERAPEUTICE USE:-ANTICONVULSANT ONDANS ETRON ODT 8MG 30UD NDC CODE:6 8462015813 FDA PRODUCT CODE.: -61 T C A 26 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-152 THERAPEUTICE USE:-ANTI EMET IC THEOPHYLLINE ER TAB 400M G 100 NDC CODE:68462038001 F DA PRODUCT CODE NO.: 63 B C B 30 H. T. S NO.: 3004.90.92. 85 ANDA NO.: 90-355 THERAPEU TICE USE: XANTHINE BRONCHODIL ATOR S/BILL NO: 3470039 DT 12-AUG-2022 S/BILL NO: 347790 5 DT 12-AUG-2022 COMMER CIAL & CUSTOM INVOICE NO. F22 352002059 DT. 11.08.2022 F223 52002062 DT. 11.08.2022 NET WT. 5,253.38 02 DATA LOGGER S NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 652400 |
2022-09-06 |
42 PKG |
8450.11KG |
42 PALLETS 2016 CARTONS PHARMACEUTICALS AS UNDER MUPIROCIN OINT 2% 22GM NDC CO DE:68462018022 FDA PRODUCT CO DE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL HEATHER TAB 0.35MG 84 NDC CODE:6846203032 9 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO.: 3006.60 .00.00 ANDA NO.:90-454 THERA PEUTICE USE: PREVENTION OF PR EGNANCY. TOPIRAMATE TAB 200 MG 60 NDC CODE:68462011060 F DA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00. 20 ANDA NO.:- 77-627 THERAPE UTICE USE:-ANTICONVULSANT TOPIRAMATE TAB 50MG 500 NDC C ODE:68462015305 FDA PRODUCT C ODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :077627 THERAPEUTICE USE: AN TICONVULSANT TOPIRAMATE TAB 50MG 60 NDC CODE:68462015360 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49. 00.20 ANDA NO.:- 77-627 THER APEUTICE USE:-ANTICONVULSANT S/BILL NO: 3433202 DT. 10-A UG-2022 S/BILL NO: 3433204 DT . 10-AUG-2022 S/BILL NO: 3433 201 DT. 10-AUG-2022 COMME RCIAL & CUSTOM INVOICE NO. F2 2352002030 DT. 09.08.2022 F22 352002032 DT. 09.08.2022 F223 52002038 DT. 09.08.2022 NET W T. 6,669.26 KGS 02 DATA LOGG ERS NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 652400 |
2022-08-30 |
2 PKG |
415.95KG |
2 PALLETS 39 CARTONS P HARMACEUTICALS AS UNDER A CYCLOVIR OINT 5% 15GM NDC CO DE:68462074617 FDA PRODUCT C ODE NO.: 62 V C J 18 H. T. S NO.: 3004.49.00.50 ANDA NO.: 205510 THERAPEUTICE US E: - AN ANTIVIRAL MEDICINE U SED TO TREAT OR PREVENT INFE CTIONS CAUSED BY CERTAIN KIN DS OF VIRUSES. EXAMPLES OF THESE INFECTIONS INCLUDE HE RPES AND SHINGLES COMMERC IAL & CUSTOM INVOICE NO. F22 352001903 DT. 31.07.2022 S/B ILL NO: 3281607 DT 03-AUG-2022 NET WT. 296.45 KGS 02 DATA LOGGERS NOTIFY PAR TY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 210690 |
2022-08-30 |
6 PKG |
1176.64KG |
6 PALLETS 167 CARTONS PHA RMACEUTICALS AS UNDER OMEPR AZOLE DR CAP 40MG 1000 NDC CO DE:68462039710 FDA PRODUCT CO DE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE USE: - TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352001 944 DT. 31.07.2022 S/BILL NO: 3293966 DT:04.08.2022 NET W T. 977.952 KGS 01 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 290719 |
2022-08-30 |
19 PKG |
3503.15KG |
19 PALLETS 685 CARTONS PHA RMACEUTICALS AS UNDER CLOBE TASOL PROP SOLN 0.05% 50ML ND C CODE:68462053253 FDA PRODUC T CODE NO.: 64 L C L 67 H. T . S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTE RILE LIQUID / CLOBETASOL PROP IONATE (GLUCOCORTICOID) MO METASONE FURO CREAM 0.1% 45GM NDC CODE:68462019255 FDA PRO DUCT CODE NO.: 62 F C J 53 H . T. S NO.: 3004.40.49.50 AN DA NO.:78-541 THERAPEUTICE US E: ANTI-INFLAMMATORY- DERMAT OLOGIC MOMETASONE FURO SOLN 0.1% 30ML NDC CODE:684620385 37 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.9 0.92.45 ANDA NO.:090506 THER APEUTICE USE: MOMETASONE FURO ATE TOPICAL SOLUTION (LOTION) IS A CORTICOSTEROID INDICAT ED FOR THE RELIEF OF THE INF LAMMATORY AND PRURITIC MANIFE STATIONS OF CORTICOSTEROID-RE SPONSIVE DERMATOSES IN PATIEN TS #12 YEARS OF AGE. NYST ATIN-TRIAM 100K UNIT/0.1% OINT 30GM NDC CODE:68462079935 F DA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 208300 THERAPEU TICE USE: - TREATMENT OF FUNG AL INFECTIONS OF THE SKIN, E SPECIALLY YEAST INFECTIONS. BETAMETHASONE DIP AUG CREAM 0.05% 50GM NDC CODE:684620290 52 FDA PRODUCT CODE NO.: 64 L C J 06 H. T. S NO.: 3004.9 0.92.45 ANDA NO.:78-930 THER APEUTICE USE: DERMALOGIC USE COMMERCIAL & CUSTOM INVOICE NO. F22335001760 DT. 25.07.2 022 F22335001813 DT. 28.07.20 22 S/BILL NO: 3061458 DT:25-J UL-22 S/BILL NO: 3197122 DT 3 0-JUL-2022 NET WT. 1,642.46 19 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 646700 |
2022-08-30 |
15 PKG |
2373.24KG |
15 PALLETS 466 CARTONS PHA RMACEUTICALS AS UNDER CLOBE TASOL PROP CREAM 0.05% 45GM N DC CODE:68462052947 FDA PRODU CT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209095 THERAPEUTICE USE : - CLOBETASOL PROPIONATE CR EAM IS A SUPER-HIGH POTENCY C ORTICOSTEROID FORMULATIONS IN DICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC M ANIFESTATIONS OF CORTICOSTERO ID-RESPONSIVE DERMATOSES C LOBETASOL PROP CREAM 0.05% 60G M NDC CODE:68462052965 FDA P RODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209095 THERAPEUTICE USE: - CLOBETASOL PROPIONATE CREAM IS A SUPER-HIGH POTEN CY CORTICOSTEROID FORMULATION S INDICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITI C MANIFESTATIONS OF CORTICOS TEROID-RESPONSIVE DERMATOSES CLOBETASOL PROP CREAM 0.05% 60GM NDC CODE:68462052965 F DA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 209095 THERAPEU TICE USE: - CLOBETASOL PROPIO NATE CREAM IS A SUPER-HIGH P OTENCY CORTICOSTEROID FORMULA TIONS INDICATED FOR THE RELIE F OF THE INFLAMMATORY AND PRU RITIC MANIFESTATIONS OF CORT ICOSTEROID-RESPONSIVE DERMATO SES CLOBETASOL PROP OINT 0. 05% 15GM NDC CODE:68462053017 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 208933 THERA PEUTICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMMATOR Y AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DERMATOESE CLOBETASOL PRO P OINT 0.05% 30GM NDC CODE:68 462053035 FDA PRODUCT CODE NO .: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 2089 33 THERAPEUTICE USE: - INDIC ATED FOR THE RELIEF OF THE IN FLAMMATORY AND PRURITIC MANIF ESTATIONS OF CORTICOSTEROID-R ESPONSIVE DERMATOESE CLOBE TASOL PROP OINT 0.05% 45GM ND C CODE:68462053047 FDA PRODUC T CODE NO.: 64 L C J 67 H. T . S NO.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTICE USE: - INDICATED FOR THE RELIEF O F THE INFLAMMATORY AND PRURI TIC MANIFESTATIONS OF CORTICO STEROID-RESPONSIVE DERMATOESE COMMERCIAL & CUSTOM INVOIC E NO. F22335001761 DT. 25.07. 2022 F22335001814 DT. 28.07.2 022 F22335001815 DT. 28.07.20 22 S/BILL NO: 3074961 DT:26-J UL-22 S/BILL NO: 3197086 DT:3 0-JUL-22 S/BILL NO: 3197060 D T:30-JUL-22 NET WT. 1,136.88 13 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 646700 |
2022-08-30 |
7 PKG |
1557.21KG |
7 PALLETS 434 CARTONS P HARMACEUTICALS AS UNDER NIT ROGLYCERIN SUBLING TAB 0.4MG 1 00 NDC CODE:68462063901 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEUTICE USE: MEDICATION USED FOR HE ART FAILURE, HIGH BLOOD PRESS URE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTENOUGH BLO OD FLOW TO THE HEART SOLIF ENACIN SUCCINATE TAB 10MG 90 NDC CODE:68462038790 FDA PROD UCT CODE NO.: 61 KCA 72 H. T . S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLA DDER WITH SYMPTOMS OF URGE UR INARY INCONTINENCE, URGENCY AND URINARY FREQUENCY S/BIL L NO: 4011169 DT:02.08.2022 COMMERCIAL & CUSTOM I NVOICE NO. F22387000688 DT. 3 1.07.2022 NET WT. 269.40 0 7 DATA LOGGERS NOTIFY PAR TY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUM A-DROZ 2 NEUCHATEL - 2000 SW ITZERLAND |
HS 662800 |
2022-08-30 |
40 PKG |
6073.25KG |
40 PALLETS 1993 CART ONS PHARMACEUTICALS AS UNDER DROSPIRENONE/EE TAB 3/0.02M G 84 NDC CODE:68462072029 FD A PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.0 0 ANDA NO.: 204296 THERAPEUT ICE USE: - ORAL CONTRACEPTIVE NORETH ACE/EE TAB 1/0.02MG 63 NDC CODE:68462013281 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.:206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA ,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING S/BILL NO : 3228404 DT 01-AUG-2022 S/B ILL NO: 3228369 DT 01-AUG-202 2 COMMERCIAL & CUSTOM INV OICE NO. F22352001902 DT. 31. 07.2022 F22352001922 DT. 31.0 7.2022 NET WT. 4,249.19 02 DATA LOGGERS NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 653900 |
2022-08-30 |
18 PKG |
3494.08KG |
18 PALLETS 888 CARTONS P HARMACEUTICALS AS UNDER HAI LEY 1.5/30 TAB 1.5MG/30MCG 63 NDC CODE:68462050481 FDA PRO DUCT CODE NO.: 65 J D A 25 H . T. S NO.: 3006.60.00.00 AN DA NO.: 209297 THERAPEUTICE U SE: - CONTRACEPTION TO PREVEN T PREGNANCY S/BILL NO: 32 54130 DT 02-AUG-2022 COMM ERCIAL & CUSTOM INVOICE NO. F 22352001938 DT. 31.07.2022 NE T WT. 2,619.24 18 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES NOTIFY PARTY:2 GLEN MARK SPECIALTY S.A. SWITZERLA ND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 652500 |
2022-08-30 |
42 PKG |
9665.76KG |
42 PALLETS 2270 CARTONS PHARMACEUTICALS AS UNDER CARVEDILOL TAB 12.5MG 500 NDC CODE:68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA N O.:- 78-251 THERAPEUTICE USE :-BETA- ADRENOACEPTOR ANTAGO NIST NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PR ODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 A NDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMATORY, ANAL GESIC POTASSIUM CL ER TAB 1 0MEQ 100 NDC CODE:68462047101 FDA PRODUCT CODE NO.: 65 R C A 14 H. T. S NO.: 3004.90. 9190 ANDA NO.: 203562 THIS M EDICATION IS A MINERAL SUPPLE MENT USED TO TREAT OR PREVENT LOW AMOUNTS OF POTASSIUM IN THE BLOOD.SOME CONDITIONS TH AT CAN LOWER YOUR BODY S POTA SSIUM LEVEL INCLUDE SEVERE P ROLONGED DIARRHEA AND VOMITIN G, HORMONE PROBLEMS SUCH AS HYPERALDOSTERONISM, OR TREATM ENT WITH WATER PILLS /DIURET ICS. NORETHINDRONE TAB 0.35 MG 84 NDC CODE:68462030529 F DA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00. 00 ANDA NO.:91-209 THERAPEUT ICE USE: PREVENTION OF PREGNA NCY. ASHLYNA TAB 0.15/0.03M G-0.01MG 182 NDC CODE:6846206 4693 FDA PRODUCT CODE NO.: 6 4 G D A 2 H. T. S NO.: 3006. 60.0000 ANDA NO.: 203163 THE RAPEUTICE USE: - INDICATED FO R USE BY WOMEN TO PREVENT PR EGNANCY NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 4 9 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTI CE USE:-ANTI-INFLAMMATORY, A NALGESIC S/BILL NO: 3211 362 DT 01-AUG-2022 S/BILL NO: 3211389 DT 01-AUG-2022 S/BI LL NO: 3211354 DT 01-AUG-2022 COMMERCIAL & CUSTOM INVOIC E NO. F22352001871 DT. 30.07. 2022 F22352001883 DT. 30.07.2 022 F22352001904 DT. 31.07.20 22 NET WT. 8,048.64 02 DAT A LOGGERS NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 622200 |
2022-08-30 |
44 PKG |
10122.99KG |
44 PALLETS 2915 CARTONS P HARMACEUTICALS AS UNDER TEL MISARTAN TAB 80MG 30 NDC CODE :68462020130 HTS NO : 3004.90 .92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAPEUTIC E USE : INDICATED FOR THE TR EATMENT OF HYPERTENSION, TO L OWER BLOOD PRESSURE NAPROX EN TAB 500MG 500 NDC CODE:684 62019005 FDA PRODUCT CODE NO .:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-25 0 THERAPEUTICE USE:-ANTI-INF LAMMATORY, ANALGESIC CARVE DILOL TAB 6.25MG 500 NDC CODE :68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST PRAVASTATIN SOD TAB 40MG 50 0 NDC CODE:68462019705 FDA P RODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: HYPOLIPDAEMIC OXCARB AZEPINE TAB 150MG 100 NDC COD E:68462013701 FDA PRODUCT COD E NO.:-61 M C A 45 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT OMEPRAZO LE DR CAP 20MG 1000 NDC CODE: 68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3 004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL RE FLUX DISEASE TELMISARTAN T AB 80MG 30 NDC CODE:684620201 30 HTS NO : 3004.90.92.20 FD A CODE : 62 O C A 09 ANDA NO. : 90032 THERAPEUTICE USE : I NDICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOO D PRESSURE ONDANSETRON ODT 8MG 30UD NDC CODE:68462015813 FDA PRODUCT CODE.:-61 T C A 26 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-152 THERAPEU TICE USE:-ANTI EMETIC COMM ERCIAL & CUSTOM INVOICE NO. F 22352001881 DT. 30.07.2022 F2 2352001908 DT. 31.07.2022 F22 352001921 DT. 31.07.2022 S/BI LL NO: 3281423 DT 03-AUG-2022 S/BILL NO: 3281025 DT 03-AUG- 2022 S/BILL NO: 3281015 DT 03 -AUG-2022 NET WT. 8,382.31 02 DATA LOGGERS NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2022-08-30 |
6 PKG |
1176.64KG |
6 PALLETS 167 CARTONS PHA RMACEUTICALS AS UNDER OMEPR AZOLE DR CAP 40MG 1000 NDC CO DE:68462039710 FDA PRODUCT CO DE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE USE: - TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352001 944 DT. 31.07.2022 S/BILL NO: 3293966 DT:04.08.2022 NET W T. 977.952 KGS 01 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 290719 |
2022-08-30 |
19 PKG |
3503.15KG |
19 PALLETS 685 CARTONS PHA RMACEUTICALS AS UNDER CLOBE TASOL PROP SOLN 0.05% 50ML ND C CODE:68462053253 FDA PRODUC T CODE NO.: 64 L C L 67 H. T . S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTE RILE LIQUID / CLOBETASOL PROP IONATE (GLUCOCORTICOID) MO METASONE FURO CREAM 0.1% 45GM NDC CODE:68462019255 FDA PRO DUCT CODE NO.: 62 F C J 53 H . T. S NO.: 3004.40.49.50 AN DA NO.:78-541 THERAPEUTICE US E: ANTI-INFLAMMATORY- DERMAT OLOGIC MOMETASONE FURO SOLN 0.1% 30ML NDC CODE:684620385 37 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.9 0.92.45 ANDA NO.:090506 THER APEUTICE USE: MOMETASONE FURO ATE TOPICAL SOLUTION (LOTION) IS A CORTICOSTEROID INDICAT ED FOR THE RELIEF OF THE INF LAMMATORY AND PRURITIC MANIFE STATIONS OF CORTICOSTEROID-RE SPONSIVE DERMATOSES IN PATIEN TS #12 YEARS OF AGE. NYST ATIN-TRIAM 100K UNIT/0.1% OINT 30GM NDC CODE:68462079935 F DA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 208300 THERAPEU TICE USE: - TREATMENT OF FUNG AL INFECTIONS OF THE SKIN, E SPECIALLY YEAST INFECTIONS. BETAMETHASONE DIP AUG CREAM 0.05% 50GM NDC CODE:684620290 52 FDA PRODUCT CODE NO.: 64 L C J 06 H. T. S NO.: 3004.9 0.92.45 ANDA NO.:78-930 THER APEUTICE USE: DERMALOGIC USE COMMERCIAL & CUSTOM INVOICE NO. F22335001760 DT. 25.07.2 022 F22335001813 DT. 28.07.20 22 S/BILL NO: 3061458 DT:25-J UL-22 S/BILL NO: 3197122 DT 3 0-JUL-2022 NET WT. 1,642.46 19 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 646700 |
2022-08-30 |
15 PKG |
2373.24KG |
15 PALLETS 466 CARTONS PHA RMACEUTICALS AS UNDER CLOBE TASOL PROP CREAM 0.05% 45GM N DC CODE:68462052947 FDA PRODU CT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209095 THERAPEUTICE USE : - CLOBETASOL PROPIONATE CR EAM IS A SUPER-HIGH POTENCY C ORTICOSTEROID FORMULATIONS IN DICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC M ANIFESTATIONS OF CORTICOSTERO ID-RESPONSIVE DERMATOSES C LOBETASOL PROP CREAM 0.05% 60G M NDC CODE:68462052965 FDA P RODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209095 THERAPEUTICE USE: - CLOBETASOL PROPIONATE CREAM IS A SUPER-HIGH POTEN CY CORTICOSTEROID FORMULATION S INDICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITI C MANIFESTATIONS OF CORTICOS TEROID-RESPONSIVE DERMATOSES CLOBETASOL PROP CREAM 0.05% 60GM NDC CODE:68462052965 F DA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 209095 THERAPEU TICE USE: - CLOBETASOL PROPIO NATE CREAM IS A SUPER-HIGH P OTENCY CORTICOSTEROID FORMULA TIONS INDICATED FOR THE RELIE F OF THE INFLAMMATORY AND PRU RITIC MANIFESTATIONS OF CORT ICOSTEROID-RESPONSIVE DERMATO SES CLOBETASOL PROP OINT 0. 05% 15GM NDC CODE:68462053017 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 208933 THERA PEUTICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMMATOR Y AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DERMATOESE CLOBETASOL PRO P OINT 0.05% 30GM NDC CODE:68 462053035 FDA PRODUCT CODE NO .: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 2089 33 THERAPEUTICE USE: - INDIC ATED FOR THE RELIEF OF THE IN FLAMMATORY AND PRURITIC MANIF ESTATIONS OF CORTICOSTEROID-R ESPONSIVE DERMATOESE CLOBE TASOL PROP OINT 0.05% 45GM ND C CODE:68462053047 FDA PRODUC T CODE NO.: 64 L C J 67 H. T . S NO.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTICE USE: - INDICATED FOR THE RELIEF O F THE INFLAMMATORY AND PRURI TIC MANIFESTATIONS OF CORTICO STEROID-RESPONSIVE DERMATOESE COMMERCIAL & CUSTOM INVOIC E NO. F22335001761 DT. 25.07. 2022 F22335001814 DT. 28.07.2 022 F22335001815 DT. 28.07.20 22 S/BILL NO: 3074961 DT:26-J UL-22 S/BILL NO: 3197086 DT:3 0-JUL-22 S/BILL NO: 3197060 D T:30-JUL-22 NET WT. 1,136.88 13 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 646700 |
2022-08-30 |
20 PKG |
4173.12KG |
20 PALLETS 1236 CARTONS PHARMACEUTICALS AS UNDER I NDOMETHACIN ER CAP 75MG 90 ND C CODE:68462032590 H. T. S NO .: 3004.90.92.40 CARVEDILO L TAB 25MG 500 NDC CODE:68462 016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 30 04.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST TEL MISARTAN-HCTZ TAB 40MG/12.5MG 30UD NDC CODE:68462084013 62 O D A 09 3004.90.92.20 2025 44 TELMISARTAN AND HYDROCHLO ROTHIAZIDE TABLETS ARE INDICA TED FOR THE TREATMENT OF HY PERTENSION, TO LOWER BLOOD PR ESSURE. PRAVASTATIN SOD TAB 40MG 500 NDC CODE:6846201970 5 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90 .92.20 ANDA NO.: 77-987 THER APEUTICE USE: HYPOLIPDAEMIC COMMERCIAL & CUSTOM INVOICE NO. F22387000659 DT. 28.07.20 22 F22387000661 DT. 29.07.202 2 F22387000664 DT. 29.07.2022 S/BILL NO: 4010895 DT.29/07/ 2022 S/BILL NO: 4010893 DT.29 /07/2022 S/BILL NO: 4010887 D T.29/07/2022 NET WT. 2,655.0 0 05 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 622200 |
2022-08-30 |
2 CTN |
415.95KG |
39 CARTONS PHARMACEUTICA LS AS UNDER ACYCLOVIR OIN T 5% 15GM NDC CODE:684620746 17 FDA PRODUCT CODE NO.: 6 2 V C J 18 H. T. S NO.: 30 04.49.00.50 ANDA NO.: 205510 THERAPEUTICE USE: - AN AN TIVIRAL MEDICINE USED TO TRE AT OR PREVENT INFECTIONS CAU SED BY CERTAIN KINDS OF VIRU SES. EXAMPLES OF THESE INFEC TIONS INCLUDE HERPES AND SHI NGLES COMMERCIAL & CUSTOM INVOICE NO. F22352001903 DT . 31.07.2022 S/BILL NO: 3281 607 DT 03-AUG-2022 NET WT. 296.45 KGS 02 DATA LOGGER S HUMIDITY:65% SET TEMPERA TURE : +18 DEGREES TEMPERATU RE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZER LAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZER LAND |
HS 621800 |
2022-08-24 |
42 PKG |
7355.12KG |
42 PALLETS 2440 CARTONS PHARMACEUTICALS AS UNDER S OLIFENACIN SUCCINATE TAB 5MG 9 0 NDC CODE:68462038690 FDA P RODUCT CODE NO.: 61 KCA 72 H . T. S NO.: 3004 49 00 70 AN DA NO.: 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENC Y AND URINARY FREQUENCY SO LIFENACIN SUCCINATE TAB 5MG 30 NDC CODE:68462038630 FDA PR ODUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 AND A NO.: 209239 INDICATED FOR T HE TREATMENT OF OVERACTIVE B LADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENCY AND URINARY FREQUENCY SOL IFENACIN SUCCINATE TAB 5MG 30 NDC CODE:68462038630 FDA PRO DUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICATED FOR TH E TREATMENT OF OVERACTIVE BL ADDER WITH SYMPTOMS OF URGE U RINARY INCONTINENCE, URGENCY AND URINARY FREQUENCY APRE PITANT CAP 125-80MG 3UOU NDC CODE:68462011233 HTS NO : 300 4.90.92.40 FDA CODE : 61 T C E 32 ANDA NO : 207777 THERAP EUTICE USE : APREPITANT IS US ED WITH OTHER MEDICATIONS TO HELP PREVENT VOMITING CAUSED BY CANCER DRUG TREATMENT A PREPITANT CAP 125-80MG 3UOU N DC CODE:68462011233 HTS NO : 3004.90.92.40 FDA CODE : 61 T C E 32 ANDA NO : 207777 THE RAPEUTICE USE : APREPITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVENT VOMITING CAUS ED BY CANCER DRUG TREATMENT NITROGLYCERIN SUBLING TAB 0. 4MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90. 9020 ANDA NO.:206391 THERAPE UTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PR ESSURE,AND TO TREAT AND PREVE NT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART A PREPITANT CAP 40MG 1UD NDC CO DE:68462058340 FDA PRODUCT CO DE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE: AP REPITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NA USEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOT HERAPY). THIS MEDICATION IS A LSO USED TO PREVENT NAUSEA AN D VOMITING AFTER SURGERY. A- EMETIC/NAUSEANT / HUMAN - RX/ SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT COMMERCIAL & CUSTOM INVOICE NO. F22387000633 DT. 26.07.2 022 F22387000634 DT. 26.07.20 22 F22387000635 DT. 26.07.202 2 F22387000636 DT. 26.07.2022 F22387000637 DT. 26.07.2022 F22387000638 DT. 26.07.2022 F22387000641 DT. 27.07.2022 N ET WT. 430.79 KGS 42 DATA L OGGERS HUMIDITY:65% SET TEMP ERATURE : +18 DEGREES TEMPERA TURE RANGE : +15 DEGREES TO +2 5 DEGREES NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 300490 |
2022-08-24 |
41 PKG |
6179.85KG |
41 PALLETS 2111 CARTONS PH ARMACEUTICALS AS UNDER ON DANSETRON ODT 4MG 30UD NDC C ODE:68462015713 FDA PRODUCT CODE NO,:-61 T C A 26 H. T . S NO.: 3004.90.92.40 AND A NO.:-78-152 THERAPEUTICE U SE:-ANTI EMETIC CICLOPI ROX OLAMINE CREAM 0.77% 15GM NDC CODE:68462029717 FDA PR ODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 ANDA NO.:- 90 - 273 THERA PEUTICE USE:-ANTIFUNGAL USE. NORETHINDRONE TAB 0.35MG 84 NDC CODE:68462030529 F DA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60. 00.00 ANDA NO.:91-209 THER APEUTICE USE: PREVENTION OF PREGNANCY. LEVONORGESTREL /EE TAB 0.15/0.03MG 273 NDC CODE:68462067295 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 AND A NO.: 203164 THERAPEUTICE U SE: - CONTRACEPTION TO PREVE NT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F22352 001724 DT. 23.07.2022 F22352 001725 DT. 23.07.2022 F22352 001727 DT. 23.07.2022 F22352 001730 DT. 23.07.2022 S/BILL NO:3020205 DT 23-JUL-2022 S /BILL NO:3020148 DT 23-JUL-202 2 S/BILL NO:3031164 DT 23-JU L-2022 S/BILL NO:3031161 DT 23-JUL-2022 NET WT. 4,581.2 3 KGS 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 612600 |
2022-08-24 |
3 PKG |
462.22KG |
3 PALLETS 145 CARTONS PHA RMACEUTICALS AS UNDER CLI NDAMYCIN-BPO GEL PUMP 1%/5% 35 GM NDC CODE:68462085924 FD A PRODUCT CODE NO.: 61 H D J 99 H. T. S NO.: 3004.49.0 0.50 ANDA NO.: #209252 THE RAPEUTICE USE: CLINDAMYCIN A ND BENZOYL PEROXIDE GEL IS I NDICATED FOR THE TOPICAL T REATMENT OF ACNE VULGARIS. COMMERCIAL & CUSTOM INVOIC E NO. F22352001726 DT. 23.07 .2022 S/BILL NO:3020288 DT 2 3-JUL-2022 NET WT. 368.30 KGS 03 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPEC IALTY S.A. SWITZERLAND (GSSA ) PLACE NUMA-DROZ 2 NEUCHA TEL - 2000 SWITZERLAND |
HS 619900 |
2022-08-24 |
13 PKG |
4444.37KG |
13 PALLETS 653 CARTONS PHA RMACEUTICALS AS UNDER GABAP ENTIN TAB 600MG 500 NDC CODE: 68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICO NVULSANT AGENT ADAPALENE-B PO GEL PUMP 0.1/2.5% 45GM NDC CODE:68462030147 FDA PRODUCT CODE NO.: 62 S D O 02 H. T. S NO.: 3004.90.92.45 ANDA N O.: 208108 THERAPEUTICE USE: - USED ON THE SKIN TO TREAT ACNE COMMERCIAL & CUSTOM IN VOICE NO. F22352001830 DT. 28 .07.2022 F22352001831 DT. 28. 07.2022 S/BILL NO: 3150836 DT 29-JUL-2022 S/BILL NO: 31508 40 DT 29-JUL-2022 NET WT. 3, 956.58 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 616900 |
2022-08-24 |
43 PKG |
7155.09KG |
43 PALLETS 2536 CARTONS PH ARMACEUTICALS AS UNDER ONDANS ETRON ODT 4MG 30UD NDC CODE:6 8462015713 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 152 THERAPEUTICE USE:-ANTI E METIC ROPINIROLE TAB 1MG 10 0 NDC CODE:68462025501 FDA P RODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTIC E USE:-TREATMENT OF PARKINSO NISM VERAPAMIL HCL ER TAB 2 40MG 100 NDC CODE:68462026001 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90. 92.20 ANDA NO.:-78-906 THERA PEUTICE USE:-ANGINA NORETH INDRONE TAB 0.35MG 84 NDC COD E:68462030529 FDA PRODUCT COD E NO.: 65 J C A 26 H. T. S N O.: 3006.60.00.00 ANDA NO.:9 1-209 THERAPEUTICE USE: PREV ENTION OF PREGNANCY. LEVONO RGESTREL/EE TAB 0.15/0.03MG 27 3 NDC CODE:68462067295 FDA P RODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 A NDA NO.: 203164 THERAPEUTICE USE: - CONTRACEPTION TO PREVE NT PREGNANCY LEVONORGESTRE L/EE TAB 0.15/0.03MG 273 NDC CODE:68462067295 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO. : 203164 THERAPEUTICE USE: - CONTRACEPTION TO PREVENT PRE GNANCY COMMERCIAL & CUSTOM INVOICE NO. F22352001736 DT. 23.07.2022 F22352001756 DT. 2 5.07.2022 F22352001764 DT. 25 .07.2022 S/BILL NO: 3054139 D T 25-JUL-2022 S/BILL NO: 3054 132 DT 25-JUL-2022 S/BILL NO: 3061440 DT 25-JUL-2022 NET W T. 5529.35 KGS 02 DATA LOGGER S NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 612600 |
2022-08-24 |
28 PKG |
7543.82KG |
28 PALLETS 2006 CARTONS PH ARMACEUTICALS AS UNDER NAPR OXEN TAB 500MG 500 NDC CODE:6 8462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78- 250 THERAPEUTICE USE:-ANTI-I NFLAMMATORY, ANALGESIC OME PRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO .: 3004.90.9160 ANDA NO.: 91 672 THERAPEUTICE USE: - TREA TMENT OF TREAT GASTROESOPHAGE AL REFLUX DISEASE CARVEDIL OL TAB 3.125MG 500 NDC CODE:6 8462016205 FDA PRODUCT CODE N O ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78 -251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST PRAVASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PRO DUCT CODE NO.: 61 J C A 13 H . T. S NO.: 3004.90.92.20 AN DA NO.: 77-987 THERAPEUTICE U SE: HYPOLIPDAEMIC COMMERCI AL & CUSTOM INVOICE NO. F2235 2001832 DT. 28.07.2022 S/BILL NO: 3151435 DT 29-JUL-2022 N ET WT. 6,590.72 KGS 01 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 624900 |
2022-08-24 |
25 PKG |
5927.64KG |
25 PALLETS 1286 CARTONS PH ARMACEUTICALS AS UNDER NORE THINDRONE TAB 0.35MG 84 NDC C ODE:68462030529 FDA PRODUCT C ODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO. :91-209 THERAPEUTICE USE: PR EVENTION OF PREGNANCY. GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F223520 01849 DT. 29.07.2022 F2235200 1850 DT. 29.07.2022 S/BILL NO : 3172267 DT 29-JUL-2022 S/BI LL NO: 3172297 DT 29-JUL-2022 NET WT. 4,958.50 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 684620 |
2022-08-24 |
11 PKG |
2666.26KG |
11 PALLETS 1139 CARTONS PHARMACEUTICALS AS UNDER C LINDAMYCIN-BPO GEL PUMP 1%/5% 50GM NDC CODE:68462085927 FD A PRODUCT CODE NO.: 61 H D J 99 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: #209252 THERAPEU TICE USE: #CLINDAMYCIN AND B ENZOYL PEROXIDE GEL IS INDICA TED FOR THE TOPICAL TREATMENT OF ACNE VULGARIS. ROSUVAS TATIN TAB 40MG 500 NDC CODE:6 8462026405 61 J C A 16 3004. 49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED COND ITIONS, AND TO PREVENT CARDI OVASCULAR DISEASE ROSUVASTA TIN TAB 40MG 30 NDC CODE:6846 2026430 FDA PRODUCT CODE NO. :61 J C A 16 H. T. S NO.: 30 04.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE COMM ERCIAL & CUSTOM INVOICE NO. F 22352001786 DT. 26.07.2022 F2 2352001788 DT. 26.07.2022 S/B ILL NO:3088241 DT 27-JUL-2022 S/BILL NO:3088253 DT 27-JUL-2 022 11 DATA LOGGERS HUMIDITY :65% SET TEMPERATURE : +18 DE GREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIF Y PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND |
HS 619900 |
2022-08-24 |
37 PKG |
9953.8KG |
37 PALLETS 2122 CARTONS PHARMACEUTICALS AS UNDER V ERAPAMIL HCL ER TAB 240MG 100 NDC CODE:68462026001 FDA PRO DUCT CODE NO.: 62 O C B 13 H . T. S NO.: 3004.90.92.20 AN DA NO.:-78-906 THERAPEUTICE USE:-ANGINA VERAPAMIL HCL E R TAB 240MG 500 NDC CODE:6846 2026005 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3 004.90.92.20 ANDA NO.:-78-906 THERAPEUTICE USE:-ANGINA MUPIROCIN CREAM 2% 15GM NDC CODE:68462056417 FDA PRODUCT CODE NO.: 61GCJ82 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 01587 THERAPEUTICE USE: - TO PICAL ANTI-BACTERIAL MUPIRO CIN CREAM 2% 30GM NDC CODE:68 462056435 FDA PRODUCT CODE NO .: 61GCJ82 H. T. S NO.: 300 4.90.92.45 ANDA NO.: 201587 THERAPEUTICE USE: - TOPICAL A NTI-BACTERIAL OMEPRAZOLE DR CAP 40MG 100 NDC CODE:684620 39701 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90 .9160 ANDA NO.: 91672 THERAP EUTICE USE: - TREATMENT OF TR EAT GASTROESOPHAGEAL REFLUX DISEASE ROPINIROLE TAB 4MG 100 NDC CODE:68462025801 FDA PRODUCT CODE NO.:-62 J C A 1 7 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUT ICE USE:-TREATMENT OF PARKIN SONISM OMEPRAZOLE DR CAP 40 MG 90 NDC CODE:68462039790 F DA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 A NDA NO.: 91672 THERAPEUTICE U SE: - TREATMENT OF TREAT GAS TROESOPHAGEAL REFLUX DISEASE GABAPENTIN TAB 600MG 500 N DC CODE:68462012605 FDA PRODU CT CODE NO: 61 N C A 69 H. T . S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE :-ANTICONVULSANT AGENT COM MERCIAL & CUSTOM INVOICE NO. F22352001740 DT. 24.07.2022 F 22352001742 DT. 24.07.2022 F2 2352001784 DT. 26.07.2022 F22 352001787 DT. 26.07.2022 S/BI LL NO:3088255 DT 27-JUL-2022 S/BILL NO:3088207 DT 27-JUL-20 22 S/BILL NO:3088254 DT 27-JU L-2022 S/BILL NO:3088246 DT 2 7-JUL-2022 NET WT. 8,751.00 KGS 02 DATA LOGGERS HUMIDIT Y:65% SET TEMPERATURE : +18 D EGREES TEMPERATURE RANGE : +1 5 DEGREES TO +25 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 621300 |
2022-08-24 |
9 PKG |
2381.4KG |
9 PALLETS 417 CARTONS PHA RMACEUTICALS AS UNDER IND OMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA PRODUC T CODE: 62 GCE42 H. T. S NO.:3004.90.92.40 ANDA NO.2 03501 THERAPEUTIC USE: IND OMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT S TIFFNESS CAUSED BY ARTHRITIS , GOUT, BURSITIS, AND TENDON ITIS. IT IS ALSO USED TO REL IEVE PAIN FROM VARIOUS OTHER CONDITIONS. THIS MEDICATI ON IS KNOWN AS A NONSTEROIDA L ANTI-INFLAMMATORY DRUG ( NSAID). ... THIS EFFECT HELP S TO DECREASE SWELLING AND PAIN. CARVEDILOL TAB 25M G 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.9 0.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO . F22387000651 DT. 27.07.202 2 NET WT. 1,958.01 KGS 03 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 622200 |
2022-08-24 |
17 PKG |
4818.59KG |
17 PALLETS 1269 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 12.5MG 500 NDC COD E:68462016405 FDA PRODUCT COD E NO : 62 O C A 22 H. T. S N O.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BE TA- ADRENOACEPTOR ANTAGONIST NAPROXEN TAB 500MG 500 ND C CODE:68462019005 FDA PRODUC T CODE NO.:-62 G C A 49 H. T . S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE :-ANTI-INFLAMMATORY, ANALGESI C CARVEDILOL TAB 3.125MG 50 0 NDC CODE:68462016205 FDA P RODUCT CODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTIC E USE:-BETA- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUS TOM INVOICE NO. F22352001852 DT. 29.07.2022 S/BILL NO: 317 2382 DT 29-JUL-2022 NET WT. 4 208.40 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 624900 |
2022-08-24 |
17 PKG |
2937.51KG |
17 PALLETS 374 CARTONS PHA RMACEUTICALS AS UNDER CLOBE TASOL PROP CREAM 0.05% 60GM N DC CODE:68462052965 FDA PRODU CT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209095 THERAPEUTICE USE : - CLOBETASOL PROPIONATE CR EAM IS A SUPER-HIGH POTENCY C ORTICOSTEROID FORMULATIONS IN DICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC M ANIFESTATIONS OF CORTICOSTERO ID-RESPONSIVE DERMATOSES M OMETASONE FURO CREAM 0.1% 15GM NDC CODE:68462019217 FDA PR ODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49.50 A NDA NO.:78-541 THERAPEUTICE U SE: ANTI-INFLAMMATORY- DERMA TOLOGIC MOMETASONE FURO SOL N 0.1% 60ML NDC CODE:68462038 502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004. 90.92.45 ANDA NO.:090506 THE RAPEUTICE USE: MOMETASONE FUR OATE TOPICAL SOLUTION (LOTION ) IS A CORTICOSTEROID INDICA TED FOR THE RELIEF OF THE IN FLAMMATORY AND PRURITIC MANIF ESTATIONS OF CORTICOSTEROID-R ESPONSIVE DERMATOSES IN PATIE NTS #12 YEARS OF AGE. COM MERCIAL & CUSTOM INVOICE NO. F22335001715 DT. 22.07.2022 F 22335001714 DT. 22.07.2022 S/ BILL NO: 3015994 DT:23/07/2022 S/BILL NO: 3008759 DT:22/07 /2022 NET WT. 1,401.98 19 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE NUMA-D ROZ 2 NEUCHATEL - 2000 SWITZ ERLAND NOTIFY PARTY:3 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA |
HS 646700 |
2022-08-24 |
13 PKG |
1707.8KG |
13 PALLETS 634 CARTONS P HARMACEUTICALS AS UNDER HEA THER TAB 0.35MG 84 NDC CODE:6 8462030329 FDA PRODUCT CODE N O.: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-4 54 THERAPEUTICE USE: PREVENT ION OF PREGNANCY. COMMERCIA L & CUSTOM INVOICE NO. F22352 001824 DT. 28.07.2022 S/BILL NO: 3061458 DT 25-JUL-2022 NE T WT. 1,102.08 02 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA |
HS 652400 |
2022-08-17 |
46 PKG |
12987.93KG |
46 PALLETS 1835 CARTONS P HARMACEUTICALS AS UNDER GABAP ENTIN TAB 800MG 500 NDC CODE: 68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT NAPROXEN TAB 500MG 500 NDC CODE:684620190 05 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:-78-250 THE RAPEUTICE USE:-ANTI-INFLAMMAT ORY, ANALGESIC NAPROXEN TA B 500MG 100 NDC CODE:68462019 001 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004. 90.92.40 ANDA NO.:-78-250 TH ERAPEUTICE USE:-ANTI-INFLAMMA TORY, ANALGESIC VERAPAMIL HCL ER TAB 120MG 100 NDC CODE :68462029201 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO .: 3004.90.92.20 ANDA NO.: 9 0-700 THERAPEUTICE USE: - AN GINA POTASSIUM CL ER TAB 20 MEQ 100 NDC CODE:68462047201 FDA PRODUCT CODE NO.: 65 R C A 14 H. T. S NO.: 3004.90.9 190 ANDA NO.: 203562 THERAPE UTICE USE: - TO TREAT OR PREV ENT LOW AMOUNTS OF POTASSIUM IN THE BLOOD MUPIROCIN OIN T 2% 22GM NDC CODE:6846201802 2 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90 .92.45 ANDA NO.: 90-480 THER APEUTICE USE: - ANTI-BACTERIA L COMMERCIAL & CUSTOM INVOICE NO. F22352001633 DT. 16.07.2 022 F22352001634 DT. 16.07.20 22 F22352001637 DT. 16.07.202 2 S/BILL NO:2894033 DT:18.07. 2022 S/BILL NO:2894392 DT:18. 07.2022 S/BILL NO:2894428 DT: 18.07.2022 NET WT. 11,263.817 KGS 02 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES N OTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 616900 |
2022-08-17 |
38 PKG |
11100.95KG |
38 PALLETS 1841 CART ONS PHARMACEUTICALS AS UNDE R OMEPRAZOLE DR CAP 20MG 10 0 NDC CODE:68462039601 FDA P RODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROE SOPHAGEAL REFLUX DISEASE A CAMPROSATE CALCIUM DR TAB 333M G 180 NDC CODE:68462043518 F DA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO.: 3004.90.92. 40 ANDA NO.:202229 THERAPEUT ICE USE: - FOR TREATING ALCOH OL DEPENDENCE PRAMIPEXOLE TAB 0.25MG 90 NDC CODE:684620 33190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 300 4.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN PAR KINSON#S DISEASE VERAPAMIL HCL ER TAB 180MG 500 NDC CODE :68462029305 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO .: 3004.90.92.20 ANDA NO.: 9 0-700 THERAPEUTICE USE: - AN GINA GABAPENTIN TAB 800MG 5 00 NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTIC E USE:-ANTICONVULSANT AGENT MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA N O.: 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL COMMERCIA L & CUSTOM INVOICE NO. F22352 001598 DT. 14.07.2022 F223520 01600 DT. 14.07.2022 F2235200 1601 DT. 14.07.2022 NET WT: 9,580.633 KGS 02 DATA LOGGER S S/BILL NO: 2841046 DT :15-JUL-22 S/BILL NO: 284154 4 DT:15-JUL-22 S/BILL NO: 28 41232 DT:15-JUL-22 NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA SET TEMPERATURE : +18 DEGREES |
HS 621000 |
2022-08-17 |
7 PKG |
1634.32KG |
7 PALLETS 584 ARTONS PHARM ACEUTICALS AS UNDER ROSUVAS TATIN TAB 20MG 1000 NDC CODE: 68462026310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 79 172 THERAPEUTICE USE: TO TRE AT HIGH CHOLESTEROL AND RELAT ED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE RO SUVASTATIN TAB 20MG 90 NDC CO DE:68462026390 FDA PRODUCT CO DE NO.:61 J C A 16 H. T. S N O.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PR EVENT CARDIOVASCULAR DISEASE S/BILL NO: 2841278 DT:15-J UL-22 COMMERCIAL & CUSTOM I NVOICE NO. F22352001602 DT. 1 4.07.2022 NET WT. 1,330.010 KGS 07 DATA LOGGERS SET T EMPERATURE : +18 DEGREES S/ BILL NO: 2841278 DT:15-JUL-22 NOTIFY PARTY:2 GLENMARK S PECIALTY S.A. SWITZERLAND (GS SA) PLACE NUMA-DROZ 2 NEUCHA TEL - 2000 SWITZERLAND |
HS 611600 |
2022-08-17 |
36 PKG |
5744.39KG |
36 PALLETS 3330 CARTONS P HARMACEUTICALS AS UNDER EZETI MIBE TAB 10MG 30 NDC CODE:684 62022630 FDA PRODUCT CODE NO. : 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #0785 60 THERAPEUTICE USE: LIPID L OWERING AGENT EZETIMIBE TAB 10MG 90 NDC CODE:68462022690 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49. 00.10 ANDA NO.: #078560 THER APEUTICE USE: LIPID LOWERING AGENT PRAVASTATIN SOD TAB 2 0MG 500 NDC CODE:68462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.9 2.20 ANDA NO.:-77-987 THERAP EUTICE USE:-HYPOLIPDAEMIC RANOLAZINE ER TAB 500MG 60 ND C CODE:68462031960 FDA PRODUC T CODE NO.: 61 D C B 02 H. T . S NO.: 3004.49.00.10 ANDA NO.:211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDIC ATION. IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENC Y) ATTACK OF ANGINA FENOFI BRATE CAP 200MG 100 NDC CODE: 68462058201 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 2055 66 THERAPEUTICE USE: - INDIC ATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LD L-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS W ITH PRMARY HYPERCHOLESTEROLEM IA OR MIXED DYSLIPIDEMIA N APROXEN SOD TAB 550MG 100 NDC CODE:68462017901 FDA PRODUCT CODE NO.:-62 G C A 50 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-314 THERAPEUTICE USE:- ANTI INFLAMMATORY, ANALGESIC CARVEDILOL TAB 12.5MG 500 NDC CODE:68462016405 FDA PROD UCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 AND A NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANT AGONIST COMMERCIAL & CUSTOM INVOICE NO. F22387000549 DT. 14.07.2022 S/BILL NO.4010158 DT.15.07.2022 NET WT. 3,271. 628 KGS DATA LOGGERS SET TEM PERATURE : +18 DEGREES |
HS 611500 |
2022-08-17 |
47 PKG |
11944.2KG |
47 PALLETS 3019CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAP 20MG 1000 NDC C ODE:68462039610 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE ONDANSETR ON TAB 4MG 30 NDC CODE:684620 10530 FDA PRODUCT CODE NO.:- 61 T C A 28 H. T. S NO.: 300 4.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANTI EMETI C TOPIRAMATE TAB 100MG 60 NDC CODE:68462010960 FDA PROD UCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 AND A NO.:- 77-627 THERAPEUTICE USE:-ANTICONVULSANT VERAPAM IL HCL ER TAB 120MG 100 NDC C ODE:68462029201 FDA PRODUCT C ODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO. : 90-700 THERAPEUTICE USE: - ANGINA POTASSIUM CL ER TAB 20MEQ 100 NDC CODE:684620472 01 FDA PRODUCT CODE NO.: 65 R C A 14 H. T. S NO.: 3004.9 0.9190 ANDA NO.: 203562 THER APEUTICE USE: - TO TREAT OR P REVENT LOW AMOUNTS OF POTASSI UM IN THE BLOOD GABAPENTIN TAB 600MG 500 NDC CODE:68462 012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 300 4.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULS ANT AGENT INV NO:F22352001 651 DT. 18.07.2022 INV NO:F22 352001652 DT. 18.07.2022 S/BI IL NO:2925571 DT 19-JUL-2022 S/BILL NO:2925177 DT 19-JUL-20 22 NET WT. 10,064.520 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEG REES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA |
HS 612800 |
2022-08-17 |
6 PKG |
1458.32KG |
6 PALLETS 200 CARTONS PHAR MACEUTICALS AS UNDER CLINDA MYCIN-BPO GEL JAR 1%/5% 25GM NDC CODE:68462048619 FDA PROD UCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 AND A NO.: 209252 ANTIBIOTIC THAT STOPS THE GROWTH OF ACNE-CAU SING BACTERIA AS WELL AS RED UCE OIL PRODUCTION IN THE SKI N, HELPING KEEP PORES OPEN NET WT. 1,140.39 KGS INV NO : F22352001667 DT. 19.07.2022 S/BILL NO:2942591 DT 20-JUL-2 022 06 DATA LOGGERS SET T EMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SP ECIALTY S.A. SWITZERLAND (G SSA) PLACE NUMA-DROZ 2 N EUCHATEL - 2000 SWITZERLAND |
HS 563100 |
2022-08-17 |
35 PKG |
9160KG |
35 PALLETS 1705 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 600MG 500 NDC CO DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT PRAVASTA TIN SOD TAB 20MG 500 NDC CODE :68462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO .: 3004.90.92.20 ANDA NO.:-7 7-987 THERAPEUTICE USE:-HYPO LIPDAEMIC FENOFIBRATE CAP 6 7MG 100 NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92. 20 ANDA NO.: 205566 THERAPEU TICE USE: - INDICATED AS ADJU NCTIVE THERAPY TO DIET FOR TH E REDUCTION OF LDL-C, TOTAL- C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA GABAPENTIN TA B 600MG 500 NDC CODE:68462012 605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-662 THE RAPEUTICE USE:-ANTICONVULSANT AGENT TACROLIMUS OINT 0.1 % 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.0 0.50 ANDA NO.: 210393 THERAP EUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE O INTMENT USED FOR THE TREATMEN T OF MODERATE-TO-SEVERE ATOP IC DERMATITIS (ECZEMA). PI MECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO .: 211769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTI NUOS CHRONIC TRERTMENT OF MIL D TO MODERATE ATOPIC DERMATI TIS IN NONIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 60GM NDC CODE:68462060965 FD A PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 211769 THERAPEUT ICE USE: - AS SECOUND-LINE TH ERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTM ENT OF MILD TO MODERATE ATOPI C DERMATITIS IN NONIMMUNOCOM PROMISED ADULT AND CHILDREN 2 YEARS OF AGE INV NO:F223870 00550 DT. 14.07.2022 INV NO:F 22387000590 DT. 21.07.2022 IN V NO:F22387000591 DT. 21.07.20 22 INV NO:F22387000593 DT. 21 .07.2022 NET WT. 7,490.94 K GS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES S/BILL NO:401043 2 DT:21.07.2022 S/BILL NO:401 0426 DT:21.07.2022 S/BILL NO: 4010429 DT:21.07.2022 S/BILL NO:4010423 DT:2107.2022 N OTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA HUMIDITY:65% |
HS 684620 |
2022-08-17 |
24 PKG |
3078.58KG |
24 PALLETS 1098 CARTONS PHARMACEUTICALS AS UNDER LEVONORGESTREL/EE TAB 0.15/0.0 3MG 273 NDC CODE:68462067 295 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 A NDA NO.: 203164 THERAPEUT ICE USE: - CONTRACEPTION TO PREVENT PREGNANCY CICLOPIROX OLAMINE CREAM 0. 77% 90GM NDC CODE:68462029792 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40. 49.50 ANDA NO.:- 90 - 273 TH ERAPEUTICE USE:-ANTIFUNGAL US E. ONDANSETRON ODT 4MG 30UD NDC CODE:68462015713 FDA PR ODUCT CODE NO,:-61 T C A 26 H. T. S NO.: 3004.90.92.40 A NDA NO.:-78-152 THERAPEUTICE USE:-ANTI EMETIC NET WT. 2 ,260.950 KGS INV NO: F2235 2001698 DT. 21.07.2022 INV NO : F22352001701 DT. 21.07.2022 INV NO: F22352001704 DT. 21.0 7.2022 01 DATA LOGGERS SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, C ORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA S/BILL NO: 2992490 D T:22.07.2022 S/BILL NO: 29924 21 DT:22.07.2022 S/BILL NO: 2992597 DT:22.07.2022 |
HS 642900 |
2022-08-17 |
17 PKG |
6076.43KG |
17 PALLETS 970 CARTONS PHARMACEUTICALS AS UNDER ROPINIROLE TAB 2MG 100 NDC CODE:68462025601 FDA PRODUCT CODE NO. :-62 J C A 17 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTIC E USE:-TREATMENT OF PARKINSONISM ZOLMIT RIPTAN TAB 5 MG 3UD NDC C ODE:68462049833 FDA PRODU CT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90 .92.28 ANDA NO.: 201779 THERAPEUTICE USE: - A NALGESIC/ HUMAN - RX/SING LE INGREDIENT / PROMPT RELEASE TABLETS / ZOLM ITRIPTAN (ANALGESIC) NE T WT: 2,172.378 KGS GROSS W T. 6,076.746 IN V NO: F22352001703 DT. 21.07.2 022 S/BILL NO: 2992522 DT:22. 07.2022 01 DATA LOG GERS SET TEMPERATURE : +18 DEGREES |
HS 621700 |
2022-08-17 |
15 PKG |
3140.73KG |
15 PALLETS 322 CARTO NS PHARMACEUTICALS AS UNDER NYSTATIN-TRIAM 100K UNIT/0.1% CREAM NDC CODE:68462031417 F DA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.40.005 0 ANDA NO.: 208136 THERAPEUT ICE USE: - TREATMENT OF FUNGA L INFECTIONS OF THE SKIN, ES PECIALLY YEAST INFECTIONS. MOMETASONE FURO OINT 0.1% 45G M NDC CODE:68462022555 FDA P RODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49.50 ANDA NO.:78-571 THERAPEUTICE USE: ANTI-INFLAMMATORY- DERM ATOLOGIC INV NO:F2233500158 6 DT. 14.07.2022 S/BILL NO:28 80741 DT:18.07.2022 15 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NET WT. 1,391.040 KGS NO TIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 646100 |
2022-08-17 |
24 PKG |
5756.64KG |
24 PALLETS 2095 CARTONS P HARMACEUTICALS AS UNDER OXCAR BAZEPINE TAB 150MG 100 NDC CO DE:68462013701 FDA PRODUCT CO DE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-802 THERAPEUTICE USE:-ANT I CONVULSANT AGENT PRAMIPE XOLE TAB 1.5MG 90 NDC CODE:68 462033490 FDA PRODUCT CODE NO .: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-7 81 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE PRAMIP EXOLE TAB 0.5MG 90 NDC CODE:6 8462033290 FDA PRODUCT CODE N O.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90- 781 THERAPEUTICE USE: USED I N PARKINSON#S DISEASE TOPIR AMATE TAB 25MG 1000 NDC CODE: 68462010810 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:- 7 7-627 THERAPEUTICE USE:-ANTI CONVULSANT ZONISAMIDE CAP 5 0MG 100 NDC CODE:68462012901 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.0 0.20 ANDA NO.:-77-651 THERAP EUTICE USE:-ANTISEIZURE DRUG ROPINIROLE TAB 2MG 100 NDC CODE:68462025601 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA N O.:- 90-135 THERAPEUTICE USE :-TREATMENT OF PARKINSONISM NET WT. 4,629.789 INV NO :F22352001693 DT. 21.07.2022 INV NO:F22352001694 DT. 21.07. 2022 07 DATA LOGGERS HUMI DITY:65% SET TEMPERATURE : + 18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 621500 |
2022-08-09 |
32 PKG |
6988.16KG |
32 PALLETS 2259 CARTONS PHARMACEUTICAL S AS UNDER TOPIRAMATE TAB 2 5MG 500 NDC CODE:68462010805 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.0 0.20 ANDA NO.:077627 THERAPE UTICE USE: ANTICONVULSANT LEVOCETIRIZINE DIHY TAB 5MG 90 NDC CODE:68462034690 FDA PR ODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.90.91.80 A NDA NO.:90385 THERAPEUTICE US E: TREATMENT OF CHRONIC IDIO PATHIC URTICARIA NAPROXEN T AB 500MG 500 NDC CODE:6846201 9005 FDA PRODUCT CODE NO.:-6 2 G C A 49 H. T. S NO.: 3004 .90.92.40 ANDA NO.:-78-250 T HERAPEUTICE USE:-ANTI-INFLAMM ATORY, ANALGESIC TOPIRAMAT E TAB 25MG 60 NDC CODE:684620 10860 FDA PRODUCT CODE NO.:- 61 M C A 40 H. T. S NO.: 300 4.49.00.20 ANDA NO.:- 77-627 THERAPEUTICE USE:-ANTICONVUL SANT OXCARBAZEPINE TAB 600M G 100 NDC CODE:68462013901 F DA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92. 30 ANDA NO.:-77-802 THERAPEU TICE USE:-ANTI CONVULSANT AGE NT TOPIRAMATE TAB 50MG 1000 NDC CODE:68462015310 FDA PR ODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 A NDA NO.:- 77-627 THERAPEUTICE USE:-ANTICONVULSANT ROPIN IROLE TAB 0.25MG 100 NDC CODE :68462025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TRE ATMENT OF PARKINSONISM COL ESEVELAM HCL OS 3.75GM 30 NDC CODE:68462062030 FDA PRODUCT CODE NO.: 62 B C L 13 H. T. S NO.: 3004.49.00.10 ANDA N O.: 202190 THERAPEUTICE USE : - COLESEVELAM IS A LIPID (L OW DENSITY LIPOPROTIN CHOLEST EROL) REDUCING DRUG THAT IS U SEFUL FOR REDUCING CHOLESTERO L. COMMERCIAL & CUSTOM INVO ICE NO. F22352001522 DT. 08.0 7.2022 S/BILL NO: 2713863 DT 09-JUL-2022 NET WT: 5823.93 K GS 02 DATA LOGGERS HUMID ITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA |
HS 614000 |
2022-08-09 |
18 PKG |
4106.89KG |
18 PALLETS 1617 CARTONS PHARMACEUTICALS AS UNDER RO SUVASTATIN TAB 20MG 90 NDC CO DE:68462026390 FDA PRODUCT CO DE NO.:61 J C A 16 H. T. S N O.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PR EVENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352001523 DT. 08.07.2 022 S/BILL NO: 2713604 DT 09- JUL-2022 NET WT: 3282.54 KGS 18 DATA LOGGERS NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 293399 |
2022-08-09 |
39 PKG |
6811.26KG |
39 PALLETS 2062 CARTONS PHARMACEUTICALS AS UNDER N ORETHINDRONE TAB 0.35MG 84 ND C CODE:68462030529 FDA PRODUC T CODE NO.: 65 J C A 26 H. T . S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTION OF PREGNANCY. D ROSPIRENONE/EE TAB 3/0.02MG 84 NDC CODE:68462072029 FDA PR ODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 A NDA NO.: 204296 THERAPEUTICE USE: - ORAL CONTRACEPTIVE HAILEY FE 1/20 TAB 1MG/20MCG-7 5MG 84 NDC CODE:68462041929 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00 .00 ANDA NO.:206597 THERAPEU TICE USE: HORMONE MEDICATION IS USED TO PREVENT PREGNANCY ROPINIROLE TAB 0.25MG 100 NDC CODE:68462025301 FDA PRO DUCT CODE NO.:-62 J C A 17 H . T. S NO.: 3004.90.92.40 AN DA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT OF PARKINSONI SM COMMERCIAL & CUSTOM INVO ICE NO. F22352001527 DT. 09.0 7.2022 F22352001536 DT. 09.07 .2022 F22352001543 DT. 09.07. 2022 S/BILL NO: 2747933 DT: 1 1-JUL-22 S/BILL NO: 2747924 DT:11-JUL-22 S/BILL NO: 27479 25 DT:11-JUL-22 NET WT. 5,2 10.77 KGS 04 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652600 |
2022-08-09 |
37 PKG |
4236.62KG |
37 PALLETS 1017 CARTONS PHARMACEUTICALS AS UNDER FL UCONAZOLE TAB 150MG 12UD NDC CODE:68462011944 NDC CODE : 68462011944 HTS NO : 3004.90. 92.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 THERAPEU TICE USE : ANTIFUNGAL COMM ERCIAL & CUSTOM INVOICE NO. F 22352001538 DT. 09.07.2022 S/ BILL NO: 2736956 DT: 11-JUL-22 NET WT: 3197.448 KGS 02 DA TA LOGGERS NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 300490 |
2022-08-09 |
4 PKG |
1003.82KG |
4 PALLETS 205 CARTONS P HARMACEUTICALS AS UNDER ROS UVASTATIN TAB 20MG 1000 NDC C ODE:68462026310 FDA PRODUCT C ODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO. : 79172 THERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND R ELATED CONDITIONS, AND TO PRE VENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 10MG 1000 NDC CODE:68462026210 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE N O. F22352001539 DT. 09.07.202 2 S/BILL NO: 2737696 DT:11-J UL-22 NET WT: 883.75 KGS 4 D ATA LOGGERS NOTIFY PARTY: 2 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE NUMA-D ROZ 2 NEUCHATEL - 2000 SWITZ ERLAND |
HS 210690 |
2022-08-09 |
29 PKG |
8909.16KG |
29 PALLETS 2233 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 800MG 500 NDC CO DE:68462012705 FDA PRODUCT CO DE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT ONDANSE TRON TAB 4MG 30 NDC CODE:6846 2010530 FDA PRODUCT CODE NO. :-61 T C A 28 H. T. S NO.: 3 004.90.92.40 ANDA NO.:- 77-53 5 THERAPEUTICE USE:-ANTI EME TIC TOPIRAMATE TAB 25MG 60 NDC CODE:68462010860 FDA PRO DUCT CODE NO.:-61 M C A 40 H . T. S NO.: 3004.49.00.20 AN DA NO.:- 77-627 THERAPEUTICE USE:-ANTICONVULSANT COMMER CIAL & CUSTOM INVOICE NO. F22 352001541 DT. 09.07.2022 F223 52001542 DT. 09.07.2022 S/BIL L NO: 2747956 DT 11-JUL-2022 S/BILL NO: 2747952 DT 11-JUL-2 022 NET WT: 7706.93 KGS 02 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 612800 |
2022-08-09 |
42 PKG |
6839.83KG |
42 PALLETS 1531 CARTONS PHARMACEUTICALS AS UNDER OM EPRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S N O.: 3004.90.9160 ANDA NO.: 9 1672 THERAPEUTICE USE: - TRE ATMENT OF TREAT GASTROESOPHAG EAL REFLUX DISEASE ONDANSE TRON ODT 4MG 30UD NDC CODE:68 462015713 FDA PRODUCT CODE N O,:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-1 52 THERAPEUTICE USE:-ANTI EM ETIC MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PR ODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 A NDA NO.: 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL ONDA NSETRON ODT 4MG 30UD NDC CODE :68462015713 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-152 THERAPEUTICE USE:-ANTI EMETIC COMMERCIAL & CUSTOM I NVOICE NO. F22352001508 DT. 0 7.07.2022 F22352001509 DT. 07 .07.2022 F22352001510 DT. 07. 07.2022 F22352001511 DT. 07.0 7.2022 S/BILL NO: 2693871 DT. 08.07.2022 S/BILL NO: 269393 8 DT. 08.07.2022 S/BILL NO: 2 693894 DT. 08.07.2022 S/BILL NO: 2693948 DT. 08.07.2022 NE T WT: 5,270.93 KGS 05 DATA L OGGERS NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 621000 |
2022-08-09 |
14 PKG |
3026.87KG |
14 PALLETS 1768 CARTONS P HARMACEUTICALS AS UNDER ROS UVASTATIN TAB 10MG 90 NDC COD E:68462026290 FDA PRODUCT COD E NO.:61 J C A 16 H. T. S NO .: 3004.49.00.10 ANDA NO.: 0 79172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND R ELATED CONDITIONS, AND TO PRE VENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 5MG 90 NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE COMMERCIAL & CUSTOM INVO ICE NO. F22352001540 DT. 09.0 7.2022 S/BILL NO: 2748031 DT :11-JUL-22 NET WT: 2305.72 KG S 14 DATA LOGGERS NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE N UMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 611600 |
2022-08-09 |
6 PKG |
1178KG |
2 PALLETS 385 CARTON S PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 10MG 1000 NDC CODE:68462026210 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND R ELATED CONDITIONS, AND TO PRE VENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352001576 DT. 13.07.20 22 S/BILL NO:2791667 DT 13-JU L-2022 NET WT: 995.63 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK SPECIALTY S .A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 210690 |
2022-08-09 |
9 PKG |
1889.24KG |
9 PALLETS 1044 CARTONS P HARMACEUTICALS AS UNDER ROS UVASTATIN TAB 10MG 90 NDC COD E:68462026290 FDA PRODUCT COD E NO.:61 J C A 16 H. T. S NO .: 3004.49.00.10 ANDA NO.: 0 79172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND R ELATED CONDITIONS, AND TO PRE VENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352001589 DT. 13.07.20 22 S/BILL NO:2818660 DT 14-JU L-2022 NET WT: 1,451.146 KG S 09 DATA LOGGERS HUMIDITY:6 5% SET TEMPERATURE : +18 DEGR EES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 210690 |
2022-08-09 |
24 PKG |
4705.65KG |
24 PALLETS 488 CARTONS PHARMACEUTICALS AS UNDER N YSTATIN-TRIAM 100K UNIT/0.1% O INT 15GM NDC CODE:68462079917 FDA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3004.49. 00.50 ANDA NO.: 208300 THERA PEUTICE USE: - TREATMENT OF F UNGAL INFECTIONS OF THE SKIN, ESPECIALLY YEAST INFECTIONS . MOMETASONE FURO OINT 0.1% 45GM NDC CODE:68462022555 F DA PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49. 50 ANDA NO.:78-571 THERAPEUT ICE USE: ANTI-INFLAMMATORY- DERMATOLOGIC CLOBETASOL PRO P SOLN 0.05% 50ML NDC CODE:68 462053253 FDA PRODUCT CODE NO .: 64 L C L 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 2101 90 THERAPEUTICE USE: - GLUCO CORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTERILE LIQU ID / CLOBETASOL PROPIONATE ( GLUCOCORTICOID) COMMERCIA L & CUSTOM INVOICE NO. F22335 001489 DT. 08.07.2022 F223350 01522 DT. 11.07.2022 F2233500 1523 DT. 11.07.2022 S/BILL NO :2771828 DT:12.07.2022 S/BILL NO:2773325 DT:12.07.2022 S/B ILL NO:2773372 DT:12.07.2022 NET WT. 2,186.880 24 DATA L OGGERS HUMIDITY:65% SET TEMP ERATURE : +18 DEGREES TEMPERA TURE RANGE : +15 DEGREES TO +2 5 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 646000 |
2022-08-09 |
10 PKG |
1601.21KG |
10 PALLETS 339 CARTO NS PHARMACEUTICALS AS UNDER CLOBETASOL PROP OINT 0.05% 6 0GM NDC CODE:68462053065 FDA PRODUCT CODE NO.: 64 L C J 6 7 H. T. S NO.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTI CE USE: - INDICATED FOR THE R ELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DER MATOESE ATOVAQUONE OS 750MG /5ML 42X5ML NDC CODE:68462042 169 COMMERCIAL & CUSTOM INV OICE NO. F22335001490 DT. 08. 07.2022 F22335001507 DT. 09.0 7.2022 S/BILL NO:2771844 DT:1 2.07.2022 S/BILL NO:2771830 D T:12.07.2022 NET WT. 1,005.12 0 KGS 10 DATA LOGGERS HUMID ITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NO TIFY PARTY:2 GLENMARK SPECIAL TY S.A. SWITZERLAND (GSSA) P LACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 646700 |
2022-08-02 |
14 PKG |
2676.69KG |
14 PALLETS 659 CARTONS P HARMACEUTICALS AS UNDER TOP IRAMATE TAB 25MG 500 NDC CODE :68462010805 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO .: 3004.49.00.20 ANDA NO.:07 7627 THERAPEUTICE USE: ANTIC ONVULSANT OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:684620396 10 FDA PRODUCT CODE NO.: 62K CF10 H. T. S NO.: 3004.90.91 60 ANDA NO.: 91672 THERAPEUT ICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DIS EASE COMMERCIAL & CUSTOM IN VOICE NO. F22352001429 DT. 30 .06.2022 S/BILL NO: 2548220 D T:01/07/2022 NET WT: 2305.47 KGS 03 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA |
HS 684620 |
2022-08-02 |
9 PKG |
2046.19KG |
9 PALLETS 751 CARTONS PHAR MACEUTICALS AS UNDER PIMECR OLIMUS CREAM 1% 30GM NDC CODE :68462060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 11769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMUNOCOMPROMISED ADUL T AND CHILDREN 2 YEARS OF AGE METFORMIN HCL ER TAB (Z) 5 00MG 100 NDC CODE:68462052001 FDA PRODUCT CODE NO.: 61 P C A 55 H. T. S NO.: 3004.90. 92.40 ANDA NO.:212969 THERAP EUTICE USE: THE MANAGEMENT OF TYPE 2 DIABETES PRAVASTAT IN SOD TAB 20MG 500 NDC CODE: 68462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO. : 3004.90.92.20 ANDA NO.:-77 -987 THERAPEUTICE USE:-HYPOL IPDAEMIC RANOLAZINE ER TAB 500MG 60 NDC CODE:68462031960 FDA PRODUCT CODE NO.: 61 D C B 02 H. T. S NO.: 3004.49. 00.10 ANDA NO.:211082 THERAP EUTIC USE: - IT IS AN ANTI-AN GINAL MEDICATION. IT WORKS BY IMPROVING BLOOD FLOW TO HEL P THE HEART WORK MORE EFFICIE NTLY. IT IS USED TO TREAT CHR ONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN ACUT E (EMERGENCY) ATTACK OF ANGI NA PROPAFENONE HCL ER CAP 4 25MG 60 NDC CODE:68462041060 FDA CODES 63 E C F 28 HTS CO DES 3004.49.00.10 ANDA NO. 2 05268 THERAPEUTIC USE AN ANT IARRHYTHMIC AGENT.IT IS USED TO TREAT IRREGULAR HEART RHYT HM AND CAN SLOW RAPID HEARTBE ATS. PROPAFENONE HCL ER CAP 425MG 60 NDC CODE:6846204106 0 FDA CODES 63 E C F 28 HTS CODES 3004.49.00.10 ANDA NO. 205268 THERAPEUTIC USE AN A NTIARRHYTHMIC AGENT.IT IS USE D TO TREAT IRREGULAR HEART RH YTHM AND CAN SLOW RAPID HEART BEATS. COMMERCIAL & CUSTOM INVOICE NO. F22387000454 DT. 29.06.2022 F22387000461 DT. 3 0.06.2022 F22387000467 DT. 30 .06.2022 F22387000468 DT. 30. 06.2022 F22387000470 DT. 30.0 6.2022 S/BILL NO: 4009341 DT: 30/06/2022 S/BILL NO: 4009347 DT:30/06/2022 S/BILL NO: 400 9348 DT:30/06/2022 S/BILL NO: 4009349 DT:30/06/2022 S/BILL NO: 4009417 DT:30/06/2022 NE T WT: 1,180.70 KGS 07 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 300449 |
2022-08-02 |
12 PKG |
1593.5KG |
12 PALLETS 949 CARTONS PHA RMACEUTICALS AS UNDER BISOP ROLOL-HCTZ TAB 2.5/6.25MG 500 NDC CODE:68462087805 FDA PRO DUCT CODE NO.: 62 O D A 18 H . T. S NO.: 3004.40.00.20 AN DA NO.: 215995 THERAPEUTICE U SE: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATED IN THE MANAGEME NT OF HYPERTENSION. DILTIA ZEM HCL ER CAP 12HR 60MG 100 NDC CODE:68462085001 62 O C B 24 3004.49.00.10 212317 FO R THE TREATMENT OF HYPERTENSI ON. FENOFIBRATE CAP 134MG 1 00 NDC CODE:68462058101 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 A NDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIV E THERAPY TO DIET FOR THE RE DUCTION OF LDL-C, TOTAL-C, TR IGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPER CHOLESTEROLEMIA OR MIXED DYSL IPIDEMIA EZETIMIBE TAB 10MG 90 NDC CODE:68462022690 FDA PRODUCT CODE NO.: 61 J C A 1 5 H. T. S NO.: 3004.49.00.10 ANDA NO.: #078560 THERAPEUT ICE USE: LIPID LOWERING AGENT COMMERCIAL & CUSTOM INVOIC E NO. F22387000453 DT. 29.06. 2022 F22387000460 DT. 30.06.2 022 S/BILL NO: 4009338 DT:30/ 06/2022 S/BILL NO: 4009344 DT :30/06/2022 NET WT: 532.15 K GS 04 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 621800 |
2022-08-02 |
56 PKG |
11223.88KG |
56 PALLETS 2055 CART ONS PHARMACEUTICALS AS UNDE R MUPIROCIN OINT 2% 22GM N DC CODE:68462018022 FDA PRODU CT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE : - ANTI-BACTERIAL OMEPRAZ OLE DR CAP 40MG 1000 NDC CODE :68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3 004.90.9160 ANDA NO.:91672 T HERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REF LUX DISEASE TELMISARTAN TA B 40MG 30 NDC CODE:6846202003 0 FDA PRODUCT CODE NO.: 62 O C A 09 H. T. S NO.: 3004.90 .92.20 ANDA NO.:090032 THERA PEUTICE USE: INDICATED FOR TH E TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE N APROXEN TAB 500MG 500 NDC COD E:68462019005 FDA PRODUCT COD E NO.:-62 G C A 49 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-ANT I-INFLAMMATORY, ANALGESIC NAPROXEN TAB 500MG 100 NDC CO DE:68462019001 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC COMMERCIAL & CUSTOM INVOICE N O. F22352001484 DT. 05.07.202 2 F22352001485 DT. 05.07.2022 S/BILL NO: 2638940 DT 06-J UL-2022 S/BILL NO: 2638410 DT 06-JUL-2022 NET WT: 9,233 .99 KGS 02 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 618100 |
2022-08-02 |
10 PKG |
2781.02KG |
10 PALLETS 667 CARTO NS PHARMACEUTICALS AS UNDER CLOBETASOL PROP OINTMENT 0 .05% 30GM NDC CODE:6846205303 5 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90 .92.45 ANDA NO.: 208933 THER APEUTICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMMATO RY AND PRURITIC MANIFESTATION S OF CORTICOSTEROID-RESPONSIV E DERMATOESE ATOVAQUONE OS 750MG/5ML 210ML NDC CODE:684 62042121 FDA PRODUCT CODE NO. : 62 L C L 44 H. T. S NO.: 3004.90.92.90 ANDA NO.: 20968 5 USED TO PREVENT OR TREAT A SERIOUS LUNG INFECTION CALLE D PNEUMOCYSTIS PNEUMONIA (PCP ). THIS MEDICATION HELPS TO S TOP INFECTION SYMPTOMS SUCH AS FEVER, COUGH, TIREDNESS, A ND SHORTNESS OF BREATH. AT OVAQUONE OS 750MG/5ML 210ML N DC CODE:68462042121 FDA PRODU CT CODE NO.: 62 L C L 44 H. T. S NO.: 3004.90.92.90 ANDA NO.: 209685 USED TO PREVENT OR TREAT A SERIOUS LUNG INFEC TION CALLED PNEUMOCYSTIS PNE UMONIA (PCP). THIS MEDICATION HELPS TO STOP INFECTION SYMP TOMS SUCH AS FEVER, COUGH, T IREDNESS, AND SHORTNESS OF BR EATH. COMMERCIAL & CUSTOM I NVOICE NO. F22335001352 DT. 3 0.06.2022 F22335001372 DT. 30 .06.2022 F22335001374 DT. 30. 06.2022 S/BILL NO: 2614005 DT : 05/07/2022 S/BILL NO:259307 5 DT: 04/07/2022 S/BILL NO:25 93290 DT:04/07/2022 NET WT: 2,315.30 KGS 06 DATA LOGGERS NOTIFY PARTY:2 GLENMARK S PECIALTY S.A. SWITZERLAND (GS SA) PLACE NUMA-DROZ 2 NEUCHA TEL - 2000 SWITZERLAND 06 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES |
HS 646700 |
2022-08-02 |
16 PKG |
1398KG |
16 PALLETS 1654 CARTONS PH ARMACEUTICALS AS UNDER EZET IMIBE TAB 10MG 30 NDC CODE:68 462022630 FDA PRODUCT CODE NO .: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #078 560 THERAPEUTICE USE: LIPID LOWERING AGENT COMMERCIAL & CUSTOM INVOICE NO. F22387000 493 DT. 30.06.2022 S/BILL NO: 4009513 DT:02/07/2022 NET W T: 238.18 KGS 01 DATA LOGGERS NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 611500 |
2022-08-02 |
25 PKG |
6021.99KG |
25 PALLETS 2033 CARTONS PHARMACEUTICALS AS UNDER ZONISAMIDE CAP 100MG 100 N DC CODE:68462013001 FDA PROD UCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77-651 THERAPEUTI CE USE:-ANTISEIZURE DRUG LEVOCETIRIZINE DIHY TAB 5MG 90 NDC CODE:68462034690 FD A PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.90.9 1.80 ANDA NO.:90385 THERAP EUTICE USE: TREATMENT OF CHR ONIC IDIOPATHIC URTICARIA NAPROXEN TAB 500MG 100 ND C CODE:68462019001 FDA PRODU CT CODE NO.:-62 G C A 49 H . T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTIC E USE:-ANTI-INFLAMMATORY, ANALGESIC COMMERCIAL & CU STOM INVOICE NO. F2235200149 5 DT. 06.07.2022 F2235200149 6 DT. 06.07.2022 S/BILL NO: S/BILL NO: NET WT: 4721. 10 KGS 05 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 614400 |
2022-08-02 |
44 PKG |
7533.84KG |
44 PALLETS 2543 CARTONS PHARMACEUTICALS AS UNDER FLUCONAZOLE TAB 200MG 30 NDC CODE:68462010430 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90.92.45 ANDA NO .:-77 - 253 THERAPEUTICE USE :-ANTIFUNGAL LEVOCETIRIZINE DIHY TAB 5MG 90 NDC CODE:684 62034690 FDA PRODUCT CODE NO. : 61 X C A 51 H. T. S NO.: 3004.90.91.80 ANDA NO.:90385 THERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPATHIC URTICAR IA OMEPRAZOLE DR CAP 20MG 1 000 NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H . T. S NO.: 3004.90.9160 AND A NO.: 91672 THERAPEUTICE USE : - TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE ONDANSETRON ODT 4MG 30UD NDC CODE:68462015713 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-152 THERAPEUTICE USE:- ANTI EMETIC ZONISAMIDE CAP 100MG 500 NDC CODE:684620130 05 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.4 9.00.20 ANDA NO.:-77-651 THE RAPEUTICE USE:-ANTISEIZURE DR UG VERAPAMIL HCL ER TAB 120 MG 100 NDC CODE:68462029201 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92 .20 ANDA NO.: 90-700 THERAPE UTICE USE: - ANGINA ZOLMIT RIPTAN ODT 5MG 3UD NDC CODE:6 8462050033 FDA PRODUCT CODE N O.: 60 L C A 90 H. T. S NO.: 3004.90.92.28 ANDA NO.: 202 560 THERAPEUTICE USE: - ANAL GESIC/ HUMAN - RX/SINGLE INGR EDIENT / PROMPT RELEASE TABL ETS / ZOLMITRIPTAN (ANALGESIC ) COMMERCIAL & CUSTOM INVOI CE NO. F22352001518 DT. 08.07 .2022 S/BILL NO: 2698977 DT: 08-JUL-22 NET WT : 5,922.15 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA |
HS 614500 |
2022-08-02 |
53 PKG |
11095.51KG |
53 PALLETS 2670 CARTONS PHARMACEUTICALS AS UNDER NA PROXEN TAB 500MG 500 NDC CODE :68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC O MEPRAZOLE DR CAP 20MG 1000 ND C CODE:68462039610 FDA PRODUC T CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE CARVED ILOL TAB 3.125MG 500 NDC CODE :68462016205 FDA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F22352001474 DT. 04.07.2 022 F22352001475 DT. 04.07.20 22 S/BILL NO: 2619911 DT: 05- JUL-22 S/BILL NO: 2620502 DT :05-JUL-22 NET WT: 9,393.79 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 684620 |
2022-08-02 |
41 PKG |
6377.62KG |
41 PALLETS 1944 CART ONS PHARMACEUTICALS AS UNDE R NORETH ACE/EE TAB 1/0.02M G 63 NDC CODE:68462013281 FD A PRODUCT CODE NO.:65 J C A 2 5 H. T. S NO.: 3006.60.00.00 ANDA NO.:206969 THERAPEUTIC E USE: - SECONDARY AMENORRHE A,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING NORETHIN DRONE ACE TAB 5MG 50 NDC CODE :68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.:-91- 090 THERAPEUTICE USE:- SECON DARY AMENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEED ING DROSPIRENONE/EE TAB 3/0 .02MG 84 NDC CODE:68462072029 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60. 00.00 ANDA NO.: 204296 THERA PEUTICE USE: - ORAL CONTRACEP TIVE COMMERCIAL & CUSTOM IN VOICE NO. F22352001489 DT. 06 .07.2022 F22352001490 DT. 06. 07.2022 S/BILL NO: 2645595 DT 06-JUL-2022 S/BILL NO:264590 5 DT 06-JUL-2022 NET WT: 4,5 26.20 KGS 02 DATA LOGGERS HU MIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652500 |
2022-07-26 |
17 PKG |
2866.3KG |
17 PALLETS 1147 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TABLETS 10MG 90 S ND C CODE:68462026290 FDA PRODUC T CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL A ND RELATED CONDITIONS, AND T O PREVENT CARDIOVASCULAR DISE ASE ROSUVASTATIN TAB 10MG 1 000 NDC CODE:68462026210 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLESTEROL A ND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE ROSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PR ODUCT CODE NO.:61 J C A 16 H . T. S NO.: 3004.49.00.10 AN DA NO.: 079172 THERAPEUTICE U SE: - TO TREAT HIGH CHOLESTER OL AND RELATED CONDITIONS, A ND TO PREVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 40 MG 500 NDC CODE:68462026405 61 J C A 16 3004.49.00.10 79 172 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DI SEASE COMMERCIAL & CUSTOM I NVOICE NO. F22352001278 DT. 2 6.06.2022 F22352001279 DT. 26 .06.2022 S/BILL NO: 2422005 DT:27-JUN-22 S/BILL NO: 24226 28 DT:27-JUN-22 17 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE NUMA-DROZ 2 N EUCHATEL - 2000 SWITZERLAND |
HS 611600 |
2022-07-26 |
6 PKG |
1495.07KG |
6 PALLETS 319 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 10MG 1000 NDC CODE :68462026210 61 J C A 16 300 4.49.00.10 79172 TO TREAT HI GH CHOLESTEROL AND RELATED CO NDITIONS, AND TO PREVENT CAR DIOVASCULAR DISEASE PREGNANCY ROSUVASTATIN TAB 20MG 1000 NDC CODE:68462026310 FDA PR ODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 A NDA NO.: 79172 THERAPEUTICE U SE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DI SEASE COMMERCIAL & CUSTOM I NVOICE NO. F22352001318 DT. 2 8.06.2022 S/BILL NO: 2472068 DT:29-JUN-22 NET WT: 1298.7 1 KGS 06 DATA LOGGERS HUMID ITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NO TIFY PARTY:2 GLENMARK SPECIAL TY S.A. SWITZERLAND (GSSA) P LACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 684620 |
2022-07-26 |
18 PKG |
3262.74KG |
18 PALLETS 855 CARTO NS PHARMACEUTICALS AS UNDER HAILEY 1.5/30 TAB 1.5MG/30MC G 63 NDC CODE:68462050481 FD A PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.0 0 ANDA NO.: 209297 THERAPEUT ICE USE: - CONTRACEPTION TO P REVENT PREGNANCY COMMERCIA L & CUSTOM INVOICE NO. F22352 001292 DT. 27.06.2022 S/BILL NO:2445270 DT 28-JUN-2022 NET WT: 2,441.88 KGS 18 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZ ERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERL AND |
HS 652500 |
2022-07-26 |
42 PKG |
5883.19KG |
42 PALLETS 1985 CARTONS PH ARMACEUTICALS AS UNDER ONDA NSETRON ODT 4MG 30UD NDC CODE :68462015713 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-152 THERAPEUTICE USE:-ANTI EMETIC NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 4 9 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTI CE USE:-ANTI-INFLAMMATORY, A NALGESIC ROPINIROLE TAB 1MG 100 NDC CODE:68462025501 FD A PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:- 90-135 THERAPEU TICE USE:-TREATMENT OF PARKI NSONISM RIZATRIPTAN BENZ TA B 5MG 18UD NDC CODE:684620465 99 FDA PRODUCT CODE NO.: 60 L C A 87 H. T. S NO.: 3004.9 0.92.28 ANDA NO.:201967 THER APEUTICE USE: - ACUTE TREATME NT OF MIGRAINE OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:684 62039610 FDA PRODUCT CODE NO. : 62KCF10 H. T. S NO.: 3004 .90.9160 ANDA NO.: 91672 THE RAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLU X DISEASE COMMERCIAL & CUS TOM INVOICE NO. F22352001380 DT. 30.06.2022 F22352001388 D T. 30.06.2022 F22352001433 DT . 30.06.2022 F22352001454 DT. 01.07.2022 F22352001460 DT. 01.07.2022 S/BILL NO: 2552438 DT 02-JUL-2022 S/BILL NO: 25 53686 DT 02-JUL-2022 S/BILL N O: 2553586 DT 02-JUL-2022 S/B ILL NO: 2556330 DT 02-JUL-2022 S/BILL NO: 2555074 DT 02-JUL -2022 NET WT 4,667.70 KGS 02 DATA LOGGERS SET TEMPERATU RE : +18 DEGREES |
HS 684620 |
2022-07-26 |
10 PKG |
1903.76KG |
10 PALLETS 500 CARTONS PHARMACEUTICALS AS UNDER HA ILEY FE 1.5/30 TAB 1.5MG/30MCG -75MG 84 NDC CODE:68462050329 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60. 00.00 ANDA NO.:206597 THERAP EUTICE USE: HORMONE MEDICATIO N IS USED TO PREVENT PREGNAN CY COMMERCIAL & CUSTOM INVO ICE NO. F22352001313 DT. 28.0 6.2022 S/BILL NO:2474202 DT 2 9-JUN-2022 NET WT: 1,476.00 KGS 10 DATA LOGGERS SET T EMPERATURE : +18 DEGREES NO TIFY PARTY:2 GLENMARK SPECIAL TY S.A. SWITZERLAND (GSSA) P LACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 652500 |
2022-07-26 |
4 PKG |
920.35KG |
4 PALLETS 160 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAP 20MG 1000 NDC C ODE:68462039610 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE COMMERCIA L & CUSTOM INVOICE NO. F22352 001459 DT. 01.07.2022 S/BILL NO: 2556321 DT 02-JUL-2022 N ET WT: 798.4 KGS 01 DATA LOG GERS NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA TEMPERAT URE RANGE : +15 DEGREES TO +25 DEGREES |
HS 271019 |
2022-07-26 |
6 PKG |
1246.49KG |
6 PALLETS 173 CARTONS PHAR MACEUTICALS AS UNDER NORETH INDRONE ACE TAB 5MG 50 NDC CO DE:68462030450 FDA PRODUCT CO DE NO.65 J C A 25 H. T. S NO .: 3004.39.00.50 ANDA NO.:-9 1-090 THERAPEUTICE USE:- SEC ONDARY AMENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BLE EDING NORETHINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00. 50 ANDA NO.:-91-090 THERAPEU TICE USE:- SECONDARY AMENORR HEA,ENDOMETRIOS IS AND ABNORM AL UTERINE BLEEDING COMMER CIAL & CUSTOM INVOICE NO. F22 352001434 DT. 30.06.2022 F223 52001452 DT. 01.07.2022 S/BIL L NO: 2538170 DT 01-JUL-2022 S/BILL NO: 2538178 DT 01-JUL-2 022 NET WT: 1041.25 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES |
HS 652500 |
2022-07-26 |
42 PKG |
7355.12KG |
42 PALLETS 2440 CARTONS PHARMACEUTICALS AS UNDER S OLIFENACIN SUCCINATE TAB 5MG 9 0 NDC CODE:68462038690 FDA P RODUCT CODE NO.: 61 KCA 72 H . T. S NO.: 3004 49 00 70 AN DA NO.: 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENC Y AND URINARY FREQUENCY SO LIFENACIN SUCCINATE TAB 5MG 30 NDC CODE:68462038630 FDA PR ODUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 AND A NO.: 209239 INDICATED FOR T HE TREATMENT OF OVERACTIVE B LADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENCY AND URINARY FREQUENCY SOL IFENACIN SUCCINATE TAB 5MG 30 NDC CODE:68462038630 FDA PRO DUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICATED FOR TH E TREATMENT OF OVERACTIVE BL ADDER WITH SYMPTOMS OF URGE U RINARY INCONTINENCE, URGENCY AND URINARY FREQUENCY APRE PITANT CAP 125-80MG 3UOU NDC CODE:68462011233 HTS NO : 300 4.90.92.40 FDA CODE : 61 T C E 32 ANDA NO : 207777 THERAP EUTICE USE : APREPITANT IS US ED WITH OTHER MEDICATIONS TO HELP PREVENT VOMITING CAUSED BY CANCER DRUG TREATMENT A PREPITANT CAP 125-80MG 3UOU N DC CODE:68462011233 HTS NO : 3004.90.92.40 FDA CODE : 61 T C E 32 ANDA NO : 207777 THE RAPEUTICE USE : APREPITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVENT VOMITING CAUS ED BY CANCER DRUG TREATMENT NITROGLYCERIN SUBLING TAB 0. 4MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90. 9020 ANDA NO.:206391 THERAPE UTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PR ESSURE,AND TO TREAT AND PREVE NT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART A PREPITANT CAP 40MG 1UD NDC CO DE:68462058340 FDA PRODUCT CO DE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE: AP REPITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NA USEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOT HERAPY). THIS MEDICATION IS A LSO USED TO PREVENT NAUSEA AN D VOMITING AFTER SURGERY. A- EMETIC/NAUSEANT / HUMAN - RX/ SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT COMMERCIAL & CUSTOM INVOICE NO. F22387000633 DT. 26.07.2 022 F22387000634 DT. 26.07.20 22 F22387000635 DT. 26.07.202 2 F22387000636 DT. 26.07.2022 F22387000637 DT. 26.07.2022 F22387000638 DT. 26.07.2022 F22387000641 DT. 27.07.2022 N ET WT. 430.79 KGS 42 DATA L OGGERS HUMIDITY:65% SET TEMP ERATURE : +18 DEGREES TEMPERA TURE RANGE : +15 DEGREES TO +2 5 DEGREES NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 300490 |
2022-07-26 |
40 PKG |
9275.21KG |
40 PALLETS 2841 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TAB 600MG 500 NDC COD E:68462012605 FDA PRODUCT COD E NO: 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-662 THERAPEUTICE USE:-ANTI CONVULSANT AGENT PRAVASTAT IN SOD TAB 40MG 500 NDC CODE: 68462019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO. : 3004.90.92.20 ANDA NO.: 77 -987 THERAPEUTICE USE: HYPOL IPDAEMIC LAMOTRIGINE TAB CD 25MG 100 NDC CODE:6846202290 1 FDA PRODUCT CODE NO.:- 61 M C A 38 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-79 # 099 T HERAPEUTICE USE:- ANTICONVULS ANT OLMESARTAN MEDOX TAB 20 MG 90 NDC CODE:68462043790 F DA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 A NDA NO.: 203281 THERAPEUTICE USE: - TREATMENT OF HYPERTEN SION, ALONE OR WITH OTHER AN TIHYPERTENSIVE AGENTS, TO LOW ER BLOOD PRESSURE HEATHER T AB 0.35MG 84 NDC CODE:6846203 0329 FDA PRODUCT CODE NO.: 6 5 J C A 24 H. T. S NO.: 3006 .60.00.00 ANDA NO.:90-454 TH ERAPEUTICE USE: PREVENTION OF PREGNANCY. NAPROXEN TAB 50 0MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAP EUTICE USE:-ANTI-INFLAMMATORY , ANALGESIC FLUCONAZOLE TA B 50MG 30 NDC CODE:6846201013 0 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90 .92.45 ANDA NO.:-77 - 253 TH ERAPEUTICE USE:-ANTIFUNGAL COMMERCIAL & CUSTOM INVOICE N O. F22352001819 DT. 28.07.202 2 F22352001820 DT. 28.07.2022 F22352001821 DT. 28.07.2022 F22352001828 DT. 28.07.2022 NET WT. 7,605.81 KGS 02 DAT A LOGGERS HUMIDITY:65% SET T EMPERATURE : +18 DEGREES TEMP ERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 611300 |
2022-07-26 |
22 PKG |
4100.54KG |
22 PALLETS 631 CARTONS PHA RMACEUTICALS AS UNDER NAPRO XEN TAB 500MG 500 NDC CODE:68 462019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI-IN FLAMMATORY, ANALGESIC MUPI ROCIN OINT 2% 22GM NDC CODE:6 8462018022 FDA PRODUCT CODE N O.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90- 480 THERAPEUTICE USE: - ANTI -BACTERIAL HAILEY 24 FE TAB 1MG/20MCG-75MG 84 NDC CODE:6 8462073129 FDA PRODUCT CODE N O.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204 847 THERAPEUTICE USE: - CONT RACEPTION TO PREVENT PREGNANC Y HEATHER TAB 0.35MG 84 ND C CODE:68462030329 FDA PRODUC T CODE NO.: 65 J C A 24 H. T . S NO.: 3006.60.00.00 ANDA NO.:90-454 THERAPEUTICE USE: PREVENTION OF PREGNANCY. C OMMERCIAL & CUSTOM INVOICE NO. F22352001217 DT. 23.06.2022 F22352001218 DT. 23.06.2022 F22352001219 DT. 23.06.2022 F 22352001228 DT. 23.06.2022 S/ BILL NO: 2335798 DT:23/06/2022 S/BILL NO: 2338702 DT:23/06/ 2022 S/BILL NO: 2339798 DT:23 /06/2022 S/BILL NO: 2339809 D T:23/06/2022 NET WT: 3192.77 KGS 04 DATA LOGGERS NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 624900 |
2022-07-26 |
1 PKG |
5000.03KG |
PHARMACEUTICALS AS UNDER |
HS 300680 |
2022-07-26 |
38 PKG |
6036.06KG |
38 PALLETS 2047 CARTONS PHARMACEUTICALS AS UNDER T OPIRAMATE TAB 100MG 500 NDC C ODE:68462010905 FDA PRODUCT C ODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. : 77627 THERAPEUTICE USE: :# ANTICONVULSANT ONDANSETRON ODT 4MG 30UD NDC CODE:6846201 5713 FDA PRODUCT CODE NO,:-6 1 T C A 26 H. T. S NO.: 3004 .90.92.40 ANDA NO.:-78-152 T HERAPEUTICE USE:-ANTI EMETIC PRAVASTATIN SOD TAB 40MG 50 0 NDC CODE:68462019705 FDA P RODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: HYPOLIPDAEMIC OMEPRA ZOLE DR CAP 40MG 1000 NDC COD E:68462039710 FDA PRODUCT COD E NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL RE FLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F223520012 77 DT. 26.06.2022 F2235200128 3 DT. 26.06.2022 S/BILL NO:24 22847 DT:27-JUN-22 S/BILL NO :2421724 DT:27-JUN-22 NET WT : 4,946.84 KGS 02 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 612600 |
2022-07-26 |
58 PKG |
12211.82KG |
58 PALLETS 2219 CARTONS PH ARMACEUTICALS AS UNDER OMEPRA ZOLE DR CAP 40MG 1000 NDC COD E:68462039710 FDA PRODUCT COD E NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL RE FLUX DISEASE NAPROXEN TAB 500MG 500 NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90 .92.40 ANDA NO.:-78-250 THER APEUTICE USE:-ANTI-INFLAMMATO RY, ANALGESIC FLUCONAZOLE TAB 50MG 30 NDC CODE:68462010 130 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004. 90.92.45 ANDA NO.:-77 - 253 THERAPEUTICE USE:-ANTIFUNGAL TOPIRAMATE TAB 100MG 60 ND C CODE:68462010960 FDA PRODUC T CODE NO.:-61 M C A 40 H. T . S NO.: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTICE US E:-ANTICONVULSANT RILUZOLE TAB 50MG 60 NDC CODE:68462038 160 FDA PRODUCT CODE NO.: 62 J C A 16 H. T. S NO.: 3004. 90.92.30 ANDA NO.: 91394 THE RAPEUTICE USE: - A-PARKINSONI AN/ HUMAN - RX/SINGLE INGREDI ENT / PROMPT RELEASE TABLETS / RILUZOLE (ANTI-PARKINSONIA N) GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PR ODUCT CODE NO: 61 N C A 69 H . T. S NO.: 3004.90.92.30 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-662 THERAPEUTICE USE:-A NTICONVULSANT AGENT COMMERCI AL & CUSTOM INVOICE NO. F2235 2001314 DT. 28.06.2022 F22352 001319 DT. 28.06.2022 F223520 01322 DT. 29.06.2022 S/BILL N O: 2472797 DT:29-JUN-22 S/BI LL NO: 2472099 DT:29-JUN-22 S/BILL NO: 2471990 DT:29-JUN- 22 NET WT. 10,747.02 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 624900 |
2022-07-26 |
41 PKG |
6179.85KG |
41 PALLETS 2111 CARTONS PH ARMACEUTICALS AS UNDER ON DANSETRON ODT 4MG 30UD NDC C ODE:68462015713 FDA PRODUCT CODE NO,:-61 T C A 26 H. T . S NO.: 3004.90.92.40 AND A NO.:-78-152 THERAPEUTICE U SE:-ANTI EMETIC CICLOPI ROX OLAMINE CREAM 0.77% 15GM NDC CODE:68462029717 FDA PR ODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 ANDA NO.:- 90 - 273 THERA PEUTICE USE:-ANTIFUNGAL USE. NORETHINDRONE TAB 0.35MG 84 NDC CODE:68462030529 F DA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60. 00.00 ANDA NO.:91-209 THER APEUTICE USE: PREVENTION OF PREGNANCY. LEVONORGESTREL /EE TAB 0.15/0.03MG 273 NDC CODE:68462067295 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 AND A NO.: 203164 THERAPEUTICE U SE: - CONTRACEPTION TO PREVE NT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F22352 001724 DT. 23.07.2022 F22352 001725 DT. 23.07.2022 F22352 001727 DT. 23.07.2022 F22352 001730 DT. 23.07.2022 S/BILL NO:3020205 DT 23-JUL-2022 S /BILL NO:3020148 DT 23-JUL-202 2 S/BILL NO:3031164 DT 23-JU L-2022 S/BILL NO:3031161 DT 23-JUL-2022 NET WT. 4,581.2 3 KGS 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA |
HS 612600 |
2022-07-26 |
3 PKG |
462.22KG |
3 PALLETS 145 CARTONS PHA RMACEUTICALS AS UNDER CLI NDAMYCIN-BPO GEL PUMP 1%/5% 35 GM NDC CODE:68462085924 FD A PRODUCT CODE NO.: 61 H D J 99 H. T. S NO.: 3004.49.0 0.50 ANDA NO.: #209252 THE RAPEUTICE USE: CLINDAMYCIN A ND BENZOYL PEROXIDE GEL IS I NDICATED FOR THE TOPICAL T REATMENT OF ACNE VULGARIS. COMMERCIAL & CUSTOM INVOIC E NO. F22352001726 DT. 23.07 .2022 S/BILL NO:3020288 DT 2 3-JUL-2022 NET WT. 368.30 KGS 03 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPEC IALTY S.A. SWITZERLAND (GSSA ) PLACE NUMA-DROZ 2 NEUCHA TEL - 2000 SWITZERLAND |
HS 619900 |
2022-07-26 |
1 PKG |
5000.03KG |
PHARMACEUTICALS AS UNDER |
HS 300680 |
2022-07-26 |
1 PKG |
5000.03KG |
PHARMACEUTICALS AS UNDER |
HS 300680 |
2022-07-26 |
11 PKG |
2666.26KG |
11 PALLETS 1139 CARTONS PHARMACEUTICALS AS UNDER C LINDAMYCIN-BPO GEL PUMP 1%/5% 50GM NDC CODE:68462085927 FD A PRODUCT CODE NO.: 61 H D J 99 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: #209252 THERAPEU TICE USE: #CLINDAMYCIN AND B ENZOYL PEROXIDE GEL IS INDICA TED FOR THE TOPICAL TREATMENT OF ACNE VULGARIS. ROSUVAS TATIN TAB 40MG 500 NDC CODE:6 8462026405 61 J C A 16 3004. 49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED COND ITIONS, AND TO PREVENT CARDI OVASCULAR DISEASE ROSUVASTA TIN TAB 40MG 30 NDC CODE:6846 2026430 FDA PRODUCT CODE NO. :61 J C A 16 H. T. S NO.: 30 04.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE COMM ERCIAL & CUSTOM INVOICE NO. F 22352001786 DT. 26.07.2022 F2 2352001788 DT. 26.07.2022 S/B ILL NO:3088241 DT 27-JUL-2022 S/BILL NO:3088253 DT 27-JUL-2 022 11 DATA LOGGERS HUMIDITY :65% SET TEMPERATURE : +18 DE GREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIF Y PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND |
HS 619900 |
2022-07-26 |
5 PKG |
455.41KG |
5 PALLETS 107 CARTONS PHA RMACEUTICALS AS UNDER CLO BETASOL PROP CREAM 0.05% 60GM NDC CODE:68462052965 FDA P RODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 209095 THERAPE UTICE USE: - CLOBETASOL PROP IONATE CREAM IS A SUPER-HIGH POTENCY CORTICOSTEROID FO RMULATIONS INDICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DERMATOSES CLOBETASOL PROP CREAM 0.05% 45GM NDC CO DE:68462052947 FDA PRODUCT C ODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209095 THERAPEUTICE US E: - CLOBETASOL PROPIONATE CREAM IS A SUPER-HIGH POTEN CY CORTICOSTEROID FORMULATIO NS INDICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRUR ITIC MANIFESTATIONS OF COR TICOSTEROID-RESPONSIVE DERMA TOSES CLOBETASOL PROP CRE AM 0.05% 60GM NDC CODE:68462 052965 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 20 9095 THERAPEUTICE USE: - C LOBETASOL PROPIONATE CREAM I S A SUPER-HIGH POTENCY CORTI COSTEROID FORMULATIONS INDIC ATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC M ANIFESTATIONS OF CORTICOSTER OID-RESPONSIVE DERMATOSES COMMERCIAL & CUSTOM INVOICE NO. F22335001715 DT. 22.07. 2022 F22335001761 DT. 25.07. 2022 NET WT. 245.52 KGS 08 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGRE ES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PL ACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 646700 |
2022-07-26 |
13 PKG |
1707.8KG |
13 PALLETS 634 CARTONS PH ARMACEUTICALS AS UNDER HEAT HER TAB 0.35MG 84 NDC CODE:68 462030329 FDA PRODUCT CODE NO .: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-45 4 THERAPEUTICE USE: PREVENTI ON OF PREGNANCY. COMMERCIA L & CUSTOM INVOICE NO. F22352 001824 DT. 28.07.2022 NET WT. 1,102.08 KGS 02 DATA LOGGER S HUMIDITY:65% NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652400 |
2022-07-26 |
37 PKG |
9953.8KG |
37 PALLETS 2122 CARTONS PHARMACEUTICALS AS UNDER V ERAPAMIL HCL ER TAB 240MG 100 NDC CODE:68462026001 FDA PRO DUCT CODE NO.: 62 O C B 13 H . T. S NO.: 3004.90.92.20 AN DA NO.:-78-906 THERAPEUTICE USE:-ANGINA VERAPAMIL HCL E R TAB 240MG 500 NDC CODE:6846 2026005 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3 004.90.92.20 ANDA NO.:-78-906 THERAPEUTICE USE:-ANGINA MUPIROCIN CREAM 2% 15GM NDC CODE:68462056417 FDA PRODUCT CODE NO.: 61GCJ82 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 01587 THERAPEUTICE USE: - TO PICAL ANTI-BACTERIAL MUPIRO CIN CREAM 2% 30GM NDC CODE:68 462056435 FDA PRODUCT CODE NO .: 61GCJ82 H. T. S NO.: 300 4.90.92.45 ANDA NO.: 201587 THERAPEUTICE USE: - TOPICAL A NTI-BACTERIAL OMEPRAZOLE DR CAP 40MG 100 NDC CODE:684620 39701 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90 .9160 ANDA NO.: 91672 THERAP EUTICE USE: - TREATMENT OF TR EAT GASTROESOPHAGEAL REFLUX DISEASE ROPINIROLE TAB 4MG 100 NDC CODE:68462025801 FDA PRODUCT CODE NO.:-62 J C A 1 7 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUT ICE USE:-TREATMENT OF PARKIN SONISM OMEPRAZOLE DR CAP 40 MG 90 NDC CODE:68462039790 F DA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 A NDA NO.: 91672 THERAPEUTICE U SE: - TREATMENT OF TREAT GAS TROESOPHAGEAL REFLUX DISEASE GABAPENTIN TAB 600MG 500 N DC CODE:68462012605 FDA PRODU CT CODE NO: 61 N C A 69 H. T . S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE :-ANTICONVULSANT AGENT COM MERCIAL & CUSTOM INVOICE NO. F22352001740 DT. 24.07.2022 F 22352001742 DT. 24.07.2022 F2 2352001784 DT. 26.07.2022 F22 352001787 DT. 26.07.2022 S/BI LL NO:3088255 DT 27-JUL-2022 S/BILL NO:3088207 DT 27-JUL-20 22 S/BILL NO:3088254 DT 27-JU L-2022 S/BILL NO:3088246 DT 2 7-JUL-2022 NET WT. 8,751.00 KGS 02 DATA LOGGERS HUMIDIT Y:65% SET TEMPERATURE : +18 D EGREES TEMPERATURE RANGE : +1 5 DEGREES TO +25 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 621300 |
2022-07-26 |
9 PKG |
2381.4KG |
9 PALLETS 417 CARTONS PHA RMACEUTICALS AS UNDER IND OMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA PRODUC T CODE: 62 GCE42 H. T. S NO.:3004.90.92.40 ANDA NO.2 03501 THERAPEUTIC USE: IND OMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT S TIFFNESS CAUSED BY ARTHRITIS , GOUT, BURSITIS, AND TENDON ITIS. IT IS ALSO USED TO REL IEVE PAIN FROM VARIOUS OTHER CONDITIONS. THIS MEDICATI ON IS KNOWN AS A NONSTEROIDA L ANTI-INFLAMMATORY DRUG ( NSAID). ... THIS EFFECT HELP S TO DECREASE SWELLING AND PAIN. CARVEDILOL TAB 25M G 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.9 0.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO . F22387000651 DT. 27.07.202 2 NET WT. 1,958.01 KGS 03 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 622200 |
2022-07-26 |
28 PKG |
5221.39KG |
28 PALLETS 723 CARTONS PH ARMACEUTICALS AS UNDER CL OBETASOL PROP SOLN 0.05% 50ML NDC CODE:68462053253 FDA P RODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 210190 THERAPE UTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIE NT / NONSTERILE LIQUID / C LOBETASOL PROPIONATE (GLUCOC ORTICOID) MOMETASONE FURO CREAM 0.1% 45GM NDC CODE:68 462019255 FDA PRODUCT CODE N O.: 62 F C J 53 H. T. S NO .: 3004.40.49.50 ANDA NO.: 78-541 THERAPEUTICE USE: A NTI-INFLAMMATORY- DERMATOLOG IC MOMETASONE FURO SOLN 0 .1% 30ML NDC CODE:6846203853 7 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 300 4.90.92.45 ANDA NO.:090506 THERAPEUTICE USE: MOMETASON E FUROATE TOPICAL SOLUTION ( LOTION) IS A CORTICOSTEROI D INDICATED FOR THE RELIEF O F THE INFLAMMATORY AND PRURI TIC MANIFESTATIONS OF CORT ICOSTEROID-RESPONSIVE DERMAT OSES IN PATIENTS #12 YEARS OF AGE. MOMETASONE FURO CREAM 0.1% 15GM NDC CODE:684 62019217 FDA PRODUCT CODE NO .: 62 F C J 53 H. T. S NO. : 3004.40.49.50 ANDA NO.:7 8-541 THERAPEUTICE USE: AN TI-INFLAMMATORY- DERMATOLOGI C MOMETASONE FURO SOLN 0. 1% 60ML NDC CODE:68462038502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004 .90.92.45 ANDA NO.:090506 THERAPEUTICE USE: MOMETASONE FUROATE TOPICAL SOLUTION (L OTION) IS A CORTICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURIT IC MANIFESTATIONS OF CORTI COSTEROID-RESPONSIVE DERMATO SES IN PATIENTS #12 YEARS OF AGE. COMMERCIAL & CUST OM INVOICE NO. F22335001760 DT. 25.07.2022 F22335001714 DT. 22.07.2022 NET WT. 2,531 .90 KGS 28 DATA LOGGERS HU MIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREE S NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA |
HS 646700 |
2022-07-26 |
1 PKG |
5000.03KG |
PHARMACEUTICALS AS UNDER |
HS 300680 |
2022-07-26 |
1 PKG |
5000.03KG |
PHARMACEUTICALS AS UNDER |
HS 300680 |
2022-07-26 |
20 PKG |
4173.12KG |
20 PALLETS 1236 CARTONS P HARMACEUTICALS AS UNDER IND OMETHACIN ER CAP 75MG 90 NDC CODE:68462032590 H. T. S NO.: 3004.90.92.40 CARVEDILOL TAB 25MG 500 NDC CODE:6846201 6505 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST PRAVA STATIN SOD TAB 40MG 500 NDC C ODE:68462019705 FDA PRODUCT C ODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. : 77-987 THERAPEUTICE USE: H YPOLIPDAEMIC TELMISARTAN-HC TZ TAB 40MG/12.5MG 30UD NDC C ODE:68462084013 62 O D A 09 3004.90.92.20 202544 TELMISA RTAN AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATED FOR TH E TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE. COMMERCIAL & CUSTOM INVOICE NO . F22387000659 DT. 28.07.2022 F22387000661 DT. 29.07.2022 F22387000664 DT. 29.07.2022 NET WT. 2,655.00 KGS 05 D ATA LOGGERS HUMIDITY:65% NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA |
HS 401253 |
2022-07-26 |
2 PKG |
501.23KG |
2 PALLETS 63 CARTONS PHAR MACEUTICALS AS UNDER NITROG LYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE,A ND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD F LOW TO THE HEART COMMERCIA L & CUSTOM INVOICE NO. F22387 000660 DT. 28.07.2022 NET WT. 33.57 KGS 02 DATA LOGGERS HUMIDITY:65% NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZ ERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERL AND |
HS 662800 |
2022-07-26 |
41 PKG |
7023.09KG |
41 PALLETS 2516 CARTONS PHARMACEUTICALS AS UNDER O NDANSETRON ODT 4MG 30UD NDC C ODE:68462015713 FDA PRODUCT C ODE NO,:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO. :-78-152 THERAPEUTICE USE:-AN TI EMETIC ROPINIROLE TAB 1 MG 100 NDC CODE:68462025501 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92 .40 ANDA NO.:- 90-135 THERAP EUTICE USE:-TREATMENT OF PAR KINSONISM VERAPAMIL HCL ER TAB 240MG 100 NDC CODE:684620 26001 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 300 4.90.92.20 ANDA NO.:-78-906 THERAPEUTICE USE:-ANGINA N ORETHINDRONE TAB 0.35MG 84 ND C CODE:68462030529 FDA PRODUC T CODE NO.: 65 J C A 26 H. T . S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTION OF PREGNANCY. L EVONORGESTREL/EE TAB 0.15/0.03 MG 273 NDC CODE:68462067295 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.00 00 ANDA NO.: 203164 THERAPEU TICE USE: - CONTRACEPTION TO PREVENT PREGNANCY COMMERCI AL & CUSTOM INVOICE NO. F2235 2001736 DT. 23.07.2022 F22352 001756 DT. 25.07.2022 S/BILL NO: 3054139 DT 25-JUL-2022 S /BILL NO: 3054132 DT 25-JUL-20 22 NET WT. 5,440.36 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 621700 |
2022-07-19 |
8 PKG |
1315.44KG |
8 PALLETS 618 CARTON S PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 10MG 90 N DC CODE:68462026290 FDA PRODU CT CODE NO.:61 J C A 16 H. T . S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DIS EASE ROSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULA R DISEASE COMMERCIAL & CUST OM INVOICE NO. F22352001203 D T. 22.06.2022 NET WT: 1,031. 82 KGS 08 DATA LOGGERS NOTIFY PARTY:2 GLENMARK SPEC IALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND S/BILL NO: 2323888 DT 23-JUN-2022 |
HS 611600 |
2022-07-19 |
36 PKG |
6647.05KG |
36 PALLETS 1538 CARTONS PH ARMACEUTICALS AS UNDER VIOR ELE TAB 0.15/0.02-0.01MG 84 N DC CODE:68462031829 FDA PRODU CT CODE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTICE USE : - ORAL CONTRACEPTIVES GA BAPENTIN TAB 800MG 500 NDC CO DE:68462012705 FDA PRODUCT CO DE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT COMMERCIA L & CUSTOM INVOICE NO. F22352 001230 DT. 23.06.2022 F223520 01239 DT. 23.06.2022 S/BILL N O: 2361438 DT 24-JUN-2022 S/B ILL NO: 2361638 DT 24-JUN-2022 NET WT: 5424.37 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 642700 |
2022-07-15 |
53 PKG |
8231.48KG |
53 PALLETS 2238 CART ONS PHARMACEUTICALS AS UNDE R OMEPRAZOLE DR CAP 40MG 10 00 NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROES OPHAGEAL REFLUX DISEASE IN DOMETHACIN CAP 50MG 500 NDC C ODE:68462030205 FDA PRODUCT C ODE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO. :91-276 THERAPEUTICE USE: AN TI-INFLAMATORY TOPIRAMATE T AB 50MG 60 NDC CODE:684620153 60 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.4 9.00.20 ANDA NO.:- 77-627 TH ERAPEUTICE USE:-ANTICONVULSAN T PRAVASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PRODUCT CODE NO.: 61 J C A 1 3 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTI CE USE: HYPOLIPDAEMIC 3004.9 0.92.40 HEATHER TAB 0.35MG 84 NDC CODE:68462030329 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-454 THERAPEUTICE USE: PREVENTION OF PREGNANCY . HEATHER TAB 0.35MG 84 ND C CODE:68462030329 FDA PRODUC T CODE NO.: 65 J C A 24 H. T . S NO.: 3006.60.00.00 ANDA NO.:90-454 THERAPEUTICE USE: PREVENTION OF PREGNANCY. C OMMERCIAL & CUSTOM INVOICE NO. F22352001128 DT. 17.06.2022 F22352001129 DT. 17.06.2022 F22352001130 DT. 17.06.2022 F 22352001136 DT. 18.06.2022 F2 2352001139 DT. 18.06.2022 S/B ILL NO: 2221908 DT.18-JUN-22 S/BILL NO: 2221955 DT.18-JUN-2 2 S/BILL NO: 2226119 DT.18-JU N-22 S/BILL NO: 2226412 DT. 1 8-JUN-22 S/BILL NO: 2226592 D T.18-JUN-22 NET WT: 6,455.3 0 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA |
HS 621000 |
2022-07-06 |
43 PKG |
7138.76KG |
43 PALLETS 1701 CART ONS PHARMACEUTICALS AS UNDE R OMEPRAZOLE DR CAP 40MG 10 00 NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROES OPHAGEAL REFLUX DISEASE NA PROXEN TAB 500MG 500 NDC CODE :68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC N ORETH ACE/EE TAB 1MG/5MCG 90 NDC CODE:68462065790 FDA PROD UCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 AND A NO.: 203038 THERAPEUTICE US E: - TREATMENT OF MODERATE T O SEVERE VASOMOTOR SYMPTOMS DUE TO MENOPAUSE; OSTEOPOROSI S PREVENTION MARLISSA TAB 0 .15/0.03MG 84 NDC CODE:684620 38829 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 300 6.60.0000 ANDA NO.: 091452 T HERAPEUTICE USE: ORAL CONTRAC EPTIVE NORETHINDRONE ACE TA B 5MG 50 NDC CODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00 .50 ANDA NO.:-91-090 THERAPE UTICE USE:- SECONDARY AMENOR RHEA,ENDOMETRIOS IS AND ABNOR MAL UTERINE BLEEDING COMME RCIAL & CUSTOM INVOICE NO. F2 2352000988 DT. 09.06.2022 F22 352000989 DT. 09.06.2022 F223 52000994 DT. 09.06.2022 NET W T: 5,541.38 KGS 03 DATA LO GGERS HUMIDITY:65% SET TEMPE RATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 2041615 DT 11-JUN-2022 S/BILL NO: 204161 8 DT 11-JUN-2022 S/BILL NO: 2 041598 DT 11-JUN-2022 |
HS 621000 |
2022-07-06 |
19 PKG |
2709.35KG |
19 PALLETS 1637 CART ONS PHARMACEUTICALS AS UNDE R ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PR ODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 A NDA NO.: 79172 THERAPEUTICE U SE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DI SEASE. ROSUVASTATIN TAB 5MG 90 NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTIC E USE: - TO TREAT HIGH CHOLES TEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCUL AR DISEASE COMMERCIAL & CUS TOM INVOICE NO. F22352000973 DT. 08.06.2022 NET WT. 2,057 .62 KGS 19 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK S PECIALTY S.A. SWITZERLAND (GS SA) PLACE NUMA-DROZ 2 NEUCHA TEL - 2000 SWITZERLAND S/B ILL NO: 2009620 DT: 09-JUN-22 |
HS 611600 |
2022-07-06 |
7 PKG |
2684.86KG |
7 PALLETS 643 CARTON S PHARMACEUTICALS AS UNDER ATOVAQUONE ORAL SUSP 750MG/ 5ML 210ML NDC CODE:6846204212 1 FDA PRODUCT CODE NO.: 62 L C L 44 H. T. S NO.: 3004.90 .92.90 ANDA NO.: 209685 USED TO PREVENT OR TREAT A SERIOU S LUNG INFECTION CALLED PNEUM OCYSTIS PNEUMONIA (PCP). THIS MEDICATION HELPS TO STOP IN FECTION SYMPTOMS SUCH AS FEVE R, COUGH, TIREDNESS, AND SHOR TNESS OF BREATH. COMMERCIA L & CUSTOM INVOICE NO. F22335 000936 DT. 31.05.2022 NET WT. 2,361.10 KGS 07 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND S/BILL NO: 1924315 DT: 06-JUN -22 |
HS 624400 |
2022-07-06 |
22 PKG |
4764.61KG |
22 PALLETS 1497 CARTONS PH ARMACEUTICALS AS UNDER CHLO RPROMAZINE HCL TAB 100MG 100 NDC CODE:68462086401 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SU CH AS SCHIZOPHRENIA OR MANIC -DEPRESSION IN ADULTS EZET IMIBE-SIMVA TAB 10/80MG 30 ND C CODE:68462032430 FDA PRODUC T CODE NO.: 61 J D C 15 H. T . S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDICATIO N IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAIS E GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLE STEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELO NGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY RE DUCING THE AMOUNT OF CHOLESTE ROL MADE BY THE LIVER. FRO VATRIPTAN SUCCINATE TAB 2.5MG 9 NDC CODE:68462069497 FDA P RODUCT CODE NO.:60 L C A 93 H. T. S NO.: 3004.90.92.28 A NDA NO.:204730 THERAPEUTICE U SE: - USE:THE TREATMENT OF M IGRAINE HEADACHES AND FOR SHO RT TERM PREVENTION OF MENSTR UAL MIGRAINE CARVEDILOL TAB 25MG 500 NDC CODE:6846201650 5 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST TOPIRAMA TE ER CAP (Q) 25MG 30 NDC COD E:68462037230 3004.49.00.20 61 M C B 40 210278 PRAVAST ATIN SOD TAB 80MG 90 NDC CODE :68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO .: 3004.90.92.20 ANDA NO.:-7 7-987 THERAPEUTICE USE:-HYPO LIPDAEMIC RUFINAMIDE TAB 40 0MG 120 NDC CODE:68462071408 61 M C A 99 3004.90.92.30 2 05075 TO USED WITH OTHER MED ICATIONS TO PREVENT OR CONTRO L SEIZURES (EPILEPSY) ASSOCI ATED WITH LENNOX-GASTAUT SYN DROME (LGS PRAVASTATIN SOD TAB 10MG 500 NDC CODE:6846201 9505 FDA PRODUCT CODE NO.:-6 1 J C A 13 H. T. S NO.: 3004 .90.92.20 ANDA NO.:-77-987 T HERAPEUTICE USE:-HYPOLIPDAEMI C COMMERCIAL & CUSTOM INVOI CE NO. F22387000307 DT. 31.05 .2022 F22387000309 DT. 31.05. 2022 F22387000310 DT. 31.05.2 022 F22387000316 DT. 31.05.20 22 F22387000317 DT. 31.05.202 2 F22387000320 DT. 31.05.2022 F22387000329 DT. 31.05.2022 S/BILL NO: 4007990 DT:02/06 /2022 S/BILL NO: 4007992 DT: 02/06/2022 S/BILL NO: 400799 3 DT:02/06/2022 S/BILL NO: 4007995 DT:02/06/2022 S/BILL NO: 4007996 DT:02/06/2022 S/BILL NO: 4007997 DT:02/06/ 2022 S/BILL NO: 4007999 DT: 02/06/2022 NET WT: 2,701.12 K GS 08 DATA LOGGERS HUMIDITY: 65% SET TEMPERATURE : +18 DEG REES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA. |
HS 611500 |
2022-07-06 |
48 PKG |
9245.28KG |
48 PALLETS 2032 CARTONS P HARMACEUTICALS AS UNDER ALY ACEN 1/35 TAB 1/0.035MG 84 ND C CODE:68462039429 FDA PRODUC T CODE NO.: 65 J D A 24 H. T . S NO.: 3006.60.00.00 ANDA NO.: 091634 THERAPEUTICE USE: ORALCONTRACEPTIVE NORETH ACE/EE TAB 1MG/5MCG 90 NDC CO DE:68462065790 FDA PRODUCT CO DE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - TREATMENT OF MODERATE TO SEVE RE VASOMOTOR SYMPTOMS DUE TO MENOPAUSE; OSTEOPOROSIS PREV ENTION OMEPRAZOLE DR CAP 40 MG 1000 NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE U SE: - TREATMENT OF TREAT GAS TROESOPHAGEAL REFLUX DISEASE NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-250 THERAPEUTICE USE: -ANTI-INFLAMMATORY, ANALGESIC CARVEDILOL TAB 6.25MG 500 NDC CODE:68462016305 FDA PRO DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST OXCARBAZEPINE TAB 300MG 100 NDC CODE:6846201380 1 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90 .92.30 ANDA NO.:-77-802 THER APEUTICE USE:-ANTI CONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22352000899 DT. 03.06.2022 F22352000903 DT. 0 3.06.2022 F22352000892 DT. 03 .06.2022 F22352000896 DT. 03. 06.2022 F22352000897 DT. 03.0 6.2022 S/BILL NO: 1894018 DT 04-JUN-2022 S/BILL NO: 189391 1 DT 04-JUN-2022 S/BILL NO: 1 894077 DT 04-JUN-2022 S/BILL NO: 1893907 DT 04-JUN-2022 S/ BILL NO: 1894071 DT 04-JUN-202 2 NET WT: 7,640.13 KGS 02 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652400 |
2022-07-06 |
58 PKG |
13375.3KG |
58 PALLETS 4577 CARTONS PH ARMACEUTICALS AS UNDER TOPI RAMATE TAB 50MG 500 NDC CODE: 68462015305 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:077 627 THERAPEUTICE USE: ANTICO NVULSANT TOPIRAMATE TAB 50M G 60 NDC CODE:68462015360 FD A PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:- 77-627 THERAPEU TICE USE:-ANTICONVULSANT O XCARBAZEPINE TAB 600MG 100 ND C CODE:68462013901 FDA PRODUC T CODE NO.:-61 M C A 45 H. T . S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE: -ANTI CONVULSANT AGENT OXC ARBAZEPINE TAB 300MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO .:-77-802 THERAPEUTICE USE:-A NTI CONVULSANT AGENT PRAVA STATIN SOD TAB 40MG 500 NDC C ODE:68462019705 FDA PRODUCT C ODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. : 77-987 THERAPEUTICE USE: H YPOLIPDAEMIC POTASSIUM CL E R TAB 20MEQ 100 NDC CODE:6846 2047201 FDA PRODUCT CODE NO.: 65 R C A 14 H. T. S NO.: 3 004.90.9190 ANDA NO.: 203562 THERAPEUTICE USE: - TO TREAT OR PREVENT LOW AMOUNTS OF PO TASSIUM IN THE BLOOD CARVE DILOL TAB 6.25MG 500 NDC CODE :68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST OXCARBAZEPINE TAB 600MG 100 NDC CODE:68462013901 FDA PR ODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 A NDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT OMEPRAZOLE DR CAP 40MG 30 ND C CODE:68462039730 FDA PRODUC T CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE COMMER CIAL & CUSTOM INVOICE NO. F22 352000936 DT. 06.06.2022 F223 52000937 DT. 06.06.2022 F2235 2000938 DT. 06.06.2022 F22352 000942 DT. 06.06.2022 S/BILL NO: 1939395 DT 06-JUN-22 S/BI LL NO: 1939400 DT 06-JUN-22 S /BILL NO: 1939468 DT 06-JUN-22 S/BILL NO: 1945362 DT 07-JUN -2022 NET WT: 11,188.47 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 614000 |
2022-06-30 |
4 PKG |
645.93KG |
4 PALLETS 357 CARTONS PHA RMACEUTICALS AS UNDER ROSUV ASTATIN TABLETS 10MG 90 S NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE COMMERCIAL & CUSTOM INVO ICE NO. F22352000775 DT. 29.0 5.2022 NET WT: 496.223 KGS 0 4 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES NOTIFY PART Y:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA -DROZ 2 NEUCHATEL - 2000 SWI TZERLAND |
HS 611600 |
2022-06-30 |
55 PKG |
10956.25KG |
55 PALLETS 3832 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 150MG 100 NDC C ODE:68462013701 FDA PRODUCT C ODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-802 THERAPEUTICE USE:-AN TI CONVULSANT AGENT OXCARB AZEPINE TAB 300MG 100 NDC COD E:68462013801 FDA PRODUCT COD E NO.:-61 M C A 45 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT ONDANSET RON TAB 8MG 30 NDC CODE:68462 010630 FDA PRODUCT CODE NO.: -61 T C A 28 H. T. S NO.: 300 4.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANTI EMETI C VERAPAMIL HCL ER TAB 240M G 100 NDC CODE:68462026001 F DA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92. 20 ANDA NO.:-78-906 THERAPEU TICE USE:-ANGINA PRAMIPEXO LE TAB 0.125MG 90 NDC CODE:68 462033090 FDA PRODUCT CODE NO .: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-7 81 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE NAPROX EN TAB 500MG 100 NDC CODE:684 62019001 FDA PRODUCT CODE NO .:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-25 0 THERAPEUTICE USE:-ANTI-INF LAMMATORY, ANALGESIC VERAP AMIL HCL ER TAB 240MG 500 NDC CODE:68462026005 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA N O.:-78-906 THERAPEUTICE USE: -ANGINA TELMISARTAN TAB 40M G 30 NDC CODE:68462020030 FD A PRODUCT CODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.2 0 ANDA NO.:090032 THERAPEUTI CE USE: INDICATED FOR THE TR EATMENT OF HYPERTENSION, TO L OWER BLOOD PRESSURE PRAMIP EXOLE TAB 0.125MG 90 NDC CODE :68462033090 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO .: 3004.90.92.40 ANDA NO.: 9 0-781 THERAPEUTICE USE: USED IN PARKINSONS DISEASE COMM ERCIAL & CUSTOM INVOICE NO. F 22352000773 DT. 29.05.2022 F2 2352000774 DT. 29.05.2022 F22 352000776 DT. 29.05.2022 F223 52000777 DT. 29.05.2022 F2235 2000788 DT. 30.05.2022 NET WT : 8,872.81 KGS 02 DATA LOGGE RS HUMIDITY:65% SET TEMPERAT URE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DE GREES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA S/BILL NO: 1772988 DT 30-MAY-2022 S/ BILL NO: 1772943 DT 30-MAY-202 2 S/BILL NO: 1772987 DT 30-MA Y-2022 S/BILL NO: 1799668 DT 31-MAY-2022 S/BILL NO: 180035 0 DT 31-MAY-2022.. |
HS 612800 |
2022-06-30 |
62 PKG |
6867.05KG |
62 PALLETS 2161 CARTONS PH ARMACEUTICALS AS UNDER FLUC ONAZOLE TABLETS 150MG 12 S (12 X1UD) NDC CODE:68462011944 N DC CODE : 68462011944 HTS NO : 3004.90.92.45 FDA CODE : 6 1 W C A 45 ANDA NO. : 77 - 25 3 THERAPEUTICE USE : ANTIFUN GAL OXCARBAZEPINE TABLETS 6 00MG 100 S NDC CODE:684620139 01 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-802 THE RAPEUTICE USE:-ANTI CONVULSAN T AGENT ACAMPROSATE CALCIUM DR TABS 333MG 180 S NDC CODE :68462043518 FDA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO .: 3004.90.92.40 ANDA NO.:20 2229 THERAPEUTICE USE: - FOR TREATING ALCOHOL DEPENDENCE CARVEDILOL TABS 3.125MG 100 S NDC CODE:68462016201 FDA PRODUCT CODE NO - 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST VERAPAMIL HCL E R TABS 120MG 100S NDC CODE:68 462029201 FDA PRODUCT CODE NO .: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-7 00 THERAPEUTICE USE: - ANGIN A COMMERCIAL & CUSTOM INVOI CE NO. F22352000741 DT. 27.05 .2022 F22352000747 DT. 27.05. 2022 S/BILL NO: 1714073 DT 27 -MAY-2022 S/BILL NO: 1714070 DT 27-MAY-2022 NET WT: 5,530 .18 KGS 02 DATA LOGGERS N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA |
HS 300490 |
2022-06-30 |
40 PKG |
7392.32KG |
40 PALLETS 1990 CARTONS PHARMACEUTICALS AS UNDER ALYACEN 1/35 TAB 1 /0.035MG 84 NDC CODE:68462039 429 FDA PRODUCT CODE NO.: 65 J D A 24 H. T. S NO.: 3006. 60.00.00 ANDA NO.: 091634 TH ERAPEUTICE USE: ORALCONTRACEP TIVE NORGEST/EE TAB .18,.21 5,.25/.035MG 84 NDC CODE:6846 2056529 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3 006.60.00.00 ANDA NO.: 200494 THERAPEUTICE USE: - ORAL CO NTRACEPTIVES COMMERCIAL & C USTOM INVOICE NO. F2235200085 1 DT. 31.05.2022 S/BILL NO: 1 855721 DT 02-JUN-2022 NET WT. 5,722.68 KGS 02 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA. |
HS 652400 |
2022-06-30 |
51 PKG |
9986.91KG |
51 PALLETS IN 2487 CARTONS PHARMACEUTICALS AS UNDER AD APALENE-BPO GEL PUMP 0.1/2.5% 45GM NDC CODE:68462030147 FD A PRODUCT CODE NO.: 62 S D O 02 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 208108 THERAPEUT ICE USE: - USED ON THE SKIN T O TREAT ACNE PRAVASTATIN S OD TAB 40MG 90 NDC CODE:68462 019790 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 30 04.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: HYPOLIPDAE MIC OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68462039710 FD A PRODUCT CODE NO.:62KCF10 H . T. S NO.: 3004.90.9160 AND A NO.:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTRO ESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 25MG 500 NDC C ODE:68462010805 FDA PRODUCT C ODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :077627 THERAPEUTICE USE: AN TICONVULSANT FELODIPINE ER TAB 5MG 100 NDC CODE:68462023 401 FDA PRODUCT CODE NO.: 62 OCB32 H. T. S NO.: 3004.90.9 2.20 ANDA NO.: 90-365 THERAP EUTICE USE: - TREATMENT OF H YPERTENSION CARVEDILOL TAB 6.25MG 100 NDC CODE:684620163 01 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.9 0.92.20 ANDA NO.:- 78-251 TH ERAPEUTICE USE:-BETA- ADRENO ACEPTOR ANTAGONIST PRAMIPE XOLE TAB 1.5MG 90 NDC CODE:68 462033490 FDA PRODUCT CODE NO .: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-7 81 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE CARVED ILOL TAB 6.25MG 500 NDC CODE: 68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO .:-78-250 THERAPEUTICE USE:- ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-250 THERAPEUTICE USE: -ANTI-INFLAMMATORY, ANALGESIC COMMERCIAL & CUSTOM INVOICE NO. F22352000803 DT. 30.05.20 22 F22352000806 DT. 30.05.202 2 F22352000819 DT. 31.05.2022 F22352000820 DT. 31.05.2022 F22352000822 DT. 31.05.2022 F22352000855 DT. 31.05.2022 F 22352000860 DT. 31.05.2022 NE T WT.: 8522.40 02 DATA LOGGER S HUMIDITY:65% NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 1834791 DT 01-JUN- 2022 S/BILL NO: 1834793 DT 01 -JUN-2022 S/BILL NO: 1834776 DT 01-JUN-2022 S/BILL NO: 183 4781 DT 01-JUN-2022 S/BILL NO : 1834792 DT 01-JUN-2022 S/BI LL NO: 1834795 DT 01-JUN-2022 S/BILL NO: 1834777 DT 01-JUN- 2022 |
HS 620200 |
2022-06-30 |
3 PKG |
496.69KG |
PHARMACEUTICALS AS UNDER FL UOCINOLONE ACE SCALP OIL 0.01% 118ML NDC CODE:68462059089 FDA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00 .50 ANDA NO.: 210539 SYNTHET IC CORTICOSTEROID FOR TOPICAL DERMATOLOGIC USE FOR THE TRE ATMENT OF PSORIASIS OF THE SC ALP NYSTATIN-TRIAM 100K UNI T/0.1% OINT 30GM NDC CODE:684 62079935 FDA PRODUCT CODE NO. : 64 L D J 60 H. T. S NO.: 3004.49.00.50 ANDA NO.: 20830 0 THERAPEUTICE USE: - TREATM ENT OF FUNGAL INFECTIONS OF T HE SKIN, ESPECIALLY YEAST IN FECTIONS. BETAMETHASONE DIP AUG CRM USP 0.05% NDC CODE:6 8462029017 FDA PRODUCT CODE N O.: 64 L C J 06 H. T. S NO.: 3004.90.92.45 ANDA NO.:78-9 30 THERAPEUTICE USE: DERMALO GIC USE MOMETASONE FURO TOP SOL 0.1% 60ML NDC CODE:68462 038502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 30 04.90.92.45 ANDA NO.:090506 THERAPEUTICE USE: MOMETASONE FUROATE TOPICAL SOLUTION (LOT ION) IS A CORTICOSTEROID IND ICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MA NIFESTATIONS OF CORTICOSTEROI D-RESPONSIVE DERMATOSES IN PA TIENTS #12 YEARS OF AGE. 13 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 642700 |
2022-06-21 |
40 PKG |
7497.1KG |
40 PALLETS 1996 CART ONS PHARMACEUTICALS AS UNDER LIDOCAINE OINTMENT JAR 5% 5 0GM NDC CODE:68462041827 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO.:206498 THERAPEUTICE USE: -USED TO TEMPORARILY RE LIEVE PAIN AND ITCHING ASSOC IATED WITH SKIN HEATHER NOR ETHINDRONE 0.35MG 84 NDC CODE :68462030329 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO .: 3006.60.00.00 ANDA NO.:90 -454 THERAPEUTICE USE: PREVE NTION OF PREGNANCY. NORETHI NDRONE 0.35MG 84 NDC CODE:684 62030529 FDA PRODUCT CODE NO. : 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTIO N OF PREGNANCY. FELODIPINE ER TABS 2.5MG 100 S NDC CODE: 68462023301 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3 004.90.92.20 ANDA NO.: 90-365 THERAPEUTICE USE: - TREATME NT OF HYPERTENSION TOPIRAM ATE TABLETS 100MG 1000 S NDC CODE:68462010910 FDA PRODUCT CODE NO.:61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :- 77-627 THERAPEUTICE USE:- ANTICONVULSANT COMMERCIAL & CUSTOM INVOICE NO. F22352000 718 DT. 26.05.2022 F223520007 19 DT. 26.05.2022 F2235200072 0 DT. 26.05.2022 NET WT: 5 ,794.78 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 1684332 DT 26-MAY-2022 S/BIL L NO: 1684334 DT 26-MAY-2022 S/BILL NO: 1684337 DT 26-MAY-2 022 |
HS 600700 |
2022-06-21 |
40 PKG |
6066.45KG |
40 PALLETS 1952 CART ONS PHARMACEUTICALS AS UNDER NORETHINDRONE ACE/EE TABS 1 /0.02MG 63 NDC CODE:684620132 81 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60 .00.00 ANDA NO.:206969 THERA PEUTICE USE: - SECONDARY AME NORRHEA,ENDOMETRIOS IS AND AB NORMAL UTERINE BLEEDING NO RETHINDRONE 0.35MG 84 NDC COD E:68462030529 FDA PRODUCT COD E NO.: 65 J C A 26 H. T. S N O.: 3006.60.00.00 ANDA NO.:9 1-209 THERAPEUTICE USE: PREV ENTION OF PREGNANCY. COMMER CIAL & CUSTOM INVOICE NO. F22 352000681 DT. 23.05.2022 NET WT: 4,323.07 KGS 02 DATA LOG GERS S/BILL NO: 1594707 DT: 23-MAY-22 NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 652500 |
2022-06-21 |
41 PKG |
6100.01KG |
41 PALLETS 1810 CART ONS PHARMACEUTICALS AS UNDER HEATHER NORETHINDRONE 0.35M G 84 NDC CODE:68462030329 FD A PRODUCT CODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.0 0 ANDA NO.:90-454 THERAPEUTI CE USE: PREVENTION OF PREGNAN CY. NORETHINDRONE 0.35MG 84 NDC CODE:68462030529 FDA PR ODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00.00 A NDA NO.:91-209 THERAPEUTICE U SE: PREVENTION OF PREGNANCY. HAILEY24FE NORE ACE/EE-FE 1 /0.02-75MG 84 NDC CODE:684620 73129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 300 6.60.00.00 ANDA NO.: 204847 THERAPEUTICE USE: - CONTRACEP TION TO PREVENT PREGNANCY ASHLYNA LEVO/EE 0.15/0.03MG 18 2 NDC CODE:68462064693 FDA P RODUCT CODE NO.: 64 G D A 2 H. T. S NO.: 3006.60.0000 AN DA NO.: 203163 THERAPEUTICE U SE: - INDICATED FOR USE BY W OMEN TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO . F22352000700 DT. 25.05.2022 F22352000701 DT. 25.05.2022 F22352000702 DT. 25.05.2022 NET WT: 4,450.30 KGS 02 DAT A LOGGERS S/BILL NO: 165441 7 DT 25-MAY-2022 S/BILL NO: 1 654291 DT 25-MAY-2022 S/BILL NO: 1654415 DT 25-MAY-2022 NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652400 |
2022-06-21 |
8 PKG |
1339.03KG |
8 PALLETS 686 CARTON S PHARMACEUTICALS AS UNDER ROSUVASTATIN TABLETS 5MG 90 S NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULA R DISEASE ROSUVASTATIN TABL ETS 5MG 1000 S NDC CODE:68462 026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 30 04.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT HI GH CHOLESTEROL AND RELATED CO NDITIONS, AND TO PREVENT CARD IOVASCULAR DISEASE. ROSUVA STATIN TABLETS 20MG 1000 S ND C CODE:68462026310 FDA PRODUC T CODE NO.: 61 J C A 16 H. T . S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEAS E COMMERCIAL & CUSTOM INVOI CE NO. F22352000690 DT. 24.05 .2022 NET WT. 1,058.48 KGS 0 8 DATA LOGGERS S/BILL NO: 1 654113 DT 25-MAY-2022 NOTIF Y PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND |
HS 611600 |
2022-06-21 |
31 PKG |
8373.91KG |
31 PALLETS 1789 CARTONS PHARMACEUTICALS AS UNDER EZ ETIMIBE-SIMVASTATIN TAB 10/20M G 90 S NDC CODE:68462032290 COLESEVELAM HCL TABLETS 625M G 180 S NDC CODE:68462043318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.0 0.10 ANDA NO.: 203480 THERAP EUTICE USE: - ANTIHYPERLIPO PROTEINEMIC. CHLORPROMAZINE HCL TABS 50MG 100 S NDC CODE :68462086301 61 T C A 04 300 4.90.92.40 212144 TO TREAT P SYCHOTIC DISORDERS SUCH AS S CHIZOPHRENIA OR MANIC-DEPRESS ION IN ADULTS EZETIMIBE-SI MVASTATIN TAB 10/20MG 30 S ND C CODE:68462032230 EZETIMIB E-SIMVASTATIN TAB 10/40MG 90 S NDC CODE:68462032390 PRAV ASTATIN SODIUM TAB 20MG 500 S NDC CODE:68462019605 FDA PRO DUCT CODE NO.:-61 J C A 13 H . T. S NO.: 3004.90.92.20 AN DA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEMIC TACROLIM US CAPSULES 0.5MG 100 S NDC C ODE:68462068501 GABAPENTIN TABLETS 600MG 500 S NDC CODE: 68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICO NVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F2238700 0269 DT. 27.05.2022 F22387000 270 DT. 27.05.2022 F223870002 71 DT. 27.05.2022 F2238700027 2 DT. 27.05.2022 F22387000273 DT. 27.05.2022 F22387000277 DT. 27.05.2022 S/BILL NO: 40 07631 DT: 27.05.2022 S/BILL N O: 4007630 DT: 27.05.2022 S/ BILL NO: 4007629 DT: 27.05.20 22 S/BILL NO: 4007627 DT: 27 .05.2022 S/BILL NO: 4007628 DT: 27.05.2022 S/BILL NO: 40 07623 DT: 27.05.2022 NET WT. 6,075.63 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 621300 |
2022-06-21 |
1 PKG |
10000.07KG |
PHARMACEUTICALS AS UNDER . |
HS 300680 |
2022-06-21 |
33 PKG |
5639.16KG |
33 PALLETS 1642 CARTONS PH ARMACEUTICALS AS UNDER NORE THINDRONE 0.35MG 84 NDC CODE: 68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO. : 3006.60.00.00 ANDA NO.:91- 209 THERAPEUTICE USE: PREVEN TION OF PREGNANCY. NORETHIN DRONE 0.35MG 84 NDC CODE:6846 2030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3 006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTION OF PREGNANCY. ASHLYNA LEVO /EE 0.15/0.03MG 182 NDC CODE: 68462064693 FDA PRODUCT CODE NO.: 64 G D A 2 H. T. S NO.: 3006.60.0000 ANDA NO.: 2031 63 THERAPEUTICE USE: - INDIC ATED FOR USE BY WOMEN TO PREV ENT PREGNANCY PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462 060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOU ND-LINE THERAPY FOR THE SHORT -TERM AND NON-CONTINUOS CHRON IC TRERTMENT OF MILD TO MODE RATE ATOPIC DERMATITIS IN NO NIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE DI LTIAZEM HCL ER CAPS 12HR 60MG 100 S NDC CODE:68462085001 6 2 O C B 24 3004.49.00.10 212 317 FOR THE TREATMENT OF HYP ERTENSION. CARVEDILOL TABS 12.5MG 100 S NDC CODE:6846201 6401 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST COMME RCIAL & CUSTOM INVOICE NO. F2 2352000708 DT. 25.05.2022 F22 352000710 DT. 25.05.2022 F223 87000238 DT. 20.05.2022 F2238 7000240 DT. 20.05.2022 F22387 000241 DT. 20.05.2022 S/BILL NO: 1680051 DT: 26/05/2022 S /BILL NO: 1680054 DT:26/05/20 22 S/BILL NO: 4007229 DT:20/ 05/2022 S/BILL NO: 4007220 D T:20/05/2022 S/BILL NO: 40072 34 DT:20/05/2022 NET WT. 3, 859.20 KGS 07 DATA LOGGERS H UMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK PHARMACEUTICALS LTD. PLOT NO 2, ISEZ, PHASE II,PHA RMA ZONE PITHAMPUR, DIST DHAR , MADHYA PRADESH INDIA GST NO . : 23AAACG2207L2ZZ |
HS 652600 |
2022-06-21 |
4 PKG |
998.83KG |
4 PALLETS 124 CARTONS PHA RMACEUTICALS AS UNDER NIT ROGLYCERIN SUBLING TABS 0.4MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90 .9020 ANDA NO.:206391 THER APEUTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOO D PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NO T ENOUGH BLOOD FLOW TO THE H EART NITROGLYCERIN SUBLIN G TABS 0.4MG 4X25 NDC CODE:6 8462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S N O.: 3004.90.9020 ANDA NO.: 206391 THERAPEUTIC USE: ME DICATION USED FOR HEART FAIL URE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST P AIN FROM NOT ENOUGH BLOOD FL OW TO THE HEART COMMERC IAL & CUSTOM INVOICE NO. F22 387000274 DT. 27.05.2022 F22 387000278 DT. 27.05.2022 S/B ILL NO:4007624 DT:27.05.2022 S/BILL NO:4007625 DT:27.05.20 22 NET WT: 66.07 KGS 04 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PA RTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND |
HS 662800 |
2022-06-21 |
34 PKG |
6948.24KG |
34 PALLETS 1730 CARTONS PHARMACEUTICALS AS UNDER LE VOCETIRIZINE DIHY TABS 5MG 90 S NDC CODE:68462034690 FDA P RODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.90.91.80 ANDA NO.:90385 THERAPEUTICE U SE: TREATMENT OF CHRONIC IDI OPATHIC URTICARIA OMEPRAZOL E DR CAPSULES 20MG 1000 S NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S N O.: 3004.90.9160 ANDA NO.: 9 1672 THERAPEUTICE USE: - TRE ATMENT OF TREAT GASTROESOPHAG EAL REFLUX DISEASE COMMERC IAL & CUSTOM INVOICE NO. F223 52000649 DT. 19.05.2022 S/BIL L NO: 1527298 DT 20-MAY-2022 NET WT: 5870.6 KGS 02 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 615100 |
2022-06-21 |
1 PKG |
15000.1KG |
PHARMACEUTICALS AS UNDER |
HS 300680 |
2022-06-21 |
51 PKG |
10845.12KG |
51 PALLETS 2655 CARTONS P HARMACEUTICALS AS UNDER MUP IROCIN OINTMENT 2% 22GM NDC C ODE:68462018022 FDA PRODUCT C ODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO. : 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL LEVOCETIRIZ INE DIHY TABS 5MG 90 S NDC CO DE:68462034690 FDA PRODUCT CO DE NO.: 61 X C A 51 H. T. S NO.: 3004.90.91.80 ANDA NO.: 90385 THERAPEUTICE USE: TREA TMENT OF CHRONIC IDIOPATHIC U RTICARIA OMEPRAZOLE DR CAPS ULES 20MG 1000 S NDC CODE:684 62039610 FDA PRODUCT CODE NO. : 62KCF10 H. T. S NO.: 3004 .90.9160 ANDA NO.: 91672 THE RAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLU X DISEASE OXCARBAZEPINE TA BLETS 150MG 100 S NDC CODE:68 462013701 FDA PRODUCT CODE N O.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-8 02 THERAPEUTICE USE:-ANTI CO NVULSANT AGENT OXCARBAZEPIN E TABLETS 300MG 100 S NDC COD E:68462013801 FDA PRODUCT COD E NO.:-61 M C A 45 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT ROPINIRO LE TABS 3MG 100 S NDC CODE:68 462025701 FDA PRODUCT CODE N O.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90- 135 THERAPEUTICE USE:-TREATM ENT OF PARKINSONISM THEOPH YLLINE ER TABS 600MG 100 S ND C CODE:68462035601 FDA PRODUC T CODE NO.: 63 B C B 30 H. T . S NO.: 3004.90.92.85 ANDA NO.: 90-355 THERAPEUTICE USE: XANTHINE BRONCHODILATOR C OMMERCIAL & CUSTOM INVOICE NO. F22352000669 DT. 21.05.2022 F22352000670 DT. 21.05.2022 F22352000671 DT. 21.05.2022 S /BILL NO: 1565337 DT: 21-MAY- 22 S/BILL NO: 1565323 DT: 21- MAY-22 S/BILL NO: 1565339 D T:21-MAY-22 NET WT:9,044.79 KGS 02 DATA LOGGERS HUMIDITY :65% SET TEMPERATURE : +18 DE GREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 621000 |
2022-06-21 |
40 PKG |
6005.21KG |
40 PALLETS 1974 CARTONS P HARMACEUTICALS AS UNDER NOR ETHINDRONE ACE/EE TABS 1/0.02M G 63 NDC CODE:68462013281 FD A PRODUCT CODE NO.:65 J C A 2 5 H. T. S NO.: 3006.60.00.00 ANDA NO.:206969 THERAPEUTIC E USE: - SECONDARY AMENORRHE A,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING COMMERCI AL & CUSTOM INVOICE NO. F2235 2000672 DT. 21.05.2022 S/BILL NO: 1565298 DT:21-MAY-22 NE T WT: 4,216.46 KGS 02 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 652500 |
2022-06-21 |
40 PKG |
6005.21KG |
40 PALLETS 1974 CARTONS P HARMACEUTICALS AS UNDER NOR ETHINDRONE ACE/EE TABS 1/0.02M G 63 NDC CODE:68462013281 FD A PRODUCT CODE NO.:65 J C A 2 5 H. T. S NO.: 3006.60.00.00 ANDA NO.:206969 THERAPEUTIC E USE: - SECONDARY AMENORRHE A,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING COMMERCI AL & CUSTOM INVOICE NO. F2235 2000672 DT. 21.05.2022 S/BILL NO: 1565298 DT:21-MAY-22 NE T WT: 4,216.46 KGS 02 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA |
HS 652500 |
2022-06-21 |
34 PKG |
6948.24KG |
34 PALLETS 1730 CARTONS PHARMACEUTICALS AS UNDER LE VOCETIRIZINE DIHY TABS 5MG 90 S NDC CODE:68462034690 FDA P RODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.90.91.80 ANDA NO.:90385 THERAPEUTICE U SE: TREATMENT OF CHRONIC IDI OPATHIC URTICARIA OMEPRAZOL E DR CAPSULES 20MG 1000 S NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S N O.: 3004.90.9160 ANDA NO.: 9 1672 THERAPEUTICE USE: - TRE ATMENT OF TREAT GASTROESOPHAG EAL REFLUX DISEASE COMMERC IAL & CUSTOM INVOICE NO. F223 52000649 DT. 19.05.2022 S/BIL L NO: 1527298 DT 20-MAY-2022 NET WT: 5870.6 KGS 02 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 615100 |
2022-06-21 |
40 PKG |
7497.1KG |
40 PALLETS 1996 CART ONS PHARMACEUTICALS AS UNDER LIDOCAINE OINTMENT JAR 5% 5 0GM NDC CODE:68462041827 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO.:206498 THERAPEUTICE USE: -USED TO TEMPORARILY RE LIEVE PAIN AND ITCHING ASSOC IATED WITH SKIN HEATHER NOR ETHINDRONE 0.35MG 84 NDC CODE :68462030329 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO .: 3006.60.00.00 ANDA NO.:90 -454 THERAPEUTICE USE: PREVE NTION OF PREGNANCY. NORETHI NDRONE 0.35MG 84 NDC CODE:684 62030529 FDA PRODUCT CODE NO. : 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTIO N OF PREGNANCY. FELODIPINE ER TABS 2.5MG 100 S NDC CODE: 68462023301 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3 004.90.92.20 ANDA NO.: 90-365 THERAPEUTICE USE: - TREATME NT OF HYPERTENSION TOPIRAM ATE TABLETS 100MG 1000 S NDC CODE:68462010910 FDA PRODUCT CODE NO.:61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :- 77-627 THERAPEUTICE USE:- ANTICONVULSANT COMMERCIAL & CUSTOM INVOICE NO. F22352000 718 DT. 26.05.2022 F223520007 19 DT. 26.05.2022 F2235200072 0 DT. 26.05.2022 NET WT: 5 ,794.78 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 1684332 DT 26-MAY-2022 S/BIL L NO: 1684334 DT 26-MAY-2022 S/BILL NO: 1684337 DT 26-MAY-2 022 |
HS 600700 |
2022-06-21 |
40 PKG |
6066.45KG |
40 PALLETS 1952 CART ONS PHARMACEUTICALS AS UNDER NORETHINDRONE ACE/EE TABS 1 /0.02MG 63 NDC CODE:684620132 81 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60 .00.00 ANDA NO.:206969 THERA PEUTICE USE: - SECONDARY AME NORRHEA,ENDOMETRIOS IS AND AB NORMAL UTERINE BLEEDING NO RETHINDRONE 0.35MG 84 NDC COD E:68462030529 FDA PRODUCT COD E NO.: 65 J C A 26 H. T. S N O.: 3006.60.00.00 ANDA NO.:9 1-209 THERAPEUTICE USE: PREV ENTION OF PREGNANCY. COMMER CIAL & CUSTOM INVOICE NO. F22 352000681 DT. 23.05.2022 NET WT: 4,323.07 KGS 02 DATA LOG GERS S/BILL NO: 1594707 DT: 23-MAY-22 NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 652500 |
2022-06-21 |
41 PKG |
6100.01KG |
41 PALLETS 1810 CART ONS PHARMACEUTICALS AS UNDER HEATHER NORETHINDRONE 0.35M G 84 NDC CODE:68462030329 FD A PRODUCT CODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.0 0 ANDA NO.:90-454 THERAPEUTI CE USE: PREVENTION OF PREGNAN CY. NORETHINDRONE 0.35MG 84 NDC CODE:68462030529 FDA PR ODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00.00 A NDA NO.:91-209 THERAPEUTICE U SE: PREVENTION OF PREGNANCY. HAILEY24FE NORE ACE/EE-FE 1 /0.02-75MG 84 NDC CODE:684620 73129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 300 6.60.00.00 ANDA NO.: 204847 THERAPEUTICE USE: - CONTRACEP TION TO PREVENT PREGNANCY ASHLYNA LEVO/EE 0.15/0.03MG 18 2 NDC CODE:68462064693 FDA P RODUCT CODE NO.: 64 G D A 2 H. T. S NO.: 3006.60.0000 AN DA NO.: 203163 THERAPEUTICE U SE: - INDICATED FOR USE BY W OMEN TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO . F22352000700 DT. 25.05.2022 F22352000701 DT. 25.05.2022 F22352000702 DT. 25.05.2022 NET WT: 4,450.30 KGS 02 DAT A LOGGERS S/BILL NO: 165441 7 DT 25-MAY-2022 S/BILL NO: 1 654291 DT 25-MAY-2022 S/BILL NO: 1654415 DT 25-MAY-2022 NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 652400 |
2022-06-21 |
8 PKG |
1339.03KG |
8 PALLETS 686 CARTON S PHARMACEUTICALS AS UNDER ROSUVASTATIN TABLETS 5MG 90 S NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULA R DISEASE ROSUVASTATIN TABL ETS 5MG 1000 S NDC CODE:68462 026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 30 04.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT HI GH CHOLESTEROL AND RELATED CO NDITIONS, AND TO PREVENT CARD IOVASCULAR DISEASE. ROSUVA STATIN TABLETS 20MG 1000 S ND C CODE:68462026310 FDA PRODUC T CODE NO.: 61 J C A 16 H. T . S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEAS E COMMERCIAL & CUSTOM INVOI CE NO. F22352000690 DT. 24.05 .2022 NET WT. 1,058.48 KGS 0 8 DATA LOGGERS S/BILL NO: 1 654113 DT 25-MAY-2022 NOTIF Y PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND |
HS 611600 |
2022-06-21 |
31 PKG |
8373.91KG |
31 PALLETS 1789 CARTONS PHARMACEUTICALS AS UNDER EZ ETIMIBE-SIMVASTATIN TAB 10/20M G 90 S NDC CODE:68462032290 COLESEVELAM HCL TABLETS 625M G 180 S NDC CODE:68462043318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.0 0.10 ANDA NO.: 203480 THERAP EUTICE USE: - ANTIHYPERLIPO PROTEINEMIC. CHLORPROMAZINE HCL TABS 50MG 100 S NDC CODE :68462086301 61 T C A 04 300 4.90.92.40 212144 TO TREAT P SYCHOTIC DISORDERS SUCH AS S CHIZOPHRENIA OR MANIC-DEPRESS ION IN ADULTS EZETIMIBE-SI MVASTATIN TAB 10/20MG 30 S ND C CODE:68462032230 EZETIMIB E-SIMVASTATIN TAB 10/40MG 90 S NDC CODE:68462032390 PRAV ASTATIN SODIUM TAB 20MG 500 S NDC CODE:68462019605 FDA PRO DUCT CODE NO.:-61 J C A 13 H . T. S NO.: 3004.90.92.20 AN DA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEMIC TACROLIM US CAPSULES 0.5MG 100 S NDC C ODE:68462068501 GABAPENTIN TABLETS 600MG 500 S NDC CODE: 68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICO NVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F2238700 0269 DT. 27.05.2022 F22387000 270 DT. 27.05.2022 F223870002 71 DT. 27.05.2022 F2238700027 2 DT. 27.05.2022 F22387000273 DT. 27.05.2022 F22387000277 DT. 27.05.2022 S/BILL NO: 40 07631 DT: 27.05.2022 S/BILL N O: 4007630 DT: 27.05.2022 S/ BILL NO: 4007629 DT: 27.05.20 22 S/BILL NO: 4007627 DT: 27 .05.2022 S/BILL NO: 4007628 DT: 27.05.2022 S/BILL NO: 40 07623 DT: 27.05.2022 NET WT. 6,075.63 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 621300 |
2022-06-21 |
33 PKG |
5639.16KG |
33 PALLETS 1642 CARTONS PH ARMACEUTICALS AS UNDER NORE THINDRONE 0.35MG 84 NDC CODE: 68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO. : 3006.60.00.00 ANDA NO.:91- 209 THERAPEUTICE USE: PREVEN TION OF PREGNANCY. NORETHIN DRONE 0.35MG 84 NDC CODE:6846 2030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3 006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTION OF PREGNANCY. ASHLYNA LEVO /EE 0.15/0.03MG 182 NDC CODE: 68462064693 FDA PRODUCT CODE NO.: 64 G D A 2 H. T. S NO.: 3006.60.0000 ANDA NO.: 2031 63 THERAPEUTICE USE: - INDIC ATED FOR USE BY WOMEN TO PREV ENT PREGNANCY PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462 060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOU ND-LINE THERAPY FOR THE SHORT -TERM AND NON-CONTINUOS CHRON IC TRERTMENT OF MILD TO MODE RATE ATOPIC DERMATITIS IN NO NIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE DI LTIAZEM HCL ER CAPS 12HR 60MG 100 S NDC CODE:68462085001 6 2 O C B 24 3004.49.00.10 212 317 FOR THE TREATMENT OF HYP ERTENSION. CARVEDILOL TABS 12.5MG 100 S NDC CODE:6846201 6401 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST COMME RCIAL & CUSTOM INVOICE NO. F2 2352000708 DT. 25.05.2022 F22 352000710 DT. 25.05.2022 F223 87000238 DT. 20.05.2022 F2238 7000240 DT. 20.05.2022 F22387 000241 DT. 20.05.2022 S/BILL NO: 1680051 DT: 26/05/2022 S /BILL NO: 1680054 DT:26/05/20 22 S/BILL NO: 4007229 DT:20/ 05/2022 S/BILL NO: 4007220 D T:20/05/2022 S/BILL NO: 40072 34 DT:20/05/2022 NET WT. 3, 859.20 KGS 07 DATA LOGGERS H UMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK PHARMACEUTICALS LTD. PLOT NO 2, ISEZ, PHASE II,PHA RMA ZONE PITHAMPUR, DIST DHAR , MADHYA PRADESH INDIA GST NO . : 23AAACG2207L2ZZ |
HS 652600 |
2022-06-21 |
1 PKG |
10000.07KG |
PHARMACEUTICALS AS UNDER . |
HS 300680 |
2022-06-21 |
4 PKG |
998.83KG |
4 PALLETS 124 CARTONS PHA RMACEUTICALS AS UNDER NIT ROGLYCERIN SUBLING TABS 0.4MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90 .9020 ANDA NO.:206391 THER APEUTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOO D PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NO T ENOUGH BLOOD FLOW TO THE H EART NITROGLYCERIN SUBLIN G TABS 0.4MG 4X25 NDC CODE:6 8462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S N O.: 3004.90.9020 ANDA NO.: 206391 THERAPEUTIC USE: ME DICATION USED FOR HEART FAIL URE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST P AIN FROM NOT ENOUGH BLOOD FL OW TO THE HEART COMMERC IAL & CUSTOM INVOICE NO. F22 387000274 DT. 27.05.2022 F22 387000278 DT. 27.05.2022 S/B ILL NO:4007624 DT:27.05.2022 S/BILL NO:4007625 DT:27.05.20 22 NET WT: 66.07 KGS 04 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PA RTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND |
HS 662800 |
2022-06-21 |
1 PKG |
15000.1KG |
PHARMACEUTICALS AS UNDER |
HS 300680 |
2022-06-21 |
51 PKG |
10845.12KG |
51 PALLETS 2655 CARTONS P HARMACEUTICALS AS UNDER MUP IROCIN OINTMENT 2% 22GM NDC C ODE:68462018022 FDA PRODUCT C ODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO. : 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL LEVOCETIRIZ INE DIHY TABS 5MG 90 S NDC CO DE:68462034690 FDA PRODUCT CO DE NO.: 61 X C A 51 H. T. S NO.: 3004.90.91.80 ANDA NO.: 90385 THERAPEUTICE USE: TREA TMENT OF CHRONIC IDIOPATHIC U RTICARIA OMEPRAZOLE DR CAPS ULES 20MG 1000 S NDC CODE:684 62039610 FDA PRODUCT CODE NO. : 62KCF10 H. T. S NO.: 3004 .90.9160 ANDA NO.: 91672 THE RAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLU X DISEASE OXCARBAZEPINE TA BLETS 150MG 100 S NDC CODE:68 462013701 FDA PRODUCT CODE N O.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-8 02 THERAPEUTICE USE:-ANTI CO NVULSANT AGENT OXCARBAZEPIN E TABLETS 300MG 100 S NDC COD E:68462013801 FDA PRODUCT COD E NO.:-61 M C A 45 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT ROPINIRO LE TABS 3MG 100 S NDC CODE:68 462025701 FDA PRODUCT CODE N O.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90- 135 THERAPEUTICE USE:-TREATM ENT OF PARKINSONISM THEOPH YLLINE ER TABS 600MG 100 S ND C CODE:68462035601 FDA PRODUC T CODE NO.: 63 B C B 30 H. T . S NO.: 3004.90.92.85 ANDA NO.: 90-355 THERAPEUTICE USE: XANTHINE BRONCHODILATOR C OMMERCIAL & CUSTOM INVOICE NO. F22352000669 DT. 21.05.2022 F22352000670 DT. 21.05.2022 F22352000671 DT. 21.05.2022 S /BILL NO: 1565337 DT: 21-MAY- 22 S/BILL NO: 1565323 DT: 21- MAY-22 S/BILL NO: 1565339 D T:21-MAY-22 NET WT:9,044.79 KGS 02 DATA LOGGERS HUMIDITY :65% SET TEMPERATURE : +18 DE GREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA |
HS 621000 |
2022-06-14 |
52 PKG |
11027.92KG |
52 PALLETS 1796 CART ONS PHARMACEUTICALS AS UNDER GABAPENTIN TABLETS 800MG 50 0 S NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 6 9 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTI CE USE:-ANTICONVULSANT AGENT OMEPRAZOLE DR CAPSULES 40M G 100 S NDC CODE:68462039701 FDA PRODUCT CODE NO.: 62KCF1 0 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS E PRAMIPEXOLE TABS 0.5MG 90 S NDC CODE:68462033290 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTIC E USE: USED IN PARKINSON#S DI SEASE COMMERCIAL & CUSTOM I NVOICE NO. F22352000580 DT. 1 5.05.2022 F22352000582 DT. 15 .05.2022 F22352000583 DT. 15. 05.2022 S/BILL NO: 1418121 DT 16-MAY-2022 S/BILL NO: 14181 83 DT 16-MAY-2022 S/BILL NO: : 1418116 DT 16-MAY-2022 NET WT. 9,762.27 KGS 02 DATA LO GGERS HUMIDITY:65% SET TEMPE RATURE : +18 DEGREES TEMPERAT URE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 616900 |
2022-06-14 |
48 PKG |
9858.09KG |
48 PALLETS 2640 CART ONS PHARMACEUTICALS AS UNDER CARVEDILOL TABS 12.5MG 500 S NDC CODE:68462016405 FDA P RODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTIC E USE:-BETA-ADRENOACEPTOR AN TAGONIST NAPROXEN TABLETS 2 50MG 100 S NDC CODE:684620188 01 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:-78-250 THE RAPEUTICE USE:-ANTI-INFLAMMAT ORY, ANALGESIC NAPROXEN TA BLETS 250MG 500 S NDC CODE:68 462018805 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI-IN FLAMMATORY, ANALGESIC NAPR OXEN TABLETS 375MG 100 S NDC CODE:68462018901 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO .:-78-250 THERAPEUTICE USE:- ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TABLETS 375MG 500 S NDC CODE:68462018905 FDA P RODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMATORY, ANA LGESIC VERAPAMIL HCL ER TAB S 120MG 100S NDC CODE:6846202 9201 FDA PRODUCT CODE NO.: 6 2 O C B 13 H. T. S NO.: 3004 .90.92.20 ANDA NO.: 90-700 T HERAPEUTICE USE: - ANGINA OMEPRAZOLE DR CAPSULES 10MG 10 0 S NDC CODE:68462039501 FDA PRODUCT CODE NO.: 62KCF10 H . T. S NO.: 3004.90.9160 AND A NO.: 91672 THERAPEUTICE USE : - TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAPSULES 10MG 3 0 S NDC CODE:68462039530 FDA PRODUCT CODE NO.: 62KCF10 H . T. S NO.: 3004.90.9160 AND A NO.: 91672 THERAPEUTICE USE : - TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE ADAPALENE-BPO GEL PUMP 0.1/2. 5% 45GM NDC CODE:68462030147 FDA PRODUCT CODE NO.: 62 S D O 02 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 208108 THERAP EUTICE USE: - USED ON THE SKI N TO TREAT ACNE MUPIROCIN O INTMENT 2% 22GM NDC CODE:6846 2018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - ANTI-BA CTERIAL COMMERCIAL & CUSTOM INVOICE NO. F22352000604 DT. 16.05.2022 F22352000605 DT. 16.05.2022 F22352000606 DT. 1 6.05.2022 S/BILL NO: 1454763 DT: 17-MAY-22 S/BILL NO:1454 691 DT: 17-MAY-22 S/BILL NO:1 454753 DT: 17-MAY-22 NET WT.8 ,233.98 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREE S NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 622200 |
2022-06-14 |
44 PKG |
9613.14KG |
44 PALLETS 1646 CARTONS P HARMACEUTICALS AS UNDER VER APAMIL HCL ER TABS 120MG 100S NDC CODE:68462029201 FDA PRO DUCT CODE NO.: 62 O C B 13 H . T. S NO.: 3004.90.92.20 AN DA NO.: 90-700 THERAPEUTICE U SE: - ANGINA OMEPRAZOLE DR CAPSULES 20MG 1000 S NDC C ODE:68462039610 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE PRAMIPEXO LE TABS 1MG 90 S NDC CODE:684 62033390 FDA PRODUCT CODE NO. : 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-78 1 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE MUPIROC IN OINTMENT 2% 22GM NDC CODE: 68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO. : 3004.90.92.45 ANDA NO.: 90 -480 THERAPEUTICE USE: - ANT I-BACTERIAL CALCIPOTRIENE C REAM 0.005% 60GM (GS) NDC COD E:51407060560 FDA PRODUCT COD E NO.: 62 N C J 04 H. T. S N O.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTICE USE: TOP ICAL ANTI-PSORIATIC CALCIPO TRIENE CREAM 0.005% 120GM (GS) NDC CODE:51407060512 FDA PR ODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 A NDA NO.: 205772 THERAPEUTICE USE: TOPICAL ANTI-PSORIATIC COMMERCIAL & CUSTOM INVOICE NO. F22352000632 DT. 18.05.20 22 F22352000633 DT. 18.05.202 2 F22352000634 DT. 18.05.2022 F22352000635 DT. 18.05.2022 F22352000636 DT. 18.05.2022 S/BILL NO: 1505141 DT 19-MAY-2 022 S/BILL NO: 1505060 DT 19- MAY-2022 S/BILL NO: 1505063 D T 19-MAY-2022 S/BILL NO: 1505 155 DT 19-MAY-2022 S/BILL NO: 1505059 DT 19-MAY-2022 NET W T: 7,856.28 KGS 06 DATA LOG GERS HUMIDITY:65% SET TEMPER ATURE : +18 DEGREES TEMPERATU RE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 621300 |
2022-06-14 |
1 PKG |
10000.07KG |
PHARMACEUTICALS AS UNDER. |
HS 300680 |
2022-06-14 |
24 PKG |
3885.54KG |
24 PALLETS 1073 CART ONS PHARMACEUTICALS AS UNDER HAILEY24FE NORE ACE/EE-FE 1 /0.02-75MG 84 NDC CODE:6846207 3129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 300 6.60.00.00 ANDA NO.: 204847 THERAPEUTICE USE: - CONTRACEP TION TO PREVENT PREGNANCY HAILEY24FE NORE ACE/EE-FE 1/0. 02-75MG 84 NDC CODE:6846207312 9 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.6 0.00.00 ANDA NO.: 204847 THE RAPEUTICE USE: - CONTRACEPTIO N TO PREVENT PREGNANCY CLO BETASOL PROP SOLUTION 0.05% 50 ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTIC E USE: - GLUCOCORTICOID / HUM AN - RX/SINGLE INGREDIENT / NONSTERILE LIQUID / CLOBETASO L PROPIONATE (GLUCOCORTICOID) COMMERCIAL & CUSTOM INVOIC E NO. F22352000553 DT. 13.05. 2022 F22352000560 DT. 13.05.2 022 F22335000562 DT. 12.05.20 22 S/BILL NO: 1396992 DT :14/05/2022 S/BILL NO: 13969 93 DT:14/05/2022 S/BILL N O: 1426939 DT:17/05/2022 NET WT. 2,626.75 KGS 08 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 0 7430 USA NOTIFY PARTY:3 GLEN MARK PHARMACEUTICALS LTD. VIL LAGE:KISHANPURA,BADDI NALAGARH ROAD TEHSIL: BADDI , DIST. S OLAN HIMACHAL PRADESH INDIA G ST NO. : 02AAACG2207L2Z3 |
HS 652500 |
2022-06-07 |
20 PKG |
3506.33KG |
20 PALLETS 362 CARTONS PH ARMACEUTICALS AS UNDER FLUO CINOLONE ACE EAR DROPS 0.01% 2 0ML NDC CODE:68462018556 FDA PRODUCT CODE NO.: 64 L C L 2 7 H. T. S NO.: 3004.49.00.50 ANDA NO.: 211815 FOR THE TR EATMENT OF CHRONIC ECZEMATOUS EXTERNAL OTITIS TRIAMCINO LONE ACE OINT 0.5% 15GM NDC C ODE:68462079817 FDA PRODUCT C ODE NO.:64 L C J 61 H. T. S NO.: 3004.49.00.50 ANDA NO.: 206379 THERAPEUTICE USE: - R EDUCES THE SWELLING, ITCHING, AND REDNESS OF SKIN MOMET ASONE FUROATE CREAM 0.1% 45GM NDC CODE:68462019255 FDA PRO DUCT CODE NO.: 62 F C J 53 H . T. S NO.: 3004.40.49.50 AN DA NO.:78-541 THERAPEUTICE US E: ANTI-INFLAMMATORY- DERMAT OLOGIC COMMERCIAL & CUSTOM INVOICE NO. F22335000438 DT. 30.04.2022 F22335000440 DT. 3 0.04.2022 S/BILL NO: 1179292 DT:05/05/2022 S/BILL NO:121 4617 DT:06/05/2022 NET WT: 1,328.64 KGS 20 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 642700 |
2022-06-07 |
40 PKG |
7457.64KG |
40 PALLETS 2000 CARTONS P HARMACEUTICALS AS UNDER NOR GEST/EE 0.18,0.215,0.25/0.035M G 84 NDC CODE:68462056529 FD A PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.0 0 ANDA NO.: 200494 THERAPEUT ICE USE: - ORAL CONTRACEPTIVE S COMMERCIAL & CUSTOM INVOI CE NO. F22352000512 DT. 11.05 .2022 S/BILL NO:1324415 DT 11 -MAY-2022 NET WT: 5,880.00 KGS 02 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA |
HS 652700 |
2022-06-07 |
60 PKG |
9898.01KG |
60 PALLETS 3519 CART ONS PHARMACEUTICALS AS UNDER RILUZOLE TABLETS 50MG 60 S NDC CODE:68462038160 FDA PRO DUCT CODE NO.: 62 J C A 16 H . T. S NO.: 3004.90.92.30 AN DA NO.: 91394 THERAPEUTICE US E: - A-PARKINSONIAN/ HUMAN - RX/SINGLE INGREDIENT / PROMP T RELEASE TABLETS / RILUZOLE (ANTI-PARKINSONIAN) THEOPH YLLINE ER TABS 400MG 100 S ND C CODE:68462038001 FDA PRODUC T CODE NO.: 63 B C B 30 H. T . S NO.: 3004.90.92.85 ANDA NO.: 90-355 THERAPEUTICE USE: XANTHINE BRONCHODILATOR O MEPRAZOLE DR CAPSULES 40MG 30 S NDC CODE:68462039730 FDA P RODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROE SOPHAGEAL REFLUX DISEASE O MEPRAZOLE DR CAPSULES 40MG 90 S NDC CODE:68462039790 FDA P RODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROE SOPHAGEAL REFLUX DISEASE C ARVEDILOL TABS 3.125MG 500 S NDC CODE:68462016205 FDA PROD UCT CODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 AND A NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANT AGONIST ONDANSETRON TABLETS 8MG 30 S NDC CODE:6846201063 0 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90. 92.40 ANDA NO.:- 77-535 THER APEUTICE USE:-ANTI EMETIC PRAVASTATIN SODIUM TAB 40MG 90 S NDC CODE:68462019790 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTIC E USE: HYPOLIPDAEMIC INDOM ETHACIN CAPS 50MG 100 S NDC C ODE:68462030201 FDA PRODUCT C ODE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO. :91-276 THERAPEUTICE USE: AN TI-INFLAMATORY INDOMETHACIN CAPS 50MG 500 S NDC CODE:684 62030205 FDA PRODUCT CODE NO. : 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: ANTI-INFL AMATORY COMMERCIAL & CUSTOM INVOICE NO. F22352000514 DT. 11.05.2022 NET WT: 8,064.07 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA S/BILL NO: 133593 4 DT 12-MAY-2022 |
HS 621600 |
2022-06-07 |
53 PKG |
9553.72KG |
53 PALLETS 3372 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TABS 12.5MG 500 S NDC CODE:68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST CARVEDILOL TABS 3.125MG 500 S NDC CODE:68462016205 FDA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.2 0 ANDA NO.:- 78-251 THERAPEU TICE USE:-BETA-ADRENOACEPTOR ANTAGONIST OMEPRAZOLE DR CA PSULES 40MG 30 S NDC CODE:684 62039730 FDA PRODUCT CODE NO. : 62KCF10 H. T. S NO.: 3004 .90.9160 ANDA NO.: 91672 THE RAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLU X DISEASE ROPINIROLE TABS 0.5MG 100 S NDC CODE:68462025 401 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004. 90.92.40 ANDA NO.:- 90-135 T HERAPEUTICE USE:-TREATMENT OF PARKINSONISM INDOMETHACIN CAPS 50MG 500 S NDC CODE:684 62030205 FDA PRODUCT CODE NO. : 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: ANTI-INFL AMATORY ADAPALENE GEL 0.1% 15GM (PLD) NDC CODE:698420088 05 NDC NO.:69842008805 FDA P RODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3004.40.00.50 ANDA NO.: 091314 THERAPEUTICE USE: - TREATMENT OF ACNE COMMERCIAL & CUSTOM INVOICE NO . F22352000554 DT. 13.05.2022 F22352000555 DT. 13.05.2022 F22352000556 DT. 13.05.2022 F22352000557 DT. 13.05.2022 F 22352000559 DT. 13.05.2022 S/ BILL NO: 1396876 DT 14-MAY-20 22 S/BILL NO: 1396881 DT 14- MAY-2022 S/BILL NO: 1396855 DT 14-MAY-2022 S/BILL NO: 13 97264 DT 14-MAY-2022 S/BILL N O: 1397019 DT 14-MAY-2022 NE T WT: 7551.23 KGS 04 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA NOTIFY PARTY:3 P&L DEVELOPMENT, LLC 275 GRAND BLVD NEW YORK WE STBURY USA- 11590 LABELER CODE : 68462: |
HS 622200 |
2022-06-07 |
39 PKG |
7301.15KG |
39 PALLETS 1638 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PR ODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOP HAGEAL REFLUX DISEASE LAMO TRIGINE TABLETS FOR OS(CD)25MG 100 S NDC CODE:68462022901 F DA PRODUCT CODE NO.:- 61 M C A 38 H. T. S NO.: 3004.90.92 .30 ANDA NO.:-79 # 099 THERA PEUTICE USE:- ANTICONVULSANT ONDANSETRON TABLETS 8MG 30 S NDC CODE:68462010630 FDA P RODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 A NDA NO.:- 77-535 THERAPEUTICE USE:-ANTI EMETIC NAPROXEN TABLETS 500MG 500 S NDC CODE :68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC T RANDOLAPRIL-VERAPAMIL TAB 2/18 0MG 100 S NDC CODE:6846202950 1 FDA PRODUCT CODE NO.:-62 O D A 11 H. T. S NO.: 3004.90 .92.20 ANDA NO.:-79-135 THER APEUTICE USE:-TREATMENT OF H YPERTENSION NORGEST/EE 0.18 ,0.215,0.25/0.035MG 84 NDC CO DE:68462056529 FDA PRODUCT CO DE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200494 THERAPEUTICE USE: - O RAL CONTRACEPTIVES 08 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F223520003 95 DT. 30.04.2022 F2235200050 7 DT. 10.05.2022 S/BILL NO: 1 282151 DT: 10/05/2022 S/BILL NO: 1321682 DT:11/05/2022 NE T WT: 6247.98 KGS NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 621000 |
2022-06-07 |
5 PKG |
1194.33KG |
5 PALLETS 97 CARTONS PHAR MACEUTICALS AS UNDER AZELAI C ACID GEL 15% 50GM NDC CODE: 68462062652 FDA PRODUCT CODE NO.: 62 S C J 03 H. T. S NO. : 3004.49.00.50 ANDA NO.: 20 4637 INDICATED FOR TOPICAL T REATMENT OF THE INFLAMMATORY PAPULES AND PUSTULES OF MILD TO MODERATE ROSACEA COMMER CIAL & CUSTOM INVOICE NO. F22 352000558 DT. 13.05.2022 S/BI LL NO: 1396988 DT 14-MAY-2022 NET WT: 978.990 KGS 05 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWITZER LAND |
HS 620300 |
2022-06-07 |
1 PKG |
140.62KG |
1 PALLETS 24CARTONS PHA RMACEUTICALS AS UNDER ROSUVAS TATIN TABLETS 40MG 30 S NDC C ODE:68462026430 FDA PRODUCT C ODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TABLETS 40MG 500 S NDC CODE:68462026405 6 1 J C A 16 3004.49.00.10 791 72 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DIS EASE INV NO: F22352000358 D T. 30.04.2022 S/BILL NO: 127 9029 DT: 09-MAY-22 NET WT : 1 26.720 KGS 16 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECI ALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 293399 |
2022-06-07 |
36 PKG |
7195.91KG |
36 PALLETS 1596 CARTONS PH ARMACEUTICALS AS UNDER METF ORMIN HCL ER TABS (Z) 500MG 10 0 S NDC CODE:68462052001 FDA PRODUCT CODE NO.: 61 P C A 5 5 H. T. S NO.: 3004.90.92.40 ANDA NO.:212969 THERAPEUTIC E USE: THE MANAGEMENT OF TYPE 2 DIABETES DILTIAZEM HCL ER CAPS 12HR 60MG 100 S NDC C ODE:68462085001 62 O C B 24 3004.49.00.10 212317 FOR THE TREATMENT OF HYPERTENSION. ESOMEPRAZOLE MAG DR CAPS 20M G 1000 S NDC CODE:68462039010 FDA PRODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004.90.9 2 60 ANDA NO.: 209495 THERA PEUTICE USE: ESOMEPRAZOLE MA GNESIUM DELAYED-RELEASE CAPSU LES ARE INDICATED FOR THE LO NG-TERM TREATMENT OF PATHOLOG ICAL HYPERSECRETORY CONDITIO NS, INCLUDING ZOLLINGER-ELLIS ON SYNDROME TACROLIMUS OIN TMENT 0.1% 60GM NDC CODE:6846 2053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLI MUS IS A TOPICAL IMMUNOSUPPRE SSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVE RE ATOPIC DERMATITIS (ECZEMA ). TACROLIMUS OINTMENT 0.1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00 .50 ANDA NO.: 210393 THERAPE UTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OI NTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPI C DERMATITIS (ECZEMA). AML ODIPINE-OLMESARTAN TABS 10/40M G 30 S NDC CODE:68462056930 FDA PRODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90.92 .20 ANDA NO.: 207807 THERAPE UTICE USE: MEDICATION USED TO TREAT HIGH BLOOD PRESSURE AN D CORONARY ARTERY DISEASE TACROLIMUS OINTMENT 0.1% 60GM NDC CODE:68462053465 FDA PRO DUCT CODE NO.: 64 T C J 08 H . T. S NO.: 3004.49.00.50 AN DA NO.: 210393 THERAPEUTICE U SE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MO DERATE-TO-SEVERE ATOPIC DERMA TITIS (ECZEMA). EZETIMIBE- SIMVASTATIN TAB 10/40MG 30 S NDC CODE:68462032330 FDA PROD UCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 AND A NO.: 208699 THERAPEUTICE US E: - THIS COMBINATION MEDICAT ION IS USED TO HELP LOWER BA D CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RA ISE GOOD CHOLESTEROL (HDL) I N THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHO LESTEROL YOUR BODY ABSORBS FR OM YOUR DIET. SIMVASTATIN BE LONGS TO A GROUP OF DRUGS KNO WN AS STATINS. IT WORKS BY REDUCING THE AMOUNT OF CHOLES TEROL MADE BY THE LIVER. T ACROLIMUS CAPSULES 5MG 100 S NDC CODE:68462068701 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERA PEUTICE USE: TO PREVENT REJEC TION OF A KIDNEY, HEART, OR LIVER TRANSPLANT NAPROXEN S ODIUM TABLETS 550MG 500 S NDC CODE:68462017905 FDA PRODUCT CODE NO.:-62 G C A 50 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-314 THERAPEUTICE USE:- ANTI INFLAMMATORY, ANALGESIC CARVEDILOL TABS 25MG 500 S NDC CODE:68462016505 FDA PRO DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST PRAVASTATIN SODIUM TAB 20MG 90 S NDC CODE:68462 019690 FDA PRODUCT CODE NO.: -61 J C A 13 H. T. S NO.: 30 04.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAE MIC TACROLIMUS OINTMENT 0.1 % 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00 .50 ANDA NO.: 210393 THERAPE UTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OI NTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPI C DERMATITIS (ECZEMA). 0 2 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES COMMERCIA L & CUSTOM INVOICE NO. F22387 000150 DT. 30.04.2022 F223870 00151 DT. 30.04.2022 F2238700 0153 DT. 30.04.2022 F22387000 154 DT. 30.04.2022 F223870001 55 DT. 30.04.2022 F2238700016 4 DT. 30.04.2022 F22387000172 DT. 30.04.2022 F22387000175 DT. 30.04.2022 F22387000179 D T. 30.04.2022 F22387000205 DT . 11.05.2022 F22387000206 DT. 11.05.2022 F22387000208 DT. 11.05.2022 S/BILL NO: 400674 3 DT: 11.05.2022 S/BILL NO: 4006751 DT: 11.05.2022 S/BI |
HS 300490 |
2022-06-07 |
8 PKG |
1983.59KG |
8 PALLETS 244 CARTONS PHAR MACEUTICALS AS UNDER NITROG LYCERIN SUBLING TABS 0.4MG 4X2 5 NDC CODE:68462063945 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 A NDA NO.:206391 THERAPEUTIC US E: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART NITROGLY CERIN SUBLING TABS 0.4MG 4X25 NDC CODE:68462063945 FDA PRO DUCT CODE NO.: 66 S C A 28 H . T. S NO.: 3004.90.9020 AND A NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEART F AILURE,HIGH BLOOD PRESSURE,AN D TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FL OW TO THE HEART NITROGLYCE RIN SUBLING TABS 0.4MG 4X25 N DC CODE:68462063945 FDA PRODU CT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEART FAI LURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOICE NO. F22387000 165 DT. 30.04.2022 F223870001 69 DT. 30.04.2022 F2238700020 7 DT. 11.05.2022 S/BILL NO:40 06762 DT: 11.05.2022 S/BILL N O: 4006764 DT: 11.05.2022 S/B ILL NO: 4006766 DT: 11.05.2022 NET WT: 130.00 KGS 08 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWITZER LAND |
HS 662800 |
2022-06-07 |
53 PKG |
9329.19KG |
53 PALLETS 2643 CARTONS P HARMACEUTICALS AS UNDER OME PRAZOLE DR CAPSULES 40MG 90 S NDC CODE:68462039790 FDA PRO DUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESO PHAGEAL REFLUX DISEASE IND OMETHACIN CAPS 50MG 100 S NDC CODE:68462030201 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA N O.:91-276 THERAPEUTICE USE: ANTI-INFLAMATORY FLUCONAZOL E TABLETS 200MG 30 S NDC CODE :68462010430 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO .: 3004.90.92.45 ANDA NO.:-7 7 - 253 THERAPEUTICE USE:-AN TIFUNGAL CLINDAMYCIN PHOSPH ATE GEL 1% 60GM NDC CODE:6846 2086665 FDA PRODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3 004.49.00.50 ANDA NO.:214251 THERAPEUTICE USE: CLINDAMYCI N PHOSPHATE GEL IS INDICATED IN THE TREATMENT OF ACNE VUL GARIS CICLOPIROX GEL 0.77% 100GM NDC CODE:68462045594 F DA PRODUCT CODE NO.: 61WCJ43 H. T. S NO.: 3004.49.00.50 ANDA NO.: 091595 THERAPEUTICE USE: - ANTIFUNGAL 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & CU STOM INVOICE NO. F22352000540 DT. 13.05.2022 F22352000541 DT. 13.05.2022 F22352000546 D T. 13.05.2022 F22352000547 DT . 13.05.2022 S/BILL NO: 1381 016 DT 13-MAY-2022 S/BILL NO: 1380995 DT 13-MAY-2022 S/BI LL NO: 1381138 DT 13-MAY-2022 S/BILL NO: 1381329 DT 13-MA Y-2022 NET WT: 7793.22 KGS NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 621000 |
2022-06-07 |
25 PKG |
5677.71KG |
25 PALLETS 1159 CARTONS PH ARMACEUTICALS AS UNDER FELO DIPINE ER TABS 10MG 100 S NDC CODE:68462023501 FDA PRODUCT CODE NO.: 62OCB32 H. T. S N O.: 3004.90.92.20 ANDA NO.: 90-365 THERAPEUTICE USE: - T REATMENT OF HYPERTENSION N APROXEN TABLETS 500MG 500 S N DC CODE:68462019005 FDA PRODU CT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE US E:-ANTI-INFLAMMATORY, ANALGES IC OXCARBAZEPINE TABLETS 30 0MG 100 S NDC CODE:6846201380 1 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90 .92.30 ANDA NO.:-77-802 THER APEUTICE USE:-ANTI CONVULSANT AGENT PRAVASTATIN SODIUM T AB 20MG 500 S NDC CODE:684620 19605 FDA PRODUCT CODE NO.:- 61 J C A 13 H. T. S NO.: 300 4.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEM IC CARVEDILOL TABS 25MG 500 S NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUST OM INVOICE NO. F22352000398 D T. 30.04.2022 F22387000220 DT . 13.05.2022 F22387000221 DT. 13.05.2022 S/BILL NO: 128678 3 DT: 10/05/2022 S/BILL NO: 4 006892 DT:13/05/2022 S/BILL N O: 4006891 DT: 13/05/2022 NET WT: 4831.90 KGS 07 DATA LO GGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK PHARMACEUTI CALS LTD. PLOT NO 2, ISEZ, PH ASE II,PHARMA ZONE PITHAMPUR, DIST DHAR, MADHYA PRADESH IND IA GST NO. : 23AAACG2207L2ZZ |
HS 623200 |
2022-06-07 |
25 PKG |
5230.01KG |
25 PALLETS 1399 CARTONS PH ARMACEUTICALS AS UNDER CLIN DAMYCIN PHOSPHATE GEL 1% 30GM NDC CODE:68462086635 FDA PRO DUCT CODE NO.: 56 J D J 31 H . T. S NO.: 3004.49.00.50 AN DA NO.:214251 THERAPEUTICE US E: CLINDAMYCIN PHOSPHATE GEL IS INDICATED IN THE TREATMEN T OF ACNE VULGARIS CLINDAM YCIN PHOSPHATE GEL 1% 60GM ND C CODE:68462086665 FDA PRODUC T CODE NO.: 56 J D J 31 H. T . S NO.: 3004.49.00.50 ANDA NO.:214251 THERAPEUTICE USE: CLINDAMYCIN PHOSPHATE GEL IS INDICATED IN THE TREATMENT O F ACNE VULGARIS NORGEST/EE 0.25/0.035MG 84 NDC CODE:684 62030929 FDA PRODUCT CODE NO. : 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO.: 20053 8 THERAPEUTICE USE: - ORAL C ONTRACEPTIVES NORGEST/EE 0. 18,0.215,0.25/0.035MG 84 NDC CODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO .: 200494 THERAPEUTICE USE: - ORAL CONTRACEPTIVES NORET HINDRONE ACETATE TABS 5MG 50 NDC CODE:68462030450 FDA PROD UCT CODE NO.65 J C A 25 H. T . S NO.: 3004.39.00.50 ANDA NO.:-91-090 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOM ETRIOS IS AND ABNORMAL UTERI NE BLEEDING COMMERCIAL & CU STOM INVOICE NO. F22352000515 DT. 11.05.2022 F22352000517 DT. 11.05.2022 F22352000526 D T. 11.05.2022 F22352000535 DT . 12.05.2022 S/BILL NO: 13701 39 DT 13-MAY-2022 S/BILL NO: 1370105 DT 13-MAY-2022 S/BILL NO: 1370141 DT 13-MAY-2022 S /BILL NO: 1372692 DT 13-MAY-20 22 NET WT: 4,205.46 KGS 03 DATA LOGGERS SET TEMPERATU RE : +18 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 563100 |
2022-06-07 |
19 PKG |
3434.21KG |
19 PALLETS 1474 CARTONS P HARMACEUTICALS AS UNDER ROS UVASTATIN TABLETS 40MG 30 S N DC CODE:68462026430 FDA PRODU CT CODE NO.:61 J C A 16 H. T . S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DIS EASE ROSUVASTATIN TABLETS 5 MG 90 S NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00 .10 ANDA NO.: 079172 THERAPE UTICE USE: - TO TREAT HIGH CH OLESTEROL AND RELATED CONDITI ONS, AND TO PREVENT CARDIOVA SCULAR DISEASE NITROGLYCERI N SUBLING TABS 0.4MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO .:206391 THERAPEUTIC USE: ME DICATION USED FOR HEART FAILU RE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW T O THE HEART COMMERCIAL & C USTOM INVOICE NO. F2235200035 9 DT. 30.04.2022 F22352000380 DT. 30.04.2022 F22387000222 DT. 13.05.2022 S/BILL NO: 12 79028 DT: 09/05/2022 S/BILL N O: 1279036 DT:09/05/2022 S/B ILL NO: 4006888 DT:13/05/2022 NET WT: 1,972.85 KGS 15 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE NUMA-DR OZ 2 NEUCHATEL - 2000 SWITZE RLAND NOTIFY PARTY:3 GLENMAR K PHARMACEUTICALS LTD. PLOT N O 2, ISEZ, PHASE II,PHARMA ZON E PITHAMPUR, DIST DHAR, MADHY A PRADESH INDIA GST NO. : 23A AACG2207L2ZZ |
HS 611600 |
2022-06-07 |
1 PKG |
1199.77KG |
PHARMACEUTICALS AS UNDER SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES |
HS 271019 |
2022-06-07 |
1 PKG |
1199.77KG |
PHARMACEUTICALS AS UNDER SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES. |
HS 271019 |
2022-06-07 |
15 PKG |
2687.58KG |
15 PALLETS 718 CARTONS PHA RMACEUTICALS AS UNDER HAILE Y 1.5/30 TABLETS 1.5MG/30MCG 3 X21 NDC CODE:68462050481 FDA PRODUCT CODE NO.: 65 J D A 2 5 H. T. S NO.: 3006.60.00.00 ANDA NO.: 209297 THERAPEUTI CE USE: - CONTRACEPTION TO PR EVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F223520 00524 DT. 11.05.2022 S/BILL N O: 1370382 DT 13-MAY-2022 NET WT: 2067.84 KGS 15 DATA LOG GERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 652500 |
2022-06-07 |
40 PKG |
5934.9KG |
40 PALLETS 1716 CARTONS P HARMACEUTICALS AS UNDER EST RADIOL VAG INSERTS USP 10MCG 1 8 S NDC CODE:68462071188 NDC NO.:68462071188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO .:210264 THERAPEUTICE USE:THE TREATMENT OF ATROPIC VAGINI TIS DUE TO MENOPAUSE. ESTR ADIOL VAG INSERTS USP 10MCG 8 S NDC CODE:68462071171 FDA P RODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE:THE TREATMENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. ESTRADIOL VAG INSERTS USP 1 0MCG 8 S NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60. 00.00 ANDA NO.:210264 THERAP EUTICE USE:THE TREATMENT OF A TROPIC VAGINITIS DUE TO MENO PAUSE. NORGEST/EE 0.25/0.03 5MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00 .00 ANDA NO.: 200538 THERAPE UTICE USE: - ORAL CONTRACEPTI VES INV NO: F22352000401 DT. 30.04.2022 INV NO: F22352 000472 DT. 06.05.2022 INV NO: F22352000473 DT. 06.05.2022 S/BILL NO:1279038 DT: 09/05/20 22 S/BILL NO:1276595 DT:09/05 /2022 S/BILL NO:1276586 DT: 09/05/2022 NET WT: 4,528.6 1 KGS 04 DATA LOGGERS SET TEMPERATURE : +18 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA |
HS 642800 |
2022-05-25 |
2 PKG |
235.87KG |
2 PALLETS 39 CARTONS PHA RMACEUTICALS AS UNDER NITRO GLYCERIN SUBLING TABS 0.3MG 10 0 S NDC CODE:68462063801 FDA PRODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOT ENOUGH BLOO D FLOW TO THE HEART COMMER CIAL & CUSTOM INVOICE NO. F22 387000124 DT. 27.04.2022 NET WT: 20.61 KGS 02 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND S/BILL NO: 4006181 DT: 29.04 .2022 |
HS 662800 |
2022-05-25 |
38 PKG |
9189.03KG |
38 PALLETS 2811 CART ONS PHARMACEUTICALS AS UNDER ESOMEPRAZOLE MAG DR CAPS 40 MG 1000 S NDC CODE:6846203911 0 FDA PRODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004.90. 92 60 ANDA NO.: 209495 THER APEUTICE USE: ESOMEPRAZOLE M AGNESIUM DELAYED-RELEASE CAPS ULES ARE INDICATED FOR THE L ONG-TERM TREATMENT OF PATHOLO GICAL HYPERSECRETORY CONDITI ONS, INCLUDING ZOLLINGER-ELLI SON SYNDROME VORICONAZOLE TABLETS 200MG 30 S NDC CODE:6 8462057330 FDA PRODUCT CODE NO.:61 W C A 59 H. T. S NO.: 3004.90.92.10 ANDA NO.:20350 3 THERAPEUTICE USE: -USED TO TREAT FUNGAL INFECTIONS P RAVASTATIN SODIUM TAB 10MG 90 S NDC CODE:68462019590 FDA P RODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEMIC RANOLA ZINE ER TABS 500MG 60 S NDC C ODE:68462031960 FDA PRODUCT C ODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO. :211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDICATI ON. IT WORKS BY IMPROVING BLO OD FLOW TO HELP THE HEART WOR K MORE EFFICIENTLY. IT IS USE D TO TREAT CHRONIC ANGINA (C HEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA RANOLAZIN E ER TABS 1000MG 60 S NDC COD E:68462032060 FDA PRODUCT COD E NO.: 61 D C B 02 H. T. S N O.: 3004.49.00.10 ANDA NO.:2 11082 THERAPEUTIC USE: - IT I S AN ANTI-ANGINAL MEDICATION . IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHE ST PAIN). IT IS NOT FOR USE D URING AN ACUTE (EMERGENCY) AT TACK OF ANGINA COLESEVELAM HCL TABLETS 625MG 180 S NDC C ODE:68462043318 FDA PRODUCT C ODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00.10 ANDA NO. : 203480 THERAPEUTICE USE: - ANTIHYPERLIPO PROTEINEMIC. TACROLIMUS OINTMENT 0.1% 100 GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTIC E USE: - TACROLIMUS IS A TOPI CAL IMMUNOSUPPRESSIVE OINTME NT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DE RMATITIS (ECZEMA). COMMERC IAL & CUSTOM INVOICE NO. F223 87000123 DT. 27.04.2022 F2238 7000125 DT. 27.04.2022 NET WT : 3,767.34 KGS 02 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA S/BILL N O: 4006184 DT: 29.04.2022 S/ BILL NO: 4006188 DT: 29.04.20 22 |
HS 620600 |
2022-05-25 |
55 PKG |
9596.36KG |
55 PALLETS 1314 CARTONS P HARMACEUTICALS AS UNDER MUP IROCIN OINTMENT 2% 22GM NDC C ODE:68462018022 FDA PRODUCT C ODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO. : 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL OMEPRAZOLE DR CAPSULES 40MG 1000 S NDC C ODE:68462039710 FDA PRODUCT C ODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE USE: - TREATME NT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE OMEPRAZOLE D R CAPSULES 40MG 90 S NDC CODE :68462039790 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22352000 306 DT. 27.04.2022 F223520003 09 DT. 27.04.2022 S/BILL NO: 1026242 DT 28-APR-2022 S/BILL NO: 1031130 DT 28-APR-2022 NET WT: 8,144.21 KGS 02 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 684620 |
2022-05-25 |
55 PKG |
10546.65KG |
55 PALLETS 2996 CART ONS PHARMACEUTICALS AS UNDER LAMOTRIGINE TABLETS FOR OS (CD)5MG100 S NDC CODE:6846202 2801 FDA PRODUCT CODE NO.:- 61 M C A 38 H. T. S NO.: 300 4.90.92.30 ANDA NO.:-79 # 099 THERAPEUTICE USE:- ANTICONV ULSANT URSODIOL TABS 500MG 100 S NDC CODE:68462047401 F DA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 3004.49.00. 10 ANDA NO.: 90-801 THERAPEU TICE USE: - FOR THE TREATMENT OF PATIENTS WITH PRIMARY BI LIARY CIRRHOSIS LAMOTRIGINE TABLETS FOR OS(CD)25MG100 S NDC CODE:68462022901 FDA PROD UCT CODE NO.:- 61 M C A 38 H . T. S NO.: 3004.90.92.30 AN DA NO.:-79 # 099 THERAPEUTICE USE:- ANTICONVULSANT URSO DIOL TABS 250MG 100 S NDC COD E:68462047301 FDA PRODUCT COD E NO.: 63 N C A 25 H. T. S N O.: 3004.49.00.10 ANDA NO.: 90-801 THERAPEUTICE USE: - FO R THE TREATMENT OF PATIENTS WITH PRIMARY BILIARY CIRRHOSI S OMEPRAZOLE DR CAPSULES 40 MG 30 S NDC CODE:68462039730 FDA PRODUCT CODE NO.: 62KCF1 0 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS E NAPROXEN TABLETS 500MG 50 0 S NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 4 9 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTI CE USE:-ANTI-INFLAMMATORY, A NALGESIC OMEPRAZOLE DR CAPS ULES 20MG 1000 S NDC CODE:684 62039610 FDA PRODUCT CODE NO. : 62KCF10 H. T. S NO.: 3004 .90.9160 ANDA NO.: 91672 THE RAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLU X DISEASE MUPIROCIN OINTME NT 2% 22GM NDC CODE:684620180 22 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.9 0.92.45 ANDA NO.: 90-480 THE RAPEUTICE USE: - ANTI-BACTERI AL COMMERCIAL & CUSTOM INVO ICE NO. F22352000296 DT. 26.0 4.2022 F22352000299 DT. 26.04 .2022 NET WT: 8699.75 KGS 01 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA S/BILL NO: 1016215 DT 28-A PR-2022 S/BILL NO: 1026241 DT 28-APR-2022 |
HS 613800 |
2022-05-25 |
4 PKG |
633.23KG |
4 PALLETS 350 CARTON S PHARMACEUTICALS AS UNDER ROSUVASTATIN TABLETS 10MG 90 S NDC CODE:68462026290 FDA P RODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 A NDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTE ROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTO M INVOICE NO. F22352000298 DT . 26.04.2022 NET WT: 486.49 KGS 04 DATA LOGGERS SET T EMPERATURE : +18 DEGREES S/BI LL NO: 1026171 DT 28-APR-2022 NOTIFY PARTY:2 GLENMARK SPEC IALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 611600 |
2022-05-25 |
20 PKG |
3210.13KG |
20 PALLETS 1793 CART ONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TABLETS 10MG 9 0 S NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTIC E USE: - TO TREAT HIGH CHOLES TEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCUL AR DISEASE COMMERCIAL & CUS TOM INVOICE NO. F22352000320 DT. 28.04.2022 NET WT:: 2,54 7.49 KGS 20 DATA LOGGERS S/BILL NO: 1050897 DT:29-APR-2 2 NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (G SSA) PLACE NUMA-DROZ 2 NEUCH ATEL - 2000 SWITZERLAND |
HS 611600 |
2022-05-25 |
47 PKG |
9115.09KG |
8 PALLETS 723 CARTONS PHARMA CEUTICALS AS UNDER ROSUVASTAT IN TABLETS 10MG 90 S NDC CODE :68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE N O. F22352000330 DT. 29.04.202 2 S/BILL NO: 1089479 DT 30-AP R-2022 NET WT: 995.98 KGS 08 DATA LOGGERS NOTIFY PARTY: 2 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE NUMA-D ROZ 2 NEUCHATEL - 2000 SWITZ ERLAND |
HS 684620 |
2022-05-25 |
14 PKG |
3475.94KG |
14 PALLETS 1417 CART ONS PHARMACEUTICALS AS UNDER SOLIFENACIN SUCCINATE TABS 5MG 30 S NDC CODE:68462038630 FDA PRODUCT CODE NO.: 61 KC A 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICAT ED FOR THE TREATMENT OF OVERA CTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENCY AND URINARY FREQUENC Y ATOVAQUONE ORAL SUSP 750M G/5ML 210ML NDC CODE:68462042 121 FDA PRODUCT CODE NO.: 62 L C L 44 H. T. S NO.: 3004. 90.92.90 ANDA NO.: 209685 US ED TO PREVENT OR TREAT A SERI OUS LUNG INFECTION CALLED PNE UMOCYSTIS PNEUMONIA (PCP). TH IS MEDICATION HELPS TO STOP INFECTION SYMPTOMS SUCH AS FE VER, COUGH, TIREDNESS, AND SH ORTNESS OF BREATH. S/BILL NO: 9972164 DT:26/04/2022 S/B ILL NO: 4006103 DT:28/04/2022 COMMERCIAL & CUSTOM INVOICE NO. F22387000126 DT. 27.04.2 022 F22335000266 DT. 25.04.20 22 NET WT: 1,389.73 KGS 1 4 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NU MA-DROZ 2 NEUCHATEL - 2000 S WITZERLAND NOTIFY PARTY:3 GLENMARK PHARMACEUTICALS LTD. PLOT NO 2, ISEZ, PHASE II,PHA RMA ZONE PITHAMPUR, DIST DHAR , MADHYA PRADESH INDIA GST NO . : 23AAACG2207L2ZZ |
HS 617200 |
2022-05-25 |
47 PKG |
8476.88KG |
47 PALLETS 2811 CART ONS PHARMACEUTICALS AS UNDER TELMISARTAN TABLETS 80MG 30 S NDC CODE:68462020130 HTS NO : 3004.90.92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAPEUTICE USE : INDICATED FOR THE TREATMENT OF HYPERT ENSION, TO LOWER BLOOD PRESSU RE OMEPRAZOLE DR CAPSULES 4 0MG 1000 S NDC CODE:684620397 10 FDA PRODUCT CODE NO.:62KC F10 H. T. S NO.: 3004.90.916 0 ANDA NO.:91672 THERAPEUTIC E USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEA SE VERAPAMIL HCL ER TABS 12 0MG 100S NDC CODE:68462029201 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90. 92.20 ANDA NO.: 90-700 THERA PEUTICE USE: - ANGINA FLUC ONAZOLE TABLETS 100MG 30 S ND C CODE:68462010230 FDA PRODUC T CODE NO : 61 W C A 45 H. T . S NO.: 3004.90.92.45 ANDA NO.:-77 - 253 THERAPEUTICE U SE:-ANTIFUNGAL CARVEDILOL T ABS 12.5MG 500 S NDC CODE:684 62016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-2 51 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST C OMMERCIAL & CUSTOM INVOICE NO. F22352000319 DT. 28.04.2022 NET WT: 7,066.14 KGS 02 D ATA LOGGERS S/BILL NO: 1060 778 DT: 29-APR-22 NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 300490 |
2022-05-25 |
11 PKG |
2156.41KG |
11 PALLETS 192 CARTONS PHARMACEUTICALS AS UNDER HYDR OCORTISONE VAL OINTMENT 0.2% 1 5GM NDC CODE:68462083617 FDA PRODUCT CODE NO.: 64 L C L 7 1 H. T. S NO.: 3004.49.00.50 ANDA NO.: 211750 THERAPEUTI CE USE: - INDICATED FOR THE R ELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DER MATOSES IN ADULT PATIENTS. CLOBETASOL PROP SOLUTION 0.05 % 50ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92 .45 ANDA NO.: 210190 THERAPE UTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTERILE LIQUID / CLOBE TASOL PROPIONATE (GLUCOCORTIC OID) TRIAMCINOLONE ACE OINT 0.5% 15GM NDC CODE:684620798 17 FDA PRODUCT CODE NO.:64 L C J 61 H. T. S NO.: 3004.49 .00.50 ANDA NO.:206379 THERA PEUTICE USE: - REDUCES THE SW ELLING, ITCHING, AND REDNESS OF SKIN COMMERCIAL & CUSTO M INVOICE NO. F22335000265 DT . 25.04.2022 NET WT. 868.80 K GS 11 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA S/BILL NO: 9968246 D T: 26/04/2022 |
HS 647100 |
2022-05-25 |
8 PKG |
1283.69KG |
8 PALLETS 723 CARTONS PHARMA CEUTICALS AS UNDER ROSUVASTAT IN TABLETS 10MG 90 S NDC CODE :68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE N O. F22352000330 DT. 29.04.202 2 NET WT: 995.98 KGS 08 DATA LOGGERS S/BILL NO: 1089479 DT 30-APR-2022 NOTIFY PART Y:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA -DROZ 2 NEUCHATEL - 2000 SWI TZERLAND |
HS 684620 |
2022-05-17 |
54 PKG |
9476.61KG |
54 PALLETS 3337 CARTONS PH ARMACEUTICALS AS UNDER ROPI NIROLE TABS 1MG 100 S NDC COD E:68462025501 FDA PRODUCT COD E NO.:-62 J C A 17 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TR EATMENT OF PARKINSONISM VE RAPAMIL HCL ER TABS 120MG 100S NDC CODE:68462029201 FDA PR ODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 A NDA NO.: 90-700 THERAPEUTICE USE: - ANGINA LITHIUM CARB ONATE ER TABS 300MG 100 S NDC CODE:68462022301 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00.20 ANDA N O.:91-544 THERAPEUTICE USE: - INDICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOL AR DISORDER. BIPOLAR DISORDER , MANIC (DSM-IV) IS EQUIVALEN T TO MANIC DEPRESSIVE ILLNESS , MANIC, IN THE OLDER DSM-II TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT F OR INDIVIDUALS WITH A DIAGNOS IS OF BIPOLAR DISORDER. MAIN TENANCE THERAPY REDUCES THE F REQUENCY OF MANIC EPISODES AN D DIMINISHES THE INTENSITY O F THOSE EPISODES WHICH MAY OC CUR. OMEPRAZOLE DR CAPSULE S 40MG 30 S NDC CODE:68462039 730 FDA PRODUCT CODE NO.: 62 KCF10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAPEU TICE USE: - TREATMENT OF TREA T GASTROESOPHAGEAL REFLUX DI SEASE HAILEY24FE NORE ACE/E E-FE 1/0.02-75MG 84 NDC CODE: 68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO. : 3006.60.00.00 ANDA NO.: 20 4847 THERAPEUTICE USE: - CON TRACEPTION TO PREVENT PREGNAN CY COMMERCIAL & CUSTOM INVO ICE NO. F22352000178 DT. 18.0 4.2022 F22352000169 DT. 18.04 .2022 S/BILL NO: 9797783 DT: 19-APR-22 S/BILL NO: 9797778 DT:19-APR-22 NET WT: 7,409. 15 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA |
HS 621300 |
2022-05-17 |
2 PKG |
394.63KG |
2 PALLETS 63 CART ONS PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TABS 0.4MG 100 S NDC CODE:68462063 901 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004. 90.9020 ANDA NO.: 206391 THE RAPEUTICE USE: MEDICATION USE D FOR HEART FAILURE, HIGH BLO OD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTE NOUGH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOIC E NO. F22387000104 DT. 22.04. 2022 S/BILL NO: 4005813 DT: 23.04.2022 NET WT: 33.11 KG S 02 DATA LOGGERS NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE N UMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 662800 |
2022-05-17 |
8 PKG |
2033.49KG |
8 PALLETS 164 CARTONS PHARMA CEUTICALS AS UNDER AZELAIC AC ID GEL 15% 50GM NDC CODE:6846 2062652 FDA PRODUCT CODE NO.: 62 S C J 03 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 204637 INDICATED FOR TOPICAL TREAT MENT OF THE INFLAMMATORY PAPU LES AND PUSTULES OF MILD TO MODERATE ROSACEA COMMERCIAL & CUSTOM INVOICE NO. F223520 00248 DT. 22.04.2022 S/BILL N O: 9911921 DT 23-APR-2022 NET WT: 1660.26 KGS 08 DATA LOG GERS NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND AGENT ADDRESS AT DESTINATION MAERSK CHARLOTTE CUSTOMER RES OURCE CENTER 9300 ARROWPOINT BLVD CHARLOTTE NC USA 28273 TEL: +1 (800) 321 8807 |
HS 620300 |
2022-05-17 |
31 PKG |
6286.9KG |
31 PALLETS 2525 CARTON S PHARMACEUTICALS AS UNDER EZETIMIBE TABS 10MG 30 S NDC CODE:68462022630 FDA PRODUCT CODE 61 J C A 15 HTS NO 30 04.49.00.10 ANDA NO. 078560 THERAPEUTICE USE LIPID LOWER ING AGENT EZETIMIBE TABS 10 MG 90 S NDC CODE:68462022690 FDA PRODUCT CODE 61 J C A 15 HTS NO 3004.49.00.10 ANDA NO. 078560 THERAPEUTICE USE LIPID LOWERING AGENT EZETI MIBE TABS 10MG 500 S NDC CODE :68462022605 FDA PRODUCT CODE 61 J C A 15 HTS NO 3004.49 .00.10 ANDA NO. 078560 THER APEUTICE USE LIPID LOWERING A GENT CARVEDILOL TABS 25MG 5 00 S NDC CODE:68462016505 FD A PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.2 0 ANDA NO.:- 78-251 THERAPEU TICE USE:-BETA- ADRENOACEPTO R ANTAGONIST VORICONAZOLE TABLETS 50MG 30 S NDC CODE:68 462057230 FDA PRODUCT CODE N O.:61 W C A 59 H. T. S NO.: 3004.90.92.10 ANDA NO.:203503 THERAPEUTICE USE: -USED TO TREAT FUNGAL INFECTIONS CH LORPROMAZINE HCL TABS 10MG 100 S NDC CODE:68462086101 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDER S SUCH AS SCHIZOPHRENIA OR M ANIC-DEPRESSION IN ADULTS CHLORPROMAZINE HCL TABS 25MG 1 00 S NDC CODE:68462086201 61 T C A 04 3004.90.92.40 2121 44 TO TREAT PSYCHOTIC DISORD ERS SUCH AS SCHIZOPHRENIA OR MANIC-DEPRESSION IN ADULTS INDOMETHACIN ER CAPSULES 75M G 60 S NDC CODE:68462032560 FDA PRODUCT CODE: 62 GCE42 H . T. S NO.:3004.90.92.40 AND A NO.203501 THERAPEUTIC USE: INDOMETHACIN IS USED TO RELI EVE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED BY ARTHRITI S, GOUT, BURSITIS, AND TENDON ITIS. IT IS ALSO USED TO RELI EVE PAIN FROM VARIOUS OTHER CONDITIONS. THIS MEDICATION I S KNOWN AS A NONSTEROIDAL AN TI-INFLAMMATORY DRUG (NSAID). . THIS EFFECT HELPS TO DECR EASE SWELLING AND PAIN. CO MMERCIAL & CUSTOM INVOICE NO. F22387000084 DT. 19.04.2022 F22387000085 DT. 19.04.2022 S /BILL NO: 4005712 DT:21.04.202 2 S/BILL NO: 4005711 DT:21.0 4.2022 NET WT: 3,642.34 KG S 02 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A |
HS 300449 |
2022-05-17 |
42 PKG |
8161.17KG |
42 PALLETS 1759 CARTONS PH ARMACEUTICALS AS UNDER VERAPA MIL HCL ER TABS 120MG 100S ND C CODE:68462029201 FDA PRODUC T CODE NO.: 62 O C B 13 H. T . S NO.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - ANGINA OMEPRAZOLE DR CA PSULES 40MG 90 S NDC CODE:684 62039790 FDA PRODUCT CODE NO. : 62KCF10 H. T. S NO.: 3004 .90.9160 ANDA NO.: 91672 THE RAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLU X DISEASE GABAPENTIN TABLET S 600MG 500 S NDC CODE:684620 12605 FDA PRODUCT CODE NO: 6 1 N C A 69 H. T. S NO.: 3004 .90.92.30 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULSA NT AGENT COMMERCIAL & CUST OM INVOICE NO. F22352000211 D T. 21.04.2022 F22352000212 DT . 21.04.2022 S/BILL NO:985561 8 DT: 21-APR-22 S/BILL NO: 98 54993 DT:21-APR-22 NET WT: 7 ,308.66 KGS 03 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA |
HS 621300 |
2022-05-17 |
25 PKG |
3555.77KG |
25 PALLETS 1216 CARTONS PHARMACEUTICALS AS UNDER DROSPIRENONE/EE 3. 0/0.02MG 84 NDC CODE:68462072 029 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006. 60.00.00 ANDA NO.: 204296 TH ERAPEUTICE USE: - ORAL CONTRA CEPTIVE 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S COMMERCIAL & CUSTOM INVOI CE NO. F22352000228 DT. 22.04 .2022 S/BILL NO: 9894475 DT:2 3-APR-22 NET WT: 2503.99 KGS NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 653900 |
2022-05-17 |
12 PKG |
2441.73KG |
12 PALLETS 1116 CART ONS PHARMACEUTICALS AS UNDER SOLIFENACIN SUCCINATE TABS 10MG 30 S NDC CODE:6846203873 0 FDA PRODUCT CODE NO.: 61 K CA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICA TED FOR THE TREATMENT OF OVER ACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE , URGENCY AND URINARY FREQUEN CY SOLIFENACIN SUCCINATE TA BS 10MG 90 S NDC CODE:6846203 8790 FDA PRODUCT CODE NO.: 6 1 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 IND ICATED FOR THE TREATMENT OF O VERACTIVE BLADDER WITH SYMPTO MS OF URGE URINARY INCONTINE NCE, URGENCY AND URINARY FREQ UENCY APREPITANT CAPSULES 4 0MG 1UD NDC CODE:68462058340 FDA PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 3004.90.9 2.40 ANDA NO.: 207777 THERAP EUTICE USE: APREPITANT IS USE D WITH OTHER MEDICATIONS TO H ELP PREVENT NAUSEA AND VOMIT ING CAUSED BY CANCER DRUG TRE ATMENT (CHEMOTHERAPY). THIS MEDICATION IS ALSO USED TO PR EVENT NAUSEA AND VOMITING AFT ER SURGERY. A-EMETIC/NAUSEANT / HUMAN - RX/SINGLE INGREDI ENT / DELAYED RELEASE TABLETS / APREPITANT COMMERCIAL & CUSTOM INVOICE NO. F22387000 086 DT. 19.04.2022 NET WT: 3 39.08 KGS 12 DATA LOGGERS S/BILL NO: 4005708 DT: 21/04 /2022 NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE NUMA-DROZ 2 N EUCHATEL - 2000 SWITZERLAND |
HS 617200 |
2022-05-17 |
24 PKG |
3542.16KG |
24 PALLETS 2152 CART ONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TABLETS 5MG 90 S NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULA R DISEASE COMMERCIAL & CUST OM INVOICE NO. F22352000213 D T. 21.04.2022 S/BILL NO:98551 83 DT: 21-APR-22 NET WT: 2 ,681.35 KGS 24 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (G SSA) PLACE NUMA-DROZ 2 NEUCH ATEL - 2000 SWITZERLAND |
HS 611600 |
2022-05-17 |
15 PKG |
2222.19KG |
15 PALLETS 750 CART ONS PHARMACEUTICALS AS UNDER DROSPIRENONE/EE 3.0/0.02MG 84 NDC CODE:68462072029 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204296 THERAPEUTIC E USE: - ORAL CONTRACEPTIVE COMMERCIAL & CUSTOM INVOICE NO. F22352000240 DT. 22.04.20 22 S/BILL NO:9894467 DT: 23. 04.2022 NET WT: 1,555.20 KG S 01 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A |
HS 653900 |
2022-05-17 |
46 PKG |
7543.82KG |
46 PALLETS 1665 CART ONS PHARMACEUTICALS AS UNDER OMEPRAZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE U SE: - TREATMENT OF TREAT GAS TROESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAPSULES 40MG 90 S NDC CODE:68462039790 F DA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 A NDA NO.: 91672 THERAPEUTICE U SE: - TREATMENT OF TREAT GAS TROESOPHAGEAL REFLUX DISEASE OXCARBAZEPINE TABLETS 150MG 100 S NDC CODE:68462013701 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92 .30 ANDA NO.:-77-802 THERAPE UTICE USE:-ANTI CONVULSANT AG ENT OMEPRAZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039 710 FDA PRODUCT CODE NO.:62K CF10 H. T. S NO.: 3004.90.91 60 ANDA NO.:91672 THERAPEUTI CE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISE ASE ACAMPROSATE CALCIUM DR TABS 333MG 180 S NDC CODE:684 62043518 FDA PRODUCT CODE NO. : 60 T C C 99 H. T. S NO.: 3004.90.92.40 ANDA NO.:202229 THERAPEUTICE USE: - FOR TRE ATING ALCOHOL DEPENDENCE C OMMERCIAL & CUSTOM INVOICE NO. F22352000221 DT. 22.04.2022 F22352000226 DT. 22.04.2022 S/BILL NO:9886665 DT 22-APR-20 22 S/BILL NO: 9886662 DT 22-A PR-2022 NET WT: 6,549.87 K GS 01 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 621000 |
2022-05-17 |
2 PKG |
275.34KG |
2 PALLETS 51 CARTONS PHAR MACEUTICALS AS UNDER EZETIM IBE-SIMVASTATIN TAB 10/80MG 90 S NDC CODE:68462032490 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTIC E USE: - THIS COMBINATION MED ICATION IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (S UCH AS LDL, TRIGLYCERIDES) AN D RAISE GOOD CHOLESTEROL (HDL ) IN THE BLOOD. EZETIMIBE WO RKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORB S FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY REDUCING THE AMOUNT OF CH OLESTEROL MADE BY THE LIVER. COMMERCIAL & CUSTOM INVOICE NO. F22387000094 DT. 21.04.2 022 NET WT: 161.57 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREE S NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 611500 |
2022-05-17 |
37 PKG |
9793.68KG |
37 PALLETS 1865 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TABLETS 600MG 500 S N DC CODE:68462012605 FDA PRODU CT CODE NO: 61 N C A 69 H. T . S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE :-ANTICONVULSANT AGENT PRA VASTATIN SODIUM TAB 20MG 500 S NDC CODE:68462019605 FDA PR ODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 A NDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEMIC METFORM IN HCL ER TABS (Z) 1000MG 90 S NDC CODE:68462052190 FDA PR ODUCT CODE NO.: 61 P C A 55 H. T. S NO.: 3004.90.92.40 A NDA NO.:212969 THERAPEUTICE U SE: THE MANAGEMENT OF TYPE 2 DIABETES CARVEDILOL TABS 2 5MG 500 S NDC CODE:6846201650 5 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST VORICONA ZOLE TABLETS 200MG 30 S NDC C ODE:68462057330 FDA PRODUCT C ODE NO.:61 W C A 59 H. T. S NO.: 3004.90.92.10 ANDA NO.: 203503 THERAPEUTICE USE: -USE D TO TREAT FUNGAL INFECTIONS TACROLIMUS OINTMENT 0.1% 3 0GM NDC CODE:68462053435 FDA PRODUCT CODE NO.: 64 T C J 0 8 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTI CE USE: - TACROLIMUS IS A TOP ICAL IMMUNOSUPPRESSIVE OINTM ENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC D ERMATITIS (ECZEMA). TACROL IMUS OINTMENT 0.1% 60GM NDC C ODE:68462053465 FDA PRODUCT C ODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO. : 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMU NOSUPPRESSIVE OINTMENT USED F OR THE TREATMENT OF MODERATE -TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PIMECROLIMUS CRE AM 1% 100GM NDC CODE:68462060 994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004. 90.92.45 ANDA NO.: 211769 TH ERAPEUTICE USE: - AS SECOUND- LINE THERAPY FOR THE SHORT-TE RM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERAT E ATOPIC DERMATITIS IN NONIM MUNOCOMPROMISED ADULT AND CHI LDREN 2 YEARS OF AGE TACRO LIMUS OINTMENT 0.1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA N O.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IM MUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERA TE-TO-SEVERE ATOPIC DERMATITI S (ECZEMA). CARVEDILOL TAB S 25MG 100 S NDC CODE:6846201 6501 FDA PRODUCT CODE NO: 62 O C A 22 H. T. S NO.: 3004. 90.92.20 ANDA NO.:- 78-251 T HERAPEUTICE USE:-BETA- ADREN OACEPTOR ANTAGONIST COMMER CIAL & CUSTOM INVOICE NO. F22 387000102 DT. 22.04.2022 F223 87000103 DT. 22.04.2022 F2238 7000105 DT. 23.04.2022 F22387 000106 DT. 23.04.2022 F223870 00107 DT. 23.04.2022 F2238700 0110 DT. 23.04.2022 S/BILL NO : 4005815 DT:23.04.2022 S/BI LL NO: 4005812 DT:23.04.2022 S/BILL NO: 4005814 DT:23.04. 2022 S/BILL NO: 4005816 DT:2 3.04.2022 S/BILL NO: 4005817 DT:23.04.2022 S/BILL NO: 40 05818 DT:23.04.2022 NET WT. 7 ,858.33 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 616900 |
2022-05-10 |
67 PKG |
11863.91KG |
67 PALLETS 3949 CARTONS P HARMACEUTICALS AS UNDER MUP IROCIN OINTMENT 2% 22GM NDC C ODE:68462018022 FDA PRODUCT C ODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO. : 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL TELMISARTAN TABLETS 40MG 30 S NDC CODE:6 8462020030 FDA PRODUCT CODE N O.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.:0900 32 THERAPEUTICE USE: INDICAT ED FOR THE TREATMENT OF HYPE RTENSION, TO LOWER BLOOD PRES SURE VERAPAMIL HCL ER TABS 180MG 100S NDC CODE:684620293 01 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.9 0.92.20 ANDA NO.: 90-700 THE RAPEUTICE USE: - ANGINA RO PINIROLE TABS 2MG 100 S NDC C ODE:68462025601 FDA PRODUCT C ODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO. :- 90-135 THERAPEUTICE USE:- TREATMENT OF PARKINSONISM LAMOTRIGINE TABLETS FOR OS(CD) 25MG100 S NDC CODE:6846202290 1 FDA PRODUCT CODE NO.:- 61 M C A 38 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-79 # 099 T HERAPEUTICE USE:- ANTICONVULS ANT TOPIRAMATE TABLETS 50MG 1000 S NDC CODE:68462015310 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.0 0.20 ANDA NO.:- 77-627 THERA PEUTICE USE:-ANTICONVULSANT INDOMETHACIN CAPS 25MG 100 S NDC CODE:68462040601 FDA PR ODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92.40 A NDA NO.:91-276 THERAPEUTICE U SE: ANTI-INFLAMATORY OMEPR AZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PRO DUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO. :91672 THERAPEUTICE USE: - T REATMENT OF TREAT GASTROESOPH AGEAL REFLUX DISEASE COMME RCIAL & CUSTOM INVOICE NO. F2 2352000118 DT. 13.04.2022 F22 352000120 DT. 13.04.2022 F223 52000125 DT. 14.04.2022 S/BIL L NO: 9736177 DT:16.04.2022 S /BILL NO: 9733188 DT: 16.04.2 022 S/BILL NO: 9733085 DT: 16 .04.2022 NET WT. 9,607.94 KG S 02 DATA LOGGERS HUMIDITY:6 5% SET TEMPERATURE : +18 DEGR EES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 620900 |
2022-05-10 |
46 PKG |
10804.75KG |
46 PALLETS 2408 CARTONS P HARMACEUTICALS AS UNDER ROP INIROLE TABS 0.25MG 100 S NDC CODE:68462025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA N O.:- 90-135 THERAPEUTICE USE :-TREATMENT OF PARKINSONISM PRAMIPEXOLE TABS 1MG 90 S N DC CODE:68462033390 FDA PRODU CT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE : USED IN PARKINSON#S DISEASE FELODIPINE ER TABS 2.5MG 1 00 S NDC CODE:68462023301 FD A PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3004.90.92.20 A NDA NO.: 90-365 THERAPEUTICE USE: - TREATMENT OF HYPERTEN SION PRAMIPEXOLE TABS 0.125 MG 90 S NDC CODE:68462033090 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.9 2.40 ANDA NO.: 90-781 THERAP EUTICE USE: USED IN PARKINSON #S DISEASE ROPINIROLE TABS 0.5MG 100 S NDC CODE:68462025 401 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004. 90.92.40 ANDA NO.:- 90-135 T HERAPEUTICE USE:-TREATMENT OF PARKINSONISM OMEPRAZOLE D R CAPSULES 20MG 1000 S NDC CO DE:68462039610 FDA PRODUCT CO DE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATME NT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE CALCIPOTRIEN E OINTMENT 0.005% 120GM NDC C ODE:68462031066 FDA PRODUCT C ODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO. : 209297 THIS MEDICATION IS U SED TO TREAT PSORIASIS. CALC IPOTRIENE IS A FORM OF VITAMI N D. IT WORKS BY SLOWING DOWN THE GROWTH OF SKIN CELLS. CLINDAMYCIN PHOSPHATE GEL 1% 60GM NDC CODE:68462086665 FD A PRODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.5 0 ANDA NO.:214251 THERAPEUTI CE USE: CLINDAMYCIN PHOSPHATE GEL IS INDICATED IN THE TRE ATMENT OF ACNE VULGARIS MU PIROCIN OINTMENT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO .: 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE NO. F223520 00069 DT. 09.04.2022 F2235200 0070 DT. 09.04.2022 S/BILL NO : 9599623 DT 10-APR-2022 S/BI LL NO: 9599621 DT 10-APR-2022 NET WT. 9,053.25 KGS 02 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 621700 |
2022-05-10 |
26 PKG |
5086.67KG |
26 PALLETS 517 CARTO NS PHARMACEUTICALS AS UNDER CLOBETASOL PROP SOLUTION 0.0 5% 50ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 210190 THERAP EUTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIEN T / NONSTERILE LIQUID / CLOB ETASOL PROPIONATE (GLUCOCORTI COID) NYSTATIN-TRIAM 100K U NIT/0.1% CREAM 15GM NDC CODE: 68462031417 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO. : 3004.40.0050 ANDA NO.: 208 136 THERAPEUTICE USE: - TREA TMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPECIALLY YEAST INFECTIONS. CLOBETASOL PROP SOLUTION 0.05% 50ML NDC CODE :68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 10190 THERAPEUTICE USE: - GL UCOCORTICOID / HUMAN - RX/SIN GLE INGREDIENT / NONSTERILE L IQUID / CLOBETASOL PROPIONATE (GLUCOCORTICOID) COMMERCI AL & CUSTOM INVOICE NO. F2233 5000059 DT. 08.04.2022 F22335 000089 DT. 11.04.2022 NET WT. 2,431.20 KGS 26 DATA LOGGE RS S/BILL NO: 9604158 DT: 11.04.2022 S/BILL NO: 966006 6 DT: 12.04.2022 NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 646700 |
2022-05-10 |
61 PKG |
10813.82KG |
61 PALLETS 3220 CARTONS P HARMACEUTICALS AS UNDER TRO SPIUM CHLORIDE TABLETS 20MG 60 S NDC CODE:68462046160 FDA P RODUCT CODE NO.:-61 K C A 69 H. T. S NO.: 3004.49.00.70 ANDA NO.:-91-575 THERAPEUTICE USE:- TREATMENT OF VENOUS D ISEASES URINARY INCONTINENCE THERAPY TOPIRAMATE TABLETS 50MG 500 S NDC CODE:68462015 305 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004. 49.00.20 ANDA NO.:077627 THE RAPEUTICE USE: ANTICONVULSANT OMEPRAZOLE DR CAPSULES 40M G 90 S NDC CODE:68462039790 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GA STROESOPHAGEAL REFLUX DISEASE RILUZOLE TABLETS 50MG 60 S NDC CODE:68462038160 FDA PR ODUCT CODE NO.: 62 J C A 16 H. T. S NO.: 3004.90.92.30 A NDA NO.: 91394 THERAPEUTICE U SE: - A-PARKINSONIAN/ HUMAN - RX/SINGLE INGREDIENT / PROM PT RELEASE TABLETS / RILUZOLE (ANTI-PARKINSONIAN) OMEPR AZOLE DR CAPSULES 40MG 90 S N DC CODE:68462039790 FDA PRODU CT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - T REATMENT OF TREAT GASTROESOPH AGEAL REFLUX DISEASE CLIND AMYCIN PHOSPHATE GEL 1% 30GM NDC CODE:68462086635 FDA PROD UCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 AND A NO.:214251 THERAPEUTICE USE : CLINDAMYCIN PHOSPHATE GEL IS INDICATED IN THE TREATMENT OF ACNE VULGARIS MUPIROCI N OINTMENT 2% 22GM NDC CODE:6 8462018022 FDA PRODUCT CODE N O.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90- 480 THERAPEUTICE USE: - ANTI -BACTERIAL NORETHINDRONE 0. 35MG 84 NDC CODE:68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.0 0.00 ANDA NO.:91-209 THERAPE UTICE USE: PREVENTION OF PREG NANCY. COMMERCIAL & CUSTOM INVOICE NO. F22352000103 DT. 12.04.2022 F22352000104 DT. 1 2.04.2022 F22352000110 DT. 13 .04.2022 F22352000102 DT. 12. 04.2022 F22352000100 DT. 12.0 4.2022 S/BILL NO: 9695842 D T:14.04.2022 S/BILL NO: 96958 15 DT:14.04.2022 S/BILL NO: 9 695836 DT:14.04.2022 S/BILL N O: 9697988 DT:14.04.2022 S/BI LL NO: 9695833 DT:14.04.2022 NET WT. 8,738.83 KGS 02 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 616900 |
2022-05-10 |
40 PKG |
6271.47KG |
40 PALLETS 1994 CARTONS P HARMACEUTICALS AS UNDER NOR ETHINDRONE 0.35MG 84 NDC CODE :68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO .: 3006.60.00.00 ANDA NO.:91 -209 THERAPEUTICE USE: PREVE NTION OF PREGNANCY. NORETHI NDRONE ACE/EE TABS 1/0.02MG 63 NDC CODE:68462013281 FDA PR ODUCT CODE NO.:65 J C A 25 H . T. S NO.: 3006.60.00.00 AN DA NO.:206969 THERAPEUTICE US E: - SECONDARY AMENORRHEA,EN DOMETRIOS IS AND ABNORMAL UTE RINE BLEEDING COMMERCIAL & CUSTOM INVOICE NO. F22352000 111 DT. 13.04.2022 F223520001 26 DT. 14.04.2022 S/BILL NO: 9721041 DT: 16.04.2022 S/BILL NO: 9720263 DT:16.04.2022 NE T WT. 4,572.63 KGS 02 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 684620 |
2022-05-10 |
40 PKG |
9575.95KG |
40 PALLETS 2916 CARTONS P HARMACEUTICALS AS UNDER OME PRAZOLE DR CAPSULES 20MG 90 S NDC CODE:68462039690 FDA PRO DUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESO PHAGEAL REFLUX DISEASE VER APAMIL HCL ER TABS 180MG 500S NDC CODE:68462029305 FDA PRO DUCT CODE NO.: 62 O C B 13 H . T. S NO.: 3004.90.92.20 AN DA NO.: 90-700 THERAPEUTICE U SE: - ANGINA VERAPAMIL HCL ER TABS 240MG 100 S NDC CODE :68462026001 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO .: 3004.90.92.20 ANDA NO.:-7 8-906 THERAPEUTICE USE:-ANGI NA PRAMIPEXOLE TABS 0.5MG 9 0 S NDC CODE:68462033290 FDA PRODUCT CODE NO.: 62 J C A 1 5 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTI CE USE: USED IN PARKINSON#S D ISEASE PRAMIPEXOLE TABS 1MG 90 S NDC CODE:68462033390 F DA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92. 40 ANDA NO.: 90-781 THERAPEU TICE USE: USED IN PARKINSON#S DISEASE NAPROXEN TABLETS 5 00MG 30 S NDC CODE:6846201903 0 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90 .92.40 ANDA NO.:-78-250 THER APEUTICE USE:-ANTI-INFLAMMATO RY, ANALGESIC OXCARBAZEPIN E TABLETS 600MG 100 S NDC COD E:68462013901 FDA PRODUCT COD E NO.:-61 M C A 45 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT ROPINIRO LE TABS 3MG 100 S NDC CODE:68 462025701 FDA PRODUCT CODE NO .:-62 J C A 17 H. T. S NO.: 3 004.90.92.40 ANDA NO.:- 90-13 5 THERAPEUTICE USE:-TREATMENT OF PARKINSONISM NORETHINDR ONE 0.35MG 84 NDC CODE:684620 30529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 300 6.60.00.00 ANDA NO.:91-209 T HERAPEUTICE USE: PREVENTION O F PREGNANCY. COMMERCIAL & C USTOM INVOICE NO. F2235200007 4 DT. 09.04.2022 F22352000094 DT. 12.04.2022 S/BILL NO: 96 60311 DT. 12.04.2022 S/BILL N O: 9660309 DT. 12.04.2022 NET WT. 7,876.88 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +18 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 621000 |
2022-05-10 |
52 PKG |
8269.13KG |
52 PALLETS 2258 CART ONS PHARMACEUTICALS AS UNDER NORETHINDRONE 0.35MG 84 ND C CODE:68462030529 FDA PRODUC T CODE NO.: 65 J C A 26 H. T . S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTION OF PREGNANCY. N ORETHINDRONE ACE/EE TABS 1/0.0 2MG 63 NDC CODE:68462013281 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.:206969 THERAPEUT ICE USE: - SECONDARY AMENORR HEA,ENDOMETRIOS IS AND ABNORM AL UTERINE BLEEDING OMEPRA ZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PROD UCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE INDOME THACIN CAPS 50MG 100 S NDC CO DE:68462030201 FDA PRODUCT CO DE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO.: 91-276 THERAPEUTICE USE: ANT I-INFLAMATORY INDOMETHACIN CAPS 50MG 500 S NDC CODE:6846 2030205 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3 004.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: ANTI-INFLA MATORY INDOMETHACIN CAPS 25 MG 100 S NDC CODE:68462040601 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90. 92.40 ANDA NO.:91-276 THERAP EUTICE USE: ANTI-INFLAMATORY COMMERCIAL & CUSTOM INVOICE NO. F22352000129 DT. 14.04.2 022 F22352000132 DT. 14.04.20 22 F22352000134 DT. 14.04.202 2 S/BILL NO: 9731836 DT:16.04 .2022 S/BILL NO:9733093 DT: 1 6.04.2022 S/BILL NO: 9733164 DT: 16.04.2022 NET WT: 6,52 5.58 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 074 30 USA |
HS 652600 |
2022-05-10 |
10 PKG |
1375.77KG |
10 PALLETS 156 CART ONS PHARMACEUTICALS AS UNDER CLOBETASOL PROP OINTMENT 0. 05% 45GM NDC CODE:68462053047 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 208933 THERA PEUTICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMMATOR Y AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DERMATOESE CLOBETASOL PRO P OINTMENT 0.05% 30GM NDC COD E:68462053035 FDA PRODUCT COD E NO.: 64 L C J 67 H. T. S N O.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTICE USE: - I NDICATED FOR THE RELIEF OF TH E INFLAMMATORY AND PRURITIC M ANIFESTATIONS OF CORTICOSTERO ID-RESPONSIVE DERMATOESE C LOBETASOL PROP OINTMENT 0.05% 60GM NDC CODE:68462053065 FD A PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 208933 THERAPEUT ICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMMATORY AN D PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DE RMATOESE CLOBETASOL PROP OI NTMENT 0.05% 45GM NDC CODE:68 462053047 FDA PRODUCT CODE NO .: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 2089 33 THERAPEUTICE USE: - INDIC ATED FOR THE RELIEF OF THE IN FLAMMATORY AND PRURITIC MANIF ESTATIONS OF CORTICOSTEROID-R ESPONSIVE DERMATOESE CLOBE TASOL PROP OINTMENT 0.05% 15GM NDC CODE:68462053017 FDA PR ODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 A NDA NO.: 208933 THERAPEUTICE USE: - INDICATED FOR THE RELI EF OF THE INFLAMMATORY AND P RURITIC MANIFESTATIONS OF COR TICOSTEROID-RESPONSIVE DERMAT OESE CLOTRIM-BETAMETHASONE CRM 1.0/.05% 45GM NDC CODE:68 462029855 FDA PRODUCT CODE NO .: 61 W D J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 2028 94 THERAPEUTICE USE: - TREAT MENT A VARIETY OF INFLAMED FU NGAL SKIN INFECTIONS COMME RCIAL & CUSTOM INVOICE NO. F2 2335000060 DT. 08.04.2022 F22 335000061 DT. 08.04.2022 F223 35000087 DT. 11.04.2022 F2233 5000088 DT. 11.04.2022 S/BILL NO: 9604214 DT:11.04.2022 S/BILL NO: 9604161 DT:11.04.2 022 S/BILL NO: 9660016 DT:12. 04.2022 S/BILL NO: 9660019 DT :12.04.2022 NET WT. 640.80 KGS 10 DATA LOGGERS NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 646700 |
2022-05-03 |
4 PKG |
1064.6KG |
4 PALLETS 97 CARTONS PHAR MACEUTICALS AS UNDER LIDOCA INE OINTMENT JAR 5% 50GM NDC CODE:68462041827 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO. :206498 THERAPEUTICE USE: -US ED TO TEMPORARILY RELIEVE PA IN AND ITCHING ASSOCIATED WIT H SKIN COMMERCIAL & CUSTOM INVOICE NO. F22252006369 DT. 31.03.2022 NET WT: 908.17 K GS 00 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 600700 |
2022-05-03 |
7 PKG |
738.91KG |
7 PALLETS 396 CARTONS PHA RMACEUTICALS AS UNDER CHLOR PROMAZINE HCL TABS 25MG 100 S NDC CODE:68462086201 61 T C A 04 3004.90.92.40 212144 T O TREAT PSYCHOTIC DISORDERS S UCH AS SCHIZOPHRENIA OR MANI C-DEPRESSION IN ADULTS FEN OFIBRATE CAPSULES 200MG 100 S NDC CODE:68462058201 FDA PRO DUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 205566 THERAPEUTICE USE : - INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUC TION OF LDL-C, TOTAL-C, TRIGL YCERIDES AND APO B IN DULT P ATIENTS WITH PRMARY HYPERCHO LESTEROLEMIA OR MIXED DYSLIPI DEMIA SIROLIMUS TABLETS 2MG 100 S NDC CODE:68462068401 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90.92 .15 ANDA NO.: 208691 THERAPE UTICE USE: TO PREVENT REJECTI ON OF KIDNEY TRANSPLANTS. TACROLIMUS CAPSULES 0.5MG 100 S NDC CODE:68462068501 TAC ROLIMUS OINTMENT 0.1% 100GM N DC CODE:68462053494 FDA PRODU CT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE : - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT US ED FOR THE TREATMENT OF MODE RATE-TO-SEVERE ATOPIC DERMATI TIS (ECZEMA). COMMERCIAL & CUSTOM INVOICE NO. F22287002 089 DT. 31.03.2022 F222870020 96 DT. 31.03.2022 F2228700209 7 DT. 31.03.2022 F22287002100 DT. 31.03.2022 S/BILL NO: 40 04993 DT: 04/04/2022 S/BILL N O: 4004910 DT: 01/04/2022 S/B ILL NO: 4004992 DT: 04/04/2022 S/BILL NO: 4004988 DT: 04/0 4/2022 NET WT: 260.01 KGS 05 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA |
HS 610900 |
2022-05-03 |
20 PKG |
3461.88KG |
20 PALLETS 766 CARTONS PH ARMACEUTICALS AS UNDER FLUO CINOLONE ACE BODY OIL 0.01% 11 8ML NDC CODE:68462059189 FDA PRODUCT CODE NO.: 64 L C L 2 7 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210556 SYNTHETIC CORTICOSTEROID FOR TOPICAL DE RMATOLOGIC USE FOR THE TREATM ENT OF PSORIASIS OF THE SCALP CLOBETASOL PROP SOLUTION 0 .05% 25ML NDC CODE:6846205322 8 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90 .92.45 ANDA NO.: 210190 THER APEUTICE USE: - GLUCOCORTICOI D / HUMAN - RX/SINGLE INGREDI ENT / NONSTERILE LIQUID / CL OBETASOL PROPIONATE (GLUCOCOR TICOID) FLUOCINOLONE ACE SC ALP OIL 0.01% 118ML NDC CODE: 68462059089 FDA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO. : 3004.49.00.50 ANDA NO.: 21 0539 SYNTHETIC CORTICOSTEROID FOR TOPICAL DERMATOLOGIC US E FOR THE TREATMENT OF PSORIA SIS OF THE SCALP NYSTATIN-T RIAM 100K UNIT/0.1% OINT 30GM NDC CODE:68462079935 FDA PRO DUCT CODE NO.: 64 L D J 60 H . T. S NO.: 3004.49.00.50 AN DA NO.: 208300 THERAPEUTICE U SE: - TREATMENT OF FUNGAL IN FECTIONS OF THE SKIN, ESPECIA LLY YEAST INFECTIONS. HYDR OCORTISONE VAL OINTMENT 0.2% 6 0GM NDC CODE:68462083665 FDA PRODUCT CODE NO.: 64 L C L 7 1 H. T. S NO.: 3004.49.00.50 ANDA NO.: 211750 THERAPEUTI CE USE: - INDICATED FOR THE R ELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DER MATOSES IN ADULT PATIENTS. COMMERCIAL & CUSTOM INVOICE N O. F22235005451 DT. 31.03.202 2 S/BILL NO: 9498224 DT:05/04 /2022 NET WT: 1,805.28 KGS 20 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA |
HS 642700 |
2022-05-03 |
10 PKG |
2071.14KG |
10 PALLETS 288 CARTONS PH ARMACEUTICALS AS UNDER NITR OGLYCERIN SUBLING TABS 0.4MG 4 X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOT ENOUGH BLOO D FLOW TO THE HEART APREPI TANT CAPSULES 40MG 1UD NDC CO DE:68462058340 FDA PRODUCT CO DE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE: AP REPITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NA USEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOT HERAPY). THIS MEDICATION IS A LSO USED TO PREVENT NAUSEA AN D VOMITING AFTER SURGERY. A- EMETIC/NAUSEANT / HUMAN - RX/ SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT NITROGLYCERIN SUBLING TABS 0.4MG 4X25 NDC CODE:684620639 45 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.9 0.9020 ANDA NO.:206391 THERA PEUTIC USE: MEDICATION USED F OR HEART FAILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PRE VENT CHEST PAIN FROM NOT ENOU GH BLOOD FLOW TO THE HEART NITROGLYCERIN SUBLING TABS 0. 4MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90. 9020 ANDA NO.:206391 THERAPE UTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PR ESSURE,AND TO TREAT AND PREVE NT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART C OMMERCIAL & CUSTOM INVOICE NO. F22287002081 DT. 31.03.2022 F22287002106 DT. 31.03.2022 F22287002112 DT. 31.03.2022 F 22287002120 DT. 31.03.2022 S/ BILL NO:4004991 DT:04/04/2022 S/BILL NO: 4004990 DT:04/04/2 022 S/BILL NO:4004994 DT:04/0 4/2022 S/BILL NO: 4004995 DT: 04/04/2022 NET WT: 128.89 KG S 10 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND |
HS 662800 |
2022-05-03 |
46 PKG |
10246.37KG |
46 PALLETS 2575 CART ONS PHARMACEUTICALS AS UNDER CARVEDILOL TABS 6.25MG 500 S NDC CODE:68462016305 FDA P RODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTIC E USE:-BETA- ADRENOACEPTOR ANTAGONIST TOPIRAMATE TABLE TS 100MG 500 S NDC CODE:68462 010905 OMEPRAZOLE DR CAPSUL ES 40MG 1000 S NDC CODE:68462 039710 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90 .9160 ANDA NO.:91672 THERAPE UTICE USE: - TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX D ISEASE CARVEDILOL TABS 6.25 MG 100 S NDC CODE:68462016301 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90. 92.20 ANDA NO.:- 78-251 THER APEUTICE USE:-BETA- ADRENOAC EPTOR ANTAGONIST CALCIPOTR IENE OINTMENT 0.005% 60GM NDC CODE:68462031065 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA N O.: 209297 THIS MEDICATION IS USED TO TREAT PSORIASIS. CA LCIPOTRIENE IS A FORM OF VITA MIN D. IT WORKS BY SLOWING DO WN THE GROWTH OF SKIN CELLS. MUPIROCIN OINTMENT 2% 22GM NDC CODE:68462018022 FDA PRO DUCT CODE NO.: 61 G J J 81 H . T. S NO.: 3004.90.92.45 AN DA NO.: 90-480 THERAPEUTICE U SE: - ANTI-BACTERIAL COMME RCIAL & CUSTOM INVOICE NO. F2 2352000058 DT. 08.04.2022 F22 352000059 DT. 08.04.2022 F223 52000061 DT. 08.04.2022 S/BIL L NO:9592888 DT:09042022 S/BI LL NO:9592875 DT: 09042022 S/ BILL NO:9592943 DT: 09042022 NET WT: 8,564.06 KGS 02 DAT A LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA |
HS 622200 |
2022-05-03 |
2 PKG |
687.2KG |
2 PALLETS 48 CARTONS PHAR MACEUTICALS AS UNDER CALCIPOT RIENE CREAM 0.005% 60GM NDC C ODE:68462050165 FDA PRODUCT C ODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO. : 205772 THERAPEUTICE USE: - TREATMENT OF PLAQUE PSORIASI S IN ADULTS COMMERCIAL & CUS TOM INVOICE NO. F22352000060 DT. 08.04.2022 S/BILL NO: 95 92865 DT:09-APR-22 NET WT: 5 78.12 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SP ECIALTY S.A. SWITZERLAND (GSS A) PLACE NUMA-DROZ 2 NEUCHAT EL - 2000 SWITZERLAND |
HS 271019 |
2022-05-03 |
42 PKG |
11501.03KG |
42 PALLETS 2220 CARTONS P HARMACEUTICALS AS UNDER LIDOC AINE OINTMENT TUBE 5% 35.44GM NDC CODE:68462041820 FDA PRO DUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 AND A NO.:206498 THERAPEUTICE USE : -USED TO TEMPORARILY RELIEV E PAIN AND ITCHING ASSOCIATE D WITH SKIN LIDOCAINE OINTM ENT TUBE 5% 35.44GM NDC CODE: 68462041820 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO.:2064 98 THERAPEUTICE USE: -USED T O TEMPORARILY RELIEVE PAIN AN D ITCHING ASSOCIATED WITH SKI N CICLOPIROX OLAMINE CREAM 0.77% 90GM NDC CODE:684620297 92 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.4 0.49.50 ANDA NO.:- 90 - 273 THERAPEUTICE USE:-ANTIFUNGAL USE. THEOPHYLLINE ER TABS 3 00MG 100 S NDC CODE:684620721 01 63 B C B 30 3004.90.92.85 212184 TO RELEASE TABLETS A RE INDICATED FOR THE TREATME NT OF THE SYMPTOMS AND REVER SIBLE AIRFLOW OBSTRUCTION ASS OCIATED WITH CHRONIC ASTHMA A ND OTHER CHRONIC LUNG DISEASE S, E.G., EMPHYSEMA AND CHRON IC BRONCHITIS LITHIUM CARBO NATE CAPS 300MG 1000 S NDC CO DE:68462022110 FDA PRODUCT CO DE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO.: - 79 -139 THERAPEUTICE USE:- ANTIMANIC AGENT VERAPAMIL H CL ER TABS 120MG 100S NDC COD E:68462029201 FDA PRODUCT COD E NO.: 62 O C B 13 H. T. S N O.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - A NGINA LITHIUM CARBONATE ER TABS 450MG 100 S NDC CODE:684 62022401 FDA PRODUCT CODE NO. : 61 N C B 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:91-616 THERAPEUTICE USE: - INDICAT ED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER . BIPOLAR DISORDER, MANIC (D SM-IV) IS EQUIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, I N THE OLDER DSM-II TERMINOLOG Y. ALSO INDICATED AS A MAINT ENANCE TREATMENT FOR INDIVIDU ALS WITH A DIAGNOSIS OF BIPO LAR DISORDER. MAINTENANCE THE RAPY REDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISH ES THE INTENSITY OF THOSE EPI SODES WHICH MAY OCCUR. VER APAMIL HCL ER TABS 240MG 500 S NDC CODE:68462026005 FDA PR ODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 A NDA NO.:-78-906 THERAPEUTICE USE:-ANGINA OLMESARTAN MED OXOMIL TABLETS 20MG NDC CODE: 68462043730 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3 004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE: - TREATMEN T OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE A GENTS, TO LOWER BLOOD PRESSUR E VERAPAMIL HCL ER TABS 120 MG 100S NDC CODE:68462029201 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.9 2.20 ANDA NO.: 90-700 THERAP EUTICE USE: - ANGINA LITHI UM CARBONATE CAPS 300MG 100 S NDC CODE:68462022101 FDA PRO DUCT CODE NO.:-61 N C E 37 H . T. S NO.: 3004.49.00.20 AN DA NO.:- 79 -139 THERAPEUTICE USE:-ANTIMANIC AGENT ZOLM ITRIPTAN TABLETS 5MG 3 S NDC CODE:68462049833 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90.92.28 ANDA NO .: 201779 THERAPEUTICE USE: - ANALGESIC/ HUMAN - RX/SINGL E INGREDIENT / PROMPT RELEAS E TABLETS / ZOLMITRIPTAN (ANA LGESIC) COMMERCIAL & CUSTOM I NVOICE NO. F22252006340 DT. 3 1.03.2022 F22252006350 DT. 31 .03.2022 F22252006367 DT. 31. 03.2022 F22252006372 DT. 31.0 3.2022 F22252006377 DT. 31.03 .2022 F22252006380 DT. 31.03. 2022 S/BILL NO: 9496822 DT: 05-APR-22 S/BILL NO: 9496828 DT: 05-APR-22 S/BILL NO: 94 97545 DT: 05-APR-22 S/BILL NO : 9496646 DT: 05-APR-22 S/BI LL NO: 9496820 DT: 05-APR-22 S/BILL NO: 9496826 DT: 05-AP R-22 NET WT: 9,414.21 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA |
HS 600700 |
2022-05-03 |
48 PKG |
11030.19KG |
48 PALLETS 2299 CARTONS P HARMACEUTICALS AS UNDER CARVE DILOL TABS 3.125MG 100 S NDC CODE:68462016201 FDA PRODUCT CODE NO - 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST LEVOCETIRIZINE DIHY TAB S 5MG 90 S NDC CODE:684620346 90 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.9 0.91.80 ANDA NO.:90385 THERA PEUTICE USE: TREATMENT OF CHR ONIC IDIOPATHIC URTICARIA LITHIUM CARBONATE ER TABS 450M G 100 S NDC CODE:68462022401 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.0 0.20 ANDA NO.:91-616 THERAPE UTICE USE: - INDICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER. BIPOLA R DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO MANIC DEPRESSI VE ILLNESS, MANIC, IN THE OLD ER DSM-II TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE T REATMENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR DISOR DER. MAINTENANCE THERAPY RED UCES THE FREQUENCY OF MANIC E PISODES AND DIMINISHES THE IN TENSITY OF THOSE EPISODES WHI CH MAY OCCUR. TOPIRAMATE T ABLETS 100MG 60 S NDC CODE:68 462010960 FDA PRODUCT CODE N O.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77- 627 THERAPEUTICE USE:-ANTICO NVULSANT LITHIUM CARBONATE CAPS 150MG 100 S NDC CODE:684 62022001 FDA PRODUCT CODE NO .:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 79 - 139 THERAPEUTICE USE:-ANTIMA NIC AGENT CARVEDILOL TABS 3 .125MG 500 S NDC CODE:6846201 6205 FDA PRODUCT CODE NO ; 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST MUPIR OCIN OINTMENT 2% 22GM NDC COD E:68462018022 FDA PRODUCT COD E NO.: 61 G J J 81 H. T. S N O.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - A NTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE NO. F223520000 26 DT. 05.04.2022 F2235200002 7 DT. 05.04.2022 F22352000028 DT. 05.04.2022 F22352000029 DT. 05.04.2022 S/BILL NO: 95 16546 DT: 06-APR-22 S/BILL NO : 9516749 DT:06-APR-22 S/BILL NO: 9516453 DT:06-APR-22 S/B ILL NO: 9516743 DT:06-APR-22 NET WT: 9,033.02 KGS 02 DAT A LOGGERS HUMIDITY:65% SET T EMPERATURE : +18 DEGREES TEMP ERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 622200 |
2022-05-03 |
5 PKG |
1078.66KG |
5 PALLETS 182 CARTONS PHAR MACEUTICALS AS UNDER ROSUVAST ATIN TABLETS 40MG 500 S NDC C ODE:68462026405 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE ROSU VASTATIN TABLETS 40MG 500 S N DC CODE:68462026405 61 J C A 16 3004.49.00.10 79172 TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE CO MMERCIAL & CUSTOM INVOICE NO. F22252006299 DT. 31.03.2022 F22252006374 DT. 31.03.2022 N ET WT: 961.84 KGS 05 DATA LOG GERS NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND S/BILL NO: 9448001 DT: 03- APR-22 S/BILL NO: 9448000 DT : 03-APR-22 |
HS 210690 |
2022-05-03 |
41 PKG |
8638.36KG |
41 PALLETS 3561 CARTONS P HARMACEUTICALS AS UNDER ONDAN SETRON TABLETS 4MG 30 S NDC C ODE:68462010530 FDA PRODUCT C ODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO. :- 77-535 THERAPEUTICE USE:-A NTI EMETIC LEVOCETIRIZINE DIHY TABS 5MG 90 S NDC CODE:6 8462034690 FDA PRODUCT CODE N O.: 61 X C A 51 H. T. S NO.: 3004.90.91.80 ANDA NO.:9038 5 THERAPEUTICE USE: TREATMEN T OF CHRONIC IDIOPATHIC URTIC ARIA OXCARBAZEPINE TABLETS 600MG 100 S NDC CODE:68462013 901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004. 90.92.30 ANDA NO.:-77-802 TH ERAPEUTICE USE:-ANTI CONVULSA NT AGENT PRAVASTATIN SODIUM TAB 40MG 500 S NDC CODE:6846 2019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3 004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: HYPOLIPDA EMIC OLMESARTAN MEDOXOMIL T ABLETS 40MG 90 S NDC CODE:684 62043890 FDA PRODUCT CODE NO. : 62 CCA 68 H. T. S NO.: 30 04.90.9220 ANDA NO.: 203281 TREATMENT OF HYPERTENSION, AL ONE OR WITH OTHER ANTIHYPERT ENSIVE AGENTS, TO LOWER BLOOD PRESSURE ZOLMITRIPTAN ODT 5MG 3 S NDC CODE:68462050033 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90.9 2.28 ANDA NO.: 202560 THERAP EUTICE USE: - ANALGESIC/ HUMA N - RX/SINGLE INGREDIENT / P ROMPT RELEASE TABLETS / ZOLM ITRIPTAN (ANALGESIC) COMMERCI AL & CUSTOM INVOICE NO. F2225 2006298 DT. 31.03.2022 S/BILL NO: 9462490 DT:04-APR-22 NE T WT: 6,837.35 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 615100 |
2022-05-03 |
2 PKG |
311.17KG |
2 PALLETS 34 CART ONS PHARMACEUTICALS AS UNDER CLINDAMYCIN-BPO GEL 1%/5% 25G M NDC CODE:68462048619 FDA P RODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO.: 209252 ANTIBIOTIC T HAT STOPS THE GROWTH OF ACNE- CAUSING BACTERIA AS WELL AS REDUCE OIL PRODUCTION IN THE SKIN, HELPING KEEP PORES OPEN CLINDAMYCIN-BPO GEL 1%/5% 50GM NDC CODE:68462048627 FD A PRODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 209252 ANTIBIOTI C THAT STOPS THE GROWTH OF AC NE-CAUSING BACTERIA AS WELL A S REDUCE OIL PRODUCTION IN T HE SKIN, HELPING KEEP PORES O PEN COMMERCIAL & CUSTOM INVOI CE NO. F22252006371 DT. 31.03 .2022 F22252006373 DT. 31.03. 2022 S/BILL NO: 9496667 DT:0 5-APR-22 S/BILL NO: 9496823 DT:05-APR-22 NET WT: 249.68 K GS 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLA CE NUMA-DROZ 2 NEUCHATEL - 20 00 SWITZERLAND |
HS 563100 |
2022-05-03 |
13 PKG |
1828.92KG |
13 PALLETS 285 CARTONS PH ARMACEUTICALS AS UNDER FLUO CINOLONE ACE EAR DROPS 0.01% 2 0ML NDC CODE:68462018556 FDA PRODUCT CODE NO.: 64 L C L 2 7 H. T. S NO.: 3004.49.00.50 ANDA NO.: 211815 FOR THE TR EATMENT OF CHRONIC ECZEMATOUS EXTERNAL OTITIS ALCLOMETA SONE DIP OINTMENT 0.05% 15GM NDC CODE:68462029917 FDA PROD UCT CODE NO.: 62 B C J 10 H. T. S NO.: 3004.49.00.50 AND A NO.: 79-227 THERAPEUTICE US E: INDICATED FOR THE RELIEF O F THE INFLAMMATORY AND PRURI TIC MANIFESTATIONS OF CORTICO STEROID-RESPONSIVE DERMATOSES . CLOBETASOL PROP SOLUTION 0.05% 50ML NDC CODE:684620532 53 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.9 0.92.45 ANDA NO.: 210190 THE RAPEUTICE USE: - GLUCOCORTICO ID / HUMAN - RX/SINGLE INGRED IENT / NONSTERILE LIQUID / C LOBETASOL PROPIONATE (GLUCOCO RTICOID) HYDROCORTISONE VAL OINTMENT 0.2% 45GM NDC CODE: 68462083647 FDA PRODUCT CODE NO.: 64 L C L 71 H. T. S NO. : 3004.49.00.50 ANDA NO.: 21 1750 THERAPEUTICE USE: - IND ICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MAN IFESTATIONS OF CORTICOSTEROID RESPONSIVE DERMATOSES IN ADU LT PATIENTS. ALCLOMETASONE DIP OINTMENT 0.05% 45GM NDC CODE:68462029947 FDA PRODUCT CODE NO.: 62 B C J 10 H. T. S NO.: 3004.49.00.50 ANDA NO .: 79-227 THERAPEUTICE USE: INDICATED FOR THE RELIEF OF T HE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTER OID-RESPONSIVE DERMATOSES. COMMERCIAL & CUSTOM INVOICE N O. F22235005479 DT. 31.03.202 2 F22235005480 DT. 31.03.2022 S/BILL NO:9517897 DT:06/04/2 022 S/BILL NO: 9519966 DT:06/ 04/2022 NET WT: 853.97 KGS 13 DATA LOGGERS SET TEMPE RATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA |
HS 642700 |
2022-05-03 |
23 PKG |
4431.22KG |
23 PALLETS 557 CARTONS PH ARMACEUTICALS AS UNDER CLOT RIM-BETAMETHASONE CRM 1.0/.05% 45GM NDC CODE:68462029855 F DA PRODUCT CODE NO.: 61 W D J 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 202894 THERAPEU TICE USE: - TREATMENT A VARIE TY OF INFLAMED FUNGAL SKIN I NFECTIONS CLOTRIM-BETAMETHA SONE CRM 1.0/.05% 45GM NDC CO DE:68462029855 FDA PRODUCT CO DE NO.: 61 W D J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 202894 THERAPEUTICE USE: - TREATMENT A VARIETY OF INFLAM ED FUNGAL SKIN INFECTIONS CLOBETASOL PROP CREAM 0.05% 15 GM NDC CODE:68462052917 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209095 CLOBETASOL PROPIONATE CREAM IS A SUPER-H IGH POTENCY CORTICOSTEROID F ORMULATIONS INDICATED FOR THE RELIEF OF THE INFLAMMATORY A ND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE D ERMATOSES CLOBETASOL PROP C REAM 0.05% 30GM NDC CODE:6846 2052935 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 209095 THERAPEUTICE USE: - CLOBETA SOL PROPIONATE CREAM IS A SUP ER-HIGH POTENCY CORTICOSTEROI D FORMULATIONS INDICATED FOR THE RELIEF OF THE INFLAMMATO RY AND PRURITIC MANIFESTATION S OF CORTICOSTEROID-RESPONSIV E DERMATOSES COMMERCIAL & CUSTOM INVOICE NO. F222350054 02 DT. 30.03.2022 F2223500545 6 DT. 31.03.2022 F22235005462 DT. 31.03.2022 S/BILL NO: 9 420565 DT:01/04/2022 S/BILL NO: 9516000 DT:06/04/2022 S/ BILL NO: 9513436 DT:06/04/2022 NET WT: 2,198.88 KGS 23 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE NUMA- DROZ 2 NEUCHATEL - 2000 SWIT ZERLAND |
HS 610400 |
2022-05-03 |
5 PKG |
1003.82KG |
5 PALLETS 306 CARTONS PHA RMACEUTICALS AS UNDER PRAVA STATIN SODIUM TAB 20MG 90 S N DC CODE:68462019690 FDA PRODU CT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE US E:-HYPOLIPDAEMIC COMMERCIAL & CUSTOM INVOICE NO. F222870 02080 DT. 31.03.2022 S/BILL N O: 9519966 DT:06/04/2022 NET WT: 724.70 KGS 01 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 611300 |
2022-04-26 |
5 PKG |
1179.36KG |
5 PALLETS 161 CARTONS PHAR MACEUTICALS AS UNDER DICLOF ENAC SODIUM GEL 3% 100GM NDC CODE:68462035594 FDA PRODUCT CODE NO.:62 G C J 18 H. T. S NO.: 3004.90.92.40 ANDA NO. :208301 THERAPEUTICE USE: - USED FOR THE RELIEF OF JOINT PAIN OF OSTEOARTHRITIS COMM ERCIAL & CUSTOM INVOICE NO. F 22252006226 DT. 26.03.2022 S/ BILL NO: 9287406 DT:28-MAR-22 NET WT. 978.42 KGS 00 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA |
HS 621800 |
2022-04-26 |
43 PKG |
11315.96KG |
43 PALLETS 3083 CARTONS P HARMACEUTICALS AS UNDER OMEPR AZOLE DR CAPSULES 40MG 100 S NDC CODE:68462039701 FDA PROD UCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO. : 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOP HAGEAL REFLUX DISEASE TOPI RAMATE TABLETS 200MG 60 S NDC CODE:68462011060 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA N O.:- 77-627 THERAPEUTICE USE :-ANTICONVULSANT ATOMOXETIN E CAPSULES 80MG 30 S NDC CODE :68462027030 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO. :3004.90.92.90 ANDA NO.: 0790 19 THERAPEUTICE USE: - ATOMO XETINE IS USED TO TREAT ATTEN TION-DEFICIT HYPERACTIVITY DI SORDER (ADHD) AS PART OF A TO TAL TREATMENT PLAN, INCLUDING PSYCHOLOGICAL, SOCIAL, AND OTHER TREATMENTS LITHIUM CA RBONATE ER TABS 300MG 100 S N DC CODE:68462022301 FDA PRODU CT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:91-544 THERAPEUTICE USE : - INDICATED IN THE TREATME NT OF MANIC EPISODES OF BIP OLAR DISORDER. BIPOLAR DISORD ER, MANIC (DSM-IV) IS EQUIVAL ENT TO MANIC DEPRESSIVE ILLNE SS MANIC, IN THE OLDER DSM-I I TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT FOR INDIVIDUALS WITH A DIAGNO SIS OF BIPOLAR DISORDER. MAI NTENANCE THERAPY REDUCES THE FREQUENCY OF MANIC EPISODES A ND DIMINISHES THE INTENSITY O F THOSE EPISODES WHICH MAY O CCUR. OMEPRAZOLE DR CAPSUL ES 40MG 90 S NDC CODE:6846203 9790 FDA PRODUCT CODE NO.: 6 2KCF10 H. T. S NO.: 3004.90. 9160 ANDA NO.: 91672 THERAPE UTICE USE: - TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX D ISEASE PRAVASTATIN SODIUM T AB 40MG 500 NDC CODE:68462019 705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004. 90.92.20 ANDA NO.: 77-987 TH ERAPEUTICE USE: HYPOLIPDAEMIC VERAPAMIL HCL ER TABS 180M G 100S NDC CODE:68462029301 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92 .20 ANDA NO.: 90-700 THERAPE UTICE USE: - ANGINA ATOVAQ UONE-PROGUANIL TAB 250/100MG NDC CODE:68462040401 FDA PROD UCT CODE NO.: 62 L D A 44 H. T. S NO.: 3004.90.92.90 AND A NO.: 91-211 THERAPEUTICE US E: - ANTI MALARIAL ACAMPRO SATE CALCIUM DR TABS 333M 180 S NDC CODE:68462043518 FDA P RODUCT CODE NO.: 60 T C C 99 H. T. S NO.: 3004.90.92.40 ANDA NO.:202229 THERAPEUTICE USE: - FOR TREATING ALCOHOL DEPENDENCE COMMERCIAL & CUS TOM INVOICE NO. F22252006255 DT. 27.03.2022 S/BILL NO: 928 7583 DT: 28-MAR-22 NET WT. 9,679.74 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA |
HS 621000 |
2022-04-26 |
12 PKG |
3045.02KG |
12 PALLETS 261 CARTONS PHARMACEUTICALS AS UNDER AZELAIC ACID GEL 1 5% 50GM NDC CODE:68462062652 FDA PRODUCT CODE NO.: 62 S C J 03 H. T. S NO.: 3004.49.0 0.50 ANDA NO.: 204637 INDICA TED FOR TOPICAL TREATMENT OF THE INFLAMMATORY PAPULES AND PUSTULES OF MILD TO MODERATE ROSACEA CLINDAMYCIN-BPO GE L 1%/5% 50GM NDC CODE:6846204 8627 FDA PRODUCT CODE NO.: 5 6 J D J 31 H. T. S NO.: 3004 .49.00.50 ANDA NO.: 209252 A NTIBIOTIC THAT STOPS THE GROW TH OF ACNE-CAUSING BACTERIA A S WELL AS REDUCE OIL PRODUCTI ON IN THE SKIN, HELPING KEEP PORES OPEN COMMERCIAL & CU STOM INVOICE NO. F22252006261 DT. 28.03.2022 S/BILL NO: 93 35766 DT:30-MAR-22 NET WT. 2 ,483.25 KGS 12 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREE S NOTIFY PARTY:2 GLENMARK SP ECIALTY S.A. SWITZERLAND (GSS A) PLACE NUMA-DROZ 2 NEUCHAT EL - 2000 SWITZERLAND |
HS 620300 |
2022-04-26 |
31 PKG |
6975.46KG |
31 PALLETS 2476 CARTONS P HARMACEUTICALS AS UNDER MUP IROCIN CREAM 2% 30GM NDC CODE :68462056435 FDA PRODUCT CODE NO.: 61GCJ82 H. T. S NO.: 3004.90.92.45 ANDA NO.: 20158 7 THERAPEUTICE USE: - TOPICA L ANTI-BACTERIAL OMEPRAZOLE DR CAPSULES 40MG 100 S NDC C ODE:68462039701 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE LITHIUM C ARBONATE ER TABS 300MG 100 S NDC CODE:68462022301 FDA PROD UCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00.20 AND A NO.:91-544 THERAPEUTICE US E: - INDICATED IN THE TREATM ENT OF MANIC EPISODES OF BI POLAR DISORDER. BIPOLAR DISOR DER, MANIC (DSM-IV) IS EQUIVA LENT TO MANIC DEPRESSIVE ILLN ESS, MANIC, IN THE OLDER DSM -II TERMINOLOGY. ALSO INDICAT ED AS A MAINTENANCE TREATMEN T FOR INDIVIDUALS WITH A DIAG NOSIS OF BIPOLAR DISORDER. M AINTENANCE THERAPY REDUCES TH E FREQUENCY OF MANIC EPISODES AND DIMINISHES THE INTENSITY OF THOSE EPISODES WHICH MAY OCCUR. PRAVASTATIN SODIUM TAB 40MG 90 S NDC CODE:68462 019790 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 30 04.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: HYPOLIPDAE MIC VERAPAMIL HCL ER TABS 1 80MG 500S NDC CODE:6846202930 5 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90 .92.20 ANDA NO.: 90-700 THER APEUTICE USE: - ANGINA ACA MPROSATE CALCIUM DR TABS 333MG 180 S NDC CODE:68462043518 FDA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO.: 3004.90.92 .40 ANDA NO.:202229 THERAPEU TICE USE: - FOR TREATING ALCO HOL DEPENDENCE OLMESARTAN MEDOXOMIL TABLETS 5MG 30 S ND C CODE:68462043630 FDA PRODUC T CODE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE: - T REATMENT OF HYPERTENSION, ALO NE OR WITH OTHER ANTIHYPERTE NSIVE AGENTS, TO LOWER BLOOD PRESSURE COMMERCIAL & CUSTOM INVOICE NO. F22252006262 DT. 28.03.2022 F22252006265 DT. 2 8.03.2022 S/BILL NO:9338733 DT:30-MAR-22 S/BILL NO: 93397 40 DT: 30-MAR-22 NET WT. 5,6 91.23 KGS 02 DATA LOGGERS H UMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 684620 |
2022-04-26 |
20 PKG |
3142.99KG |
20 PALLETS 1000 CARTONS PHARMACEUTICALS AS UNDER VIOR ELE DESO/EE-EE .15/.02-.01MG 8 4 NDC CODE:68462031829 FDA P RODUCT CODE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTICE USE: - ORAL CONTRACEPTIVES COMMERCIAL & CUSTOM INVOICE NO. F22252006266 DT. 28.03.20 22 S/BILL NO: 9333360 DT 30- MAR-2022 NET WT. 2,289.60 K GS 01 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 642700 |
2022-04-26 |
20 PKG |
3105.35KG |
20 PALLETS 997 CARTONS PH ARMACEUTICALS AS UNDER HAIL EY24FE NORE ACE/EE-FE 1/0.02-7 5MG 84 NDC CODE:68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00 .00 ANDA NO.: 204847 THERAPE UTICE USE: - CONTRACEPTION TO PREVENT PREGNANCY COMMERC IAL & CUSTOM INVOICE NO. F222 52006260 DT. 28.03.2022 S/BIL L NO: 9334201 DT:30-MAR-22 NE T WT. 2,261.20 KGS 01 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
HS 652500 |
2022-04-26 |
3 PKG |
349.73KG |
3 PALLETS 54 CARTONS PHARMACEUTICAL S AS UNDER APREPITANT CAPSU LES 80MG 2UOU NDC CODE:684620 58458 FDA PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 300 4.90.92.40 ANDA NO.:207777 T HERAPEUTICE USE:APREPITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVENT NAUSEA AND V OMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHERAPY). TH IS MEDICATION IS ALSO USED T O PREVENT NAUSEA AND VOMITING AFTER SURGERY. A-EMETIC/NAUS EANT / HUMAN - RX/SINGLE ING REDIENT / DELAYED RELEASE TAB LETS / APREPITANT NITROGLY CERIN SUBLING TABS 0.6MG 100 S NDC CODE:68462064001 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERCI AL & CUSTOM INVOICE NO. F2228 7002071 DT. 30.03.2022 S/BILL NO: 4004810 DT: 31.03.2022 NET WT. 12.37 KGS 03 DATA LO GGERS NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 613200 |
2022-04-26 |
40 PKG |
9439.42KG |
40 PALLETS 2455 CART ONS PHARMACEUTICALS AS UNDER GABAPENTIN TABLETS 600MG 500 S NDC CODE:68462012605 FDA P RODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 A NDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT PRAVASTATIN SODIUM TAB 20MG 5 00 S NDC CODE:68462019605 FD A PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.2 0 ANDA NO.:-77-987 THERAPEUT ICE USE:-HYPOLIPDAEMIC TAC ROLIMUS OINTMENT 0.1% 100GM N DC CODE:68462053494 FDA PRODU CT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE : - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT US ED FOR THE TREATMENT OF MODE RATE-TO-SEVERE ATOPIC DERMATI TIS (ECZEMA). PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462 060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOU ND-LINE THERAPY FOR THE SHORT -TERM AND NON-CONTINUOS CHRON IC TRERTMENT OF MILD TO MODE RATE ATOPIC DERMATITIS IN NO NIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE PI MECROLIMUS CREAM 1% 60GM NDC CODE:68462060965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO .: 211769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTI NUOS CHRONIC TRERTMENT OF MIL D TO MODERATE ATOPIC DERMATI TIS IN NONIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE TACROLIMUS CAPSULES 1M G 100 S NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CO DE : 64 T C E 08 ANDA NO.2066 62 THERAPEUTIC USE : TO PREV ENT REJECTION OF A KIDNEY,HEA RT, OR LIVER TRANSPLANT EZ ETIMIBE-SIMVASTATIN TAB 10/20M G 30 S NDC CODE:68462032230 PRAVASTATIN SODIUM TAB 80MG 90 S NDC CODE:68462019890 FD A PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.2 0 ANDA NO.:-77-987 THERAPEUT ICE USE:-HYPOLIPDAEMIC RAN OLAZINE ER TABS 1000MG 60 S N DC CODE:68462032060 FDA PRODU CT CODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.:211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDI CATION. IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGEN CY) ATTACK OF ANGINA INDOM ETHACIN ER CAPSULES 75MG 90 S NDC CODE:68462032590 H. T. S NO.: 3004.90.92.40 COMMERCI AL & CUSTOM INVOICE NO. F2228 7002068 DT. 30.03.2022 F22287 002070 DT. 30.03.2022 F222870 02073 DT. 30.03.2022 F2228700 2079 DT. 31.03.2022 S/BILL NO : 4004814 DT: 31.03.2022 S/BI LL NO: 4004815 DT: 31.03.2022 S/BILL NO: 4004806 DT: 31.03. 2022 S/BILL NO: 4004813 DT: 3 1.03.2022 NET WT. 5,632.06 K GS 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
HS 300490 |
2022-04-26 |
13 PKG |
2356.91KG |
13 PALLETS 352 CARTONS PHARMACEUTICALS AS UNDER CLOTRIM-BETAMETHASO NE CRM 1.0/.05% 45GM NDC CODE :68462029855 FDA PRODUCT CODE NO.: 61 W D J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 02894 THERAPEUTICE USE: - TR EATMENT A VARIETY OF INFLAMED FUNGAL SKIN INFECTIONS CL OBETASOL PROP OINTMENT 0.05% 4 5GM NDC CODE:68462053047 FDA PRODUCT CODE NO.: 64 L C J 6 7 H. T. S NO.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTI CE USE: - INDICATED FOR THE R ELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DER MATOESE CLOBETASOL PROP OIN TMENT 0.05% 30GM NDC CODE:684 62053035 FDA PRODUCT CODE NO. : 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 20893 3 THERAPEUTICE USE: - INDICA TED FOR THE RELIEF OF THE INF LAMMATORY AND PRURITIC MANIFE STATIONS OF CORTICOSTEROID-RE SPONSIVE DERMATOESE COMMERCI AL & CUSTOM INVOICE NO. F2223 5005315 DT. 24.03.2022 F22235 005316 DT. 24.03.2022 S/BILL NO: 9274327 DT: 28-MAR-22 S/ BILL NO: 9266795 DT:28-MAR-22 NET WT: 1,166.40 KGS 13 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWITZER LAND |
HS 684620 |
2022-04-26 |
42 PKG |
8845.65KG |
42 PALLETS 1745 CARTONS P HARMACEUTICALS AS UNDER TOP IRAMATE TABLETS 50MG 500 S ND C CODE:68462015305 FDA PRODUC T CODE NO.: 61 M C A 40 H. T . S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVULSANT OMEPRAZOLE DR CAPSULES 20MG 1000 S NDC C ODE:68462039610 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE OXCARBAZE PINE TABLETS 300MG 100 S NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO .:-77-802 THERAPEUTICE USE:-A NTI CONVULSANT AGENT COMME RCIAL & CUSTOM INVOICE NO. F2 2252006288 DT. 30.03.2022 S/B ILL NO:9426433 DT: 01-APR-22 NET WT: 7,534.86 KGS 02 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 614000 |
2022-04-26 |
21 PKG |
4610.39KG |
21 PALLETS 1769 CART ONS PHARMACEUTICALS AS UNDER TELMISARTAN TABLETS 80MG 30 S NDC CODE:68462020130 HTS NO : 3004.90.92.20 FDA CODE : 6 2 O C A 09 ANDA NO.: 90032 T HERAPEUTICE USE : INDICATED F OR THE TREATMENT OF HYPERTEN SION, TO LOWER BLOOD PRESSURE TELMISARTAN TABLETS 40MG 3 0 S NDC CODE:68462020030 FDA PRODUCT CODE NO.: 62 O C A 0 9 H. T. S NO.: 3004.90.92.20 ANDA NO.:090032 THERAPEUTIC E USE: INDICATED FOR THE TRE ATMENT OF HYPERTENSION, TO LO WER BLOOD PRESSURE ZOLMITR IPTAN ODT 2.5MG 6 S NDC CODE: 68462049976 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO. : 3004.90.92.28 ANDA NO.: 20 2560 THERAPEUTICE USE: - ANA LGESIC/ HUMAN - RX/SINGLE ING REDIENT / PROMPT RELEASE TAB LETS / ZOLMITRIPTAN (ANALGESI C) COMMERCIAL & CUSTOM INVOIC E NO. F22252006280 DT. 30.03. 2022 S/BILL NO: 9402486 DT: 01-APR-22 NET WT: 3,617.91 KGS 01 DATA LOGGERS NOTI FY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA AGENT ADDRESS AT DESTINATION MAERSK CHARLOTTE CUSTOMER RESOURCE CENTER 9300 ARROWPOINT BLVD CHARLOTTE N C USA 28273 TEL: +1 (800) 32 1 8807 |
HS 300490 |
2022-04-26 |
25 PKG |
4437.12KG |
25 PALLETS 1630 CARTONS PHARMACEUTICALS AS UNDER ESTRADIOL VAG INSERT S USP 10MCG 8 S NDC CODE:6846 2071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3 006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE:THE TREATME NT OF ATROPIC VAGINITIS DUE T O MENOPAUSE. VIORELE DESO/ EE-EE .15/.02-.01MG 84 NDC CO DE:68462031829 FDA PRODUCT CO DE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTICE USE: - O RAL CONTRACEPTIVES LEVONOR GESTREL/EE 0.09/0.02MG 84 NDC CODE:68462063729 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO .: 202791 THERAPEUTICE USE: - : USED FOR PREVENTING PREGN ANCY NORETHINDRONE ACE/EE T AB 0.5MG/2.5MCG 84 NDC CODE:6 8462065629 FDA PRODUCT CODE N O.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 203 038 THERAPEUTICE USE: - TREA TMENT OF MODERATE TO SEVERE V ASOMOTOR SYMPTOMS DUE TO MEN OPAUSE; OSTEOPOROSIS PREVENTI ON NORETHINDRONE ACE/EE TAB S 1/0.005MG 90 NDC CODE:68462 065790 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 30 06.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - TREATMEN T OF MODERATE TO SEVERE VASOM OTOR SYMPTOMS DUE TO MENOPAU SE; OSTEOPOROSIS PREVENTION COMMERCIAL & CUSTOM INVOICE NO. F22252006289 DT. 30.03.20 22 F22252006339 DT. 31.03.202 2 F22252006368 DT. 31.03.2022 S/BILL NO: 9426141 DT:01-APR -22 S/BILL NO: 9426027 DT:01- APR-22 S/BILL NO: 9426166 DT: 01-APR-22 NET WT. 3,369.64 KG S NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 642800 |
2022-04-26 |
24 PKG |
4731.96KG |
24 PALLETS 708 CARTONS PH ARMACEUTICALS AS UNDER OMEPRA ZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PROD UCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE COMMER CIAL & CUSTOM INVOICE NO. F22 252006336 DT. 31.03.2022 S/BI LL NO: 9403363 DT:01-APR-22 NET WT: 4,158.83 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
HS 621000 |
2022-04-19 |
41 PKG |
11046.07KG |
41 PALLETS 1568 CARTONS P HARMACEUTICALS AS UNDER EST RADIOL VAG INSERTS USP 10MCG 1 8 S NDC CODE:68462071188 NDC NO.:68462071188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO .:210264 THERAPEUTICE USE:THE TREATMENT OF ATROPIC VAGINI TIS DUE TO MENOPAUSE. DESM OPRESSIN ACETATE TABLETS 0.2MG 100S NDC CODE:68462027601 F DA PRODUCT CODE NO.: 61QCA03 H. T. S NO.: 2937.19.0000 A NDA NO.:201831 THERAPEUTICE U SE: - MANAGEMENT OF CENTRAL DIABETES INSIPIDUS AND TEMPOR ARY POLYURIA AND POLYDIPSIA ASHLYNA LEVO/EE 0.15/0.03MG 182 NDC CODE:68462064693 FDA PRODUCT CODE NO.: 64 G D A 2 H. T. S NO.: 3006.60.0000 ANDA NO.: 203163 THERAPEUTICE USE: - INDICATED FOR USE BY WOMEN TO PREVENT PREGNANCY GABAPENTIN TABLETS 800MG 500 S NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTIC E USE:-ANTICONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22252006158 DT. 22.03.2 022 F22252006148 DT. 21.03.20 22 F22252006153 DT. 21.03.202 2 S/BILL NO: 9120133 DT:22-MA R-22 S/BILL NO: 9120061 DT :22-MAR-22 S/BILL NO: 9120267 DT:22-MAR-22 02 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NET WT.: 9,712.12 KGS NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 642800 |
2022-04-19 |
40 PKG |
4665.73KG |
40 PALLETS 1120 CARTONS P HARMACEUTICALS AS UNDER FLUCO NAZOLE TABLETS 150MG 12 S (12X 1UD) NDC CODE:68462011944 ND C CODE : 68462011944 HTS NO : 3004.90.92.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 THERAPEUTICE USE : ANTIFUNG AL COMMERCIAL & CUSTOM INVOIC E NO. F22252006110 DT. 17.03. 2022 S/BILL NO: 9045668 DT:19 /03/2022 NET WT. 3,521.28 K GS 02 DATA LOGGERS NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA |
HS 300490 |
2022-04-19 |
9 PKG |
1623.89KG |
9 PALLETS 543 CARTONS PHARMA CEUTICALS AS UNDER NITROGLY CERIN SUBLING TABS 0.4MG 4X25 NDC CODE:68462063945 FDA PRO DUCT CODE NO.: 66 S C A 28 H . T. S NO.: 3004.90.9020 AND A NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEART F AILURE,HIGH BLOOD PRESSURE,AN D TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FL OW TO THE HEART ASPIRIN-ER DIPYRIDAMOLE CAPS 25/200MG 60 NDC CODE:68462040560 FDA PR ODUCT CODE NO.: 60 L D F 05 H. T. S NO.: 3004.90.9220 AN DA NO.:210318 DEFERASIROX T ABS ORAL SUSP 250MG 30 S NDC CODE:68462049530 FDA PRODUCT CODE NO.: 63 J C A 09 H. T. S NO.: 3004.90.92.70 ANDA NO .:209433 THERAPEUTICE USE:TR EATMENT OF CHRONIC IRON OVERL OAD DUE TO BLOOD TRANSFUSIONS IN PATIENTS 2 YEAR OF AGE A ND OLDER. APREPITANT CAPSUL ES 80MG 6UD NDC CODE:68462058 476 FDA PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 3004. 90.92.40 ANDA NO.:207777 THE RAPEUTICE USE:APREPITANT IS U SED WITH OTHER MEDICATIONS TO HELP PREVENT NAUSEA AND VOM ITING CAUSED BY CANCER DRUG T REATMENT (CHEMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSEA AND VOMITING A FTER SURGERY. A-EMETIC/NAUSEA NT / HUMAN - RX/SINGLE INGRE DIENT / DELAYED RELEASE TABLE TS / APREPITANT DEFERASIRO X TABS ORAL SUSP 125MG 30 S N DC CODE:68462049430 FDA PRODU CT CODE NO.: 63 J C A 09 H. T. S NO.: 3004.90.92.70 ANDA NO.:209433 THERAPEUTICE USE :TREATMENT OF CHRONIC IRON OV ERLOAD DUE TO BLOOD TRANSFUSI ONS IN PATIENTS 2 YEAR OF AGE AND OLDER. COMMERCIAL & C USTOM INVOICE NO. F2228700203 3 DT. 22.03.2022 F22287002034 DT. 22.03.2022 S/BILL NO: 40 04207 DT: 23.03.2022 S/BILL N O: 4004203 DT: 23.03.2022 NET WT. 336.57 KGS 09 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE NUMA-DROZ 2 N EUCHATEL - 2000 SWITZERLAND |
HS 662800 |
2022-04-19 |
6 PKG |
1122.66KG |
6 PALLETS 197 CARTONS PHAR MACEUTICALS AS UNDER CLINDAMY CIN-BPO GEL 1%/5% 25GM NDC CO DE:68462048619 FDA PRODUCT CO DE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO.: 209252 ANTIBIOTIC THAT STOPS THE GROWTH OF ACNE-CAUSING BACTERIA AS WELL AS REDUCE OI L PRODUCTION IN THE SKIN, HEL PING KEEP PORES OPEN COMMERC IAL & CUSTOM INVOICE NO. F222 52006212 DT. 25.03.2022 S/BIL L NO: 9246883 DT: 26-MAR-22 N ET WT. 717.73 KGS 06 DATA LOG GERS NOTIFY PARTY:2 GLEN MARK SPECIALTY S.A. SWITZERLA ND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 293299 |
2022-04-19 |
34 PKG |
7598.71KG |
34 PALLETS 1521 CART ONS PHARMACEUTICALS AS UNDER TOPIRAMATE TABLETS 200MG 60 S NDC CODE:68462011060 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTI CE USE:-ANTICONVULSANT THE OPHYLLINE ER TABS 400MG 100 S NDC CODE:68462038001 FDA PRO DUCT CODE NO.: 63 B C B 30 H . T. S NO.: 3004.90.92.85 AN DA NO.: 90-355 THERAPEUTICE U SE: XANTHINE BRONCHODILATOR ATOVAQUONE-PROGUANIL TAB 250 /100MG 24S NDC CODE:684620404 67 FDA PRODUCT CODE NO.: 62 L D A 44 H. T. S NO.: 3004.9 0.92.90 ANDA NO.: 91-211 THE RAPEUTICE USE: - ANTI MALARIA L POTASSIUM CL ER TAB 20MEQ (1500MG) 500 S NDC CODE:6846 2047205 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3 004.90.9020 ANDA NO.: 206391 THERAPEUTICE USE: - MEDICATI ON USED FOR HEART FAILURE, HI GH BLOOD PRESSURE, AND TO TRE AT AND PREVENT CHEST PAIN FR OM NOT ENOUGH BLOOD FLOW TO T HE HEART METRONIDAZOLE VAGI NAL GEL 0.75% 70GM NDC CODE:6 8462018449 FDA PRODUCT CODE N O.: 62 L C J 40 H. T. S NO.: 3004.90.92.45 ANDA NO.: 215 794 THERAPEUTICE USE: METRON IDAZOLE VAGINAL GEL IS INDICA TED IN THE TREATMENT OF BACTE RIAL VAGINOSIS (FORMERLY REF ERRED TO AS HAEMOPHILUS VAGI NITIS, GARDNERELLA VAGINITIS, NONSPECIFIC VAGINITIS, CORY NEBACTERIUM VAGINITIS, OR ANA EROBIC VAGINOSIS). COMMERCIA L & CUSTOM INVOICE NO. F22252 006222 DT. 26.03.2022 F222520 06211 DT. 25.03.2022 S/BILL N O: 9246750 DT: 26-MAR-22 S/B ILL NO: 9246776 DT: 26-MAR-2 2 NET WT: 6,181.02 KGS 02 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 614000 |
2022-04-19 |
35 PKG |
7981.55KG |
35 PALLETS 1829 CART ONS PHARMACEUTICALS AS UNDER METFORMIN HCL ER TABS (Z) 5 00MG 100 S NDC CODE:684620520 01 FDA PRODUCT CODE NO.: 61 P C A 55 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:212969 THER APEUTICE USE: THE MANAGEMENT OF TYPE 2 DIABETES POTASSI UM CL ER CAPS 10MEQ (750MG) 10 0 S NDC CODE:68462035701 FDA P RODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTI ON OF HYPOKALEMIA TOPIRAMA TE ER CAPSULES (Q) 200MG 30 S NDC CODE:68462037130 3004.49 .00.20 61 M C B 40 210278 CHLORPROMAZINE HCL TABS 10MG 100 S NDC CODE:68462086101 6 1 T C A 04 3004.90.92.40 212 144 TO TREAT PSYCHOTIC DISOR DERS SUCH AS SCHIZOPHRENIA OR MANIC-DEPRESSION IN ADULTS CHLORPROMAZINE HCL TABS 50M G 100 S NDC CODE:68462086301 61 T C A 04 3004.90.92.40 2 12144 TO TREAT PSYCHOTIC DIS ORDERS SUCH AS SCHIZOPHRENIA OR MANIC-DEPRESSION IN ADULT S CHLORPROMAZINE HCL TABS 1 00MG 100 S NDC CODE:684620864 01 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SUCH AS SCHIZOPHREN IA OR MANIC-DEPRESSION IN AD ULTS FENOFIBRATE CAPSULES 1 34MG 100 S NDC CODE:684620581 01 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90. 92.20 ANDA NO.: 205566 THERA PEUTICE USE: - INDICATED AS A DJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOT AL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMAR Y HYPERCHOLESTEROLEMIA OR MI XED DYSLIPIDEMIA GABAPENTIN TABLETS 600MG 500 S NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT PRAVASTATI N SODIUM TAB 20MG 90 S NDC CO DE:68462019690 FDA PRODUCT CO DE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: -77-987 THERAPEUTICE USE:-HY POLIPDAEMIC COMMERCIAL & CU STOM INVOICE NO. F22287002025 DT. 22.03.2022 F22287002026 DT. 22.03.2022 F22287002032 D T. 22.03.2022 S/BILL NO: 4004 200 DT:23.03.2022 S/BILL NO: 4004198 DT:23.03.2022 S/BILL NO: 4004206 DT:23.03.2022 NET WT. 5,509.71 KGS 02 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA |
HS 615500 |
2022-04-19 |
28 PKG |
7026.72KG |
28 PALLETS 1904 CART ONS PHARMACEUTICALS AS UNDER GABAPENTIN TABLETS 600MG 500 S NDC CODE:68462012605 FDA P RODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 A NDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT CALCIPOTRIENE OINTMENT 0.005% 60GM NDC CODE:68462031065 F DA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 209297 THIS MED ICATION IS USED TO TREAT PSOR IASIS. CALCIPOTRIENE IS A FOR M OF VITAMIN D. IT WORKS BY SLOWING DOWN THE GROWTH OF SK IN CELLS. TELMISARTAN TABLE TS 20MG 30 S NDC CODE:6846201 9930 FDA PRODUCT CODE NO.: 6 2 O C A 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.:090032 TH ERAPEUTICE USE: INDICATED FOR THE TREATMENT OF HYPERTENSI ON, TO LOWER BLOOD PRESSURE TOPIRAMATE TABLETS 100MG 100 0 S NDC CODE:68462010910 FDA PRODUCT CODE NO.:61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTI CE USE:-ANTICONVULSANT FEL ODIPINE ER TABS 2.5MG 100 S N DC CODE:68462023301 FDA PRODU CT CODE NO.: 62OCB32 H. T. S NO.: 3004.90.92.20 ANDA NO. : 90-365 THERAPEUTICE USE: - TREATMENT OF HYPERTENSION URSODIOL TABS 500MG 100 S ND C CODE:68462047401 FDA PRODUC T CODE NO.: 63 N C A 25 H. T . S NO.: 3004.49.00.10 ANDA NO.: 90-801 THERAPEUTICE USE : - FOR THE TREATMENT OF PAT IENTS WITH PRIMARY BILIARY CI RRHOSIS TRANDOLAPRIL-VERAP AMIL TAB 4/240MG 100 S NDC CO DE:68462032901 FDA PRODUCT CO DE NO.:-62 O D A 11 H. T. S NO.: 3004.90.92.20 ANDA NO.: -79-135 THERAPEUTICE USE:-TR EATMENT OF HYPERTENSION UR SODIOL TABS 500MG 100 S NDC C ODE:68462047401 FDA PRODUCT C ODE NO.: 63 N C A 25 H. T. S NO.: 3004.49.00.10 ANDA NO. : 90-801 THERAPEUTICE USE: - FOR THE TREATMENT OF PATIEN TS WITH PRIMARY BILIARY CIRRH OSIS COMMERCIAL & CUSTOM INV OICE NO. F22252006174 DT. 23. 03.2022 F22252006179 DT. 23.0 3.2022 F22252006180 DT. 23.03 .2022 F22252006182 DT. 23.03. 2022 NET WT: 6,053.86 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA S/BILL NO: 9186587 DT: 24-MAR-22 S/BILL NO: 9186582 DT:24-MAR-22 S/BILL NO: 9186 627 DT:24-MAR-22 S/BILL NO: 9 186583 DT:24-MAR-22 |
HS 616900 |
2022-04-19 |
4 PKG |
934.42KG |
4 PALLETS 275 CARTON S PHARMACEUTICALS AS UNDER T ACROLIMUS OINTMENT 0.1% 60GM NDC CODE:68462053465 FDA PROD UCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 AND A NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERMAT ITIS (ECZEMA). PIMECROLIMU S CREAM 1% 30GM NDC CODE:6846 2060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECO UND-LINE THERAPY FOR THE SHOR T-TERM AND NON-CONTINUOS CHRO NIC TRERTMENT OF MILD TO MOD ERATE ATOPIC DERMATITIS IN N ONIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE COM MERCIAL & CUSTOM INVOICE NO. F22287002038 DT. 24.03.2022 N ET WT. 604.51 KGS 02 DATA L OGGERS S/BILL NO: 400427 8 DT:24/03/2022 NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA |
HS 640800 |
2022-04-19 |
24 PKG |
4720.16KG |
24 PALLETS 495 CARTO NS PHARMACEUTICALS AS UNDER CLOBETASOL PROP SOLUTION 0.0 5% 50ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 210190 THERAP EUTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIEN T / NONSTERILE LIQUID / CLOB ETASOL PROPIONATE (GLUCOCORTI COID) CLOBETASOL PROP SOLUT ION 0.05% 50ML NDC CODE:68462 053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOCOR TICOID / HUMAN - RX/SINGLE IN GREDIENT / NONSTERILE LIQUID / CLOBETASOL PROPIONATE (GLU COCORTICOID) COMMERCIAL & C USTOM INVOICE NO. F2223500526 1 DT. 18.03.2022 F22235005273 DT. 21.03.2022 S/BILL NO: 9 054625 DT:19/03/2022 S/BILL NO: 9180281 DT:24/03/2022 NE T WT: 2,376.00 KGS 24 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA |
HS 646700 |
2022-04-19 |
10 PKG |
1648.84KG |
10 PALLETS 293 CARTO NS PHARMACEUTICALS AS UNDER CLOBETASOL PROP CREAM 0.05% 60 GM NDC CODE:68462052965 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 209095 THERAPEUTIC E USE: - CLOBETASOL PROPIONAT E CREAM IS A SUPER-HIGH POTE NCY CORTICOSTEROID FORMULATIO NS INDICATED FOR THE RELIEF O F THE INFLAMMATORY AND PRURIT IC MANIFESTATIONS OF CORTICO STEROID-RESPONSIVE DERMATOSES CLOBETASOL PROP OINTMENT 0 .05% 60GM NDC CODE:6846205306 5 FDA PRODUCT CODE NO.: 64 L C J 67 H. T. S NO.: 3004.90 .92.45 ANDA NO.: 208933 THER APEUTICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMMATO RY AND PRURITIC MANIFESTATION S OF CORTICOSTEROID-RESPONSIV E DERMATOESE COMMERCIAL & CU STOM INVOICE NO. F22235005262 DT. 18.03.2022 NET WT. 843. 84 KGS 10 DATA LOGGERS S/BILL NO: 9055654 DT:19/03/2 022 NOTIFY PARTY:2 GLENMAR K SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NEU CHATEL - 2000 SWITZERLAND |
HS 646700 |
2022-04-19 |
19 PKG |
4648.04KG |
19 PALLETS 2334 CART ONS PHARMACEUTICALS AS UNDER CLINDAMYCIN-BPO GEL 1%/5% 50G M NDC CODE:68462048627 FDA P RODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO.: 209252 ANTIBIOTIC T HAT STOPS THE GROWTH OF ACNE- CAUSING BACTERIA AS WELL AS REDUCE OIL PRODUCTION IN THE SKIN, HELPING KEEP PORES OPEN ROSUVASTATIN TABLETS 10MG 90 S NO : 08.MAR.2022 29.FEB .2024 NDC CODE:68462026290 F DA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.1 0 ANDA NO.: 079172 THERAPEUT ICE USE: - TO TREAT HIGH CHOL ESTEROL AND RELATED CONDITION S, AND TO PREVENT CARDIOVASC ULAR DISEASE ROSUVASTATIN T ABLETS 5MG 90 S NDC CODE:6846 2026190 FDA PRODUCT CODE NO. :61 J C A 16 H. T. S NO.: 30 04.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE ROSU VASTATIN TABLETS 40MG 30 S ND C CODE:68462026430 FDA PRODUC T CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL A ND RELATED CONDITIONS, AND T O PREVENT CARDIOVASCULAR DISE ASE COMMERCIAL & CUSTOM INVOI CE NO. F22252006177 DT. 23.03 .2022 F22252006178 DT. 23.03. 2022 S/BILL NO: 9186598 DT:2 4-MAR-22 S/BILL NO: 9186691 DT:24-MAR-22 NET WT: 3,649.0 2 KGS 19 DATA LOGGERS HUMID ITY:65% GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND |
HS 563100 |
2022-04-19 |
4 PKG |
994.74KG |
4 PALLETS 125 CARTON S PHARMACEUTICALS AS UNDER N ITROGLYCERIN SUBLING TABS 0.4M G 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.90 20 ANDA NO.:206391 THERAPEUT IC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRES SURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH B LOOD FLOW TO THE HEART COMME RCIAL & CUSTOM INVOICE NO. F2 2287002039 DT. 24.03.2022 NET WT. 66.60 KGS 04 DATA LOGGE RS S/BILL NO: 4004276 DT: 24/03/2022 NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZ ERLAND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERL AND |
HS 662800 |
2022-04-05 |
42 PKG |
8791.68KG |
1 X 40 HC REF 35 PALLETS CON SIST OF 2412 CARTONS PHARMAC EUTICALS AS UNDER CLINDAMYCI N PHOSPHATE GEL 1% 30GM NDC CODE:68462086635 FDA PRODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA N O.:214251 THERAPEUTICE USE: CLINDAMYCIN PHOSPHATE GEL IS INDICATED IN THE TREATMENT OF ACNE VULGARIS CLINDAMYCI N PHOSPHATE GEL 1% 60GM NDC CODE:68462086665 FDA PRODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA N O.:214251 THERAPEUTICE USE: CLINDAMYCIN PHOSPHATE GEL IS I NDICATED IN THE TREATMENT OF ACNE VULGARIS CLOTRIMAZO LE CREAM 1% 15GM NDC CODE:68 462018117 FDA PRODUCT CODE N O.:61#W#C#J#04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-2 19 THERAPEUTICE USE: TREATME NT OF CANDIDIASIS CLOTRIM AZOLE CREAM 1% 45GM NDC CODE :68462018147 FDA PRODUCT COD E NO: 61 W C J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 9 0-219 THERAPEUTICE USE: TREATM ENT OF CANDIDIASIS ZONISA MIDE CAPSULES 25MG 100 S NDC CODE:68462012801 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO .:-77-651 THERAPEUTICE USE:- ANTISEIZURE DRUG ATOMOXET INE CAPSULES 25MG 30 S NDC C ODE:68462026730 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.: 3004.90.92.90 ANDA NO.: 0 79019 THERAPEUTICE USE : - A TOMOXETINE IS USED TO TREAT ATTENTION-DEFICIT HYPERACTIVIT Y DISORDER (ADHD) AS PART OF A TOTAL TREATMENT PLAN, INCLU DING PSYCHOLOGICAL, SOCIAL, AND OTHER TREATMENTS GABA PENTIN TABLETS 800MG 500 S N DC CODE:68462012705 FDA PROD UCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 AND A NO.:-77-662 THERAPEUTICE U SE:-ANTICONVULSANT AGENT NAPROXEN TABLETS 500MG 500 S NDC CODE:68462019005 FDA PR ODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 A NDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMATORY, ANALG ESIC LEVOCETIRIZINE DIHY TABS 5MG 90 S NDC CODE:68462 034690 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 30 04.90.91.80 ANDA NO.:90385 T HERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPATHIC URTICARIA NET WT: 9,996.23 KGS G ROSS WT: 11,505.34 KGS CO MMERCIAL & CUSTOM INVOICE NO. F22252005900 DT. 28.02.2022 F22252005883 DT. 28.02.2022 F22252005895 DT. 28.02.2022 F22252005902 DT. 28.02.2022 F22252005893 DT. 28.02.2022 F22252005890 DT. 28.02.2022 F22252005926 DT. 02.03.2022 F22252005929 DT. 02.03.2022 SB NO.: 8644915 DT: 02/03 /22 SB NO.: 8644804 DT: 02/0 3/22 SB NO.: 8644736 DT: 02/ 03/22 SB NO.: 8644708 DT: 02 /03/22 SB NO.: 8644681 DT: 0 2/03/22 SB NO.: 8644588 DT: 02/03/22 SB NO.: 8644920 DT: 02/03/22 SB NO.: 8644391 DT : 02/03/22 02 DATA LOGGER S CONTAINER NO. MNBU907140 0 |
HS 847480 |
2022-04-05 |
35 PKG |
8791.68KG |
1X40 HC REF 2249 CARTONS PACK ED IN 35 PALLETS PHARMACEUTIC ALS AS UNDER ROPINIROLE TABS 5MG 100 S NDC CODE:6846202590 1 FDA PRODUCT CODE NO.:62 J C A 17 H. T. S NO.: 3004.90.92 .40 ANDA NO.:- 90-135 THERAP 1X40 REF 320 CARTONS PACKED I N 7 PALLETS PHARMACEUTICALS A S UNDER ADAPALENE GEL 0.1% 15 GM (PLD) NDC CODE:69842008805 NDC NO.:69842008805 FDA PRO DUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3004.40.00.50 ANDA EUTICE USE:-TREATMENT OF PARK INSONISM ROPINIROLE TABS 3MG 100 S NDC CODE:68462025701 F DA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPE UTICE USE:-TREATMENT OF PARKI NSONISM PRAMIPEXOLE TABS 0.5M G 90 S NDC CODE:68462033290 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 THERAPEUT ICE USE: USED IN PARKINSON#S DISEASE OXCARBAZEPINE TABLETS 600MG 100 S NDC CODE:6846201 3901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-802 THE RAPEUTICE USE:-ANTI CONVULSANT AGENT OMEPRAZOLE DR CAPSULES 10MG 100 S NDC CODE:68462039 501 FDA PRODUCT CODE NO.: 62K CF10 H. T. S NO.: 3004.90.916 0 ANDA NO.: 91672 THERAPEUTI CE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEA SE OMEPRAZOLE DR CAPSULES 10M G 30 S NDC CODE:68462039530 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 AN DA NO.: 91672 THERAPEUTICE US E: - TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE POTASSIUM CL ER TAB 20MEQ (15 00MG) 100 S NDC CODE:68462047 201 FDA PRODUCT CODE NO.: 65 R C A 14 H. T. S NO.: 3004. 90.9190 ANDA NO.: 203562 THE RAPEUTICE USE: - TO TREAT OR PREVENT LOW AMOUNTS OF POTASS IUM IN THE BLOOD OMEPRAZOLE DR CAPSULES 20MG 1000 S NDC C ODE:68462039610 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE GROSS WT.: 8,791.96 KGS NET WT.: 7,550.6 4 KGS COMMERCIAL & CUSTOM INV OICE NO. F22252005782 DT. 23. 02.2022 F22252005791 DT. 23.0 2.2022 F22252005815 DT. 24.02 .2022 SB NO.: 8492699 DT.: 24 /02/22 SB NO.: 8494162 DT.: 2 5/02/22 SB NO.: 8515041 DT.: 25/02/22 03 DATA LOGGERS S ET TEMPERATURE : +20 DEGREES CONTAINER NO. MNBU4115887 MAN UFACTURE D FOR GLENMARK PHA RMACEUTICAL S INC., USA 301, ISLAND RD MAHWAH MNBU411588 7 ML-IN4125979 40 REEF 9 6 35 PACKAGE 8791.960 KGS TEMPERAT URE: 20.0 C CUSTOMS SEAL : KL IK20081690 THE PLACE OF ISSUA NCE OF THIS DOCUMENT SHALL BE DEEMED TO BE THE MAERSK LINE I NDIA PVT LTD OFFICE LOCATED E ITHER IN THE SAME STATE OR THE NEAREST STATE WITH RESPECT TO THE ABOVE REFERENCED CARGO P ICK-UP / DROP-OFF LOCATION GO ODS SHIPPED IN REFRIGERATED CO NTAINER(S) SET AT SHIPPER S RE QUESTED CARRIAGE TEMPERATURE AS PER ABOVE SHIPPER S LOAD, STOW, WEIGHT AND COUNT FREI GHT PREPAID ALSO NOTIFY: GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA CY/CY NO.: 091314 THERAPEUTICE USE : - TREATMENT OF ACNE ADAPALE NE GEL 0.1% 45GM (PLD) NDC CODE:69842008816 NDC NO.:6984 2008816 FDA PRODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 300 4.40.00.50 ANDA NO.: 091314 THERAPEUTICE USE: - TREATMENT OF ACNE 00 DATA LOGGERS CO NTAINER NO. MNBU9046937 NET W T: 1,126.69 KGS GROSS WT: 1,6 26.72 KGS COMMERCIAL & CUSTOM INVOICE NO. F22252005775 DT. 23.02.2022 F22252005776 DT. 23.02.2022 |
HS 224900 |
2022-04-05 |
6 PKG |
1473.75KG |
1X40 HC REF 6 PALLETS CONSIS T OF261 CARTONS PHARMACEU TICALS AS UNDER CARVEDILO L TABS 25MG 500 S NDC CODE:6 8462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST NET WT.: 1233.49 KGS GRO SS WT: 1,474.05 KGS COMM ERCIAL & CUSTOM INVOICE NO. F22287001882 DT. 24.02.2022 SB NO.: 4002775 DT.: 24/02/ 22 02 DATA LOGGERS SE T TEMPERATURE : +20 DEGREES CONTAINER NO. MNBU3663802 |
HS 290719 |
2022-04-05 |
5 PKG |
557.93KG |
1X40 HC REF 147 CARTONS P ACKED IN 5 PALLETS PHARMA CEUTICALS AS UNDER FLUOCI NOLONE ACE SCALP OIL 0.01% 118 ML NDC CODE:68462059089 FD A PRODUCT CODE NO.: 64 L C L 2 7 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210539 SYNTHETI C CORTICOSTEROID FOR TOPICAL DERMATOLOGIC USE FOR THE TR EATMENT OF PSORIASIS OF THE SCALP NET WT.: 370.44 KG S GROSS WT.: 558.28 KGS COMMERCIAL & CUSTOM INVOICE NO. F22235004867 DT. 23.02. 2022 SB NO.: 8470162 DT.: 24/02/22 05 DATA LOGGERS SET TEMPERATURE : +20 DEG REES CONTAINER NO. MNBU36 63802 |
HS 271019 |
2022-04-05 |
13 PKG |
2295.67KG |
1X40 HC REF 219 CARTONS P ACKED IN 13 PALLETS PHARM ACEUTICALS AS UNDER CLOTR IM-BETAMETHASONE CRM 1.0/.05% 15GM NDC CODE:68462029817 FDA PRODUCT CODE NO.:61 W D J 04 H. T. S NO.: 3004.90. 92.45 ANDA NO.:202894 THER APEUTICE USE: - TREATMENT A VARIETY OF INFLAMED FUNGAL S KIN INFECTIONS GROSS WT .: 2,295.88 KGS NET WT.: 94 6.08 KGS COMMERCIAL & CUS TOM INVOICE NO. F22235004871 DT. 23.02.2022 SB NO.: 8 4701631 DT.: 24/02/22 13 DATA LOGGERS SET TEMPERATU RE : +20 DEGREES CONTAINER NO. MNBU3663802 |
HS 292143 |
2022-04-05 |
2 PKG |
217.27KG |
1X40 HC REF 22 CARTONS PA CKED IN 2 PALLETS PHARMAC EUTICALS AS UNDER ACYCLOV IR OINTMENT 5% 15GM NDC CODE :68462074617 FDA PRODUCT COD E NO.: 62 V C J 18 H. T. S N O.: 3004.49.00.50 ANDA NO.: 205510 THERAPEUTICE USE: - A N ANTIVIRAL MEDICINE USED TO TREAT OR PREVENT INFECTIONS CAUSED BY CERTAIN KINDS O F VIRUSES. EXAMPLES OF THESE INFECTIONS INCLUDE HERPES A ND SHINGLES GROSS WT.: 21 7.45 KGS NET WT.: 157.91 KGS COMMERCIAL & CUSTOM INVO ICE NO. F22252005836 DT. 25. 02.2022 SB NO.: 85395301 DT: 26/02/22 02 DATA LOGG ERS SET TEMPERATURE : +20 DEGREES CONTAINER NO. MNB U3663802 |
HS 847439 |
2022-04-05 |
13 PKG |
2976.52KG |
1X40 HC REF 805 CARTONS PACK ED IN 13 PALLETS PHARMACE UTICALS AS UNDER OXCARBAZ EPINE TABLETS 150MG 100 S ND C CODE:68462013701 FDA PRODU CT CODE NO.:-61 M C A 45 H . T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTIC E USE:-ANTI CONVULSANT AGENT OXCARBAZEPINE TABLETS 15 0MG 100 S NDC CODE:684620137 01 FDA PRODUCT CODE NO.:-6 1 M C A 45 H. T. S NO.: 30 04.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CO NVULSANT AGENT MOEXIPRIL HCL TABLETS 15MG 100 S NDC C ODE:68462020801 FDA PRODUCT CODE NO.:62 O C A 47 H. T. S NO.: 3004.49.00.10 ANDA NO.:-90-416 THERAPEUTICE USE:-ANTIHYPERTENSIVE AGENT- ACE INHIBITOR LITHIUM CAR BONATE ER TABS 450MG 100 S N DC CODE:68462022401 FDA PROD UCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:91-616 THERAPEUTIC E USE: - INDICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER. BIPOLAR DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO MANIC DEPRESS IVE ILLNESS, MANIC, IN THE O LDER DSM-II TERMINOLOGY. ALS O INDICATED AS A MAINTENANCE TREATMENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR DISORDER. MAINTENANCE THERAPY REDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISHE S THE INTENSITY OF THOSE EPI SODES WHICH MAY OCCUR. CICLOPIROX OLAMINE CREAM 0.77% 90GM NDC CODE:68462029792 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.4 0.49.50 ANDA NO.:- 90 - 273 THERAPEUTICE USE:-ANTIFUNG AL USE. NET WT: 2,422.81 KGS GROSS WT.: 2,976.83 KGS COMMERCIAL & CUSTOM INVO ICE NO. F22252005837 DT. 25. 02.2022 F22252005838 DT. 25. 02.2022 F22252005839 DT. 25. 02.2022 SB NO.: 8536485 D T.: 26/02/22 SB NO.: 8541387 DT.: 26/02/22 SB NO.: 85413 91 DT.: 26/02/22 04 DA TA LOGGERS SET TEMPERATURE : +20 DEGREES CONTAINER N O. MNBU3663802 |
HS 847480 |
2022-04-05 |
10 PKG |
2328.78KG |
1X40 HC REF 907 CARTONS PACK ED IN 10 PALLETS PHARMACE UTICALS AS UNDER ROSUVAST ATIN TABLETS 20MG 90 S NDC C ODE:68462026390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE US E: - TO TREAT HIGH CHOLESTER OL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCUL AR DISEASE ROSUVASTATIN T ABLETS 20MG 1000 S NDC CODE: 68462026310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 79172 THERAPEUTICE USE: T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DIS EASE ROSUVASTATIN TABLETS 5MG 90 S NDC CODE:684620261 90 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 300 4.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TRE AT HIGH CHOLESTEROL AND RELA TED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE ROSUVASTATIN TABLETS 20MG 1 000 S NDC CODE:68462026310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.4 9.00.10 ANDA NO.: 79172 TH ERAPEUTICE USE: TO TREAT HIG H CHOLESTEROL AND RELATED CO NDITIONS, AND TO PREVENT CAR DIOVASCULAR DISEASE GRO SS WT.: : 2,328.86 KGS NET W T.: 1,911.69 KGS COMMERCI AL & CUSTOM INVOICE NO. F222 52005783 DT. 23.02.2022 F222 52005794 DT. 23.02.2022 F222 52005814 DT. 24.02.2022 S B NO.: 8515206 DT: 25/02/22 SB NO.: 8513855 DT: 25/02/22 SB NO.: 8513805 DT: 25/02/22 10 DATA LOGGERS SET T EMPERATURE : +20 DEGREES C ONTAINER NO. MNBU4115887 |
HS 210690 |
2022-03-23 |
8 CTN |
11044.25KG |
1 CONTAINER SAID TO CONTAIN 44 PALLETS 1X40 REF HC 44 PALLETS CONSISIT OF 2557 CARTO NS PHARMACEUTICALS AS UNDER ONDANSETRON TABLETS 4MG 30 S NDC CODE:68462010530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUTI CE USE:-ANTI EMETIC OXCARB AZEPINE TABLETS 300MG 100 S N DC CODE:68462013801 FDA PRODU CT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE :-ANTI CONVULSANT AGENT PR AVASTATIN SODIUM TAB 40MG 500 S NDC CODE:68462019705 FDA P RODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: HYPOLIPDAEMIC GABAPE NTIN TABLETS 800MG 500 S NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO .:-77-662 THERAPEUTICE USE:- ANTICONVULSANT AGENT METRO NIDAZOLE VAGINAL GEL 0.75% 70G M NDC CODE:68462018449 FDA P RODUCT CODE NO.: 62 L C J 40 H. T. S NO.: 3004.90.92.45 ANDA NO.: 215794 THERAPEUTICE USE: METRONIDAZOLE VAGINAL G EL IS INDICATED IN THE TREAT MENT OF BACTERIAL VAGINOSIS ( FORMERLY REFERRED TO AS HAEM OPHILUS VAGINITIS, GARDNERELL A VAGINITIS, NONSPECIFIC VAG INITIS, CORYNEBACTERIUM VAGI NITIS, OR ANAEROBIC VAGINOSIS ). PRAVASTATIN SODIUM TAB 4 0MG 90 S NDC CODE:68462019790 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90. 92.20 ANDA NO.: 77-987 THERA PEUTICE USE: HYPOLIPDAEMIC NET WT.: 8904.93 KGS GROSS W T.: 11044.19 KGS COMMERCIAL & CUSTOM INVOICE NO. F222520 05704 DT. 18.02.2022 F2225200 5706 DT. 18.02.2022 F22252005 707 DT. 18.02.2022 F222520057 08 DT. 18.02.2022 SB NO.: 8 359153 DT.: 19/02/22. SB NO.: 8357045 DT.: 19/02/22. SB NO .: 8358831 DT.: 19/02/22. SB NO.: 8358608 DT.: 19/02/22. 02 DATA LOGGERS HUMIDITY:6 5% SET TEMPERATURE : +20 DEGR EES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES CONTAIN ER NO. MNBU4142780 MANUFA CTURE D FOR GLENMARK PHARMA CEUTICAL S INC., USA 301, IS LAND RD MAHWAH MNBU4142780 M L-IN9999999 40 REEF 9 6 8 CART ONS 11,044.19 KGS TEMPERATURE : 20.0 C THE PLACE OF ISSUANC E OF THIS DOCUMENT SHALL BE DE EMED TO BE THE MAERSK LINE IND IA PVT LTD OFFICE LOCATED EIT HER IN THE SAME STATE OR THE N EAREST STATE WITH RESPECT TO T HE ABOVE REFERENCED CARGO PIC K-UP / DROP-OFF LOCATION GOOD S SHIPPED IN REFRIGERATED CONT AINER(S) SET AT SHIPPER S REQU ESTED CARRIAGE TEMPERATURE AS PER ABOVE SHIPPER S LOAD, STOW, WEIGHT AND COUNT FREIGH T PREPAID ALSO NOTIFY: GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA CY/CY |
HS 210690 |
2022-03-23 |
6 PKG |
1540.88KG |
1X40 REF 267 CARTONS PACKED I N 6 PALLETS PHARMACEUTICALS A S UNDER ROSUVASTATIN TABLETS 40MG 500 S NDC CODE:684620264 05 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TABLETS 20MG 1000 S NDC CODE:68462026 310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004 .49.00.10 ANDA NO.: 79172 TH ERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDI TIONS, AND TO PREVENT CARDIOV ASCULAR DISEASE NET WT: 1,3 74.96 KGS GROSS WT: 1,541.19 KGS 06 DATA LOGGERS SET TEMPERATURE : +20 DEGREES C ONTAINER NO. TTNU8759835 CO MMERCIAL & CUSTOM INVOICE NO. F22252005768 DT. 23.02.2022 F22252005786 DT. 23.02.2022 SB NO.: 8492798 DT.: 25/02/22 SB NO,: 8492826 DT.: 25/02/2 2 |
HS 611600 |
2022-03-23 |
40 PKG |
6061.91KG |
1X40 REF 1994 CARTONS PACKED IN40 PALLETS PHARMACEUTICALS AS UNDER NORGEST/EE 0.25/0.03 5MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.0 0 ANDA NO.: 200538 THERAPEUT ICE USE: - ORAL CONTRACEPTIVE S DROSPIRENONE/EE 3.0/0.02MG 84 NDC CODE:68462072029 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00 00 ANDA NO.: 204296 THERAPEUTIC E USE: - ORAL CONTRACEPTIVE DROSPIRENONE/EE 3.0/0.03MG 84 NDC CODE:68462073329 FDA PRO DUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204848 THERAPEUTICE USE : - CONTRACEPTION TO PREVENT PREGNANCY NET WT: 4,361.42 KGS GROSS WT: 6,062.05 KGS 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES CONTAI NER NO. MNBU9139449 COMMERC IAL & CUSTOM INVOICE NO. F222 52005773 DT. 23.02.2022 SB NO.: 8463761 DT.: 24/02/22 |
HS 652700 |
2022-03-23 |
46 PKG |
12463.57KG |
1X40 REF 3858 CARTONS PACKED IN 46 PALLETS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 50 0MG 500 S NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAPE UTICE USE:-ANTI-INFLAMMATORY, ANALGESIC PRAMIPEXOLE TABS 1M G 90 S NDC CODE:68462033390 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 THERAPEUTI CE USE: USED IN PARKINSON#S DI SEASE PRAMIPEXOLE TABS 0.25MG 90 S NDC CODE:68462033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92. 40 ANDA NO.: 90-781 THERAPEUT ICE USE: USED IN PARKINSON#S D ISEASE PRAMIPEXOLE TABS 0.5MG 90 S NDC CODE:68462033290 F DA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTIC E USE: USED IN PARKINSON#S DIS EASE OXCARBAZEPINE TABLETS 30 0MG 100 S NDC CODE:6846201380 1 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-802 THERAPE UTICE USE:-ANTI CONVULSANT AGE NT OLMESARTAN MEDOXOMIL TABLE TS 5MG 30 S NDC CODE:68462043 630 FDA PRODUCT CODE NO.: 62C CA68 H. T. S NO.: 3004.90.922 0 ANDA NO.: 203281 THERAPEUTI CE USE: -TREATMENT OF HYPERTEN SION, ALONE ORWITH OTHER ANTI HYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE POTASSIUM CL ER TAB 20MEQ (1500MG) 500 S N DC CODE:68462047205 FDA PRODU CT CODE NO.: 66 S C A 28 H. T . S NO.: 3004.90.9020 ANDA NO. : 206391 THERAPEUTICE USE: - MEDICATION USED FOR HEART FAIL URE, HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART URSODIOL TABS 2 50MG 100 S NDC CODE:684620473 01 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 3004.49. 00.10 ANDA NO.: 90-801 THERA PEUTICE USE: - FOR THE TREATME NT OF PATIENTS WITH PRIMARY B ILIARY CIRRHOSIS GABAPENTIN TABLETS 600MG 100 S NDC CODE: 68462012601 FDA PRODUCT COD E NO : 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICON VULSANT AGENT NET WT : 10,381 .95 KGS GROSS WT : 12,463.41 KGS COMMERCIAL & CUSTOM INVOI CE NO. F22252005778 DT. 23.02 .2022 F22252005780 DT. 23.02. 2022 SB NO.: 8492215 DT.: 24/ 02/22 SB NO.: 8492102 DT.: 24 /02/22 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : + 20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES |
HS 624900 |
2022-03-23 |
18 PKG |
3313.09KG |
1X40 REF 894 CARTONS PACKED IN 18 PALLETS PHARMACEUTICAL S AS UNDER HAILEY 1.5/30 TABL ETS 1.5MG/30MCG 3X21 NDC CODE :68462050481 FDA PRODUCT CODE NO.:65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 2092 97 THERAPEUTICE USE: - CONTRA CEPTION TO PREVENT PREGNANCY NET WT: 2,559.70 KGS GROSS WT: 3,313.05 KGS COMMERCIA L & CUSTOM INVOICE NO. F22252 005784 DT. 23.02.2022 SB NO .: 8492291 DT.: 24/02/22 01 DATA LOGGERS SET TEMPERATU RE : +20 DEGREES CONTAINER NO. MNBU9046937 |
HS 684620 |
2022-03-23 |
7 PKG |
3648.3KG |
1X40 REF 987 CARTONS PACKED I N 21 PALLETS PHARMACEUTICALS AS UNDER ADAPALENE GEL 0.1% 1 5GM (PLD) NDC CODE:6984200880 5 NDC NO.:69842008805 FDA PR ODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3004.40.00.50 A NDA NO.: 091314 THERAPEUTICE USE: - TREATMENT OF ACNE A DAPALENE GEL 0.1% 45GM (PLD) NDC CODE:69842008816 NDC NO.: 69842008816 FDA PRODUCT CODE NO.: 62 S C J 02 H. T. S NO. : 3004.40.00.50 ANDA NO.: 09 1314 THERAPEUTICE USE: - TRE ATMENT OF ACNE DROSPIRENONE/E E 3.0/0.03MG 84 NDC CODE:6846 2073329 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3 006.60.00.00 ANDA NO.: 204848 THERAPEUTICE USE: - CONTRAC EPTION TO PREVENT PREGNANCY GROSS WT: 3,648.47 KGS NET WT : 2,583.42 KGS COMMERCIAL & C USTOM INVOICE NO. F2225200577 5 DT. 23.02.2022 F22252005776 DT. 23.02.2022 F22252005788 DT. 23.02.2022 SB NO.: 849249 8 DT.: 24/02/22 SB NO.: 84925 55 DT.: 24/02/22 SB NO.: 8492 590 DT.: 24/02/22 NOTIFY PA RTY 3: P&L DEVELOPMENT, LLC 275 GRAND BLVD NEW YORK WE STBURY USA- 11590 01 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +20 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES CONTAINER NO. MNBU 9046937 MANUFACTURE D FOR G LENMARK PHARMACEUTICAL S INC ., USA 301, ISLAND RD MAHWAH |
HS 620200 |
2022-03-23 |
10 PKG |
7521.6KG |
1X40 REF 1966 CARTONS PACKED IN 40 PALLETS PHARMACEUTICALS AS UNDER NORGEST/EE 0.18,0.2 15,0.25/0.035MG 84 NDC CODE:6 8462056529 FDA PRODUCT CODE N O.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200 494 THERAPEUTICE USE: - ORAL CONTRACEPTIVES NORGEST/EE 0. 25/0.035MG 84 NDC CODE:6846 2030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3 006.60.00.00 ANDA NO.: 200538 THERAPEUTICE USE: - ORAL CO NTRACEPTIVES NORGEST/EE 0.25/ 0.035MG 84 NDC CODE:684620309 29 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.6 0.00.00 ANDA NO.: 200538 THE RAPEUTICE USE: - ORAL CONTRAC EPTIVES NET WT.: 5898.00 KGS GROSS WT.: 7521.61 KGS COMME RCIAL & CUSTOM INVOICE NO. F2 2252005658 DT. 15.02.2022 F22 252005745 DT. 21.02.2022 F222 52005746 DT. 21.02.2022 SB NO.: 8265334 DT.: 16/02/22 SB NO.: 8418073 DT.: 22/02/22 S B NO.: 8422454 DT.: 22/02/22 03 DATA LOGGERS SET TEMPERA TURE : +20 DEGREES CONTAINE R NO.: MNBU0513120 MANUFACT URE D FOR GLENMARK PHARMACE UTICAL S INC., USA 301, ISLA ND RD MAHWAH |
HS 652700 |
2022-03-23 |
10 PKG |
8373.46KG |
1X40 REF 861 CARTONS PACKED I N 42 PALLETS PHARMACEUTICALS AS UNDER CLOBETASOL PROP SOLU TION 0.05% 50ML NDC CODE:6846 2053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOCO RTICOID / HUMAN - RX/SINGLE I NGREDIENT / NONSTERILE LIQU ID / CLOBETASOL PROPIONATE ( GLUCOCORTICOID) MOMETASONE FU ROATE OINTMENT 0.1% 15GM NDC CODE:68462022517 FDA PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49.50 ANDA NO .:78-571 THERAPEUTICE USE: A NTI-INFLAMMATORY- DERMATOLOGI C NYSTATIN-TRIAM 100K UNIT/0. 1% CREAM 15GM NDC CODE:684620 31417 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 300 4.40.0050 ANDA NO.: 208136 T HERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE S KIN, ESPECIALLY YEAST INFECT IONS. NYSTATIN-TRIAM 100K UNI T/0.1% OINT 15GM NDC CODE:684 62079917 FDA PRODUCT CODE NO. : 64 L D J 60 H. T. S NO.: 3004.49.00.50 ANDA NO.: 20830 0 THERAPEUTICE USE: - TREA TMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPECIALLY YEAST INFECTIONS. NYSTATIN-TRIAM 10 0K UNIT/0.1% OINT 30GM NDC CO DE:68462079935 FDA PRODUCT CO DE NO.: 64 L D J 60 H. T. S NO.: 3004.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTION S OF THE SKIN, ESPECIALLY YEA ST INFECTIONS. CLOBETASOL PR OP SOLUTION 0.05% 50ML NDC CO DE:68462053253 FDA PRODUCT CO DE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOCORTICOID / HUMAN - RX/S INGLE INGREDIENT / NONSTERILE LIQUID / CLOBETASOL PROPIONA TE (GLUCOCORTICOID) TRIAMCIN OLONE ACE OINT 0.5% 15GM NDC CODE:68462079817 FDA PRODUCT CODE NO.:64 L C J 61 T. S NO.: 3004.49.00.50 ANDA NO.: 206379 THERAPEUTICE USE: - R EDUCES THE SWELLING, ITCHING, AND REDNESS OF SKIN TRIAMCI NOLONE ACE OINT 0.5% 15GM NDC CODE:68462079817 FDA PRODUCT CODE NO.:64 L C J 61 H. T. S NO.: 3004.49.00.50 ANDA NO .:206379 THERAPEUTICE USE: - REDUCES THE SWELLING, ITCHIN G, AND REDNESS OF SKIN NET W T.: 3046.85 KGS GROSS WT.: 83 73.58 KGS COMMERCIAL & CUSTOM INVOICE NO. F22235004705 DT. 14.02.2022 F22235004711 DT. 14.02.2022 F22235004712 DT. 1 4.02.2022 F22235004734 DT. 16 .02.2022 F22235004769 DT. 18. 02.2022 SB NO.: 8242942 DT. : 15/02/22 SB NO.: 8242987 DT .: 15/02/22 SB NO.: 8242994 D T.: 15/02/22 SB NO.: 8286010 DT.: 17/02/22 SB NO.: 8337852 DT.: 18/02/22 42 DATA LOGG ERS HUMIDITY:65% SET TEMPERA TURE : +20 DEGREES TEMPERATUR E RANGE : +15 DEGREES TO +25 D EGREES CONTAINER NO. MANUFAC TURE D FOR GLENMARK PHARMAC EUTICAL S INC., USA 301, ISL AND RD MAHWAH |
HS 646700 |
2022-03-23 |
10 PKG |
4035.23KG |
1X40 REF 485 CARTONS PACKED I N 21 PALLETS PHARMACEUTICAL S AS UNDER CLOBETASOL PROP SOLUTION 0.05% 50ML NDC CODE: 68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO. : 3004.90.92.45 ANDA NO.: 21 0190 THERAPEUTICE USE: - GLU COCORTICOID / HUMAN - RX/SING LE INGREDIENT / NONSTERILE LI QUID / CLOBETASOL PROPIONATE (GLUCOCORTICOID) CLOBETASO L PROP SOLUTION 0.05% 25ML ND C CODE:68462053228 FDA PRODUC T CODE NO.: 64 L C L 67 H. T . S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTE RILE LIQUID / CLOBETASOL PROP IONATE (GLUCOCORTICOID) FL UOCINOLONE ACE BODY OIL 0.01% 118ML NDC CODE:68462059189 F DA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 210556 SYNTHETI C CORTICOSTEROID FOR TOPICAL DERMATOLOGIC USE FOR THE TREA TMENT OF PSORIASIS OF THE SCA LP NYSTATIN-TRIAM 100K UNIT /0.1% OINT 15GM NDC CODE:6846 2079917 FDA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - TREATME NT OF FUNGAL INFECTIONS OF TH E SKIN, ESPECIALLY YEAST INF ECTIONS. NYSTATIN-TRIAM 100 K UNIT/0.1% OINT 60GM NDC COD E:68462079965 FDA PRODUCT COD E NO.: 64 L D J 60 H. T. S N O.: 3004.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - T REATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPECIALLY YEAS T INFECTIONS. MOMETASONE F UROATE CREAM 0.1% 45GM NDC CO DE:68462019255 FDA PRODUCT CO DE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49.50 ANDA NO.: 78-541 THERAPEUTICE USE: ANT I-INFLAMMATORY- DERMATOLOGIC FLUOCINOLONE ACE SCALP OIL 0.01% 118ML NDC CODE:68462059 089 FDA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 210539 SY NTHETIC CORTICOSTEROID FOR TO PICAL DERMATOLOGIC USE FOR TH E TREATMENT OF PSORIASIS OF T HE SCALP GROSS WT. : 4,035. 32 KGS NET WT.: 2,019.00 KG S COMMERCIAL & CUSTOM INVOI CE NO. F22235004770 DT. 18.02 .2022 F22235004795 DT. 19.02. 2022 F22235004837 DT. 22.02.2 022 SB NO.: 8337857 DT.: 18 /02/2022 SB NO.: 8391230 DT.: 21/02/2022 SB NO.: 8435491 D T.: 23/02/2022 21 DATA LO GGERS HUMIDITY:65% SET TEMPE RATURE : +20 DEGREES TEMPERAT URE RANGE : +15 DEGREES TO +25 DEGREES CONTAINER NO. MNBU3 560002 MANUFACTURE D FOR GLENMARK PHARMACEUTICAL S IN C., USA 301, ISLAND RD MAHWA H |
HS 646700 |
2022-03-23 |
10 PKG |
3635.6KG |
1X40 REF 641 CARTONS PACKED I N 19 PALLETS PHARMACEUTICAL S AS UNDER CLOTRIM-BETAMETH ASONE CRM 1.0/.05% 15GM NDC C ODE:68462029817 FDA PRODUCT C ODE NO.:61 W D J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 202894 THERAPEUTICE USE: - T REATMENT A VARIETY OF INFLAME D FUNGAL SKIN INFECTIONS N ITROGLYCERIN SUBLING TABS 0.3M G 100 S NDC CODE:68462063801 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9 020 ANDA NO.:206391 THERAPEU TIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRE SSURE,AND TO TREAT AND PREVEN T CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART AP REPITANT CAPSULES 125-80MG 3UO U NDC CODE:68462011233 HTS N O : 3004.90.92.40 FDA CODE : 61 T C E 32 ANDA NO : 207777 THERAPEUTICE USE : APREPITAN T IS USED WITH OTHER MEDICATI ONS TO HELP PREVENT VOMITING CAUSED BY CANCER DRUG TREATME NT SOLIFENACIN SUCCINATE TA BS 5MG 90 S NDC CODE:68462038 690 FDA PRODUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 INDIC ATED FOR THE TREATMENT OF OVE RACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENC E, URGENCY AND URINARY FREQUE NCY GROSS WT.: 3,635.94 KGS NET WT.: 1,062.37 KGS C OMMERCIAL & CUSTOM INVOICE NO. F22235004838 DT. 22.02.2022 F22287001881 DT. 24.02.2022 SB NO.: 8435480 DT.: 23/02/2 2 SB NO.: 4002774 DT.: 23/02/ 22 NOTIFY PARTY: GLENMARK PHARMACEUTICALS LTD. PLOT NO 2, ISEZ, PHASE II,PHARMA ZONE PITHAMPUR, DIST DHAR, MADHYA PRADESH INDIA GST NO. : 23AAA CG2207L2ZZ 19 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES CONTAINER NO. MNBU3560002 MANUFACTURE D FOR GLENMA RK PHARMACEUTICAL S INC., US A 301, ISLAND RD MAHWAH |
HS 300490 |
2022-03-23 |
36 PKG |
9122.8KG |
1X40 REF 3328 CARTONS PACKED IN 36 PALLETS PHARMACEUT ICALS AS UNDER TELMISARTA N TABLETS 40MG 30 S NDC CODE :68462020030 FDA PRODUCT COD E NO.: 62 O C A 09 H. T. S N O.: 3004.90.92.20 ANDA NO.:0 90032 THERAPEUTICE USE: INDI CATED FOR THE TREATMENT OF H YPERTENSION, TO LOWER BLOOD PRESSURE PRAMIPEXOLE TABS 0.5MG 90 S NDC CODE:6846203 3290 FDA PRODUCT CODE NO.: 6 2 J C A 15 H. T. S NO.: 3004 .90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN P ARKINSON#S DISEASE LITHIU M CARBONATE ER TABS 300MG 100 S NDC CODE:68462022301 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:91-544 THERAPEUTI CE USE: - INDICATED IN THE T REATMENT OF MANIC EPISODES O F BIPOLAR DISORDER. BIPOLAR DI SORDER, MANIC (DSM-IV) IS EQ UIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, IN THE OLDER DSM-II TERMINOLOGY. ALSO IND ICATED AS A MAINTENANCE TREA TMENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR DISORDER . MAINTENANCE THERAPY REDUCE S THE FREQUENCY OF MANIC EPI SODES AND DIMINISHES THE INTEN SITY OF THOSE EPISODES WHICH MAY OCCUR GROSS WT: 9122 .71 KGS NET WT: 7,375.52 KG S COMMERCIAL & CUSTOM INV OICE NO. F22252005767 DT. 23 .02.2022 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATU RE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DE GREES CONTAINER NO. TTNU8759 835 |
HS 684620 |
2022-03-15 |
2 PKG |
485.81KG |
1X40 REF HC 2 PALLETS CONSI ST OF 61 CARTONS. PHARMACEU TICALS AS UNDER NITROGLYCERIN SUBLING TABS 0.4MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO. :206391 THERAPEUTIC USE: M EDICATION USED FOR HEART FAIL URE,HIGH BLOOD PRESSURE,AND T O TREAT AND PREVENT CHEST PAI N FROM NOT ENOUGH BLOOD FLOW TO THE HEART NET WT: 32.50 KGS GROSS WT: 486.20 KGS COMMERCIAL & CUSTOM INVOICE NO . F22287001825 DT. 16.02.2022 SB NO.: 4002289 DT.:16/02/ 22 02 DATA LOGGERS SET TEM PERATURE : +20 DEGREES CONT AINER NO.: MNBU3482234 |
HS 210690 |
2022-03-15 |
9 PKG |
2312.91KG |
1X40 HC REF 9 PALLETS CON SIST OF 700 CARTONS PHARM ACEUTICALS AS UNDER COLES EVELAM HCL TABLETS 625MG 180 S NDC CODE:68462043318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00.10 ANDA NO.: 203480 THERAPEUTI CE USE: - ANTIHYPERLIPO PROT EINEMIC GROSS WT: 2,313.1 5 KGS NET WT: 1,389.23 KGS COMMERCIAL & CUSTOM INVOIC E NO. F22287001824 DT. 16.02 .2022 03 DATA LOGGERS S ET TEMPERATURE : +20 DEGREES CONTAINER NO. MNBU3482234 |
HS 210690 |
2022-03-15 |
9 PKG |
1892.87KG |
1X40 REF HC 9 PALLETS CONSI ST OF 1063 CARTONS. PHARMA CEUTICALS AS UNDER ROSUVASTAT IN TABLETS 10MG 90 S NDC CODE :68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVEN T CARDIOVASCULAR DISEASE ROSU VASTATIN TABLETS 10MG 90 S ND C CODE:68462026290 FDA PROD UCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE : - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND T O PREVENT CARDIOVASCULAR DISE ASE NET WT: 1479.71 KGS GR OSS WT: 1892.97 KGS SB NO.: 8185055 DT.: 12-02-22 SB NO. : 8185282 DT: 12-02-22 COMM ERCIAL & CUSTOM INVOICE NO. F 22252005623 DT. 11.02.2022 F2 2252005624 DT. 11.02.2022 09 DATA LOGGERS SET TEMPERATURE : +20 DEGREES CONTAINER NO. MNBU3593691 |
HS 210690 |
2022-03-15 |
32 PKG |
6422.07KG |
1X40 REF HC 32 PALLETS CONT AINS 676 CARTONS. PHARMACE UTICALS AS UNDER CLOBETASOL PROP SOLUTION 0.05% 50ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.45 ANDA N O.: 210190 THERAPEUTICE USE: - GLUCOCORTICOID / HUMAN - R X/SINGLE INGREDIENT / NONSTER ILE LIQUID / CLOBETASOL PROPI ONATE (GLUCOCORTICOID) MOM ETASONE FUROATE OINTMENT 0.1% 15GM NDC CODE:68462022517 FD A PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49.5 0 ANDA NO.:78-571 THERAPEUTI CE USE: ANTI-INFLAMMATORY- D ERMATOLOGIC MOMETASONE FURO ATE OINTMENT 0.1% 45GM NDC CO DE:68462022555 FDA PRODUCT CO DE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49.50 ANDA NO.: 78-571 THERAPEUTICE USE: ANT I-INFLAMMATORY- DERMATOLOGIC GROSS WT.: 6422.21 KGS NET WT: 3069.89 KGS COMMERCIAL & CUSTOM INVOICE NO. F222350 04639 DT. 09.02.2022 F2223500 4610 DT. 06.02.2022 32 DATA LOGGERS SET TEMPERATURE : +20 DEGREES CONTAINER NO. MNBU3482234 |
HS 326760 |
2022-03-15 |
46 PKG |
11856.65KG |
1X40 REF HC 46 PALLETS CONT AINS 2978 CARTONS. PHARMAC EUTICALS AS UNDER OMEPRAZOLE DR CAPSULES 40MG 100 S NDC CO DE:68462039701 FDA PRODUCT CO DE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL RE FLUX DISEASE. LAMOTRIGINE TAB LETS FOR OS (CD)5MG100 S NDC CODE:68462022801 FDA PRODUCT CODE NO.:- 61 M C A 38 H. T. S NO.: 3004.90.92.30 ANDA N O.:-79 # 099 THERAPEUTICE USE :- ANTICONVULSANT ROPINIROLE TABS 4MG 100 S NDC CODE:68462 025801 FDA PRODUCT CODE NO.:- 62 J C A 17 H. T. S NO.: 3004 .90.92.40 ANDA NO.:- 90-135 T HERAPEUTICE USE:-TREATMENT OF PARKINSONISM TOPIRAMATE TABL ETS 50MG 60 S NDC CODE:684620 15360 FDA PRODUCT CODE NO.:-6 1 M C A 40 H. T. S NO.: 3004. 49.00.20 ANDA NO.:- 77-627 TH ERAPEUTICE USE:-ANTICONVULSAN T PRAVASTATIN SODIUM TAB 40MG 90 S NDC CODE:68462019790 F DA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTIC E USE: HYPOLIPDAEMIC VERAPAM IL HCL ER TABS 240MG 100 S ND C CODE:68462026001 FDA PRODUC T CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO .:-78-906 THERAPEUTICE USE:-A NGINA VERAPAMIL HCL ER TABS 2 40MG 500 S NDC CODE:684620260 05 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90. 92.20 ANDA NO.:-78-906 THER APEUTICE USE:-ANGINA PRAVAST ATIN SODIUM TAB 40MG 500 S ND C CODE:68462019705 FDA PRODUC T CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO .: 77-987 THERAPEUTICE USE: H YPOLIPDAEMIC VERAPAMIL HCL ER TABS 240MG 100 S NDC CODE:68 462026001 FDA PRODUCT CODE NO .: 62 O C B 13 H. T. S NO.: 3 004.90.92.20 ANDA NO.:-78-906 THERAPEUTICE USE:-ANGINA VE RAPAMIL HCL ER TABS 240MG 500 S NDC CODE:68462026005 FDA P RODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 DI CLOFENAC SODIUM GEL 3% 100GM NDC CODE:68462035594 FDA PROD UCT CODE NO.:62 G C J 18 H. T. S NO.:3004.90.92.40 ANDA N O.:208301 THERAPEUTICE USE: - USED FOR THE RELIEF OF JOINT PAIN OF OSTEOARTHRITIS COM MERCIAL & CUSTOM INVOICE NO. F22252005671 DT. 16.02.2022 F 22252005676 DT. 16.02.2022 F2 2252005678 DT. 16.02.2022 N ET WT: 10,089.40 KGS GROSS WT : 11,856.85 KGS SB NO.: 830 2065 DT.: 17-02-22 SB NO.: 83 02581 DT.: 17-02-22 SB NO.: 8 302322 DT.: 17-02-22 02 DAT A LOGGERS HUMIDITY:65% SET T EMPERATURE : +20 DEGREES TEMP ERATURE RANGE : +15 DEGREES TO +25 DEGREES CONTAINER NO. MN BU4205091 |
HS 462978 |
2022-03-15 |
32 PKG |
6630.27KG |
1X40 REF HC 2015 CARTONS PHA RMACEUTICALS AS UNDER EZETIMI BE-SIMVASTATIN TAB 10/20MG 30 S NDC CODE:68462032230 FDA P RODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 AN DA NO.: 208699 THERAPEUTICE U SE: - THIS COMBINATION MEDICAT ION IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUCH A S LDL, TRIGLYCERIDES) AND RAIS E EZETIMIBE-SIMVASTATIN TAB 1 0/40MG 90 S NDC CODE:68462032 390 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49 .00.10 ANDA NO.: 208699 THERA PEUTICE USE: - THIS COMBINATI ON MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL AND FAT S (SUCH AS LDL, TRIGLYCERIDES ) AND RAISE PRAVASTATIN SODIU M TAB 80MG 90 S NDC CODE:6846 2019890 FDA PRODUCT CODE NO.: -61 J C A 13 H. T. S NO.: 300 4.90.92.20 ANDA NO.:-77-987 T HERAPEUTICE USE:-HYPOLIPDAEMI C PRAVASTATIN SODIUM TAB 20 MG 90 S NDC CODE:68462019690 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.9 2.20 ANDA NO.:-77-987 THERAP EUTICE USE:-HYPOLIPDAEMIC VORICONAZOLE TABLETS 200MG 30 S NDC CODE:68462057330 FDA P RODUCT CODE NO.:61 W C A 59 H . T. S NO.: 3004.90.92.10 AND A NO.:203503 THERAPEUTICE USE : -USED TO TREAT FUNGAL INFEC TIONS FENOFIBRATE CAPSULES 67 MG 100 S NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 205566 THERAPEUT ICE USE: - INDICATED AS ADJUNC TIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DUL T PATIENTS WITH PRMARY HYPER CHOLESTEROLEMIA OR MIXED DYSLI PIDEMIA AMLODIPINE-OLMESARTAN TABS 5/40MG 30 S NDC CODE:68 462056830 FDA PRODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90.92.20 ANDA NO.: 2078 07 THERAPEUTICE USE: MEDICATI ON USED TO TREAT HIGH BLOOD P RESSURE AND CORONARY ARTERY DI SEASE PIMECROLIMUS CREAM 1% 3 0GM NDC CODE:68462060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOUND-LINE THERAP Y FOR THE SHORT-TERM AND NON- CONTINUOS CHRONIC TRERTMENT O F MILD TO MODERATE ATOPIC DER MATITIS IN NONIMMUNOCOMPROMISE D ADULT AND CHILDREN 2 YEARS OF AGE AMLODIPINE-OLMESARTAN TABS 10/40MG 90 S NDC CODE:68 462056990 FDA PRODUCT CODE NO .: 62 C D A 68 H. T. S NO.: 3 004.90.92.20 ANDA NO.: 207807 THERAPEUTICE USE: MEDICATION USED TO TREAT HIGH BLOOD PRE SSURE AND CORONARY ARTERY DISE ASE COMMERCIAL & CUSTOM INV OICE NO. F22287001811 DT. 14. 02.2022 F22287001813 DT. 14.0 2.2022 F22287001814 DT. 14.02 .2022 F22287001815 DT. 15.02. 2022 SB NO.: 4002236 DT.: 1 5-02-22 SB NO.: 4002233 DT.: 15-02-22 SB NO.: 4002235 DT.: 15-02-22 SB NO.: 4002225 DT. : 15-02-22 NET WT: 3,240.09 KGS GROSS WT: 6,630.27 KGS 02 DATA LOGGERS SET TEMPERA TURE : +20 DEGREES |
HS 201500 |
2022-03-15 |
8 PKG |
1619.81KG |
1X40 REF HC 301 CARTONS PHAR MACEUTICALS AS UNDER NITROGLY CERIN SUBLING TABS 0.3MG 100 S NDC CODE:68462063801 FDA PR ODUCT CODE NO.: 66 S C A 28 H . T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEART FAI LURE,HIGH BLOOD PRESSURE,AND T O TREAT AND PREVENT CHEST PAI N FROM NOT ENOUGH BLOOD FLOW T O THE HEART. NITROGLYCERIN SU BLING TABS 0.4MG 4X25 NDC COD E:68462063945 FDA PRODUCT C ODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:20 6391 THERAPEUTIC USE: MEDICAT ION USED FOR HEART FAILURE,HI GH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE H EART ASPIRIN-ER DIPYRIDAMOLE CAPS 25/200MG 60 NDC CODE:684 62040560 FDA PRODUCT CODE NO. : 60 L D F 05 H. T. S NO.: 30 04.90.9220 ANDA NO.:210318 NET WT: 234.82 KGS GROSS WT: 1,620.23 KGS SB NO.: 40022 31 DT.: 15-02-22 COMMERCIAL & CUSTOM INVOICE NO. F222870 01812 DT. 14.02.2022 08 DAT A LOGGERS SET TEMPERATURE : + 20 DEGREES CONTAINER NO. TL LU1195351 |
HS 847439 |
2022-03-15 |
38 PKG |
7459.91KG |
1X40 REF 38 PALLETS CONSIST OF 3387 CARTONS. PHARMACEU TICALS AS UNDER TOPIRAMATE TA BLETS 50MG 500 S NDC CODE:684 62015305 FDA PRODUCT CODE NO. : 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVU LSANT OMEPRAZOLE DR CAPSULES 40MG 30 S NDC CODE:6846203973 0 FDA PRODUCT CODE NO.: 62KC F10 H. T. S NO.: 3004.90.916 0 ANDA NO.: 91672 THERAPEUTI CE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISE ASE ONDANSETRON ODT 4MG 30 S (3X10) NDC CODE:68462015713 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO.: 3004.90.92 .40 ANDA NO.:-78-152 THERAPE UTICE USE:-ANTI EMETIC FLUCO NAZOLE TABLETS 200MG 30 S NDC CODE:68462010430 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90.92.45 ANDA N O.:-77 - 253 THERAPEUTICE US E:-ANTIFUNGAL RILUZOLE TABLET S 50MG 60 S NDC CODE:68462038 160 FDA PRODUCT CODE NO.: 62 J C A 16 H. T. S NO.: 3004. 90.92.30 ANDA NO.: 91394 THE RAPEUTICE USE: - A-PARKINSONI AN/ HUMAN - RX/SINGLE INGREDI ENT / PROMPT RELEASE TABLETS / RILUZOLE (ANTI-PARKINSONIA N) NET WT: 5,877.55 KGS GR OSS WT: 7459.83 KGS COMMERC IAL & CUSTOM INVOICE NO. F222 52005622 DT. 11.02.2022 S/B NO.: 8185415 DT. 12-FEB-2022 02 DATA LOGGERS SET TEMPER ATURE : +20 DEGREES CONTAINER NO. MNBU3593691 |
HS 614000 |
2022-03-08 |
16 PKG |
2835KG |
1 X 40 PART OF FCL REEFER 16 PALLETS CONSISTING OF 314 CART ONS PHARMACEUTICALS AS UNDER CLOTRIM-BETAMETHASO NE CRM 1.0/.05% 15GM NDC CODE :68462029817 FDA PRODUCT CODE NO.:61 W D J 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.:202894 T HERAPEUTICE USE: - TREATM ENT A VARIETY OF INFLAMED FUNGAL SKIN INFECTIONS CLOTRIM-BETAMETHASON E CRM 1.0/.05% 45GM NDC CODE: 68462029855 FDA PRODUCT C ODE NO.: 61 W D J 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 202894 THERAPEUTICE USE: - TREAT MENT A VARIETY OF INFLAME D FUNGAL SKIN INFECTIONS CLOTRIM-BETAMETHASO NE CRM 1.0/.05% 45GM NDC CODE :68462029855 FDA PRODUCT CODE NO.: 61 W D J 04 H. T. S NO.: 3004.90.92 .45 ANDA NO.: 202894 THERAPEUTICE USE: - TREA TMENT A VARIETY OF INFLAM ED FUNGAL SKIN INFECTIONS 16 DATA LOGG ERS SET TEMPERATURE : + 20 DEGREES COMMERCIAL & CUS TOM INVOICE NO. F22235004575 DT. 03.02.2022 F22235004576 D T. 03.02.2022 TOTAL GR WT .:2835.33KGS TOTAL NT WT:1356 .48KGS SBILL NO. DT. 797 0459 04/02/2022 7970462 04/02/2022 |
HS 684620 |
2022-03-08 |
44 PKG |
11437.98KG |
1 X 40 FCL REEFER CONTAINER 44 PALLETS CONSISTING OF 420 4 CARTONS PHARMACEUTICALS AS UNDER TOPIRAMATE TABLETS 25MG 500 S NDC CODE: 684 62010805 FDA PRODUCT CODE NO .: 61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:0 77627 THERAPEUTICE USE: AN TICONVULSANT TOPIRAMATE TABL ETS 25MG 60 S NDC CODE: 68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO .:- 77-627 THERAPEUTICE US E:-ANTICONVULSANT OXCARBAZEP INE TABLETS 600MG 100 S ND C CODE:68462013901 FDA PRODU CT CODE NO.:-61 M C A 45 H . T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTIC E USE:-ANTI CONVULSANT AGENT OMEPRAZOLE DR CAPSULES 40 MG 30 S NDC CODE:68462039730 FDA PRODUCT CODE NO.: 62K CF10 H. T. S NO.: 3004.90. 9160 ANDA NO.: 91672 THERA PEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REF LUX DISEASE ATOVAQUONE-PROGU ANIL TAB 250/100MG 24S NDC CODE:68462040467 FDA PRODUC T CODE NO.: 62 L D A 44 H. T. S NO.: 3004.90.92.90 A NDA NO.: 91-211 THERAPEUTICE USE: - ANTI MALARIAL NAPR OXEN TABLETS 500MG 500 S N DC CODE: 68462019005 FDA P RODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:-78-250 THERAPE UTICE USE:-ANTI-INFLAMMATORY , ANALGESIC 02 DATA LOGGER S SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUS TOM INVOICE NO. F22252005416 DT. 30.01.2022 F222520055 34 DT. 04.02.2022 F2225200 5537 DT. 04.02.2022 TOT AL NET WT. 9214.16KGS |
HS 614000 |
2022-03-08 |
4 PKG |
979.78KG |
1 X 40 PART OF FCL REEFER CONT AINER 04 PALLETS CONSISTING OF 123 CARTONS PHARMACEUTIC ALS AS UNDER NITROGLYCERIN SU BLING TABS 0.4MG 4X25 NDC COD E:68462063945 FDA PRODUCT COD E NO.: 66 S C A 28 H. T. S N O.: 3004.90.9020 ANDA NO.:20 6391 THERAPEUTIC USE: MEDICA TION USED FOR HEART FAILURE,H IGH BLOOD PRESSURE,AND TO TRE AT AND PREVENT CHEST PAIN FRO M NOT ENOUGH BLOOD FLOW TO T HE HEART 02 DATA LOGGERS SET TEMPERATURE : +20 DEGREES CO MMERCIAL & CUSTOM INVOICE NO. F22287001797 DT. 09.02.2022 TOTAL GR.WT.979.944KGS TOTAL NT WT.:65.535 KGS ALSO NOTIFY GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE NUMA-DR OZ 2 NEUCHATEL 2000 SWITZERL AND SHIPPING MARKS MANUFACTU RE D FOR GLENMARK PHARMACEU TICAL S INC., USA 301, ISLAN D RD MAHWAH SBILL NO.4002033 DT.10/02/2022 MNBU4242963 ML -IN4160238 40 REEF 9 6 4 PACKA GE 979.94 KGS TEMPERATURE: 20 .0 C CUSTOMS SEAL : 3289807 THE PLACE OF ISSUANCE OF THIS DOCUMENT SHALL BE DEEMED TO BE THE MAERSK LINE INDIA PVT LTD OFFICE LOCATED EITHER IN THE SAME STATE OR THE NEAREST STA TE WITH RESPECT TO THE ABOVE REFERENCED CARGO PICK-UP / DRO P-OFF LOCATION GOODS SHIPPED IN REFRIGERATED CONTAINER(S) S ET AT SHIPPER S REQUESTED CARR IAGE TEMPERATURE AS PER ABOVE SHIPPER S LOAD, STOW, WEIGHT AND COUNT FREIGHT PREPAID |
HS 170240 |
2022-03-08 |
48 PKG |
13155.31KG |
1 X 40 FCL REEFER CONTAINER 48 PALLETS CONSISTING 2252 C ARTONS PHARMACEUTICALS AS UNDER GABAPENTIN TABLETS 6 00MG 500 S NDC CODE: 68462 012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTI CONVULSANT AGENT TOPIRAMAT E TABLETS 25MG 60 S NDC CO DE: 68462010860 FDA PRODUC T CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 A NDA NO.:- 77-627 THERAPEUTIC E USE:-ANTICONVULSANT VERA PAMIL HCL ER TABS 120MG 100S NDC CODE: 68462029201 F DA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.9 0.92.20 ANDA NO.: 90-700 T HERAPEUTICE USE: - ANGINA MUPIROCIN CREAM 2% 30GM ND C CODE: 68462056435 FDA PR ODUCT CODE NO.: 61GCJ82 H. T. S NO.: 3004.90.92.45 A NDA NO.: 201587 THERAPEUTICE USE: - TOPICAL ANTI-BACTERI AL MUPIROCIN OINTMENT 2% 2 2GM NDC CODE:68462018022 F DA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 90-480 THE RAPEUTICE USE: - ANTI-BACTER IAL 02 DATA LOGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INV OICE NO. F22252005560 DT. 07.02.2022 F22252005561 DT . 07.02.2022 F22252005562 DT. 07.02.2022 TOTAL NET WT.: 11337.40KGS |
HS 616900 |
2022-03-08 |
49 PKG |
13478.27KG |
1 X 40 FCL REEFER 49 PACKAGE CONSISTING OF 3295 CARTONS PH ARMACEUTICALS AS UNDER NAPROX EN TABLETS 500MG 100 S NDC CO DE:68462019001 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC N APROXEN TABLETS 500MG 500 S N DC CODE:68462019005 FDA PRODU CT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE US E:-ANTI-INFLAMMATORY, ANALGES IC CARVEDILOL TABS 6.25MG 500 S NDC CODE:68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST TOPIRAMATE TABLET S 25MG 60 S NDC CODE:68462010 860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004. 49.00.20 ANDA NO.:- 77-627 T HERAPEUTICE USE:-ANTICONVULSA NT GABAPENTIN TABLETS 600MG 5 00 S NDC CODE:68462012605 FD A PRODUCT CODE NO: 61 N C A 6 9 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTI CE USE:-ANTICONVULSANT AGENT OMEPRAZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 A NDA NO.:91672 THERAPEUTICE US E: - TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE 03 DATA LOGGERS COMMERCIAL & CUSTOM INVOICE NO. F222520055 51 DT. 05.02.2022 F2225200555 2 DT. 05.02.2022 F22252005553 DT. 05.02.2022 TOTAL NET.WT. :11610.44KGS SBILL NOS DT. 8053058 07-FEB-2022 80532 61 07-FEB-2022 8053408 07- FEB-2022 |
HS 624900 |
2022-03-08 |
45 PKG |
12738KG |
1 X 40 FCL REEFER CONTAINER 45 PALLETS CONSISTING OF 282 1 CARTONS PHARMACEUTICALS AS UNDER ESTRADIOL VAG INSERTS USP 10MCG 8 S NDC CODE: 68 462071171 FDA PRODUCT CODE NO .: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:21026 4 THERAPEUTICE USE:THE TREAT MENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. GABAPENTIN TA BLETS 600MG 500 S NDC CODE: 68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT NAPROXEN TAB LETS 500MG 500 S NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC 02 D ATA LOGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & C USTOM INVOICE NO. F2225200556 6 DT. 07.02.2022 F2225200556 7 DT. 07.02.2022 F2225200556 8 DT. 07.02.2022 TOTAL NET.W T. 11031.92KGS SBILL NO 808 1445 DT 08-FEB-2022 8081704 D T 08-FEB-2022 8081645 DT 08-F EB-2022 |
HS 642800 |
2022-03-08 |
26 PKG |
5755.73KG |
1 X 40 PART OF FCL REEFER 26 PALLETS CONSISTING 2583 C ARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TABLETS 10MG 90 S NDC CODE: 68462 026290 FDA PRODUCT CODE NO .:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079 172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISE ASE AZELAIC ACID GEL 15% 5 0GM NDC CODE: 68462062652 FDA PRODUCT CODE NO.: 62 S C J 03 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 204637 INDICATED FOR TOPICAL TREATM ENT OF THE INFLAMMATORY PAPU LES AND PUSTULES OF MILD TO MODERATE ROSACEA 26 DATA L OGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F222520 05540 DT. 05.02.2022 F2225 2005538 DT. 04.02.2022 SBILL NO. DT. 8023741 06- FEB-2022 8023564 06-FEB-20 22 TOTAL NET WT.4483.56KGS GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE NUMA- DROZ 2 NEUCHATEL - 2000 SWITZERLAND |
HS 611600 |
2022-03-08 |
19 PKG |
4880.28KG |
1 X 40 PART OF FCL REEFER 19 PALLETS CONSISTING OF1600 C ARTONS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500 MG 500 S NDC CODE: 6846201 9005 FDA PRODUCT CODE NO.: -62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC OM EPRAZOLE DR CAPSULES 40MG 30 S NDC CODE:68462039730 FD A PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTI CE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX D ISEASE MUPIROCIN CREAM 2% 15GM NDC CODE: 68462056417 FDA PRODUCT CODE NO.: 61G CJ82 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 201587 THE RAPEUTICE USE: - TOPICAL ANT I-BACTERIAL MUPIROCIN CREAM 2% 30GM NDC CODE: 684620 56435 FDA PRODUCT CODE NO. : 61GCJ82 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 20158 7 THERAPEUTICE USE: - TOPI CAL ANTI-BACTERIAL 02 DATA L OGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2225200 5541 DT. 05.02.2022 F2225200 5539 DT. 04.02.2022 TOTAL NE T WT.:3982.30KGS SBILL NO DT. 8023698 06-F EB-2022 8023636 06-FEB- 2022 NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
HS 624900 |
2022-03-08 |
8 PKG |
1535.89KG |
1 X 40 PART OF FCL REEFER 8 PACKAGES CONSISTING OF 168 CARTONS PHARMACEUTICALS A S UNDER EZETIMIBE-SIMVASTATI N TAB 10/40MG 30 S NDC COD E:68462032330 FDA PRODUCT CO DE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE : - THIS COMBINATION MEDICAT ION IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SU CH AS LDL, TRIGLYCERIDES) AN D RAISE GOOD CHOLESTEROL (HD L) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUN T OF CHOLESTEROL YOUR BODY A BSORBS FROM YOUR DIET. SIMVA STATIN BELONGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY REDUCING THE AM OUNT OF CHOLESTEROL MADE BY THE LIVER. 02 DATA LOGGERS SET TEMPERATURE : +20 DEGRE ES COMMERCIAL & CUSTOM INV OICE NO. F22287001796 DT. 09.02.2022 TOTAL NET WT.: 266.063KGS SBILL NO. DT. 4002032 10/02/2022 |
HS 210690 |
2022-03-08 |
18 PKG |
2919.82KG |
1 X 40 PART OF FCL REEFER 18 PACKAGES CONSISTING OF 37 3 CARTONS PHARMACEUTICALS AS UNDER DESOXIMETASONE OI NTMENT 0.25% 15GM NDC CODE:6 8462053117 FDA PRODUCT CODE NO.: 62 G C J 17 H. T. S N O.: 3004.39.0050 ANDA NO.: 202838 THERAPEUTICE USE: FOR THE RELIEF OF VARIOUS INF LAMMATORY SKIN CONDITIONS, I NCLUDING RASHES FLUOCINOLO NE ACE EAR DROPS 0.01% 20ML NDC CODE:68462018556 FDA P RODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 211815 FOR THE TREATMENT OF CHRONIC ECZEMA TOUS EXTERNAL OTITIS MOMET ASONE FUROATE OINTMENT 0.1% 45GM NDC CODE:68462022555 FDA PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40 .49.50 ANDA NO.:78-571 THE RAPEUTICE USE: ANTI-INFLAMMA TORY- DERMATOLOGIC 18 DATA LOGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22235004 597 DT. 05.02.2022 SBIL L NO. DT. 8037245 07/02/ 2022 -GST NO. : 02AAACG22 07L2Z3 TOTAL NET WT.:1359.36 0KGS |
HS 621700 |
2022-03-08 |
8 PKG |
1607.56KG |
1 X 40 PART OF FCL REEFER 8 PALLETS CONSISTING OF 718 CARTONS PHARMACEUTICALS AS UNDER PRAVASTATIN SODIUM TAB 10MG 500 S NDC CODE:6846 2019505 FDA PRODUCT CODE N O.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-7 7-987 THERAPEUTICE USE:-HY POLIPDAEMIC PRAVASTATIN SODI UM TAB 10MG 90 S NDC CODE: 68462019590 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO .:-77-987 THERAPEUTICE USE :-HYPOLIPDAEMIC 02 DATA LOGG ERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22287001795 DT. 09/02/2022 TOTAL NET WT.:501 .143KGS SBILL NO. DT. 40 02029 10/02/2022 |
HS 611300 |
2022-03-08 |
32 PKG |
5973KG |
1 X 40 PART OF FCL REEFER 32 PACKAGES CONSISTING OF 66 0 CARTONS PHARMACEUTICALS AS UNDER CLOTRIM-BETAMETHASO NE CRM 1.0/.05% 45GM NDC C ODE: 68462029855 FDA PRODU CT CODE NO.: 61 W D J 04 H . T. S NO.: 3004.90.92.45 ANDA NO.: 202894 THERAPEUTIC E USE: - TREATMENT A VARIETY OF INFLAMED FUNGAL SKIN INF ECTIONS CLOTRIM-BETAMETHASONE CRM 1.0/.05% 15GM NDC CODE: 68462029817 FDA PRODUCT CO DE NO.:61 W D J 04 H. T. S NO.: 3004.90.92.45 ANDA N O.:202894 THERAPEUTICE USE: - TREATMENT A VARIETY OF I NFLAMED FUNGAL SKIN INFECTIO NS CLOTRIM-BETAMETHASONE C RM 1.0/.05% 45GM NDC CODE: 68462029855 FDA PRODUCT COD E NO.: 61 W D J 04 H. T. S NO.: 3004.90.92.45 ANDA N O.: 202894 THERAPEUTICE USE: - TREATMENT A VARIETY OF INFLAMED FUNGAL SKIN INFECTI ONS 32 DATA LOGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22235004473 DT. 31.01.2 022 F22235004573 DT. 03.02.2 022 TOTAL NET WT.:2851.20 KGS SBILL NO. DT. 7908842 01/02/2022 79704 66 04/02/2022 NOTIFY PA RTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NU MA-DROZ 2 NEUCHATEL - 2000 S WITZERLAND |
HS 610400 |
2022-03-01 |
19 PKG |
6067.35KG |
1 CONTAINER 19 PALLETS 19 P ALLETS CONSISTING OF 947 CARTO NS 1X40 PART OF FCL REEFER PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500MG 100 S NDC CODE:6846201900 1 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S N O.: 3004.90.92.40 AN DA NO.:-78-250 THERAPEUTI CE USE:-ANTI-INFLAMMATORY , ANALGESIC NA PROXEN TABLETS 500MG 500 S NDC CODE:68462019005 FD A PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE U SE:-ANTI-INFLAMMATORY, AN ALGESIC PRAMIPEXOLE TABS 1MG 90 S NDC CODE:6 8462033390 FDA PRODUCT CO DE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 T HERAPEUTICE USE: USED IN PARKINSON#S DISEASE GABAPENTIN TABLETS 800MG 500 S NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT A GENT 01 DATA LOGGERS SET TEMPERATUR E : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F222520053 54 DT. 28.01.2022 F2225200535 6 DT. 28.01.2022 SBILL NOS DT. 7836397 29-JAN-20 22 7835871 29-JAN-2022 T OTAL GR.WT.: 6,067.50 KGS TOT AL NT.WT: 5,359.75 KGS |
HS 624900 |
2022-03-01 |
47 PKG |
10979.39KG |
1 X 40 FCL REEFER 47 PALLET S CONSISTING OF 2091 CARTONS PHARMACEUTICALS AS UNDER CALCIPOTRIENE OINTMENT 0 .005% 60GM NDC CODE: 68462 031065 FDA PRODUCT CODE NO .: 62 N C J 04 H. T. S NO. : 3004.90.92.45 ANDA NO.: 209297 THIS MEDICATION IS US ED TO TREAT PSORIASIS. CAL CIPOTRIENE IS A FORM OF VITA MIN D. IT WORKS BY SLOWING D OWN THE GROWTH OF SKIN CELLS . CALCIPOTRIENE OINTMENT 0 .005% 120GM NDC CODE:6846203 1066 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 2092 97 THIS MEDICATION IS USED TO TREAT PSORIASIS. CALCIPO TRIENE IS A FORM OF VITAMIN D. IT WORKS BY SLOWING DOWN THE GROWTH OF SKIN CELLS. LIDOCAINE OINTMENT JAR 5% 50GM NDC CODE: 68462041827 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004. 49.00.50 ANDA NO.:206498 T HERAPEUTICE USE: -USED TO TE MPORARILY RELIEVE PAIN AND I TCHING ASSOCIATED WITH SKIN OMEPRAZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF 10 H. T. S NO.: 3004.90.91 60 ANDA NO.:91672 THERAPEU TICE USE: - TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX DISEASE FELODIPINE ER TA BS 10MG 100 S NDC CODE:68462 023501 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 30 04.90.92.20 ANDA NO.: 90-365 THERAPEUTICE USE: - TREAT MENT OF HYPERTENSION CO LESEVELAM ORAL SUSP 3.75GM 30 S NDC CODE:68462062030 FDA PRODUCT CODE NO.: 62 B C L 13 H. T. S NO.: 3004.49.00 .10 ANDA NO.: 202190 THERA PEUTICE USE : - COLESEVELAM IS A LIPID (LOW DENSITY LIPO PROTIN CHOLESTEROL) REDUCING DRUG THAT IS USEFUL FOR R EDUCING CHOLESTEROL. CLIN DAMYCIN PHOSPHATE GEL 1% 30GM NDC CODE:68462086635 FDA PRO DUCT CODE NO.: 56 J D J 31 H . T. S NO.: 3004.49.00.50 AN DA NO.:214251 THERAPEUTICE US E: CLINDAMYCIN PHOSPHATE GEL IS INDICATED IN THE TREATMEN T OF ACNE VULGARIS GABAPEN TIN TABLETS 600MG 500 S NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT 02 DATA LOGGERS SET TEMPERATURE : +2 0 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22252005457 DT. 31.01.2022 F22252005458 DT. 31.01.2022 F22252005460 DT. 3 1.01.2022 F22252005476 DT. 31 .01.2022 F22252005494 DT. 31. 01.2022 TOTAL NET WT.:9380. 82KGS SBILL NO. DT. 79 39078 02-FEB-2022 7939097 02-FEB-20 22 7939133 02-FEB -2022 7939144 02- FEB-2022 7939282 02-FEB-2022 |
HS 620400 |
2022-03-01 |
42 PKG |
8737.24KG |
1 CONTAINER SAID TO CONTAIN 42 PACKAGE 1X40 PART OF FCL REE FER 42 PALLETS CONSISTING OF 1761 CARTONS IN DESCRIPTION NOW READ AS SBILL NOS DT. 4001698 03/02/2022 4001686 0 3/02/2022 4001694 03/02/2022 4001695 03/02/2022 4001687 0 3/02/2022 4001688 03/02/2022 4001689 03/02/2022 4001693 0 3/02/20 SBILL NOS DT. 40 01698 03/02/2022 4001686 03/0 2/2022 4001694 03/02/2022 40 01695 03/02/2022 4001687 03/0 2/2022 4001688 03/02/2022 40 01689 03/02/2022 4001692 03/0 2/2022 4001690 03/02/2022 40 01693 03/02/2022 NET WT : 5,6 93.11 KGS |
HS 870323 |
2022-03-01 |
23 PKG |
3547.15KG |
1 X 40 PART OF FCL REEFER 23 PACKAGES CONSISTING OF 1084 C ARTONS PHARMACEUTICALS AS U NDER NORETHINDRONE 0.35MG 84 NDC CODE: 68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.6 0.00.00 ANDA NO.:91-209 TH ERAPEUTICE USE: PREVENTION O F PREGNANCY. DROSPIRENONE/EE 3.0/0.02MG 84 NDC CODE: 68462072029 FDA PRODUCT COD E NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA N O.: 204296 THERAPEUTICE US E: - ORAL CONTRACEPTIVE 01 DATA LOGGERS SET TEMP ERATURE : +20 DEGREES SB ILL NO. DT. 7835434 29-JA N-2022 COMMERCIAL & CUSTOM IN VOICE NO. F22252005352 DT. 2 8.01.2022 TOTAL NET.WT: 2 569.90KGS |
HS 652600 |
2022-03-01 |
44 PKG |
12092.52KG |
1 X 40 FCL REEFER 44 PALLET S CONSISTING OF2477 CARTONS PHARMACEUTICALS AS UNDER LIDOCAINE OINTMENT TUBE 5% 35.44GM NDC CODE:68462041820 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004. 49.00.50 ANDA NO.:206498 T HERAPEUTICE USE: -USED TO TE MPORARILY RELIEVE PAIN AND I TCHING ASSOCIATED WITH SKIN OMEPRAZOLE DR CAPSULES 40M G 90 S NDC CODE:68462039790 FDA PRODUCT CODE NO.: 62KC F10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAP EUTICE USE: - TREATMENT OF T REAT GASTROESOPHAGEAL REFLUX DISEASE VERAPAMIL HCL E R TABS 240MG 500 S NDC CODE: 68462026005 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO .:-78-906 THERAPEUTICE USE :-ANGINA TOPIRAMATE TABLET S 50MG 1000 S NDC CODE:68462 015310 FDA PRODUCT CODE NO .:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 7 7-627 THERAPEUTICE USE:-AN TICONVULSANT ROPINIROLE TABS 0.25MG 100 S NDC CODE:684 62025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:- TREATMENT OF PARKINSONISM GABAPENTIN TABLETS 800MG 500 S NDC CODE: 68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULS ANT AGENT NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES CUS TOM INVOICE NO.& F22252005384 DT. 29.01.2022 F22252005388 DT. 29.01.2022 F22252005397 DT. 29.01.2022 F22252005376 DT. 29.01.2022 F22252005392 DT. 29.01.2022 TOTAL NET W T.:10695.27KGS SB NO & DATE ON BL 7911492 01-FEB-2022 7911445 01-FEB-2022 7911424 01-FEB-2022 7911407 01-FEB -2022 7910960 01-FEB-2022 |
HS 600700 |
2022-03-01 |
46 PKG |
9665.76KG |
1 X40 FCL REEFER 46 PACKAGES CONSISTING OF 2140 CARTONS PH ARMACEUTICALS AS UNDER OM EPRAZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FD A PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DIS EASE TOPIRAMATE TABLETS 2 5MG 500 S NDC CODE:684620108 05 FDA PRODUCT CODE NO.: 6 1 M C A 40 H. T. S NO.: 30 04.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONV ULSANT TOPIRAMATE TABLETS 100MG 500 S NDC CODE:684620 10905 VERAPAMIL HCL ER TA BS 120MG 100S NDC CODE:68462 029201 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90 -700 THERAPEUTICE USE: - A NGINA OMEPRAZOLE DR CAPSU LES 40MG 1000 S NDC CODE:684 62039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3 004.90.9160 ANDA NO.:91672 THERAPEUTICE USE: - TREATME NT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE OMEPRAZ OLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PRO DUCT CODE NO.:62KCF10 H. T . S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE ZOLMITRIPTAN TABLETS 2.5M G 6 S NDC CODE:68462049776 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.9 0.92.28 ANDA NO.: 201779 T HERAPEUTICE USE: - ANALGESIC / HUMAN - RX/SINGLE INGREDIE NT / PROMPT RELEASE TABLET S / ZOLMITRIPTAN (ANALGESIC) MUPIROCIN OINTMENT 2% 22 GM NDC CODE:68462018022 FD A PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 90-480 THER APEUTICE USE: - ANTI-BACTERI AL 02 DATA LOGGERS H UMIDITY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES COMMERCIAL & CUSTOM INVOI CE NO. F22252005445 DT. 31.01 .2022 F22252005450 DT. 31.01. 2022 F22252005484 DT. 31.01.2 022 F22252005387 DT. 29.01.20 22 TOTAL GR.WT.:9665.68KGS T OTAL NT.WT.:8136.05KGS SBIL L NOS DT. 7939189 02-FEB -2022 7939209 02-FEB-2022 7 939264 02-FEB-2022 7939272 02-FEB-2022 |
HS 621000 |
2022-03-01 |
40 PKG |
5855.98KG |
1 X 40 FCL REEFER 40 PAL LETS CONSISTING OF 1866 CA RTONS PHARMACEUTICALS AS U NDER NORETHINDRONE ACETATE TABS 5MG 50 NDC CODE:684620 30450 FDA PRODUCT CODE NO. 65 J C A 25 H. T. S NO.: 3 004.39.00.50 ANDA NO.:-91-09 0 THERAPEUTICE USE:- SECON DARY AMENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BL EEDING DROSPIRENONE/EE 3.0/0.02MG 84 NDC CODE: 68 462072029 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO .: 204296 THERAPEUTICE USE: - ORAL CONTRACEPTIVE DROSPIRENONE/EE 3.0/0.02MG 8 4 NDC CODE: 68462072029 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60 .00.00 ANDA NO.: 204296 TH ERAPEUTICE USE: - ORAL CON TRACEPTIVE 02 DATA LOGGERS SET TEMPERATURE : +20 DEG REES COMMERCIAL & CUS TOM INVOICE NO. F22252005424 DT. 31.01.2022 F222520054 38 DT. 31.01.2022 TOTAL NE T WT:4233.02KGS SB NO & DAT E ON BL 7911538 DT 01-FEB-20 22 7912686 DT 02-FEB-2022 |
HS 652500 |
2022-03-01 |
41 PKG |
6916.04KG |
1 X 40 FCL REEFER PHARMACEUTI CALS 41 PALLETS CONSISTING OF 2446 CARTONS AS UNDER ES TRADIOL VAG INSERTS USP 10 MCG 8 S NDC CODE: 68462071 171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:2102 64 THERAPEUTICE USE:THE TR EATMENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. DESMOPR ESSIN ACETATE TABLETS 0.2M G 100S NDC CODE:68462027601 FDA PRODUCT CODE NO.: 61QC A03 H. T. S NO.: 2937.19.0 000 ANDA NO.:201831 THERAP EUTICE USE: - MANAGEMENT OF CENTRAL DIABETES INSIPIDUS A ND TEMPORARY POLYURIA AND POLYDIPSIA DROSPIRENONE/EE 3.0/0.03MG 84 NDC CODE: 6 8462073329 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S N O.: 3006.60.00.00 ANDA NO. : 204848 THERAPEUTICE USE: - CONTRACEPTION TO PREVENT PREGNANCY 03 DATA LOGGERS SET TEMPERATURE : +20 DEGR EES COMMERCIAL & CUSTOM INVOICE NO. F22252005475 D T. 31.01.2022 F22252005489 DT. 31.01.2022 F22252005495 DT. 31.01.2022 TOTAL NET WT. :5174.25KGS SBILL NOS. DT. 7934626 DT 02-F EB-2022 7934341 DT 02-FEB-202 2 |
HS 642800 |
2022-03-01 |
7 PKG |
1284.6KG |
1 X 40 PART OF FCL REEFER 07 PALLETS CONSISTING OF 197 C ARTONS PHARMACEUTICALS AS UN DER NITROGLYCERIN SUBLING TABS 0.6MG 100 S NDC CODE:68 462064001 FDA PRODUCT CODE N O.: 66 S C A 28 H. T. S NO .: 3004.90.9020 ANDA NO.:2 06391 THERAPEUTIC USE: MED ICATION USED FOR HEART FAILU RE,HIGH BLOOD PRESSURE,AND T O TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLO W TO THE HEART NITROGLYCER IN SUBLING TABS 0.4MG 100 S NDC CODE:68462063901 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEU TICE USE: MEDICATION USED FO R HEART FAILURE, HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTE NOUGH BLOOD FLOW TO THE HEAR T NITROGLYCERIN SUBLING TA BS 0.4MG 4X25 NDC CODE:68462 063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:2063 91 THERAPEUTIC USE: MEDICA TION USED FOR HEART FAILURE, HIGH BLOOD PRESSURE,AND TO T REAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW T O THE HEART 07 DATA LOGGER S COMMERCIAL & CUSTOM INVOICE NO. F22287001739 DT. 31.01.2022 F22287001740 DT. 31.01.2022 F22287001757 DT. 31.01.2022 SBILL NO. DT. 4001696 03. 02.2022 4001685 03.02.2 022 4001684 03.02.2022 TOTAL NET WT. 104.02KG S |
HS 662800 |
2021-12-13 |
16 PKG |
3094.46KG |
1X 40 PART OF FCL REEFER 16 PALLETS CONSISTING OF324 CARTO NS PHARMACEUTICALS AS UNDER CLOBETASOL PROP SOLUTION 0.0 5% 50ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004 .90.92.45 ANDA NO.: 210190 16 DATA LOGGERS SET TEMPERA TURE : +20 DEGREES TEMPERATU RE RANGE : +15 DEGREES TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22235003089 DT. 12.11.2021 SBILL NO. DT. TOTAL GR.WT.:3094.46KGS TOTAL NT. WT.:1555.20KGS |
HS 646700 |
2021-12-13 |
5 PKG |
1313.63KG |
1X 40 PART OF FCL REEFER 5 P ALLETS CONSISTING OF 615 CARTO NS PHARMACEUTICALS AS UNDER TACROLIMUS CAPSULES 1MG 100 S NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 PIMECROLIMUS CREAM 1% 30 GM NDC CODE:68462060935 FD A PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 211769 02 D ATA LOGGERS SET TEMPERATURE : +20 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES COMMERCIAL & CUSTOM INVOI CE NO. F22287001322 DT. 16.1 1.2021 F22287001323 DT. 16.1 1.2021 SBILL NO. DT. TOTAL GR.WT.:1313.95 KGS TOTAL NT.WT:534.04KGS |
HS 300490 |
2021-12-13 |
2 PKG |
470.84KG |
1X 40 PART OF FCL REEFER 2 P ALLETS CONSISTING OF 59 CARTON S PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TABS 0. 4MG 4X25 NDC CODE:6846206394 5 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 300 4.90.9020 ANDA NO.:206391 01 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES TEMPERA TURE RANGE : +15 DEGREES TO +25 DEGREES COMMERCIAL & CUS TOM INVOICE NO. F22287001324 DT. 16.11.2021 SBILL NO. DT. TOTAL GR.WT.:471. 11KGS TOTAL NT.WT.:31.44KGS |
HS 662800 |
2021-12-13 |
19 PKG |
5243.62KG |
1X40 PART OF FCL REEFER 19 PA LLETS CONSISTING OF 1606 CARTO NS PHARMACEUTICALS AS UNDER ATOMOXETINE CAPSULES 10MG 30 S NDC CODE:68462026530 FD A PRODUCT CODE NO.: 64 UC A 99 H. T. S NO.: 30 04.90.92.90 ANDA NO.: 079 019 OLMESARTAN MEDO XOMIL TABLETS 40MG 90 S N DC CODE:68462043890 FDA P RODUCT CODE NO.: 62 CCA 6 8 H. T. S NO.: 3004. 90.9220 ANDA NO.: 203281 ATOMOXETINE CAPSULE S 18MG 30 S NDC CODE:6846 2026630 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.: 3004.90.92.90 ANDA NO.: 079019 ATOMOXETINE CAPSULES 80MG 30 S NDC CODE:68462027030 FDA PRODUCT CODE NO.: 6 4 UCA 99 H. T. S NO. :3004.90.92.90 ANDA NO.: 079019 ROPINIROLE T ABS 5MG 100 S NDC CODE:68 462025901 FDA PRODUCT COD E NO.:62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 CICLOPIROX OLAMINE CREAM 0 .77% 30GM NDC CODE:684620 29735 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 ANDA NO.:- 90 - 273 06 DATA LOGGERS SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES COM MERCIAL & CUSTOM INVOICE NO. F22252004214 DT. 17.11.2021 F 22252004229 DT. 18.11.2021 F2 2252004230 DT. 18.11.2021 SBI LL NO.6089553 DT: 18.11.2021 / 6107083 / 6107085 DT:19.11.20 21 TOTAL GR.WT.:5243.56KGS TOTAL NT.WT.:4225.97KGS |
HS 649900 |
2021-12-07 |
10 PKG |
1796.71KG |
1 X 40 PART OF FCL REEFER CONT AINER 10 PALLETS CONSISTING OF 199 CARTONS PHARMACEUTICA LS AS UNDER FLUOCINONIDE CREAM 0.1% 120GM NDC CODE:68 462050566 FDA PRODUCT CODE N O.: 64 L C L 28 H. T. S NO .: 3004.32.00.00 ANDA NO.: 91-282 THERAPEUTICE USE: - INDICATED FOR THE RELIEF OF VARIOUS INFLAMMATORY AND P RURITIC MANIFESTATIONS OF CO RTICOSTEROID RESPONSIVE DERM ATOSES IN PATIENTS. FLUOCI NONIDE CREAM 0.1% 60GM NDC C ODE:68462050565 FDA PRODUCT CODE NO.: 64 L C L 28 H. T . S NO.: 3004.32.00.00 AND A NO.: 91-282 THERAPEUTICE U SE: - INDICATED FOR THE RELI EF OF VARIOUS INFLAMMATORY A ND PRURITIC MANIFESTATIONS O F CORTICOSTEROID RESPONSIVE DERMATOSES IN PATIENTS. CLOBETASOL PROP SOLUTION 0. 05% 50ML NDC CODE:6846205325 3 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 300 4.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOC ORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTERILE LIQ UID / CLOBETASOL PROPIONATE (GLUCOCORTICOID) HYDROC ORTISONE VAL OINTMENT 0.2% 15G M NDC CODE:68462083617 FDA PRODUCT CODE NO.: 64 L C L 71 H. T. S NO.: 3004.49.00 .50 ANDA NO.: 211750 THERA PEUTICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMMAT ORY AND PRURITIC MANIFESTATI ONS OF CORTICOSTEROID RESPON SIVE DERMATOSES IN ADULT P ATIENTS 07 DATA LOGGERS SE T TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F222350 02998 DT. 31.10.2021 F222350 03000 DT. 31.10.2021 F222350 03004 DT. 31.10.2021 TOTAL G R.WT.:1796.71KGS TOTAL NT.WT .:922.56 KGS SBILL NO. DT. 5825919 05-11 -21 5825940 05-11-21 5 797455 03-11-21 NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA |
HS 642800 |
2021-12-07 |
6 PKG |
1312.26KG |
1 X 40 PART OF REEFER FCL 6 P ALLETS CONSISTING OF 654 CARTO NS PHARMACEUTICALS AS UNDER PIMECROLIMUS CREAM 1% 30G M NDC CODE:68462060935 FDA P RODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOUND-LINE THERA PY FOR THE SHORT-TERM AND NO N-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMUNOCOMPRO MISED ADULT AND CHILDREN 2 Y EARS OF AGE TACROLIMUS CAPS ULES 1MG 100 S NDC CODE:68462 068601 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE : T O PREVENT REJECTION OF A KID NEY,HEART, OR LIVER TRANSPLAN T TACROLIMUS OINTMENT 0.03% 3 0GM NDC CODE:68462088135 03 DATA LOGGERS SET TEMPERAT URE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DE GREES COMMERCIAL & CUSTOM INV OICE NO. F22287001303 DT. 10. 11.2021 SBILL NO. DT. 4017938 11.11.2021 TOTAL GR.WT.:1312.50 KGS TOTA L NT.WT.:598.31 KGS |
HS 300490 |
2021-12-07 |
3 PKG |
659.99KG |
1 X 40 PART OF FCL REEFER CONT AINER 3 PALLETS CONSISTING O F 152 CARTONS PHARMACEUTICAL S AS UNDER ROSUVASTATIN TABL ETS 10MG 1000 S NDC CODE:684 62026210 61 J C A 16 3004. 49.00.10 79172 TO TREAT HI GH CHOLESTEROL AND RELATED C ONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE RO SUVASTATIN TABLETS 20MG 1000 S NDC CODE:68462026310 FDA PRODUCT CODE NO.: 61 J C A 1 6 H. T. S NO.: 3004.49.00. 10 ANDA NO.: 79172 THERAPE UTICE USE: TO TREAT HIGH CHO LESTEROL AND RELATED CONDITI ONS, AND TO PREVENT CARDIOVA SCULAR DISEASE 03 DATA LOG GERS SET TEMPERATURE : +20 D EGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES CO MMERCIAL & CUSTOM INVOICE NO. F22252004066 DT. 03.11.2021 SBILL NO. DT. 5 828594 05/11/2021 TOTAL G R.WT:660.20KGS TOTAL NT.WT:5 58.76KGS |
HS 611600 |
2021-12-07 |
24 PKG |
3827.93KG |
1 X 40 PART OF FCL REEFER CONT AINER 24 PALLETS CONSISTING OF 695 CARTONS PHARMACEUTICA LS AS UNDER ESTRADIOL VAG IN SERTS USP 10MCG 18 S NDC COD E:68462071188 NDC NO.:684620 71188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:2102 64 THERAPEUTICE USE:THE TR EATMENT OF ATROPIC VAGINITIS DUE T ESTRADIOL VAG INSE RTS USP 10MCG 18 S NDC CODE: 68462071188 NDC NO.:68462071 188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3 006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE:THE TREA TMENT OF ATROPIC VAGINITIS D UE TO MENOPAUSE. LIDOCA INE OINTMENT JAR 5% 50GM NDC CODE:68462041827 FDA PRODUC T CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 AN DA NO.:206498 THERAPEUTICE U SE: -USED TO TEMPORARILY REL IEVE PAIN AND ITCHING ASSO CIATED WITH SKIN 05 DAT A LOGGERS SET TEMPERATURE : +20 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22252004069 DT. 03.11.2 021 F22252004070 DT. 03.11.2 021 F22252004074 DT. 03.11.2 021 SBILL NOS DT. 5827009 0 5-NOV-21 5827010 05-NOV-21 5 828596 05-NOV-21 TOTAL G R.WT.:3828.18 KGS TOTAL NT.W T:3058.16 KGS |
HS 642800 |
2021-11-17 |
48 PKG |
12055.33KG |
1X40 REEFER FCL CONTAINER 48 PALLETS CONSISTING OF 3532 CAR TONS PHARMACEUTICALS AS UNDER TELMISARTAN TABLETS 40MG 30 S NDC CODE:68462020030 FDA P RODUCT CODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.:090032 THERAPEUTICE USE: INDICATED FOR THE TREAT MENT OF HYPERTENSION, TO LOWE R BLOOD PRESSURE OMEPRAZOLE DR CAPSULES 40MG 30 S NDC COD E:68462039730 FDA PRODUCT COD E NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATME NT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE PRAMIPEXOLE T ABS 0.125MG 90 S NDC CODE:684 62033090 FDA PRODUCT CODE NO. : 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-78 1 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE CALCIPOTR IENE OINTMENT 0.005% 60GM NDC CODE:68462031065 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA N O.: 209297 THIS MEDICATION IS USED TO TREAT PSORIASIS. CA LCIPOTRIENE IS A FORM OF VITA MIN D. IT WORKS BY SLOWING DO WN THE GROWTH OF SKIN CELLS. CLOTRIMAZOLE CREAM 1% 30GM N DC CODE:68462018135 FDA PRODU CT CODE NO :61 W C J 04 H. T . S NO.: 3004.90.92.45 ANDA NO.: 90-219 THERAPEUTICE USE: TREATMENT OF CANDIDIASIS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22252003 759 DT. 20.10.2021 F222520037 60 DT. 20.10.2021 SBILL NO. D T. 5472027 22-OCT-2021 5473 740 22-OCT-2021 TOTAL GR.WT. : 12055.14KGS TOTAL NT.WT: 95 10.15KGS FREIGHT PREPAID |
HS 620900 |
2021-11-17 |
40 PKG |
8072.27KG |
1 X 40 REEFER FCL CONTAINER 4 0 PALLETS CONSISTING OF 2421 C ARTONS PHARMACEUTICALS AS UND ER GABAPENTIN TABLETS 800MG 5 00 S NDC CODE:68462012705 FD A PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.3 0 ANDA NO. -77-662 THERAPEUT ICE USE:-ANTICONVULSANT AGEN T ESTRADIOL VAG INSERTS USP 1 0MCG 8 S NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60. 00.00 ANDA NO.:210264 THERAP EUTICE USE:THE TREATMENT OF A TROPIC VAGINITIS DUE TO MENO PAUSE. ALYACEN 1/35 NORETH/EE 1/0.035MG 84 NDC CODE:684620 39429 FDA PRODUCT CODE NO.: 65 J D A 24 H. T. S NO.: 300 6.60.00.00 ANDA NO.: 091634 THERAPEUTICE USE: ORALCONTRAC EPTIVE 02 DATA LOGGERS SET T EMPERATURE PLUS 20 DEGREES TE MPERATURE RANGE PLUS 15 DEGREE S TO PLUS 25 DEGREES COMMERCI AL & CUSTOM INVOICE NO. F2225 2003762 DT. 21.10.2021 F22252 003771 DT. 21.10.2021 TOTAL G R.WT.: 8072.46KGS TOTAL NT.WT .:6400.76 KGS SBILL NOS. DT. 5463509 21.10.2021 5463237 21.10.2021 FREIGHT PREPAID |
HS 616900 |
2021-11-17 |
32 PKG |
5208.24KG |
1X 40 REEFER PART OF FCL CONTA INER 32 PALLETS CONSISTING OF 1851 CARTONS PHARMACEUTICALS AS UNDER CARVEDILOL TABS 12. 5MG 100 S NDC CODE:6846201640 1 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST CARVEDILOL TABS 12.5MG 500 S NDC CODE:6 8462016405 FDA PRODUCT CODE N O : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78 -251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST T ELMISARTAN-HCTZ TABS 80MG/12.5 MG 30 S NDC CODE:68462084113 62 O D A 09 3004.90.92.20 2 02544 TELMISARTAN AND HYDROC HLOROTHIAZIDE TABLETS ARE IND ICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE. TELMISARTAN-HCTZ TA BS 80MG/25MG 30 S NDC CODE:68 462084213 62 O D A 09 3004.9 0.92.20 202544 TELMISARTAN A ND HYDROCHLOROTHIAZIDE TABLE TS ARE INDICATED FOR THE TREA TMENT OF HYPERTENSION, TO LOW ER BLOOD PRESSURE. EZETIMIBE -SIMVASTATIN TAB 10/20MG 30 S NDC CODE:68462032230 AMLODIP INE-OLMESARTAN TABS 5/20MG 90 S NDC CODE:68462056690 FDA P RODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90.92.20 ANDA NO.: 207807 THERAPEUTICE USE: MEDICATION USED TO TREA T HIGH BLOOD PRESSURE AND CO RONARY ARTERY DISEASE TACROLI MUS OINTMENT 0.1% 100GM NDC C ODE:68462053494 FDA PRODUCT C ODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO. : 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMU NOSUPPRESSIVE OINTMENT USED F OR THE TREATMENT OF MODERATE -TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PIMECROLIMUS CREAM 1% 100GM NDC CODE:6846206099 4 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90 .92.45 ANDA NO.: 211769 THER APEUTICE USE: - AS SECOUND-LI NE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC T RERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMU NOCOMPROMISED ADPREVENT REJEC TION OF A KIDNEY,HEART, OR LI VER TRANSPLANT ULT AND CHILD REN 2 YEARS OF AGE TACROLIMU S CAPSULES 1MG 100 S NDC CODE :68462068601 HTS NO: 3004.90. 92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC U SE : TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRA NSPLANT 02 DATA LOGGERS HUMI DITY:65% SET TEMPERATURE : +2 0 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES C OMMERCIAL & CUSTOM INVOICE NO. F22287001198 DT. 21.10.2021 F22287001199 DT. 21.10.2021 F22287001200 DT. 21.10.2021 F 22287001203 DT. 21.10.2021 TO TAL GR.WT: 5208.15KGS TOTAL N T.WT: 1731.97KGS 4016837 21/10/2021 4016840 21/10/2021 4016841 2 1/10/2021 4016838 21/1 0/2021 |
HS 300490 |
2021-11-17 |
8 PKG |
2090.64KG |
1X40 PART OF FCL REEFER 8 (EI GHT)PALLETS CONSISTING OF 1060 CARTONS PHARMACEUTICALS AS U NDER ROSUVASTATIN TABLETS 40M G 30 S NDC CODE:68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTER OL AND RELATED CONDITIONS , AND TO PREVENT CAR DIOVASCULAR DISEASE ROSUVASTATIN TABLETS 5MG 90 S NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO. : 079172 THERAPEUTICE USE : - TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIO NS, AND TO PREVENT C ARDIOVASCULAR DISEASE 08 DATA LOGGERS SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES COMME RCIAL & CUSTOM INVOIC E NO. F22287001173 DT. 18.10.2021 S BILL NO. 4016671 DT. 18/10/20 21 TOTAL GR.WT.: 2090.95KGS TOTAL NT.WT.:391.78KGS |
HS 611600 |
2021-11-17 |
9 PKG |
1659.27KG |
1X40 REEFER PART OF FCL CONTAI NER 9 PALLETS CONSISTING OF 3 48 CARTONS PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TABS 0.4MG 100 S NDC CODE:684 62063901 FDA PRODUCT CODE NO. : 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEUTICE USE: MEDICATIO N USED FOR HEART FAILURE, HIG H BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTENOUGH BLOOD FLOW TO THE HEART NITROGLYCERIN SUBLING T ABS 0.4MG 4X25 NDC CODE:68462 063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 30 04.90.9020 ANDA NO.:206391 T HERAPEUTIC USE: MEDICATION US ED FOR HEART FAILURE,HIGH BLO OD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEAR T NITROGLYCERIN SUBLING TABS 0.3MG 100 S NDC CODE:68462063 801 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004. 90.9020 ANDA NO.:206391 THER APEUTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PR EVENT CHEST PAIN FROM NOT ENO UGH BLOOD FLOW TO THE HEART APREPITANT CAPSULES 40MG 5UD NDC CODE:68462058385 FDA PROD UCT CODE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 AND A NO.:207777 THERAPEUTICE US E:APREPITANT IS USED WITH OTH ER MEDICATIONS TO HELP PREVEN T NAUSEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CH EMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSE A AND VOMITING AFTER SURGERY. A-EMETIC/NAUSEANT / HUMAN - RX/SINGLE INGREDIENT / DELAY ED RELEASE TABLETS / APREPIT ANT 09 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES COM MERCIAL & CUSTOM INVOICE NO. F22287001201 DT. 21.10.2021 F 22287001202 DT. 21.10.2021 TO TAL GR.WT.: 1659.31KGS TOTAL NT.WT: 113.27KGS SBILL NOS DT 4016836 21.1 0.2021 4016835 21.10.2 021 NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. AVENUE L EOPOLD-ROBERT 37 LA CHAUX-D E-FONDS - 2300 SWITZERLAND |
HS 662800 |
2021-11-17 |
28 PKG |
6393.49KG |
1 X 40 REEFER PART OF FCL 28( TWENTY EIGHT) PALLETS CONSISTI NG OF 1752 CARTONS PHARMACEUT ICALS AS UNDER PIMECROLIM US CREAM 1% 30GM NDC CODE:68 462060935 FDA PRODUCT CODE N O.: 61 S C J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CON TINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DE RMATITIS IN NONIMMUNOCOMPROM ISED ADULT AND CHILDREN 2 YEARS OF AGE TACROLIMUS O INTMENT 0.1% 100GM NDC CODE: 68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DER MATITIS (ECZEMA). PIMEC ROLIMUS CREAM 1% 60GM NDC CO DE:68462060965 FDA PRODUCT C ODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE US E: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NO N-CONTINUOS CHRONIC TRERTMEN T OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMUNOCO MPROMISED ADULT AND CHILDREN 2 YEARS OF AGE PIMECRO LIMUS CREAM 1% 100GM NDC COD E:68462060994 FDA PRODUCT CO DE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE : - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON -CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMUNOCOM PROMISED ADULT AND CHILDREN 2 YEARS OF AGE TACROLIM US CAPSULES 5MG 100 S NDC CO DE:68462068701 HTS NO: 3004. 90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPE UTICE USE: TO PREVENT REJECT ION OF A KIDNEY, HEART, OR LIVER TRANSPLANT NAPROXE N SODIUM TABLETS 550MG 100 S NDC CODE:68462017901 FDA PR ODUCT CODE NO.:-62 G C A 50 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-314 THERAPEU TICE USE:-ANTI INFLAMMATORY, ANALGESIC CARVEDILOL TAB S 12.5MG 500 S NDC CODE:6846 2016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-B ETA- ADRENOACEPTOR ANTAGON IST PRAVASTATIN SODIUM TAB 1 0MG 90 S NDC CODE:6846201959 0 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 300 4.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPD AEMIC 12 DATA LOGGERS S ET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES SBILL NO. DT. 4016667 18/10/2 021 4016657 18/10/2021 4016659 18/10/2021 4016 661 18/10/2021 4016666 18/10/2021 4016664 18/10/2021 4016665 18/10 /2021 COMMERCIAL & CUSTOM INV OICE NO. F22287001082 DT. 30. 09.2021 F22287001166 DT. 18.1 0.2021 F22287001167 DT. 18.10 .2021 F22287001168 DT. 18.10. 2021 F22287001170 DT. 18.10.2 021 F22287001171 DT. 18.10.20 21 F22287001172 DT. 18.10.202 1 TOTAL GR.WT.: 6393.68KGS TOTAL NT.WT.:3265.63KGS |
HS 300490 |
2017-11-06 |
116 CTN |
908.11KG |
(116 CARTONS PKED IN 5 PKGS) PHARMACEUTICALS AS UNDER ---- ----------------------------- ROSUVASTATIN CALCIUM TABLETS 10MG 90 S NDC CODE:6846202629 0 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00 .10 ANDA NO.: 079172 THERAPE UTICE USE: - TO TREAT HIGH CHO LESTEROL AND RELATED CONDITIO NS, AND TO PREVENT CARDIOVASCU LAR DISEASE ----------------- ------------------- CUSTOM IN VOICE NO. 2157205729 DT. 08.1 0.2017 TOTAL NET WT.: 625.0 50 KGS. S.B.NO: 9181539 DTD .09.10.2017 FREIGHT PREPAID HUMIDITY-65% TEMPERATURE / STORAGE CONDITION:18 DEGREE CE LCIUS 5 WORKING DAYS FREE AT NEW YORK TERMINAL SHIPPING MARKS MANUFACTURED FOR GLENM ARK PHARMACEUTICALS INC., USA 301, ISLAND RD MAHWAH |
HS 611600 |
2017-10-30 |
321 CTN |
2134.64KG |
(321 CARTONS PKED IN 13 PKGS) PHARMACEUTICALS AS UNDER --- ------------------------------ -------- FLUOCINONIDE CREAM U SP, 0.1% 120GM US NDC CODE:68 462050566 FDA PRODUCT CODE NO .: 64 L C L 28 H. T. S NO.: 3 004.32.00.00 ANDA NO.: 91-282 THERAPEUTICE USE: - INDICATE D FOR THE RELIEF OF VARIOUS I NFLAMMATORY AND PRURITIC MANIF ESTATIONS OF CORTICOSTEROID R ESPONSIVE DERMATOSES IN PATIEN TS ALCLOMETASONE DIP CREAM 0.05% 60GM NDC CODE:684620300 65 FDA PRODUCT CODE NO.:62 B C J 10 H. T. S NO.:3004.49.00 .50 ANDA NO.:79-061 THERAPEU TICE USE:INDICATED FOR THE REL IEF OF THE INFLAMMATORY AND P RURITIC MANIFESTATIONS OF COR TICOSTEROID-RESPONSIVE DERMATO SES. DESOXIMETASONE OINTMEN T USP,0.25% 60G NDC CODE:6846 2053165 FDA PRODUCT CODE NO.: 62 G C J 17 H. T. S NO.:3004. 39.0050 ANDA NO.:202838 THER APEUTICE USE: FOR THE RELIEF O F VARIOUS INFLAMMATORY SKIN C ONDITIONS, INCLUDING RASHES BETAMETHASONE DIP AUGM CREAM 0.05% 50GM NDC CODE:684620290 52 FDA PRODUCT CODE NO.:64 L C J 06 H. T. S NO.: 3004.90.9 2.45 ANDA NO.:78-930 THERAPE UTICE USE: DERMALOGIC USE --- ------------------------------ ------------ CUSTOM INVOICE N O. 2155700599 DT. 22.09.2017 2155700600 DT. 22.09.2017 21 55700601 DT. 22.09.2017 21557 00603 DT. 22.09.2017 TOTAL NET WT.: 1350.508 KGS. S.B. NO:8984869,8984798,8984878 DT: 28.09.2017 8998161 DT:29.09.2 017 FREIGHT PREPAID HUMIDI TY-65% TEMPERATURE / STORAGE CONDITION:18 DEGREE CELCIUS 5 WORKING DAYS FREE AT NEW YORK TERMINAL SHIPPING MARKS M ANUFACTURED FOR GLENMARK PHAR MACEUTICALS INC., USA 301, IS LAND RD MAHWAH |
HS 642800 |
2017-10-30 |
552 CTN |
3610.66KG |
(552 CARTONS PKED IN 27 PKGS) PHARMACEUTICALS AS UNDER --- ------------------------------ ----------- ATOVAQUONE&PROGUA NIL TAB 250/100 MG 100S NDC C ODE:68462040401 FDA PRODUCT C ODE NO.:62 L D A 44 H. T. S N O.:3004.90.92.90 ANDA NO.: 91 -211 THERAPEUTICE USE: - ANTI MALARIAL LEVOCETIRIZINE DI HY TABS 5MG 90 S NDC CODE:684 62034690 FDA PRODUCT CODE NO. : 61 X C A 51 H. T. S NO.: 30 04.90.91.80 ANDA NO.:90385 T HERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPATHIC URTICARIA RIZATRIPTAN BENZOATE ODT TAB S 10 MG NDC CODE:68462046806 FDA PRODUCT CODE NO.: 60 L C A 87 H. T. S NO.: 3004.90.92. 28 ANDA NO.:201914 THERAPEUT ICE USE: -ANALGESIC/ HUMAN -RX /SINGLE INGREDIENT /PROMPTRELE ASE TABLETS /RIZATRIPTAN BEN ZOATE (ANALGESIC) NAPROXEN TABLETS USP 500 MG 500 S NDC CODE:68462019005 FDA PRODUCT CODENO.:-62 G C A 49 H. T. S NO.:3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC ----- ------------------------------ ------ CUSTOM INVOICE NO. 21 57205641 DT. 28.09.2017 21572 05642 DT. 28.09.2017 TOTAL NET WT: 2654.320 KGS. S.B.N O:9011087, 9011933 DT:29.09.20 17 FREIGHT PREPAID HUMIDIT Y-65% TEMPERATURE / STORAGE C ONDITION:18 DEGREE CELCIUS 5 WORKING DAYS FREE AT NEW YORK TERMINAL SHIPPING MARKS MA NUFACTURED FOR GLENMARK PHARM ACEUTIC ALS INC., USA 301, IS LAND RD MAHWAH |
HS 615100 |
2017-10-30 |
773 CTN |
6527.3KG |
(773 CARTONS PKED IN 32 PKGS) PHARMACEUTICALS AS UNDER --- ------------------------------ -------- MUPIROCIN OINTMENT 2 % 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.:61 G J J 81 H. T. S NO.:3004.90.92.45 ANDA NO.: 90-480 THERAPEUTIC E USE: -ANTI-BACTERIAL CARV EDILOL TABS USP 6.25MG 500 S NDC CODE:68462016305 FDA PROD UCT CODE NO :62 O C A 22 H. T . S NO.:3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE:- BETA-ADRENOACEPTORANTAGONIST FLUCONAZOLE TABLETS USP 100M G 30 S NDC CODE:68462010230 FDA PRODUCT CODE NO :61 W C A 45 H. T. S NO.:3004.90.92.45 ANDA NO.:-77 - 253 THERAPEUT ICE USE:-ANTIFUNGAL PRAMIPE XOLE TABS 0.125MG 90 S NDC CO DE:68462033090 FDA PRODUCT CO DE NO.:62 J C A 15 H. T. S NO .:3004.90.92.40 ANDA NO.: 90- 781 THERAPEUTICE USE: USED IN PARKINSONS DISEASE ACAMPRO SATE CALCIUM DR TABS 333MG180 S NDC CODE:68462043518 FDA P RODUCT CODE NO.:60 T C C 99 H . T. S NO.:3004.90.92.40 ANDA NO.:202229 THERAPEUTICE USE: - FORTREATING ALCOHOL DEPENDE NCE NORGESTIMATE/EE TABLETS (TRI-CYCLEN LO) NDC CODE:684 62071929 FDA PRODUCT CODE NO. :65 J D A 27 H. T. S NO.:3006 .60.00.00 ANDA NO.: 204057 T HERAPEUTICE USE: - ORAL CONTRA CEPTIVES -------------------- ------------- CUSTOM INVOICE NO. 2157205699 DT. 30.09.2017 2157205714 DT. 06.10.2017 2 157205715 DT. 06.10.2017 2156 700728 DT. 30.09.2017 TOTAL NET WT.:4642.830 KGS. FREI GHT PREPAID HUMIDITY-65% TEM PERATURE / STORAGE CONDITION:1 8 DEGREE CELCIUS 5 WORKING DA YS FREE AT PHILADELPHIA TERMIN AL SHIPPING MARKS MANUFACT URED FOR GLENMARK PHARMACEUTI CALS INC., USA 301, ISLAND RD MAHWAH |
HS 618100 |
2017-10-30 |
725 CTN |
5976.18KG |
(725 CARTONS PKED IN 40 PKGS) PHARMACEUTICALS AS UNDER --- ------------------------------ ------ ATOVAQUONE&PROGUANIL T AB 250/100 MG 24S NDC CODE:68 462040467 FDA PRODUCT CODE NO .:62 L D A 44 H. T. S NO.:300 4.90.92.90 ANDA NO.: 91-211 THERAPEUTICE USE: - ANTI MALAR IAL PRAMIPEXOLE TABS 0.5MG 90 S NDC CODE:68462033290 FD A PRODUCT CODE NO.:62 J C A 15 H. T. S NO.:3004.90.92.40 A NDA NO.: 90-781 THERAPEUTICE USE: USED IN PARKINSONS DISEAS E RIZATRIPTAN BENZOATE ODT TABS 10 MG 18 S NDC CODE:6846 2046806 FDA PRODUCT CODE NO.: 60 L C A 87 H. T. S NO.:3004. 90.92.28 ANDA NO.:201914 THE RAPEUTICE USE: -ANALGESIC/ HUM AN - RX/SINGLE INGREDIENT /PR OMPT RELEASE TABLETS / RIZATR IPTAN BENZOATE (ANALGESIC) TELMISARTAN TABLETS USP 40 MG 30 S NDC CODE:68462020013 FD A PRODUCT CODE NO.:62 O C A 09 H. T. S NO.:3004.90.92.20 A NDA NO.: 090032 THERAPEUTICE USE: -INDICATED FOR THE TREAT MENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE NAPROXEN TA BLETS USP 500 MG 100 S NDC CO DE:68462019001 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S N O.: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC MUP IROCIN OINTMENT 2% 22GM NDC C ODE:68462018022 FDA PRODUCT C ODE NO.:61 G J J 81 H. T. S N O.:3004.90.92.45 ANDA NO.: 90 -480 THERAPEUTICE USE: -ANTI- BACTERIAL ------------------- -------------- CUSTOM INVOICE NO. 2157205695 DT. 30.09.201 7 2157205696 DT. 30.09.2017 TOTAL NET WT.:4274.460 KGS. SBILL NO.9061078 DTD.04.10. 2017 & 9086575 DTD.05.10.2017 FREIGHT PREPAID HUMIDITY-6 5% TEMPERATURE / STORAGE COND ITION:18 DEGREE CELCIUS 5 WOR KING DAYS FREE AT NEW YORK T ERMINAL SHIPPING MARKS MAN UFACTURED FOR GLENMARK PHARMA CEUTICALS INC., USA 301, ISLA ND RD MAHWAH |
HS 624400 |
2017-10-23 |
1072 CTN |
7023.54KG |
(1072 CARTNS PKED IN 40 PKGS) PHARMACEUTICALS AS UNDER -- ------------------------------ ------ ONDANSETRON ODT USP 4M G (10 SX3) NDC CODE:684620157 13 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO.: 3004.90. 92.40 ANDA NO.:-78-152 THERA PEUTICE USE:-ANTI- EMETIC V ERAPAMIL HCL ER TABS USP 120MG 100S NDC CODE:68462029201 F DA PRODUCT CODE NO.:62 O C B 1 3 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTIC E USE: - ANGINA OMEPRAZOLE DR CAPSULES USP 20 MG 90 S ND C CODE:68462039690 FDA PRODUC T CODE NO.:62KCF10 H. T. S NO .:3004.90.9160 ANDA NO.: 9167 2 THERAPEUTICE USE: -TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE --------------- ------------------- CUSTOM IN VOICE NO. 2157205597 DT. 24.0 9.2017 2157205596 DT. 24.09.2 017 TOTAL NET WT.:4799.560 KGS. SBILL NO.8886810 DTD.2 5.09.2017 & 8886806 DTD.25.09 .2017 FREIGHT PREPAID HUMI DITY-65% TEMPERATURE / STORAG E CONDITION:18 DEGREE CELCIUS 5 WORKING DAYS FREE AT NEW Y ORK TERMINAL SHIPPING MARKS MANUFACTURED FOR GLENMARK P HARMACEUTICALS INC., USA 301, ISLAND RD MAHWAH |
HS 612600 |
2017-10-13 |
966 CTN |
6376.26KG |
(966 CARTONS PKED IN 40 PKGS) PHARMACEUTICALS AS UNDER --- ------------------------------ ------ ONDANSETRON ODT USP 4M G (10 SX3) NDC CODE:684620157 13 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO.: 3004.90. 92.40 ANDA NO.:-78-152 THERA PEUTICE USE:-ANTI EMETIC MU PIROCIN OINTMENT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - A NTI-BACTERIAL TOPIRAMATE TA BLETS USP 50 MG 60 S NDC CODE :68462015360 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:- 77 -627 THERAPEUTICE USE:-ANTICO NVULSANT -------------------- -------------------- CUSTOM I NVOICE NO. 2157205578 DT. 22. 09.2017 2157205579 DT. 22.09. 2017 TOTAL NET WT.:4233.730 KGS S/B NO.8836185 & 8834172 DT.22.09.2017 FREIGHT PRE PAID HUMIDITY-65% TEMPERATUR E / STORAGE CONDITION:18 DEGRE E CELCIUS 5 WORKING DAYS FREE AT PHILADELPHIA TERMINAL S HIPPING MARKS MANUFACTURED FO R GLENMARK PHARMACEUTICALS IN C., USA 301, ISLAND RD MAHWA H |
HS 612600 |
2017-03-20 |
759 CTN |
6747.75KG |
(759 CARTONS PKED IN 40 PKGS) PHARMACEUTICALS AS UNDER --- ------------------------------ ------------------------------ -- POTASSIUM CL ER CAPS(750MG )10MEQ K 100 S NDC CODE:68462 035701 FDA PRODUCT CODENO.:65 R C F 14 H. T. S NO.:3004.90 .9190 ANDA NO.:202868 THERAP EUTICE USE: -TREATMENT OR PREV ENTION OF HYPOKALEMIA PRAV ASTATIN SODIUM TAB USP 10MG 90 S NDC CODE:68462019590 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.:-3004 90 91 20 A NDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEMIC PRAVASTA TIN SODIUM TABLETS 20MG 90 S NDC CODE:68462019690 FDA PROD UCT CODE NO.:-61 J C A 13 H. T. S NO.:-3004 90 91 20 ANDA NO.:-77-987 THERAPEUTICE USE: -HYPOLIPDAEMIC PRAVASTATIN SODIUM TABLETS 20MG 500 S NDC CODE:68462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.:-3004 90 91 20 ANDA NO. :-77-987 THERAPEUTICE USE:-HY POLIPDAEMIC --------------- ------------------------------ ---------- COMMERCIAL INVOICE NO. 2169460122 DT. 22.02.201 7 2169460123 DT. 23.02.2017 2169460132 DT. 24.02.2017 C USTOM INVOICE NO. 2171701000 DT. 22.02.2017 2171701008 DT. 23.02.2017 2171701009 DT. 24 .02.2017 TOTAL NET WT.:1194 .112 KGS SBILL NO.0002343 DT D.25.02.2017 , 0002345 DTD.25. 02.2017 & 0002344 DTD.25.02. 2017. FREIGHT PREPAID 4 WOR KING DAYS FREE AT PHILADELPHIA TERMINAL HUMIDITY-65% SHIPPING MARKS MANUFACTURE D FOR GLENMARK PHARMACEUTICA LS INC 750 CORPORATE DRIVE M AHWAH, NEW JERSEY 07430 USA |
HS 611300 |
2017-02-27 |
649 CTN |
5674.08KG |
(649 CARTONS PKED IN 36 PKGS) PHARMACEUTICALS AS UNDER --- ------------------------------ ------------------- PRAVASTAT IN SODIUM TABLETS 20MG 500 S NDC CODE:68462019605 FDA PROD UCT CODE NO.:-61 J C A 13 H. T. S NO.:-3004 90 91 20 ANDA NO.:-77-987 THERAPEUTICE USE: -HYPOLIPDAEMIC POTASSIUM CL ER CAPS(750MG)10MEQ K 100 S NDC CODE:68462035701 FDA PROD UCT CODE NO.:65 R C F 14 H. T . S NO.: 3004.90.9190 ANDA NO .:202868 THERAPEUTICE USE: -T REATMENT OR PREVENTION OF HYPO KALEMIA --------------------- ------------------------ COMM ERCIAL INVOICE NO. 2169459881 DT. 31.01.2017 2169459874 DT . 31.01.2017 2169459875 DT. 3 1.01.2017 CUSTOM INVOICE NO . 2171700963 DT. 31.01.2017 2171700970 DT. 31.01.2017 217 1700971 DT. 31.01.2017 TOTA L NET WT.:1809.528 KGS. SBILL NO.0001334 , 0001335 & 000133 6 DTD.02.02.2017 FREIGHT PREP AID HUMIDITY-65% TEMPERATURE / STORAGE CONDITION:18 DEGREE CELCIUS 5 WORKING DAYS FREE AT PHILADELPHIA TERMINAL SH IPPING MARKS MANUFACTURED FOR GLENMARK PHARMACEUTICALS IN C 750 CORPORATE DRIVE MAHWAH , NEW JERSEY 07430 USA |
HS 611300 |
2017-01-09 |
721 CTN |
6743.22KG |
(721 CARTONS PKED IN 42 PKGS) PHARMACEUTICALS AS UNDER --- ------------------------------ ------------- PRAVASTATIN SOD IUM TABLETS 20MG 90 S NDC COD E:68462019690 FDA PRODUCT COD E NO.:-61 J C A 13 H. T. S NO .:-3004 90 91 20 ANDA NO.:-77 -987 THERAPEUTICE USE:-HYPOLI PDAEMIC PRAVASTATIN SODIUM TABLETS 20MG 500 S NDC CODE:6 8462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: -3004 90 91 20 ANDA NO.:-77-9 87 THERAPEUTICE USE:-HYPOLIPD AEMIC POTASSIUM CL ER CAPS( 750MG)10MEQ K 100 S NDC CODE: 68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.9190 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA 2 DATA LOGGER ------------ ------------------------------ ---------------- COMMERCIAL I NVOICE NO. 2169458997 DT. 12. 12.2016 CUSTOM INVOICE NO. 2171700862 2171700863 DT. 12. 12.2016 TOTAL NET WT.: 2174 .076 KGS. FREIGHT PREPAID HUMIDITY-65% TEMPERATURE / ST ORAGE CONDITION:18 DEGREE CELC IUS 5 WORKING DAYS FREE AT PH ILADELPHIA TERMINAL S.B.NO: 0013888 & 0013890 DT:13.12.20 16 SHIPPING MARKS MANUFACT URED FOR GLENMARK PHARMACEUT ICALS INC 750 CORPORATE DRIVE MAHWAH, NEW JERSEY 07430 U SA |
HS 611300 |
2016-12-28 |
688 CTN |
6741.4KG |
(688 CARTONS PKED IN 41 PKGS) PHARMACEUTICALS AS UNDER -- ------------------------------ ----------------- POTASSIUM C L ER CAPS(750MG)10MEQ K 100 S NDC CODE:68462035701 FDA PRO DUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.9190 ANDA N O.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HY POKALEMIA POTASSIUM CL ER C APS(750MG)10MEQ K 500 S NDC C ODE:68462035705 FDA PRODUCT C ODE NO.:65 R C F 14 H. T. S N O.:3004.90.9190 ANDA NO.:2028 68 THERAPEUTICE USE: -TREATME NT OR PREVENTION OFHYPOKALEMIA RALOXIFENE TABLETS 60MG 10 0 S NDC CODE:68462039301 FDA PRODUCT CODE NO.:63 A C A 06 H. T. S NO.: 3004.90.9190 AN DA NO.:204491 THERAPEUTICE US E: - USED FOR THE TREATMENT A ND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN PRA VASTATIN SODIUM TAB USP 10MG 5 00 S NDC CODE:68462019505 FD A PRODUCT CODE NO.:-61 J C A 1 3 H. T. S NO.:-3004 90 91 20 ANDA NO.:-77-987 THERAPEUTIC E USE:-HYPOLIPDAEMIC PRAVAS TATIN SODIUM TABLETS 20MG 90 S NDC CODE:68462019690 FDA PR ODUCT CODE NO.:-61 J C A 13 H . T. S NO.:-3004 90 91 20 AND A NO.:-77-987 THERAPEUTICE US E:-HYPOLIPDAEMIC PRAVASTATI N SODIUM TABLETS 20MG 500 S N DC CODE:68462019605 FDA PRODU CT CODE NO.:-61 J C A 13 H. T . S NO.:-3004 90 91 20 ANDA N O.:-77-987 THERAPEUTICE USE:- HYPOLIPDAEMIC --------------- ------------------------------ ------------ COMMERCIAL INVOI CE NO. 2169458963 DT. 30.11.2 016 2169458964 DT. 30.11.2016 CUSTOM INVOICE NO. 217170 0849 DT. 30.11.2016 217170084 8 DT. 30.11.2016 TOTAL NET WT.: 2542.820 KGS. FREIGHT PREPAID HUMIDITY-65% TEMPERA TURE / STORAGE CONDITION:18 DE GREE CELCIUS 5 WORKING DAYS F REE AT PHILADELPHIA TERMINAL S.B. NO.0013502 & 0013503 DT .01.12.2016 SHIPPING MARKS MANUFACTURED FOR GLENMARK P HARMACEUTICALS INC 750 CORPOR ATE DRIVE MAHWAH, NEW JERSEY 07430 USA |
HS 651400 |
total import quantity of GLENMARK PHARMACEUTICALS INC US
| Imports in 2021 |
|---|
 53198 KG |
 250 CTNS
|
 14 orders
|
Imports / year in kg
GLENMARK PHARMACEUTICALS INC US supplier cooperation insights
GLENMARK PHARMACEUTICALS LTD
#1 supplier
GLENMARK PHARMACEUTICALS INC US
glenmark pharmaceuticals ltd is the major supplier of glenmark pharmaceuticals inc us
glenmark pharmaceuticals ltd support from india. Their major products are PHARMACEUTICALS, PHARMA, PHARMACEUTICAL . glenmark pharmaceuticals inc us gets its from glenmark pharmaceuticals ltd.
Address:
- plot no s-7 colvale industrial est colvale bardez - 403513 goa india gst no : 30aaacg2207l1z5
- We don't have this supplier's contact information.
You might find it on Google.
Summary of glenmark pharmaceuticals inc us and glenmark pharmaceuticals ltd's cooperation.
Between 2014 and 2017, glenmark pharmaceuticals inc us ordered 14 shipments from glenmark pharmaceuticals ltd.
In 2014, glenmark pharmaceuticals inc us made up 0% of glenmark pharmaceuticals ltd's sales to USA. This number went to 0% by 2015 and 1% in 2016. In 2017, glenmark pharmaceuticals inc us made up 25% of glenmark pharmaceuticals ltd’s sales to USA
glenmark pharmaceuticals ltd products
-
1.PHARMACEUTICALS
-
2.PHARMA
-
3.PHARMACEUTICAL
glenmark pharmaceuticals inc us ordered
Total trades among the two parties
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 1 | 10 | 0 | 0 | 0 | 14 | 452 | 339 | 68 | 0 |